Psyllid ID: psy1096
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | 2.2.26 [Sep-21-2011] | |||||||
| P11799 | 1906 | Myosin light chain kinase | yes | N/A | 0.845 | 0.105 | 0.520 | 3e-57 | |
| Q15746 | 1914 | Myosin light chain kinase | yes | N/A | 0.828 | 0.103 | 0.511 | 2e-54 | |
| Q28824 | 1176 | Myosin light chain kinase | yes | N/A | 0.828 | 0.168 | 0.511 | 2e-54 | |
| Q6PDN3 | 1941 | Myosin light chain kinase | yes | N/A | 0.828 | 0.102 | 0.511 | 3e-54 | |
| P29294 | 1147 | Myosin light chain kinase | yes | N/A | 0.828 | 0.172 | 0.507 | 9e-54 | |
| O02827 | 438 | Myosin light chain kinase | N/A | N/A | 0.828 | 0.452 | 0.497 | 6e-53 | |
| Q8VCR8 | 613 | Myosin light chain kinase | no | N/A | 0.715 | 0.278 | 0.479 | 7e-47 | |
| P20689 | 610 | Myosin light chain kinase | yes | N/A | 0.715 | 0.280 | 0.473 | 1e-46 | |
| Q3UIZ8 | 795 | Myosin light chain kinase | no | N/A | 0.736 | 0.221 | 0.505 | 2e-46 | |
| E9PT87 | 786 | Myosin light chain kinase | no | N/A | 0.732 | 0.222 | 0.513 | 2e-46 |
| >sp|P11799|MYLK_CHICK Myosin light chain kinase, smooth muscle OS=Gallus gallus PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 221 bits (564), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 112/215 (52%), Positives = 149/215 (69%), Gaps = 13/215 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+EM +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1526 VLEMVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1585
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG E+DMWSIGVI Y+L+S
Sbjct: 1586 TGTSIKLIDFGLARRLESAGSLKVLFGTPEFVAPEVINYEPIGYETDMWSIGVICYILVS 1645
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1646 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKSRLNCTQCLQH 1705
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSRH 239
W+ QKD+ K +S D++KKY+ RRKWQ + H
Sbjct: 1706 PWL-QKDTKNMEAKKLSKDRMKKYMARRKWQKTGH 1739
|
Phosphorylates a specific serine in the N-terminus of a myosin light chain, which leads to the formation of calmodulin/MLCK signal transduction complexes which allow selective transduction of calcium signals. Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 8 |
| >sp|Q15746|MYLK_HUMAN Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 108/211 (51%), Positives = 145/211 (68%), Gaps = 13/211 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1537 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1596
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1597 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1656
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1657 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 1716
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1717 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1746
|
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus GN=MYLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 108/211 (51%), Positives = 145/211 (68%), Gaps = 13/211 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 798 VLEIVSGGELFERIIDEDFELTERECIKYMKQISEGVEYIHKQGIVHLDLKPENIMCVNK 857
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 858 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 917
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 918 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLNCTQCLQH 977
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 978 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1007
|
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|Q6PDN3|MYLK_MOUSE Myosin light chain kinase, smooth muscle OS=Mus musculus GN=Mylk PE=1 SV=3 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 108/211 (51%), Positives = 145/211 (68%), Gaps = 13/211 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1559 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1618
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1619 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1678
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1679 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 1738
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1739 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1768
|
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus GN=MYLK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 107/211 (50%), Positives = 144/211 (68%), Gaps = 13/211 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 769 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 828
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPI +DMWSIGVI Y+L+S
Sbjct: 829 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPISYATDMWSIGVICYILVS 888
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 889 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 948
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 949 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 978
|
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|O02827|MYLK_SHEEP Myosin light chain kinase, smooth muscle (Fragment) OS=Ovis aries GN=MYLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (526), Expect = 6e-53, Method: Compositional matrix adjust.
Identities = 105/211 (49%), Positives = 142/211 (67%), Gaps = 13/211 (6%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 59 VLEIVSGGELFERIIDEDFELTERECIKYMKQISEGVEYIHKQGIVHLDLKPENIMCVNK 118
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 119 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 178
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T A +DFDDEAF+ +S+DAKDFIS+LL K + RL QCL H
Sbjct: 179 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDIKNRLNCTQCLQH 238
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ + K +S ++KKY+ RRKWQ
Sbjct: 239 PWLXXXTKNMEAKK-LSKHRMKKYMARRKWQ 268
|
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Ovis aries (taxid: 9940) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|Q8VCR8|MYLK2_MOUSE Myosin light chain kinase 2, skeletal/cardiac muscle OS=Mus musculus GN=Mylk2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 7e-47, Method: Compositional matrix adjust.
Identities = 83/173 (47%), Positives = 128/173 (73%), Gaps = 2/173 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H + + + PENI+CV+ T H +KIIDFGLA++ NP+ +V FGTPEF+ PE++NY+
Sbjct: 415 HKMRVLHLDLKPENILCVNTTGHLVKIIDFGLARRYNPNEKLKVNFGTPEFLSPEVVNYD 474
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
I ++DMWS+GVITY+LLSGLSPF+G++D+ET N+ A + FD+E FEA+S++AKDF+
Sbjct: 475 QISDKTDMWSLGVITYMLLSGLSPFLGDDDTETLNNVLSANWYFDEETFEAVSDEAKDFV 534
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQ-KDSSPGVNKIISTD-KLKKYIYRRKWQ 235
S+LL K + R++A+QCL+H W+ + + N+ + + LKKY+ +R+W+
Sbjct: 535 SNLLTKDQSARMSAEQCLAHPWLNNLAEKAKRCNRRLKSQILLKKYLMKRRWK 587
|
Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|P20689|MYLK2_RAT Myosin light chain kinase 2, skeletal/cardiac muscle OS=Rattus norvegicus GN=Mylk2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 82/173 (47%), Positives = 128/173 (73%), Gaps = 2/173 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H + + + PENI+CV+ T H +KIIDFGLA++ NP+ +V FGTPEF+ PE++NY+
Sbjct: 412 HKMRVLHLDLKPENILCVNTTGHLVKIIDFGLARRYNPNEKLKVNFGTPEFLSPEVVNYD 471
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
I ++DMWS+GVITY+LLSGLSPF+G++D+ET N+ A + FD+E FEA+S++AKDF+
Sbjct: 472 QISDKTDMWSLGVITYMLLSGLSPFLGDDDTETLNNVLSANWYFDEETFEAVSDEAKDFV 531
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQ-KDSSPGVNKIISTD-KLKKYIYRRKWQ 235
S+L+ K + R++A+QCL+H W+ + + N+ + + LKKY+ +R+W+
Sbjct: 532 SNLITKDQSARMSAEQCLAHPWLNNLAEKAKRCNRRLKSQILLKKYLMKRRWK 584
|
Implicated in the level of global muscle contraction and cardiac function (By similarity). Phosphorylates a specific serine in the N-terminus of a myosin light chain. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|Q3UIZ8|MYLK3_MOUSE Myosin light chain kinase 3 OS=Mus musculus GN=Mylk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 91/180 (50%), Positives = 125/180 (69%), Gaps = 4/180 (2%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
L H ++ +D K PENI+CVS+T H IKIIDFGLA++ P +V FGTPEF+ PE++
Sbjct: 603 LHQHYILHLDLK--PENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 660
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
NYE + +DMWS+GVITY+LLSGLSPF+GE D+ET I +DFD + F+ LSE+AK
Sbjct: 661 NYEFVSFPTDMWSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFKGLSEEAK 720
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKDS-SPGVN-KIISTDKLKKYIYRRKWQFSRH 239
DF+S LLVK K R++A QCL H W++ + + G N ++ S L+KY+ + KW+ H
Sbjct: 721 DFVSRLLVKEKSCRMSATQCLKHEWLSHLPAKASGSNVRLRSQQLLQKYMAQSKWKKHFH 780
|
May play a role in smooth muscle contraction. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
| >sp|E9PT87|MYLK3_RAT Myosin light chain kinase 3 OS=Rattus norvegicus GN=Mylk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 93/181 (51%), Positives = 124/181 (68%), Gaps = 6/181 (3%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
L H ++ +D K PENI+CVS+T H IKIIDFGLA++ P +V FGTPEF+ PE++
Sbjct: 594 LHQHYILHLDLK--PENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 651
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
NYE + +DMWS+GVITY+LLSGLSPF+GE D+ET I +DFD + F+ LSE+AK
Sbjct: 652 NYEFVSFPTDMWSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFKGLSEEAK 711
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSSPGVNKIISTDKLKKYIYRRKWQFSR 238
DF+S LLVK K R++A QCL H W+ K S V ++ S L+KY+ +RKW+
Sbjct: 712 DFVSRLLVKEKSCRMSATQCLKHEWLNHLIAKASGSNV-RLRSQLLLQKYMAQRKWKKHF 770
Query: 239 H 239
H
Sbjct: 771 H 771
|
Calmodulin-dependent kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes. Increases cardiomyocyte contractility. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 8 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | ||||||
| 328705497 | 6908 | PREDICTED: hypothetical protein LOC10015 | 0.711 | 0.024 | 0.725 | 2e-68 | |
| 242022544 | 6699 | myosin light chain kinase, putative [Ped | 0.711 | 0.025 | 0.708 | 4e-68 | |
| 270003693 | 11744 | hypothetical protein TcasGA2_TC002962 [T | 0.707 | 0.014 | 0.695 | 4e-66 | |
| 350422387 | 10117 | PREDICTED: hypothetical protein LOC10074 | 0.711 | 0.016 | 0.68 | 9e-66 | |
| 307204648 | 9315 | Myosin light chain kinase, smooth muscle | 0.715 | 0.018 | 0.666 | 2e-65 | |
| 345496511 | 1391 | PREDICTED: hypothetical protein LOC10011 | 0.719 | 0.123 | 0.672 | 2e-64 | |
| 442623877 | 7905 | Stretchin-Mlck, isoform T [Drosophila me | 0.707 | 0.021 | 0.678 | 2e-64 | |
| 442623875 | 8216 | Stretchin-Mlck, isoform S [Drosophila me | 0.707 | 0.020 | 0.678 | 2e-64 | |
| 442623879 | 8255 | Stretchin-Mlck, isoform U [Drosophila me | 0.707 | 0.020 | 0.678 | 2e-64 | |
| 442623881 | 7944 | Stretchin-Mlck, isoform V [Drosophila me | 0.707 | 0.021 | 0.678 | 3e-64 |
| >gi|328705497|ref|XP_001948683.2| PREDICTED: hypothetical protein LOC100159331 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 264 bits (675), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 124/171 (72%), Positives = 142/171 (83%), Gaps = 1/171 (0%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H V + PENIMC SRTSH +K+IDFGLAQKI P P RVLFGTPEFIPPEII YE
Sbjct: 6425 HKQNVVHLDLKPENIMCQSRTSHSVKLIDFGLAQKIVPGQPMRVLFGTPEFIPPEIIGYE 6484
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG+ESDMWS+GVI YVLLSGLSPFMG+ND ETF NIT+AEFDFDDEAF+A+S+DAKDFI
Sbjct: 6485 PIGLESDMWSVGVICYVLLSGLSPFMGDNDPETFTNITKAEFDFDDEAFDAVSQDAKDFI 6544
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
S+LL+KRKE RLTA++CL H W+AQ+D I+STDKLKK+I RRKWQ
Sbjct: 6545 SALLIKRKELRLTARECLKHKWLAQQDMDMSC-VILSTDKLKKFIIRRKWQ 6594
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242022544|ref|XP_002431700.1| myosin light chain kinase, putative [Pediculus humanus corporis] gi|212517008|gb|EEB18962.1| myosin light chain kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 263 bits (673), Expect = 4e-68, Method: Compositional matrix adjust.
Identities = 124/175 (70%), Positives = 151/175 (86%), Gaps = 5/175 (2%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
+ +++V +D K PENIMC SRTSH IK+IDFGLAQK++P+ P RVLFGTPEF+PPEII
Sbjct: 6187 MHKNNIVHLDLK--PENIMCQSRTSHEIKLIDFGLAQKLDPNTPVRVLFGTPEFVPPEII 6244
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
NYEPIG+E+DMWS+GVI YVLLSGLSPFMGEND+ETFANITRA FDFDDEAF+A+S+DAK
Sbjct: 6245 NYEPIGLETDMWSVGVICYVLLSGLSPFMGENDAETFANITRATFDFDDEAFDAISQDAK 6304
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLW-IAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
DFIS L+VKRKEKRLTA +CL + W +++ D + V ++STDKLKK+I RRKWQ
Sbjct: 6305 DFISMLIVKRKEKRLTASECLKNKWMMSEHDKTMKV--VLSTDKLKKFIIRRKWQ 6357
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270003693|gb|EFA00141.1| hypothetical protein TcasGA2_TC002962 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 4e-66, Method: Composition-based stats.
Identities = 119/171 (69%), Positives = 145/171 (84%), Gaps = 2/171 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
HS V + PENIMC +RTSH IKIIDFGLAQK+NPD P RVLFGTPEFIPPEIINYE
Sbjct: 11193 HSQNIVHLDLKPENIMCHTRTSHEIKIIDFGLAQKLNPDKPIRVLFGTPEFIPPEIINYE 11252
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG+ESDMWS+GVI YVLLSGLSPFMG+ND+ETFANITRA++DF+DEAF +S++A+DFI
Sbjct: 11253 PIGVESDMWSLGVICYVLLSGLSPFMGDNDAETFANITRADYDFEDEAFNTVSQNARDFI 11312
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
++LL+KR+E RL+A+QCL H+W+ + V ++STDKLKK+I RRKWQ
Sbjct: 11313 AALLLKRREDRLSAEQCLKHIWLDPESHKNTV--VLSTDKLKKFIIRRKWQ 11361
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350422387|ref|XP_003493149.1| PREDICTED: hypothetical protein LOC100743398 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 255 bits (652), Expect = 9e-66, Method: Compositional matrix adjust.
Identities = 119/175 (68%), Positives = 147/175 (84%), Gaps = 5/175 (2%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
+ + +V +D K PENIMC +RTSH IK+IDFGLAQ + PD P RVLFGTPEFIPPEII
Sbjct: 9486 MHQNKVVHLDLK--PENIMCRTRTSHQIKLIDFGLAQTLKPDTPIRVLFGTPEFIPPEII 9543
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
+YEPIG ESDMWS+GVI YVLL+GLSPFMG+ND+ETFANITRA++D +DEAF+A+S DAK
Sbjct: 9544 SYEPIGTESDMWSVGVICYVLLTGLSPFMGDNDAETFANITRADYDLEDEAFDAISNDAK 9603
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI-ISTDKLKKYIYRRKWQ 235
DFISSLLVKRKE R++A+QCL H W+AQ + +++I + T+KLKK+I RRKWQ
Sbjct: 9604 DFISSLLVKRKESRMSARQCLEHAWMAQH--AEAMSRIALPTEKLKKFIVRRKWQ 9656
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307204648|gb|EFN83270.1| Myosin light chain kinase, smooth muscle [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 254 bits (649), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 116/174 (66%), Positives = 145/174 (83%), Gaps = 3/174 (1%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
+ + +V +D K PEN+MC +RTSH IK+IDFGLAQ + PD P RVLFGTPEFIPPEII
Sbjct: 8751 MHQNKIVHLDLK--PENVMCRTRTSHQIKLIDFGLAQTLKPDTPIRVLFGTPEFIPPEII 8808
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
+YEPIG ESDMWS+GVI YVLL+GLSPFMG+ND+ETFANITRA++D +DEAF+A+S DAK
Sbjct: 8809 SYEPIGTESDMWSVGVICYVLLTGLSPFMGDNDAETFANITRADYDLEDEAFDAISNDAK 8868
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
DFIS LL+KRKE R++A QCL H W+AQ++++ ++ TDKLKK+I RRKWQ
Sbjct: 8869 DFISGLLIKRKELRMSAAQCLEHPWMAQRNAAMS-RVVLPTDKLKKFIVRRKWQ 8921
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345496511|ref|XP_003427742.1| PREDICTED: hypothetical protein LOC100118156 isoform 2 [Nasonia vitripennis] gi|345496513|ref|XP_001602198.2| PREDICTED: hypothetical protein LOC100118156 isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 251 bits (641), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 119/177 (67%), Positives = 149/177 (84%), Gaps = 5/177 (2%)
Query: 60 RGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119
R + +++V +D K PENIMC +RTSH IK+IDFGLAQ ++P P RVLFGTPEFIPPE
Sbjct: 806 RYMHKNNVVHLDLK--PENIMCHTRTSHRIKLIDFGLAQILSPSQPVRVLFGTPEFIPPE 863
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
IINYEPIG ESDMWS+GVI YVLL+GLSPFMG+ND+ETFANI RA++DF+DEAF+A+S D
Sbjct: 864 IINYEPIGTESDMWSVGVICYVLLTGLSPFMGDNDAETFANIVRADYDFEDEAFDAISPD 923
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI-ISTDKLKKYIYRRKWQ 235
AKDFIS+LL K+KE R++AKQCLSH W+AQ + ++++ + TDKLKK+I RRKWQ
Sbjct: 924 AKDFISNLLQKKKELRMSAKQCLSHSWLAQH--TENMSRVALPTDKLKKFIVRRKWQ 978
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442623877|ref|NP_001188955.2| Stretchin-Mlck, isoform T [Drosophila melanogaster] gi|440214442|gb|ADV37201.2| Stretchin-Mlck, isoform T [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 116/171 (67%), Positives = 140/171 (81%), Gaps = 2/171 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
S+V +D K PENIMC +RTSH IKIIDFGLAQ+++ P RVLFGTPEFIPPEII+YE
Sbjct: 7697 QSVVHLDLK--PENIMCHTRTSHQIKIIDFGLAQRLDTKAPVRVLFGTPEFIPPEIISYE 7754
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG +SDMWS+GVI YVLLSGLSPFMG+ D ETF+NITRA++D+DDEAF+ +S++AKDFI
Sbjct: 7755 PIGFQSDMWSVGVICYVLLSGLSPFMGDTDVETFSNITRADYDYDDEAFDCVSQEAKDFI 7814
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
S LLV RKE RLTA+QCL+ W++Q+ N I TDKLKK+I RRKWQ
Sbjct: 7815 SQLLVHRKEDRLTAQQCLASKWLSQRPDDSLSNNKICTDKLKKFIIRRKWQ 7865
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442623875|ref|NP_001261018.1| Stretchin-Mlck, isoform S [Drosophila melanogaster] gi|440214441|gb|AGB93550.1| Stretchin-Mlck, isoform S [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 116/171 (67%), Positives = 140/171 (81%), Gaps = 2/171 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
S+V +D K PENIMC +RTSH IKIIDFGLAQ+++ P RVLFGTPEFIPPEII+YE
Sbjct: 7697 QSVVHLDLK--PENIMCHTRTSHQIKIIDFGLAQRLDTKAPVRVLFGTPEFIPPEIISYE 7754
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG +SDMWS+GVI YVLLSGLSPFMG+ D ETF+NITRA++D+DDEAF+ +S++AKDFI
Sbjct: 7755 PIGFQSDMWSVGVICYVLLSGLSPFMGDTDVETFSNITRADYDYDDEAFDCVSQEAKDFI 7814
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
S LLV RKE RLTA+QCL+ W++Q+ N I TDKLKK+I RRKWQ
Sbjct: 7815 SQLLVHRKEDRLTAQQCLASKWLSQRPDDSLSNNKICTDKLKKFIIRRKWQ 7865
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442623879|ref|NP_001261019.1| Stretchin-Mlck, isoform U [Drosophila melanogaster] gi|440214443|gb|AGB93551.1| Stretchin-Mlck, isoform U [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 116/171 (67%), Positives = 140/171 (81%), Gaps = 2/171 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
S+V +D K PENIMC +RTSH IKIIDFGLAQ+++ P RVLFGTPEFIPPEII+YE
Sbjct: 7736 QSVVHLDLK--PENIMCHTRTSHQIKIIDFGLAQRLDTKAPVRVLFGTPEFIPPEIISYE 7793
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG +SDMWS+GVI YVLLSGLSPFMG+ D ETF+NITRA++D+DDEAF+ +S++AKDFI
Sbjct: 7794 PIGFQSDMWSVGVICYVLLSGLSPFMGDTDVETFSNITRADYDYDDEAFDCVSQEAKDFI 7853
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
S LLV RKE RLTA+QCL+ W++Q+ N I TDKLKK+I RRKWQ
Sbjct: 7854 SQLLVHRKEDRLTAQQCLASKWLSQRPDDSLSNNKICTDKLKKFIIRRKWQ 7904
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|442623881|ref|NP_725510.2| Stretchin-Mlck, isoform V [Drosophila melanogaster] gi|440214444|gb|AAF58087.3| Stretchin-Mlck, isoform V [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 116/171 (67%), Positives = 140/171 (81%), Gaps = 2/171 (1%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
S+V +D K PENIMC +RTSH IKIIDFGLAQ+++ P RVLFGTPEFIPPEII+YE
Sbjct: 7736 QSVVHLDLK--PENIMCHTRTSHQIKIIDFGLAQRLDTKAPVRVLFGTPEFIPPEIISYE 7793
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
PIG +SDMWS+GVI YVLLSGLSPFMG+ D ETF+NITRA++D+DDEAF+ +S++AKDFI
Sbjct: 7794 PIGFQSDMWSVGVICYVLLSGLSPFMGDTDVETFSNITRADYDYDDEAFDCVSQEAKDFI 7853
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
S LLV RKE RLTA+QCL+ W++Q+ N I TDKLKK+I RRKWQ
Sbjct: 7854 SQLLVHRKEDRLTAQQCLASKWLSQRPDDSLSNNKICTDKLKKFIIRRKWQ 7904
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | ||||||
| FB|FBgn0265045 | 9270 | Strn-Mlck "Stretchin-Mlck" [Dr | 0.698 | 0.018 | 0.654 | 7.7e-61 | |
| UNIPROTKB|B4DUE3 | 714 | MYLK "cDNA FLJ53659, highly si | 0.828 | 0.277 | 0.473 | 5.4e-52 | |
| UNIPROTKB|F1NQ78 | 1906 | MYLK "Uncharacterized protein" | 0.845 | 0.105 | 0.483 | 1.9e-51 | |
| UNIPROTKB|P11799 | 1906 | P11799 "Myosin light chain kin | 0.845 | 0.105 | 0.483 | 1.9e-51 | |
| UNIPROTKB|Q28824 | 1176 | MYLK "Myosin light chain kinas | 0.769 | 0.156 | 0.5 | 4.5e-50 | |
| UNIPROTKB|F1N269 | 1177 | LOC100850955 "Uncharacterized | 0.769 | 0.156 | 0.5 | 4.5e-50 | |
| UNIPROTKB|Q15746 | 1914 | MYLK "Myosin light chain kinas | 0.828 | 0.103 | 0.473 | 1.5e-49 | |
| RGD|1310915 | 1942 | Mylk "myosin light chain kinas | 0.828 | 0.101 | 0.478 | 1.6e-49 | |
| UNIPROTKB|F1PIF6 | 1960 | MYLK "Uncharacterized protein" | 0.828 | 0.101 | 0.478 | 2.1e-49 | |
| MGI|MGI:894806 | 1941 | Mylk "myosin, light polypeptid | 0.828 | 0.102 | 0.473 | 5.4e-49 |
| FB|FBgn0265045 Strn-Mlck "Stretchin-Mlck" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 7.7e-61, Sum P(2) = 7.7e-61
Identities = 112/171 (65%), Positives = 132/171 (77%)
Query: 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP 125
S+V +D K PENIMC +RTSH IKIIDFGLAQ+++ P RVLFGTPEFIPPEII+YEP
Sbjct: 8752 SVVHLDLK--PENIMCHTRTSHQIKIIDFGLAQRLDTKAPVRVLFGTPEFIPPEIISYEP 8809
Query: 126 IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFIS 185
IG +SDMWS+GVI YVLLSGLSPFMG+ D ETF+NITR +S++AKDFIS
Sbjct: 8810 IGFQSDMWSVGVICYVLLSGLSPFMGDTDVETFSNITRADYDYDDEAFDCVSQEAKDFIS 8869
Query: 186 SLLVKRKEKRLTAKQCLSHLWIAQK-DSSPGVNKIISTDKLKKYIYRRKWQ 235
LLV RKE RLTA+QCL+ W++Q+ D S NKI TDKLKK+I RRKWQ
Sbjct: 8870 QLLVHRKEDRLTAQQCLASKWLSQRPDDSLSNNKIC-TDKLKKFIIRRKWQ 8919
|
|
| UNIPROTKB|B4DUE3 MYLK "cDNA FLJ53659, highly similar to Myosin light chain kinase, smooth muscle (EC2.7.11.18)" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 5.4e-52, Sum P(2) = 5.4e-52
Identities = 100/211 (47%), Positives = 135/211 (63%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 337 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 396
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 397 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 456
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 457 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 516
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 517 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 546
|
|
| UNIPROTKB|F1NQ78 MYLK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 1.9e-51, Sum P(2) = 1.9e-51
Identities = 104/215 (48%), Positives = 139/215 (64%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+EM +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1526 VLEMVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1585
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG E+DMWSIGVI Y+L+S
Sbjct: 1586 TGTSIKLIDFGLARRLESAGSLKVLFGTPEFVAPEVINYEPIGYETDMWSIGVICYILVS 1645
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1646 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKSRLNCTQCLQH 1705
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSRH 239
W+ QKD+ K +S D++KKY+ RRKWQ + H
Sbjct: 1706 PWL-QKDTKNMEAKKLSKDRMKKYMARRKWQKTGH 1739
|
|
| UNIPROTKB|P11799 P11799 "Myosin light chain kinase, smooth muscle" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 1.9e-51, Sum P(2) = 1.9e-51
Identities = 104/215 (48%), Positives = 139/215 (64%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+EM +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1526 VLEMVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1585
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG E+DMWSIGVI Y+L+S
Sbjct: 1586 TGTSIKLIDFGLARRLESAGSLKVLFGTPEFVAPEVINYEPIGYETDMWSIGVICYILVS 1645
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1646 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKSRLNCTQCLQH 1705
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSRH 239
W+ QKD+ K +S D++KKY+ RRKWQ + H
Sbjct: 1706 PWL-QKDTKNMEAKKLSKDRMKKYMARRKWQKTGH 1739
|
|
| UNIPROTKB|Q28824 MYLK "Myosin light chain kinase, smooth muscle" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 4.5e-50, Sum P(2) = 4.5e-50
Identities = 94/188 (50%), Positives = 127/188 (67%)
Query: 48 VELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR 107
++ +++ E E + +V +D K PENIMCV++T IK+IDFGLA+++ +
Sbjct: 824 IKYMKQISEGVEY-IHKQGIVHLDLK--PENIMCVNKTGTRIKLIDFGLARRLENAGSLK 880
Query: 108 VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRXXXX 167
VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+SGLSPFMG+ND+ET AN+T
Sbjct: 881 VLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVSGLSPFMGDNDNETLANVTSATWD 940
Query: 168 XXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKK 227
+S+DAKDFIS+LL K + RL QCL H W+ KD+ K +S D++KK
Sbjct: 941 FDDEAFDEISDDAKDFISNLLKKDMKNRLNCTQCLQHPWL-MKDTKNMEAKKLSKDRMKK 999
Query: 228 YIYRRKWQ 235
Y+ RRKWQ
Sbjct: 1000 YMARRKWQ 1007
|
|
| UNIPROTKB|F1N269 LOC100850955 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 4.5e-50, Sum P(2) = 4.5e-50
Identities = 94/188 (50%), Positives = 127/188 (67%)
Query: 48 VELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR 107
++ +++ E E + +V +D K PENIMCV++T IK+IDFGLA+++ +
Sbjct: 825 IKYMKQISEGVEY-IHKQGIVHLDLK--PENIMCVNKTGTRIKLIDFGLARRLENAGSLK 881
Query: 108 VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRXXXX 167
VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+SGLSPFMG+ND+ET AN+T
Sbjct: 882 VLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVSGLSPFMGDNDNETLANVTSATWD 941
Query: 168 XXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKK 227
+S+DAKDFIS+LL K + RL QCL H W+ KD+ K +S D++KK
Sbjct: 942 FDDEAFDEISDDAKDFISNLLKKDMKNRLNCTQCLQHPWL-MKDTKNMEAKKLSKDRMKK 1000
Query: 228 YIYRRKWQ 235
Y+ RRKWQ
Sbjct: 1001 YMARRKWQ 1008
|
|
| UNIPROTKB|Q15746 MYLK "Myosin light chain kinase, smooth muscle" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 1.5e-49, Sum P(2) = 1.5e-49
Identities = 100/211 (47%), Positives = 135/211 (63%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1537 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1596
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1597 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1656
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1657 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 1716
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1717 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1746
|
|
| RGD|1310915 Mylk "myosin light chain kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 1.6e-49, Sum P(2) = 1.6e-49
Identities = 101/211 (47%), Positives = 135/211 (63%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1561 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1620
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1621 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1680
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +SEDAKDFIS+LL K + RL QCL H
Sbjct: 1681 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISEDAKDFISNLLKKDMKNRLDCTQCLQH 1740
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1741 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1770
|
|
| UNIPROTKB|F1PIF6 MYLK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 2.1e-49, Sum P(2) = 2.1e-49
Identities = 101/211 (47%), Positives = 135/211 (63%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1581 VLEIVSGGELFERIIDEDFELTERECIQYMRQISAGVEYIHRQGIVHLDLKPENIMCVNK 1640
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+K+ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1641 TGTRIKLIDFGLARKLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1700
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1701 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 1760
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1761 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1790
|
|
| MGI|MGI:894806 Mylk "myosin, light polypeptide kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 5.4e-49, Sum P(2) = 5.4e-49
Identities = 100/211 (47%), Positives = 135/211 (63%)
Query: 37 VVEMKAGTQPWVELSERLFESTER-----------GLGH-HSLVTVDPKILPENIMCVSR 84
V+E+ +G + + + + FE TER G+ + H V + PENIMCV++
Sbjct: 1559 VLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIMCVNK 1618
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
T IK+IDFGLA+++ +VLFGTPEF+ PE+INYEPIG +DMWSIGVI Y+L+S
Sbjct: 1619 TGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVS 1678
Query: 145 GLSPFMGENDSETFANITRXXXXXXXXXXXXLSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
GLSPFMG+ND+ET AN+T +S+DAKDFIS+LL K + RL QCL H
Sbjct: 1679 GLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKNRLDCTQCLQH 1738
Query: 205 LWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
W+ KD+ K +S D++KKY+ RRKWQ
Sbjct: 1739 PWL-MKDTKNMEAKKLSKDRMKKYMARRKWQ 1768
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q28824 | MYLK_BOVIN | 2, ., 7, ., 1, 1, ., 1, 8 | 0.5118 | 0.8284 | 0.1683 | yes | N/A |
| Q15746 | MYLK_HUMAN | 2, ., 7, ., 1, 1, ., 1, 8 | 0.5118 | 0.8284 | 0.1034 | yes | N/A |
| P29294 | MYLK_RABIT | 2, ., 7, ., 1, 1, ., 1, 8 | 0.5071 | 0.8284 | 0.1726 | yes | N/A |
| P11799 | MYLK_CHICK | 2, ., 7, ., 1, 1, ., 1, 8 | 0.5209 | 0.8451 | 0.1059 | yes | N/A |
| Q6PDN3 | MYLK_MOUSE | 2, ., 7, ., 1, 1, ., 1, 8 | 0.5118 | 0.8284 | 0.1020 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 239 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-21 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-15 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd00063 | 93 | cd00063, FN3, Fibronectin type 3 domain; One of th | 8e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-05 | |
| smart00060 | 83 | smart00060, FN3, Fibronectin type 3 domain | 6e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.001 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.001 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 0.001 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.002 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.002 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 0.003 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-42
Identities = 49/132 (37%), Positives = 71/132 (53%), Gaps = 2/132 (1%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+ H+K+ DFGLA++++P GTPE++ PE++ + G D+WS+
Sbjct: 125 PENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSL 182
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GVI Y LL+G PF G++ +S +AKD I LLVK EKR
Sbjct: 183 GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR 242
Query: 196 LTAKQCLSHLWI 207
LTA++ L H +
Sbjct: 243 LTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-36
Identities = 49/137 (35%), Positives = 70/137 (51%), Gaps = 7/137 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMW 133
PENI+ +KI DFGLA + + GTP ++ PE++ G + D+W
Sbjct: 126 PENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 134 SIGVITYVLLSGLSPFMGE---NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
S+GVI Y LL+G PF GE + + I +FD+ + + SE+AKD I L K
Sbjct: 184 SLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNK 243
Query: 191 RKEKRLTAKQCLSHLWI 207
KR TA++ L H W
Sbjct: 244 DPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEPIGIESDMW 133
PENI+ + HIK+ DFGLA K R GTPE++ PE++ + G D W
Sbjct: 121 PENILLDAD--GHIKLTDFGLA-KELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
S+GV+ Y +L+G PF E+ E + I + F E LS +A+D IS LL K
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPT 233
Query: 194 KRLTAK 199
KRL +
Sbjct: 234 KRLGSG 239
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 27/145 (18%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---------------------GTPE 114
PENI+ + + HIKI DFG A+ ++P+ P GT E
Sbjct: 130 PENIL-LDK-DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE 187
Query: 115 FIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174
++ PE++N +P G SD+W++G I Y +L+G PF G N+ TF I + E+ F
Sbjct: 188 YVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFP- 246
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAK 199
DAKD I LLV + RL
Sbjct: 247 ---PDAKDLIEKLLVLDPQDRLGVN 268
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 47/133 (35%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLA---------QKINPDHPPRVLFGTPEFIPPEIINYEPI 126
P+NI+ S + H+K+ DFGL+ + + + + GTP++I PE+I +
Sbjct: 121 PDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISS 186
D WS+G I Y L G+ PF GE E F NI + ++ + +S++A D IS
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLISK 236
Query: 187 LLVKRKEKRLTAK 199
LLV EKRL AK
Sbjct: 237 LLVPDPEKRLGAK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 8e-23
Identities = 45/112 (40%), Positives = 66/112 (58%), Gaps = 9/112 (8%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFG+ ++ I GTP++I PEI++Y+P G D W++GV+ Y +L+G
Sbjct: 134 HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAF--EALSEDAKDFISSLLVKRKEKRL 196
SPF G+++ E F +I +DE LS++AK + S L K EKRL
Sbjct: 194 SPFEGDDEDELFQSI------LEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-21
Identities = 46/143 (32%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 59 ERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ--KINPDHPPRVLFGTPEFI 116
+RG+ H I PEN + + +T H +K+ DFGL++ N GTP+++
Sbjct: 115 QRGIIHRD-------IKPEN-LLIDQTGH-LKLTDFGLSRNGLENKK-----FVGTPDYL 160
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE I SD WS+G + + L G PF E F NI ++ +E E
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC 220
Query: 177 SEDAKDFISSLLVKRKEKRLTAK 199
S +A D I+ LL KRL A
Sbjct: 221 SPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 32/172 (18%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPP------------------ 106
H L + I P+NI+ + H IK+ DFGL +K+N
Sbjct: 118 HKLGFIHRDIKPDNIL-IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 107 --------RVLF----GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND 154
RV GTP++I PE++ P G+E D WS+GVI Y +L G PF +
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 155 SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
ET+ I + +S +A D I LL +++ + ++ SH +
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-21
Identities = 43/110 (39%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFG+ ++ I R GTP++I PEII Y+P G D W+ GV+ Y +L+G
Sbjct: 139 HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
PF GE++ E F +I + ++LS++A LL K KRL
Sbjct: 199 PPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-19
Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 38/132 (28%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHP-PRVLFGTPEFIPPEII-NYEPIGIESDMW 133
PENI+ + + +K+ DFGL++ + D + + GTP ++ PE++ +SD+W
Sbjct: 120 PENIL-LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
S+GVI Y L + KD I +L K E
Sbjct: 179 SLGVILYEL-----------------------------------PELKDLIRKMLQKDPE 203
Query: 194 KRLTAKQCLSHL 205
KR +AK+ L HL
Sbjct: 204 KRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 4e-19
Identities = 44/123 (35%), Positives = 64/123 (52%), Gaps = 12/123 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEPIGIESDMW 133
PEN++ S +IKI DFG A+++ R L GTPE++ PEII + G D W
Sbjct: 129 PENLLLDSDG--YIKITDFGFAKRV----KGRTYTLCGTPEYLAPEIILSKGYGKAVDWW 182
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
++G++ Y +L+G PF +N + + I + F S DAKD I +LL
Sbjct: 183 ALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----FSPDAKDLIRNLLQVDLT 238
Query: 194 KRL 196
KRL
Sbjct: 239 KRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 48/140 (34%), Positives = 76/140 (54%), Gaps = 14/140 (10%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP--PRVLFGTPEFIPPEI-- 120
H + V I PEN++ + RT H IK+ DFG A ++ + ++ GTP++I PE+
Sbjct: 119 HQMGYVHRDIKPENVL-IDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 121 -INYEP---IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDFDDEAFE 174
+N + G+E D WS+GVI Y ++ G SPF ++T+ NI + F ++
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP-- 234
Query: 175 ALSEDAKDFISSLLVKRKEK 194
+S D D I SLL +KE+
Sbjct: 235 KVSSDFLDLIQSLLCGQKER 254
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PEN++ S ++K++DFG A+K+ GTPE++ PEII + D WS+
Sbjct: 121 PENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178
Query: 136 GVITYVLLSGLSPFMGENDS--ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
G++ Y LL+G PF +++ E + +I + + + + + AKD I LL + E
Sbjct: 179 GILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLRRNPE 236
Query: 194 KRL 196
+RL
Sbjct: 237 ERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-18
Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 31 CMITGYV-------VEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCV 82
CM+ YV + G P V+++ F T L + H+ V + P+N++
Sbjct: 77 CMVMEYVEGGDCATLLKNIGALP-VDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT 135
Query: 83 SRTSHHIKIIDFGLAQ----------------KINPDHPPRVLFGTPEFIPPEIINYEPI 126
S HIK+ DFGL++ K + + + GTPE+I PE+I +
Sbjct: 136 SMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISS 186
G D W++G+I Y L G PF G+ E F + + ++ + EAL DA+D IS
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDLISR 252
Query: 187 LLVKRKEKRL 196
LL + +RL
Sbjct: 253 LLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 34/154 (22%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--------------------------- 108
PENI+ S HI + DF L+++ + + PP
Sbjct: 131 PENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 109 ---LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165
GT E+I PE+I+ + G D W++G++ Y +L G +PF G N ETF+NI + E
Sbjct: 189 SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE 248
Query: 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199
F +S A+D I LLVK KRL +K
Sbjct: 249 VTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 80.6 bits (197), Expect = 1e-17
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 20/181 (11%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKI-------NPDHPPRVLFGTPEFIPPEII---NYEP 125
PENI+ + R +K+IDFGLA+ + + P GTP ++ PE++ +
Sbjct: 129 PENIL-LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187
Query: 126 IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI---------TRAEFDFDDEAFEAL 176
SD+WS+G+ Y LL+GL PF GE +S + E +
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELI 247
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQF 236
S+ A D + LL K + RL++ LSH +A + +
Sbjct: 248 SKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPS 307
Query: 237 S 237
Sbjct: 308 L 308
|
Length = 384 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 52/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 49 ELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH-PPR 107
E+S LF RG+ + L +N+M S HIKI DFG+ ++ D R
Sbjct: 109 EISVGLFFLHRRGIIYRDLKL-------DNVMLDSEG--HIKIADFGMCKEHMVDGVTTR 159
Query: 108 VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167
GTP++I PEII Y+P G D W+ GV+ Y +L+G PF GE++ E F +I
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRL 196
+ ++LS++A L+ K KRL
Sbjct: 220 YP----KSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-17
Identities = 49/144 (34%), Positives = 70/144 (48%), Gaps = 19/144 (13%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEII- 121
H L V I P+N++ HI++ DFG ++ D + V GTP++I PEI+
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 122 -------NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FDFDDEA 172
Y P E D WS+GV Y +L G +PF E+ ET+ I + F F +
Sbjct: 177 AMEDGKGRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233
Query: 173 FEALSEDAKDFISSLLVKRKEKRL 196
+SE+AKD I L+ E RL
Sbjct: 234 -TDVSEEAKDLIRRLICSP-ETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-17
Identities = 43/127 (33%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 77 ENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEPIGIES--DM 132
ENI+ S H+ + DFGL+++ + R GT E++ PE+I G + D
Sbjct: 134 ENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
WS+GV+T+ LL+G SPF + + + + I+R + +S +A+DFI LL K
Sbjct: 192 WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDP 251
Query: 193 EKRLTAK 199
+KRL A
Sbjct: 252 KKRLGAN 258
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 47/141 (33%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPP 118
LG+ HSL V + PENI+ S+ HI + DFGL ++ I + GTPE++ P
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178
E+++ +P D W +G + Y +L GL PF N +E + NI ++
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITN 221
Query: 179 DAKDFISSLLVKRKEKRLTAK 199
A+ + LL K + KRL AK
Sbjct: 222 SARHLLEGLLQKDRTKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 44/132 (33%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
HS V + PENI+ + + H IK+ DFG A+K+ L GTPE++ PE+I +
Sbjct: 118 HSKEIVYRDLKPENIL-LDKEGH-IKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSK 173
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
D W++G++ Y +L G PF +N + I + +F L AKD I
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLI 229
Query: 185 SSLLVKRKEKRL 196
LLV + +RL
Sbjct: 230 KKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 41/123 (33%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 88 HIKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+K+ DFG+A K+N + GTP ++ PE+I SD+WS+G LL+G
Sbjct: 137 VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
Query: 147 SPFMGENDSETFANITRAEFDFDDEAF--EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P+ N I + DD E +S + KDF+ K R TAKQ L H
Sbjct: 197 PPYYDLNPMAALFRIVQ-----DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251
Query: 205 LWI 207
WI
Sbjct: 252 PWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 41/110 (37%), Positives = 59/110 (53%), Gaps = 5/110 (4%)
Query: 88 HIKIIDFGLA-QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFG+ + +N + GTP++I PEI+ + D WS GV+ Y +L G
Sbjct: 134 HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
SPF GE++ E F +I F +S++AKD +S L + KRL
Sbjct: 194 SPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 12/135 (8%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN + + + H IK+ DFGL++ + + + G+P+++ PE++ + D WS
Sbjct: 129 PENFL-IDASGH-IKLTDFGLSKGIVTYANS---VVGSPDYMAPEVLRGKGYDFTVDYWS 183
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEF-----DFDDEAFEALSEDAKDFISSLLV 189
+G + Y L G PF G +ET+ N+ + +DD F LS++A D I+ L+
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN-LSDEAWDLITKLIN 242
Query: 190 KRKEKRLTAKQCLSH 204
+ + + +H
Sbjct: 243 DPSRRFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-16
Identities = 52/141 (36%), Positives = 74/141 (52%), Gaps = 13/141 (9%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIIN 122
H L V I P+N++ + HI++ DFG K+N D + V GTP++I PEI+
Sbjct: 119 HQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 123 YEPIGI-----ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FDFDDEAFEA 175
G+ E D WS+GV Y +L G +PF E+ ET+ I E F F +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD- 235
Query: 176 LSEDAKDFISSLLVKRKEKRL 196
+SE+AKD I L+ R E+RL
Sbjct: 236 VSEEAKDLIQRLICSR-ERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-16
Identities = 44/121 (36%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 77 ENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSI 135
+N+M S HIKI DFG+ ++ D F GTP++I PEII Y+P G D W+
Sbjct: 130 DNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ Y +L+G +PF GE++ E F +I + +++S++A L+ K KR
Sbjct: 188 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKR 243
Query: 196 L 196
L
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 41/114 (35%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFG+ ++ + D GTP++I PEI+ + D WS GV+ Y +L G
Sbjct: 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAF-EALSEDAKDFISSLLVKRKEKRLTAK 199
SPF G ++ E F +I D+ + L+ +AKD + L V+ E+RL K
Sbjct: 194 SPFHGHDEEELFQSIR-----MDNPCYPRWLTREAKDILVKLFVREPERRLGVK 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
I NI+ ++ + +K+IDFGL+ +++ + GTP ++ PE+IN +P ++D+W
Sbjct: 124 IKAANIL-LT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 134 SIGVITYV-LLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
S+G IT + L G P+ + I E S++ KDF+ L K
Sbjct: 182 SLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP-EKWSDEFKDFLKKCLQKNP 239
Query: 193 EKRLTAKQCLSH 204
EKR TA+Q L H
Sbjct: 240 EKRPTAEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 8/138 (5%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIES 130
I NI+ + +K+ DFG A+++ + GTP ++ PE+I E G +
Sbjct: 127 IKGANIL--VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184
Query: 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITR-AEFDFDDEAFEALSEDAKDFISSLLV 189
D+WS+G + +G P+ A + + E E LSE+AKDF+ L
Sbjct: 185 DIWSLGCTVIEMATGKPPW--SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLR 242
Query: 190 KRKEKRLTAKQCLSHLWI 207
+ +KR TA + L H ++
Sbjct: 243 RDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-15
Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 65 HSLVTVDPKIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPP 118
H+ +L P NI + +++K+ DFGLA+ + D + GTP ++ P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDAN--NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178
E +N+ +SD+WS+G + Y L + PF N + + I +F + S
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY---SS 236
Query: 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ + I S+L +KR + ++ L I
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-15
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 7/136 (5%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINY 123
HSL + + PENI+ S+ H+ + DFGL ++ I GTPE++ PE++
Sbjct: 113 HSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDF 183
+P D W +G + Y +L GL PF + +E + NI +S A+
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHL 226
Query: 184 ISSLLVKRKEKRLTAK 199
+ LL K + KRL AK
Sbjct: 227 LEGLLQKDRTKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-15
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIIN 122
HS + + PEN++ ++ H+K+ DFG A+K+ P R L GTPE++ PE+I
Sbjct: 135 HSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQ 188
Query: 123 YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKD 182
+ G D W++GV+ Y ++G PF + + I F A+D
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARD 244
Query: 183 FISSLLVKRKEKRL 196
+ LL KRL
Sbjct: 245 LVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-15
Identities = 52/163 (31%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 46 PWVELSERLFESTER--GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINP 102
P E LF + E GL H TV + PENI+ HI+I D GLA KI
Sbjct: 97 PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL--DDYGHIRISDLGLAVKIPE 154
Query: 103 DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT 162
R GT ++ PE++N + + D W +G + Y ++ G SPF G + +
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVK 209
Query: 163 RAEFDF----DDEAFEA-LSEDAKDFISSLLVKRKEKRLTAKQ 200
R E D +E + A SE+AK LL K ++RL ++
Sbjct: 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 8/139 (5%)
Query: 62 LGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPE 119
L H H + + PENI+ ++ H+K+ DFGL ++ I+ GT E++ PE
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
I+ G D WS+G + Y +L+G PF EN +T I + + + L+ +
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPE 226
Query: 180 AKDFISSLLVKRKEKRLTA 198
A+D + LL + RL A
Sbjct: 227 ARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 4/135 (2%)
Query: 88 HIKIIDFGLAQKINPDHPPRV-LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+K+ DFG A ++ + R + GTP ++ PE+I + G + D+WS+G++ + G
Sbjct: 154 SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
Query: 147 SPFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
P++ E I T+ + E S + KDF++ LVK EKR +A++ L H
Sbjct: 214 PPYLREPPLRALFLITTKGIPPLKNP--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271
Query: 206 WIAQKDSSPGVNKII 220
++ + +I
Sbjct: 272 FLKKACPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDM 132
I P N++ S+ +KI DFG+++ + F GT ++ PE I E +D+
Sbjct: 126 IKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADI 183
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA--LSEDAKDFISSLLVK 190
WS+G+ G PF+ +F + +A D + A S + +DFIS+ L K
Sbjct: 184 WSLGLTLLECALGKFPFLP-PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQK 242
Query: 191 RKEKRLTAKQCLSHLWIAQKDS 212
+KR +A + L H +I + D+
Sbjct: 243 DPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 1e-14
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 19/141 (13%)
Query: 73 KIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-----GTPEFIPPEIIN 122
KIL P+NI S +K+ DFG+++ ++ V GTP ++ PE+
Sbjct: 123 KILHRDIKPQNIFLTSN--GLVKLGDFGISKVLSST----VDLAKTVVGTPYYLSPELCQ 176
Query: 123 YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKD 182
+P +SD+WS+G + Y L + PF GEN E I + ++ + S + ++
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY---SSELRN 233
Query: 183 FISSLLVKRKEKRLTAKQCLS 203
+SSLL K E+R + Q L
Sbjct: 234 LVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
I P+NI+ + H+ I DF +A K+ PD GTP ++ PE++ + + D W
Sbjct: 126 IKPDNILLDEQG--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWW 183
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL-SEDAKDFISSLLVKRK 192
S+GV Y L G P+ S T + RA+ + D + A S +A D I+ LL +
Sbjct: 184 SLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241
Query: 193 EKRL--TAKQCLSHLWI 207
+KRL K +H +
Sbjct: 242 QKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 2/121 (1%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+ R HI+I D GLA +I R GT ++ PE+IN E D W +
Sbjct: 130 PENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G + Y ++ G SPF + + R + +E E SEDAK LL K ++R
Sbjct: 188 GCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
Query: 196 L 196
L
Sbjct: 248 L 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 34/122 (27%), Positives = 63/122 (51%), Gaps = 2/122 (1%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG +++ + P R L GTP ++ PE+I+ P G E D+WS+G++ ++ G
Sbjct: 154 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
P+ E + I + S + F+ +LV+ +R TA + L+H ++
Sbjct: 214 PYFNEPPLQAMKRIRDNLPPKLKNLHKV-SPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
Query: 208 AQ 209
A+
Sbjct: 273 AK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-14
Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 7/133 (5%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ-KINPDHPPRVLFGTPEFIPPEIINY 123
H + + PENI+ HI + DFGL + + D GTPE++ PE++
Sbjct: 110 HKFNVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDF 183
D W++GV+ Y +L+GL PF EN +E + I + F D DAKD
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDL 223
Query: 184 ISSLLVKRKEKRL 196
+ LL + +RL
Sbjct: 224 LIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 36 YVVEMKAGTQPWVELS-ERLF-ESTERGLGH---------HSLVTVDPKILPENIMCVSR 84
+V+E G + + LS ER+F E R G HS V I EN+M
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--D 129
Query: 85 TSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL 143
HIKI DFGL ++ I+ + GTPE++ PE++ G D W +GV+ Y ++
Sbjct: 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 144 SGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL-----TA 198
G PF ++ F I E F LS +AK ++ LL K ++RL A
Sbjct: 190 CGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 245
Query: 199 KQCLSH 204
K+ + H
Sbjct: 246 KEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 59/186 (31%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 36 YVVEMKAGTQPWVELS-ERLF-ESTERGLGH---------HSLVTVDPKILPENIMCVSR 84
+V+E G + + LS ER+F E R G HS V + EN+M
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML--D 129
Query: 85 TSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL 143
HIKI DFGL ++ I + GTPE++ PE++ G D W +GV+ Y ++
Sbjct: 130 KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 144 SGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL-----TA 198
G PF ++ + F I + F LS DAK +S LL+K KRL A
Sbjct: 190 CGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDA 245
Query: 199 KQCLSH 204
K+ + H
Sbjct: 246 KEIMRH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 41/137 (29%), Positives = 58/137 (42%), Gaps = 3/137 (2%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119
GL H V + PENI+ HI+I D GLA +I R GT ++ PE
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPE 171
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
++ E D W +G + Y ++ G SPF + + R + +E E SE
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231
Query: 180 AKDFISSLLVKRKEKRL 196
A+ LL K RL
Sbjct: 232 ARSICRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-14
Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFIPP 118
L H HSL + + PENI+ HIK+ DFGL+ + I+ + GT E++ P
Sbjct: 110 ALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178
E++N +D WS GV+ + +L+G PF G++ ET I +A+ + LS
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSP 223
Query: 179 DAKDFISSLLVKRKEKRLTA 198
+A+ + +L + RL A
Sbjct: 224 EAQSLLRALFKRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-14
Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 7/111 (6%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
H K+ DFG+ ++ I GTP++I PEI+ G D W++GV+ Y +++G
Sbjct: 134 HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEA-LSEDAKDFISSLLVKRKEKRL 196
PF +N+ + F +I DD + LS++A + + + K KRL
Sbjct: 194 PPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINY 123
HSL + + PENI+ S+ H+ + DFGL ++ + P+ GTPE++ PE++
Sbjct: 113 HSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDF 183
EP D W +G + Y +L GL PF + S+ + NI A A D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA----ACDL 226
Query: 184 ISSLLVKRKEKRLTAK 199
+ LL K + +RL AK
Sbjct: 227 LVGLLHKDQRRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-13
Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 12/139 (8%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIIN 122
H L V I P+NI+ + HI++ DFG K+ D + V GTP++I PEI+
Sbjct: 119 HQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 123 YEP-----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDFDDEAFEA 175
G E D WS+GV Y +L G +PF E+ ET+ I + F F + +
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD- 235
Query: 176 LSEDAKDFISSLLVKRKEK 194
+SEDAKD I L+ R+ +
Sbjct: 236 VSEDAKDLIRRLICSREHR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 46/136 (33%), Positives = 72/136 (52%), Gaps = 6/136 (4%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIIN 122
H L + I ENI+ S + H+ + DFGL+++ + D R GT E++ P+I+
Sbjct: 122 HKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 123 YEPIGIES--DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDA 180
G + D WS+GV+ Y LL+G SPF + + + A I+R + + +S A
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 181 KDFISSLLVKRKEKRL 196
KD I LL+K +KRL
Sbjct: 240 KDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 35/122 (28%), Positives = 66/122 (54%), Gaps = 2/122 (1%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG +I+ D P R L GTP ++ PE+I+ P G E D+WS+G++ ++ G
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
P+ ++ + + R + +S +DF+ +L + ++R TA++ L H ++
Sbjct: 216 PYFSDSPVQAMKRL-RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
Query: 208 AQ 209
Q
Sbjct: 275 LQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
H K+ DFG+ ++ I GTP++I PEI+ G D W++GV+ Y +L G
Sbjct: 134 HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
+PF EN+ + F I E + LS+DA D + + + K RL
Sbjct: 194 APFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 45/140 (32%), Positives = 73/140 (52%), Gaps = 13/140 (9%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIIN 122
HS+ + + P+N M + + S H+K+ DFG K++ + R GTP++I PE++
Sbjct: 159 HSMGFIHRDVKPDN-MLLDK-SGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 123 YEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDFDDEAFEAL 176
+ G E D WS+GV Y +L G +PF ++ T++ I + F D+ +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EI 274
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S+ AKD I + L R E RL
Sbjct: 275 SKQAKDLICAFLTDR-EVRL 293
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK-INPDHPPRVLFGTPEFIPP 118
LG+ HS+ V + PENI+ S+ H+ + DFGL ++ I GTPE++ P
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178
E+I +P D W +G + Y +L GL PF + +E + NI A S
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA----SL 221
Query: 179 DAKDFISSLLVKRKEKRLTAKQ 200
A + LL K +++RL AK+
Sbjct: 222 TAWSILEELLEKDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFGL ++ I+ + GTPE++ PE++ G D W +GV+ Y ++ G
Sbjct: 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL-----TAKQC 201
PF ++ + F I E F LS +AK ++ LL K ++RL AK+
Sbjct: 193 LPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248
Query: 202 LSHLWIAQKDSSPGVNKIIS 221
+ H + A + V K +
Sbjct: 249 MEHRFFASINWQDVVQKKLE 268
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 42/127 (33%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFGL ++ I + GTPE++ PE++ G D W +GV+ Y ++ G
Sbjct: 134 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL-----TAKQC 201
PF ++ + F I E F LS +AK +S LL K ++RL AK+
Sbjct: 194 LPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEI 249
Query: 202 LSHLWIA 208
+ H + A
Sbjct: 250 MQHKFFA 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 44/142 (30%), Positives = 73/142 (51%), Gaps = 13/142 (9%)
Query: 63 GHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEI 120
HS+ + + P+N++ S H+K+ DFG K+N + R GTP++I PE+
Sbjct: 157 AIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 121 INYEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDFDDEAFE 174
+ + G E D WS+GV Y +L G +PF ++ T++ I + F D+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-- 272
Query: 175 ALSEDAKDFISSLLVKRKEKRL 196
+S++AK+ I + L R E RL
Sbjct: 273 DISKEAKNLICAFLTDR-EVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+KI DFGL ++ + GTPEF+ PE++ D W +GV+ Y +L G
Sbjct: 139 FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTA 198
SPF G+++ E F +I E + LS +A + LL + E+RL +
Sbjct: 199 SPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIMRRLLRRNPERRLGS 246
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 3/137 (2%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119
GL H H V + PEN++ +++I D GLA ++ + GTP ++ PE
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPE 164
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
++ E D +++G Y +++G SPF + + R + E + S +
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPE 224
Query: 180 AKDFISSLLVKRKEKRL 196
AKD +LL K EKRL
Sbjct: 225 AKDLCEALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-12
Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG +I P+ R + GTP ++ PE++ + G + D+WS+G++ ++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 148 PFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P++ EN I T + + E LS +DF++ L EKR +AK+ L H
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-12
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV-LFGTPEFIPPEIINY 123
HS + I +NI+ S +K+ DFG +I P+ R + GTP ++ PE++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKD 182
+ G + D+WS+G++ ++ G P++ EN I T + + E LS +D
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRD 248
Query: 183 FISSLLVKRKEKRLTAKQCLSH--LWIAQKDSS 213
F++ L EKR +AK+ L H L IA+ SS
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-12
Identities = 45/137 (32%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIIN 122
H L V I ENI+ S H+ + DFGL+++ + R GT E++ PEII
Sbjct: 122 HKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 123 YEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
+ G D WS+G++ + LL+G SPF E + T + ++R D + +A+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 182 DFISSLLVKRKEKRLTA 198
D + LL K +KRL A
Sbjct: 240 DLLHKLLRKDPKKRLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-12
Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG +I P+ R + GTP ++ PE++ + G + D+WS+G++ ++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 148 PFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P++ EN I T + + E LS +DF++ L EKR +AK+ L H
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNP--EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 38/133 (28%), Positives = 58/133 (43%), Gaps = 22/133 (16%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
I EN++ R I + D+GL + I P GT ++ PE I + D W
Sbjct: 135 IKLENVLY-DRAKDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYDVSFDWW 190
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD---------EAFEALSEDAKDFI 184
++GV+TY LL+G PF + D E D + + +S++A DF+
Sbjct: 191 AVGVLTYELLTGKHPFKEDEDE---------ELDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 185 SSLLVKRKEKRLT 197
S+L RLT
Sbjct: 242 QSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 5/110 (4%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIKI DFG+ ++ + D+ GTP++I PEI+ D WS GV+ Y +L G
Sbjct: 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
Query: 147 SPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
SPF G+++ E F +I + +++++KD + L + +RL
Sbjct: 194 SPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-11
Identities = 33/129 (25%), Positives = 58/129 (44%), Gaps = 4/129 (3%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
+NI+ + + +KI DFG+++ ++ + GTP +I PE+ +P +SD+W++
Sbjct: 129 TQNIL-LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G + Y L S F N I F + + S D + I S+L KR
Sbjct: 188 GCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY---SPDLRQLILSMLNLDPSKR 244
Query: 196 LTAKQCLSH 204
Q ++
Sbjct: 245 PQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 2/122 (1%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG +++ + P R L GTP ++ PE+I+ P G E D+WS+G++ ++ G
Sbjct: 155 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
P+ E + I R + +S K F+ LLV+ +R TA + L H ++
Sbjct: 215 PYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
Query: 208 AQ 209
A+
Sbjct: 274 AK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 2/121 (1%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+ HI+I D GLA + + GT ++ PE++ E D W++
Sbjct: 130 PENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G + Y +++G SPF + R + +E E S DA+ LL K ++R
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
Query: 196 L 196
L
Sbjct: 248 L 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 9/139 (6%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ-KINPDHPPRVLFGTPEFIPPEI 120
L + +V D K PENI+ + HI + DFGL++ + + GT E++ PE+
Sbjct: 112 LHKYDIVYRDLK--PENILL--DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
Query: 121 INYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
+ E D WS+GV+ + + G SPF E+ + + NI + F LS++
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDE 224
Query: 180 AKDFISSLLVKRKEKRLTA 198
+ F+ LL + + RL A
Sbjct: 225 GRQFVKGLLNRNPQHRLGA 243
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 2/117 (1%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
IK+ DFG +++ + P R L GTP ++ PE+I+ P G E D+WS+G++ ++ G
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P+ E + I R + +S + F+ +LV+ +R TA++ L H
Sbjct: 217 PYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-11
Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 6/142 (4%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINY 123
HS + I +NI+ S +K+ DFG +I P+ R + GTP ++ PE++
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKD 182
+ G + D+WS+G++ ++ G P++ EN I T + + E LS +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--ERLSAVFRD 247
Query: 183 FISSLLVKRKEKRLTAKQCLSH 204
F++ L ++R +AK+ L H
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 6e-11
Identities = 38/152 (25%), Positives = 55/152 (36%), Gaps = 40/152 (26%)
Query: 88 HIKIIDFGLAQKINPDHPP----RVLFGTPEFIPPEII----NYEPIGIESDMWSIGVIT 139
+K+ DFGLA+ + RV+ T + PPE++ Y P E DMWS+G I
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGATRYGP---EVDMWSVGCIL 192
Query: 140 YVLLSGLSPFMGENDSETFANI-------TRAEFD--------------------FDDEA 172
L G F G + E I T + +
Sbjct: 193 AELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ A D + LL +KR++A Q L H
Sbjct: 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 32/140 (22%), Positives = 66/140 (47%), Gaps = 6/140 (4%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H + + NI+ V+ + +KI D G++ K+ + + GTP ++ PE+
Sbjct: 120 HEQKILHRDLKSANILLVA--NDLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
P +SD+WS+G + Y + + PF + + + R ++ + S+D ++FI
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIY---SQDLQNFI 233
Query: 185 SSLLVKRKEKRLTAKQCLSH 204
S+L + + R + L+
Sbjct: 234 RSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 1e-10
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 43/166 (25%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPI 126
P+NI+ ++R +K+ DFGLA+ P R T E + PEI+ +Y
Sbjct: 126 PQNIL-INRDGV-LKLADFGLARAFG--IPLRTY--THEVVTLWYRAPEILLGSKHY--- 176
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT-----RAEF 166
D+WS+G I +++G F G++ E++ +T + F
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 167 DF-----DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
++ L + D +S +L KR++AK+ L H +
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 5/118 (4%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG+A+++ + G+P ++ PE+I + G+ +D+WS+G + +G
Sbjct: 141 VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
Query: 148 PFMGENDSETFANITRAEFDFDDEAF-EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P+ + E A + + + + LS++AKDFI L + R TA + L H
Sbjct: 201 PW---SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 35/88 (39%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 111 GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDF 168
GTP++I PEI + G E D WS+G I + L G PF EN ET+ I R F
Sbjct: 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF 269
Query: 169 DDEAFEALSEDAKDFISSLLVKRKEKRL 196
D+ LS +A+D I L+ E RL
Sbjct: 270 PDDI--HLSVEAEDLIRRLITN-AENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 7/133 (5%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-----GTPEFIPPEIINYEPIGIESDM 132
N++ + T ++I DFG A ++ F GT F+ PE++ E G D+
Sbjct: 133 NLL-IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITR-AEFDFDDEAFEALSEDAKDFISSLLVKR 191
WS+G + + + P+ E S A I + A E LS +D L +
Sbjct: 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ 251
Query: 192 KEKRLTAKQCLSH 204
E R +++ L H
Sbjct: 252 PEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 50/173 (28%), Positives = 70/173 (40%), Gaps = 46/173 (26%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPP---RVLF----------- 110
H L + I P+N++ ++ HIK+ DFGL + H R+L
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 111 -------------------------GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG 145
GTP++I PE+ E D WS+GVI Y +L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 146 LSPFMGENDSETFANIT--RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
PF +N ET+ I + F DE LS +AKD I L + E+RL
Sbjct: 236 YPPFCSDNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCCE-AERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 65 HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDH----PPRVLFGTPEFIPPE 119
HS + V I NI+ R S ++K+ DFG ++++ + + GTP ++ PE
Sbjct: 121 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR-AEFDFDDEAFEALSE 178
+I+ E G ++D+WS+G +L+ P+ + E A I + A + + +S
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 179 DAKDFISSLLVKRKEKRLTAKQCLSH 204
DA++F+ V+ +KR +A++ L H
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-10
Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 12/125 (9%)
Query: 89 IKIIDFGLAQKI-----NPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYV 141
IK+IDFG A+++ + H + + GTP ++ PE+IN G +SD+WSIG +
Sbjct: 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200
Query: 142 LLSGLSPF--MGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199
+ +G P M + + R ++F S A DF++S L + + +R +A
Sbjct: 201 MATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF---SAAAIDFVTSCLTRDQHERPSAL 257
Query: 200 QCLSH 204
Q L H
Sbjct: 258 QLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 4/115 (3%)
Query: 89 IKIIDFGLAQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
IK+ DFG+++ + ++ + GTP ++ PE+ +SD+W++G + Y LL+
Sbjct: 140 IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
F N I + + + S + + SLL + EKR TA + L
Sbjct: 200 TFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 40/165 (24%), Positives = 63/165 (38%), Gaps = 54/165 (32%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI----------PPEII----NY-EPIGIESDM 132
+KI DFGLA+ ++PD F+ PE++ Y + I D+
Sbjct: 141 DLKICDFGLARGVDPDED------EKGFLTEYVVTRWYRAPELLLSSSRYTKAI----DI 190
Query: 133 WSIGVITYVLLSGLSPFMGEN---------------DSETFANITRAEF----------- 166
WS+G I LL+ F G + E IT +
Sbjct: 191 WSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKP 250
Query: 167 --DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
+ F S +A D + +LV +KR+TA + L+H ++AQ
Sbjct: 251 KKPL-SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 2e-09
Identities = 38/118 (32%), Positives = 61/118 (51%), Gaps = 7/118 (5%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIE--SDMWSIGVITYVLLSGLS 147
KI DFGL++ I + GTP + PE++ +E + SDMW++G I Y L SG +
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 148 PFMGEND-SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
PF N+ S+ + + R D + S++ I +LL ++R +A QCL +
Sbjct: 242 PFHKANNFSQLISELKRGP----DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 42/182 (23%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP----PRVLFGTPE 114
+G+ + H+ + + P N++ +S +KI DFGLA+ + + P +V T
Sbjct: 110 KGVAYMHANGIMHRDLKPANLL-ISADGV-LKIADFGLARLFSEEEPRLYSHQV--ATRW 165
Query: 115 FIPPEII----NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA------ 164
+ PE++ Y+P D+W++G I LL+G F GEND E A + R
Sbjct: 166 YRAPELLYGARKYDP---GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE 222
Query: 165 ----EF----DFDDEAFEA------------LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
D++ F S +A D + LLV KRL+A + L H
Sbjct: 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
Query: 205 LW 206
+
Sbjct: 283 PY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 38/121 (31%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
P NIM + I DFGLA++ P+ + GT + PEI+ EP G ++D+W+
Sbjct: 142 PNNIMLGED--DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAF 199
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFD-FDDEAFEALSEDAKDFISSLLVKRKEK 194
G I Y + + PF N I A ++ + + SED D I+S L E
Sbjct: 200 GCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY---SEDVTDVITSCLTPDAEA 256
Query: 195 R 195
R
Sbjct: 257 R 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 16/145 (11%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV-----LFGTPEFIPPEIINYEPI-- 126
I P NI IK+ DFG A K+ + L GTP ++ PE+I
Sbjct: 125 IKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 127 -GIESDMWSIGVITYVLLSGLSPFMGENDSE---TFANITRAEFDFDDEAFEALSEDAKD 182
G +D+WS+G + + +G P+ E D+E F + D LS + KD
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW-SELDNEFQIMFHVGAGHKPPIPDS--LQLSPEGKD 239
Query: 183 FISSLLVKRKEKRLTAKQCLSHLWI 207
F+ L +KR TA + L H ++
Sbjct: 240 FLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 14/147 (9%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG++ ++ R F GTP ++ PE+I ++D+WS+G+ L G
Sbjct: 137 VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196
Query: 148 PFMGENDSETFANITRAEFD-FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
P + I + + F S+ KDF+S L K ++R +AK+ L H +
Sbjct: 197 PLSDLHPMRVLFLIPKNNPPSLEGNKF---SKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
Query: 207 IAQKDSSPGVNKIISTDKLKKYIYRRK 233
I K T L I R K
Sbjct: 254 IK---------KAKKTSYLTLLIERIK 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 13/140 (9%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIIN 122
HS+ + + P+N++ H+K+ DFG K++ R GTP++I PE++
Sbjct: 159 HSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 123 YEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEFDFDDEAFEAL 176
+ G E D WS+GV + +L G +PF ++ T++ I + +F ++ +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV--EI 274
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S+ AK+ I + L R E RL
Sbjct: 275 SKHAKNLICAFLTDR-EVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIK+ D+G+ ++ + P GTP +I PEI+ E G D W++GV+ + +++G
Sbjct: 134 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
Query: 147 SPF 149
SPF
Sbjct: 194 SPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-09
Identities = 34/136 (25%), Positives = 72/136 (52%), Gaps = 12/136 (8%)
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEII----NYEPIGIESDMWSIGVIT 139
+ ++K+ DFG+A +N + R F GTP ++ PE+I Y+ ++D+WS+G+
Sbjct: 136 NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD---TKADIWSLGITI 192
Query: 140 YVLLSGLSPFMGENDSETFANITRAEFD-FDDEAFEALSEDAKDFISSLLVKRKEKRLTA 198
Y + +G P+ + I +++ +D + S+ ++F+++ L + ++RL+A
Sbjct: 193 YEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY---SKLLREFVAACLDEEPKERLSA 249
Query: 199 KQCLSHLWIAQKDSSP 214
++ L WI +P
Sbjct: 250 EELLKSKWIKAHSKTP 265
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVS---RTSHHIKIIDFGLAQKINPDHP-PR 107
R F GL H HS KIL +I ++ ++KI D G+A+ ++ +
Sbjct: 105 RFFIQILLGLAHLHS-----KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159
Query: 108 VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167
+ GTP ++ PE+ +P +SD+W++GV+ Y +G PF N I R F
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP 219
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
+ + S+ I L K +R Q L
Sbjct: 220 PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 8e-09
Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 38/150 (25%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII---NYEPIGIESDMWSIGVITY 140
+K+ DFGLA+ P R + T + + PE++ + +G+ DMWS+G I
Sbjct: 141 LKLADFGLARSFG--SPNRKM--THQVVTRWYRAPELLFGARHYGVGV--DMWSVGCIFA 194
Query: 141 VLLSGLSPFMGENDSETFANITRA-------------------EFDFD-----DEAFEAL 176
LL + G++D + I A EF + F A
Sbjct: 195 ELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAA 254
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
S+DA D + LL KR+TA+Q L H +
Sbjct: 255 SDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-09
Identities = 25/71 (35%), Positives = 43/71 (60%), Gaps = 3/71 (4%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIK+ D+G+ ++ + P GTP +I PEI+ E G D W++GV+ + +++G
Sbjct: 134 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
Query: 147 SPF--MGENDS 155
SPF +G +D+
Sbjct: 194 SPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 57/187 (30%)
Query: 60 RGLGH---HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP----------- 105
+GL H ++ D K PEN++ T +K+ DFGLA+
Sbjct: 109 QGLAFCHSHGILHRDLK--PENLLI--NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWY 164
Query: 106 --PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR 163
P +L G + P D+WS+G I LLS F G+++ + I R
Sbjct: 165 RAPELLLGDKGYSTP-----------VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213
Query: 164 A-------------------EFDFDDEA-------FEALSEDAKDFISSLLVKRKEKRLT 197
+F F +A F S A D +S +L KR+T
Sbjct: 214 TLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
Query: 198 AKQCLSH 204
A+Q L+H
Sbjct: 274 AEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 88 HIKIIDFGLAQK-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
HIK+ D+G+ ++ I P GTP +I PEI+ E G D W++GV+ + +++G
Sbjct: 134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
Query: 147 SPF 149
SPF
Sbjct: 194 SPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 2/98 (2%)
Query: 107 RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEF 166
R+L GTP+++ PE++ +P G D W++GV + L+G+ PF E + F NI +
Sbjct: 539 RIL-GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI 597
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ + E LS +A++ I LL KR K+ H
Sbjct: 598 PWPEGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQH 634
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
+ P NI+ SR IK+ DFG++ ++ + + GT ++ PE I ++SD+W
Sbjct: 127 VKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------DEAFEAL-----SEDAKD 182
S+G+ L +G P+ END + F+ +E L S D +D
Sbjct: 184 SLGLSLIELATGRFPYPPENDP--------PDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 183 FISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212
F++ L+K +R + K+ L H +I + +S
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-08
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINY 123
H V I +N++ V+ S +KI DFG ++++ +P F GT +++ PE+I+
Sbjct: 125 HDNQIVHRDIKGDNVL-VNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 124 EP--IGIESDMWSIGVITYVLLSGLSPF--MGENDSETFANITRAEFDFDDEAFEALSED 179
P G +D+WS+G + +G PF +GE + F F E E+LS +
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---KVGMFKIHPEIPESLSAE 240
Query: 180 AKDFISSLLVKRKEKRLTAKQCL 202
AK+FI +KR +A L
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-08
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 8/158 (5%)
Query: 48 VELSERLFESTE--RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH 104
+E+ + S + G+ H HS+ V + PEN++ + ++ D GLA ++
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGK 149
Query: 105 PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA 164
GT ++ PEI+ EP D +++G Y +++G +PF + + R
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209
Query: 165 EFDFDDEAFE--ALSEDAKDFISSLLVKRKEKRLTAKQ 200
+ D+ FE +E++KD L K+ E RL +++
Sbjct: 210 TLE-DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSRE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 7e-08
Identities = 42/163 (25%), Positives = 64/163 (39%), Gaps = 39/163 (23%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII----NYE-PIGIES 130
PEN++ +KI DFGLA++I P T + PEI+ +Y P+
Sbjct: 127 PENLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV---- 180
Query: 131 DMWSIGVITYVLLSGLSP-FMGENDSETFANIT-------------------RAEFDFD- 169
D+W++G I L + L P F G ++ + I + F F
Sbjct: 181 DIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239
Query: 170 ------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
+ S +A D I +L +KR TA Q L H +
Sbjct: 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 43/158 (27%), Positives = 60/158 (37%), Gaps = 42/158 (26%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH------------PPRVLF-- 110
H L + I P+N++ S+ H+K+ DFGL + H P F
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 111 ----------------------GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSP 148
GTP++I PE+ D WS+GVI Y +L G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 149 FMGENDSETFANIT--RAEFDFDDEAFEALSEDAKDFI 184
F E ET+ + + F E +SE AKD I
Sbjct: 236 FCSETPQETYKKVMNWKETLIFPPEV--PISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-08
Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 89 IKIIDFGLAQKIN---PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG 145
+K+ DFG ++ D R GTP ++ PEI +P ++DM+S+GV+ Y LL+
Sbjct: 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241
Query: 146 LSPFMGENDSETFANITRAEFD-FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
PF GEN E +D +S + ++ +++LL ++R ++ + L
Sbjct: 242 KRPFDGENMEEVMHKTLAGRYDPLPPS----ISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 8/140 (5%)
Query: 61 GLGH---HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI-NPDHPPRVLFGTPEFI 116
GL H ++ D K PEN++ +++I D GLA ++ + + GTP F+
Sbjct: 109 GLEHLHQRRIIYRDLK--PENVLL--DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE++ E D +++GV Y +++ PF + + + + +
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKF 224
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S +K F +LL K EKRL
Sbjct: 225 SPASKSFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-07
Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 71 DPKILPENI----MCVSRTSHHIKIIDFGLAQKINPDHP-PRVLFGTPEFIPPEIINYEP 125
D KIL +I + +S+ K+ DFG+A+++N GTP ++ PEI P
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 126 IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFIS 185
++D+WS+G + Y L + PF G N + I + F F S D + IS
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF---SRDLRSLIS 235
Query: 186 SLL 188
L
Sbjct: 236 QLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLF 110
++ ES +GL + HS + I P NI+ + +K+ DFG++ + +N
Sbjct: 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL--AGTFT 164
Query: 111 GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-----ETFANITRAE 165
GT ++ PE I +P I SD+WS+G+ + PF E + E + I
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224
Query: 166 -FDFDDEAFEAL--SEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ DE + SE+ KDFI L K +R T L H WI
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 46/169 (27%), Positives = 67/169 (39%), Gaps = 13/169 (7%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
SL V + PEN++ IK+ DFG A+ + D L GTPE+I PEI+
Sbjct: 148 QSLNIVYRDLKPENLLL--DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNV 203
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
G +D W++G+ Y +L G PF + I F + L + K +
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHLM 259
Query: 185 SSLLVKRKEKRL-----TAKQCLSHLWIAQKDSSPGVNKIISTDKLKKY 228
LL KR A+ H W D ++K + KY
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 44/158 (27%), Positives = 62/158 (39%), Gaps = 42/158 (26%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH-----------PP------- 106
H L + I P+N++ ++ H+K+ DFGL + H PP
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 107 --------------RVL----FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSP 148
R L GTP++I PE+ D WS+GVI Y +L G P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 149 FMGENDSETFANIT--RAEFDFDDEAFEALSEDAKDFI 184
F E ET+ + + F E +SE AKD I
Sbjct: 236 FCSETPQETYRKVMNWKETLVFPPEV--PISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 46/162 (28%)
Query: 88 HIKIIDFGLAQKINP---DHPPRVL---FGTPEFIPPEII----NYEPIGIESDMWSIGV 137
+K+ DFGLA+ ++ + VL T + PEI+ Y G+ DMWS+G
Sbjct: 145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTK-GV--DMWSVGC 201
Query: 138 ITYVLLSGLSPFMGENDSETFANITR--------AEFDFD-------------------- 169
I +L G F G + T + + + D +
Sbjct: 202 ILGEMLLGKPLFPG---TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK 258
Query: 170 --DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
DE S+DA D + LLV KRLTA++ L H ++AQ
Sbjct: 259 PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 17/153 (11%)
Query: 54 LFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV---LF 110
L E R + H L + + ++P I IK+ DFG +++ + V
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGI---------IKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 111 GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD 170
GTP ++ PE+ + ++DMWS+GVI Y LL+ PF G + E + ++D
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--- 289
Query: 171 EAFEA-LSEDAKDFISSLLVKRKEKRLTAKQCL 202
F +S K + LL K R T +Q L
Sbjct: 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 24/132 (18%)
Query: 88 HIKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
K+ DFG++ ++ R + GTP ++ PE+I ++D+WS+G+ + G
Sbjct: 137 QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
Query: 147 SP----------FM-GENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
P FM T ++ + S + DF+ LVK E+R
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEK------------WSPEFNDFVKKCLVKDPEER 244
Query: 196 LTAKQCLSHLWI 207
+A Q L H +I
Sbjct: 245 PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 81 CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGV 137
C+ +KI DFGL++ I RV + ++PPE I Y ESD+WS GV
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 138 ITYVLLS-GLSPFMGENDSE 156
+ + + S GL P+ G ++ E
Sbjct: 215 VLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 21/175 (12%)
Query: 48 VELSERLFESTERGLGH----HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA-QKINP 102
VE+ ++ + GL + H ++ D K P NI+ SR IK+ DFG++ + IN
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIK--PSNILVNSRG--QIKLCDFGVSGELINS 157
Query: 103 DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT 162
V GT ++ PE I ++SD+WS+G+ L G PF N + +
Sbjct: 158 IADTFV--GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 163 RAEFDFDDEAF---------EALSEDAKDFISSLLVKRKEKRLTAKQ-CLSHLWI 207
D + ED +DF+ + L+K +R T +Q C +I
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 33/179 (18%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
RGL + HS + + P N+ +KI+DFGLA+ + + V T + P
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAP 186
Query: 119 EI-INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL- 176
EI +N+ D+WS+G I LL+G + F G + + I R E + +
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246
Query: 177 SEDAKDFISSL--------------------------LVKRKEKRLTAKQCLSHLWIAQ 209
SE A+++I SL LV +KR+TA Q L+H + AQ
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 33/108 (30%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 109 LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--RAEF 166
L GTP +I PE++ D WS+GVI Y +L G PF+ + +ET +
Sbjct: 204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRL---TAKQCLSHLWIAQKD 211
+A LS +A D I L E RL A + +H + D
Sbjct: 264 HIPSQA--KLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGID 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|238020 cd00063, FN3, Fibronectin type 3 domain; One of three types of internal repeats found in the plasma protein fibronectin | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-07
Identities = 22/59 (37%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
P PP+ TSV ++W+ P DGG ITGYVVE + G+ W E+ T
Sbjct: 1 PSPPTNLRVTDVTSTSVTLSWTPPEDDGGP-ITGYVVEYREKGSGDWKEVEVTPGSETS 58
|
Its tenth fibronectin type III repeat contains an RGD cell recognition sequence in a flexible loop between 2 strands. Approximately 2% of all animal proteins contain the FN3 repeat; including extracellular and intracellular proteins, membrane spanning cytokine receptors, growth hormone receptors, tyrosine phosphatase receptors, and adhesion molecules. FN3-like domains are also found in bacterial glycosyl hydrolases. Length = 93 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-07
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 27/199 (13%)
Query: 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELS-ERLFESTERGLGH-HSLVTVDPKILPENI 79
W Y GG G + ++ T P EL + T +GL + HS + I NI
Sbjct: 82 WICMEYCGG----GSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137
Query: 80 MCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIES---DMWSI 135
+ +K+ DFG+A KI R F GTP ++ PE+ E G + D+W++
Sbjct: 138 LLTDNGD--VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE--ALSEDAK------DFISSL 187
G IT + L+ L P M + + RA F F+ L + K +F+
Sbjct: 196 G-ITAIELAELQPPMFD------LHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKIS 248
Query: 188 LVKRKEKRLTAKQCLSHLW 206
L K +KR TA++ L+HL+
Sbjct: 249 LTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 33/166 (19%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP--PRVLFGTPEFIPPEIIN 122
H +V D K P+NI+ V+ +KI DFGLA+ + + V+ T + PE++
Sbjct: 126 HRIVHRDLK--PQNIL-VTSDGQ-VKIADFGLARIYSFEMALTSVVV--TLWYRAPEVLL 179
Query: 123 YEPIGIESDMWSIGVITYVLLSGLSP-FMGENDSETFANI------------------TR 163
DMWS+G I L P F G ++++ I R
Sbjct: 180 QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238
Query: 164 AEFDF----DDEAF-EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ F ++F + E+ D + +L KR++A + L H
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 46/182 (25%), Positives = 67/182 (36%), Gaps = 55/182 (30%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI--NPDHP------------PRVLF 110
HS + I PENI+ VS + +K+ DFG A+ + P P P +L
Sbjct: 117 HSHNIIHRDIKPENIL-VSESGV-LKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 111 GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA------ 164
G + P D+W+IG I LL G F G++D + I +
Sbjct: 175 GDTNYGKP-----------VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 165 ----EFD----FDDEAF--------------EALSEDAKDFISSLLVKRKEKRLTAKQCL 202
F F AF +S A DF+ + L ++RLT + L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
Query: 203 SH 204
H
Sbjct: 284 QH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H+++ D K P N++ + +K+ DFG++ + + G ++ PE I
Sbjct: 122 HNIIHRDVK--PTNVLV--NGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSG 176
Query: 125 -PIG-----IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF-EALS 177
P ++SD+WS+G+ + G P+ E + FA ++ A D D S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-AIVDGDPPTLPSGYS 235
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+DA+DF++ L K +R T Q L H W+
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPD-HPPRVLFGTP-EFIPPEIINYEPIGIESD 131
++ E++MC KI DFGLA+ I + + R P ++ PE IN+ I+SD
Sbjct: 135 LVSESLMC--------KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 132 MWSIGVITYVLLS-GLSPFMGENDSETFANITRA 164
+WS G++ Y +++ G P+ G ++S+ + + R
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 2/112 (1%)
Query: 109 LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF 168
L GTP +I PE++ + D WS+GVI + +L G PF+ +ET + E
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 169 DDEAFEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDSSPGVNK 218
LS +A D I+ L +E+ R A +H + ++ D S +
Sbjct: 268 HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRT 319
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 32/150 (21%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLSGLS 147
+KI+DFGLA+ + + V T + PEI+ N+ D+WS+G I LL+G +
Sbjct: 157 LKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
Query: 148 PFMGEN---------------DSETFANI-------------TRAEFDFDDEAFEALSED 179
F G + D E I + DF + F +
Sbjct: 215 LFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPL 273
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
A D + +LV +KR+TA + L+H ++A+
Sbjct: 274 AIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 35/132 (26%), Positives = 53/132 (40%), Gaps = 19/132 (14%)
Query: 88 HIKIIDFGL-AQKINPDHPPRVLFGTPEFIPPEII----NYEP-IGIESDMWSIGVITYV 141
+K++DFG+ AQ + GTP ++ PE+I + SD+WS+G+
Sbjct: 151 EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 142 LLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK------DFISSLLVKRKEKR 195
L G P + RA F L DFIS L+K E+R
Sbjct: 211 LADGKPPLCDMHP-------MRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR 263
Query: 196 LTAKQCLSHLWI 207
++ L H +I
Sbjct: 264 PFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 38/145 (26%), Positives = 74/145 (51%), Gaps = 11/145 (7%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN----PDHPPRVLFGTPEFIPPEI 120
HS + V I NI+ ++ ++K+ DFG ++++ R + GTP ++ PE+
Sbjct: 123 HSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA-LSED 179
I+ E G ++D+WS+G +L+ P+ + E A I + + + +SE
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLPSHISEH 237
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSH 204
A+DF+ + V+ + R +A++ L H
Sbjct: 238 ARDFLGCIFVEARH-RPSAEELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 11/90 (12%)
Query: 77 ENIMCVSRTSHHIKIIDFGLAQKINPDH-PPRVLFGTP-EFIPPEIINYEPIGIESDMWS 134
EN++C KI DFGLA+ I D R P ++ PE NY I+SD+WS
Sbjct: 138 ENLVC--------KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 135 IGVITYVLLS-GLSPFMGENDSETFANITR 163
G++ +++ G P+ G + E + R
Sbjct: 190 FGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 44/154 (28%), Positives = 63/154 (40%), Gaps = 10/154 (6%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL-AQKINPDHPPRVLFGTPEFIPP 118
GL H H T+ + NI+ T +K++DFG+ AQ + GTP ++ P
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLT--TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 119 EIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173
E+I E D+WS+G+ L G P + I R +
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP- 252
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
E S + DFI L K EKR T L H++I
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-06
Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
P N++ +R +K+ DFG++ Q +N V GT ++ PE I+ E GI SD+WS
Sbjct: 123 PSNMLVNTRG--QVKLCDFGVSTQLVNSIAKTYV--GTNAYMAPERISGEQYGIHSDVWS 178
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL-----SEDAKDFISSLLV 189
+G+ L G P+ ++ + DE L SE FI+ +
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238
Query: 190 KRKEKRLTAKQCLSHLWIAQKD 211
K+ ++R + + H +I Q +
Sbjct: 239 KQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 39/129 (30%), Positives = 59/129 (45%), Gaps = 19/129 (14%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIG---IESDMWSIGVITYVLL 143
+K+ DFG++ ++ R F GTP ++ PE+ E G + D+W++G IT + L
Sbjct: 139 DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG-ITAIEL 197
Query: 144 SGLSPFMGENDSETFANITRAEFDFDDEAFEA--LSEDAK------DFISSLLVKRKEKR 195
+ L P M + + RA F F L + K DFI L K +KR
Sbjct: 198 AELQPPMFD------LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR 251
Query: 196 LTAKQCLSH 204
TA + L H
Sbjct: 252 PTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFG----LAQKINPDHPPRVLFGTPEFIPPEI 120
H V I P N++ S ++KI DFG LAQ ++P + GT ++ PE
Sbjct: 185 HRRHIVHRDIKPSNLLINSA--KNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPER 239
Query: 121 IN-------YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173
IN Y+ G D+WS+GV G PF + + + EA
Sbjct: 240 INTDLNHGAYD--GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP 297
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215
S + + FIS L + KR +A Q L H +I + G
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339
|
Length = 353 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 26/79 (32%), Positives = 36/79 (45%)
Query: 109 LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF 168
L GTP +I PE++ D WS+GVI Y +L G PF+ + ET + +
Sbjct: 208 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
Query: 169 DDEAFEALSEDAKDFISSL 187
LS +A D I L
Sbjct: 268 HIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 41/188 (21%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLSGLS 147
+KI+DFGLA+ + + V+ T + PE+I N+ D+WS+G I +L+G +
Sbjct: 156 LKILDFGLARHADAEMTGYVV--TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
Query: 148 PFMGENDSETFANITRA------EF--DFDDEA-------------------FEALSEDA 180
F G++ + I + EF +D+A F S A
Sbjct: 214 LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQA 273
Query: 181 KDFISSLLVKRKEKRLTAKQCLSHLWI-----AQKDSSPGV------NKIISTDKLKKYI 229
D + +L +KRLTA + L H + A +++ N+ +S D+ KK+I
Sbjct: 274 VDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDSLENEKLSVDEWKKHI 333
Query: 230 YRRKWQFS 237
Y+ FS
Sbjct: 334 YKEVKSFS 341
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-06
Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKI-NPDHPPRVLFGTP-EFIPPEIINYEPIGIESDMWSI 135
NI+ VS T KI DFGLA+ I + ++ R P ++ PE INY I+SD+WS
Sbjct: 132 NIL-VSETLC-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189
Query: 136 GV-ITYVLLSGLSPFMGENDSETFANITR 163
G+ +T ++ G P+ G + E N+ R
Sbjct: 190 GILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEF----IPPEIINYEPIGIESDMW 133
N++ V T H+ KI DFGL++ + D ++ PE +NY +SD+W
Sbjct: 125 NVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVW 182
Query: 134 SIGVITYVLLS-GLSPFMGENDSETFANITRAE 165
S GV+ + S G P+ G +E I E
Sbjct: 183 SFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 31/142 (21%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYE-----PIGIESDMWSIGVITYVL 142
+K+ DFG++ K R F GTP ++ PE++ E P ++D+WS+G IT +
Sbjct: 142 VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG-ITLIE 200
Query: 143 L-------SGLSPF-----MGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
L L+P + +++ T ++ F DF+ S LVK
Sbjct: 201 LAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF------------NDFLKSCLVK 248
Query: 191 RKEKRLTAKQCLSHLWIAQKDS 212
+ R TA + L H +++ +
Sbjct: 249 DPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-06
Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 89 IKIIDFGLAQKI-NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG A+ + +P GTP ++PPEI P +SD+WS+G I Y L +
Sbjct: 139 VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH 198
Query: 148 PF 149
PF
Sbjct: 199 PF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 12/126 (9%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG+A ++ R F GTP ++ PE+I ++D+WS+G+ L G
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 199
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEAL----SEDAKDFISSLLVKRKEKRLTAKQCLS 203
P + + R F + L S+ K+F+ + L K R TAK+ L
Sbjct: 200 PN-------SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
Query: 204 HLWIAQ 209
H +I +
Sbjct: 253 HKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGT---PEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
H+KI D GL+++I RV + ++PPE I Y +SD+WS GV+ + + S
Sbjct: 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
Query: 145 -GLSPFMGENDSETFANITRAEF 166
GL P+ G ++ E + + +
Sbjct: 222 FGLQPYYGFSNQEVIEMVRKRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
RGL + HS V + P NI+ +KI DFGLA+ +P V T + P
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDPQMTGYV--STRYYRAP 174
Query: 119 EI-INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT--------------- 162
EI + ++ +E D+WS G I +L G F G++ F+ IT
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 163 -------------RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208
R F E F+ A D + +LV +KR++A + L+H ++A
Sbjct: 235 SENTLRFVQSLPKREPVPF-SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 7e-06
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIP 117
RGL H H + I +N++ +K++DFG++ +++ R F GTP ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 118 PEIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172
PE+I + +SD+WS+G+ + G P + I R
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS- 238
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ S+ + FI S LVK +R T +Q + H +I
Sbjct: 239 -KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 38/160 (23%), Positives = 54/160 (33%), Gaps = 45/160 (28%)
Query: 89 IKIIDFGLAQ-----KINPDHPPRV-------LFGTPEFIPPEII----NYEPIGIESDM 132
+KI DFGLA+ NP L T + PPE++ Y D+
Sbjct: 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT---AVDI 210
Query: 133 WSIGVITYVLLSGLSPFMGEND---------------SETFANIT-----RAEFDFDD-- 170
W IG + + + G++D ET+ F +
Sbjct: 211 WGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP 270
Query: 171 ----EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
E F L + D +S LL KRLTA L H +
Sbjct: 271 RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 10/80 (12%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
K+ DFGLA+ I D V + + IP PE ++ +SD+WS G++ Y + +
Sbjct: 144 KVADFGLARLIKED----VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ G N+ E + IT
Sbjct: 200 YGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-06
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYE-----PIGIESDMWSIGVITYVL 142
IK+ DFG++ K R F GTP ++ PE++ E P ++D+WS+G IT +
Sbjct: 149 IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIE 207
Query: 143 LSGLSPFMGE-NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQC 201
++ + P E N I ++E + S + +DF+ + L K E R +A Q
Sbjct: 208 MAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWSMEFRDFLKTALDKHPETRPSAAQL 266
Query: 202 LSHLWIAQKDSSPGVNKIISTDK 224
L H +++ S+ + ++++ K
Sbjct: 267 LEHPFVSSVTSNRPLRELVAEAK 289
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 34/123 (27%), Positives = 56/123 (45%), Gaps = 6/123 (4%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG+A ++ R F GTP ++ PE+I ++D+WS+G+ L G
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEA-LSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
P + I + + S+ K+FI + L K R TAK+ L H +
Sbjct: 200 PNSDMHPMRVLFLIPK----NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
Query: 207 IAQ 209
I +
Sbjct: 256 IVK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 14/125 (11%)
Query: 89 IKIIDFGLAQKI-NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
IK+ D G+A+ + N L GTP ++ PE+ + +P +SD+W++G Y + +
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200
Query: 148 PFMGENDSETFANITRAEF-----DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
F ++ + I + D+ E E I+++L KR EKR + K L
Sbjct: 201 AFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE--------LIATMLSKRPEKRPSVKSIL 252
Query: 203 SHLWI 207
+I
Sbjct: 253 RQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 42/158 (26%), Positives = 59/158 (37%), Gaps = 42/158 (26%)
Query: 90 KIIDFGLAQKINPD----------HPPRVLFGTPEFI-----PPEII-NYEPIGIESDMW 133
KI DFGLA++ R T + + PE++ E DMW
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITR-------------------AEF------DF 168
S+G I LL+G F GEN+ + I EF D
Sbjct: 219 SVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL 278
Query: 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
F S+DA D + SLL +R++AK+ L H +
Sbjct: 279 KT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 26/84 (30%), Positives = 39/84 (46%), Gaps = 18/84 (21%)
Query: 89 IKIIDFGLAQKI----------NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVI 138
+KI DFGL++ I N P R ++PPE I Y ESD+W+ GV+
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIR-------WMPPESIFYNRYTTESDVWAYGVV 221
Query: 139 TYVLLS-GLSPFMGENDSETFANI 161
+ + S G+ P+ G E +
Sbjct: 222 LWEIFSYGMQPYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-05
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+K+ DFG+A ++ R F GTP ++ PE+I ++D+WS+G+ L G
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEA-LSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
P + + I + + E S+ K+F+ + L K R TAK+ L H +
Sbjct: 200 PHSELHPMKVLFLIPKN----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
Query: 207 I 207
I
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 37/161 (22%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII----NYEPIGIE 129
I PENI+ +K+ DFG + I P T + PE + Y P +
Sbjct: 126 IKPENILI---KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP---K 179
Query: 130 SDMWSIGVITYVLLSGLSP-FMGENDSETFANI------------------TRAEFDF-- 168
D+W++G + + +LS L P F G N+ + A I ++F
Sbjct: 180 MDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238
Query: 169 -DDEAFEAL----SEDAKDFISSLLVKRKEKRLTAKQCLSH 204
L S + D + LL ++R+TAKQ L H
Sbjct: 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-05
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI---PPEIINYEPIGIESDMWS 134
N + V+ +KI DFGL++ I D R G I PE + +SD+WS
Sbjct: 132 NCL-VTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWS 189
Query: 135 IGVITYVLLS-GLSPFMGENDSETFANITR 163
GV+ + + + G P+ G ++ E +
Sbjct: 190 FGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
H ++ D K P NI+ + + +K+ DFG++ ++ G ++ PE I+
Sbjct: 134 HGVIHRDVK--PSNILLDASGN--VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPP 189
Query: 125 PIG----IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA-----FEA 175
I +D+WS+G+ L +G P+ +E F +T+ +E E
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKN-CKTE-FEVLTKI---LQEEPPSLPPNEG 244
Query: 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213
S D F+ L K KR ++ L H +I + +++
Sbjct: 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 109 LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE--NDSETFANITRAEF 166
L GTP ++ PE I+ +SD+WS+G + Y + + SPF G+ N I +
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-- 223
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTA 198
D+ + SE+ +D +S + EKR
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 1/79 (1%)
Query: 89 IKIIDFGLAQKINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
IK+ DFG+A+ +N R GTP ++ PEI P +SD+W++G + Y + +
Sbjct: 140 IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
Query: 148 PFMGENDSETFANITRAEF 166
F N I R +
Sbjct: 200 AFEAGNMKNLVLKIIRGSY 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 9/133 (6%)
Query: 89 IKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYE-----PIGIESDMWSIGVITYVL 142
IK+ DFG++ K R F GTP ++ PE++ E P ++D+WS+G IT +
Sbjct: 142 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG-ITLIE 200
Query: 143 LSGLSPFMGE-NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQC 201
++ + P E N I ++E + S + KDF+ L K + R T Q
Sbjct: 201 MAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDFLKKCLEKNVDARWTTTQL 259
Query: 202 LSHLWIAQKDSSP 214
L H ++ + P
Sbjct: 260 LQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 18/167 (10%)
Query: 65 HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-- 121
HS + I NI+ T +K+ DFG A ++P + GTP ++ PE+I
Sbjct: 132 HSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPANS---FVGTPYWMAPEVILA 185
Query: 122 ----NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
Y+ + D+WS+G+ L P N +I A+ D + S
Sbjct: 186 MDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNDSPTLSSNDWS 240
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDK 224
+ ++F+ S L K + R ++++ L H ++ ++ + +I K
Sbjct: 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTK 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 39/168 (23%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI------PPEI-INYEPIGI 128
P N++ + +KI DFGLA+ + + F T E++ PEI ++++
Sbjct: 133 PGNLLVNADCE--LKICDFGLARGFSENPGENAGFMT-EYVATRWYRAPEIMLSFQSYTK 189
Query: 129 ESDMWSIGVITYVLLSGLSPFMGEN---------------DSETFANI------------ 161
D+WS+G I LL F G++ D ET + I
Sbjct: 190 AIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSL 249
Query: 162 -TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208
+ F + F + A D + LL KR++ ++ L H ++A
Sbjct: 250 PNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 31/124 (25%), Positives = 57/124 (45%), Gaps = 8/124 (6%)
Query: 89 IKIIDFGLAQKI--NPDHPPRVLF---GTPEFIPPEIINYEP-IGIESDMWSIGVITYVL 142
+KI DFG++ + D +V GTP ++ PE++ ++D+WS G+ L
Sbjct: 141 VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200
Query: 143 LSGLSPFMGENDSETFANITRAEF-DFDDEA-FEALSEDAKDFISSLLVKRKEKRLTAKQ 200
+G +P+ + + + + A ++ S+ + IS L K KR TA++
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
Query: 201 CLSH 204
L H
Sbjct: 261 LLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214495 smart00060, FN3, Fibronectin type 3 domain | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-05
Identities = 19/52 (36%), Positives = 24/52 (46%), Gaps = 1/52 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGG-CMITGYVVEMKAGTQPWVELSE 52
P PPS TSV ++W PP DG I GY VE + W E++
Sbjct: 1 PSPPSNLRVTDVTSTSVTLSWEPPPDDGITGYIVGYRVEYREEGSEWKEVNV 52
|
One of three types of internal repeat within the plasma protein, fibronectin. The tenth fibronectin type III repeat contains a RGD cell recognition sequence in a flexible loop between 2 strands. Type III modules are present in both extracellular and intracellular proteins. Length = 83 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 48/186 (25%), Positives = 72/186 (38%), Gaps = 55/186 (29%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ-KINPD------------HP 105
RGL + H + + P+N++ + +K+ DFGLA+ K P P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 106 PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPF---------------M 150
P VL G+ E+ P DMW +G I Y + +G F +
Sbjct: 172 PDVLLGSTEYSTP-----------IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
Query: 151 GENDSETFANITRAEFDFDDEAFEA------------LSEDAKDFISSLLVKRKEKRLTA 198
G ET+ IT E +F F L D D +SSLL+ + R++A
Sbjct: 221 GTPTEETWPGITSNE-EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279
Query: 199 KQCLSH 204
+ L H
Sbjct: 280 EAALRH 285
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 42/188 (22%), Positives = 71/188 (37%), Gaps = 42/188 (22%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFIPPEIINY 123
H ++ D K P NI+ SR IK+ DFG++ Q I D GT ++ PE +
Sbjct: 119 HKIMHRDVK--PSNILVNSRGE--IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQG 172
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGEN-------------DSETFANITRAEFDFDD 170
++SD+WS+G+ + G P + + E + D
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
Query: 171 EA-----FEAL----------------SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
FE L S++ +DF+ L K ++R K+ H +I +
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI-K 291
Query: 210 KDSSPGVN 217
+ V+
Sbjct: 292 RAELEEVD 299
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 42/158 (26%)
Query: 88 HIKIIDFGLAQKI-NPDHP--PRVLFGTPEFIPPEIINYEPIGIES-----DMWSIGVIT 139
+KI DFGLA+ P P P+V+ T + PE++ +G + DMW++G I
Sbjct: 146 CLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELL----LGCTTYTTAIDMWAVGCIL 199
Query: 140 YVLLSGLSPFM-------------------GENDSETFANITRAE--------FDFDDEA 172
LL+ P + E+ F+++ ++
Sbjct: 200 AELLAH-KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210
F LSE ++ LL+ +KR TA++ L + +K
Sbjct: 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 52/160 (32%)
Query: 89 IKIIDFGLAQKI-NPDHP------------PRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
+KI DFGLA++ +P P P +L G E+ DMWS+
Sbjct: 145 LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA-----------IDMWSV 193
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRA-------------------EFDFDD------ 170
G I LL+ F G+++ + I + + F
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 171 -EAFEA--LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ F A LS++ D ++ LL KR++A+ L H +
Sbjct: 254 RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-05
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 30/149 (20%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLSGLS 147
+KI+DFGLA++ + + V+ T + PE+I N+ D+WS+G I +L+G
Sbjct: 157 LKILDFGLARQTDSEMTGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 148 PFMGENDSETFANITRAEFDFDDEAFEAL-SEDAKDFISSL------------------- 187
F G + + I + E + L SEDAK+++ L
Sbjct: 215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLA 274
Query: 188 -------LVKRKEKRLTAKQCLSHLWIAQ 209
LV E R+TA + L+H + +
Sbjct: 275 VNVLEKMLVLDAESRITAAEALAHPYFEE 303
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119
GL H H+ V + P NI+ H++I D GLA + P GT ++ PE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKP-HASVGTHGYMAPE 165
Query: 120 IIN----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175
++ Y+ +D +S+G + + LL G SPF ++ ++ I R + E ++
Sbjct: 166 VLQKGTAYDS---SADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPDS 221
Query: 176 LSEDAKDFISSLLVKRKEKRL 196
S + K + LL + KRL
Sbjct: 222 FSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 19/129 (14%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIES---DMWSIGVITYVLL 143
H+K+ DFG++ +I R F GTP ++ PE+ E G + D+W++G IT + L
Sbjct: 144 HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG-ITAIEL 202
Query: 144 SGLSPFMGENDSETFANITRAEFDFDDEAFE--------ALSEDAKDFISSLLVKRKEKR 195
+ L P M + + RA F F+ S F+ L K +KR
Sbjct: 203 AELQPPMFD------LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 196 LTAKQCLSH 204
TA++ L H
Sbjct: 257 PTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN----PDHPPRVLFGTPEFIPPEI 120
HS + V I NI+ + ++K+ DFG ++++ + + GTP ++ PE+
Sbjct: 123 HSNMIVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA-LSED 179
I+ E G ++D+WS+G +L+ P+ + E A I + + +S+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVLPPHVSDH 237
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+DF+ + V+ K R +A + L H ++
Sbjct: 238 CRDFLKRIFVEAKL-RPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 89 IKIIDFGLAQKI--NPDHPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFGLA+ I +PD+ + P +++ PE I + +SD+WS GV+ + + S
Sbjct: 212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271
Query: 145 GLSPFMGENDSETFAN 160
G SP+ G E F
Sbjct: 272 GASPYPGVQIDEEFCR 287
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ----KINPDHPPRVLFGTPEFIPPEI 120
HS + I P N+ + + +K+ D GL + K H L GTP ++ PE
Sbjct: 123 HSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHS---LVGTPYYMSPER 177
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGE 152
I+ +SD+WS+G + Y + + SPF G+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPP----RVLFGTPEFIPPEI 120
HS + V I NI+ ++ ++K+ DFG +++I + + GTP ++ PE+
Sbjct: 123 HSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR-AEFDFDDEAFEALSED 179
I+ E G ++D+WS+ +L+ P+ + E A I + A + +S+
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSDA 237
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSH 204
+DF+ + V+ K +R TA+ L H
Sbjct: 238 CRDFLKQIFVEEK-RRPTAEFLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ----KINPDHPPRVLFGTPEFIPPEI 120
HS + I P N+ + + +K+ D GL + K H L GTP ++ PE
Sbjct: 123 HSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHS---LVGTPYYMSPER 177
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGE 152
I+ +SD+WS+G + Y + + SPF G+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 32/128 (25%), Positives = 55/128 (42%), Gaps = 14/128 (10%)
Query: 89 IKIIDFGLAQKI--------NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITY 140
IKI DFG+++K+ P L G+ ++ PE++ ++D+WS+G +
Sbjct: 145 IKISDFGISKKLEANSLSTKTNGARPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203
Query: 141 VLLSGLSPFMGENDSETFANI-TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199
+L+G PF + I A + S +A DF+ KR TA
Sbjct: 204 EMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI----SSEAIDFLEKTFEIDHNKRPTAA 259
Query: 200 QCLSHLWI 207
+ L H ++
Sbjct: 260 ELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 4/74 (5%)
Query: 89 IKIIDFGLAQKI--NPDHPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFGLA+ I +PD+ + P +++ PE I I+SD+WS GV+ + + S
Sbjct: 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
Query: 145 GLSPFMGENDSETF 158
G SP+ G E F
Sbjct: 278 GASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 51 SERLFESTE--RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR 107
+E F + E GL H H+ V + P NI+ H++I D GLA + P
Sbjct: 97 AEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP-H 153
Query: 108 VLFGTPEFIPPEIINYEPIGIES--DMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165
GT ++ PE++ + + +S D +S+G + + LL G SPF + I R
Sbjct: 154 ASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT 211
Query: 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
E ++ S + + + LL + +RL
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIP 117
RGL H H+ + I +N++ +K++DFG++ +++ R F GTP ++
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 118 PEIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172
PE+I + SD+WS+G+ + G P + I R
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPKLK 247
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ S+ DFI LVK R + +Q L H +I
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 3/78 (3%)
Query: 90 KIIDFGLAQKI-NPDHPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGV-ITYVLLSGL 146
KI DFGLA+ I + ++ R P ++ PE IN+ I+SD+WS G+ + ++ G
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
Query: 147 SPFMGENDSETFANITRA 164
P+ G ++ E + R
Sbjct: 202 IPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFG+++ + RV T ++PPE I Y ESD+WS GVI + + +
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221
Query: 145 GLSPFMGENDSETFANITRA 164
G P+ +++E IT+
Sbjct: 222 GKQPWFQLSNTEVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 81 CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGV 137
C+ ++ +K+ DFG+ + + D G ++ PPE+ N+ +SD+WS GV
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 138 ITY-VLLSGLSPFMGENDSETFANITR 163
+ + V G PF +++ E I+R
Sbjct: 190 LMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 47/199 (23%)
Query: 61 GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119
G+ H HS + + P NI V ++ +KI+DFGLA+ + T + PE
Sbjct: 135 GIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 120 IINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR------AEFD------ 167
+I D+WS+G I L+ G F G + + + + AEF
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 168 -------------------FDDEAFEALSE-------DAKDFISSLLVKRKEKRLTAKQC 201
F D F + SE A+D +S +LV +KR++ +
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 202 LSHLWI------AQKDSSP 214
L H +I A+ ++ P
Sbjct: 313 LRHPYITVWYDPAEAEAPP 331
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 23/82 (28%), Positives = 31/82 (37%), Gaps = 11/82 (13%)
Query: 87 HHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYV 141
+KI DFGLA+ + D + P P PE + SD+WS GV Y
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYV-KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYE 204
Query: 142 LLSGLSPFMGENDSETFANITR 163
L + G+ A R
Sbjct: 205 LFT-----YGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 90 KIIDFGLAQKINPD-HPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGVITYVLLS-GL 146
K+ DFGLA+ I D + R P ++ PE Y I+SD+WS G++ +++ G
Sbjct: 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
Query: 147 SPFMGENDSETFANITR 163
P+ G ++E + +
Sbjct: 203 MPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPD---HPPRVLFGTP-EFIPPEIINYEPIGIESDMW 133
N++ V++ H+ KI DFGL++ + D + R P ++ PE IN+ SD+W
Sbjct: 125 NVLLVNQ--HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVW 182
Query: 134 SIGVITYVLLS-GLSPFMGENDSETFANITRAE 165
S G+ + S G P+ E + I + +
Sbjct: 183 SYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK 215
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 15/93 (16%)
Query: 76 PENIM-CVSRTSHHIKIIDFGL-----------AQKINPDHPPRVLFGTPEFIPPEIINY 123
P+NIM + H K++DFG+ + + GTP + PE +
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE---VLGTPTYCAPEQLRG 163
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSE 156
EP+ SD+++ G+I L+G G + +E
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFG+++ + RV T ++PPE I Y ESD+WS+GV+ + + +
Sbjct: 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
Query: 145 GLSPFMGENDSETFANITRA 164
G P+ +++E IT+
Sbjct: 219 GKQPWYQLSNNEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 6/75 (8%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTP----EFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
+KI DFGLA+ I D P V G+ +++ PE I + +SD+WS GV+ + + S
Sbjct: 213 VKICDFGLARDIYKD-PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
Query: 145 -GLSPFMGENDSETF 158
G SP+ G +E F
Sbjct: 272 LGASPYPGVQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGT--P-EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFG+++ + RV T P ++PPE I Y ESD+WS GV+ + + +
Sbjct: 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
Query: 145 GLSPFMGENDSETFANIT 162
G P+ G ++ E IT
Sbjct: 221 GKQPWYGLSNEEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 51/191 (26%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFI------PPEI-INYEPIGIESDMWSIGVITYV 141
+KI DFGLA+ +P+H F T E++ PEI +N + D+WS+G I
Sbjct: 145 LKICDFGLARIADPEHDHTG-FLT-EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAE 202
Query: 142 LLSG--LSP-------------FMGENDSETFANIT--RA-----------EFDFDDEAF 173
+LS L P +G E I RA + ++ F
Sbjct: 203 MLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNK-LF 261
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSSPGVNKII---------- 220
A D + +L KR+T ++ L+H ++ Q P +
Sbjct: 262 PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDL 321
Query: 221 STDKLKKYIYR 231
+KLK+ I+
Sbjct: 322 PKEKLKELIFE 332
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 4/79 (5%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGT--P-EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+KI DFG+++ I RV T P ++PPE I Y ESD+WS GV+ + + +
Sbjct: 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220
Query: 145 GLSPFMGENDSETFANITR 163
G P+ +++E IT+
Sbjct: 221 GKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 31/125 (24%), Positives = 49/125 (39%), Gaps = 10/125 (8%)
Query: 87 HHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYV 141
+KI DFGLA+ I D V +P PE I ESD+WS G++ +
Sbjct: 178 KIVKICDFGLARDIMNDSNYVVKGNA--RLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235
Query: 142 LLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200
+ S G +P+ G F + + + + D + + KR T KQ
Sbjct: 236 IFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA--PAEIYDIMKTCWDADPLKRPTFKQ 293
Query: 201 CLSHL 205
+ +
Sbjct: 294 IVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 39/132 (29%), Positives = 65/132 (49%), Gaps = 20/132 (15%)
Query: 30 GCMITGYVVEMK--AGTQ---PW-VELSERLFESTERGLGHHSLVTVDPKILPENIMCVS 83
GC++ YV E K G+Q W V++++ + ER L H L N++
Sbjct: 93 GCLLD-YVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAA-------RNVLV-- 142
Query: 84 RTSHHIKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGVITY 140
++ +H+KI DFGLA+ + D G +++ E I+Y +SD+WS GV +
Sbjct: 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIW 202
Query: 141 VLLS-GLSPFMG 151
L++ G P+ G
Sbjct: 203 ELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 26/179 (14%)
Query: 59 ERGLGHHSLVTVDP--------KIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHP 105
E LG ++ TV KI+ P NI+ + R + IK+ DFG++ ++
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL-LDRNGN-IKLCDFGISGQLVDSIA 163
Query: 106 PRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT 162
G ++ PE I+ + + SD+WS+G+ Y + +G P+ N F +T
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLT 221
Query: 163 R-----AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGV 216
+ + E E S +FI+ L+K + KR K+ L H +I +
Sbjct: 222 QVVKGDPPILSNSEERE-FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 7/125 (5%)
Query: 89 IKIIDFGLAQKINPDHPPR-VLFGTPEFIPPEIINYE-----PIGIESDMWSIGVITYVL 142
+K++DFG++ ++ R GTP ++ PE+I E D+WS+G+ L
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
Query: 143 LSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
G P + +T I R E FIS L+K E R + L
Sbjct: 227 GDGDPPLFDMHPVKTLFKIPRNPPPTLLHP-EKWCRSFNHFISQCLIKDFEARPSVTHLL 285
Query: 203 SHLWI 207
H +I
Sbjct: 286 EHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.001
Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTP---EFIPPEIINYEPIGIESDMWSIGVITYVLLS- 144
+K+ DFGLA+ + D GT ++ PPE+ +Y +SD+WS GV+ + + S
Sbjct: 139 VKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
Query: 145 GLSPFMGENDSETFANITR 163
G P+ ++SE +++
Sbjct: 198 GKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 8/126 (6%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGI---ESDMWSIGVITYVLLS 144
+K+ DFG A +P + GTP ++ PE+I G + D+WS+G+ L
Sbjct: 163 QVKLADFGSASIASPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219
Query: 145 GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
P N +I + E S+ ++F+ S L K + R T+++ L H
Sbjct: 220 RKPPLFNMNAMSALYHIAQNESPTLQS--NEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277
Query: 205 LWIAQK 210
+++ ++
Sbjct: 278 MFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 53/187 (28%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ-KINPD------------HP 105
RGL + H + + P+N++ R +K+ DFGLA+ K P P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 106 PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPF---------------M 150
P +L G+ ++ + DMW +G I Y + +G F +
Sbjct: 173 PDILLGSTDY-----------STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 151 GENDSETFANITRAE----FDFDDEAFEA-------LSEDAKDFISSLLVKRKEKRLTAK 199
G ET+ I E +++ + L D + +S LL KR++A+
Sbjct: 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281
Query: 200 QCLSHLW 206
+ + H +
Sbjct: 282 EAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 90 KIIDFGLAQKI-NPDHPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGV-ITYVLLSGL 146
KI DFGLA+ I + ++ R P ++ PE Y I+SD+WS G+ +T ++ G
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 147 SPFMGENDSETFANITRA 164
P+ G N+ E + R
Sbjct: 202 VPYPGMNNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 25/83 (30%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 81 CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSI 135
C+ ++ +KI DFG++++ V G + IP PE +NY ESD+WS
Sbjct: 124 CLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQ-IPIKWTAPEALNYGRYTSESDVWSY 181
Query: 136 GVITYVLLS-GLSPFMGENDSET 157
G++ + S G +P+ G ++ +T
Sbjct: 182 GILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 36/152 (23%), Positives = 60/152 (39%), Gaps = 35/152 (23%)
Query: 88 HIKIIDFGLAQKINPD----HPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVL 142
IK+ DFGLA+ N + + +V+ T + PPE++ E G D+WS G I L
Sbjct: 154 QIKLADFGLARLYNSEESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
Query: 143 ---------------LSGLSPFMGENDSETFANITRAEFDFDD------------EAFEA 175
L +S G + ++ + + F+ E F
Sbjct: 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY-FNTMKPKKQYRRRLREEFSF 270
Query: 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ A D + +L KR TA++ L+ W+
Sbjct: 271 IPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 41/163 (25%), Positives = 63/163 (38%), Gaps = 25/163 (15%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
HS V + P+NI+ S S IK+ DFGLA+ + + T + PE++
Sbjct: 127 HSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI-----TRAEFDFDDE------AF 173
D+WS+G I + F G +D + I E D+ + AF
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244
Query: 174 EA------------LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ + E KD + L KR++A LSH
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 33/179 (18%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
RGL + HS + + P N+ ++I+DFGLA++ + + V T + P
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAV--NEDCELRILDFGLARQADDEMTGYV--ATRWYRAP 184
Query: 119 EI-INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL- 176
EI +N+ D+WS+G I LL G + F G + + I E + +
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 177 SEDAKDFISSL--------------------------LVKRKEKRLTAKQCLSHLWIAQ 209
SE A+ +I SL LV +KR++A + L+H + +Q
Sbjct: 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 36/183 (19%), Positives = 64/183 (34%), Gaps = 50/183 (27%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPD-------------HP 105
+G+ H H + + P+N++ V + +KI D GL + +
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLL-VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 106 PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR-- 163
P VL G+ + P D+WS+G I + F G+++ + +I +
Sbjct: 180 PEVLLGSTHYSTP-----------VDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 164 ---------AEFDFDD-------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQC 201
D A LS + D + +L KR++AK
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288
Query: 202 LSH 204
L+H
Sbjct: 289 LTH 291
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.003
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI---PPEIINYEPIGIESDMWS 134
N + V +KI DFGL++ + D R G I PE + +SD+WS
Sbjct: 135 NCL-VGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS 192
Query: 135 IGVITYVLLS-GLSPFMGENDSETFANITR 163
GV+ + + + G +P+ G ++ E + +
Sbjct: 193 FGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (87), Expect = 0.003
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 56/192 (29%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ-KINPDH------------P 105
RGL + H + + P+N++ +S T +K+ DFGLA+ K P H P
Sbjct: 114 RGLSYIHQRYILHRDLKPQNLL-ISDTGE-LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 106 PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND-----SETFAN 160
P VL G+ E+ DMW +G I ++ G++ F G D F
Sbjct: 172 PDVLLGSTEY-----------STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220
Query: 161 ITRAEFD----------FDDEAFEALSED--------------AKDFISSLLVKRKEKRL 196
+ D F E F S A+D S LL + RL
Sbjct: 221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280
Query: 197 TAKQCLSHLWIA 208
+A+ LSH + +
Sbjct: 281 SAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 37/154 (24%), Positives = 57/154 (37%), Gaps = 49/154 (31%)
Query: 89 IKIIDFGLAQKIN-P----DH--------PPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
IK+ DFGLA+ P H P VL G+P + P D+WSI
Sbjct: 140 IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP-----------VDIWSI 188
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRA-------------------------EFDFDD 170
G I + + F G+++ + I R +
Sbjct: 189 GTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR 248
Query: 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
A + L ED D + +L+ KR++AK+ L+H
Sbjct: 249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| KOG0577|consensus | 948 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| KOG0584|consensus | 632 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| KOG0690|consensus | 516 | 99.98 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| KOG0607|consensus | 463 | 99.98 | ||
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| KOG0587|consensus | 953 | 99.97 | ||
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG2345|consensus | 302 | 99.97 | ||
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG0665|consensus | 369 | 99.97 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0671|consensus | 415 | 99.97 | ||
| KOG0193|consensus | 678 | 99.97 | ||
| KOG0666|consensus | 438 | 99.97 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG1026|consensus | 774 | 99.97 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG0608|consensus | 1034 | 99.97 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| KOG0662|consensus | 292 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0669|consensus | 376 | 99.96 | ||
| KOG4257|consensus | 974 | 99.96 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| KOG0194|consensus | 474 | 99.96 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1006|consensus | 361 | 99.96 | ||
| KOG1095|consensus | 1025 | 99.96 | ||
| KOG0670|consensus | 752 | 99.96 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0199|consensus | 1039 | 99.96 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG4278|consensus | 1157 | 99.96 | ||
| KOG1027|consensus | 903 | 99.95 | ||
| KOG0196|consensus | 996 | 99.95 | ||
| KOG0695|consensus | 593 | 99.95 | ||
| KOG4250|consensus | 732 | 99.94 | ||
| KOG1187|consensus | 361 | 99.94 | ||
| KOG0200|consensus | 609 | 99.94 | ||
| KOG0668|consensus | 338 | 99.93 | ||
| KOG0984|consensus | 282 | 99.93 | ||
| KOG1151|consensus | 775 | 99.93 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1094|consensus | 807 | 99.93 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0576|consensus | 829 | 99.92 | ||
| KOG1024|consensus | 563 | 99.92 | ||
| KOG0664|consensus | 449 | 99.91 | ||
| KOG1025|consensus | 1177 | 99.91 | ||
| KOG2052|consensus | 513 | 99.91 | ||
| KOG1290|consensus | 590 | 99.9 | ||
| KOG1345|consensus | 378 | 99.9 | ||
| KOG1167|consensus | 418 | 99.9 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG3653|consensus | 534 | 99.88 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG1152|consensus | 772 | 99.84 | ||
| KOG1033|consensus | 516 | 99.82 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG0195|consensus | 448 | 99.79 | ||
| KOG1164|consensus | 322 | 99.79 | ||
| KOG0603|consensus | 612 | 99.78 | ||
| KOG1240|consensus | 1431 | 99.77 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158|consensus | 598 | 99.74 | ||
| KOG1165|consensus | 449 | 99.73 | ||
| KOG0606|consensus | 1205 | 99.72 | ||
| KOG1023|consensus | 484 | 99.72 | ||
| KOG1163|consensus | 341 | 99.69 | ||
| KOG0590|consensus | 601 | 99.6 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.56 | |
| KOG1166|consensus | 974 | 99.53 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.52 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.51 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.5 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.5 | |
| KOG1266|consensus | 458 | 99.45 | ||
| KOG0606|consensus | 1205 | 99.38 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.33 | |
| KOG0601|consensus | 524 | 99.28 | ||
| KOG2137|consensus | 700 | 99.22 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.17 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.15 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.12 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.12 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.09 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.04 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.9 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.75 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.69 | |
| KOG0601|consensus | 524 | 98.64 | ||
| KOG3087|consensus | 229 | 98.63 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.53 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| KOG1243|consensus | 690 | 98.2 | ||
| KOG1035|consensus | 1351 | 98.01 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.6 | |
| KOG3741|consensus | 655 | 97.34 | ||
| KOG0576|consensus | 829 | 97.28 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.89 | |
| KOG1235|consensus | 538 | 96.79 | ||
| KOG1826|consensus | 2724 | 95.95 | ||
| KOG2270|consensus | 520 | 95.18 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.7 | |
| KOG1093|consensus | 725 | 94.51 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.49 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.77 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.74 | |
| KOG2268|consensus | 465 | 93.55 | ||
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.64 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.64 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.59 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 92.47 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.1 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.85 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 91.34 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.42 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.86 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.79 | |
| PLN02236 | 344 | choline kinase | 89.64 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 89.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.24 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 88.63 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 87.69 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 86.9 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.6 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 85.29 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 85.28 | |
| KOG2269|consensus | 531 | 84.2 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 81.75 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 81.49 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=300.27 Aligned_cols=189 Identities=28% Similarity=0.460 Sum_probs=171.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg~~ 97 (239)
..|+||||++||.|.+.+ ..++.+.+...+.++.|++.|+.| |++||+||||||+|||+..+ ..-.+|++|||++
T Consensus 250 s~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 348999999999999998 568888899999999999999999 99999999999999999655 3467899999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhccCCCchHHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI---GIESDMWSIGVITYVLLSGLSPFMGENDSE-TFANITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~ 173 (239)
+..+......+.+|||.|+|||.+.+..+ ..+.|+||+||++|-+++|.+||.+..... ..+.|.++.+.+.+..|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 99988888888999999999999977654 447899999999999999999998766555 88999999999999999
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..++.+..+|+++||..||+.|||++++|+||||+...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999999998533
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=292.05 Aligned_cols=182 Identities=24% Similarity=0.322 Sum_probs=160.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-++++||||++|+|..++. ..+.+++.....++.++++||.| |+ ++||||||||+|||| ...|.|||||||++
T Consensus 152 ~isI~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv--NskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV--NSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee--ccCCCEEecccccc
Confidence 5788999999999999984 34889999999999999999999 85 999999999999999 77889999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CchHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE-----NDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~ 172 (239)
....+. ...+++||..|||||.+.+..|+.++||||||+.++|+++|+.||... ...+.+..|..+..+..+.
T Consensus 227 ~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~- 304 (364)
T KOG0581|consen 227 GILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE- 304 (364)
T ss_pred HHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc-
Confidence 888766 667889999999999999999999999999999999999999999764 4456666776654332221
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+++++++|+..||++||.+|||+.|+++|||+++
T Consensus 305 -~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 305 -GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 148999999999999999999999999999999986
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=271.37 Aligned_cols=218 Identities=26% Similarity=0.451 Sum_probs=193.2
Q ss_pred ceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEec
Q psy1096 17 SVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDF 94 (239)
Q Consensus 17 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~df 94 (239)
+..+.|+|.|++.|+.|..-+.. ....++..+...++||+.+|.| |.+||||||+||+|+++-+ +.+..+||+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ccceeEEEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeeccc
Confidence 34478999999999998765543 2566778889999999999999 9999999999999999854 44567999999
Q ss_pred ccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
|++...+....-....|||.||+||..+..+|+-.+|||+.||++|-++.|.+||++.+....++.|..+.+..+.+.|.
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~ 237 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD 237 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC
Confidence 99998886656666789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC-CccccccchhHHHHHHHHhhhccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS-PGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
.+++..++|+++||..||.+|.|+.|+|+|||+++++.- ......-..++|+++.++||+|.+
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKga 301 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGA 301 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHH
Confidence 999999999999999999999999999999999885533 344555566899999999999875
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=293.46 Aligned_cols=186 Identities=27% Similarity=0.458 Sum_probs=174.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++.||++||.|.+++. ..|.+++..+.++|.||+.|+.| |..+|+|||+||+|+|+ +..+.+|++|||.+.
T Consensus 86 ~lylvlEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL--d~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL--DVKNNIKIADFGMAS 160 (786)
T ss_pred eEEEEEEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh--hcccCEeeeccceee
Confidence 4568899999999999995 57899999999999999999999 99999999999999999 666679999999999
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...++....+.+|+|.|++||.+.|.+| +.++||||+||+||.+++|.+||.+++-...+.+++++.+.+| .+++
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is 236 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNIS 236 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCC
Confidence 8888888899999999999999999999 8999999999999999999999999999999999999999998 4899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.++++|+++||..||++|.|.++|++|||+......+
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 9999999999999999999999999999998766554
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=264.96 Aligned_cols=218 Identities=26% Similarity=0.396 Sum_probs=189.3
Q ss_pred CCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 15 RTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 15 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~d 93 (239)
-.+...+|+|.|.|+.|.|.+++ ...-.+++...+.|++|++.|+.| |.++|||||+||+||++ +++..++++|
T Consensus 92 yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl--ddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL--DDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee--ccccceEEec
Confidence 33455678899999999999999 557789999999999999999999 99999999999999999 7788999999
Q ss_pred cccceecCCCCCCccccCCCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC
Q psy1096 94 FGLAQKINPDHPPRVLFGTPEFIPPEIINYE------PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 94 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
||+++...++......+|||+|+|||.+.+. +|+...|+|++||++|.++.|.+||+......++..|..+.+.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 9999999999888899999999999999653 5788999999999999999999999999999999999999999
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC--CccccccchhHHHHHHHHhhhccc
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS--PGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
+..+.|..++...++|+.+||+.||.+|.|++++|+||||.+.-.. +........+.++.+-..|.+|..
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~~~~~~k~qt~~~aRkrF 318 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVVEVELVKDQTSERARKRF 318 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCcchhhhhhhhhHHhhhhe
Confidence 9999999999999999999999999999999999999999542111 111223345667776666655543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=281.70 Aligned_cols=181 Identities=28% Similarity=0.490 Sum_probs=167.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~~ 97 (239)
.+|+|||||.||.|.+++. ..+.+.+..++.+|.|+++|++| |++||+||||||+||++ +.+ +.+||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill--d~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL--DGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe--cCCCCCEEEeccccc
Confidence 4789999999999999995 37889999999999999999999 99999999999999999 555 89999999999
Q ss_pred eec-CCCCCCccccCCCCccCccccccCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 98 QKI-NPDHPPRVLFGTPEFIPPEIINYEP-I-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~-~~~~~~~~~~~~~~~~aPE~~~~~~-~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
... .......+..|++.|+|||.+.+.. | +.++|+||+||++|.|++|..||...+.......+.++.+..+.
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~---- 244 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS---- 244 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----
Confidence 888 4666777889999999999999988 8 68999999999999999999999998888899999999888874
Q ss_pred hc-CHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 AL-SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~-~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+ +.++++|+++||..||.+|+|+.+++.|+||+.
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 55 999999999999999999999999999999996
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=280.19 Aligned_cols=186 Identities=29% Similarity=0.474 Sum_probs=170.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|.|+||+++|.|.+++ ..-|.+.+..++.++.+|+.||.| |++|||||||||+|||+ +.+++++|+|||.++
T Consensus 148 sLYFvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL--d~dmhikITDFGsAK 222 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL--DKDGHIKITDFGSAK 222 (604)
T ss_pred ceEEEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE--cCCCcEEEeeccccc
Confidence 456799999999999999 556999999999999999999999 99999999999999999 888899999999988
Q ss_pred ecCCCCC--------------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Q psy1096 99 KINPDHP--------------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA 164 (239)
Q Consensus 99 ~~~~~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~ 164 (239)
.+.+... ..+++||..|++||.+.....+..+|+|+|||++|+|+.|.+||.+.+.--+.++|.+.
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 7643211 14578999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.+.+++ .+++.+++|++++|..||.+|+|+++|.+||||...+|+.
T Consensus 303 ~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 303 DYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 998885 7899999999999999999999999999999999888764
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=282.67 Aligned_cols=183 Identities=26% Similarity=0.438 Sum_probs=162.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||++||+|.+++- +..+.|.++..++++++.||+| |.+||+|||||.+|||+ ..+|.+||+|||++.
T Consensus 344 eLWVVMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL--~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL--TMDGSVKLTDFGFCA 417 (550)
T ss_pred eeEEEEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe--ccCCcEEEeeeeeee
Confidence 5899999999999999974 4559999999999999999999 99999999999999999 777789999999988
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.+.... ...+.+|||.|||||......|+.+.||||||++.+||+.|++||.+.+....+..|..... +.....+.++
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk~~~klS 496 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLKNPEKLS 496 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcCCccccC
Confidence 876554 66778999999999999999999999999999999999999999998887777776655433 3333446789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+++|+.+||+.|+++|+++.+||+||||+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999999999954
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=282.42 Aligned_cols=183 Identities=27% Similarity=0.415 Sum_probs=171.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++.|+|..++|.+++ +....++|.+++.++.||+.||.| |+++|+|||||..|+++ +.+..||++|||++.
T Consensus 92 nVYivLELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL--~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL--NENMNVKIGDFGLAT 166 (592)
T ss_pred ceEEEEEecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee--cCcCcEEecccceee
Confidence 578999999999999888 567899999999999999999999 99999999999999999 777789999999999
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... ....+.+|||-|+|||++.....+..+||||+||++|.++.|++||...+..+++.+|....+.+|. .++
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls 242 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLS 242 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccC
Confidence 98854 5667789999999999999999999999999999999999999999999999999999999998885 789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.++++||.++|+.||.+|||++++|.|+||+++.
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 9999999999999999999999999999996543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=254.62 Aligned_cols=188 Identities=27% Similarity=0.458 Sum_probs=173.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++|||++||.|..++ .+.+.+++..++-++.||+.||+| |+.+|++||+||||||+ +.+|.+|++|||+++
T Consensus 118 ~lymvmeyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl--D~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL--DQNGHIKITDFGFAK 192 (355)
T ss_pred eEEEEEeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee--ccCCcEEEEeccceE
Confidence 567999999999999998 568899999999999999999999 99999999999999999 889999999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ..+.+|||-|+|||.+...++..++|=|+|||++|+|+.|.+||...+...++++|..+...+|. .++.
T Consensus 193 ~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~ 266 (355)
T KOG0616|consen 193 RVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSS 266 (355)
T ss_pred EecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCH
Confidence 87644 45678999999999999999999999999999999999999999999999999999999999885 7899
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCCCcccc
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSSPGVNK 218 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~~~~~~ 218 (239)
.+++|++++|+.|-.+|. ..++|.+||||++.++..-.+.
T Consensus 267 ~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred HHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 999999999999999993 5678999999998887654433
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=259.01 Aligned_cols=186 Identities=25% Similarity=0.425 Sum_probs=169.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+|++|+.||.|...+ ..++.+++..++-++.+|+.||.| |+.|||||||||+|||+ +..|+++|+|||+++
T Consensus 99 kLylVld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL--d~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL--DEQGHIKLTDFGLCK 173 (357)
T ss_pred eEEEEEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee--cCCCcEEEeccccch
Confidence 567899999999999777 568999999999999999999999 99999999999999999 888999999999998
Q ss_pred e-cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 K-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
. ...+....+.+||+.|||||.+.+.+|+..+|-||+|+++|+|++|.+||.+.+.....++|.++....++ ..++
T Consensus 174 ~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls 250 (357)
T KOG0598|consen 174 EDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLS 250 (357)
T ss_pred hcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCC
Confidence 5 44455666789999999999999999999999999999999999999999999999999999998854443 2479
Q ss_pred HHHHHHHHHhhhhCcccCC----CHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL----TAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp----t~~~ll~h~~~~~~~~~ 213 (239)
.+.+++++++|..||.+|. +++++-+||||+...|+
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 9999999999999999995 69999999999886655
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=259.03 Aligned_cols=188 Identities=23% Similarity=0.418 Sum_probs=168.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CC---CcEEEEec
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TS---HHIKIIDF 94 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~---~~vkl~df 94 (239)
.+|+|||||.||+|.+|+ ...+.+++.+++.++.|++.||++ |+++||||||||+|||++.. .+ -.+|++||
T Consensus 83 ~i~lVMEyC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred eEEEEEEeCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 678999999999999999 457799999999999999999999 99999999999999999654 22 57899999
Q ss_pred ccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
|+++.+.+.....+..|++.|||||++...+|+.|+|+||+|+++|+|++|..||...+..+....+.++....+... .
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~ 238 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-A 238 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-h
Confidence 999999988888889999999999999999999999999999999999999999999999999988887766554322 4
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.++....+++...+..++..|.+.++-+.|+++....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 5677788999999999999999999999999997533
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=261.83 Aligned_cols=188 Identities=29% Similarity=0.403 Sum_probs=154.4
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
...++.|||+.+|+|.+++.. .++.+++..++.+..||+.||.| |++|+||+||||+|||+ +. ++.+||+|||.
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~--~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl--~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKR--YGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL--DPSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE--eCCCCeEEeccCcc
Confidence 467788999999999999863 33389999999999999999999 99999999999999999 55 67999999999
Q ss_pred ceecCC----CCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhccCCCch
Q psy1096 97 AQKINP----DHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFDFDD 170 (239)
Q Consensus 97 ~~~~~~----~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~i~~~~~~~~~ 170 (239)
+..... ........||+.|||||.+... ....++||||+||++.+|+||..||.. .........+......+
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-- 242 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--
Confidence 877663 1223346799999999999853 234599999999999999999999987 34444444444443211
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++...++|+.+|+..+|++|||++++|+|||+++...
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 333578999999999999999999999999999999987443
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=246.60 Aligned_cols=194 Identities=24% Similarity=0.418 Sum_probs=172.9
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFG 95 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg 95 (239)
.-.+.+|||.++||.|..-+.+ .....++++++.+|+.||..|+.| |+.+|.||||||+|+|.+.. .+..+||+|||
T Consensus 131 rkcLLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred ceeeEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 3356789999999999988866 445669999999999999999999 99999999999999998653 44578999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHHHhccCCCchH
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN----DSETFANITRAEFDFDDE 171 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~ 171 (239)
+++.........+...||.|+|||.+.-.+|+...|+||+||++|-|++|.+||..+. ...+..+|..+.+.+|.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 9998877677778889999999999998899999999999999999999999997543 345677889999999999
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.|..+|...+++++++|..+|.+|.|++++++|||+.+...
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 99999999999999999999999999999999999987443
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=249.15 Aligned_cols=184 Identities=20% Similarity=0.286 Sum_probs=159.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+++|.|||+...|.++- ..++| ++.+.+++++.|++.|+.| |++++|||||||+||+| ..+|.+||||||+++
T Consensus 75 klhLVFE~~dhTvL~eLe--~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi--t~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELE--RYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI--TQNGVVKLCDFGFAR 149 (396)
T ss_pred eeEEEeeecchHHHHHHH--hccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE--ecCCcEEeccchhhH
Confidence 578899999999999654 35555 5567889999999999999 99999999999999999 788899999999998
Q ss_pred ecC-CCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH----
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA---- 172 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~---- 172 (239)
... ++...+.++.|.+|.|||.+.+ .+|+...|||++||++.+|++|.+.|+|.++.+.+..|.+......++-
T Consensus 150 ~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 150 TLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred hhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 877 6677788899999999999987 6799999999999999999999999999999999888876544333221
Q ss_pred -----------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 173 -----------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 173 -----------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
...++.-+.+|+++||..||++|++.+++|.|++|.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 123456688999999999999999999999999994
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=264.08 Aligned_cols=188 Identities=28% Similarity=0.412 Sum_probs=164.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||.+||++..+| ...+.++++.++.++.+++.|+.. |+.|+|||||||+|+|| +..|++||+|||++.
T Consensus 215 ~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi--D~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI--DAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee--cCCCCEeeccccccc
Confidence 578899999999999999 568899999999999999999999 99999999999999999 999999999999975
Q ss_pred ecCC------------------------CC----CC--------------------ccccCCCCccCccccccCCCCchh
Q psy1096 99 KINP------------------------DH----PP--------------------RVLFGTPEFIPPEIINYEPIGIES 130 (239)
Q Consensus 99 ~~~~------------------------~~----~~--------------------~~~~~~~~~~aPE~~~~~~~~~~~ 130 (239)
.... .. .. ...+|||.|+|||++.+.+|+...
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 4311 00 00 024699999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhcccc
Q psy1096 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWI 207 (239)
Q Consensus 131 DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~ 207 (239)
|-|||||++|||+.|.+||.+.+..+++.+|..-...+..+.-..++.++.+||.+||+ ||++|.. ++||.+||||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999998766444333334678999999999999 9999985 9999999999
Q ss_pred ccCCCC
Q psy1096 208 AQKDSS 213 (239)
Q Consensus 208 ~~~~~~ 213 (239)
+..+|.
T Consensus 449 ~~v~W~ 454 (550)
T KOG0605|consen 449 KGVDWD 454 (550)
T ss_pred ccCCcc
Confidence 988776
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=254.83 Aligned_cols=191 Identities=19% Similarity=0.333 Sum_probs=162.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+||+|+.+|++.+++..+.+.| +.+..+..|+++++.||.| |++|.||||||+.|||| +.+|.|+|+|||++.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi--~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI--DSDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE--cCCCcEEEcCceeee
Confidence 5789999999999999999988777 8888999999999999999 99999999999999999 888999999999876
Q ss_pred ecCCCCC----C-ccccCCCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC----
Q psy1096 99 KINPDHP----P-RVLFGTPEFIPPEIIN--YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD---- 167 (239)
Q Consensus 99 ~~~~~~~----~-~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~---- 167 (239)
.+-.... . .+.+|++.|||||.+. ..+|+.|+||||||+...|+++|..||....+...+.....+..+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 5533221 1 4568999999999963 456899999999999999999999999888777665554444432
Q ss_pred --CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 168 --FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 168 --~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.+......++..++.++..||..||.+|||++++|+|+||+..+.+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 2333345678889999999999999999999999999999986655
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=263.78 Aligned_cols=199 Identities=26% Similarity=0.363 Sum_probs=165.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++||||.||++.+++ ..++.+.+..+.-++.+++.||.| |.++.+|||||+.||++ ...|.++|+|||++-
T Consensus 85 ~LwiiMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~--s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL--SESGDVKLADFGVAG 159 (467)
T ss_pred cHHHHHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE--eccCcEEEEecceee
Confidence 578899999999999998 667777888888999999999999 99999999999999999 555899999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... ..+++||+.|||||++.+..|+.++||||||++.++|++|.+|+........+..|-+. .|+.....++
T Consensus 160 ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S 236 (467)
T KOG0201|consen 160 QLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFS 236 (467)
T ss_pred eeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccC
Confidence 7765443 36789999999999999999999999999999999999999999877764443333333 2333335789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHHHHhhhc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 235 (239)
+.+++|+..||++||+.||+|.++|+|+|++... ....|+.++.++++.
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~---------k~s~L~~~i~r~~~~ 285 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK---------KTSELKELIDRYKRW 285 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC---------CchHHHHHHHHHHHH
Confidence 9999999999999999999999999999998622 233555555555443
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=260.91 Aligned_cols=188 Identities=38% Similarity=0.620 Sum_probs=174.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC--CcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS--HHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~--~~vkl~dfg~ 96 (239)
.+|+|||+|.||.|.+.+... .+++..+..++.|++.++.| |+.|++||||||+|+++..... +.++++|||+
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 567899999999999999764 39999999999999999999 9999999999999999976543 5899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+............+||+.|+|||.+.+..|+...|+||+||++|.|++|.+||.+.+.......+..+.+.+....|..+
T Consensus 186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 99988755667788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..+++|++.||..||.+|+|+.++|+|||++...
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 99999999999999999999999999999998753
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=242.68 Aligned_cols=175 Identities=23% Similarity=0.320 Sum_probs=155.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcC-CCchHHHHHHHHHHHHHHHHH-hh--hc--ccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAG-TQPWVELSERLFESTERGLGH-HS--LV--TVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~i~~~l~~-h~--~~--ivH~dikp~nili~~~~~~~vkl~d 93 (239)
.++++||||++|+|.+++..++.. ..+++.++-+++.|+++||.. |. .. +.||||||.||++ +.+|.|||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeecc
Confidence 367899999999999999988664 566778889999999999999 98 45 9999999999999 8899999999
Q ss_pred cccceecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 94 FGLAQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 94 fg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
||+++.+..... ..+.+|||.||+||.+.+.+|+.++||||+||++|+|+.-+.||.|++-.+.-.+|..+.+++.+
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-- 249 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--
Confidence 999988875433 34578999999999999999999999999999999999999999999988888888888665332
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCH
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTA 198 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~ 198 (239)
.+.+|.++..++..|++.||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 25789999999999999999999984
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=254.24 Aligned_cols=187 Identities=24% Similarity=0.308 Sum_probs=163.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||++ .+|++++.+ .+..+++..++.|+.||++||++ |++|+-|||+||||||+ .+...+||+|||+++
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi--~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI--SGNDVIKIADFGLAR 158 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe--cccceeEeccccccc
Confidence 8899999998 556667664 38899999999999999999999 99999999999999999 557789999999999
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-----
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA----- 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----- 172 (239)
......+.+.++.|.+|.|||++.. .-|+.+.|+|++||+++|+.+-++.|+|.+..+.+.+|...-..+....
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 9999999999999999999999954 4579999999999999999999999999999988888866543333221
Q ss_pred ---------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 ---------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ---------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
....+.++.+++..|+.+||++||||+++|+||||....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 123578899999999999999999999999999997644
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=258.67 Aligned_cols=184 Identities=27% Similarity=0.398 Sum_probs=158.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+++..+..++.|++.||+| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 69 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll--~~~~~~kl~DfG~a~ 143 (323)
T cd05571 69 RLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML--DKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--CCCCCEEEeeCCCCc
Confidence 4678999999999988874 46788999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 144 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~ 219 (323)
T cd05571 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLS 219 (323)
T ss_pred ccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 5322 2223345699999999999988999999999999999999999999988777777777766655554 3678
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~ 212 (239)
..+.+|+++||+.||++|| ++.++++|+||++..+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999999999999 8999999999987443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=250.10 Aligned_cols=188 Identities=27% Similarity=0.453 Sum_probs=173.9
Q ss_pred ccCCCceeEEE----------eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeE
Q psy1096 12 SNNRTSVVITW----------SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIM 80 (239)
Q Consensus 12 ~~~~~~~~~~~----------~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nil 80 (239)
+.+|++++.+| +||||..+|.|++|+.+ .+.+++++++.+|+||.+|+.| |+++++|||||.+|||
T Consensus 109 sLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENIL 185 (668)
T KOG0611|consen 109 SLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENIL 185 (668)
T ss_pred hcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhccceecccchhhee
Confidence 46777777655 67999999999999954 7899999999999999999999 9999999999999999
Q ss_pred EecCCCCcEEEEecccceecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy1096 81 CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFA 159 (239)
Q Consensus 81 i~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~ 159 (239)
+ +.++.+|++|||++..+.......+++|+|-|.+||...+.+| ++..|.|||||++|.++.|..||.|.+-.....
T Consensus 186 L--D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 186 L--DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred e--cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 9 8899999999999999988888899999999999999999999 899999999999999999999999999999999
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+|..+.+.-+. -+.+..-||+.||..+|++|.|++++..|.|+.=
T Consensus 264 QIs~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 264 QISRGAYREPE-----TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HhhcccccCCC-----CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 99999887664 3677889999999999999999999999999963
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=253.88 Aligned_cols=185 Identities=25% Similarity=0.424 Sum_probs=160.8
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-.+|+|.|||..|.+...- .....+.+.++++++++++.||.| |.+|||||||||+|+|+ ++.|+|||+|||++
T Consensus 183 ~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl--~~~g~VKIsDFGVs 257 (576)
T KOG0585|consen 183 DKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL--SSDGTVKISDFGVS 257 (576)
T ss_pred CceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE--cCCCcEEeecccee
Confidence 3678999999999988653 334449999999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCC------CCCccccCCCCccCccccccCC---C-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC
Q psy1096 98 QKINPD------HPPRVLFGTPEFIPPEIINYEP---I-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 98 ~~~~~~------~~~~~~~~~~~~~aPE~~~~~~---~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
...... .......|||.|+|||.+.++. + +.+.||||+||+||-++.|+.||.+....+...+|......
T Consensus 258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~ 337 (576)
T KOG0585|consen 258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE 337 (576)
T ss_pred eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc
Confidence 866222 2223367999999999998733 2 78999999999999999999999999999999999999887
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
++... .+...+++||++||++||++|.++.++..|||+.+.
T Consensus 338 fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 338 FPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 77542 568899999999999999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=250.94 Aligned_cols=190 Identities=25% Similarity=0.289 Sum_probs=153.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++.. ..+..+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill--~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEEecCCCcHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--CCCCCEEEeeCCCcE
Confidence 36789999999999877754 234568888999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............|+..|+|||.+.+..++.++|+||+||++|+|++|..||.+.........+..............++.
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCH
Confidence 76544333445689999999999988999999999999999999999999987655333322222111111112235789
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
.+.+|+++||+.||++|++ ++++++||||.+..+
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 9999999999999999997 899999999987443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=250.93 Aligned_cols=211 Identities=20% Similarity=0.231 Sum_probs=173.8
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|+|.||++....- ++. .++-.+++.+++.++.|+++||.| |.+|++|||||.+|||| +.+|.+||+|||++
T Consensus 191 ~siYlVFeYMdhDL~G-Ll~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi--dn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSG-LLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI--DNNGVLKIADFGLA 265 (560)
T ss_pred ceEEEEEecccchhhh-hhc--CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE--cCCCCEEeccccce
Confidence 3678888999876544 443 556789999999999999999999 99999999999999999 88999999999999
Q ss_pred eecCCCC--CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDH--PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
..+.... ..+..+-|++|.+||.+.|. .|+.+.|+||+||++.+|++|++.|.|.+..+.+..|.+....+....|.
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 9776443 56778899999999999876 58999999999999999999999999999999999997765544433332
Q ss_pred -------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHH
Q psy1096 175 -------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYI 229 (239)
Q Consensus 175 -------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~ 229 (239)
.++....+|+..+|..||.+|.|+.++|+++||+..........+-.....+++.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~ 425 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELD 425 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHH
Confidence 3577888999999999999999999999999996655555544444455555544
Q ss_pred HHhhh
Q psy1096 230 YRRKW 234 (239)
Q Consensus 230 ~~~~~ 234 (239)
..++.
T Consensus 426 ~K~r~ 430 (560)
T KOG0600|consen 426 AKRRR 430 (560)
T ss_pred HHHHH
Confidence 44433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=247.74 Aligned_cols=182 Identities=29% Similarity=0.459 Sum_probs=159.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ..+.+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli--~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL--DKEGHIKLTDFGFAK 149 (291)
T ss_pred eEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEEEecCcch
Confidence 5789999999999999884 45678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++.
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~ 223 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDL 223 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCH
Confidence 65432 22346899999999999888999999999999999999999999988888888888777665543 5688
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
.+++++++||+.||.+|++ ++++++|+||+..++
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999999999999995 999999999986443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=251.85 Aligned_cols=184 Identities=23% Similarity=0.350 Sum_probs=158.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~iv~Ey~~~g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli--~~~~~~kL~DfG~~~ 144 (320)
T cd05590 70 RLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL--DHEGHCKLADFGMCK 144 (320)
T ss_pred EEEEEEcCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--CCCCcEEEeeCCCCe
Confidence 3689999999999998774 45678899999999999999999 99999999999999999 777899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (320)
T cd05590 145 EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLS 220 (320)
T ss_pred ecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Confidence 5432 2223345689999999999988899999999999999999999999998888888777776655544 2578
Q ss_pred HHHHHHHHHhhhhCcccCCCH------HHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA------KQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~------~~ll~h~~~~~~~~ 212 (239)
..+.+++++||+.||++|+++ +++++||||...++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999999999999998 99999999976443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=251.65 Aligned_cols=182 Identities=25% Similarity=0.417 Sum_probs=157.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 67 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili--~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 67 KLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCK 141 (312)
T ss_pred eEEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE--CCCCcEEEEECcccc
Confidence 4688999999999998884 45678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 142 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 217 (312)
T cd05585 142 LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFD 217 (312)
T ss_pred cCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCC
Confidence 54322 223345689999999999998899999999999999999999999998877777777766655544 3678
Q ss_pred HHHHHHHHHhhhhCcccCC---CHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRL---TAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp---t~~~ll~h~~~~~~ 210 (239)
..+.+++.+||..||++|+ ++.++++||||++.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=252.94 Aligned_cols=183 Identities=22% Similarity=0.390 Sum_probs=159.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++. ..+.++++.+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 92 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAK 166 (329)
T ss_pred EEEEEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--CCCCCEEEeeccCce
Confidence 4688999999999998884 45678889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
...... ....|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+..+....+ ..++.
T Consensus 167 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~ 240 (329)
T PTZ00263 167 KVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDG 240 (329)
T ss_pred EcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCH
Confidence 664322 235689999999999988899999999999999999999999998887777777776665544 25788
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~ 213 (239)
.+++|+++||+.||.+|++ ++++++||||++.++.
T Consensus 241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 9999999999999999997 7999999999875433
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=251.93 Aligned_cols=183 Identities=27% Similarity=0.399 Sum_probs=156.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|.+.+ ...+.+++..+..++.|++.||+| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 69 ~~~lv~Ey~~~g~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll--~~~~~~kL~DfG~~~ 143 (328)
T cd05593 69 RLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML--DKDGHIKITDFGLCK 143 (328)
T ss_pred EEEEEEeCCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE--CCCCcEEEecCcCCc
Confidence 467899999999998776 345678899999999999999999 99999999999999999 777899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 144 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~ 219 (328)
T cd05593 144 EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLS 219 (328)
T ss_pred cCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCC
Confidence 5322 2223345689999999999988899999999999999999999999988777666666665555444 3578
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+|+++||+.||++|+ +++++++|+||...+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999999997 899999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=250.37 Aligned_cols=183 Identities=27% Similarity=0.391 Sum_probs=157.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|.+++ ..++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 69 ~~~lv~E~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 69 RLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEEeCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--cCCCCEEecccHHhc
Confidence 467899999999998777 345678899999999999999999 99999999999999999 777899999999876
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 144 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~ 219 (323)
T cd05595 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLS 219 (323)
T ss_pred cccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Confidence 5322 2223345689999999999988899999999999999999999999988877777777766655554 3578
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
+.+.+++++||+.||++|+ ++.++++|+||.+..
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999999998 899999999998744
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=253.25 Aligned_cols=183 Identities=23% Similarity=0.364 Sum_probs=159.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL--DKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--CCCCCEEEecCCCCe
Confidence 4789999999999998884 45678899999999999999999 99999999999999999 778899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++.
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 253 (340)
T PTZ00426 180 VVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDN 253 (340)
T ss_pred ecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCH
Confidence 65432 23456899999999999888999999999999999999999999988887777787776655543 5788
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~ 213 (239)
.+.+++++||+.||++|+ +++++++||||+..++.
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999999999995 89999999999875533
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=252.60 Aligned_cols=180 Identities=24% Similarity=0.394 Sum_probs=165.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+|+|||.| .|.+++ ...+.++++.+..+..++++||.| |+.+|.|+|+||.||++ +.+|.+|++|||+++
T Consensus 75 ~~~vVte~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl--~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL--EKGGTLKLCDFGLAR 148 (808)
T ss_pred eEEEEehhhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee--cCCCceeechhhhhh
Confidence 57899999999 888888 568899999999999999999999 99999999999999999 999999999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.+..+. ......|||.|||||...+.+|+..+|+||+||++|+++.|++||...+-....+.|.+....++. ..+
T Consensus 149 ~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S 224 (808)
T KOG0597|consen 149 AMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TAS 224 (808)
T ss_pred hcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----ccc
Confidence 877543 344567999999999999999999999999999999999999999988888888999988888775 679
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+.+|++..|..||.+|.|..+++.|||.++
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 99999999999999999999999999999976
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=248.42 Aligned_cols=183 Identities=23% Similarity=0.363 Sum_probs=155.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++|||+.+++|.+++. .++.+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 70 HLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML--DRDGHIKIADFGMCK 144 (316)
T ss_pred EEEEEECCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEeCccCCCe
Confidence 5689999999999998874 45678889999999999999999 99999999999999999 777899999999876
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~ 220 (316)
T cd05620 145 ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWIT 220 (316)
T ss_pred ecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 5322 1223345689999999999998999999999999999999999999988877777776665544333 2578
Q ss_pred HHHHHHHHHhhhhCcccCCCH-HHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-KQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-~~ll~h~~~~~~~ 211 (239)
..+++++++||..||++|+++ +++++||||+..+
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 899999999999999999997 6899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=248.95 Aligned_cols=184 Identities=28% Similarity=0.438 Sum_probs=158.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+.+..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--cCCCCEEEeecCcce
Confidence 4688999999999998874 45678889999999999999999 99999999999999999 777899999999876
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 225 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLS 225 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 5322 2223345689999999999998899999999999999999999999998888778777776665544 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCH-----HHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-----KQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-----~~ll~h~~~~~~~~ 212 (239)
..+.+++++||..||++|++. +++++||||+..++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999999999976 89999999987443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=249.70 Aligned_cols=185 Identities=22% Similarity=0.335 Sum_probs=159.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|...+. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~E~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill--~~~~~~kL~Dfg~~~ 144 (321)
T cd05591 70 RLFFVMEYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL--DAEGHCKLADFGMCK 144 (321)
T ss_pred eEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEeecccce
Confidence 3689999999999988774 45678888999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+. .++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 220 (321)
T cd05591 145 EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLS 220 (321)
T ss_pred ecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCC
Confidence 54322 2233456899999999999888999999999999999999999999988888888888776655442 578
Q ss_pred HHHHHHHHHhhhhCcccCC-------CHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-------TAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-------t~~~ll~h~~~~~~~~~ 213 (239)
..+.+++++||+.||++|+ +++++++||||...++.
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 9999999999999999999 99999999999765433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=239.43 Aligned_cols=190 Identities=23% Similarity=0.299 Sum_probs=158.3
Q ss_pred CCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 14 NRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 14 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
.....--+|+|+|++ +.+|..++ ..+..++++-+.-++.|++.||.| |+.|++|||+||+|+++ +.+..+|++
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~--n~~c~lKI~ 167 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL--NADCDLKIC 167 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee--ccCCCEEec
Confidence 344677899999999 56677776 556679999999999999999999 99999999999999999 556678999
Q ss_pred ecccceecCC---CCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINP---DHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||+++.... ....+..+.|.+|.|||.+. ...|+.+.||||+||++.+|++|++.|.|.+....+..|......+
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9999988764 33345678999999999984 5668999999999999999999999999988777666665443333
Q ss_pred chHH---------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 169 DDEA---------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 169 ~~~~---------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+. ....++.+.+|+.+||..||.+|+|++++|+|||+..
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 3222 2345778899999999999999999999999999975
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=240.77 Aligned_cols=189 Identities=29% Similarity=0.424 Sum_probs=168.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++||||.||+|..+. +..++..++++.++-++.+++.||+| |-.|||+|||||||||| +.+|+|.|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~Lr-qkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv--redGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLR-QKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV--REDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHH-hhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE--ecCCcEEeeeccccc
Confidence 567899999999999655 45889999999999999999999999 99999999999999999 999999999999864
Q ss_pred ecCC---------------------------------CCC------------------------CccccCCCCccCcccc
Q psy1096 99 KINP---------------------------------DHP------------------------PRVLFGTPEFIPPEII 121 (239)
Q Consensus 99 ~~~~---------------------------------~~~------------------------~~~~~~~~~~~aPE~~ 121 (239)
.+.. ... ....+||--|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 4310 000 0124688999999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC----
Q psy1096 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---- 197 (239)
Q Consensus 122 ~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---- 197 (239)
++...+.+.|=|+||+++|||+.|..||-|.+..+++.+|......++... ..+..+++||+++|.+||.+|..
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999999999999999999999988887643 56799999999999999999998
Q ss_pred HHHHhhccccccCCCC
Q psy1096 198 AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 198 ~~~ll~h~~~~~~~~~ 213 (239)
+++|-+||||+...|.
T Consensus 386 A~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWA 401 (459)
T ss_pred hHHhhcCccccCCChh
Confidence 9999999999988776
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=252.83 Aligned_cols=186 Identities=24% Similarity=0.351 Sum_probs=153.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||+|++|.+++. .++.+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi--~~~~~vkL~DFGla~ 149 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCT 149 (363)
T ss_pred eEEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--CCCCCEEEeeccCcc
Confidence 4689999999999999884 45678999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCCC------------------------------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHH
Q psy1096 99 KINPDH------------------------------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVL 142 (239)
Q Consensus 99 ~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~ 142 (239)
...... ......||+.|+|||.+.+..++.++|+||+||++|+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 542110 01234689999999999988999999999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHhcc--CCCchHHHhhcCHHHHHHHHHhhhhCcc---cCCCHHHHhhccccccCCCC
Q psy1096 143 LSGLSPFMGENDSETFANITRAE--FDFDDEAFEALSEDAKDFISSLLVKRKE---KRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 143 ~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~ll~~~l~~~p~---~Rpt~~~ll~h~~~~~~~~~ 213 (239)
++|..||.+.+..+...++.... ..++. ...++..+.+++.+|+. +|. .||+++++++||||++.+++
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 99999999888877777776533 22222 12468899999998765 454 45899999999999876544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=243.67 Aligned_cols=183 Identities=23% Similarity=0.262 Sum_probs=150.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||+++ +|.+++.. .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 84 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVDQ-DLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCCC-CHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--cCCCCEEEccccceEe
Confidence 5788999975 67767653 334568889999999999999999 99999999999999999 7778999999999877
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch---------
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--------- 170 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------- 170 (239)
...........|++.|+|||.+.+..++.++|+||+||++|+|++|.+||.+.+..+....+......+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 65444444456899999999998888999999999999999999999999988777766666432211110
Q ss_pred --------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 --------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 --------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+++.+||+.||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1112467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=247.30 Aligned_cols=188 Identities=26% Similarity=0.477 Sum_probs=171.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++.|+=++|.|++|++ +-...+.++.++++|.||+.|+.| |+-.+|||||||+|+++. +.-|.|||.|||++.
T Consensus 91 KlyLiLELGD~GDl~DyIm--KHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF-EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIM--KHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF-EKLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHH--hhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe-eecCceEeeeccccc
Confidence 3457789999999999998 446678999999999999999999 999999999999998754 445799999999999
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.+.++....+.+|++.|-|||.+.+..| -++.|||||||++|.+++|++||...++.+.+-.|....+..|. .++
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS 243 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVS 243 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhh
Confidence 9999999999999999999999999999 47899999999999999999999999999999999888888774 679
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.++++||..||..||.+|.+.++|..++|++..+...
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999999999999877553
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=251.53 Aligned_cols=183 Identities=27% Similarity=0.385 Sum_probs=157.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+||||+++++|.+++ ..++.+++..+..++.|++.||.| |+ .|++||||||+||++ +.++.++|+|||++
T Consensus 69 ~~~lv~E~~~~~~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll--~~~~~~kL~Dfg~~ 143 (325)
T cd05594 69 RLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLC 143 (325)
T ss_pred EEEEEEeCCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE--CCCCCEEEecCCCC
Confidence 468899999999998776 345678899999999999999999 97 799999999999999 77789999999998
Q ss_pred eecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..+
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 219 (325)
T cd05594 144 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTL 219 (325)
T ss_pred eecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCC
Confidence 65432 2223345699999999999988899999999999999999999999988877777777666655554 357
Q ss_pred CHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
++.+.+++++||+.||++|+ ++.++++|+||....
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 89999999999999999997 999999999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=246.39 Aligned_cols=179 Identities=17% Similarity=0.246 Sum_probs=153.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc-ccCCCCCCCCeEEecCCCC-cEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV-TVDPKILPENIMCVSRTSH-HIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~-ivH~dikp~nili~~~~~~-~vkl~dfg~ 96 (239)
...+||||+++|+|.+++... .++.++...+..++.||++||.| |+.+ ||||||||+|||+ +..+ ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv--~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV--DLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE--cCCCCEEEECCCcc
Confidence 355789999999999999753 58899999999999999999999 9999 9999999999999 6675 999999999
Q ss_pred ceecCCC-CCCccccCCCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 97 AQKINPD-HPPRVLFGTPEFIPPEIIN--YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 97 ~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
++..... .......||+.|||||.+. ...|+.++||||+|+++|+|+||..||.+.........+.....++..+
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p-- 268 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP-- 268 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Confidence 9877654 2333367999999999999 6689999999999999999999999999988866666666554443322
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...++.+..++..||..||++||++.+++.
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 247899999999999999999999999863
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=256.67 Aligned_cols=185 Identities=26% Similarity=0.383 Sum_probs=168.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|.||||+.||++.-. ...+.+++..++-++..|+.||.| |++||||||||.+|||+ |..|++||+|||+++
T Consensus 443 ~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL--D~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL--DTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE--cccCcEEeccccccc
Confidence 46789999999994422 556899999999999999999999 99999999999999999 888999999999987
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..- .+....+..|||-|+|||.+.+..|+.+.|=|||||++|+|+.|+.||.|++..+..+.|......+|. .++
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls 592 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLS 592 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----ccc
Confidence 654 556677889999999999999999999999999999999999999999999999999999999888884 789
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~~ 214 (239)
.++.++++++|..+|++|.. +++|.+||||+..+|..
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 99999999999999999995 68899999999866653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=250.27 Aligned_cols=185 Identities=22% Similarity=0.373 Sum_probs=156.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++ ...+.+.+..+..++.|++.||.| |+.|++||||||+||++ +..+.++|+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEEeCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCCEEEEeCcCCc
Confidence 468999999999999988 345678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH----Hh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA----FE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----~~ 174 (239)
.... ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+........... ..
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence 6543 23345689999999999988999999999999999999999999998887776666654322111111 12
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.++..+.+++.+||..+|.+||+++++++||||+...
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 4688999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=247.50 Aligned_cols=184 Identities=28% Similarity=0.444 Sum_probs=157.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+.+. ..+.+++..+..++.|++.||+| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 70 RLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL--DSEGHIKIADFGMCK 144 (318)
T ss_pred EEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE--CCCCcEEecccCCCe
Confidence 4688999999999987773 45678999999999999999999 99999999999999999 777899999999886
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (318)
T cd05570 145 EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLS 220 (318)
T ss_pred ecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCC
Confidence 5322 2222334689999999999999999999999999999999999999988877777777766555444 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCH-----HHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-----KQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-----~~ll~h~~~~~~~~ 212 (239)
..+.+|+++||..||++|||+ .++++||||+..++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999999999999 99999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=241.10 Aligned_cols=183 Identities=22% Similarity=0.278 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.+..+. .....+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 74 KLYLVFEYVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCDFGFAR 148 (287)
T ss_pred EEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEEeeccCcc
Confidence 468999999998877443 234568888999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
...... ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 149 NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 654322 223356889999999999888999999999999999999999999877655544433322111110
Q ss_pred ----------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 ----------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 ----------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+|+++||+.||++|||++++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112367789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=247.29 Aligned_cols=183 Identities=25% Similarity=0.404 Sum_probs=158.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+.+. .++.+.+..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 74 KLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCK 148 (323)
T ss_pred eEEEEEeCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEeeCcCCe
Confidence 4688999999999998873 46678888899999999999999 99999999999999999 777899999999986
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (323)
T cd05584 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLT 224 (323)
T ss_pred ecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 54322 223345689999999999988889999999999999999999999998888777777777665544 3578
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+++++||+.||++|| +++++++||||+...
T Consensus 225 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999999999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=242.12 Aligned_cols=192 Identities=19% Similarity=0.266 Sum_probs=153.0
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++... ..+..+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||.+
T Consensus 67 ~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~ 144 (280)
T cd05608 67 DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL--DNDGNVRISDLGLA 144 (280)
T ss_pred eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCccc
Confidence 367899999999998777543 245678999999999999999999 99999999999999999 77788999999998
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.......+......+
T Consensus 145 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (280)
T cd05608 145 VELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKF 224 (280)
T ss_pred eecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccC
Confidence 76543322 23346889999999999999999999999999999999999999765433222222211111111112357
Q ss_pred CHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~ 213 (239)
+..+.+++.+||+.||++|+ +++++++||||++..+.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 89999999999999999999 88999999999875433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.52 Aligned_cols=183 Identities=27% Similarity=0.426 Sum_probs=158.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|.+++. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~kL~DfG~~~ 149 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE--CCCCcEEEccCCCce
Confidence 3678999999999988874 45678889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 225 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMS 225 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCC
Confidence 5432 22233456899999999999999999999999999999999999999988888887777776655543 578
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~ 211 (239)
..+.+++++||+.||++|++ .+++++|+||+..+
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999999999998 48999999998644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.18 Aligned_cols=183 Identities=26% Similarity=0.377 Sum_probs=156.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~gg~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill--~~~~~~kL~Dfg~a~ 144 (316)
T cd05592 70 HLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--DKDGHIKIADFGMCK 144 (316)
T ss_pred EEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE--CCCCCEEEccCcCCe
Confidence 4678999999999998874 35678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (316)
T cd05592 145 ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWIS 220 (316)
T ss_pred ECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 64322 223345689999999999988899999999999999999999999998887777777665544333 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCH-HHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-KQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-~~ll~h~~~~~~~ 211 (239)
..+.+++++||+.||++|+++ +++++|+||+..+
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 899999999999999999985 5899999998644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.78 Aligned_cols=189 Identities=19% Similarity=0.266 Sum_probs=150.4
Q ss_pred eEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFG 95 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg 95 (239)
..++++|||++++ +.+++... ..+..+++..+..++.|++.||+| |++||+||||||+||++ +.. +.++|+|||
T Consensus 140 ~~l~lvmE~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl--~~~~~~vkL~DFG 216 (440)
T PTZ00036 140 IFLNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFG 216 (440)
T ss_pred eEEEEEEecCCcc-HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE--cCCCCceeeeccc
Confidence 3567899999974 55454432 356788899999999999999999 99999999999999999 533 479999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH---
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE--- 171 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--- 171 (239)
++.............+++.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+..+....+......+...
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 99876554444456789999999998664 68999999999999999999999999887766655554322111100
Q ss_pred ----------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ----------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ----------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....+.++.+|+.+||..||.+|+|+.++++||||...
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 011356789999999999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=246.06 Aligned_cols=187 Identities=22% Similarity=0.208 Sum_probs=146.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||+ ++|.+++ ..++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 78 ~~~lv~e~~~-~~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 78 DIYVVFELME-SDLHQVI---KANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLAR 151 (338)
T ss_pred eEEEEEecCC-CCHHHHH---HhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCcEEEccCcccc
Confidence 4689999996 4676666 345678899999999999999999 99999999999999999 778899999999987
Q ss_pred ecCCCC----CCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC----
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF---- 168 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~---- 168 (239)
...... ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.......+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 1233568999999999865 567899999999999999999999998766544332221111110
Q ss_pred -----------------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 169 -----------------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 169 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
........+..+.+++.+||+.||++|||++++++||||++...
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 01111245778899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=248.00 Aligned_cols=184 Identities=24% Similarity=0.414 Sum_probs=157.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+.+..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll--~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 70 KLYFVLDYVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCK 144 (323)
T ss_pred EEEEEEcCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--CCCCcEEEeccCCCc
Confidence 4578999999999988874 46678889999999999999999 99999999999999999 777899999999886
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (323)
T cd05575 145 EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNIS 220 (323)
T ss_pred ccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 5322 2223345689999999999988899999999999999999999999998887777777766655444 3568
Q ss_pred HHHHHHHHHhhhhCcccCCCH----HHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA----KQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~~~~~~ 212 (239)
..+.+++++||+.||.+||++ +++++||||....+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999999999999987 69999999976443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.29 Aligned_cols=192 Identities=23% Similarity=0.293 Sum_probs=156.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+.+.. .....+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEeccCCCcHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE--CCCCCEEEeeCCCce
Confidence 47789999999999977753 234568899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............|++.|++||.+.+..++.++|+||+||++|+|++|..||.+.+.......+..............++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05605 151 EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSE 230 (285)
T ss_pred ecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCH
Confidence 76544333445688999999999888899999999999999999999999987665443333322111111111235788
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~~ 214 (239)
.+.+|+.+||..||++|| +++++++|+||+..+++.
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 999999999999999999 999999999998765554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=239.73 Aligned_cols=183 Identities=23% Similarity=0.305 Sum_probs=146.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++. ..+..++...+..++.|++.||+| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 77 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~DfG~~~ 151 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLD--NCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI--NEKGELKLADFGLAR 151 (288)
T ss_pred eEEEEEeCCCc-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEECcCccee
Confidence 36789999986 6776664 334567888999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH----
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA---- 172 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~---- 172 (239)
...... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+......++...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 654322 2233567889999999865 4579999999999999999999999988776666555443222111111
Q ss_pred ----------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 ----------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 ----------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...++.++.+|+++||..||.+|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 12357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=251.38 Aligned_cols=184 Identities=25% Similarity=0.422 Sum_probs=157.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+++..+..++.|++.||+| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili--~~~~~~kl~Dfg~a~ 144 (330)
T cd05586 70 DLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL--DATGHIALCDFGLSK 144 (330)
T ss_pred eEEEEEcCCCCChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEecCCcCc
Confidence 4689999999999988774 46778999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
.... ........|++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+....+..+...++. ..+
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~ 221 (330)
T cd05586 145 ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVL 221 (330)
T ss_pred CCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccC
Confidence 5432 2223345689999999998754 4789999999999999999999999988877777777766655543 246
Q ss_pred CHHHHHHHHHhhhhCcccCC----CHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRL----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rp----t~~~ll~h~~~~~~~ 211 (239)
+..+.+|+++||+.||.+|| +++++++||||+...
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 89999999999999999998 799999999998644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=235.26 Aligned_cols=185 Identities=24% Similarity=0.309 Sum_probs=158.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+|||||+...-. +++..+ ..+...+++.++.|+++|++| |..+|+|||||++|+|+ ...|.+|++|||+++
T Consensus 151 ~iy~VMe~~EhDLks--l~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm--~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKS--LMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL--SHKGILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHHHhhHHH--HHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee--ccCCcEEecccchhh
Confidence 689999999987666 555343 678888999999999999999 99999999999999999 788899999999999
Q ss_pred ecCCC-CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh--
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE-- 174 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~-- 174 (239)
.++.. .+.+..+-|.+|.|||.+.+.+ |+.+.|+||+||++.+++++.+.|+|.+..+.+.+|......+....|+
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 88755 3455677899999999998765 7999999999999999999999999999998888886654433322222
Q ss_pred --------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 --------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 --------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++....+|+..+|.+||.+|.|+++.|+|.||++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 13477889999999999999999999999999987
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=251.16 Aligned_cols=185 Identities=30% Similarity=0.472 Sum_probs=157.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.+++|.+++.. .+.+++..+..++.|++.||+| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll--~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI--DADGHIKLADFGLCK 149 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEeecCCCCc
Confidence 46899999999999998853 4788999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC------------------------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q psy1096 99 KINPDH------------------------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSP 148 (239)
Q Consensus 99 ~~~~~~------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p 148 (239)
...... ......|++.|+|||.+.+..++.++||||+||++|+|++|..|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654332 22335689999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHh--ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC-HHHHhhccccccCCC
Q psy1096 149 FMGENDSETFANITR--AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT-AKQCLSHLWIAQKDS 212 (239)
Q Consensus 149 ~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt-~~~ll~h~~~~~~~~ 212 (239)
|.+.+.......+.. .....+. ...++..+.+++.+||. ||.+|++ ++++++||||+..++
T Consensus 230 f~~~~~~~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 230 FYSDTLQETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCCCCHHHHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 998887777777665 2222222 12368999999999997 9999999 999999999987544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.30 Aligned_cols=183 Identities=27% Similarity=0.365 Sum_probs=148.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .+..++++.+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili--~~~~~~kl~DfG~~~ 153 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL--DSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE--CCCCCEEEeeCcCCc
Confidence 3578999999999998874 35678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHhccCCCchH
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDS----ETFANITRAEFDFDDE 171 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~ 171 (239)
...... ......|++.|+|||.+.+.. ++.++||||+||++|+|++|..||...... .....+.......+
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP-- 231 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--
Confidence 653322 222356899999999998654 688999999999999999999999653322 22223333222222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..++..+.+++.+||+.||++|| +++++++||||+..+
T Consensus 232 --~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 232 --SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred --CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 35789999999999999999999 889999999998744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=244.02 Aligned_cols=184 Identities=28% Similarity=0.381 Sum_probs=155.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~~ 144 (316)
T cd05619 70 NLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL--DTDGHIKIADFGMCK 144 (316)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--CCCCCEEEccCCcce
Confidence 3678999999999998874 34678888899999999999999 99999999999999999 777899999999986
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.......+ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (316)
T cd05619 145 ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLT 220 (316)
T ss_pred ECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCC
Confidence 54322 223345689999999999988899999999999999999999999988887777776665544333 2578
Q ss_pred HHHHHHHHHhhhhCcccCCCHH-HHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAK-QCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~-~ll~h~~~~~~~~ 212 (239)
..+.+++.+||+.||++|+++. ++++||||+..++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 8999999999999999999986 8999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=245.51 Aligned_cols=184 Identities=22% Similarity=0.322 Sum_probs=150.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 70 RLFFVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL--DAEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEECcCcccc
Confidence 4689999999999987763 45789999999999999999999 99999999999999999 777899999999886
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHhccCCC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND---------SETFANITRAEFDF 168 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---------~~~~~~i~~~~~~~ 168 (239)
... .........|++.|+|||.+.+..++.++|+||+||++|+|++|..||..... ......+.......
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (329)
T cd05588 145 EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224 (329)
T ss_pred ccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC
Confidence 532 22233345689999999999998899999999999999999999999963211 11233344443333
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCC------HHHHhhccccccCCC
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLT------AKQCLSHLWIAQKDS 212 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt------~~~ll~h~~~~~~~~ 212 (239)
+ ..++..+.+++++||+.||.+|+| ++++++||||...++
T Consensus 225 p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 225 P----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred C----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 3 357889999999999999999987 799999999986443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=250.19 Aligned_cols=187 Identities=28% Similarity=0.402 Sum_probs=154.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||.|++|.+++. .++.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCT 149 (364)
T ss_pred eEEEEECCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEeecccce
Confidence 4678999999999999884 35678999999999999999999 99999999999999999 778899999999886
Q ss_pred ecCCCC---------------------------------------CCccccCCCCccCccccccCCCCchhhHHHHHHHH
Q psy1096 99 KINPDH---------------------------------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVIT 139 (239)
Q Consensus 99 ~~~~~~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 139 (239)
...... ......||+.|+|||.+....++.++|+||+||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 543211 00123589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhccccccCCC
Q psy1096 140 YVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWIAQKDS 212 (239)
Q Consensus 140 ~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~~~~~~ 212 (239)
|+|++|..||.+.+.......+..............++..+.+|+++|+. +|.+|++ ++++++||||+..++
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999888777666665433222211112468899999999997 8999998 999999999987554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=244.10 Aligned_cols=182 Identities=25% Similarity=0.369 Sum_probs=156.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|...+. .+.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill--~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL--DTEGFVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--CCCCcEEeCcccCCc
Confidence 4689999999999987653 4578899999999999999999 99999999999999999 777899999999876
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 225 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLS 225 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 5332 2223345689999999999988899999999999999999999999998887777777776665544 3578
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+++++||..||++|| +++++++|+||+...
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999999999999 799999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=249.25 Aligned_cols=187 Identities=24% Similarity=0.380 Sum_probs=155.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++||+|.+++. +..+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--~~~~~~kL~DfG~~~ 190 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--cCCCCEEEEecccee
Confidence 4678999999999998874 3457888899999999999999 99999999999999999 778899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYE----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......|++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+.......+...........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 664332 22345699999999998653 368899999999999999999999998888777777765432222222
Q ss_pred HhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~~ 212 (239)
...++..+.+|+++||..+|.+ |+|++++++||||+..++
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 2357899999999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.55 Aligned_cols=183 Identities=24% Similarity=0.326 Sum_probs=166.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
+++++|+||+||++.+.+.+. .+..++++.+..|+.|++.|+.| |+.+|+|||||+.||++ ...+.|+|.|||+++
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl--tk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL--TKDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc--cccCceeecchhhhh
Confidence 689999999999999999874 47888899999999999999999 99999999999999999 555578999999999
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...+.. ...+.+||+.|++||.+.+.+|..|+|||||||++|+|++-+.+|.+.+......+|......+.+ ..++
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys 231 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYS 231 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---cccc
Confidence 988765 666788999999999999999999999999999999999999999999999999999888755444 3679
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
.+++.+++.||..+|..||++.++|.+|.+.
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999999999999998775
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=243.14 Aligned_cols=184 Identities=28% Similarity=0.440 Sum_probs=158.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill--~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--DSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEecccccc
Confidence 4789999999999998874 45678999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 225 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLS 225 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCC
Confidence 54322 223345689999999999988899999999999999999999999998887777777776665554 3578
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
..+.+++.+||..+|.+|++ .+++++|+||+..++
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 89999999999999999997 578999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=251.92 Aligned_cols=186 Identities=20% Similarity=0.261 Sum_probs=144.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCC------------
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTS------------ 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~------------ 86 (239)
.|++||+++ +.|.+++. ..+.+.+..+..++.||+.||.| |+ .|||||||||+||+++.++.
T Consensus 207 ~~iv~~~~g-~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 207 MCIVMPKYG-PCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEEEeccC-CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 567788884 45555653 35678899999999999999999 97 59999999999999954321
Q ss_pred --CcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Q psy1096 87 --HHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA 164 (239)
Q Consensus 87 --~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~ 164 (239)
+.+||+|||.+.... .......||+.|+|||.+.+..++.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 259999999875432 2233467999999999999999999999999999999999999999887766655554433
Q ss_pred cCCCchHHHh--------------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 165 EFDFDDEAFE--------------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 165 ~~~~~~~~~~--------------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
...++..... ..+..+.+|+.+||++||.+|||++|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 2222211000 01345779999999999999999999999999
Q ss_pred cccCCC
Q psy1096 207 IAQKDS 212 (239)
Q Consensus 207 ~~~~~~ 212 (239)
|.+...
T Consensus 441 ~~~~~~ 446 (467)
T PTZ00284 441 VLKYYP 446 (467)
T ss_pred ccccCC
Confidence 987443
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=236.44 Aligned_cols=184 Identities=20% Similarity=0.251 Sum_probs=149.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++++||+.+ ++.+++.. .....+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECccCccc
Confidence 46789999986 66666643 334568899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC----------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF---------- 168 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 168 (239)
............++..|+|||.+.+..++.++|+||+||++|+|++|.+||.+.........+.......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 6654444444568899999999998889999999999999999999999998776665555443311100
Q ss_pred -------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 169 -------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 169 -------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.......++..+.+++.+||+.||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011123467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.65 Aligned_cols=183 Identities=25% Similarity=0.398 Sum_probs=158.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+..++++.+..++.|++.||+| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 72 KLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSK 146 (318)
T ss_pred EEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE--CCCCcEEEeeccCCc
Confidence 4678999999999998873 45678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 147 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~ 222 (318)
T cd05582 147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLS 222 (318)
T ss_pred ccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 65433 223345689999999999988889999999999999999999999998887777777766665544 3578
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~ 211 (239)
..+.+++++||+.||++||+ ++++++|+||....
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 99999999999999999999 78899999997643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=221.28 Aligned_cols=183 Identities=27% Similarity=0.438 Sum_probs=170.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|+++||..+|.+...|.+ ..+..+.+..+..++.|++.||.| |..+++||||||+|+|+ +..|.+|++|||-+
T Consensus 95 ~riyLilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl--g~~~~lkiAdfGws 171 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL--GSAGELKIADFGWS 171 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc--CCCCCeeccCCCce
Confidence 378899999999999999976 578889999999999999999999 99999999999999999 88889999999988
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... .....+.+||..|++||...+..++...|+|++|++.|+++.|.+||...+..+.+++|.+....+| ..++
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is 246 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STIS 246 (281)
T ss_pred eecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccC
Confidence 6655 5667788999999999999999999999999999999999999999999999999999999998888 4789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..++++|.+||..+|.+|.+..++++|||+..
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999999964
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.97 Aligned_cols=187 Identities=23% Similarity=0.329 Sum_probs=159.0
Q ss_pred eeEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
...++++|||+.+|+|.+++... ..+..+++..+..++.|++.||.| |+.+|+||||||+||++ +.++.++|+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl--~~~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL--CSNGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--eCCCCEEEEecc
Confidence 34578999999999999988654 235678899999999999999999 99999999999999999 667899999999
Q ss_pred cceecCCC---CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 96 LAQKINPD---HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 96 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
++...... .......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+........+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 266 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP-- 266 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC--
Confidence 98765432 1223456899999999999989999999999999999999999999888777776666655443222
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..++..+.+++.+||..||++||++.++++|||++.
T Consensus 267 -~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 -PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 367899999999999999999999999999999764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=246.58 Aligned_cols=187 Identities=26% Similarity=0.423 Sum_probs=154.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+.+++..+..++.|++.||.| |+.|++||||||+||++ +..+.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAA 150 (330)
T ss_pred eEEEEECCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE--CCCCCEEeccCCCCe
Confidence 46899999999999998853 24678899999999999999999 99999999999999999 778899999999987
Q ss_pred ecCCCCC--CccccCCCCccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIIN------YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
....... .....|++.|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+.........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 7654322 22346899999999986 345678999999999999999999999888777777666544322111
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.....++..+.+|+++||. +|.+|+|++++++||||+..+
T Consensus 231 ~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 231 PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 1113578899999999998 999999999999999998644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=249.06 Aligned_cols=187 Identities=25% Similarity=0.351 Sum_probs=152.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+|||||++|+|.+++. ..+.+++..+..++.|++.||.| |+.||+||||||+||++ +.+|.++|+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl--~~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEEeECCCCc
Confidence 4688999999999998884 34678899999999999999999 99999999999999999 778899999999864
Q ss_pred ecCCC------------------------------------------------CCCccccCCCCccCccccccCCCCchh
Q psy1096 99 KINPD------------------------------------------------HPPRVLFGTPEFIPPEIINYEPIGIES 130 (239)
Q Consensus 99 ~~~~~------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~ 130 (239)
..... .......||+.|+|||.+.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 32100 001124689999999999988999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhcccc
Q psy1096 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWI 207 (239)
Q Consensus 131 DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~ 207 (239)
|+||+||++|+|++|..||.+.+..+....+..............+++.+.+++.+|+ .+|++|++ ++++++||||
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF 308 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence 9999999999999999999988777666666543332222222457899999999876 59999997 9999999999
Q ss_pred ccCCC
Q psy1096 208 AQKDS 212 (239)
Q Consensus 208 ~~~~~ 212 (239)
+..++
T Consensus 309 ~~~~~ 313 (382)
T cd05625 309 KTIDF 313 (382)
T ss_pred CCcCh
Confidence 87543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=251.49 Aligned_cols=185 Identities=24% Similarity=0.311 Sum_probs=158.2
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+||||+.|++|.+++... .....+++..+..++.|++.||.| |+++|+||||||+||++ +..+.++|+|||++
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--~~~~~~kL~DFgla 216 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE--CCCCcEEEEeCcCc
Confidence 467899999999999887643 345678888999999999999999 99999999999999999 77789999999999
Q ss_pred eecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
....... ......||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+..+.....+ .
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~ 293 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP---C 293 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---c
Confidence 8765332 233456899999999999888999999999999999999999999888777777776665543222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++..+.+++.+||..||++||++++++.|+|++.
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 57889999999999999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.83 Aligned_cols=184 Identities=22% Similarity=0.330 Sum_probs=149.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|..++. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~E~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili--~~~~~~kL~DfG~~~ 144 (329)
T cd05618 70 RLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--CCCCCEEEeeCCccc
Confidence 4688999999999987763 45678999999999999999999 99999999999999999 777899999999986
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------chHHHHHHHhccCCC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---------DSETFANITRAEFDF 168 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~---------~~~~~~~i~~~~~~~ 168 (239)
... .........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.... .......+.......
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 224 (329)
T cd05618 145 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224 (329)
T ss_pred cccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC
Confidence 532 2222334568999999999999889999999999999999999999995211 111223333333333
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCC------HHHHhhccccccCCC
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLT------AKQCLSHLWIAQKDS 212 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt------~~~ll~h~~~~~~~~ 212 (239)
+ ..++..+.+++++||+.||++|++ ++++++||||+..++
T Consensus 225 p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 225 P----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred C----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 3 357889999999999999999998 589999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.82 Aligned_cols=188 Identities=24% Similarity=0.340 Sum_probs=149.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.|++.||.| |+.||+||||||+||++ +..+.++|+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili--~~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI--DLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE--CCCCCEEEeeCcCCc
Confidence 4678999999999998884 45678889999999999999999 99999999999999999 777899999999865
Q ss_pred ecCCCC------------------------------------------------CCccccCCCCccCccccccCCCCchh
Q psy1096 99 KINPDH------------------------------------------------PPRVLFGTPEFIPPEIINYEPIGIES 130 (239)
Q Consensus 99 ~~~~~~------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~ 130 (239)
...... ......||+.|+|||.+.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 321000 01124689999999999988899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhh--hCcccCCCHHHHhhccccc
Q psy1096 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV--KRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 131 DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~--~~p~~Rpt~~~ll~h~~~~ 208 (239)
|+||+||++|+|++|..||...+.......+..............+++++.+|+.+|+. .++..|++++++++||||+
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 99999999999999999998877666655554322222211123578999999999654 4555599999999999998
Q ss_pred cCCC
Q psy1096 209 QKDS 212 (239)
Q Consensus 209 ~~~~ 212 (239)
+.++
T Consensus 310 ~~~~ 313 (381)
T cd05626 310 EVDF 313 (381)
T ss_pred CCCh
Confidence 7543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=242.52 Aligned_cols=182 Identities=22% Similarity=0.294 Sum_probs=143.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.+. .+ ...++++.+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 100 ~~~lv~e~~~~~l~~-~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQ-VI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHH-HH-----hccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEecCCCcc
Confidence 368899999876443 33 2346778889999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------- 171 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------- 171 (239)
............+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+....+..+..........
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 6544444445578999999999999899999999999999999999999998776544433332211111000
Q ss_pred -------------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 172 -------------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 172 -------------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.....+..+++|+.+||+.||++|||++++++|||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00113567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=243.10 Aligned_cols=183 Identities=26% Similarity=0.452 Sum_probs=156.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ..+.+.+..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili--~~~~~~kl~DfG~a~ 144 (325)
T cd05602 70 KLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCK 144 (325)
T ss_pred eEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEEccCCCCc
Confidence 4678999999999998874 45678888889999999999999 99999999999999999 677899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+........ ..++
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (325)
T cd05602 145 ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNIT 220 (325)
T ss_pred ccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCC
Confidence 5432 2233445699999999999998899999999999999999999999998887777777766544433 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHH----HHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAK----QCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~----~ll~h~~~~~~~ 211 (239)
..+.+++++||+.||.+|+++. ++++|+|+...+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999999999999865 899999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=241.28 Aligned_cols=183 Identities=22% Similarity=0.321 Sum_probs=149.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|..++. ..+.+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili--~~~~~~kl~Dfg~~~ 144 (327)
T cd05617 70 RLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL--DADGHIKLTDYGMCK 144 (327)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--eCCCCEEEeccccce
Confidence 3679999999999987773 45678999999999999999999 99999999999999999 667789999999986
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------c-hHHHHHHHhccCCCch
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN------D-SETFANITRAEFDFDD 170 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~------~-~~~~~~i~~~~~~~~~ 170 (239)
... .........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.... . ......+.......+
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p- 223 (327)
T cd05617 145 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP- 223 (327)
T ss_pred eccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-
Confidence 532 2223334568999999999998899999999999999999999999995322 1 122333333333333
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCC------HHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLT------AKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt------~~~ll~h~~~~~~~ 211 (239)
..++..+.+++++||+.||++|++ ++++++|+||+..+
T Consensus 224 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 224 ---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 357889999999999999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=237.62 Aligned_cols=189 Identities=23% Similarity=0.303 Sum_probs=150.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++.. .....+++..+..++.|++.||.| |+.+++|+||||+||++ +..+.++|+|||++.
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~--~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL--DDHGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--CCCCCEEEeecccee
Confidence 46789999999999988754 233468888999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+........................++.
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05630 151 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP 230 (285)
T ss_pred ecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCH
Confidence 65544333345689999999999988899999999999999999999999986543221111111111111112235788
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~ 211 (239)
.+.+|+++||+.||++|+| ++++++||||++..
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 8999999999999999999 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=240.22 Aligned_cols=186 Identities=19% Similarity=0.271 Sum_probs=148.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++. ....+++..+..++.|++.||.| |+. +++||||||+||++ +.++.++|+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~ 151 (331)
T cd06649 77 EISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV--NSRGEIKLCDFGVS 151 (331)
T ss_pred EEEEEeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE--cCCCcEEEccCccc
Confidence 4678999999999999884 35568889999999999999999 986 69999999999999 66778999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc------------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE------------ 165 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~------------ 165 (239)
...... ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||......+....+....
T Consensus 152 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 152 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred cccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 665432 2234568999999999998889999999999999999999999997655433322111100
Q ss_pred --------------------------------CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 166 --------------------------------FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 166 --------------------------------~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...+......++.++++|+.+||..||++|||++++++||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000000123578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=248.99 Aligned_cols=186 Identities=26% Similarity=0.359 Sum_probs=151.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||++++|.+++. ..+.+++..+..++.||+.||+| |+.||+||||||+||++ +..+.++|+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--~~~~~ikL~DFG~a~ 149 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE--CCCCCEEEEeCCCCc
Confidence 4678999999999999984 45678899999999999999999 99999999999999999 777899999999864
Q ss_pred ecCCC--------------------------------------------CCCccccCCCCccCccccccCCCCchhhHHH
Q psy1096 99 KINPD--------------------------------------------HPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134 (239)
Q Consensus 99 ~~~~~--------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws 134 (239)
.+... .......||+.|+|||.+.+..++.++|+||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 32100 0011246899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCC---CHHHHhhccccccCC
Q psy1096 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL---TAKQCLSHLWIAQKD 211 (239)
Q Consensus 135 lG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---t~~~ll~h~~~~~~~ 211 (239)
+||++|+|++|..||.+.+..+....+..............++..+.+++.+|+ .+|++|+ |++++++||||+..+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999999999999888776666555443322222222357889999999976 5999999 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=243.40 Aligned_cols=182 Identities=24% Similarity=0.377 Sum_probs=155.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|...+ ..++.+++..+..++.||+.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll--~~~~~~kL~DfG~~~ 144 (325)
T cd05604 70 KLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCK 144 (325)
T ss_pred EEEEEEcCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEEeecCCcc
Confidence 467899999999998776 446788999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+........ ...+
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 220 (325)
T cd05604 145 EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGAS 220 (325)
T ss_pred cCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCC
Confidence 5322 2223345689999999999998899999999999999999999999998887777777766554433 2568
Q ss_pred HHHHHHHHHhhhhCcccCCCH----HHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA----KQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~~~~ 210 (239)
..+.+++++||+.+|.+||++ +++++||||...
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 889999999999999999976 589999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.06 Aligned_cols=183 Identities=25% Similarity=0.422 Sum_probs=154.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|...+. ....+.+..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 70 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 70 KLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCK 144 (321)
T ss_pred EEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEccCCCCc
Confidence 4678999999999987763 45678888899999999999999 99999999999999999 777899999999876
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
... .........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.......+ ...+
T Consensus 145 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 220 (321)
T cd05603 145 EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKT 220 (321)
T ss_pred cCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Confidence 532 22223345689999999999988899999999999999999999999998877777777766554444 2568
Q ss_pred HHHHHHHHHhhhhCcccCCCH----HHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA----KQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~~~~~ 211 (239)
..+.+++.+||+.||.+|+++ .++++|+||...+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 889999999999999999875 5999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.46 Aligned_cols=186 Identities=22% Similarity=0.376 Sum_probs=152.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++. +..+++..+..++.|++.||+| |++||+||||||+||++ +..+.++|+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl--~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--CCCCCEEEEecccce
Confidence 4688999999999998874 3357888999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCC--CccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINYEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
....... .....||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.+.......+...........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 7643322 23456999999999997543 67899999999999999999999998887777777765443222222
Q ss_pred HhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+++++..||..++.+ |+|++++++||||+...
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 2356889999999999865544 88999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=242.22 Aligned_cols=177 Identities=21% Similarity=0.279 Sum_probs=155.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+||||+..|+|.++|.. ..++.+.......++.||+.||+| +++++|||||...|||| +.+..+|++|||+++
T Consensus 275 piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV--~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV--DEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee--ccCceEEEccccccc
Confidence 46889999999999999986 457788888999999999999999 99999999999999999 888899999999999
Q ss_pred ecCCCCCCcccc--CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLF--GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...++....... -...|.|||.+....++.++|||||||++|||.| |+.||.+++..+....+.++-..+.+ +.
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~ 428 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EG 428 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CC
Confidence 555443222222 3347999999999999999999999999999998 99999999999999999888665554 46
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
+|+.+.++++.||..+|++|||++.+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 899999999999999999999999765
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=247.68 Aligned_cols=186 Identities=27% Similarity=0.376 Sum_probs=150.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll--~~~~~~kl~DfGla~ 149 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI--DRGGHIKLSDFGLST 149 (377)
T ss_pred eeEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--CCCCCEEEeeccccc
Confidence 4688999999999998884 45678899999999999999999 99999999999999999 777899999999885
Q ss_pred ecCCCC------------------------------------------------CCccccCCCCccCccccccCCCCchh
Q psy1096 99 KINPDH------------------------------------------------PPRVLFGTPEFIPPEIINYEPIGIES 130 (239)
Q Consensus 99 ~~~~~~------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~ 130 (239)
...... ......||+.|+|||.+.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 321100 00123589999999999988899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccC---CCHHHHhhcccc
Q psy1096 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR---LTAKQCLSHLWI 207 (239)
Q Consensus 131 DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R---pt~~~ll~h~~~ 207 (239)
|+||+||++|+|++|..||.+.+..+....+..............++..+.+|+++||. +|.+| +|++++++||||
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence 99999999999999999998877766666665432222111112468899999999998 67775 599999999999
Q ss_pred ccCC
Q psy1096 208 AQKD 211 (239)
Q Consensus 208 ~~~~ 211 (239)
+..+
T Consensus 309 ~~~~ 312 (377)
T cd05629 309 RGVD 312 (377)
T ss_pred CCCC
Confidence 8643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=242.09 Aligned_cols=182 Identities=21% Similarity=0.274 Sum_probs=146.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||++++ +.+.+. ..+....+..++.|++.||+| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCC-HHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE--CCCCcEEEEeCCCcc
Confidence 468999999875 444442 246778888999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA------ 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 172 (239)
............+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+....+..+......+.+..
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 66544444456789999999999998999999999999999999999999988776665555543222111110
Q ss_pred --------------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 --------------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 --------------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....+..+++|+.+||+.||.+|||++++|+||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0012456889999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=235.38 Aligned_cols=187 Identities=22% Similarity=0.277 Sum_probs=142.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+++. ...+.+.++.+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 77 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 77 TLTLVFEYVHT-DLCQYMD--KHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLAR 151 (303)
T ss_pred eEEEEEECCCc-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECCCCcce
Confidence 46789999975 4444543 334668888999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCC-CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCC-------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDF------- 168 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~------- 168 (239)
..... .......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.... .....+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred eccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 54322 223345688999999998654 4788999999999999999999999875432 2222221110000
Q ss_pred ----------------ch---HHH--hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 169 ----------------DD---EAF--EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 169 ----------------~~---~~~--~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+. ..+ ...+..+.+|+++||+.||++|||++++++||||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 000 12356788999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=240.83 Aligned_cols=182 Identities=21% Similarity=0.255 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.. +.+. ..++...+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 96 ~~~lv~e~~~~~l~-~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill--~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHH-HHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE--CCCCCEEEeeCcccc
Confidence 46899999987543 3332 246778888999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------- 171 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------- 171 (239)
............+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+........++
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 7654444445678999999999998889999999999999999999999998776544443332211111000
Q ss_pred -------------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 172 -------------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 172 -------------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.....+..+++|+.+||+.||++|||++++++||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00112456889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=246.16 Aligned_cols=187 Identities=25% Similarity=0.365 Sum_probs=152.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.|++.||.| |+.|++||||||+||++ +..+.++|+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli--~~~~~vkL~DfG~~~ 149 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--CCCCCEEEeeccCCc
Confidence 4689999999999999884 45678999999999999999999 99999999999999999 778899999999876
Q ss_pred ecCCCC------------------------------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHH
Q psy1096 99 KINPDH------------------------------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVL 142 (239)
Q Consensus 99 ~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~ 142 (239)
...... ......||+.|+|||.+.+..++.++|+||+||++|+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 432110 01134689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCC---CHHHHhhccccccCCC
Q psy1096 143 LSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL---TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 143 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---t~~~ll~h~~~~~~~~ 212 (239)
++|..||.+.+.......+..............++..+++++.+|+ .||.+|+ +++++++||||...++
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 9999999988877777766543221111111246889999999976 5999998 4899999999987554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=244.28 Aligned_cols=191 Identities=23% Similarity=0.268 Sum_probs=155.4
Q ss_pred CCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 14 NRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 14 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
.+.+.++++. +. ..+|++++.++...| ++-..++.+..||+.||.+ |+.||||+||||||||++.-....||++
T Consensus 259 fr~HlciVfE---LL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 259 FRNHLCIVFE---LL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred cccceeeeeh---hh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEE
Confidence 3445555555 33 467888988755555 8888999999999999999 9999999999999999988777799999
Q ss_pred ecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 93 DFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 93 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
|||.++....... +.+-+..|.|||++.+.+|+.+.|||||||+++||.+|.+.|+|.+..+.+..|......++...
T Consensus 334 DFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 334 DFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999977664433 67789999999999999999999999999999999999999999998888777744332222111
Q ss_pred Hh-----------------------------------------------------------hcCHHHHHHHHHhhhhCcc
Q psy1096 173 FE-----------------------------------------------------------ALSEDAKDFISSLLVKRKE 193 (239)
Q Consensus 173 ~~-----------------------------------------------------------~~~~~~~~ll~~~l~~~p~ 193 (239)
.+ .-...+.+|+++||++||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00 0123478999999999999
Q ss_pred cCCCHHHHhhccccccCC
Q psy1096 194 KRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 194 ~Rpt~~~ll~h~~~~~~~ 211 (239)
+|+|+.++|+|||+++..
T Consensus 492 ~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGTS 509 (586)
T ss_pred hcCCHHHHhcCccccccc
Confidence 999999999999998533
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=233.95 Aligned_cols=187 Identities=20% Similarity=0.299 Sum_probs=150.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+.+.. .....+.+..+..++.|++.||+| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 67 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 67 HLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--DDQGNCRLSDLGLAV 143 (277)
T ss_pred eEEEEEecCCCCCHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE--cCCCCEEEeeceeee
Confidence 46789999999999887754 233457788888999999999999 99999999999999999 777889999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE----TFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~----~~~~i~~~~~~~~~~~~~ 174 (239)
............++..|+|||.+.+..++.++|+||+||++|+|++|..||.+..... ............. ..
T Consensus 144 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 220 (277)
T cd05607 144 ELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQ 220 (277)
T ss_pred ecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cc
Confidence 7654433344568899999999988889999999999999999999999997643322 2222222222111 13
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCH----HHHhhccccccCCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTA----KQCLSHLWIAQKDS 212 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~~~~~~ 212 (239)
.++..+.+++++||+.||++||++ ++++.|+||+...+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 578899999999999999999999 67889999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=244.05 Aligned_cols=197 Identities=21% Similarity=0.345 Sum_probs=168.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+..|||+||.+..++.|. +..+.+.++.-+++|++.||.| |+.+|||||||.-|||+ ...|.|+|+|||++.
T Consensus 103 kLwiliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~--TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL--TLDGDIRLADFGVSA 178 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE--EecCcEeeecccccc
Confidence 578889999999999988864 6789999999999999999999 99999999999999999 566689999999976
Q ss_pred ecCC-CCCCccccCCCCccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEII-----NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
.... .....+++|||.|||||.. +..+|+.++||||||+.+.+|..+.+|-...+.+..+-+|.+...+....+
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 5432 2345568899999999997 456789999999999999999999999998888888888877654333222
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIIS 221 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~ 221 (239)
..++..+.+|+++||..||..||++.+||+|||+....++...++++.
T Consensus 259 -S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlA 306 (1187)
T KOG0579|consen 259 -SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLA 306 (1187)
T ss_pred -chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHHH
Confidence 356889999999999999999999999999999998777765555543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=241.87 Aligned_cols=186 Identities=24% Similarity=0.408 Sum_probs=152.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ...+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll--~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE--CCCCCEEEEeCCcee
Confidence 4688999999999998874 2357888899999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.+.......+...........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 765332 223456999999999997543 68899999999999999999999998887777777765443222222
Q ss_pred HhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+++++.+||..++.+ |++++++++|+||++..
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 2357899999999999844433 78999999999998744
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=232.84 Aligned_cols=191 Identities=25% Similarity=0.329 Sum_probs=155.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+.+++|.+.+.. .....+++..+..++.|++.||.| |+.||+|+||||+||++ +..+.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili--~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL--DDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEeccCccHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--CCCCCEEEecCCcce
Confidence 46789999999999877754 234568999999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............|+..|+|||.+.+..++.++|+||+|+++|++++|..||.+.........+..............++.
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCH
Confidence 65443333445689999999999888899999999999999999999999987665444444433222211122235788
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~ 213 (239)
.+.+|+.+||..||++||+ ++++++|+||++...+
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 8999999999999999999 8999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=228.25 Aligned_cols=185 Identities=25% Similarity=0.373 Sum_probs=156.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ..+.+++..+..++.|++.||.| |+.+++|+||+|+||++ +..+.++|+|||++.
T Consensus 71 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 145 (260)
T cd05611 71 YLYLVMEYLNGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLTDFGLSR 145 (260)
T ss_pred eEEEEEeccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCcEEEeecccce
Confidence 4578999999999999884 34578889999999999999999 99999999999999999 667889999999876
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
.... .....++..|++||.+.+..++.++|+||+|+++|++++|..||...+.......+.......+......++.
T Consensus 146 ~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 146 NGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred eccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCH
Confidence 5433 2234578889999999888889999999999999999999999988877777766666555444444446789
Q ss_pred HHHHHHHHhhhhCcccCC---CHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL---TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp---t~~~ll~h~~~~~~~~ 212 (239)
.+.+++++||..+|++|| ++++++.||||+..++
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 999999999999999999 5589999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=215.65 Aligned_cols=182 Identities=24% Similarity=0.302 Sum_probs=154.1
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
+|.||++ .+|+.++. .++..++...++.++.+++.|++| |+++|+||||||.|+|+ +.+|.+|++|||+++.+.
T Consensus 78 lVfEfm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI--SSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE--cCCCcEEeecccchhccC
Confidence 3444665 45666665 567788889999999999999999 99999999999999999 788899999999999887
Q ss_pred CCCC-CccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh----
Q psy1096 102 PDHP-PRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA---- 175 (239)
Q Consensus 102 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~---- 175 (239)
+... ....+-|.+|.|||.+.|. .|+...|+||.||++.|++.|.+.|+|.++.+.+..|...-..+.+..|++
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5543 3334789999999999765 589999999999999999999999999999999998877655554444332
Q ss_pred --------------------cCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 176 --------------------LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 176 --------------------~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+.+..+|+.+||.+||.+|.|+.|+|+|+||++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 3567789999999999999999999999999987
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=224.15 Aligned_cols=182 Identities=20% Similarity=0.322 Sum_probs=153.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+.+.. ..+..+++..+..++.+++.|+++ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~-~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~--~~~~~~~l~df~~~~ 150 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL--TRTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEEecccCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE--ecCCcEEEecccceE
Confidence 57899999999999988864 345568899999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......+++.|+|||.+.+..++.++|+||+|++++++++|..||...+.......+..+..... ....+
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (257)
T cd08223 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYS 227 (257)
T ss_pred EecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---ccccC
Confidence 66432 223345688899999999988889999999999999999999999987766555555544433221 13578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||+.+|++|||+.++++||||
T Consensus 228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 228 PELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=237.76 Aligned_cols=183 Identities=23% Similarity=0.314 Sum_probs=140.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+.. ...+..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 146 ~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI--NSAKNVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--cCCCCEEEcccccce
Confidence 467899999999987432 34566778899999999999 99999999999999999 677899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......|+..|+|||.+... ..+.++|||||||++|+|++|..||...........+...........
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA 296 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC
Confidence 654322 22345689999999998432 235689999999999999999999974333222221111111111112
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+.+|+.+||..||++|||++++++|+||.+..
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 235788999999999999999999999999999998753
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=228.11 Aligned_cols=180 Identities=22% Similarity=0.340 Sum_probs=146.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++. .++.+.++.+..++.|++.||.+ |+.|++|+||+|+||++ +..+ .++++|||.+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY--DRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--eCCCCeEEEecCccc
Confidence 4678999999999999884 34588999999999999999999 99999999999999999 5555 8999999988
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET-FANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 176 (239)
...... ....++..|+|||.+.+..++.++|+||+|+++++|++|..||........ ...+.... ..........
T Consensus 158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (267)
T PHA03390 158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNV 233 (267)
T ss_pred eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCccccc
Confidence 765432 234578899999999988899999999999999999999999975543321 11111111 1111222367
Q ss_pred CHHHHHHHHHhhhhCcccCCC-HHHHhhccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLT-AKQCLSHLWIA 208 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt-~~~ll~h~~~~ 208 (239)
+..+.+|+.+||+.+|.+|++ ++++++||||+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 899999999999999999996 69999999996
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=226.06 Aligned_cols=191 Identities=21% Similarity=0.304 Sum_probs=154.8
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcC-CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAG-TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
...+|+++||++... ..++...... ..++...++.++.|++.||+| |+++|+||||||.||+| +.+|.+||+|||
T Consensus 89 ~~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi--~~~G~lKlaDFG 165 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI--SSSGVLKLADFG 165 (323)
T ss_pred cceEEEEEEeecccH-HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE--CCCCcEeeeccc
Confidence 346778888887544 4444332211 345558999999999999999 99999999999999999 668899999999
Q ss_pred cceecC-CCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 96 LAQKIN-PDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 96 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
++.... +.......++|.+|.|||.+.+. .|+...||||+||++++|+++++.|.|.+..+....|......+....|
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 998776 44456677899999999999877 5899999999999999999999999999998888888654433322221
Q ss_pred h--------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 E--------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~--------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+ ..+.+..+++.+||+++|.+|.|++.+|.|+||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1 2245788999999999999999999999999998743
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=231.20 Aligned_cols=187 Identities=19% Similarity=0.201 Sum_probs=138.0
Q ss_pred EEEeeCccCCCCccchhhhhhh------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec--CCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--RTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--~~~~~vk 90 (239)
.+|+++||+++ ++.+++.... ....+++..+..++.|++.||.| |+.|++||||||+||++.. +..+.++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 74 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEE
Confidence 46788999876 5555553221 12358888999999999999999 9999999999999999953 3457899
Q ss_pred EEecccceecCCCC----CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------H
Q psy1096 91 IIDFGLAQKINPDH----PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS---------E 156 (239)
Q Consensus 91 l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---------~ 156 (239)
|+|||++....... ......+|+.|+|||.+.+. .++.++|+||+||++++|++|.+||.+.... .
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence 99999987654321 12335688999999999764 4789999999999999999999999654321 1
Q ss_pred HHHHHHhccCCCchHH----------------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 157 TFANITRAEFDFDDEA----------------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 157 ~~~~i~~~~~~~~~~~----------------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
....+......+.... ....+..+.+|+++||..||.+|+|++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence 1222211111000000 001245688999999999999999999999
Q ss_pred hcccc
Q psy1096 203 SHLWI 207 (239)
Q Consensus 203 ~h~~~ 207 (239)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07868 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=243.63 Aligned_cols=191 Identities=26% Similarity=0.393 Sum_probs=175.9
Q ss_pred ccCCCcee----------EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeE
Q psy1096 12 SNNRTSVV----------ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIM 80 (239)
Q Consensus 12 ~~~~~~~~----------~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nil 80 (239)
+.+||+++ ++|+||||+.+|.+++++ .+++.+.+..++.+|.|+.+|++| |+++|||||||.+||+
T Consensus 111 ~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl---~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNil 187 (596)
T KOG0586|consen 111 SLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYL---VKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENIL 187 (596)
T ss_pred hcCCcceeeeeeeeeecceeEEEEEeccCchhHHHH---HhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcc
Confidence 35677765 567899999999999999 568889999999999999999999 9999999999999999
Q ss_pred EecCCCCcEEEEecccceecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy1096 81 CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFA 159 (239)
Q Consensus 81 i~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~ 159 (239)
+ +.+..+||+|||++..+.......++.|++.|.|||.+.+..| ++..|+||+|+++|.++.|.+||.+.+-.+...
T Consensus 188 L--~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 188 L--DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred c--ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 9 7776799999999999998888999999999999999999988 789999999999999999999999999999999
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.+..+.+..+. .++.++.++++++|.++|.+|++.++++.|.|+....
T Consensus 266 rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 266 RVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99888888875 6799999999999999999999999999999997543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=229.69 Aligned_cols=187 Identities=22% Similarity=0.313 Sum_probs=149.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+++..+..++.|++.||.| |+.+++|+||||+||++ +.++.++++|||++.
T Consensus 71 ~~~lv~e~~~~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--~~~~~~~l~dfg~~~ 145 (279)
T cd05633 71 KLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLAC 145 (279)
T ss_pred eEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE--CCCCCEEEccCCcce
Confidence 3578999999999998874 45678999999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCCCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... .....|++.|+|||.+. +..++.++|+||+||++++|++|..||........ ..+..............++
T Consensus 146 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd05633 146 DFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFS 223 (279)
T ss_pred eccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccC
Confidence 554322 22346889999999986 45678999999999999999999999975433221 1121111111222224678
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~ 213 (239)
..+.+++++||..||++|+ |++++++||||+...+.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 9999999999999999999 69999999999885544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=230.96 Aligned_cols=186 Identities=19% Similarity=0.273 Sum_probs=146.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+++. ..+..++...+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 78 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMD--DCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI--NERGELKLADFGLAR 152 (309)
T ss_pred eEEEEEeCCCC-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECccccce
Confidence 35788999986 5555554 335567888899999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
...... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 644322 2233457889999999865 45789999999999999999999999887765554444332111110
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....++..+.+++.+||..||.+|||++++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 1112357789999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=228.63 Aligned_cols=191 Identities=24% Similarity=0.277 Sum_probs=158.2
Q ss_pred eEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
+.+-+||||++. +|.+++.++ ..+..++.-.++-+..||++||+| |+.||+||||||.|+|++.+. |.+||||||.
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGS 172 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGS 172 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCc
Confidence 344457777774 455566544 235677777788899999999999 999999999999999995533 7999999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH--
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF-- 173 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~-- 173 (239)
++....+.+..+...+..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.|.+...++..|.+.-..+..+..
T Consensus 173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 9999988888888899999999999765 5899999999999999999999999999998888887665444333221
Q ss_pred -----------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 -----------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 -----------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...+++..+|+.++|.++|.+|.++.+++.||||.+-+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 23578899999999999999999999999999996533
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=224.63 Aligned_cols=181 Identities=22% Similarity=0.331 Sum_probs=150.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ..+.+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 78 ~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv--~~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeecccce
Confidence 5678899999999998874 35678889999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCCC----ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPP----RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
........ ....++..|+|||.+.+..++.++|+||+|+++|++++|..||...+.......+........ ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 230 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPS 230 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCc
Confidence 65432111 224577889999999988899999999999999999999999987666555555444333222 223
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+..+.+++++||..+|++|||+.++++|+||
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 231 HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=232.93 Aligned_cols=185 Identities=24% Similarity=0.326 Sum_probs=146.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++++++ +++|.+++ ..+.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV--NEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE--CCCCCEEEcCCccc
Confidence 3467888887 56666654 34578899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-----
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE----- 171 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----- 171 (239)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+..........
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 765432 234568999999999976 457899999999999999999999998776555544443321111111
Q ss_pred ----------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 172 ----------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 172 ----------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++.+.+|+.+||..||++|||++++++||||.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 01134566889999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=233.60 Aligned_cols=186 Identities=17% Similarity=0.246 Sum_probs=146.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+.+++|.+++. ..+.+++..+..++.+++.||.| |+. +++|+||||+||++ +..+.++|+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~ 151 (333)
T cd06650 77 EISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE--cCCCCEEEeeCCcc
Confidence 4678999999999999884 35678889999999999999999 975 79999999999999 66778999999988
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-------------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA------------- 164 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~------------- 164 (239)
...... ......++..|+|||.+.+..++.++|+||+||++|+|++|..||...........+...
T Consensus 152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 152 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 655322 223346889999999999888999999999999999999999999765443222111000
Q ss_pred -----------------------------cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 165 -----------------------------EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 165 -----------------------------~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
....+......++..+++|+.+||+.||++|||++++++|+||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000113567899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=227.34 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=166.0
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.-+|+|||||+.|+++++++ ..+..++++++..+++..+.||.| |...-+|||||.-|||+ ...|..||+|||++
T Consensus 101 sDLWIVMEYCGAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL--NT~G~AKLADFGVA 176 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL--NTDGIAKLADFGVA 176 (502)
T ss_pred CceEeehhhcCCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE--cccchhhhhhcccc
Confidence 36899999999999999987 678899999999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
-...+. ....+..|||.|||||.+..-.|..++||||||+...+|..|++||...-.....-.|-... ++........
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P-PPTF~KPE~W 255 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP-PPTFKKPEEW 255 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC-CCCCCChHhh
Confidence 666543 34556789999999999999999999999999999999999999998665544333222111 1111222356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccch
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIIST 222 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~ 222 (239)
+.++-+|+++||..+|++|.|+.++++|+|++....+.-.+.+++.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~ 301 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQD 301 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHH
Confidence 8999999999999999999999999999999987666655555554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=235.77 Aligned_cols=188 Identities=28% Similarity=0.435 Sum_probs=152.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+|+|.+++.. .+..+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili--~~~~~~kL~DfG~a~ 150 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEEeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--CCCCCEEEeecchhe
Confidence 46899999999999999863 34578889999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCCCC--CccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-h
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-D 170 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~ 170 (239)
....... .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+........ +
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 6533221 223468999999999863 3578899999999999999999999998887777777765432221 1
Q ss_pred HHHhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~ 211 (239)
.....++..+.+|+++||+.++.+ |++++++++||||...+
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 112357899999999999765554 68999999999998644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.98 Aligned_cols=185 Identities=22% Similarity=0.251 Sum_probs=147.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+ .|.+.+ ..+..+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 78 ~~~lv~e~~~~-~l~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 78 EIYVVTELMQS-DLHKII---VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV--NSNCVLKICDFGLAR 151 (372)
T ss_pred eEEEEeecccc-CHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE--CCCCCEEecccccee
Confidence 57899999985 455555 446678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH----
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE---- 171 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---- 171 (239)
...... ......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.+.......+..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 654322 222345788999999998754 6899999999999999999999998877665555543321111100
Q ss_pred ------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....+..+.+|+.+||+.||.+|||++++++||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 012346789999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=225.61 Aligned_cols=183 Identities=23% Similarity=0.411 Sum_probs=148.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+..+++..+..++.|++.|++| |+++++|+||+|+||++ +.++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili--~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE--CCCCCEEEccCCCce
Confidence 47899999999999998864 234578889999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCC-CCCccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+........ .
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 237 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--K 237 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC--C
Confidence 65432 22334568889999999863 3578899999999999999999999976554444443333221111 1
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...++..+.+|+.+||..+|.+|||+++++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 13467899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=230.41 Aligned_cols=189 Identities=30% Similarity=0.455 Sum_probs=157.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++.. ..+..+++..+..++.|++.||+| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~ 151 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL--HESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEEecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE--cCCCCEEEeecchhh
Confidence 56889999999999988753 345678889999999999999999 99999999999999999 667889999999876
Q ss_pred ecCCCCC------------------------------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q psy1096 99 KINPDHP------------------------------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSP 148 (239)
Q Consensus 99 ~~~~~~~------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p 148 (239)
....... .....|+..|++||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 5432110 1123578889999999988889999999999999999999999
Q ss_pred CCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC----HHHHhhccccccCCCC
Q psy1096 149 FMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 149 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt----~~~ll~h~~~~~~~~~ 213 (239)
|.+.+.......+.......+.. ..++..+.+++++||+.||++||| ++++++|+||++.++.
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 232 FKGSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred CCCCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 98887777766666544443321 236899999999999999999999 9999999999986654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=225.86 Aligned_cols=191 Identities=20% Similarity=0.318 Sum_probs=150.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|..++........+++..+..++.+++.||.| |+ .+++|+||+|+||++ +.++.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~ 150 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV--NGNGQVKLCDFGVS 150 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE--CCCCCEEEeecCCc
Confidence 577899999999999887543334578999999999999999999 96 599999999999999 66789999999988
Q ss_pred eecCCCCCCccccCCCCccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEP------IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
...... ......+++.|++||.+.+.. ++.++|+||+||++|+|++|..||...........+.......+..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 151 GNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred ccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 665432 223345788899999986543 4789999999999999999999997665544443333221111122
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
....++..+.+++.+||..+|++||+++++++||||...+..
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 223578999999999999999999999999999999875543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.78 Aligned_cols=185 Identities=18% Similarity=0.149 Sum_probs=140.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++++|++. +.|.+++. ....++...+..++.|++.||.| |++||+||||||+||++ +..+.++|+|||++.
T Consensus 157 ~~~lv~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll--~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI--NHPGDVCLGDFGAAC 230 (391)
T ss_pred eeEEEEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE--cCCCCEEEEeCCccc
Confidence 3567888886 45665653 34567888899999999999999 99999999999999999 777889999999986
Q ss_pred ecCCC--CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHhccC---
Q psy1096 99 KINPD--HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND-------SETFANITRAEF--- 166 (239)
Q Consensus 99 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-------~~~~~~i~~~~~--- 166 (239)
..... .......||+.|+|||.+.+..++.++|+||+||++|+|++|..||..... ......+.....
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 53321 122345699999999999988899999999999999999999988754321 111111111100
Q ss_pred ----------------------------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 167 ----------------------------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 167 ----------------------------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.........++.++.+|+.+||..||.+|||++++|+||||++.
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00011112346688999999999999999999999999999763
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=239.26 Aligned_cols=181 Identities=20% Similarity=0.295 Sum_probs=152.8
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
.++||||..|.|.++| +.+..+..+....|..+|+.|+.| |.+.|||||||.-|||| ..+..|||+|||-++..
T Consensus 188 CIiMEfCa~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI--s~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI--SYDDVVKISDFGTSKEL 262 (904)
T ss_pred EEeeeccccccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe--eccceEEeccccchHhh
Confidence 3679999999999999 668889999999999999999999 99999999999999999 66668999999999887
Q ss_pred CCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHH
Q psy1096 101 NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDA 180 (239)
Q Consensus 101 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 180 (239)
......-.+.||..|||||+++..+.+.|.|||||||+||+|+||..||.+-....++--+-.+....+- ....++.+
T Consensus 263 ~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~Gf 340 (904)
T KOG4721|consen 263 SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGF 340 (904)
T ss_pred hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHH
Confidence 7666666688999999999999999999999999999999999999999755443332222222222222 23578899
Q ss_pred HHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 181 KDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 181 ~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+-|+++||.-.|..||++.+++.|.=+..
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 99999999999999999999999976543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=223.45 Aligned_cols=186 Identities=24% Similarity=0.386 Sum_probs=153.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ....+++..+..++.|++.||.+ |+++++|+||+|+||++ +.++.++|+|||.+.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv--~~~~~~~l~df~~~~ 141 (262)
T cd05572 67 YIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAK 141 (262)
T ss_pred ccEEEEecCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--cCCCCEEEeeCCccc
Confidence 3678999999999999884 34568889999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhccCCCchHHHhhc
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN--DSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
............+++.|++||.+.+..++.++|+||+|+++|++++|..||.... .......+.........+ ...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 219 (262)
T cd05572 142 KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYI 219 (262)
T ss_pred ccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--ccc
Confidence 7654433334568889999999988888999999999999999999999998766 444455554322221111 234
Q ss_pred CHHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
+..+.+++.+||..+|++|++ ++++++||||++.++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 789999999999999999999 999999999987544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=232.89 Aligned_cols=188 Identities=27% Similarity=0.430 Sum_probs=151.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++.. .+..+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCL 150 (331)
T ss_pred eEEEEEecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE--CCCCCEEEEECCcee
Confidence 46899999999999998853 35678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCC--ccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--CCCc
Q psy1096 99 KINPDHPP--RVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FDFD 169 (239)
Q Consensus 99 ~~~~~~~~--~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~--~~~~ 169 (239)
........ ....|++.|+|||.+.. ..++.++|+||+||++|+|++|..||.+.+..+....+.... ...+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 65433222 22458999999999963 346789999999999999999999998877777666665432 2222
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~~ 212 (239)
. ....++..+++++++||+.++.+ |++++++++||||...++
T Consensus 231 ~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 231 P-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred C-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 2 12347899999999998764444 789999999999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=226.35 Aligned_cols=197 Identities=19% Similarity=0.303 Sum_probs=155.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++++..++. .....+++..+..++.|++.|+.+ |++|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 83 ~~~lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~ 158 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL--TLDGDIKLADFGVSA 158 (292)
T ss_pred eEEEEEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE--cCCCCEEEccCccce
Confidence 4678999999999987765 334568889999999999999999 99999999999999999 677899999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......+++.|++||.+. ...++.++|+||+||++|+|++|..||...+.......+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 237 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQ 237 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCC
Confidence 543322 223456788999999984 334678999999999999999999999876655554444333221 1111
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIIS 221 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~ 221 (239)
...++..+.+++++||..+|++||+++++++|||++.....+.....++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~ 286 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVA 286 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHHHHH
Confidence 2356788999999999999999999999999999987666665554443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=226.38 Aligned_cols=190 Identities=22% Similarity=0.291 Sum_probs=153.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++... ....+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~--~~~~~~~l~dfg~~~ 143 (277)
T cd05577 67 DLCLVMTLMNGGDLKYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL--DDHGNVRISDLGLAV 143 (277)
T ss_pred eEEEEEecCCCCcHHHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEccCcchh
Confidence 467899999999999888542 22468889999999999999999 99999999999999999 777899999999887
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............++..|++||.+.+..++.++|+||+|+++++|++|..||...........+.......+......+++
T Consensus 144 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (277)
T cd05577 144 ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSP 223 (277)
T ss_pred hhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCH
Confidence 65443333345577889999999888889999999999999999999999976654333333333222222222245789
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~ 212 (239)
.+.+++++||..+|++|| +++++++||||++.++
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 999999999999999999 8999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=220.08 Aligned_cols=182 Identities=23% Similarity=0.329 Sum_probs=154.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++.. ..+..+++..+..++.+++.||.| |+.|++|+||+|+||++ +..+.++|+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili--~~~~~~~l~df~~~~ 149 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL--DAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--eCCCCEEEcccccce
Confidence 46889999999999998865 345678888999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+......... ..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 226 (256)
T cd08529 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYS 226 (256)
T ss_pred eccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccC
Confidence 6654322 23345788999999999888899999999999999999999999877766666666555433222 2578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||+.+|++||++.++++|||+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=226.27 Aligned_cols=186 Identities=22% Similarity=0.329 Sum_probs=151.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. .+..+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili--~~~~~~~l~d~g~~~ 151 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL--TLDGDVKLADFGVSA 151 (280)
T ss_pred eEEEEeeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--CCCCCEEEccCccch
Confidence 46889999999999988753 34578899999999999999999 99999999999999999 777899999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......+++.|++||.+. ...++.++|+||+|+++|+|++|..||.+.........+........ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 230 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQ 230 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CC
Confidence 544322 223345888999999985 33467899999999999999999999987776666655554432211 11
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...++..+.+++.+||+.+|++||+++++++|+|+++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 13568899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=224.77 Aligned_cols=187 Identities=20% Similarity=0.269 Sum_probs=150.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++. ..+.+++..+..++.|++.|+.| |+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 71 ~~~~v~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili--~~~~~~kl~dfg~~~ 145 (278)
T cd05606 71 KLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE--CCCCCEEEccCcCcc
Confidence 4678999999999998773 45679999999999999999999 99999999999999999 677889999999986
Q ss_pred ecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....|+..|++||.+.+. .++.++|+||+|+++|+|++|..||.+.... .............+ .
T Consensus 146 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 220 (278)
T cd05606 146 DFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----D 220 (278)
T ss_pred ccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----C
Confidence 554322 2334688999999999744 5789999999999999999999999765322 22222222222222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCCCcc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSSPGV 216 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~~~~ 216 (239)
..+..+.+++.+||..+|++|+ +++++++||||+...+....
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~ 267 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhh
Confidence 4689999999999999999999 99999999999886655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=225.74 Aligned_cols=182 Identities=29% Similarity=0.448 Sum_probs=156.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ..+.+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili--~~~~~~kl~dfg~~~ 149 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL--DSDGYIKITDFGFAK 149 (290)
T ss_pred eEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--CCCCCEEEeeCCCcc
Confidence 4678999999999998874 35778899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....+++.|++||.+.+...+.++|+||+|+++++|++|..||...........+..+....+ ..++.
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 223 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSP 223 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCH
Confidence 76543 2334688899999999888888999999999999999999999987776666666665544443 35689
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~ 212 (239)
.+++++++||..||.+|+ +++++++||||+..++
T Consensus 224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999999999999999 9999999999987553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=225.41 Aligned_cols=183 Identities=23% Similarity=0.398 Sum_probs=146.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+..+.++.+..++.|++.|++| |+.|++|+||+|+||++ +..+.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili--~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHH-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCcchh
Confidence 56899999999999998864 334567888899999999999999 99999999999999999 677789999999876
Q ss_pred ecCCC-CCCccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......+++.|+|||.+.. ..++.++|+||+||++|+|++|..||...........+..... +...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 247 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKLK 247 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--CCCc
Confidence 54322 22334568889999999863 4567899999999999999999999976554443333322211 1111
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...++..+.+|+.+||..||.+|||+.++++||||
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 23578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=235.45 Aligned_cols=186 Identities=20% Similarity=0.310 Sum_probs=155.2
Q ss_pred ceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 17 SVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 17 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
.-.-+|+|||++.|+.+.+-+. ...... ..+..|+.+|+.|+.| |++|+||||+||+|||+. ++.|+++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEec
Confidence 3447899999999999988764 333444 7788899999999999 999999999999999994 366789999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCCchHHHh
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~ 174 (239)
.++..... ..+..-|..|.|||......++.++|+||||++||+|++|+.||...... ++...+....+. .
T Consensus 462 ~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~ 533 (612)
T KOG0603|consen 462 FWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------E 533 (612)
T ss_pred hhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------c
Confidence 98776654 33445788999999999999999999999999999999999999766555 566566554443 4
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
.+|..+++|+++||+.||.+|+++.+++.|+|+.+....+.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p~ 574 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFPP 574 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCCCCc
Confidence 78999999999999999999999999999999955444433
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=224.41 Aligned_cols=187 Identities=20% Similarity=0.295 Sum_probs=151.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|..++. .....+++..+..++.|++.||.| |+.|++||||+|+||++ +.++.++++|||++.
T Consensus 76 ~~~~v~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili--~~~~~~kl~dfg~~~ 151 (282)
T cd06643 76 NLWILIEFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF--TLDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEEecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE--ccCCCEEEccccccc
Confidence 4578999999999988765 335678899999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCCC-CCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......++..|++||.+. +..++.++|+||+||++|+|++|.+||...+..+....+......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 230 (282)
T cd06643 152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-Q 230 (282)
T ss_pred cccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-C
Confidence 654321 223346888999999984 344678999999999999999999999877665555555443322111 1
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+.+++.+||..+|++|||++++++|||++...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 135688999999999999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=226.65 Aligned_cols=189 Identities=28% Similarity=0.423 Sum_probs=155.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.++++.+..++.|++.||.| |+.+++|+||+|+||++ +..+.++++|||.+.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll--~~~~~~~l~dfg~~~ 149 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE--CCCCCEEEeeCCCcc
Confidence 4578999999999999884 35678999999999999999999 99999999999999999 777899999999875
Q ss_pred ecCCCC----------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q psy1096 99 KINPDH----------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT 162 (239)
Q Consensus 99 ~~~~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~ 162 (239)
...... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||.+.+..+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 321100 0112346778999999988888999999999999999999999998887777676666
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhccccccCCCCC
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~~~~~~~~ 214 (239)
......+... ..++..+.+++++||..+|++||+ +.++++||||...+...
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 230 SDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred hcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 5544333221 257889999999999999999998 79999999998766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=214.70 Aligned_cols=167 Identities=21% Similarity=0.336 Sum_probs=141.6
Q ss_pred cCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccccCCCCccCcc
Q psy1096 42 AGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPE 119 (239)
Q Consensus 42 ~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE 119 (239)
-.+.+++.++-++...++.||.| .+++|+|||+||+|||+ |..|.+||||||++-......-.....|.+.|||||
T Consensus 184 ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl--De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPE 261 (391)
T KOG0983|consen 184 IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPE 261 (391)
T ss_pred hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE--ccCCCEEeecccccceeecccccccccCCccccCcc
Confidence 35679999999999999999999 78899999999999999 889999999999998887766666677999999999
Q ss_pred ccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccC
Q psy1096 120 IIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGE-NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195 (239)
Q Consensus 120 ~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 195 (239)
.+. ...|+.++|+||||+.+++++||+.||.+. ...+.+-++.....+.. ..-..+++.+++|+..||..|+.+|
T Consensus 262 Ridp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L-~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 262 RIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL-PGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred ccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC-CcccCcCHHHHHHHHHHhhcCcccC
Confidence 994 446899999999999999999999999874 45566666655433211 1122489999999999999999999
Q ss_pred CCHHHHhhccccccCC
Q psy1096 196 LTAKQCLSHLWIAQKD 211 (239)
Q Consensus 196 pt~~~ll~h~~~~~~~ 211 (239)
|...++|+|||++..+
T Consensus 341 P~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 341 PKYNKLLEHPFIKRYE 356 (391)
T ss_pred cchHHHhcCcceeecc
Confidence 9999999999998744
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=239.28 Aligned_cols=193 Identities=22% Similarity=0.316 Sum_probs=164.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+|||||-|..-. ++ + --...+.+..+..|..+.+.||+| |+++.||||||.-|||+ ...|.|||+|||.+.
T Consensus 100 TaWLVMEYClGSAsD-ll-e-VhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL--se~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 100 TAWLVMEYCLGSASD-LL-E-VHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL--SEPGLVKLADFGSAS 174 (948)
T ss_pred hHHHHHHHHhccHHH-HH-H-HHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe--cCCCeeeeccccchh
Confidence 568999999987644 33 2 224467788889999999999999 99999999999999999 888999999999876
Q ss_pred ecCCCCCCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
... +-.+++|||.|||||++.. +.|+-++||||||++..++..+++|+++++.+..+..|..+..+... ...
T Consensus 175 i~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~e 249 (948)
T KOG0577|consen 175 IMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNE 249 (948)
T ss_pred hcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--Cch
Confidence 654 3456789999999999953 56899999999999999999999999999999999998776543332 245
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccch
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIIST 222 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~ 222 (239)
++..+++|+..||.+-|.+|||.+++|.|+|+...+......++++.
T Consensus 250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqR 296 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQR 296 (948)
T ss_pred hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHH
Confidence 68999999999999999999999999999999987777776666664
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=233.62 Aligned_cols=189 Identities=28% Similarity=0.433 Sum_probs=153.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.||+|.+++.. .+..+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill--~~~~~~kl~DfG~a~ 150 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE--cCCCCEEEEecccee
Confidence 46899999999999998863 24578889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCC--ccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-h
Q psy1096 99 KINPDHPP--RVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-D 170 (239)
Q Consensus 99 ~~~~~~~~--~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~ 170 (239)
........ ....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+.......+ +
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 66543221 23468999999999875 4568899999999999999999999988877777776655432221 1
Q ss_pred HHHhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++..+++++.+||+.++.+ |++++++++|+||...++
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 112346889999999999876554 468999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=232.49 Aligned_cols=185 Identities=21% Similarity=0.218 Sum_probs=138.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+ +|.+++. .....+++..+..++.|++.||.| |++||+||||||+||++ +..+.++|+|||.+.
T Consensus 131 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 131 ITCMVLPHYSS-DLYTYLT--KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQ 205 (357)
T ss_pred eeEEEEEccCC-cHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEecCcccc
Confidence 35678899965 5565654 345678899999999999999999 99999999999999999 777889999999986
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCch---------HHHHHHHhc-cC-
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPF-MGENDS---------ETFANITRA-EF- 166 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~-~~~~~~---------~~~~~i~~~-~~- 166 (239)
............|++.|+|||.+.+..++.++|+||+||++|+|+++..++ ...... ..+..+... ..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 543333333456899999999999889999999999999999999854444 322111 011111110 00
Q ss_pred --CCc--------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 167 --DFD--------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 167 --~~~--------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++ ......++..+.+|+.+||+.||.+|||++++|+||||++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 0000134567778999999999999999999999999975
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=223.83 Aligned_cols=185 Identities=22% Similarity=0.279 Sum_probs=144.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+++.....+..+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 73 ~~~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 149 (285)
T cd07861 73 RLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLADFGLAR 149 (285)
T ss_pred eEEEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--cCCCcEEECccccee
Confidence 46789999984 676676554455788999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC--------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF-------- 168 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 168 (239)
...... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+.......+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 654321 22234568889999998654 46889999999999999999999998765443332221111000
Q ss_pred -----------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 169 -----------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 169 -----------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.......++.++.+++++||+.||++|||+++++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011122467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.65 Aligned_cols=187 Identities=19% Similarity=0.211 Sum_probs=145.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||++.+ .|.+++ ...+.+++..+..++.|++.||.| |++||+||||||+||++ +..+.++|+|||++.
T Consensus 160 ~~~lv~e~~~~-~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill--~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 160 TVCMVMPKYKC-DLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEEehhcCC-CHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--cCCCCEEEccCcccc
Confidence 46788999975 555555 446788999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccC------
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANITRAEF------ 166 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~~~~~------ 166 (239)
...... ......||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.... ..+..+.+...
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 654332 122456899999999999989999999999999999999999999765432 12222211100
Q ss_pred -----------------------CCchH-HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 167 -----------------------DFDDE-AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 167 -----------------------~~~~~-~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.. ....++.++.+++++||..||++|||+.++|+||||++...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00000 00134667889999999999999999999999999987443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=229.21 Aligned_cols=155 Identities=22% Similarity=0.267 Sum_probs=122.9
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEI 120 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~ 120 (239)
.++...+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++........ .....+++.|+|||.
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE--cCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 46677788999999999999 99999999999999999 6678999999999876432211 122345678999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 121 INYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 121 ~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
+.+..++.++||||+||++|+|++ |..||.+................... ....+..+.+++.+||..||++|||+.
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA--PENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 998889999999999999999997 99999876544333333222221111 135688999999999999999999999
Q ss_pred HHhh
Q psy1096 200 QCLS 203 (239)
Q Consensus 200 ~ll~ 203 (239)
++++
T Consensus 326 el~~ 329 (338)
T cd05102 326 ALVE 329 (338)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=226.10 Aligned_cols=187 Identities=24% Similarity=0.407 Sum_probs=152.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+.+.+..+..++.|++.||.| |++|++||||+|+||++ +.++.++|+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--~~~~~~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL--TSDGRIKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--cCCCCEEEccCcchh
Confidence 4689999999999998763 3468888999999999999999 99999999999999999 667789999999886
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|+|||.+.+..++.++|+||+|++++++++|..||.+.+.......+.... ..........+
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVS 245 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccC
Confidence 543222 2233468889999999988889999999999999999999999998776655554443321 11111123468
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
..+.+++.+||..||++|||++++++|+||+.....
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 889999999999999999999999999999864433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=222.84 Aligned_cols=186 Identities=21% Similarity=0.335 Sum_probs=151.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++....+...+.+..+..++.|++.||++ |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~--~~~~~~~l~df~~~~ 150 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL--GEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE--cCCCCEEEcccchHH
Confidence 356899999999999998654444678899999999999999999 99999999999999999 667789999999887
Q ss_pred ecCCCCCC-----ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHPP-----RVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
........ ....++..|++||.+... .++.++|+||+|+++++|++|..||...+...................
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence 65533221 234578899999998766 679999999999999999999999987766555544443322111111
Q ss_pred --HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 --FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 --~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...++..+.+++.+||..||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12567889999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=222.83 Aligned_cols=183 Identities=21% Similarity=0.303 Sum_probs=147.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.+..+. .....+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 148 (286)
T cd07847 74 KLHLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR 148 (286)
T ss_pred EEEEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE--cCCCcEEECccccce
Confidence 457899999999888765 335568899999999999999999 99999999999999999 677799999999987
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC---------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD--------- 167 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~--------- 167 (239)
...... ......++..|++||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+....+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 149 ILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred ecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 765433 2333457788999999876 44688999999999999999999999877665544433221100
Q ss_pred ----------Cc--------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 168 ----------FD--------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 168 ----------~~--------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.+ ......++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 01123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=221.98 Aligned_cols=182 Identities=23% Similarity=0.332 Sum_probs=152.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++.. ..+++..+..++.|++.|+.+ |+.+++|+||+|+||++ +.++.++++|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~ 146 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL--SEEGDVKLADFGVSG 146 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEcccccce
Confidence 56789999999999988742 278889999999999999999 99999999999999999 778899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......+++.|++||.+.+..++.++|+||+|+++|+|++|..||...+.......+......... ...++
T Consensus 147 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 224 (274)
T cd06609 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFS 224 (274)
T ss_pred eecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccC
Confidence 77644 2233456788899999999888999999999999999999999999876655555444443222111 11268
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+.+++.+||..+|++|||++++++|+||+.
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 88999999999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=224.56 Aligned_cols=175 Identities=14% Similarity=0.119 Sum_probs=146.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++|||+.+|+|.+++. .+..+++.....++.+++.||.+ |+. +++||||||+||++ +.++.++++|||++
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill--~~~~~~kl~dfg~~ 170 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV--TENYKLKIICHGLE 170 (283)
T ss_pred ceEEEEEeCCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE--CCCCcEEEcccchH
Confidence 4578999999999999985 35678888899999999999999 984 99999999999999 77789999999998
Q ss_pred eecCCCCCCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
....... ....++..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+....+......++.. ..
T Consensus 171 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~ 246 (283)
T PHA02988 171 KILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LD 246 (283)
T ss_pred hhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--Cc
Confidence 7554322 23457889999999976 678999999999999999999999999888777777765544333221 24
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 6889999999999999999999999985
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=225.90 Aligned_cols=183 Identities=28% Similarity=0.425 Sum_probs=147.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+.+++|.+++. .++.++...+..++.|++.||.+ |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~--~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL--DENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE--STTSEEEESSGTTTE
T ss_pred ccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc
Confidence 4568999999999998885 57788999999999999999999 99999999999999999 778899999999987
Q ss_pred ec-CCCCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH---
Q psy1096 99 KI-NPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF--- 173 (239)
Q Consensus 99 ~~-~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~--- 173 (239)
.. ..........++..|+|||.+. +...+.++|+||+|+++++|++|..||...........+............
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 64 2233334456888999999998 778899999999999999999999999877333333333222211111110
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...+..+.+++++||..||++|||++++++||||
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 1113789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=222.33 Aligned_cols=182 Identities=21% Similarity=0.309 Sum_probs=146.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.|+.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili--~~~~~~~l~dfg~~~ 154 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEEeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECcceeee
Confidence 4678999999999999874 45678999999999999999999 99999999999999999 777889999999986
Q ss_pred ecCCCC-CCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-HH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE-AF 173 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~ 173 (239)
...... ......|+..|+|||.+. ...++.++|+||+||++|+|++|..||...................+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 654322 223346889999999974 4457889999999999999999999997655444443333333322211 11
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
..++..+.+++.+||..+|++|||++++++|||
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=221.52 Aligned_cols=182 Identities=24% Similarity=0.302 Sum_probs=149.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++. ..+.+++..+..++.|++.||++ |+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 150 (265)
T cd06631 76 TISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCAR 150 (265)
T ss_pred eEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE--CCCCeEEeccchhhH
Confidence 5788999999999999884 34567888999999999999999 99999999999999999 677899999999876
Q ss_pred ecCCC-------CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 99 KINPD-------HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 99 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
..... .......++..|++||.+.+..++.++|+||+|++++++++|..||...+.......+.......+ .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 229 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-R 229 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-C
Confidence 54211 111234578899999999988889999999999999999999999987665544444433322211 1
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
....++..+.+++++||..+|++||+++++++||||
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=218.51 Aligned_cols=183 Identities=22% Similarity=0.321 Sum_probs=153.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+++++|.+++.. ..+..+++..+..++.+++.|+.+ |++|++|+||+|+||+++. .++.++++|||.+.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~~ 150 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGISK 150 (256)
T ss_pred EEEEEEecCCCCCHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCce
Confidence 46889999999999999864 234567888999999999999999 9999999999999999943 23468999999988
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............++..|+|||.+.+...+.++|+||+|+++++|++|..||.+.+.......+......... ..++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (256)
T cd08220 151 ILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DRYSP 227 (256)
T ss_pred ecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---CCcCH
Confidence 776544444456888999999999888899999999999999999999999877766666555544332211 35788
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.+.+++.+||..+|++|||++++++|||+
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=218.93 Aligned_cols=183 Identities=23% Similarity=0.339 Sum_probs=149.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++. ..+..+++..+..++.|++.|+.| |+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~--~~~~~~~l~dfg~~~ 147 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL--NEEGQAKLADFGVSG 147 (256)
T ss_pred cEEEEEecCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--CCCCcEEEcccccch
Confidence 4568999999999999885 345678899999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|++||.+.+..++.++|+||+|+++++|++|..||...........+...... .......++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (256)
T cd06612 148 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWS 226 (256)
T ss_pred hcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcC
Confidence 765433 223345788999999998888899999999999999999999999876554443333222111 111123467
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||+.+|++|||++++++||||
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=248.78 Aligned_cols=189 Identities=23% Similarity=0.296 Sum_probs=152.0
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhh-------cccCCCCCCCCeEEecC------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSL-------VTVDPKILPENIMCVSR------ 84 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~-------~ivH~dikp~nili~~~------ 84 (239)
.+|+||||+++++|.+++... ...+.+++..+..|+.||+.||.| |+. +|||+||||+|||+..+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 468999999999999988653 235679999999999999999999 985 49999999999999542
Q ss_pred ---------CCCcEEEEecccceecCCCCCCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy1096 85 ---------TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGEN 153 (239)
Q Consensus 85 ---------~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~ 153 (239)
..+.++|+|||++.............||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 234689999999877654444445579999999999864 347899999999999999999999997665
Q ss_pred chHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 154 DSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...............+ ....+..+.+||..||..+|.+||++.++|.|+|++...
T Consensus 248 ~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 248 NFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred cHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 5444433333222222 134688999999999999999999999999999997543
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=232.35 Aligned_cols=185 Identities=21% Similarity=0.316 Sum_probs=142.1
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
.-.+|+||| |+..+|..+|. ..++.+....++.+..|++.++.+ |++||||.||||.|+++. .|.+||+|||.
T Consensus 432 d~~lYmvmE-~Gd~DL~kiL~--k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 432 DGYLYMVME-CGDIDLNKILK--KKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred CceEEEEee-cccccHHHHHH--hccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 347888998 57778888886 445566656889999999999999 999999999999999973 46899999999
Q ss_pred ceecCCCCC---CccccCCCCccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHH
Q psy1096 97 AQKINPDHP---PRVLFGTPEFIPPEIINYEP-----------IGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANI 161 (239)
Q Consensus 97 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-----------~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i 161 (239)
+..+..... ..+.+||+-||+||.+.+.. .++++|||||||++|+|+.|++||.... ....+..|
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 988765432 33467999999999995332 4689999999999999999999995432 33334444
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..-...++... ..-..++.++++.||..||.+|||+.++|+|||+.-
T Consensus 586 ~~P~~~Iefp~-~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 586 TDPNHEIEFPD-IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCCccccccC-CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 33322111111 011234899999999999999999999999999964
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=219.26 Aligned_cols=183 Identities=23% Similarity=0.339 Sum_probs=155.2
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-h-----hhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-H-----SLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h-----~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
..|++|||+++++|.+++... ..++.+++..+..++.|++.||.+ | +.+++|+||+|+||++ +.++.++++
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili--~~~~~~kl~ 152 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLG 152 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE--ecCCCEEEe
Confidence 468999999999999988653 235678889999999999999999 9 8999999999999999 667899999
Q ss_pred ecccceecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 93 DFGLAQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 93 dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
|||.+........ .....+++.|++||.+.+..++.++|+||+|+++++|++|..||...+.......+........
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 230 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI-- 230 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC--
Confidence 9999887665433 3345688999999999888889999999999999999999999988776555555555443222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...++..+.+++.+||..+|++|||++++++|||+
T Consensus 231 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 -PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 13578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=220.95 Aligned_cols=180 Identities=22% Similarity=0.319 Sum_probs=148.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~--~~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE--cCCCCEEecccCCCc
Confidence 4568899999999998884 34678888999999999999999 99999999999999999 677789999999887
Q ss_pred ecCCCC-------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 99 KINPDH-------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 99 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
...... ......++..|++||.+.+..++.++|+||+|+++|++++|..||.+.+.......+...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~ 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP---E 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC---c
Confidence 664221 111234778899999998888899999999999999999999999876655544444332221 1
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
....++..+.+++++||+.||.+||+++++++|+||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=240.18 Aligned_cols=186 Identities=20% Similarity=0.269 Sum_probs=153.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCc--hHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQP--WVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~--~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.-+.||.++||+|+.+++ ..+|++ .+.+..-+-+||+.||.| |+..|||||||-+|++|+. -+|.+|++|||-+
T Consensus 647 ~kIFMEqVPGGSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTs 723 (1226)
T KOG4279|consen 647 FKIFMEQVPGGSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTS 723 (1226)
T ss_pred EEEEeecCCCCcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccc
Confidence 345689999999999997 668888 788888999999999999 9999999999999999843 5589999999999
Q ss_pred eecCC-CCCCccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhccCCCchHHH
Q psy1096 98 QKINP-DHPPRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~ 173 (239)
++.-. +++..++.||..|||||.+..+ +|+.++|||||||...+|.||++||.... ....+-++ +.+.-.++..
T Consensus 724 KRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKvHP~iP 801 (1226)
T KOG4279|consen 724 KRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKVHPPIP 801 (1226)
T ss_pred hhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceecCCCCc
Confidence 88654 4455667899999999999765 47899999999999999999999995433 22222222 3332233333
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.+++.++++|+.+|+.+||.+||++.++|++||+....
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 57899999999999999999999999999999998653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=224.41 Aligned_cols=186 Identities=23% Similarity=0.374 Sum_probs=152.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++. ...+++..+..++.+++.|+++ |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili--~~~~~~kl~dfg~~~ 163 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL--GMDGSVKLTDFGFCA 163 (296)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEccCccch
Confidence 4678999999999998764 3457889999999999999999 99999999999999999 677889999999877
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....++..|++||.+.+..++.++|+||+||++|++++|..||.+.+.......+..... ........++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLS 242 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCC
Confidence 6543322 2234588899999999888889999999999999999999999987766555444433321 1111223578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++++||..||++|||++++++||||+....
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 89999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=224.54 Aligned_cols=185 Identities=22% Similarity=0.277 Sum_probs=144.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++. .....+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 78 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~ 152 (301)
T cd07873 78 SLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI--NERGELKLADFGLAR 152 (301)
T ss_pred eEEEEEecccc-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE--CCCCcEEECcCcchh
Confidence 36789999985 6666664 335567888999999999999999 99999999999999999 677789999999986
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
...... ......+++.|++||.+.+. .++.++|+||+||++|+|++|.+||.+.+..+....+........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 544222 22234578899999998654 468899999999999999999999987766554444332111100
Q ss_pred -------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 -------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 -------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......++..+.+|+.+||+.||.+|||++++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0111246788999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=225.56 Aligned_cols=185 Identities=25% Similarity=0.397 Sum_probs=150.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. +..+....+..++.|++.||+| |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill--~~~~~~kl~dfg~~~ 164 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEEeecccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--cCCCCEEECccccch
Confidence 4678999999999998874 3457788889999999999999 99999999999999999 777899999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+..... ........++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 243 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLS 243 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccC
Confidence 654322 12234688899999999888889999999999999999999999987765444433333221 1111123578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||..+|++|||++++++|+|+...+
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 8899999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=229.01 Aligned_cols=182 Identities=23% Similarity=0.297 Sum_probs=144.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+.+.. .++...+..++.|++.||+| |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~--~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEccCccce
Confidence 46899999976 55555431 27788889999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA------ 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 172 (239)
............++..|+|||.+.+..++.++|+||+||++++|++|..||...+....+..+......++...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 76544333445678899999999998899999999999999999999999987765544444432211111000
Q ss_pred ---------------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 ---------------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ---------------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....+..+++++.+||+.||++|||++++|+|||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0123556889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=224.67 Aligned_cols=188 Identities=23% Similarity=0.393 Sum_probs=151.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ...+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++++|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili--~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 163 (297)
T ss_pred EEEEeecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEECcCccce
Confidence 4678999999999998874 3457788899999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....+++.|++||.+.+..++.++|+||+||++|++++|..||.+.+.......+.... .........++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLS 242 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccC
Confidence 6543322 223468889999999998888999999999999999999999997765543333222221 11111223567
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
..+.+++.+||..+|++||+++++++||||+......
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 8899999999999999999999999999998755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=218.54 Aligned_cols=183 Identities=22% Similarity=0.331 Sum_probs=149.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++|+||+|+||++ +.++.++++|||.+.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~ 149 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL--TEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE--CCCCCEEECccccch
Confidence 46789999999999988753 33678899999999999999999 99999999999999999 677889999999887
Q ss_pred ecCCCC-CCccccCCCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-HHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE---PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD-EAF 173 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~ 173 (239)
...... ......++..|++||.+... .++.++|+||+|+++|+|++|..||.+.+.......+.......+. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 654322 22334678889999999776 7889999999999999999999999877766555555444332211 112
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
...+..+.+++++||..+|.+|||+++++.|+|
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 345778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=226.19 Aligned_cols=188 Identities=13% Similarity=0.183 Sum_probs=142.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++... ....+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++++||+...
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~--~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE--ecCCcEEEcccchhh
Confidence 356899999999999988542 23457888999999999999999 99999999999999999 666789999997643
Q ss_pred ecCCCC--------CCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC
Q psy1096 99 KINPDH--------PPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 99 ~~~~~~--------~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 322111 1112346678999999976 357899999999999999999999997654433322222111100
Q ss_pred -------c-----------------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 169 -------D-----------------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 169 -------~-----------------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
+ ......+++.+.+|+++||+.||++|||++++++|||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0 0011234678999999999999999999999999999
Q ss_pred cccC
Q psy1096 207 IAQK 210 (239)
Q Consensus 207 ~~~~ 210 (239)
|++.
T Consensus 310 f~~~ 313 (327)
T cd08227 310 FKQI 313 (327)
T ss_pred hhhc
Confidence 9763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=220.71 Aligned_cols=183 Identities=21% Similarity=0.282 Sum_probs=140.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++ ++.+++. ..++.+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 73 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~--~~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCDQ-DLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI--NKNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCCC-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--cCCCcEEECccchhh
Confidence 46889999986 5555553 335678999999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhccCCCc------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFM-GENDSETFANITRAEFDFD------ 169 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~-~~~~~~~~~~i~~~~~~~~------ 169 (239)
..... .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..|+. +.+.......+.+......
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 65432 2223345788999999987654 6899999999999999999888754 3433333333322111000
Q ss_pred -------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 -------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 -------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
......++..+.+++++||+.||.+|||++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 01112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=221.91 Aligned_cols=186 Identities=24% Similarity=0.347 Sum_probs=148.8
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.... .+..+.+..+..++.|++.||.+ |+++++|+||||+||++ +..+.++|+|||.+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili--~~~~~~kl~dfg~~ 175 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVS 175 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--cCCCCEEEeecccc
Confidence 3678999999999998875432 35678889999999999999999 99999999999999999 66778999999988
Q ss_pred eecCCCCC-CccccCCCCccCccccccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEP-----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~-----~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
........ .....++..|++||.+.... ++.++|+||+||++|+|++|..||...........+........ .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 254 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-L 254 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-C
Confidence 76543221 22345788899999986443 57899999999999999999999987766555555443322111 1
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
.....+..+.+++.+||..+|++||+++++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1124567899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=219.79 Aligned_cols=182 Identities=22% Similarity=0.272 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+.+.. ....+++..+..++.|++.||.+ |+.|++|+||+|+||++ +. +.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l--~~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI--KD-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE--cC-CCeEEEeccccc
Confidence 45889999986 55555542 24578899999999999999999 99999999999999999 55 899999999987
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
............++..|+|||.+.. ..++.++|+||+||++|+|++|..||.+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 7654444444567889999998754 44688999999999999999999999887665544444321111100
Q ss_pred ------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 ------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 ------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+++++||..+|++|||++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=219.53 Aligned_cols=184 Identities=24% Similarity=0.299 Sum_probs=147.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+ +++|.+++.. ....+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++++|||.+.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~--~~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--SADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE--cCCCcEEEeeeeecc
Confidence 467899999 9999988753 34678899999999999999999 99999999999999999 667889999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-----
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD----- 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 170 (239)
...... ......++..|+|||.+.+.. ++.++|+||+|+++++|++|.++|.+.+.......+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 665432 123356888999999986544 589999999999999999999888877665555444332111100
Q ss_pred ---------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 171 ---------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 171 ---------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
......+..+.+++++||..+|++|||++++++||||.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11124568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=224.71 Aligned_cols=185 Identities=19% Similarity=0.259 Sum_probs=146.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.||.| |+ .+++|+||+|+||++ +.++.++|+|||++
T Consensus 73 ~~~lv~ey~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~ 147 (308)
T cd06615 73 EISICMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVS 147 (308)
T ss_pred EEEEEeeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE--ecCCcEEEccCCCc
Confidence 4678999999999999884 34678889999999999999999 97 589999999999999 66778999999987
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC---------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF--------- 168 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 168 (239)
...... ......++..|++||.+.+..++.++|+||+|+++++|++|..||...+.......+.......
T Consensus 148 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 148 GQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred cccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 654322 2234568889999999988888999999999999999999999997655333322221110000
Q ss_pred -------------------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 169 -------------------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 169 -------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+......++..+.+|+.+||..+|++|||++++++||||.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000011357789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=219.36 Aligned_cols=185 Identities=26% Similarity=0.425 Sum_probs=149.3
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.... .+..+++..+..++.|++.||.| |+.+++|+||+|+||++ +.++.++|+|||.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~--~~~~~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE--ccCCeEEECCCccc
Confidence 4689999999999998876432 35788999999999999999999 99999999999999999 66788999999988
Q ss_pred eecCCCC-CCccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
....... ......++..|+|||.+... .++.++|+||+|++++++++|..||...........+........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 239 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL-K 239 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC-C
Confidence 7654322 22335588899999988542 357889999999999999999999986655555555544322111 1
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
....++..+.+++++||..||++|||++++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 112467889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=221.25 Aligned_cols=185 Identities=23% Similarity=0.423 Sum_probs=152.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.|++|.+++.. +.+++..+..++.|++.||++ |++|++||||+|+||++ +.++.++++|||.+.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL--TSDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE--cCCCcEEEcccccch
Confidence 35688999999999988742 568888999999999999999 99999999999999999 777899999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|++||.+.+..++.++|+||+|+++++|++|..||.+.+.......+........ .....++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVS 242 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCC
Confidence 543322 22334588899999999888889999999999999999999999987776666665554422111 1112367
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||..+|++|||++++++|+|++...
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 8999999999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=218.12 Aligned_cols=185 Identities=23% Similarity=0.332 Sum_probs=152.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. .+.+++..+..++.|++.|+++ |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~--~~~~~~~l~dfg~~~ 149 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE--cCCCCEEEcccccce
Confidence 4789999999999998874 3467888889999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....++..|+|||.+.+...+.++|+||+|+++|+|++|..||...........+..... +.....++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 226 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFS 226 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhh
Confidence 6654322 2234577889999999888889999999999999999999999987766555444433221 12223567
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
..+.+++.+||+.+|++||+++++++|+|+.....+
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 889999999999999999999999999999764443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=220.55 Aligned_cols=191 Identities=24% Similarity=0.292 Sum_probs=150.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+ +++|.+++.. ....+++..+..++.|++.||.| |++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill--~~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI--ASDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE--cCCCCEEEccceeee
Confidence 568899999 8899888753 22378899999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
...... ......+++.|+|||.+.+ ..++.++|+||+||++++|++|.++|.+.+.......+......+..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 765432 2233456778999999855 45689999999999999999998888877765555544332111111
Q ss_pred ------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 171 ------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 171 ------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
......+..+.+++.+||..+|++|||++++++|+||++......
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 011234678999999999999999999999999999998555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=251.48 Aligned_cols=191 Identities=25% Similarity=0.343 Sum_probs=158.9
Q ss_pred cCCCceeEEEee----------CccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEE
Q psy1096 13 NNRTSVVITWSS----------PPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMC 81 (239)
Q Consensus 13 ~~~~~~~~~~~~----------~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili 81 (239)
.+|+++|..|.| ||||+||+|.+++. -++-..+-...-+..|++.|++| |++|||||||||+||++
T Consensus 1291 lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L 1367 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL 1367 (1509)
T ss_pred ccCccccccCceeecHHHHHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee
Confidence 567788766654 99999999999984 35566666678899999999999 99999999999999999
Q ss_pred ecCCCCcEEEEecccceecCCCC-----CCccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC-C
Q psy1096 82 VSRTSHHIKIIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPFMG-E 152 (239)
Q Consensus 82 ~~~~~~~vkl~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~-~ 152 (239)
+.+|.+|++|||.+....++. ......||+.|||||.+.+.. ...++||||+||++.+|+||+.||.. +
T Consensus 1368 --d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1368 --DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred --ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 888899999999998876553 122357999999999996544 57899999999999999999999965 4
Q ss_pred CchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 153 NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+...++.++-.+..+..+ .+++..-++|+..||..||.+|.++.||++|-|-+.+.
T Consensus 1446 ne~aIMy~V~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1446 NEWAIMYHVAAGHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred chhHHHhHHhccCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 566676666655543333 35899999999999999999999999999999987643
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=222.59 Aligned_cols=188 Identities=22% Similarity=0.233 Sum_probs=148.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++.. ....+++..+..++.|++.||.| |+.|++|+||+|+||++ +..+.++|+|||.+.
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~kL~dfg~~~ 156 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL--TDKGCLKIADFGLAR 156 (309)
T ss_pred eEEEEEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECccceee
Confidence 46889999986 56666642 24678889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
...... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.+.+..+....+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765432 2222345778999999865 45689999999999999999999999888777666655442111100
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
......+..+.+++++||..||++|||+++++.||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 001124788899999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=223.16 Aligned_cols=187 Identities=19% Similarity=0.186 Sum_probs=135.8
Q ss_pred EEEeeCccCCCCccchhhhhh------hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec--CCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM------KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--RTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--~~~~~vk 90 (239)
..|+++||++++ +.+++... .....+++..+..++.|++.||.| |+.|++||||||+||++.. +.++.++
T Consensus 74 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07867 74 KVWLLFDYAEHD-LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred eEEEEEeeeCCc-HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEE
Confidence 457889998874 44444321 122357888899999999999999 9999999999999999953 3456899
Q ss_pred EEecccceecCCCC----CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------H
Q psy1096 91 IIDFGLAQKINPDH----PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS---------E 156 (239)
Q Consensus 91 l~dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---------~ 156 (239)
|+|||++....... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|.+||...... .
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07867 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232 (317)
T ss_pred EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence 99999987654322 12234678899999999764 4789999999999999999999999643321 1
Q ss_pred HHHHHHhccCCC--------------c-------------hH-------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 157 TFANITRAEFDF--------------D-------------DE-------AFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 157 ~~~~i~~~~~~~--------------~-------------~~-------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
....+....... + .. .....+..+.+|+.+||+.||.+|||++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 111111000000 0 00 0012345688999999999999999999999
Q ss_pred hcccc
Q psy1096 203 SHLWI 207 (239)
Q Consensus 203 ~h~~~ 207 (239)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07867 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=244.52 Aligned_cols=186 Identities=30% Similarity=0.469 Sum_probs=163.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||+.||+|..++. +.+.+++..++-++..|..||.- |+-|+|||||||+|||+ +..|+++|+|||.+-
T Consensus 149 ~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl--d~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL--DKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe--cccCcEeeccchhHH
Confidence 6899999999999999884 34489999999999999999999 99999999999999999 889999999999887
Q ss_pred ecCCCCC--CccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--cCCCc
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA--EFDFD 169 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~--~~~~~ 169 (239)
.+...+. ....+|||.|++||++.. +.|+...|=||+||++|+|+.|..||+..+..+++-+|..- .+.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 7765443 445789999999999942 45789999999999999999999999999999999998765 55555
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhccccccCCCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~~~~~~~ 213 (239)
.. ..+|.+.++||.+.++ +|+.|.. ++++.+||||.+-+|.
T Consensus 304 ~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 304 DE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred cc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 22 2489999999999987 6999998 9999999999987774
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=215.15 Aligned_cols=182 Identities=21% Similarity=0.300 Sum_probs=154.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+++++|.+++... ....+++..+..++.|++.|+.+ |+.|++|+||+|+||++ +.++.++++|||.+.
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~--~~~~~~kl~d~~~~~ 149 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--TKAGLIKLGDFGISK 149 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE--eCCCCEEECcCcceE
Confidence 457789999999999988642 25678889999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......+++.|++||.+.+..++.++|+||+|+++++|++|..||...+..+....+......... ..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 226 (256)
T cd08221 150 ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYS 226 (256)
T ss_pred EcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccC
Confidence 664433 233456889999999998888899999999999999999999999887777777666655443322 4578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||..+|++||+++++++|+|+
T Consensus 227 ~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 227 SELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=219.78 Aligned_cols=187 Identities=18% Similarity=0.250 Sum_probs=146.0
Q ss_pred eEEEeeCccCCCCccchhhhhhhc--CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEec
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKA--GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDF 94 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~df 94 (239)
...|++|||+++ ++.+++..... +..+++..+..++.|++.||.| |++|++|+||+|+||++ +. ++.++|+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~--~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE--ecCCCeEEEeec
Confidence 347899999997 57766654322 3567899999999999999999 99999999999999999 55 678999999
Q ss_pred ccceecCCC-CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc---
Q psy1096 95 GLAQKINPD-HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD--- 169 (239)
Q Consensus 95 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 169 (239)
|.+...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 998765422 22223356788999998865 4468999999999999999999999988766555444332111000
Q ss_pred ---------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 170 ---------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 170 ---------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
......++..+.+|+.+||..||++|||+++++.||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111234788899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=216.43 Aligned_cols=182 Identities=23% Similarity=0.321 Sum_probs=152.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++.+ .....+++..+..++.|++.|+.+ |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~--~~~~~~~l~d~~~~~ 149 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--TKDGTIKLGDFGIAR 149 (256)
T ss_pred eEEEEEecCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEEeecccee
Confidence 46789999999999988764 234467888899999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....+++.|+|||.+.+...+.++|+||+|++++++++|..||...+..+....+..+..... ...++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 226 (256)
T cd08218 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYS 226 (256)
T ss_pred ecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCC
Confidence 6654322 1234578889999999888889999999999999999999999987776666666655543322 13578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||+.+|++||++.++++|+||
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 227 YDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=217.29 Aligned_cols=185 Identities=28% Similarity=0.443 Sum_probs=155.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++. ..+.+++..+..++.|++.||++ |+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~--~~~~~~~l~dfg~~~ 141 (265)
T cd05579 67 NLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI--DSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE--cCCCCEEEEecccch
Confidence 4688999999999998884 34478999999999999999999 99999999999999999 677899999999876
Q ss_pred ecCCCC---------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc
Q psy1096 99 KINPDH---------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD 169 (239)
Q Consensus 99 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 169 (239)
...... ......++..|++||.......+.++|+||+|++++++++|..||...........+..+...++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 543321 12234577889999999888889999999999999999999999988877777766666554444
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCH---HHHhhccccccCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTA---KQCLSHLWIAQKD 211 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~---~~ll~h~~~~~~~ 211 (239)
.. ..++..+.+++++||+.+|++|||+ .++++||||++.+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 31 1248999999999999999999999 9999999998644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=224.10 Aligned_cols=189 Identities=25% Similarity=0.346 Sum_probs=163.9
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
.+|+..+.||+|.-.+.. ..++.++++.+.-++.+|+.||.. |+.+||+||+||+|||+ |+.|+|+|+|+|++..+
T Consensus 261 ClVLtlMNGGDLkfHiyn-~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL--Dd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYN-HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL--DDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeec-cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee--ccCCCeEeeccceEEec
Confidence 356779999999976654 234688899999999999999999 99999999999999999 89999999999999999
Q ss_pred CCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHH
Q psy1096 101 NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDA 180 (239)
Q Consensus 101 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 180 (239)
....+....+||.+|||||.+....|+...|=||+||++|+|+.|+.||.........+.+.......+....+.+++++
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 88888888899999999999999999999999999999999999999998766655555554444444444456899999
Q ss_pred HHHHHHhhhhCcccCCC-----HHHHhhccccccCCCC
Q psy1096 181 KDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 181 ~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~ 213 (239)
+++++..|..||++|.. ++++.+||||+.-.+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 99999999999999974 6789999999986655
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=218.50 Aligned_cols=179 Identities=20% Similarity=0.242 Sum_probs=148.3
Q ss_pred EEeeCccCCCCccchhhhhhhcC-------------CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAG-------------TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|++|||+++++|.+++...... ..++...+..++.|++.||.| |+.|++|+||||+||++ +.+
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~--~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE--cCC
Confidence 56889999999999988653221 457788889999999999999 99999999999999999 667
Q ss_pred CcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 789999999987653322 1223346788999999988889999999999999999998 999999888777776666
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....... ...++..+.+++++||+.||.+||++.+++++
T Consensus 241 ~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5443322 24678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=218.54 Aligned_cols=184 Identities=23% Similarity=0.322 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+++||+++++|.+++... ...+++..+..++.|++.|+++ |+ .|++|+||+|+||++ +.++.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~--~~~~~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV--NSRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE--CCCCCEEEeecccc
Confidence 467899999999999988532 2678888999999999999999 99 999999999999999 66789999999987
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN-----DSETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~~~ 172 (239)
......... ...++..|++||.+.+..++.++|+||+|++++++++|..||.... .......+.........
T Consensus 149 ~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (265)
T cd06605 149 GQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-- 225 (265)
T ss_pred hhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--
Confidence 655432211 2567889999999998889999999999999999999999996542 12222222222211111
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...++..+.+++.+||..+|++|||+.+++.||||++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 11278899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=219.48 Aligned_cols=185 Identities=25% Similarity=0.384 Sum_probs=147.1
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||++|++|.+++... ..+..+.+..+..++.|++.||.| |+.+++|+||||+||++ +..+.++|+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili--~~~~~~kl~dfg~~ 171 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVS 171 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE--CCCCCEEEccCCce
Confidence 468999999999999887643 245678888899999999999999 99999999999999999 66778999999998
Q ss_pred eecCCCC-CCccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
....... ......|++.|+|||.+.. ..++.++|+||+||++|+|++|..||...........+...... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 250 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP-TLH 250 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC-ccc
Confidence 7654332 2233468899999999853 34688999999999999999999999776554444333222111 111
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....+..+.+++.+||..||++|||+.++++|+||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=218.99 Aligned_cols=184 Identities=22% Similarity=0.299 Sum_probs=145.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++.. ....+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||++
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili--~~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE--CCCCcEEEeecCce
Confidence 357889999986 77766642 23468899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCC-CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH----
Q psy1096 98 QKINPD-HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE---- 171 (239)
Q Consensus 98 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---- 171 (239)
...... .......+++.|+|||.+.+.. .+.++|+||+|+++++|++|..||...+.......+......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 776543 2333455788899999987654 5899999999999999999999998777665555443321111000
Q ss_pred ----------------------HHhh--cCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 ----------------------AFEA--LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ----------------------~~~~--~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.... ++..+.+++++||+.+|++|||++++++|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011 47788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=217.11 Aligned_cols=181 Identities=22% Similarity=0.309 Sum_probs=146.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. .++.+++.....++.|++.||.+ |+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~--~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEccCCCcc
Confidence 5678899999999998884 34567888888999999999999 99999999999999999 677789999999886
Q ss_pred ecCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ......++..|+|||.+.+..++.++|+||+||++|++++|..||...........+......+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~ 232 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP--QLPS 232 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC--CCch
Confidence 543211 1122457888999999998888999999999999999999999998765555444443322221 1123
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
.++..+++++ +||..+|++||+++++++||||+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 5678889998 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=218.08 Aligned_cols=183 Identities=22% Similarity=0.337 Sum_probs=149.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+.+.+..+..++.|++.|+.| |++|++|+||+|+||++ +.++.++++|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i--~~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL--SEQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE--eCCCCEEEccccccc
Confidence 4689999999999998763 3568889999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|++||.+.+..++.++|+||+|+++++|++|..||...........+...... ......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccC
Confidence 654332 122345788899999999888899999999999999999999999766554444433322211 1113467
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||..+|++|||+.++++|+|++...
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 8899999999999999999999999999997633
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=231.01 Aligned_cols=185 Identities=17% Similarity=0.193 Sum_probs=139.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++||++. ++|.+++. .....+++..+..++.|++.||.| |++||+||||||+||++ +..+.++|+|||++.
T Consensus 234 ~~~lv~e~~~-~~L~~~l~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl--~~~~~vkL~DFGla~ 308 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLG--ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV--NGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEEccC-CCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE--CCCCCEEEcccCCce
Confidence 3567788886 46665654 234578899999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHHHHhccCC
Q psy1096 99 KINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN--------DSETFANITRAEFD 167 (239)
Q Consensus 99 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~--------~~~~~~~i~~~~~~ 167 (239)
....... .....||+.|++||.+.+..++.++|||||||++|+|++|..++.... .......+......
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 6543211 223468999999999999899999999999999999999876654321 11222222221110
Q ss_pred ---Cc---------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 168 ---FD---------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 168 ---~~---------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
++ ......++..+.+|+.+||..||.+|||++|+|+||||++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0001134567899999999999999999999999999975
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=218.55 Aligned_cols=182 Identities=23% Similarity=0.338 Sum_probs=145.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .++.+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill--~~~~~~~l~dfg~~~ 154 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--TDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCCEEECcCccce
Confidence 4678999999999998874 35678889999999999999999 99999999999999999 777789999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-HHH
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD-EAF 173 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~ 173 (239)
...... ......++..|+|||.+. ...++.++|+||+||++++|++|..||...........+.......+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 664322 223346888999999984 334678999999999999999999999765544333333333222221 111
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
..++..+.+|+++||..+|++|||++++++|+|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=220.30 Aligned_cols=186 Identities=24% Similarity=0.430 Sum_probs=153.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ...+++..+..++.|++.||++ |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 92 ~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill--~~~~~~kL~dfg~~~ 165 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL--TLDGRVKLSDFGFCA 165 (297)
T ss_pred eEEEEEecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE--ccCCcEEEeechhHh
Confidence 4678999999999988653 3567888999999999999999 99999999999999999 777899999999886
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||......+....+...... .......++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (297)
T cd06659 166 QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKIS 244 (297)
T ss_pred hcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCC
Confidence 544322 223356888999999998888999999999999999999999999877666655555433221 111223567
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++++||+.+|++||+++++++|+||.+...
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 88999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=215.14 Aligned_cols=184 Identities=25% Similarity=0.312 Sum_probs=146.7
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..++++||+++++|.+++. .++.+++..+..++.+++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~--~~~~~~kl~d~g~~ 146 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDFGCA 146 (264)
T ss_pred CEEEEEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEcccccc
Confidence 35788999999999999874 35567888999999999999999 99999999999999999 66789999999998
Q ss_pred eecCCCCCCc-----cccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc
Q psy1096 98 QKINPDHPPR-----VLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD 169 (239)
Q Consensus 98 ~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 169 (239)
.......... ...++..|++||.+.+.. .+.++|+||+|++++++++|..||....................
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP 226 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC
Confidence 7765432211 235778999999998766 78999999999999999999999976533332222222222211
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.......+..+.+++.+||..+|++|||+++++.|||+
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11222458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=222.71 Aligned_cols=189 Identities=24% Similarity=0.316 Sum_probs=152.3
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++ ..++.+++..+..++.+++.||++ |+.|++|+||||+||++ +.++.++|+|||.+
T Consensus 77 ~~~~lv~e~~~~-~l~~~l---~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili--~~~~~~~L~dfg~~ 150 (330)
T cd07834 77 NDVYIVTELMET-DLHKVI---KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV--NSNCDLKICDFGLA 150 (330)
T ss_pred cceEEEecchhh-hHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEcccCce
Confidence 356899999995 666666 345588999999999999999999 99999999999999999 66789999999998
Q ss_pred eecCCCC----CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-
Q psy1096 98 QKINPDH----PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE- 171 (239)
Q Consensus 98 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~- 171 (239)
....... ......++..|++||.+.+. .++.++|+||+|+++++|++|..||.+.+..+....+......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 23345678889999999887 78999999999999999999999998877665555544322211111
Q ss_pred --------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 172 --------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 172 --------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
....++..+.+++.+||+.+|++|||++++++||||++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 112357889999999999999999999999999999864433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=217.08 Aligned_cols=183 Identities=22% Similarity=0.299 Sum_probs=151.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+++||+++++|.+++.. .+.+++..+..++.|++.|+.+ |+ .+++|+||+|+||++ +.++.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~--~~~~~~~l~df~~~ 147 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI--NSKGEVKIADFGIS 147 (264)
T ss_pred eEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE--CCCCCEEEccCccc
Confidence 56788999999999999853 4778999999999999999999 99 999999999999999 77889999999998
Q ss_pred eecCCCCCCc-cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhccCCCchHHH
Q psy1096 98 QKINPDHPPR-VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---DSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~ 173 (239)
.......... ...++..|++||.+....++.++|+||+|+++|+|++|..||.... .......+........ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 224 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---P 224 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---C
Confidence 7765433322 4567888999999988888999999999999999999999997664 3333334332222111 1
Q ss_pred hh-cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 174 EA-LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 174 ~~-~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.. ++..+.+++++||..+|++|||++++++|||+++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 23 68899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=216.95 Aligned_cols=179 Identities=22% Similarity=0.353 Sum_probs=142.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||++++++..+ ..+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill--~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 74 ISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV--NTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE--CCCCCEEEeeCCccee
Confidence 5678999999998643 246777888999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHhccCCCchHH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-------ETFANITRAEFDFDDEA 172 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-------~~~~~i~~~~~~~~~~~ 172 (239)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .....+...... ...
T Consensus 145 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 221 (279)
T cd06619 145 LVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--VLP 221 (279)
T ss_pred cccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--CCC
Confidence 5433 233456889999999999888999999999999999999999999643211 111111111111 111
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
....+..+.+++.+||+.+|++||+++++++|||++...
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 124678899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=232.87 Aligned_cols=186 Identities=28% Similarity=0.438 Sum_probs=170.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~~ 97 (239)
.+|+|||-..|..|+=++. ...|.+++++.+-++.||+.||+| |.+||+|+||||+|||+.+.+. -++||||||++
T Consensus 637 rvFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred eEEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence 5789999999999995554 568999999999999999999999 9999999999999999955433 47999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
+.++......+.+|||.|+|||.+....|...-|+||+||++|.-+.|..||.. +.++-++|+...+.+|+.+|..++
T Consensus 715 RiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 715 RIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred eecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcC
Confidence 999988888889999999999999999999999999999999999999999954 456777899999999999999999
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....+||...|+..-.+|.|++..|.|+|+++
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999999999999976
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=220.42 Aligned_cols=189 Identities=15% Similarity=0.192 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++++.+++... ....+++..+..++.|++.||.| |+++|+|+||||+||++ +.++.++++||+.+.
T Consensus 73 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili--~~~~~~kl~d~~~~~ 149 (314)
T cd08216 73 ELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL--SGDGKVVLSGLRYSV 149 (314)
T ss_pred eEEEEEeccCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE--ecCCceEEecCccce
Confidence 358889999999999988653 34567888889999999999999 99999999999999999 667789999999876
Q ss_pred ecCCCCC--------CccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccC--
Q psy1096 99 KINPDHP--------PRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEF-- 166 (239)
Q Consensus 99 ~~~~~~~--------~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~-- 166 (239)
....... .....++..|+|||.+.+. .++.++|+||+||++++|++|..||..............+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcc
Confidence 5432111 1223466789999998763 478899999999999999999999976544332221111100
Q ss_pred ----------------------------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 167 ----------------------------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 167 ----------------------------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.........++..+.+|+.+||+.||++|||++++++||||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000011123456788999999999999999999999999998644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=215.15 Aligned_cols=181 Identities=20% Similarity=0.283 Sum_probs=146.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.||.+ |+++++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR--DSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe--cCCCCEEECcCcccc
Confidence 5678999999999998874 34567888889999999999999 99999999999999999 677899999999886
Q ss_pred ecCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||...........+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 232 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV--LPP 232 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC--Cch
Confidence 543211 11224578899999999888889999999999999999999999987655555444433322211 123
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
.++..+.+++++|+. +|++||+++++++|+|+.
T Consensus 233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 233 HVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 567889999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=215.83 Aligned_cols=183 Identities=21% Similarity=0.279 Sum_probs=147.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+.+++|.+++.. .+.+++..+..++.|++.||.+ |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~--~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV--DADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE--cCCCeEEEeeccccc
Confidence 45788999999999998853 4678889999999999999999 99999999999999999 677899999999886
Q ss_pred ecCCCC---CCccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--CCCchH
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEP--IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FDFDDE 171 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~ 171 (239)
...... ......++..|++||.+.... ++.++|+||+|++++++++|..||...........+.... ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 654221 122345788899999987654 7899999999999999999999997655544443332222 122222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
....++..+.+++.+||..+|++|||++++++|||+
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 233568899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=213.47 Aligned_cols=175 Identities=18% Similarity=0.193 Sum_probs=145.0
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+++|||+++++|.+++. ....+++..+..++.|++.||.+ |++|++||||||+||++ +.++.++|+|||.+...
T Consensus 71 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 71 MLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--VTQHYAKISDFGLSKAL 145 (257)
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE--cCCCeEEECCCcccccc
Confidence 67899999999998874 34578889999999999999999 99999999999999999 66778999999998765
Q ss_pred CCCCCC----ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 101 NPDHPP----RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 101 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... ....++..|+|||.+....++.++|+||+|+++|+|++ |..||.+.+.......+..+..... ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 222 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQR 222 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCC
Confidence 433211 11223568999999988888999999999999999998 9999988777777777765543221 135
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
++..+.+++.+||+.||++||++++|...
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHH
Confidence 78999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=219.24 Aligned_cols=191 Identities=27% Similarity=0.411 Sum_probs=169.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|.||||+.||.|..-+++ -|.+-+..+.-++.+|+.||-+ |++||++||||.+||++ +..|++||+|||+++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL--d~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DSEGHIKIADFGMCK 498 (683)
T ss_pred heeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe--ccCCceEeeeccccc
Confidence 68999999999999977754 5667777888899999999999 99999999999999999 888999999999986
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.-- ......+..|||.|+|||.+...+|+.+.|-||+||++|+|+.|++||.|.+..+....|......+|. +++
T Consensus 499 Eni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slS 574 (683)
T KOG0696|consen 499 ENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLS 574 (683)
T ss_pred ccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----ccc
Confidence 532 344566789999999999999999999999999999999999999999999999999999998888885 789
Q ss_pred HHHHHHHHHhhhhCcccCCCH-----HHHhhccccccCCCCCccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-----KQCLSHLWIAQKDSSPGVNKI 219 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-----~~ll~h~~~~~~~~~~~~~~~ 219 (239)
.++.++++..|...|.+|... +++-.||||+..+|...-+.+
T Consensus 575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~e 621 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERRE 621 (683)
T ss_pred HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhcc
Confidence 999999999999999999854 679999999988876543333
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=217.96 Aligned_cols=186 Identities=24% Similarity=0.405 Sum_probs=151.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+.+.+..+..++.|++.|+++ |+.|++||||+|+||++ +.++.++++|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv--~~~~~~~l~dfg~~~ 164 (292)
T cd06657 91 ELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCA 164 (292)
T ss_pred EEEEEEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEcccccce
Confidence 4678999999999988653 4567888899999999999999 99999999999999999 667789999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|++||.+.+..++.++|+||+|+++|++++|..||.+.........+..... ........++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 243 (292)
T cd06657 165 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVS 243 (292)
T ss_pred ecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCC
Confidence 554322 22334578899999999888889999999999999999999999987665555444433221 1111123568
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++.+||..+|.+||+++++++|+||.....
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 88999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=216.22 Aligned_cols=183 Identities=22% Similarity=0.286 Sum_probs=145.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.+..+. .....+.++.+..++.|++.||.| |+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 74 ~~~iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~--~~~~~~kl~d~g~~~ 148 (288)
T cd07833 74 RLYLVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV--SESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEEeeeccc
Confidence 468899999998877554 334568889999999999999999 99999999999999999 678899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-----
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD----- 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 170 (239)
...... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||.+.+..+....+.......++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 665433 33345678889999999887 7799999999999999999999999876554433332221100000
Q ss_pred -----------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 -----------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 -----------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+|+++||..+|++|||++++++|+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0011237889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=215.53 Aligned_cols=184 Identities=22% Similarity=0.288 Sum_probs=144.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+. +.|.+++.. ..++.+++..+..++.|++.||+| |+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill--~~~~~~~l~dfg~~~ 148 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--NTEGAIKLADFGLAR 148 (284)
T ss_pred cEEEEeeccc-cCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEeeccchh
Confidence 4678999997 467766643 345678899999999999999999 99999999999999999 777899999999886
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
...... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.......+........
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 654321 222345678899999987655 58899999999999999999999987765544433332211111
Q ss_pred ------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 ------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 ------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
......++..+.+++.+||+.||++|||++++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01112467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=223.06 Aligned_cols=189 Identities=22% Similarity=0.271 Sum_probs=147.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++ ..++.+++..+..++.|++.||+| |+.|++|+||||+||++ +.++.++|+|||++
T Consensus 81 ~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~dfg~~ 154 (334)
T cd07855 81 KDVYVVMDLMES-DLHHII---HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV--NEDCELRIGDFGMA 154 (334)
T ss_pred ceEEEEEehhhh-hHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEecccccc
Confidence 357899999975 676665 345668999999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCCC-----CccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--
Q psy1096 98 QKINPDHP-----PRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-- 169 (239)
Q Consensus 98 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-- 169 (239)
........ .....++..|++||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 76543221 123468889999999865 4578999999999999999999999987665444333222111110
Q ss_pred -------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 170 -------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 -------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.......+..+.+++++||+.+|++|||++++++||||.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 11123467889999999999999999999999999999764433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=213.30 Aligned_cols=181 Identities=23% Similarity=0.301 Sum_probs=149.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ..+.+++..+..++.|++.|+++ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~--~~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEccCccce
Confidence 4678899999999998884 34568888999999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............++..|++||.+.... ++.++|+||+|+++|++++|..||...........+...... ......++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 228 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLS 228 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC--CCcCCCcC
Confidence 765444334456888999999997766 899999999999999999999999766544444444331211 11123578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++++||..+|++|||+++++.|||+
T Consensus 229 ~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 229 DEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=225.52 Aligned_cols=187 Identities=22% Similarity=0.332 Sum_probs=172.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+.||-|-||.++..+ ...|.+.+.+++-++..++.|+.| |++|||+|||||+|.++ +..|-+||.|||+++
T Consensus 494 yvYmLmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL--d~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL--DNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhhHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee--ccCCceEEeehhhHH
Confidence 689999999999999998 568899999999999999999999 99999999999999999 889999999999999
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
....+....+++|||-|.|||.+.....+.++|.||||+++|++++|.+||.+.+...++..|.++--.+..+ ..++.
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k 646 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITK 646 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccch
Confidence 9999988889999999999999999999999999999999999999999999999999999998875432221 46788
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~ 213 (239)
...+|++++...+|.+|.. +.+|-+|.||...+|.
T Consensus 647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 647 TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 9999999988999999986 8899999999887766
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.22 Aligned_cols=179 Identities=21% Similarity=0.320 Sum_probs=153.7
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+++|++..|+|..|. +..+.+....+++|++||+.||.| |++. |+|||||.+||+|+. ..|.|||+|+|++..
T Consensus 120 ~iTEL~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCceeecchhHHHH
Confidence 578999999999998 557788889999999999999999 9997 999999999999944 337999999999987
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM-GENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ....+|||-|||||.+. ..|....||||||+++.+|+|+..||. ..+..++++++..+..+ .....--++
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP--~sl~kV~dP 271 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP--AALSKVKDP 271 (632)
T ss_pred hhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--HHhhccCCH
Confidence 65433 23367999999999998 889999999999999999999999995 57788888888877543 222223378
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
++++||.+||.. .+.|+|+.+||+|+||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=215.40 Aligned_cols=184 Identities=24% Similarity=0.294 Sum_probs=147.4
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|+++||+++ ++.+++. ..++.+++..+..++.|++.||.+ |+.+++|+||+|+||++ +.++.++++|||.+
T Consensus 71 ~~~~~v~e~~~~-~l~~~l~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~df~~~ 145 (283)
T cd05118 71 GDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI--NTEGVLKLADFGLA 145 (283)
T ss_pred CCEEEEEeccCC-CHHHHHH--hhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE--CCCCcEEEeeeeee
Confidence 356788999986 6665654 334688999999999999999999 99999999999999999 67788999999998
Q ss_pred eecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc------
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------ 169 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 169 (239)
....... ......++..|++||.+.+. ..+.++|+||+|++++++++|+.||.+.+..+....+........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 146 RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred EecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 7765443 23334577889999999776 678999999999999999999999987776555444432211100
Q ss_pred --------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 --------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 --------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
......++..+.+++.+||+.||.+||++++++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11223467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=215.00 Aligned_cols=177 Identities=14% Similarity=0.157 Sum_probs=145.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ...+.+++..+..++.|++.||+| |++|++|+||||+||++ +.++.++++|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili--~~~~~~~l~dfg~~~ 155 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV--NSDLVCKISGFRRLQ 155 (266)
T ss_pred CcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE--cCCCcEEECCCcccc
Confidence 3678999999999998885 334678899999999999999999 99999999999999999 677899999999765
Q ss_pred ecCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
......... ...++..|+|||.+.+..++.++|+||+||++|++++ |..||.+.+..+....+........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA---PRN 232 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCC
Confidence 543222111 1234567999999998889999999999999999775 9999988877776666654432221 245
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
++..+.+++.+||..+|++|||+++|++
T Consensus 233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 233 CPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=214.78 Aligned_cols=179 Identities=17% Similarity=0.243 Sum_probs=148.5
Q ss_pred EEEeeCccCCCCccchhhhhhh-----------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-----------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH 87 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~ 87 (239)
..|++|||+++++|.+++.... ....+.+..+..++.|++.|+.+ |+.|++|+||||+||++ +..+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili--~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--GYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE--cCCC
Confidence 4688999999999999986432 23457778889999999999999 99999999999999999 6778
Q ss_pred cEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHh
Q psy1096 88 HIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITR 163 (239)
Q Consensus 88 ~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~ 163 (239)
.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999986543221 1122345678999999998899999999999999999998 9999988877777777765
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+...... ...+..+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443332 357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=235.36 Aligned_cols=181 Identities=22% Similarity=0.319 Sum_probs=151.4
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~df 94 (239)
..=+++.||||.||.|-+++......+ +++.++++||.+++.|+++ |... |||||||-||||| ...|..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCEEeCcc
Confidence 566778899999999999987655555 9999999999999999999 9998 9999999999999 77889999999
Q ss_pred ccceecCCCCCCc----------cccCCCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy1096 95 GLAQKINPDHPPR----------VLFGTPEFIPPEII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI 161 (239)
Q Consensus 95 g~~~~~~~~~~~~----------~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i 161 (239)
|.+.-.-...... ...-|+.|.+||.+ ++.+.+.|+|||+|||+||-++....||.+... ..|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence 9876543322111 13478899999998 566679999999999999999999999975533 356
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+.+|+. ..++..+.+||+.||+.||++||++-+++.+-+.
T Consensus 267 lng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 267 LNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred EeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 7777777753 4689999999999999999999999999876543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=218.26 Aligned_cols=183 Identities=20% Similarity=0.252 Sum_probs=141.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+++. ..+..+++..+..++.|++.||.| |++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 93 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~ 167 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLS--NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI--TKDGILKLADFGLAR 167 (310)
T ss_pred eEEEEEcCCCc-CHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--CCCCcEEECcCCCcc
Confidence 45899999986 5555553 334578899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCC-----CccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHP-----PRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
....... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.......+.......+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543211 12235678899999987654 68899999999999999999999987765544443333211111100
Q ss_pred H----------------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 F----------------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 ~----------------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+ ...+..+.+++.+||..||++|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0125677899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=215.51 Aligned_cols=184 Identities=20% Similarity=0.373 Sum_probs=148.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .+.+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++++|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~ 149 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV--TNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE--cCCCCEEEccCCcee
Confidence 3578999999999998864 2378889999999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... ......|+..|+|||.+... .++.++|+||+|+++|+|++|..||.+.........+.... .+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 227 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGY 227 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccC
Confidence 765433 22334688899999998653 46889999999999999999999997765544433332221 111111236
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..+.+++.+||+.||++||++++++.|+|+++..
T Consensus 228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 228 SKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 78999999999999999999999999999997744
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=214.49 Aligned_cols=190 Identities=28% Similarity=0.417 Sum_probs=168.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+..||||..||.|.-.+ .....+++...+-+-..|++||.| |+++||+||+|.+|+++ +.+|++|++|||+++
T Consensus 242 rlCFVMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL--DkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL--DKDGHIKITDFGLCK 316 (516)
T ss_pred eEEEEEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee--ccCCceEeeecccch
Confidence 456789999999999666 557788999999999999999999 99999999999999999 888899999999986
Q ss_pred e-cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 K-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
. +.......+++|||-|+|||.+....|+.+.|-|.+||++|+|++|++||.+.+.......|..+...+|. .++
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls 392 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLS 392 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCC
Confidence 5 33445667789999999999999999999999999999999999999999999988888888888888874 789
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCCCCcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDSSPGVNK 218 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~~~~~~~ 218 (239)
++++.|+..+|..||.+|. .+.++.+|+||+..+|....++
T Consensus 393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK 438 (516)
T ss_pred HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence 9999999999999999997 3889999999998776644443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=214.54 Aligned_cols=179 Identities=25% Similarity=0.348 Sum_probs=149.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.|++|.+++.. ...+.+..+..++.|++.||.| |+.|++|+||+|+||++ +..+.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--~~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--cCCCCEEEeeccccc
Confidence 57889999999999988743 4678899999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND---SETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~ 175 (239)
............++..|++||.+....++.++|+||+|+++|++++|..||...+. .............. ...
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 224 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PAT 224 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccC----ccc
Confidence 76554333445688889999999888889999999999999999999999987664 22222222122222 235
Q ss_pred cCHHHHHHHHHhhhhCcccCCCH--HHHhhcccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTA--KQCLSHLWI 207 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~--~~ll~h~~~ 207 (239)
.+..+.+++.+||..||.+||++ +++++||||
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 78999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=216.16 Aligned_cols=190 Identities=26% Similarity=0.341 Sum_probs=147.8
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.... ....+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~--~~~~~~~l~dfg~~ 152 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL--TRKGQVKLCDFGVS 152 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--ecCCeEEEeecccc
Confidence 4678999999999998875433 35668888999999999999999 99999999999999999 66778999999987
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHHHhccCCCch-H
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN-----DSETFANITRAEFDFDD-E 171 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~-~ 171 (239)
....... .....++..|++||.+.+..++.++|+||+|+++|+|++|..||.... ..+....+......... .
T Consensus 153 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd06621 153 GELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231 (287)
T ss_pred ccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC
Confidence 6543222 123457788999999988889999999999999999999999997652 22333333221111100 0
Q ss_pred H--HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 172 A--FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 172 ~--~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
. ....+..+.+++.+||..+|++|||+.+++.|+|++....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 0 0123568999999999999999999999999999965433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=209.43 Aligned_cols=193 Identities=28% Similarity=0.503 Sum_probs=162.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|+|+|-+.||.|...+.+ ..-+++.++..+..+|++||.| |.+||.|||+||+|||... +.--.|||+||.+.
T Consensus 150 ~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 67899999999999888754 5678899999999999999999 9999999999999999743 22235899999886
Q ss_pred eecCCCC--------CCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------
Q psy1096 98 QKINPDH--------PPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGEND---------- 154 (239)
Q Consensus 98 ~~~~~~~--------~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---------- 154 (239)
..+..+. ...+.+|+.-|||||... ...|+.+.|.|||||++|-|+.|.+||.|.-.
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 5543221 233467888999999972 34578999999999999999999999976432
Q ss_pred -----hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 155 -----SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 155 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
....+.|+.+.+.+|...|..++...+++++.+|..|+..|.++.++++|||+.....+..
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 3567889999999999999999999999999999999999999999999999987555433
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=215.13 Aligned_cols=184 Identities=21% Similarity=0.266 Sum_probs=145.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
..++++||+.+++|.+++.. .+.+++..+..++.|++.||.+ |++|++|+||+|+||++ +.++ .++|+|||.+
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~--~~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI--DSTGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEEcccccc
Confidence 45688899999999998853 4578889999999999999999 99999999999999999 4443 6999999998
Q ss_pred eecCCCC-----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-cCCCchH
Q psy1096 98 QKINPDH-----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA-EFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~ 171 (239)
....... ......++..|++||.+.+..++.++|+||+|++++++++|..||...........+... .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence 6654321 122345788999999998888899999999999999999999999755433322222111 1111111
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
....++..+.+++.+||..+|++|||+.++++||||+
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2235788999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=216.10 Aligned_cols=179 Identities=18% Similarity=0.251 Sum_probs=147.0
Q ss_pred EEEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+++++|.+++.... ..+.+++..+..++.|++.|+++ |++|++|+||||+||++ +.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--GA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE--cc
Confidence 3688999999999999986432 23457888999999999999999 99999999999999999 67
Q ss_pred CCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 77999999999865543221 222346778999999998889999999999999999998 99999877776666665
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
......... ...+..+.+++.+||+.+|++|||++++++
T Consensus 239 ~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 554432221 346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=216.76 Aligned_cols=179 Identities=15% Similarity=0.198 Sum_probs=143.7
Q ss_pred EEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|+++||+++++|.+++.... ..+.++...+..++.|++.||++ |++|++|+||||+||++ +.+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~ 155 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV--GEN 155 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE--CCC
Confidence 578999999999999986432 12357788899999999999999 99999999999999999 667
Q ss_pred CcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcc
Q psy1096 87 HHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~ 165 (239)
+.++|+|||++..............+..|++||.+.+..++.++|+||+||++|+|++ |..||...........+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 7899999998754322111111223456999999988889999999999999999997 999998877766666655432
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.... ...++..+.+|+.+||..+|.+|||++++++.
T Consensus 236 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2111 13578899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=209.96 Aligned_cols=179 Identities=30% Similarity=0.486 Sum_probs=152.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ....+++..+..++.|++.|+.+ |+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 67 ~~~~v~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~--~~~~~~~l~d~~~~~ 141 (250)
T cd05123 67 KLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL--DADGHIKLTDFGLAK 141 (250)
T ss_pred eeEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE--cCCCcEEEeecCcce
Confidence 5688999999999998884 44578889999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......++..|++||...+...+.++|+||+|++++++++|..||...........+.......+ ...+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 217 (250)
T cd05123 142 ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLS 217 (250)
T ss_pred ecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Confidence 76543 223345678899999999888889999999999999999999999987766566666655444433 3458
Q ss_pred HHHHHHHHHhhhhCcccCCCH---HHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA---KQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~---~~ll~h~~~ 207 (239)
..+.+++++||..||++|||+ +++++||||
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=212.90 Aligned_cols=173 Identities=20% Similarity=0.200 Sum_probs=140.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++.. ...+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++++|||.+.
T Consensus 59 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~df~~~~ 133 (237)
T cd05576 59 SVFLVLQHAEGGKLWSHISK---FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--DDRGHIQLTYFSRWS 133 (237)
T ss_pred eEEEEEecCCCCCHHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--cCCCCEEEecccchh
Confidence 56899999999999988853 3458889999999999999999 99999999999999999 777889999999875
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
...... ....++..|++||.+.+..++.++|+||+|+++++|++|..|+....... . .......+ ..++.
T Consensus 134 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~----~~~~~ 203 (237)
T cd05576 134 EVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIP----EWVSE 203 (237)
T ss_pred cccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCc----ccCCH
Confidence 554321 22345677999999988888999999999999999999998875332110 0 00111112 35788
Q ss_pred HHHHHHHHhhhhCcccCCCH-----HHHhhcccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTA-----KQCLSHLWI 207 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~-----~~ll~h~~~ 207 (239)
.+.+++++||+.||++|+|+ +++++||||
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=219.08 Aligned_cols=187 Identities=19% Similarity=0.296 Sum_probs=141.4
Q ss_pred EEeeCccCCCCccchhhhh--hhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 21 TWSSPPYDGGCMITGYVVE--MKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
.|++|||+.. ++.++... ...++.+++..+..++.+++.||+| |+. +++||||||+||++ +..+.++|+|||+
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~ 154 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFGI 154 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE--ccCCcEEEeecch
Confidence 4577888875 33332211 1235778999999999999999999 974 99999999999999 6677899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhcc-CCCchH
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYE---PIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAE-FDFDDE 171 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~-~~~~~~ 171 (239)
+.............+++.|++||.+.+. .++.++|+||+|+++|+|++|..||..... .+....+.... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 8765544333344688899999999766 578999999999999999999999975542 11222222111 111111
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....++..+.+|+++||..+|++|||++++++||||+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 113478899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=214.43 Aligned_cols=184 Identities=21% Similarity=0.263 Sum_probs=148.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+ .+.+++.. .....+++..+..++.|++.||.+ |+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~-~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili--~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHH-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE--ccCCCEEEeccCcce
Confidence 47889999986 57666643 333468889999999999999999 99999999999999999 666899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccC------------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEF------------ 166 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~------------ 166 (239)
............++..|++||.+.+..++.++|+||+|+++|+|++|.+||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 76544333344578889999999988899999999999999999999999988776665555433110
Q ss_pred -----------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 167 -----------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 167 -----------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.........++..+.+++.+||+.||++||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00011122456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=211.50 Aligned_cols=180 Identities=17% Similarity=0.220 Sum_probs=150.8
Q ss_pred EEEeeCccCCCCccchhhhhhhc------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
..|++|||+++++|.+++..... +..+++..+..++.|++.||.+ |++|++|+||+|+||++ +.++.++|+
T Consensus 70 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili--~~~~~~~l~ 147 (262)
T cd00192 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV--GEDLVVKIS 147 (262)
T ss_pred ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE--CCCCcEEEc
Confidence 56889999999999999865321 4788999999999999999999 99999999999999999 777899999
Q ss_pred ecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||.+....... ......++..|+|||.+....++.++|+||+|+++++|++ |..||...........+.......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999987765432 1223447788999999988888999999999999999998 699998887777777766533222
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
. ...++..+.+++.+||..+|++|||+++++++
T Consensus 228 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 228 K---PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred C---CccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1 13568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=221.09 Aligned_cols=184 Identities=21% Similarity=0.253 Sum_probs=144.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+++||+++ +|.+++ ..++.+++..+..++.|++.||.| |+.+++|+||||+||++ +.++.++|+|||++.
T Consensus 83 ~~~lv~e~~~~-~L~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMDT-DLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCCC-CHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEECcCcccc
Confidence 47899999974 566565 456789999999999999999999 99999999999999999 667889999999987
Q ss_pred ecCCC-CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC---------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD--------- 167 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~--------- 167 (239)
..... .......++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.+.+.......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 65433 22233457889999998864 45789999999999999999999999776543332222211000
Q ss_pred -----------------C-chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 168 -----------------F-DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 168 -----------------~-~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
. .......++..+.+++++||+.+|++|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 01112356888999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=212.14 Aligned_cols=179 Identities=22% Similarity=0.314 Sum_probs=149.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++++.+++.. ..+..++++.+..++.|++.||.+ |++|++|+||+|+||++ +.++.++++|||.+.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL--TQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE--CCCCcEEEcccCcce
Confidence 46789999999999988754 345567888999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+..+.....+ ..++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 225 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYS 225 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccC
Confidence 665332 223356888999999998888999999999999999999999999877766666665554433222 3568
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+.+++.+||+.||++|||+.+++..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=215.55 Aligned_cols=190 Identities=24% Similarity=0.386 Sum_probs=154.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++.... ..++...+..++.+++.||++ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i--~~~~~~~l~d~~~~~ 164 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL--SKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE--cCCCCEEECccchhh
Confidence 5788999999999999986422 478888999999999999999 99999999999999999 677789999999876
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......++..|++||.+.+..++.++|+||+|+++|+|++|..||...+.......+....... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCC
Confidence 544321 1123357788999999988888999999999999999999999998766555544444332221 11223478
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
..+.+++++||+.+|.+|||+.+++.|+|+++.....
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 8999999999999999999999999999998844443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=223.63 Aligned_cols=155 Identities=19% Similarity=0.261 Sum_probs=123.9
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEI 120 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~ 120 (239)
.+..+.+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 285 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 285 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE--eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHH
Confidence 46777888999999999999 99999999999999999 6677899999999876543221 112234567999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 121 INYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 121 ~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
+....++.++|+||+||++|+|++ |..||..................... ....+.++.+++.+||+.||++|||++
T Consensus 286 ~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ 363 (374)
T cd05106 286 IFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKMCWNLEPTERPTFS 363 (374)
T ss_pred hcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 988889999999999999999997 99999876554444444443322221 124688999999999999999999999
Q ss_pred HHhh
Q psy1096 200 QCLS 203 (239)
Q Consensus 200 ~ll~ 203 (239)
++++
T Consensus 364 ~l~~ 367 (374)
T cd05106 364 QISQ 367 (374)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=213.58 Aligned_cols=186 Identities=16% Similarity=0.225 Sum_probs=148.0
Q ss_pred EEeeCccCCCCccchhhhhhhc-------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
.|++|||+.+++|.+++..... ...+....+..++.|++.||.| |+++++||||||+||++ +.++.++|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili--~~~~~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV--AHDFTVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE--cCCCcEEEC
Confidence 5789999999999999864322 1334556778899999999999 99999999999999999 667899999
Q ss_pred ecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||++........ .....++..|++||.+.+..++.++|+||+||++|+|++ |..||.+....+....+..+....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998865432211 111234567999999988888999999999999999998 889998776666655554443222
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh------ccccccCC
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS------HLWIAQKD 211 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~------h~~~~~~~ 211 (239)
.+ ...+..+.+++.+||+.||++|||+.++++ ||||+..+
T Consensus 242 ~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 242 QP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 11 245789999999999999999999999986 88887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=212.81 Aligned_cols=180 Identities=16% Similarity=0.219 Sum_probs=146.4
Q ss_pred EEEeeCccCCCCccchhhhhhh---cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK---AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..+++|||+.+++|.+++.... ....+++..+..++.|++.||+| |+++++||||||+||++ +.++.++++|||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg 157 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML--NENMNVCVADFG 157 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE--cCCCCEEECCCC
Confidence 3567889999999998774322 23457888899999999999999 99999999999999999 677789999999
Q ss_pred cceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 96 LAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 96 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
++........ .....+++.|++||...+..++.++|+||+|+++|+|++ |..||.+.........+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 236 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP- 236 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 9876643321 122335667999999998889999999999999999998 89999887777776666655432211
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||+.||++|||+++++++
T Consensus 237 --~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 --PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=214.89 Aligned_cols=186 Identities=18% Similarity=0.309 Sum_probs=146.2
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|++|||++ ++|.+++... ..+..+++..+..++.|++.||.| |++ +++||||||+||++ +.++.++|+|||.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~--~~~~~~kl~dfg~ 150 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI--NRNGQVKLCDFGI 150 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE--CCCCCEEEeeccc
Confidence 3678999997 5666666543 244678899999999999999999 997 99999999999999 7778999999999
Q ss_pred ceecCCCCCCccccCCCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhccC-CCch
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINY----EPIGIESDMWSIGVITYVLLSGLSPFMGE-NDSETFANITRAEF-DFDD 170 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~~~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~ 170 (239)
+.............++..|++||.+.+ ..++.++|+||+|+++|+|++|..||... ...+....+..... ..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 229 (283)
T cd06617 151 SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP- 229 (283)
T ss_pred ccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC-
Confidence 876544333333457888999999865 34588999999999999999999999643 23333333332211 111
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+.+++.+||..+|++|||++++++|+||....
T Consensus 230 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 --AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 135788999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=210.87 Aligned_cols=184 Identities=26% Similarity=0.367 Sum_probs=154.3
Q ss_pred eEEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
-..|+++||+++++|.+++.... .+..+++..+..++.+++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~--~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL--TSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE--cCCCcEEECCccc
Confidence 35678899999999999886532 25788899999999999999999 99999999999999999 6677899999999
Q ss_pred ceecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 97 AQKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 97 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
+....... ......+++.|++||.+.+..++.++|+||+|+++++|++|..||...+................+ ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 226 (258)
T cd08215 150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQ 226 (258)
T ss_pred eeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CC
Confidence 87765443 233346888999999998888899999999999999999999999877666655555444332222 25
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
++..+.+++++||..+|++|||++++++||||
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=214.21 Aligned_cols=179 Identities=18% Similarity=0.238 Sum_probs=146.7
Q ss_pred EEEeeCccCCCCccchhhhhhh----------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK----------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHH 88 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~ 88 (239)
..|+++||+++++|.+++.... ....+++..+..++.|++.||+| |++|++||||||+||++ +..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili--~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--GENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE--ccCCc
Confidence 4678999999999999886432 12358889999999999999999 99999999999999999 77789
Q ss_pred EEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc
Q psy1096 89 IKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRA 164 (239)
Q Consensus 89 vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~ 164 (239)
++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|++ |..||...........+..+
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875533221 122335678999999998889999999999999999998 99999887777777776665
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...... ...+..+.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 433221 356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=209.60 Aligned_cols=182 Identities=25% Similarity=0.386 Sum_probs=148.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++.. ....+++..+..++.|++.|+.+ |+.|++||||+|+||++ +.++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKS--TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL--TSDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE--ccCCeEEEeeccccc
Confidence 56788999999999988753 22678889999999999999999 99999999999999999 667889999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............++..|++||.+.+...+.++|+||+|+++++|++|..||...+................. ....++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSD 225 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCH
Confidence 765443234456888999999998888899999999999999999999999876554444444332211111 1112378
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.+.+++.+||..||++|||++++++|||
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=210.62 Aligned_cols=182 Identities=24% Similarity=0.349 Sum_probs=149.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
..|+++||+.+++|.+++.. ..+..+++..+..++.+++.||.| |+.+++|+||+|+||++ +.++ .++++|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~--~~~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL--SKNGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--cCCCCeEEecccccc
Confidence 46789999999999998864 234467888999999999999999 99999999999999999 4443 5799999988
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ .....|++.|+|||.+.+..++.++|+||+|++++++++|..||...+.......+......... ..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCC---CCC
Confidence 76653322 22235788899999998888899999999999999999999999877666655555444332211 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+..+.+++.+||..+|++|||++++++||||
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=218.93 Aligned_cols=186 Identities=22% Similarity=0.289 Sum_probs=143.5
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|+++||+++ .+.+++ ....+++..+..++.|++.||++ |+.|++|+||||+||++ +.++.++|+|||++
T Consensus 81 ~~~~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill--~~~~~~kl~dfg~~ 153 (336)
T cd07849 81 NDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTNCDLKICDFGLA 153 (336)
T ss_pred ceEEEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--CCCCCEEECcccce
Confidence 346889999986 444443 34578899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCCC----CccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC----
Q psy1096 98 QKINPDHP----PRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF---- 168 (239)
Q Consensus 98 ~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~---- 168 (239)
........ .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76543221 123457889999998754 457899999999999999999999997765443333222111100
Q ss_pred ----------------------c-hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 169 ----------------------D-DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 169 ----------------------~-~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+ .......+..+.+++.+||+.+|++|||+.++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 011124577899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=211.96 Aligned_cols=182 Identities=23% Similarity=0.331 Sum_probs=150.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+.+++..+..++.+++.|+.+ |+.|++|+||+|+||++ +.++.++++|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE--CCCCCEEEeecccce
Confidence 3678999999999998763 3568889999999999999999 99999999999999999 677889999999887
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....++..|++||.+.+...+.++|+||+||++++|++|..||...........+...... .....++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccC
Confidence 6543321 22345788899999998888899999999999999999999999876655555544333221 1123568
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
..+.+++.+||..+|++||++.++++|+|+.+.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=212.81 Aligned_cols=180 Identities=14% Similarity=0.189 Sum_probs=144.4
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl 91 (239)
..+++|||+++++|.+++..... ...++...+..++.|++.||.| |+.|++|+||||+||++ +.++.++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~--~~~~~~~l 160 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKI 160 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE--cCCCCEEE
Confidence 35688999999999998864322 1234667788999999999999 99999999999999999 66788999
Q ss_pred EecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCC
Q psy1096 92 IDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 92 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998865543221 112235678999999988889999999999999999998 78999887776666655554432
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+ ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222 3568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=213.66 Aligned_cols=183 Identities=20% Similarity=0.284 Sum_probs=145.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||++++.+.++.. ..+.+.+..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~--~~~~~~~l~dfg~~~ 148 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR 148 (286)
T ss_pred eEEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCcEEEEeeeeee
Confidence 5789999999999987653 34458889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
...... ......++..|++||.+.+.. ++.++|+||+|+++++|++|.+||.+....+....+........
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred eccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 654332 223345788899999987543 68899999999999999999999977665444333322111000
Q ss_pred --------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 --------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 --------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
......++..+.+++.+||..+|++||+++++++|+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 01123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=230.16 Aligned_cols=187 Identities=18% Similarity=0.161 Sum_probs=135.0
Q ss_pred EEeeCccCCCCccchhhhhhh--cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.|++++++.+.. .+++.... .........+..++.|++.||.| |++||+||||||+||++ +..+.++|+|||++
T Consensus 238 ~~lv~e~~~~~l-~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--~~~~~vkL~DFGla 314 (501)
T PHA03210 238 TYMITQKYDFDL-YSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--NCDGKIVLGDFGTA 314 (501)
T ss_pred eEEEEeccccCH-HHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEEEeCCCc
Confidence 567888886544 43432211 12233456677899999999999 99999999999999999 77789999999999
Q ss_pred eecCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCc--hHHHHHHHhccC----CC
Q psy1096 98 QKINPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-END--SETFANITRAEF----DF 168 (239)
Q Consensus 98 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~--~~~~~~i~~~~~----~~ 168 (239)
........ .....|+..|+|||.+.+..++.++||||+||++|+|++|..++.+ ... ...+..+..... .+
T Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (501)
T PHA03210 315 MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF 394 (501)
T ss_pred eecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhc
Confidence 77654322 2235699999999999999999999999999999999997754432 221 111111111000 00
Q ss_pred c----------------------hHH--HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 169 D----------------------DEA--FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 169 ~----------------------~~~--~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+ ... ...++..+.+++.+||..||.+|||+.++|+||||...
T Consensus 395 p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 395 PDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred CCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 0 000 01246678888999999999999999999999999764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=216.74 Aligned_cols=185 Identities=25% Similarity=0.397 Sum_probs=149.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++. ...+++..+..++.|++.|+++ |++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili--~~~~~~kL~dfg~~~ 163 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 163 (293)
T ss_pred cEEEEEecCCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE--cCCCCEEEccCccee
Confidence 4688999999999998874 2356788889999999999999 99999999999999999 667789999999876
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....+++.|++||.+....++.++|+||+|+++|++++|..||...+.......+..... ........++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLS 242 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccC
Confidence 6543322 2234578889999999888889999999999999999999999977655443333222211 1111223467
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||+.+|++||++++++.|+||+..+
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 8899999999999999999999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=211.00 Aligned_cols=184 Identities=22% Similarity=0.313 Sum_probs=140.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCc--hHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQP--WVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~--~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|+++||+.+++|.+++... ...+ .+..+..++.|++.|++| |+.|++|+||||+||+++. ..+.++|+|||.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchh
Confidence 467889999999999988632 2334 677788999999999999 9999999999999999933 146899999999
Q ss_pred ceecCCCCC-CccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 97 AQKINPDHP-PRVLFGTPEFIPPEIINYEP--IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 97 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
+........ .....++..|++||.+.... ++.++|+||+|+++|++++|..||............. ......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIP 234 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCCC
Confidence 876543222 22345788999999986543 6889999999999999999999997543322211111 1001111112
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..++..+.+++++||..+|++|||+++++.||||
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 3568899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=210.08 Aligned_cols=175 Identities=13% Similarity=0.171 Sum_probs=144.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. .....+++..+..++.|++.||++ |++|++|+||||+||++ +.++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV--SEDNVAKVSDFGLTKE 151 (256)
T ss_pred eEEEEECCCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE--cCCCcEEecCCcccee
Confidence 5789999999999998864 233457888899999999999999 99999999999999999 7778999999998876
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+.+.... .....++.
T Consensus 152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 226 (256)
T cd05082 152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPP 226 (256)
T ss_pred ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCH
Confidence 44322 22334567999999988888999999999999999997 99999877766666655543221 12245789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+.+++.+||..+|++|||++++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=217.41 Aligned_cols=181 Identities=17% Similarity=0.245 Sum_probs=144.0
Q ss_pred EEEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+++++|.+++.... .+..+++..+..++.|++.|++| |++|++||||||+||++ +.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili--~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe--cC
Confidence 3678999999999999886432 12467888999999999999999 99999999999999999 67
Q ss_pred CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc
Q psy1096 86 SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRA 164 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~ 164 (239)
++.++|+|||++..............+..|++||.+.+..++.++|+||+||++++|++ |..||.+.+..+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 77899999998754322111112224567999999988888999999999999999998 99999877766665555332
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
. ... .....+..+.+++.+||+.+|++||++++++++.
T Consensus 240 ~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 240 Y-RLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred C-cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 111 1124678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=211.71 Aligned_cols=184 Identities=22% Similarity=0.268 Sum_probs=143.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||++ ++|.+++.. .....+.+..+..++.|++.||+| |+.+++||||+|+||++ +.++.++|+|||.+.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~--~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDS-SPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI--DREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE--cCCCcEEEeeccccc
Confidence 5678899996 577777643 222468899999999999999999 99999999999999999 667899999999986
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC--------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF-------- 168 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 168 (239)
...... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 554221 12233467889999988664 46889999999999999999999998776544443332211111
Q ss_pred -----------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 169 -----------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 169 -----------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.......++..+.+++.+||+.+|++|||++++++|+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 011123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=209.18 Aligned_cols=176 Identities=17% Similarity=0.268 Sum_probs=145.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+.+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++++|||.+..
T Consensus 74 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEEEEEcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE--cCCCeEEECCCCCccc
Confidence 5789999999999988753 23568888999999999999999 99999999999999999 6777899999998865
Q ss_pred cCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+..+.....+ ...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~ 226 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLA 226 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCC
Confidence 53322111 1234557999999988888999999999999999999 99999888877777777665432222 235
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||+.+|++|||++++++
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=212.41 Aligned_cols=184 Identities=19% Similarity=0.267 Sum_probs=144.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++ ++.+++........++++.+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 73 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 73 LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI--NKRGELKLADFGLARA 149 (284)
T ss_pred EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--CCCCcEEEeecchhhh
Confidence 5789999996 677676543434578999999999999999999 99999999999999999 7778999999998865
Q ss_pred cCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 100 INPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 100 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
..... ......++..|++||.+.+. .++.++|+||+|++++++++|..||.+.+..+....+......+..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 43221 12234567889999998664 4688999999999999999999999887766554444322111100
Q ss_pred ------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 ------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 ------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
......+..+.+++.+||+.||.+||+++++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112457788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=207.72 Aligned_cols=183 Identities=20% Similarity=0.296 Sum_probs=153.6
Q ss_pred eEEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
-..|+++||+++++|.+++.... .+..+++..+..++.|++.||++ |+.|++|+||+|+||++ +.++.++|+|||.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~--~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE--ecCCcEEEeeccc
Confidence 35789999999999998875532 24667888899999999999999 99999999999999999 5577899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+...... ......++..|++||.+.+..++.++|+||+|++++++++|..||...+.......+......... ..+
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 225 (256)
T cd08530 150 SKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIY 225 (256)
T ss_pred hhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhh
Confidence 8776544 233355788999999999888899999999999999999999999887766665555544433222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+.++.+++.+||..+|++|||++++++||++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 226 SQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 8899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=211.47 Aligned_cols=176 Identities=17% Similarity=0.169 Sum_probs=143.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.++++||+.+++|.+++. ...+.+++..+..++.|++.||+| |+++++|+||||+||++ +.++.++|+|||.+..
T Consensus 83 ~~~i~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili--~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVR--QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL--KSDSIVQIADFGVADL 158 (279)
T ss_pred cEEEEEeCCCCcHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE--cCCCcEEEcCCcccee
Confidence 357889999999999885 334578888999999999999999 99999999999999999 6778999999999876
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... .....++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.........+..+.....+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QI 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CC
Confidence 543221 122346678999999988889999999999999999998 99999877665555555444332221 23
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||..+|++|||++++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=210.27 Aligned_cols=178 Identities=15% Similarity=0.229 Sum_probs=144.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||+++++|.+++.. .....+++..+..++.|++.||++ |+.|++|+||||+||++ +.++.++|+|||.+..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE--cCCCcEEeCCCccccc
Confidence 4688999999999998854 234567888899999999999999 99999999999999999 6778899999999876
Q ss_pred cCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ ...++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+..... . ......
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 230 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-M--ERPEGC 230 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-C--CCCCCC
Confidence 54332111 1223567999999988889999999999999999998 9999988776666555544321 1 112467
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..+|++|||+.++++.
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 8999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=210.42 Aligned_cols=184 Identities=23% Similarity=0.294 Sum_probs=146.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+ ++++.+++.. ..+..+.+..+..++.|++.+|.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i--~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHh-cccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--cCCCCEEEeecccce
Confidence 567899999 6777777653 223578899999999999999999 99999999999999999 778899999999988
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-------- 169 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 169 (239)
............++..|+|||.+.+ ..++.++|+||+|++++++++|.+||.+.+..+....+........
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 148 EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred eccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 7665444445568889999998854 4468999999999999999999999987766555544332111110
Q ss_pred ------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 ------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 ------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.......+..+.+++++||..+|++|||+++++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01111235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=212.32 Aligned_cols=179 Identities=30% Similarity=0.494 Sum_probs=152.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ..+.++...+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++++|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i--~~~~~~~l~df~~~~ 150 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL--DKDMHIKITDFGTAK 150 (280)
T ss_pred eEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEecCCcccc
Confidence 5788999999999998884 45578999999999999999999 99999999999999999 677789999999887
Q ss_pred ecCCCCC---------------------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Q psy1096 99 KINPDHP---------------------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET 157 (239)
Q Consensus 99 ~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~ 157 (239)
....... .....++..|++||.......+.++|+||+|++++++++|..||...+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 6543221 1123467889999999888889999999999999999999999987776666
Q ss_pred HHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCH----HHHhhcccc
Q psy1096 158 FANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTA----KQCLSHLWI 207 (239)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~ 207 (239)
...+.......+ ..++..+.+++++||+.+|++|||+ +++++||||
T Consensus 231 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 666554444444 3568899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=217.65 Aligned_cols=156 Identities=22% Similarity=0.268 Sum_probs=124.3
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEI 120 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~ 120 (239)
.+++..+..++.|++.||+| |+.||+||||||+||++ +..+.++|+|||++........ .....++..|+|||.
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE--eCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 57788889999999999999 99999999999999999 6677899999999876543221 122345678999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 121 INYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 121 ~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
+.+..++.++|+||+||++++|++ |..||.+....+.............. ....+..+.+++.+||+.+|++||+++
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999999999999999999998 99999875544433333222211111 134678899999999999999999999
Q ss_pred HHhhc
Q psy1096 200 QCLSH 204 (239)
Q Consensus 200 ~ll~h 204 (239)
+++++
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=209.28 Aligned_cols=177 Identities=17% Similarity=0.213 Sum_probs=144.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ....+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||++..
T Consensus 69 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL--VNQHYAKISDFGLSKA 144 (257)
T ss_pred eEEEEEeCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE--cCCCcEEeccCCcccc
Confidence 5789999999999988753 35578889999999999999999 99999999999999999 6677899999999875
Q ss_pred cCCCCCC----ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHPP----RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
....... ....++..|+|||.+....++.++|+||+|+++|++++ |..||.+....+....+..+..... ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 221 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PA 221 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CC
Confidence 5432211 11123467999999988888999999999999999996 9999988877776666655432211 13
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+..+.+++.+||..+|++||+++++.+.
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=209.07 Aligned_cols=182 Identities=25% Similarity=0.333 Sum_probs=149.3
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|+++||+++++|.+++.. ...+++..+..++.+++.||++ |+.+++|+||+|+||++ +.++.++|+|||.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i--~~~~~~~l~d~~~~ 148 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKLADFGCA 148 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--cCCCCEEEcccccE
Confidence 356788999999999998853 3488899999999999999999 99999999999999999 66789999999998
Q ss_pred eecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhccCCCchHHH
Q psy1096 98 QKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~ 173 (239)
........ .....++..|++||.+.+...+.++|+||+|++++++++|..||.... .......+...... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 226 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--PEIP 226 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC--cCCC
Confidence 87765442 344568889999999988889999999999999999999999997665 22222222211111 1112
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..++..+.+++.+||+.+|++||++.++++||||
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 3568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=207.83 Aligned_cols=180 Identities=26% Similarity=0.365 Sum_probs=150.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.|+.+ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT--TKDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--CCCCCEEEeccccce
Confidence 4678999999999998874 34788999999999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... .....++..|++||...+...+.++|+|++|++++++++|..||................... ....++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCC
Confidence 7654332 223457889999999988888999999999999999999999997666544444443322221 123578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||..+|++|||+++++.|+||
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.11 Aligned_cols=181 Identities=19% Similarity=0.272 Sum_probs=145.0
Q ss_pred EEEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+++||+++++|.+++..... +..++++.+..++.|++.||+| |++|++|+||+|+||++ +.++.++++|||.+
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~--~~~~~~~l~d~g~~ 153 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE--cCCCCEEECccccc
Confidence 46788999999999988865433 4567888999999999999999 99999999999999999 66778999999988
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND--SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~ 174 (239)
........ .....+++.|+|||.+.+...+.++|+||+|+++|+|++|..||..... ......+..... ++....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (267)
T cd08228 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTE 231 (267)
T ss_pred eeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CCCChh
Confidence 76653321 2234578899999999888889999999999999999999999965432 233333332222 222223
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+..+.+++.+||..+|++|||++++++.
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 568889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=216.30 Aligned_cols=186 Identities=21% Similarity=0.274 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++++|+++ +|.+++ ..+..+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 80 ~~~~~~e~~~~-~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili--~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEA-DLHQII---RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV--NADCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccC-CHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE--cCCCCEEeCcCCCce
Confidence 46788888874 566665 346678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCC-----CccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc---
Q psy1096 99 KINPDHP-----PRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD--- 169 (239)
Q Consensus 99 ~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 169 (239)
....... .....|++.|+|||.+.+ ..++.++|+||+|++++++++|.+||.+.+.......+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543211 123468889999998865 4578999999999999999999999977654433332222111000
Q ss_pred ------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 170 ------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 170 ------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.......+..+.+++.+||+.||++|||+++++.|||+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 011123578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=217.16 Aligned_cols=185 Identities=25% Similarity=0.347 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||++ ++|.+++. ...+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 94 ~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill--~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMG-ADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV--NEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCC-CCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEccccccc
Confidence 4788999984 57777653 3568889999999999999999 99999999999999999 667889999999987
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
..... .....++..|++||.+.+ ..++.++|+||+|+++|++++|..||.+.+.......+.......++
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65432 233457888999999865 35689999999999999999999999877766555554332221111
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.....++..+.+++.+||+.+|++|||++++++||||.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1112357889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=214.63 Aligned_cols=186 Identities=19% Similarity=0.274 Sum_probs=143.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++ .+.++.. ...+.+++..+..++.|++.|++| |+ .|++||||+|+||++ +.++.++|+|||.+
T Consensus 88 ~~~~v~e~~~~-~l~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill--~~~~~~kL~dfg~~ 162 (296)
T cd06618 88 DVFICMELMST-CLDKLLK--RIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNVKLCDFGIS 162 (296)
T ss_pred eEEEEeeccCc-CHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE--cCCCCEEECccccc
Confidence 57889999865 5555543 234578889999999999999999 97 599999999999999 67789999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEP----IGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~ 172 (239)
.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||..... .+....+......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-P 241 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-C
Confidence 7655433333345778899999997554 68899999999999999999999975432 2333333332211111 1
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...++..+.+|+.+||..||++||+++++++|+|+....
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 114678899999999999999999999999999997633
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=220.49 Aligned_cols=156 Identities=24% Similarity=0.283 Sum_probs=123.2
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEI 120 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~ 120 (239)
.++++.+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 287 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPES 287 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE--ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhH
Confidence 46677788999999999999 99999999999999999 6677899999999876543321 112234567999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 121 INYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 121 ~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
+.+..++.++|+||+||++|+|++ |..||.+................... ....+.++.+++.+||+.||++|||+.
T Consensus 288 ~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 288 IFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred hcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 998889999999999999999998 89999776544433333333222111 124578899999999999999999999
Q ss_pred HHhhc
Q psy1096 200 QCLSH 204 (239)
Q Consensus 200 ~ll~h 204 (239)
++++.
T Consensus 366 eil~~ 370 (375)
T cd05104 366 QIVQL 370 (375)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=208.94 Aligned_cols=175 Identities=21% Similarity=0.204 Sum_probs=144.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++. .++.+++..+..++.|++.||++ |+.+++|+||||+||++ +.++.++|+|||.+..
T Consensus 70 ~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili--~~~~~~kl~df~~~~~ 144 (257)
T cd05060 70 LMLVMELAPLGPLLKYLK---KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL--VNRHQAKISDFGMSRA 144 (257)
T ss_pred eEEEEEeCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE--cCCCcEEeccccccce
Confidence 468899999999999884 34578899999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCCCc----cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHPPR----VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
........ ...++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+....... ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 221 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPE 221 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCC
Confidence 64332211 1123457999999988889999999999999999998 999998777666666655443221 123
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+..+.+++.+||..+|++|||+.++++
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 57889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=209.99 Aligned_cols=184 Identities=22% Similarity=0.291 Sum_probs=146.5
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|+++||+++ +|.+++.. ....+++..+..++.+++.||.+ |+.|++||||+|+||++ +.++.++|+|||.+
T Consensus 71 ~~~~~v~e~~~~-~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~--~~~~~~~l~d~g~~ 145 (282)
T cd07829 71 RKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI--NRDGVLKLADFGLA 145 (282)
T ss_pred CceEEEecCcCc-CHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE--cCCCCEEEecCCcc
Confidence 357789999985 78877753 22578899999999999999999 99999999999999999 66789999999988
Q ss_pred eecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-----
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD----- 170 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 170 (239)
....... ......++..|+|||.+.+. .++.++|+||+|++++++++|..||.+.+.......+.........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 146 RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 7654332 22233466789999999766 6799999999999999999999999887765555444332111111
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+++++||..+|++||++++++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1122357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=211.21 Aligned_cols=177 Identities=18% Similarity=0.191 Sum_probs=143.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++++|+++|+|.+++.+ ..+.+++..+..++.|++.||+| |+.+++|+||||+||++ +..+.++|+|||++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNHVKITDFGLARL 158 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--cCCCcEEECCCCceee
Confidence 4578899999999998863 34578889999999999999999 99999999999999999 6677899999999877
Q ss_pred cCCCCCCc---cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHPPR---VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
........ ...+++.|++||.+.+..++.++|+||+||++|++++ |..||...........+........+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---PI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---cc
Confidence 65332211 1224567999999988889999999999999999998 99999776665555545443322211 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||+.||++||++.+++..
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=208.84 Aligned_cols=177 Identities=21% Similarity=0.304 Sum_probs=144.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ....+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++++|||.+..
T Consensus 74 ~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili--~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV--DDQGCVKVSDFGLSRY 149 (256)
T ss_pred cEEEEEcCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--cCCCCEEECCCcccee
Confidence 4788999999999998853 23468889999999999999999 99999999999999999 6777999999998876
Q ss_pred cCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ ...++..|++||.+.+..++.++|+||+|+++|+|++ |..||...+.......+......... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 226 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLA 226 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCC
Confidence 54322111 1224567999999988889999999999999999998 99999877766666666554332222 245
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..+|++|||+.+++.+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 7899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.60 Aligned_cols=179 Identities=16% Similarity=0.225 Sum_probs=142.3
Q ss_pred EEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|++|||+.+++|.+++.... ....++.+.+..++.|++.|++| |+.|++|+||||+||++ +.+
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili--~~~ 148 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GEN 148 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE--cCC
Confidence 578999999999999986532 12357788899999999999999 99999999999999999 777
Q ss_pred CcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcc
Q psy1096 87 HHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~ 165 (239)
+.++++|||++..............+..|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+.......+....
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 228 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence 8999999998753322111111223456999999988888999999999999999997 999998777666665554432
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.. . .....+..+.+++.+||..+|.+|||++++++.
T Consensus 229 ~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 229 RL-E--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred CC-C--CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 11 1 112467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=212.23 Aligned_cols=183 Identities=19% Similarity=0.262 Sum_probs=138.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++ +|.+++. ...+.+.+..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 77 ~~~lv~e~~~~-~L~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~ 151 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMD--DCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLAR 151 (291)
T ss_pred eEEEEEecCCC-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE--cCCCCEEECcccccc
Confidence 46789999986 7777664 334577889999999999999999 99999999999999999 777899999999876
Q ss_pred ecCCCC-CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhccCCC-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANITRAEFDF------- 168 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~~~~~~~------- 168 (239)
...... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.. ..+....+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 543211 1222346778999999875 447899999999999999999999997655 222222221110000
Q ss_pred ----------------ch---HHHhhcC--HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 169 ----------------DD---EAFEALS--EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 169 ----------------~~---~~~~~~~--~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+. .....++ ..+.+++.+||+.+|++|||+.++++|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0011233 778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=214.89 Aligned_cols=185 Identities=27% Similarity=0.385 Sum_probs=146.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .+..+.+..+..++.|++.||.+ |+.+++|+||+|+||++ +.++.++++|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~--~~~~~~~l~dfg~~~ 153 (288)
T cd05583 79 KLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL--DSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEEECcccc
Confidence 4678999999999998874 35678888999999999999999 99999999999999999 667889999999876
Q ss_pred ecCCCCC--CccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHhccCCCch
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINYEP--IGIESDMWSIGVITYVLLSGLSPFMGENDS----ETFANITRAEFDFDD 170 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~----~~~~~i~~~~~~~~~ 170 (239)
....... .....++..|++||.+.+.. .+.++|+||+|+++++|++|..||...... .....+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP- 232 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC-
Confidence 6543321 12235788999999987655 688999999999999999999999643322 22222222222222
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhccccccCCCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~~~~~~~ 213 (239)
..++..+.+++.+||+.||++||| +.++++|+||+...++
T Consensus 233 ---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 233 ---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 356889999999999999999998 5778999999886553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=213.88 Aligned_cols=183 Identities=21% Similarity=0.321 Sum_probs=145.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.|+ +.+++. .....+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 89 ~~~lv~e~~~g~-l~~~~~--~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~--~~~~~~kL~dfg~~~ 163 (307)
T cd06607 89 TAWLVMEYCLGS-ASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFGSAS 163 (307)
T ss_pred eEEEEHHhhCCC-HHHHHH--HcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--CCCCCEEEeecCcce
Confidence 357899999864 444443 234568889999999999999999 99999999999999999 777899999999886
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ....++..|+|||.+. ...++.++|+||+|+++|+|++|..||.+.+.......+........ ....
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (307)
T cd06607 164 LVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSND 238 (307)
T ss_pred ecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--Cchh
Confidence 65432 2345788899999884 34578899999999999999999999987766555544443322111 1124
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
++..+.+++.+||..+|++||++.+++.|+|+.....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 6788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=207.71 Aligned_cols=176 Identities=16% Similarity=0.215 Sum_probs=141.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. .+..+.+..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 68 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 68 IYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV--TEKNVLKISDFGMSRE 143 (252)
T ss_pred eEEEEeeccCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE--cCCCcEEECccccCcc
Confidence 5789999999999998852 34568888999999999999999 99999999999999999 6677899999999865
Q ss_pred cCCCCCCc---cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHPPR---VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
........ ....+..|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+........ ...
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 220 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---PEL 220 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---ccc
Confidence 44321111 1122346999999988889999999999999999997 9999977666555555544322111 235
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=212.94 Aligned_cols=183 Identities=22% Similarity=0.278 Sum_probs=146.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+++||+++++|.+++. ..+.+++..+..++.+++.||.| |+ .+++|+||+|+||++ +.++.++|+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--~~~~~~~l~d~gl~ 151 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV--NSRGQIKLCDFGVS 151 (284)
T ss_pred EEEEEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE--CCCCcEEEccCCcc
Confidence 4678999999999998874 35678899999999999999999 97 689999999999999 67789999999987
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHhccC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-----------ETFANITRAEF 166 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-----------~~~~~i~~~~~ 166 (239)
...... ......++..|++||.+.+..++.++|+||+||+++++++|..||...... .....+.....
T Consensus 152 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 152 GELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred cchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 654322 223356889999999998888899999999999999999999999765432 12222222211
Q ss_pred CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 167 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.. .....++..+.+|+.+||..||++|||++++++|+|+.+.
T Consensus 231 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 231 PR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11 1112367889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=211.16 Aligned_cols=179 Identities=18% Similarity=0.232 Sum_probs=145.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcC------------CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAG------------TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~------------~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
..|++|||+.+++|.+++.....+ ..+++..+..++.|++.|++| |+.|++|+||||+||++ +..
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~--~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV--GQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE--cCC
Confidence 357899999999999998643221 357788899999999999999 99999999999999999 667
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||......+....+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 7899999999865533221 122234678999999998889999999999999999998 999998777666666665
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
....... ...+++.+.+++.+||..||++||+++++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5432211 1357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=210.81 Aligned_cols=181 Identities=16% Similarity=0.191 Sum_probs=143.9
Q ss_pred EEeeCccCCCCccchhhhhhhcC----CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAG----TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~df 94 (239)
.|++|||+.|++|.+++...... ..+++..+..++.|++.|++| |+.+++|+||||+||+++.++ ...++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 46899999999999988654321 257888899999999999999 999999999999999995433 346899999
Q ss_pred ccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|.+........ ......+..|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+.......+........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~- 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP- 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC-
Confidence 99876532211 112223457999999988889999999999999999997 9999988776666555544322111
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...++..+.+++.+||+.+|++|||++++++|
T Consensus 243 --~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 243 --PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 13578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=207.94 Aligned_cols=177 Identities=19% Similarity=0.275 Sum_probs=145.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+..++...+..++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill--~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV--GDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE--cCCCeEEECCCccceE
Confidence 5789999999999998864 234457888889999999999999 99999999999999999 7778899999999876
Q ss_pred cCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ....++..|++||...+...+.++|+||+|+++|+|++ |..||.+....+....+..... .+ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MP--CPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccc
Confidence 5433211 12235567999999988889999999999999999999 9999988777666666554322 11 11357
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++++||..||++||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=208.53 Aligned_cols=177 Identities=20% Similarity=0.321 Sum_probs=145.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. .....++...+..++.+++.||+| |+.+++|+||+|+||++ +.++.++|+|||.+..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe--cCCCcEEECCCcccee
Confidence 5688999999999998864 345667888889999999999999 99999999999999999 6777899999999877
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+..... .+ ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MP--RMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCC
Confidence 653321 112235567999999988888999999999999999998 9999988777666666654422 22 11357
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||..+|++|||++++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=207.85 Aligned_cols=177 Identities=19% Similarity=0.280 Sum_probs=144.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+.+++..+..++.|++.|+++ |+.|++|+||||+||++ +.++.++++|||.+..
T Consensus 74 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARY 149 (256)
T ss_pred eEEEEecCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE--CCCCcEEECCccccee
Confidence 5689999999999998853 23478888999999999999999 99999999999999999 7778999999998866
Q ss_pred cCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+....+........+ ...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 226 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP---KLA 226 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC---CCC
Confidence 54322111 1123457999999998889999999999999999998 89999877766666665543221111 346
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..+|++|||++++++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=229.34 Aligned_cols=188 Identities=25% Similarity=0.423 Sum_probs=160.2
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
-=.+|+|||||+||+..+++.... +..+.++.+.-|+..++.|+.+ |...++|||||-.||++ ..+|.|||+|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL--T~e~~VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL--TENAEVKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE--eccCcEEEeeeee
Confidence 347899999999999999998766 8899999999999999999999 99999999999999999 7777899999999
Q ss_pred ceecCCC-CCCccccCCCCccCccccccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 97 AQKINPD-HPPRVLFGTPEFIPPEIINYEP-----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 97 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-----~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
+...... ....+.+|||.|||||.+.+.+ |+..+|+||||++..+|..|.+|+..+-+...+-.|-....+-.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL- 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL- 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc-
Confidence 8776643 3455678999999999997653 67899999999999999999999987777666655544432211
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+...+..+.+||..||..|.++||+..++|+|||+++
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 113456888999999999999999999999999999984
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=213.30 Aligned_cols=180 Identities=18% Similarity=0.208 Sum_probs=146.6
Q ss_pred EEEeeCccCCCCccchhhhhh-------------hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-------------KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+.+++|.+++... ...+.+++..+..++.|++.||+| |+.+++|+||||+||++ +.
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--~~ 167 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TE 167 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--cC
Confidence 367899999999999998643 234678888899999999999999 99999999999999999 67
Q ss_pred CCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+||++|++++ |..||.+.+..+....+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 78999999999876543221 111234567999999988889999999999999999997 99999887766666655
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
........ ....+..+.+|+.+||..||++|||+++++++
T Consensus 248 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44432111 12567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=214.55 Aligned_cols=185 Identities=20% Similarity=0.208 Sum_probs=138.6
Q ss_pred EEEeeCccCCCCccchhhhhhhc--CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC----CCcEEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA--GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT----SHHIKII 92 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~----~~~vkl~ 92 (239)
..|++|||++++ +.+++..... ...+++..+..++.|++.||.| |+.+++|+||||+||++ +. .+.++++
T Consensus 78 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~--~~~~~~~~~~kl~ 154 (316)
T cd07842 78 SVYLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV--MGEGPERGVVKIG 154 (316)
T ss_pred eEEEEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE--cCCCCccceEEEC
Confidence 578999999875 4445433222 2478899999999999999999 99999999999999999 55 7899999
Q ss_pred ecccceecCCCCC----CccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------HH
Q psy1096 93 DFGLAQKINPDHP----PRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSE---------TF 158 (239)
Q Consensus 93 dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~---------~~ 158 (239)
|||++........ .....++..|+|||.+.+. .++.++|+||+|+++++|++|..||.+..... ..
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999876543221 1223577889999988664 47899999999999999999999997654322 11
Q ss_pred HHHHhc--------------------------cCCCc-hH----HH--hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 159 ANITRA--------------------------EFDFD-DE----AF--EALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 159 ~~i~~~--------------------------~~~~~-~~----~~--~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
..+... ....+ .. .. ...+..+.+++.+||..||++|||++++++||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 111000 00000 00 00 13567899999999999999999999999999
Q ss_pred cc
Q psy1096 206 WI 207 (239)
Q Consensus 206 ~~ 207 (239)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=213.27 Aligned_cols=184 Identities=20% Similarity=0.307 Sum_probs=147.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+ ++.+++. .....+.+..+..++.|++.|+.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 95 ~~~lv~e~~~~-~l~~~l~--~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili--~~~~~~kL~dfg~~~ 169 (313)
T cd06633 95 TAWLVMEYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEEEecCCC-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE--CCCCCEEEeecCCCc
Confidence 46899999976 4554543 335568888999999999999999 99999999999999999 677789999999875
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
.... .....++..|++||.+. ...++.++|+||+|+++|+|++|..||...+.......+....... .....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 244 (313)
T cd06633 170 KSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNE 244 (313)
T ss_pred ccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCccc
Confidence 4322 22345888999999984 3457889999999999999999999998877666665554433221 11234
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
++..+++|+.+||+.+|.+||++++++.||||+..+..
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 67889999999999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=211.89 Aligned_cols=189 Identities=20% Similarity=0.234 Sum_probs=143.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ .+.+.+.. .....+.+..+..++.|++.||.| |+++++|+||+|+||+++. .++.++++|||++.
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~~ 151 (294)
T PLN00009 75 RLYLVFEYLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLAR 151 (294)
T ss_pred eEEEEEecccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEccccccc
Confidence 56789999975 55555532 233345778888999999999999 9999999999999999943 33579999999986
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
...... ......+++.|++||.+.+. .++.++|+||+|+++|+|++|..||...+..+...++........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 152 AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 654321 22334577899999998664 468999999999999999999999987766555444322111000
Q ss_pred ------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 170 ------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 170 ------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
......++..+.+++.+||+.+|++||+++++++|+||++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 001124678899999999999999999999999999998644
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=216.96 Aligned_cols=188 Identities=16% Similarity=0.233 Sum_probs=141.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+++||+.++++.+++.... ...+++..+..++.|++.||+| |+.|++||||||+||++ +..+.++++||+....
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill--~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI--SGDGLVSLSGLSHLYS 150 (328)
T ss_pred eEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--eCCCcEEEechHHHhh
Confidence 467899999999998886533 3457888899999999999999 99999999999999999 6667899999975432
Q ss_pred cCCCC-C-------CccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC--
Q psy1096 100 INPDH-P-------PRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD-- 167 (239)
Q Consensus 100 ~~~~~-~-------~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~-- 167 (239)
..... . .....++..|++||.+.+. .++.++|+||+||++|+|++|..||.+................
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 21111 0 0112245679999999764 4689999999999999999999999766544433322211100
Q ss_pred -----------------------------------------CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 168 -----------------------------------------FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 168 -----------------------------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
........++..+.+|+++||+.||++|||++++++|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 001112235678999999999999999999999999999
Q ss_pred cccCC
Q psy1096 207 IAQKD 211 (239)
Q Consensus 207 ~~~~~ 211 (239)
|+...
T Consensus 311 ~~~~~ 315 (328)
T cd08226 311 FKQVK 315 (328)
T ss_pred HHHHH
Confidence 97643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=215.03 Aligned_cols=189 Identities=23% Similarity=0.263 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++ .....++++.+..++.|++.||.+ |+.|++|+||+|+||++ +..+.++|+|||.+.
T Consensus 94 ~~~lv~e~~~~-~l~~~l---~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill--~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMAS-DLKKVV---DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI--NSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEecccc-CHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE--CCCCCEEECCcccee
Confidence 46788999985 666666 345678899999999999999999 99999999999999999 777899999999887
Q ss_pred ecCCC---------------CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q psy1096 99 KINPD---------------HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT 162 (239)
Q Consensus 99 ~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~ 162 (239)
..... .......+++.|++||.+.+.. ++.++|+||+|+++++|++|..||.+.+..+.+..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 65411 1111234677899999987644 6899999999999999999999998877666555543
Q ss_pred hccCCCch------------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 163 RAEFDFDD------------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 163 ~~~~~~~~------------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.....+.. ......+..+.+++++||+.+|++|||+++++.|+||++.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 32111110 01123477899999999999999999999999999998755443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=212.83 Aligned_cols=183 Identities=26% Similarity=0.375 Sum_probs=146.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++. ....+++..+..++.|++.||.+ |+.|++||||+|+||++ +.++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~ 153 (290)
T cd05613 79 KLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSK 153 (290)
T ss_pred eEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--CCCCCEEEeeCccce
Confidence 4678999999999998884 35568888899999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHHhccCCCch
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDD 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~----~~~i~~~~~~~~~ 170 (239)
...... ......++..|++||.+... ..+.++|+||+|+++|+|++|..||........ ...+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 232 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC-
Confidence 654322 12234588899999998753 357899999999999999999999965433222 222222222222
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..++..+.+++++||..||++|+ ++++++.||||....
T Consensus 233 ---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 ---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 35788999999999999999997 899999999998744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=207.05 Aligned_cols=182 Identities=21% Similarity=0.276 Sum_probs=149.7
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..++++||+++++|.+++.+. ..+..+++..+..++.|++.||.+ |+.|++|+||+|+||++ +. +.++++|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili--~~-~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL--KN-NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe--ec-CCEeecccCce
Confidence 357899999999999888654 345678999999999999999999 99999999999999999 33 46999999988
Q ss_pred eecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ......+++.|++||.+.+..++.++|+||+|++++++++|..||...........+....... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---Ccchh
Confidence 7654332 2223457888999999988888999999999999999999999997766555555544332221 12356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+..+.+++.+||..+|++||+++++++||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=207.26 Aligned_cols=177 Identities=19% Similarity=0.257 Sum_probs=144.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. .....+++..+..++.+++.||+| |+.+++|+||+|+||++ +.++.++|+|||.+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili--~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV--GDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE--eCCceEEeCCceeeee
Confidence 4789999999999998864 334567888999999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+....+...... + .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 228 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-P--CPQDC 228 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcC
Confidence 5433211 11234567999999988888999999999999999999 99999887777766666543221 1 11356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||..+|++|||++++.+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=210.31 Aligned_cols=180 Identities=18% Similarity=0.250 Sum_probs=144.5
Q ss_pred EEEeeCccCCCCccchhhhhhhc--------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA--------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~ 84 (239)
..|++|||+.+++|.+++..... ...+++..+..++.|++.||.| |++|++|+||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili--~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI--G 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE--c
Confidence 35789999999999998753221 2346778888999999999999 99999999999999999 6
Q ss_pred CCCcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q psy1096 85 TSHHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFAN 160 (239)
Q Consensus 85 ~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~ 160 (239)
..+.++|+|||++....... ......++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+.........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 67789999999987654322 1222335667999999988889999999999999999998 9999987766555555
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+........ ...++..+.+++.+||+.||++||++++++++
T Consensus 239 ~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLPC---SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554433221 23578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=214.33 Aligned_cols=176 Identities=19% Similarity=0.214 Sum_probs=141.9
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+++++|+.+|+|.+++.+ ....+....+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill--~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe--cCCCcEEEccccccccc
Confidence 467899999999998864 24467788888999999999999 99999999999999999 67778999999999776
Q ss_pred CCCCCCc---cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 101 NPDHPPR---VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 101 ~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ...++..|++||.+.+..++.++|+||+|+++|++++ |..||.+....+....+.... ..+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCCC--CCC
Confidence 5332211 1223567999999998889999999999999999997 999998766555444333332 22211 346
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..+|++|||+.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=206.93 Aligned_cols=177 Identities=19% Similarity=0.241 Sum_probs=144.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++... .+..+++..+..++.|++.||++ |+.+++|+||+|+||++ +.++.++|+|||.+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill--~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE--cCCCcEEeccCCceee
Confidence 47899999999999988642 34567888899999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ....++..|++||...+..++.++|+||+|+++|++++ |..||.+....+....+...... +. ...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC--PPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CC--cccc
Confidence 5433221 12335567999999988889999999999999999999 89999887776666665443221 11 1357
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+|++.+|++|||++++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=207.83 Aligned_cols=177 Identities=18% Similarity=0.224 Sum_probs=146.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+..+....+..++.|++.|+.| |++|++|+||+|+||++ +.++.++++|||.+..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv--~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV--GEDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE--cCCceEEEccccchhh
Confidence 5789999999999999864 235668888999999999999999 99999999999999999 6777899999999876
Q ss_pred cCCCCCC-ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 100 INPDHPP-RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 100 ~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... ....++..|++||.+....++.++|+||+|+++++|++ |..||.+.+..+....+..... .+. ....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 230 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MPC--PAKCP 230 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CCC--CCCCC
Confidence 5432211 12235567999999988888999999999999999998 8999988777777666664322 111 13678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.+++.+||..||++|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=207.13 Aligned_cols=181 Identities=15% Similarity=0.178 Sum_probs=148.1
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+.+++|.+++..... ..+++..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~--~~~~~~kl~dfg~~ 144 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL--ASDDKVKIGDFGLM 144 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE--ecCCEEEecccccc
Confidence 356789999999999999865322 578889999999999999999 99999999999999999 66689999999998
Q ss_pred eecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
........ .....++..|++||.+.+..++.++|+||+|+++++|++ |..||...+..+....+.........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 222 (257)
T cd05040 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER-- 222 (257)
T ss_pred ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--
Confidence 77643211 112346678999999988889999999999999999998 99999877777666666543322221
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....+..+.+++.+||+.+|++|||++++++.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 13568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=206.38 Aligned_cols=177 Identities=16% Similarity=0.223 Sum_probs=144.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+..++...+..++.|++.|+.+ |+.|++|+||||+||++ +.++.++|+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV--GENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE--cCCCCEEECCcceEEE
Confidence 5789999999999998864 224568889999999999999999 99999999999999999 6777899999999877
Q ss_pred cCCCCCCcc--ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPRV--LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
......... ...+..|++||.+.+..++.++|+||+|++++++++ |..||.+.+.......+..... .+. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPC--PPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC--CCcC
Confidence 653322111 112347999999988889999999999999999999 9999988777666666654422 111 1356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=208.14 Aligned_cols=177 Identities=16% Similarity=0.233 Sum_probs=145.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+.++...+..++.|++.|+.+ |+.+++|+||+|+||++ +.++.++|+|||++..
T Consensus 80 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili--~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCCEEECccchhhc
Confidence 5789999999999998853 34578889999999999999999 99999999999999999 6777899999999877
Q ss_pred cCCC-CCCcc--ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPD-HPPRV--LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~-~~~~~--~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
.... ..... ..++..|++||.+.+..++.++|+||+|+++|++++ |..||...........+......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 232 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---MD 232 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---CC
Confidence 6421 11111 224567999999998889999999999999999998 99999877766666666544222111 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 233 CPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 68899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=211.48 Aligned_cols=177 Identities=19% Similarity=0.270 Sum_probs=141.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.++++|||.+|+|.+++... ....++......++.|++.||.| |+.+++|++|+++||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill--~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL--DSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE--ETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 66789999999999999752 35778889999999999999999 99999999999999999 6677999999999877
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... .........|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+........+ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 229 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---DN 229 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec---cc
Confidence 632211 122346678999999998889999999999999999999 78999888777777777555443222 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
++..+.+++.+||..+|++|||++++++
T Consensus 230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 230 CPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred hhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 7899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=208.78 Aligned_cols=180 Identities=20% Similarity=0.300 Sum_probs=144.1
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+.+++|.+++.... .+..+++..+..++.|++.||.| |++|++|+||+|+||++ +.++.++++|||.+
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~ 153 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEECcchhh
Confidence 4678999999999999886432 35678889999999999999999 99999999999999999 67788999999987
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS--ETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~ 174 (239)
........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.... .....+..... ++....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (267)
T cd08229 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSD 231 (267)
T ss_pred hccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC--CCCCcc
Confidence 66543322 22345888999999998888999999999999999999999999765432 22233332222 211223
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+..+.+++.+||..+|++|||++++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 57889999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=210.01 Aligned_cols=180 Identities=16% Similarity=0.175 Sum_probs=146.3
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl 91 (239)
..|++|||+++++|.+++..... .+.+.+..+..++.|++.||.| |+.+++|+||+|+||++ +.++.++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill--~~~~~~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--AEDLTVKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE--cCCCCEEE
Confidence 35788999999999999865322 2346778889999999999999 99999999999999999 77789999
Q ss_pred EecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCC
Q psy1096 92 IDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 92 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
+|||.+........ .....++..|+|||.+....++.++|+||+|+++|++++ |..||.+.+..+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99998866543221 222346678999999988888999999999999999998 99999887777766666543322
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+ ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 241 DLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111 3468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=215.45 Aligned_cols=186 Identities=22% Similarity=0.268 Sum_probs=142.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++ ..+.+++..+..++.|++.||.| |+.|++|+||||+||+++. .++.++++|||.+.
T Consensus 90 ~~~lv~e~~~~-~L~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~-~~~~~kl~dfg~~~ 163 (342)
T cd07854 90 SVYIVQEYMET-DLANVL----EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT-EDLVLKIGDFGLAR 163 (342)
T ss_pred eEEEEeecccc-cHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-CCceEEECCcccce
Confidence 46899999985 666554 34568889999999999999999 9999999999999999943 34578999999987
Q ss_pred ecCCCC----CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC------
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD------ 167 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~------ 167 (239)
...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 653221 1122357888999998754 45688999999999999999999999877655444433221100
Q ss_pred -------------------C-chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 168 -------------------F-DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 168 -------------------~-~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
. .......++..+.+|+.+||+.||++|||+++++.|+||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 0 0111234678899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=212.78 Aligned_cols=181 Identities=13% Similarity=0.105 Sum_probs=138.7
Q ss_pred EEeeCccCCCCccchhhhhhh----------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK----------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS 83 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~ 83 (239)
.|++|||+.+++|.+++.... ....++...+..++.|++.||.| |+.|++||||||+||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill-- 171 (304)
T cd05096 94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV-- 171 (304)
T ss_pred eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEE--
Confidence 578999999999998875421 11345667788999999999999 99999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchHHH
Q psy1096 84 RTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS--GLSPFMGENDSETF 158 (239)
Q Consensus 84 ~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~--g~~p~~~~~~~~~~ 158 (239)
+.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ +..||.+.+.....
T Consensus 172 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 251 (304)
T cd05096 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI 251 (304)
T ss_pred cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHH
Confidence 6778999999999876543221 122345678999999988889999999999999999986 67788776655544
Q ss_pred HHHHhc----cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 159 ANITRA----EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 159 ~~i~~~----~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+... ...........++..+.+++.+||..||++|||++++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 252 ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 433221 000000011246788999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=210.20 Aligned_cols=179 Identities=17% Similarity=0.215 Sum_probs=145.3
Q ss_pred EEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.++++||+.+++|.+++.... ....+....+..++.|++.||.| |++|++||||||+||++ +..
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~--~~~ 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDK 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe--cCC
Confidence 466789999999998875321 12346777888999999999999 99999999999999999 666
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 7899999998776533221 122345678999999988889999999999999999998 889998877777777766
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.......+ ..++..+.+++.+||+.+|++||+++++++.
T Consensus 241 ~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 65543222 3578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=209.08 Aligned_cols=183 Identities=20% Similarity=0.239 Sum_probs=135.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+ ++.+.+. ...+.+.+..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 77 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 77 TLTFVFEYMHT-DLAQYMI--QHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLAR 151 (291)
T ss_pred eEEEEEecccC-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE--cCCCcEEEecccccc
Confidence 45788999975 4444443 233557777888899999999999 99999999999999999 677899999999886
Q ss_pred ecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCC-------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDF------- 168 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~------- 168 (239)
...... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.... +....+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 543221 22334578899999998754 4788999999999999999999999765432 2222211100000
Q ss_pred ----------------ch---HHHh--hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 169 ----------------DD---EAFE--ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 169 ----------------~~---~~~~--~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+. ..+. ..+..+.+++.+||+.||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0000 125678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=211.57 Aligned_cols=178 Identities=20% Similarity=0.256 Sum_probs=144.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. .....+++..+..++.+++.||.| |+.+++|+||||+||++ +.++.++++|||.+..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE--cCCCeEEECCCccccc
Confidence 5799999999999998864 223447889999999999999999 99999999999999999 6777899999999876
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... .....++..|+|||.+.+..++.++|+||+||++|+|++ |..||..................... ...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 268 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ--PEH 268 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC--CCC
Confidence 543221 112345678999999988889999999999999999998 99999877665555444443322221 124
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||..+|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=212.64 Aligned_cols=183 Identities=23% Similarity=0.315 Sum_probs=142.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++|||+++. +.+.+. ..+..+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 89 ~~~lv~~~~~~~-l~~~~~--~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 163 (311)
T cd07866 89 SVYMVTPYMDHD-LSGLLE--NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI--DNQGILKIADFGLAR 163 (311)
T ss_pred eEEEEEecCCcC-HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECcCccch
Confidence 568899999875 444443 345679999999999999999999 99999999999999999 778899999999886
Q ss_pred ecCCCCC------------CccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Q psy1096 99 KINPDHP------------PRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 99 ~~~~~~~------------~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~ 165 (239)
....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5432211 1123467789999988654 47899999999999999999999998777665555443321
Q ss_pred CCCc--------------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 166 FDFD--------------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 166 ~~~~--------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.... ......++..+.+++++||..||++|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1100 01112345678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=207.86 Aligned_cols=181 Identities=15% Similarity=0.196 Sum_probs=147.1
Q ss_pred eEEEeeCccCCCCccchhhhhhh---cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMK---AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
...++++||+.+++|.+++.... ....+++..+..++.|++.||.| |+.+++|+||||+||++ +..+.++|+||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~df 157 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML--REDMTVCVADF 157 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE--CCCCeEEECCc
Confidence 34678899999999998875432 22467888899999999999999 99999999999999999 66778999999
Q ss_pred ccceecCCCCCCc---cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDHPPR---VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|++.......... ...++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~- 236 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ- 236 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 9987654332211 1224567999999988888999999999999999999 9999988777777666655432221
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....+..+.+++.+||+.||++|||+.+++++
T Consensus 237 --~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 237 --PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 13578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=204.52 Aligned_cols=178 Identities=15% Similarity=0.223 Sum_probs=144.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ....+.++.+..++.+++.||.+ |++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 66 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili--~~~~~~~l~d~g~~~ 141 (250)
T cd05085 66 PIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV--GENNVLKISDFGMSR 141 (250)
T ss_pred ccEEEEECCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE--cCCCeEEECCCccce
Confidence 35789999999999988753 34567888999999999999999 99999999999999999 677789999999986
Q ss_pred ecCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
........ ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.........+...... . ....
T Consensus 142 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~ 218 (250)
T cd05085 142 QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-S--CPQK 218 (250)
T ss_pred eccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCC
Confidence 54432211 11234567999999988888999999999999999998 99999887766666555543221 1 1135
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
++..+.+++.+||..+|++|||+.++++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 78999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=208.81 Aligned_cols=184 Identities=26% Similarity=0.299 Sum_probs=144.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|+++||+++ +|.+++.. ....+++..+..++.|++.||++ |+.|++|+||+|+||++ +.++.++++|||.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~--~~~~~~~l~d~g~~ 147 (287)
T cd07840 73 GSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI--NNDGVLKLADFGLA 147 (287)
T ss_pred CcEEEEeccccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--cCCCCEEEccccce
Confidence 357789999986 66666642 23578889999999999999999 99999999999999999 77889999999998
Q ss_pred eecCCCC--CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch----
Q psy1096 98 QKINPDH--PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD---- 170 (239)
Q Consensus 98 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---- 170 (239)
....... ......++..|++||.+.+. .++.++|+||+|+++++|++|..||...+.......+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 7765432 12234567789999987653 5689999999999999999999999877665554444332111110
Q ss_pred ----------------------HHHhh-cCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 ----------------------EAFEA-LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 ----------------------~~~~~-~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..... .+..+.+++++||..+|++||+++++++|+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00112 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=205.75 Aligned_cols=174 Identities=13% Similarity=0.242 Sum_probs=135.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC------CcEEEEe
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS------HHIKIID 93 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~------~~vkl~d 93 (239)
.+++|||+++++|.+++.. .+..+++..+..++.|++.||+| |+.|++||||||+||+++.+.. +.++++|
T Consensus 74 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred cEEEEecCCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 5688999999999988753 34467888899999999999999 9999999999999999955432 2379999
Q ss_pred cccceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHhccCCCchH
Q psy1096 94 FGLAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGL-SPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 94 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~-~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
||++...... ....+++.|+|||.+.+. .++.++|+||+|+++|++++|. .|+......... .........+.
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~- 226 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPA- 226 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCC-
Confidence 9987654432 234578889999999864 4689999999999999999984 666544443322 22222222221
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+..+.+++.+||+.+|++|||++++++.
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 ---PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=211.92 Aligned_cols=180 Identities=17% Similarity=0.180 Sum_probs=145.3
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+.+++|.+++..... +..++...+..++.|++.||.| |++|++|+||||+||++ +.
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--~~ 169 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TE 169 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE--cC
Confidence 36789999999999999875321 3457888889999999999999 99999999999999999 66
Q ss_pred CCcEEEEecccceecCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||.+......... ....++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 249 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 778999999998765432211 11223457999999988888999999999999999999 89999887776666666
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
........ ....+..+.+++.+||..+|++|||+.++++.
T Consensus 250 ~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 250 REGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54432111 13567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=210.49 Aligned_cols=180 Identities=18% Similarity=0.195 Sum_probs=145.9
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+.+++|.+++..... ...++...+..++.|++.||.| |+.|++|+||||+||++ +.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili--~~ 172 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV--TE 172 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE--cC
Confidence 35789999999999998865321 2356677788999999999999 99999999999999999 67
Q ss_pred CCcEEEEecccceecCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||++......... ....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+....+
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 252 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 789999999998776432211 12235567999999988889999999999999999998 88999887776766666
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
........ ....+..+.+++.+||..+|++|||+.++++.
T Consensus 253 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 253 KEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 54432211 13568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=213.13 Aligned_cols=184 Identities=23% Similarity=0.312 Sum_probs=141.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.. .+..+. +..++++.+..++.|++.||+| |+.+++||||+|+||++ +.++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll--~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV--NEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCCCCc
Confidence 34788898864 444332 3467888999999999999999 99999999999999999 677899999999976
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-------- 169 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 169 (239)
..... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.......+........
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 54321 223457788999999876 4578999999999999999999999987765444443332111000
Q ss_pred ----------------h---HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 170 ----------------D---EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 ----------------~---~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
. ......+..+.+|+.+||+.||++||++++++.||||...+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 0012356788999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=205.61 Aligned_cols=177 Identities=20% Similarity=0.287 Sum_probs=145.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+..++...+..++.|++.||++ |+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKT-PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV--SETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE--cCCCCEEEccCcceee
Confidence 5789999999999988754 345678888999999999999999 99999999999999999 7778899999999876
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+.......+...... + .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 228 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-P--RPDNC 228 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-C--CCCCC
Confidence 653221 112235568999999988888999999999999999998 99999887776666655443221 1 11356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||+.+|++|||+++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=206.85 Aligned_cols=180 Identities=22% Similarity=0.323 Sum_probs=146.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++++||+++++|.+++. ..+.+.+..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 80 ~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEECcccccc
Confidence 4567889999999998874 34567888899999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ......++..|++||.+.+...+.++|+||+||+++++++|..||...........+...... +....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~ 232 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLPD 232 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCCc
Confidence 653211 112345788999999998888899999999999999999999999876655555444433221 11224
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.++..+.+++.+||. ++.+|||+.+++.|||+
T Consensus 233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 678999999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=206.40 Aligned_cols=177 Identities=17% Similarity=0.197 Sum_probs=144.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ....+++..+..++.+++.||.| |+.|++|+||||+||++ +.++.++++|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili--~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV--SSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE--ecCCCeEEccCceeee
Confidence 4688999999999999853 24467888999999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCCCCc--cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
........ ...++..|+|||.+....++.++|+||+|++++++++ |..||.+.+..+....+..+..... ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~ 233 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PPNC 233 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCC
Confidence 54432211 1223457999999988888999999999999999886 9999988777666666654432221 1367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+|+..+|++|||+.+++..
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=205.38 Aligned_cols=180 Identities=22% Similarity=0.305 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++..... +..++++.+..++.+++.|+++ |+.|++|+||+|+||++ +.++.++++|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~--~~~~~~~l~d~~~~ 153 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI--TATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE--CCCCcEEEecccee
Confidence 46789999999999998865433 4568889999999999999999 99999999999999999 67788999999988
Q ss_pred eecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND--SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~ 174 (239)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+..+..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 231 (267)
T cd08224 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PAD 231 (267)
T ss_pred eeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--Chh
Confidence 7654332 22334578889999999888899999999999999999999999965432 223333333322211 123
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+++.+||..+|++|||+.++++
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 57889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=205.17 Aligned_cols=177 Identities=19% Similarity=0.232 Sum_probs=140.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ....+....+..++.|++.||.| |+.+++|+||||+||++ +.++.++|+|||++..
T Consensus 72 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili--~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARD 147 (262)
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE--cCCCcEEECCcccccc
Confidence 5688999999999998753 23445666778899999999999 99999999999999999 6677899999998865
Q ss_pred cCCCC-----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 100 INPDH-----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 100 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
..... ......++..|+|||.+....++.++|+||+|+++|+|++ |.+||...+.......+........+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 224 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP--- 224 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---
Confidence 43211 1112235567999999988889999999999999999999 56777766665655555444322211
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...+..+.+++.+||..+|++||++.++++.
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=204.01 Aligned_cols=176 Identities=16% Similarity=0.206 Sum_probs=143.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. .....+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili--~~~~~~~l~d~g~~~ 150 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAK 150 (256)
T ss_pred CeEEEEEecCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE--eCCCCEEEccccccc
Confidence 45789999999999998854 223468899999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
....... ....+..|++||.+....++.++|+||+|++++++++ |..||...+.......+..... . ......+
T Consensus 151 ~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 225 (256)
T cd05039 151 EASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCP 225 (256)
T ss_pred ccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCC
Confidence 6632221 2234567999999988888999999999999999997 9999987766665555544321 1 1113568
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.+++.+||..+|++|||++++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=209.49 Aligned_cols=183 Identities=23% Similarity=0.283 Sum_probs=143.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++ .+..++. .....+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 90 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili--~~~~~~kl~dfg~~~ 164 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLE--SGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL--NNKGQIKLADFGLAR 164 (302)
T ss_pred cEEEEEcccCc-cHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCcEEeCcccccc
Confidence 57889999997 4444543 224578889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-----
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD----- 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 170 (239)
...... ......++..|++||.+.+. .++.++|+||+||++++|++|.+||...+.......+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 654332 12223457789999988654 4688999999999999999999999876665555554442211110
Q ss_pred ---------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 171 ---------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 171 ---------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
.....++..+.+++.+||..||++|||+++++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=210.20 Aligned_cols=181 Identities=22% Similarity=0.297 Sum_probs=145.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+ ++.+++. ..+..+.+..+..++.|++.|+.| |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 89 ~~~lv~e~~~~-~l~~~~~--~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCLG-SASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccCC-CHHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE--CCCCcEEECCcccce
Confidence 46789999975 6665554 234567888899999999999999 99999999999999999 667899999999886
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ....+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+........ ....
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGH 238 (308)
T ss_pred eecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--Cccc
Confidence 65432 2345788999999985 34568899999999999999999999977665555555444333221 1235
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
++..+.+++++||..+|++||+++++++|+|+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 68889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=205.43 Aligned_cols=174 Identities=12% Similarity=0.153 Sum_probs=134.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-----CcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-----HHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-----~~vkl~df 94 (239)
.|++|||+++++|..++. ...+.+++..+..++.|++.||+| |+.+++|+||||+||++..++. ..++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 357899999999987764 335668888999999999999999 9999999999999999954321 23899999
Q ss_pred ccceecCCCCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLL-SGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~-~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
|.+...... ....++..|+|||.+. +..++.++||||+||++|+|+ +|..||......+.. ..........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~--- 229 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLV--- 229 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCC---
Confidence 987654322 2345778899999986 456799999999999999998 588888765543332 2222222221
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...+..+.+++.+||+.||.+||++.+|+++
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 1235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=208.82 Aligned_cols=186 Identities=22% Similarity=0.314 Sum_probs=149.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.| ++.+++. .....+.+..+..++.+++.|+.| |+.+++|+||+|+||++ +..+.++|+|||++.
T Consensus 99 ~~~lv~e~~~g-~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~--~~~~~~kl~dfg~~~ 173 (317)
T cd06635 99 TAWLVMEYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFGSAS 173 (317)
T ss_pred eEEEEEeCCCC-CHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE--CCCCCEEEecCCCcc
Confidence 45789999986 5555543 335568888999999999999999 99999999999999999 777899999999876
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
.... .....++..|++||.+. ...++.++|+||+||++|+|++|..||...........+......... ...
T Consensus 174 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 248 (317)
T cd06635 174 IASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNE 248 (317)
T ss_pred ccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--Ccc
Confidence 5432 22345788999999984 345789999999999999999999999877666666666554432221 134
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
.+..+.+++.+||+.+|.+||+++++++|+|+........
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 6788999999999999999999999999999987555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=212.03 Aligned_cols=185 Identities=25% Similarity=0.273 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++. .+.+.+.....++.|++.||+| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 83 ~~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill--~~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIR----ANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL--NSDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEeccccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEEeeccchh
Confidence 46889999985 6766653 2367788888999999999999 99999999999999999 778899999999887
Q ss_pred ecCCCC------CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC----
Q psy1096 99 KINPDH------PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD---- 167 (239)
Q Consensus 99 ~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~---- 167 (239)
...... ......++..|++||.+.+ ..++.++|+||+|+++|+|++|+.||.+.........+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654322 1223458889999998865 44688999999999999999999999876554443333222111
Q ss_pred -----------------------CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 168 -----------------------FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 168 -----------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
........++..+.+++.+||+.||++|||+.++++|+|+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 11112233678899999999999999999999999999997753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=210.19 Aligned_cols=180 Identities=19% Similarity=0.206 Sum_probs=143.9
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+++++|.+++..... ...++...+..++.|++.||+| |+.|++|+||||+||++ +.
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--~~ 175 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TE 175 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--cC
Confidence 46789999999999999875322 2357788899999999999999 99999999999999999 66
Q ss_pred CCcEEEEecccceecCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||.+......... ....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+....+
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 779999999998665432111 11223467999999988888999999999999999998 88999876665555555
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...... . .....+..+.+++.+||..+|++|||+++++++
T Consensus 256 ~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 KEGHRM-D--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCC-C--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 443321 1 113568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=203.28 Aligned_cols=175 Identities=17% Similarity=0.177 Sum_probs=143.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. .....++...+..++.|++.|+.+ |+.|++||||+|+||++ +.++.++|+|||++..
T Consensus 73 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili--~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--SEDGVAKVSDFGLARV 149 (254)
T ss_pred cEEEEECCCCCCHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--cCCCcEEECCCcccee
Confidence 4788999999999998864 234467888889999999999999 99999999999999999 6778999999998865
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
.... ......+..|++||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+.+... +. ....++.
T Consensus 150 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 224 (254)
T cd05083 150 GSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-ME--PPEGCPA 224 (254)
T ss_pred cccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-CC--CCCcCCH
Confidence 4322 112234567999999988889999999999999999997 9999988776666665554422 21 1246789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+.+++.+||+.+|++||++++++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=204.71 Aligned_cols=177 Identities=15% Similarity=0.234 Sum_probs=144.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+.+++..+..++.|++.|+.| |+.|++|+||||+||++ +.++.++++|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE--cCCCcEEECCCccce
Confidence 35789999999999988753 35678889999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCCCc--c--ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDHPPR--V--LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~~~~--~--~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
......... . ...+..|++||.+.+..++.++|+||+|+++|++++ |..||...+.......+.... ..+. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~ 232 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPA--P 232 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCC--C
Confidence 654322111 1 113346999999988888999999999999999997 999998777766666665432 2221 1
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...+..+.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=225.67 Aligned_cols=191 Identities=18% Similarity=0.281 Sum_probs=132.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhc-----------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeE
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKA-----------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIM 80 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nil 80 (239)
...|+++||+++++|.+++..... +.......+..++.|++.||.| |+++|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 357889999999999988753210 1112234466899999999999 9999999999999999
Q ss_pred EecCCCCcEEEEecccceecCCC--CCCccccCCCCccCccccccCC----------------------CCchhhHHHHH
Q psy1096 81 CVSRTSHHIKIIDFGLAQKINPD--HPPRVLFGTPEFIPPEIINYEP----------------------IGIESDMWSIG 136 (239)
Q Consensus 81 i~~~~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~DiwslG 136 (239)
++. ..+.+||+|||++...... .......+++.|+|||.+.... ++.++||||+|
T Consensus 288 l~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 933 2468999999999765322 2234467899999999764322 23456999999
Q ss_pred HHHHHHHhCCCCCCCCCchHHHHH-HHhccCC-----------CchH------HHhhcCHHHHHHHHHhhhhCcccCCCH
Q psy1096 137 VITYVLLSGLSPFMGENDSETFAN-ITRAEFD-----------FDDE------AFEALSEDAKDFISSLLVKRKEKRLTA 198 (239)
Q Consensus 137 ~~l~~~~~g~~p~~~~~~~~~~~~-i~~~~~~-----------~~~~------~~~~~~~~~~~ll~~~l~~~p~~Rpt~ 198 (239)
|++|+|+++..++.. ....... +...... .... ..+.......+|+++||+.||++|||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999987666432 1111111 1111110 0000 000112335589999999999999999
Q ss_pred HHHhhccccccCCC
Q psy1096 199 KQCLSHLWIAQKDS 212 (239)
Q Consensus 199 ~~ll~h~~~~~~~~ 212 (239)
+++|+||||.+...
T Consensus 445 ~e~L~Hpff~~~~~ 458 (566)
T PLN03225 445 KAALAHPYFDREGL 458 (566)
T ss_pred HHHhCCcCcCCCCc
Confidence 99999999987544
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=198.30 Aligned_cols=183 Identities=22% Similarity=0.239 Sum_probs=144.8
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCC-CchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGT-QPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~d 93 (239)
-..+|++.+|...|+|.+.+...+.+| .+++..+..|+.++++||.+ |+.. ++||||||.||++ .+.+.+++.|
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D 172 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMD 172 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEe
Confidence 345788999999999999988776665 88999999999999999999 9999 9999999999999 6688999999
Q ss_pred cccceecCCCCC----------CccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHH
Q psy1096 94 FGLAQKINPDHP----------PRVLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPFMGEN--DSETF 158 (239)
Q Consensus 94 fg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~~~--~~~~~ 158 (239)
||.+....-... ....-.|..|.|||.+.... .+.+.|||||||++|.|+.|..||...- ....-
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 998765431110 11234788999999996554 4789999999999999999999995211 11111
Q ss_pred HHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 159 ANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
-.+......+|.. ..++..+.++++.||+.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2334444444433 2489999999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=207.61 Aligned_cols=178 Identities=16% Similarity=0.210 Sum_probs=142.8
Q ss_pred EEeeCccCCCCccchhhhhhh---------------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK---------------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPEN 78 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~---------------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~n 78 (239)
.|+++||+.+++|.+++.... ....++...+..++.|++.||.| |+.+++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 467899999999999875421 12357778889999999999999 99999999999999
Q ss_pred eEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy1096 79 IMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGEND 154 (239)
Q Consensus 79 ili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~ 154 (239)
|++ +.++.++|+|||++........ .....++..|++||.+.+..++.++|+||+|+++++|++ |..||.+...
T Consensus 158 ill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEE--cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999 6678999999999865432221 112234567999999988888999999999999999998 9999988776
Q ss_pred hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 155 SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
......+..... .+. ....+.++.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYR-MER--PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCC-CCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 666655544322 111 1357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=202.88 Aligned_cols=178 Identities=16% Similarity=0.234 Sum_probs=145.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+.+++|.+++.. ..+.++++.+..++.+++.|+++ |+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~ 148 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV--GENQVVKVSDFGMTR 148 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE--cCCCeEEECCCccee
Confidence 45788999999999988753 34567888999999999999999 99999999999999999 677899999999887
Q ss_pred ecCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
....... .....++..|++||.+.+..++.++|+||+|+++|++++ |..||...........+..+.....+ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 225 (256)
T cd05112 149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RL 225 (256)
T ss_pred ecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CC
Confidence 6543221 112234568999999998889999999999999999998 99999877766666666544322221 23
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||+.+|++|||++++++.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 57889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=204.24 Aligned_cols=175 Identities=16% Similarity=0.152 Sum_probs=136.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-----CCcEEEEe
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-----SHHIKIID 93 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-----~~~vkl~d 93 (239)
..|+||||+++++|..++. ...+.+++..+..++.|++.||+| |+++++||||||+||+++..+ ...++++|
T Consensus 90 ~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d 167 (274)
T cd05076 90 ENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167 (274)
T ss_pred ceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecC
Confidence 3568899999999998875 335677888899999999999999 999999999999999995432 23589999
Q ss_pred cccceecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 94 FGLAQKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLL-SGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 94 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~-~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
||.+...... ....++..|++||.+.+ ..++.++|+||+|+++|+++ +|..||.+....+....... ....+
T Consensus 168 ~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~-- 241 (274)
T cd05076 168 PGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK-KHRLP-- 241 (274)
T ss_pred Cccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh-ccCCC--
Confidence 9987544322 22347788999998865 45799999999999999985 69999987665544333222 22222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...+..+.+++.+||+.+|++|||+++++++
T Consensus 242 --~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 242 --EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred --CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 1345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=205.34 Aligned_cols=177 Identities=19% Similarity=0.187 Sum_probs=144.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++|||+.+++|.+++.. ..+.+++..+..++.|++.|++| |+++++|+||+|+||++ +..+.++|+|||.+.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~--~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE--cCCCeEEECCCcccc
Confidence 35688999999999998863 34568899999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCCCcc---ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRV---LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
.......... ..++..|++||.+....++.++|+||+|++++++++ |..||.+....+....+........+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 234 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---P 234 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---C
Confidence 6553322111 123457999999988888999999999999999998 99999887776666666544322211 2
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+..+.+++.+||..+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 46788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=231.16 Aligned_cols=185 Identities=21% Similarity=0.341 Sum_probs=147.1
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..++|+-||||+..++.+++..+..+. .....-.+|++|+.||+| |+.|||||||||.||++ +..+.|||+|||+
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL--d~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL--DSRNSVKIGDFGL 743 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE--cCCCCeeeccccc
Confidence 378999999999999999986532221 345667899999999999 99999999999999999 6777899999999
Q ss_pred ceecC-------------------CCCCCccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCC-CCCC
Q psy1096 97 AQKIN-------------------PDHPPRVLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPF-MGEN 153 (239)
Q Consensus 97 ~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~-~~~~ 153 (239)
++... +....+..+||..|+|||.+.+.. |+.|.|+||+|+++++|+.- | ..+.
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsME 820 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSME 820 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHH
Confidence 87610 011234567999999999997665 89999999999999999853 4 3566
Q ss_pred chHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 154 DSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+...+.++.++..+.+...+..--+.-..+|+.|++.||.+||||.++|++.|+-.
T Consensus 821 Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 77777777766665552222222344578999999999999999999999999964
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=211.22 Aligned_cols=183 Identities=21% Similarity=0.300 Sum_probs=144.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+ |++|.+++. ...+++..+..++.|++.||+| |+.|++|+||+|+||++ +.++.++++|||++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill--~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeeccccc
Confidence 357889998 567766652 4578899999999999999999 99999999999999999 667889999999987
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
..... .....+++.|++||.+.+ ..++.++|+||+|++++++++|..||.+.+.......+.+.....+.
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 65432 223457888999999876 35789999999999999999999999876655444443332211110
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.....++..+.+++.+||+.||++|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11124577899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=201.91 Aligned_cols=177 Identities=16% Similarity=0.222 Sum_probs=142.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ....++...+..++.+++.|+.+ |+++++|+||+|+||++ +.++.++|+|||++..
T Consensus 67 ~~~v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili--~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 67 IYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV--GENNVLKISDFGMSRE 142 (251)
T ss_pred eEEEEEcCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE--cCCCcEEEeecccccc
Confidence 5788999999999998853 34567888899999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
....... .....+..|+|||.+.+..++.++|+||+|+++++|++ |..||...........+..... .+. ...
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 219 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MPA--PQL 219 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-CCC--Ccc
Confidence 5422111 11223456999999988888999999999999999998 8999987776665555544321 111 135
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||..+|++|||++++++.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 68899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=203.33 Aligned_cols=181 Identities=23% Similarity=0.304 Sum_probs=147.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+||||+....-. ++. ..+.-+..+.++.|++.|+.+ |+.||+||||||+||++ .....+|+.|||++.
T Consensus 95 e~y~v~e~m~~nl~~-vi~-----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv--~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQ-VIL-----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV--NSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhhHHHH-HHH-----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee--cchhheeeccchhhc
Confidence 456788888765444 332 244557788999999999999 99999999999999999 666689999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh---
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA--- 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~--- 175 (239)
..+..-..+..+.+..|.|||.+.+..+...+||||+||++.+|++|...|+|.+..+.+.++......+.+.....
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 77655445567789999999999999999999999999999999999999998887777777655544333222110
Q ss_pred -----------------------------------cCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 176 -----------------------------------LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 176 -----------------------------------~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
-...+++++.+||..||++|.+++++|+|||++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 123477999999999999999999999999997
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=203.01 Aligned_cols=178 Identities=21% Similarity=0.269 Sum_probs=145.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+..++...+..++.+++.|+.| |+.|++|+||+|+||++ +.++.++++|||.+.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~-~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili--~~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV--GENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE--cCCCCEEECccccce
Confidence 46889999999999998864 334578889999999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
........ .....+..|++||.+.+...+.++|+||+|++++++++ |..||.+.+.......+........+ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 228 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP---PN 228 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CC
Confidence 66532111 11224567999999998888999999999999999998 99999887776666666544221111 24
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=208.01 Aligned_cols=182 Identities=15% Similarity=0.143 Sum_probs=142.9
Q ss_pred EEEeeCccCCCCccchhhhhhhc--------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA--------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vk 90 (239)
..|++|||+.+++|.+++..... ...+++..+..++.|++.||+| |++|++|+||||+||++ +..+.++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili--~~~~~~~ 170 (296)
T cd05051 93 PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV--GKNYTIK 170 (296)
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee--cCCCceE
Confidence 36788999999999998864321 2267888999999999999999 99999999999999999 6668999
Q ss_pred EEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHhc-
Q psy1096 91 IIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS--GLSPFMGENDSETFANITRA- 164 (239)
Q Consensus 91 l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~--g~~p~~~~~~~~~~~~i~~~- 164 (239)
|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ +..||...+.......+...
T Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 250 (296)
T cd05051 171 IADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFF 250 (296)
T ss_pred EccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcc
Confidence 99999987543322 1223345678999999988889999999999999999987 77888776666665555432
Q ss_pred ---cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 165 ---EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 165 ---~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
............+.++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 251 RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 111111111245789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=201.73 Aligned_cols=178 Identities=17% Similarity=0.221 Sum_probs=147.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++.... ...+++..+..++.|++.|+++ |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~--~~~~~~~l~dfg~~~ 151 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV--GENLVVKISDFGLSR 151 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE--ccCCeEEEcccCCce
Confidence 4778999999999999885422 1228899999999999999999 99999999999999999 777799999999987
Q ss_pred ecCCCCCCcc--ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRV--LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
.......... ..+++.|++||.+.+..++.++|+||+|+++++|++ |..||...+.......+......... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 228 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---EN 228 (258)
T ss_pred ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---Cc
Confidence 7654322221 236678999999988888999999999999999998 89999887777777666655433222 34
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||..+|++|||+.++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 229 CPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7899999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=203.59 Aligned_cols=176 Identities=18% Similarity=0.290 Sum_probs=142.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+.++...+..++.|++.|++| |++|++|+||+|+||++ +.++.++++|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili--~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 80 VMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRF 155 (269)
T ss_pred eEEEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE--cCCCcEEECCCccccc
Confidence 5789999999999988753 35678888899999999999999 99999999999999999 6777999999998865
Q ss_pred cCCCCCCcc----ccC--CCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 100 INPDHPPRV----LFG--TPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 100 ~~~~~~~~~----~~~--~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
......... ..+ +..|++||.+.+..++.++|+||+|+++|++++ |..||...+.......+... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~-- 232 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP-- 232 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--
Confidence 543221111 111 346999999998889999999999999999886 99999877766666665433 22221
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...++..+.+++.+||..+|++||++++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1356888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=203.09 Aligned_cols=181 Identities=25% Similarity=0.304 Sum_probs=149.6
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|++|||++|++|.+++... .....+++..+..++.|++.||.+ |+ .+++|+||+|+||++ +..+.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~--~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE--CCCCcEEEecccc
Confidence 467899999999999887553 345678889999999999999999 96 789999999999999 7778899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+.............++..|++||.+.+..++.++|+||+|+++|++++|..||...........+......... ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--EGMY 238 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--cccC
Confidence 87765544344456888999999999888899999999999999999999999776665555555544433222 1256
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++++||..||++||++.++..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=209.72 Aligned_cols=180 Identities=18% Similarity=0.198 Sum_probs=145.0
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|+++||+++++|.+++..... ...+....+..++.|++.||+| |++|++||||||+||++ +.+
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill--~~~ 170 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV--TED 170 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--cCC
Confidence 6789999999999999875322 2346677788999999999999 99999999999999999 667
Q ss_pred CcEEEEecccceecCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++......... ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 78999999998765432211 11223457999999998889999999999999999998 899998877666666654
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
....... ....+..+.+++.+||..+|++|||+.+++++.
T Consensus 251 ~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 251 EGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 4332211 135678899999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=201.81 Aligned_cols=178 Identities=20% Similarity=0.282 Sum_probs=144.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+..++...+..++.|++.||.+ |+.|++|+||+|+||++ +..+.++|+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHh-CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE--cCCCcEEECCCccee
Confidence 35889999999999998865 235567788889999999999999 99999999999999999 777899999999887
Q ss_pred ecCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
........ ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+.......+..... .+ ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-CC--Cccc
Confidence 65432211 11234567999999988888999999999999999998 9999988776666555543322 11 1246
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=210.46 Aligned_cols=182 Identities=26% Similarity=0.342 Sum_probs=141.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++++++ |++|.+++. ...+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++..
T Consensus 97 ~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARH 169 (345)
T ss_pred EEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE--cCCCCEEEeccccccc
Confidence 56677776 567766653 3468888999999999999999 99999999999999999 6778999999999865
Q ss_pred cCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH------
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA------ 172 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 172 (239)
.... .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+.......+...
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 4322 223457888999999866 4578899999999999999999999987665544444332221111111
Q ss_pred ---------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 ---------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ---------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
....++.+.+++.+||+.||.+|+|+.+++.|+||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 012467789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=213.42 Aligned_cols=155 Identities=22% Similarity=0.282 Sum_probs=123.1
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEI 120 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~ 120 (239)
.++...+..++.|++.||.| |+.+++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 310 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE--eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence 35666778899999999999 99999999999999999 6677899999999876543221 222346678999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 121 INYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 121 ~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
+.+..++.++|+||+||++|+|++ |..||..................++. ...++..+.+++.+||+.+|++|||+.
T Consensus 311 ~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 311 IFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK--PDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCC--CccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 988889999999999999999997 99999876544433333333322221 135788999999999999999999999
Q ss_pred HHhh
Q psy1096 200 QCLS 203 (239)
Q Consensus 200 ~ll~ 203 (239)
++.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=206.09 Aligned_cols=176 Identities=15% Similarity=0.139 Sum_probs=136.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ...+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL--DNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE--cCCCcEEEeeccccc
Confidence 4678999999999998874 2358899999999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H------------HHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE--T------------FAN 160 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~--~------------~~~ 160 (239)
....... .....++..|++||.+.+..++.++|+||+|+++++|++|..||....... . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6543221 112234567999999988888999999999999999999999985432110 0 000
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
........+ .....+..+.+++.+||+.+|++|||++++++
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000011111 11346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=202.08 Aligned_cols=180 Identities=16% Similarity=0.228 Sum_probs=142.8
Q ss_pred EEeeCccCCCCccchhhhhhh----cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC---CCcEEEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK----AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT---SHHIKII 92 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~---~~~vkl~ 92 (239)
.|++|||+++++|.+++.... ....+....+..++.|++.|++| |+.+++|+||+|+||+++.+. ...++++
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence 678899999999999886432 23456778889999999999999 999999999999999994432 2279999
Q ss_pred ecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||++....... ......++..|++||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+.......
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 999986553221 1122345678999999988889999999999999999998 999998776666655554332211
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
. ...++..+.+++.+||..+|++||+++++++
T Consensus 234 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 K---PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred C---cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 1356888999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=201.44 Aligned_cols=174 Identities=16% Similarity=0.146 Sum_probs=135.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-----cEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-----HIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-----~vkl~df 94 (239)
.|++|||+++++|.+++.. ....++...+..++.|++.||+| |++|++|+||||+||+++.+... .++++||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 4789999999999998853 22378888899999999999999 99999999999999999543321 7999999
Q ss_pred ccceecCCCCCCccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
|++..... .....++..|++||.+.+. .++.++|+||+|+++|++++ |..||...+............ ..+.
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~- 227 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM- 227 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC-
Confidence 99876543 2233466789999999876 67999999999999999998 688886654333333222211 1111
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.....+.+++.+||..+|++|||+.++++.
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 228 ---PDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred ---CCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 123789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=204.84 Aligned_cols=178 Identities=16% Similarity=0.195 Sum_probs=144.3
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIM 80 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nil 80 (239)
.|+++||+++++|.+++..... ...+++..+..++.|++.||.+ |+.+++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 5789999999999999864321 1346677888999999999999 9999999999999999
Q ss_pred EecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchH
Q psy1096 81 CVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSE 156 (239)
Q Consensus 81 i~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~ 156 (239)
+ +..+.++++|||++........ ......+..|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+
T Consensus 163 ~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 163 V--GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred e--cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9 6778899999998865432211 112234567999999988889999999999999999997 888998877777
Q ss_pred HHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 157 TFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
....+..+.....+ ...+..+.+++.+||+.+|++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77666655432211 356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=205.67 Aligned_cols=173 Identities=15% Similarity=0.094 Sum_probs=132.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++++++... +.+++. .....++..+..++.|++.||.| |+.+++||||||+||++ +..+.++|+|||++.
T Consensus 101 ~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill--~~~~~~~l~DFGla~ 174 (294)
T PHA02882 101 YRFILLEKLVEN-TKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV--DGNNRGYIIDYGIAS 174 (294)
T ss_pred EEEEEEehhccC-HHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCcEEEEEcCCce
Confidence 446667766543 333332 23345677788999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCC--------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---------HHH
Q psy1096 99 KINPDH--------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF---------ANI 161 (239)
Q Consensus 99 ~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~---------~~i 161 (239)
...... ......||+.|+|||.+.+..++.++|+||+||++++|++|..||.+.+..... ..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PHA02882 175 HFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL 254 (294)
T ss_pred eeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh
Confidence 653221 112245899999999999999999999999999999999999999876432221 122
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...... ....+..+.++++.|+..+|++||+++++++
T Consensus 255 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 255 HEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222111 1345788999999999999999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=207.00 Aligned_cols=185 Identities=25% Similarity=0.360 Sum_probs=142.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||++ ++|.+++. ++.+.+..+..++.|++.||.+ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 84 ~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili--~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI--NENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE--CCCCCEEeCcccccc
Confidence 3568899985 46666552 4567788888999999999999 99999999999999999 677899999999886
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccC-----------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEF----------- 166 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~----------- 166 (239)
..... .....++..|++||.+.+ ..++.++|+||+|++++++++|..||.+.........+.....
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 54322 223457788999998865 5679999999999999999999999977654333222211100
Q ss_pred ---------------CCc-hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 167 ---------------DFD-DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 167 ---------------~~~-~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
..+ ......++..+.+++++||+.+|++|||+++++.|+|++...-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 001 11123467889999999999999999999999999999764433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=202.97 Aligned_cols=181 Identities=16% Similarity=0.220 Sum_probs=137.7
Q ss_pred EEeeCccCCCCccchhhhhhhc--CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA--GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.|++|||+.+++|.+++..... .....+..+..++.|++.|++| |++|++||||||+||++ +.++.++++|||++
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill--~~~~~~kl~dfg~~ 147 (269)
T cd05042 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL--TADLSVKIGDYGLA 147 (269)
T ss_pred eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe--cCCCcEEEeccccc
Confidence 6789999999999999865432 2334567788999999999999 99999999999999999 77789999999987
Q ss_pred eecCCCCC---CccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcc-
Q psy1096 98 QKINPDHP---PRVLFGTPEFIPPEIINY-------EPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAE- 165 (239)
Q Consensus 98 ~~~~~~~~---~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~- 165 (239)
........ .....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 65432211 122335567999999743 345789999999999999998 888998776655555443332
Q ss_pred CCCch-HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 166 FDFDD-EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...+. .....++..+.+++..|+ .||++|||++++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 22221 122356788899999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=202.46 Aligned_cols=177 Identities=18% Similarity=0.245 Sum_probs=143.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+.++...+..++.|++.|+++ |+.+++|+||||+||++ +.++.++++|||.+.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili--~~~~~~~l~dfg~~~ 154 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLVCKVSDFGLSR 154 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE--CCCCeEEeCCCCccc
Confidence 35789999999999998863 34567888899999999999999 99999999999999999 677799999999987
Q ss_pred ecCCCCCC----ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDHPP----RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
........ ....++..|++||.+.+..++.++|+||+|++++++++ |..||......+....+..... .+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~ 231 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPA--P 231 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CCC--C
Confidence 65432211 11123457999999998889999999999999999886 9999987776666666654422 221 1
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...+..+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=205.20 Aligned_cols=190 Identities=23% Similarity=0.289 Sum_probs=146.7
Q ss_pred cCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC------
Q psy1096 13 NNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT------ 85 (239)
Q Consensus 13 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~------ 85 (239)
..+.+++++|.+ -|.++.+++.+ .+-..++-..++.+..|++.++++ |+.+++|.||||+||++.+..
T Consensus 161 dyrghiCivfel----lG~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 161 DYRGHICIVFEL----LGLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hccCceEEEEec----cChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 346677777663 34567777754 233456677889999999999999 999999999999999984322
Q ss_pred ------------CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy1096 86 ------------SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN 153 (239)
Q Consensus 86 ------------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~ 153 (239)
+-.|+++|||.+..... -..+.+.|..|.|||.+.+-+++...|+||+||+|+|+.+|...|+...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 23589999998866443 2356789999999999999999999999999999999999999998887
Q ss_pred chHHHHHHHhccCCCchHHHhh------------------------------------------cCHHHHHHHHHhhhhC
Q psy1096 154 DSETFANITRAEFDFDDEAFEA------------------------------------------LSEDAKDFISSLLVKR 191 (239)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~------------------------------------------~~~~~~~ll~~~l~~~ 191 (239)
+.+.+..+.....++|...... .-..+.+|+++||.+|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 7765444433333333211100 1224779999999999
Q ss_pred cccCCCHHHHhhcccccc
Q psy1096 192 KEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 192 p~~Rpt~~~ll~h~~~~~ 209 (239)
|.+|+|+.|+|.||||+.
T Consensus 394 P~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccHHHHhcCHHhhc
Confidence 999999999999999976
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=215.86 Aligned_cols=177 Identities=20% Similarity=0.269 Sum_probs=142.7
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
+|+-+|+|.+|+.+++ .....+.-.....|++||+.|+.| |.++|||+|||..||++ +.++.|+|+|||++..-.
T Consensus 464 IiTqwCeGsSLY~hlH--v~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl--~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLH--VQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL--HEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeehhccCchhhhhcc--chhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE--ccCCcEEEecccceeeee
Confidence 4567999999999987 344566666788999999999999 99999999999999999 777899999999986543
Q ss_pred C---CCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-Hh
Q psy1096 102 P---DHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA-FE 174 (239)
Q Consensus 102 ~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-~~ 174 (239)
. ........|...|||||++. ..+|+..+||||+|+++|||++|..||...+..+++-.+-.+-..+.... ..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 2 22333456788999999995 34689999999999999999999999996666666555544433322222 23
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.++++|+..||.+++++||++.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 45668999999999999999999999987
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=199.34 Aligned_cols=193 Identities=21% Similarity=0.247 Sum_probs=147.4
Q ss_pred eeEEEeeCccCCCCccchhhhhh--hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC--CCCcEEEE
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEM--KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR--TSHHIKII 92 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~--~~~~vkl~ 92 (239)
.-.+|++.||.+...+. ++... .....++...++.|+.||+.|+.| |+..++||||||.||+|..+ ..|.||++
T Consensus 100 d~~v~l~fdYAEhDL~~-II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWH-IIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhhhHHH-HHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 34688999999987666 44433 234678888999999999999999 99999999999999999554 34899999
Q ss_pred ecccceecCCCC----CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc---------hHHH
Q psy1096 93 DFGLAQKINPDH----PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGEND---------SETF 158 (239)
Q Consensus 93 dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~---------~~~~ 158 (239)
|+|+++.+.+.- .....+-|.+|.|||.+.+.. |+.+.|+|++||++.++++-.+.|.+... ...+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998876432 122346788999999998765 69999999999999999999999865422 1233
Q ss_pred HHHHhccCCCchHHHh---------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 159 ANITRAEFDFDDEAFE---------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 159 ~~i~~~~~~~~~~~~~---------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
.+|......+....|+ .-++...+|+.+||.+||.+|.|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 3443322221111111 1144577999999999999999999999999
Q ss_pred ccccCC
Q psy1096 206 WIAQKD 211 (239)
Q Consensus 206 ~~~~~~ 211 (239)
||++-+
T Consensus 339 yF~~d~ 344 (438)
T KOG0666|consen 339 YFTEDP 344 (438)
T ss_pred ccccCC
Confidence 998754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=205.20 Aligned_cols=176 Identities=19% Similarity=0.217 Sum_probs=140.9
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
++++||+.+|+|.+++.. ....+++..+..++.|++.||.| |+++++|+||||+||++ +.++.++|+|||.+...
T Consensus 84 ~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill--~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV--KSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee--cCCCceEEccccccccc
Confidence 467899999999988753 34467888899999999999999 99999999999999999 66778999999998765
Q ss_pred CCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 101 NPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 101 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... .....++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.........+......... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP---PIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCC
Confidence 43221 112234668999999998889999999999999999997 99999876655444444433222111 245
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..+|++||+++++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=197.15 Aligned_cols=182 Identities=32% Similarity=0.481 Sum_probs=149.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++++||+++++|.+++.. ...++...+..++.+++.++.+ |+.+++|+||+|+||++ +.++.++++|||.+.
T Consensus 61 ~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~--~~~~~~~l~d~~~~~ 135 (244)
T smart00220 61 KLYLVMEYCDGGDLFDLLKK---RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL--DEDGHVKLADFGLAR 135 (244)
T ss_pred EEEEEEeCCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE--CCCCcEEEcccccee
Confidence 56788999999999988753 3337888899999999999999 99999999999999999 666899999999988
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............++..|++||...+..++.++|+|++|++++++++|..||.. .........+......... ....++
T Consensus 136 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 214 (244)
T smart00220 136 QLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKIS 214 (244)
T ss_pred eeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCC
Confidence 77654444455688899999999888888999999999999999999999977 4444444444433333221 111178
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+.+++.+||..+|++||++.++++||||
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=202.98 Aligned_cols=178 Identities=15% Similarity=0.190 Sum_probs=143.2
Q ss_pred EEeeCccCCCCccchhhhhhhcC-----CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAG-----TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
.|++++|+.+++|.+++...... ..+++..+..++.|++.||.| |+.+++|+||+|+||++ +..+.++++||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~--~~~~~~kl~d~ 161 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDN 161 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE--cCCCcEEECCC
Confidence 45678899999999988653322 568889999999999999999 99999999999999999 66789999999
Q ss_pred ccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|+++....... .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+.... .+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCCC
Confidence 99876533221 112335667999999988889999999999999999998 999998776666555544432 2221
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...++..+.+++.+||..+|++|||+.++++
T Consensus 241 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 --PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=220.16 Aligned_cols=185 Identities=19% Similarity=0.282 Sum_probs=155.2
Q ss_pred ccccCCCceeEEEeeCccCCCCccchhhhhhhcC-------CC----chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCC
Q psy1096 10 GVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAG-------TQ----PWVELSERLFESTERGLGH-HSLVTVDPKILPE 77 (239)
Q Consensus 10 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~-------~~----~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~ 77 (239)
|+|....+++++ .||+..|+|.++|+...+. .. ++..+...|+.||+.||.| -++.+|||||-..
T Consensus 556 GVC~~~~P~~Mv---FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 556 GVCREGDPLCMV---FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEccCCeeEEE---EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 444444444444 5699999999999765432 22 6777889999999999999 9999999999999
Q ss_pred CeEEecCCCCcEEEEecccceecCCCCCCccc---cCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy1096 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVL---FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGEN 153 (239)
Q Consensus 78 nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~ 153 (239)
|+|| ..+..||++|||+++..-....+... .-...||+||.+..++|+.++||||+||++||+.+ |..||.+.+
T Consensus 633 NCLV--ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 633 NCLV--GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hcee--ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999 77889999999999776544433322 23458999999999999999999999999999998 999999999
Q ss_pred chHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 154 DSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
..+..+.+..+..-..+ +..+..+.+|+..||+..|++||++.+|-
T Consensus 711 n~EVIe~i~~g~lL~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 711 NQEVIECIRAGQLLSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hHHHHHHHHcCCcccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999988873333 57899999999999999999999999974
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=204.62 Aligned_cols=181 Identities=14% Similarity=0.139 Sum_probs=139.0
Q ss_pred EEeeCccCCCCccchhhhhhhc--------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA--------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl 91 (239)
.|++|||+.+++|.+++..... ...+++..+..++.|++.||+| |+.|++|+||||+||++ +.++.++|
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili--~~~~~~~l 171 (296)
T cd05095 94 LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--GKNYTIKI 171 (296)
T ss_pred cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE--cCCCCEEe
Confidence 5789999999999998864321 2346677889999999999999 99999999999999999 66778999
Q ss_pred EecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHh---
Q psy1096 92 IDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS--GLSPFMGENDSETFANITR--- 163 (239)
Q Consensus 92 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~--g~~p~~~~~~~~~~~~i~~--- 163 (239)
+|||++........ .....++..|++||...+..++.++|+||+||++|+|++ |..||...+..+.......
T Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~ 251 (296)
T cd05095 172 ADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR 251 (296)
T ss_pred ccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh
Confidence 99999876543221 122234567999999888889999999999999999998 7889876665554433211
Q ss_pred -ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 164 -AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 164 -~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
............++..+.+|+.+||..||++|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 252 DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000000011246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=225.87 Aligned_cols=181 Identities=18% Similarity=0.253 Sum_probs=137.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcC--------CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAG--------TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vk 90 (239)
..|++|||++|++|.+++...... ..++...+..++.|++.||+| |++|++||||||+||++ +..+.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL--d~dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE--cCCCCEE
Confidence 457899999999999988643222 233445677899999999999 99999999999999999 7778899
Q ss_pred EEecccceecCCC-------------------CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy1096 91 IIDFGLAQKINPD-------------------HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG 151 (239)
Q Consensus 91 l~dfg~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~ 151 (239)
++|||++...... .......||+.|+|||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999998765210 011124689999999999998999999999999999999999999977
Q ss_pred CCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 152 ENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
............. ..........+++.+.+++.+||+.||++|++..+.+.
T Consensus 234 ~~~~ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 234 KKGRKISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred cchhhhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5543332221111 00001112357888999999999999999987555443
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=215.94 Aligned_cols=189 Identities=25% Similarity=0.345 Sum_probs=154.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|.||+|++||++..+| -.-|.+.+++++-++.++..|+.+ |+.|+|||||||+|||| |..|+|||.|||++.
T Consensus 703 nLYFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI--DrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 777 (1034)
T ss_pred ceEEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE--ccCCceeeeeccccc
Confidence 357799999999999988 457899999999999999999999 99999999999999999 888999999999975
Q ss_pred ec---------CCCC------------------C----------------CccccCCCCccCccccccCCCCchhhHHHH
Q psy1096 99 KI---------NPDH------------------P----------------PRVLFGTPEFIPPEIINYEPIGIESDMWSI 135 (239)
Q Consensus 99 ~~---------~~~~------------------~----------------~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 135 (239)
.+ +.+. + -...+||+-|+|||.+....++...|-||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 43 1000 0 012579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCC---HHHHhhccccccCCC
Q psy1096 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLT---AKQCLSHLWIAQKDS 212 (239)
Q Consensus 136 G~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt---~~~ll~h~~~~~~~~ 212 (239)
||+||+|+.|++||...+..+.-.++..=.-.+.......++.++.++|.++.+ +++.|.. ++++-.||||+..++
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 999999999999998887766655554322222222335789999999998654 6888884 778999999998665
Q ss_pred CC
Q psy1096 213 SP 214 (239)
Q Consensus 213 ~~ 214 (239)
..
T Consensus 937 ss 938 (1034)
T KOG0608|consen 937 SS 938 (1034)
T ss_pred Hh
Confidence 53
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=207.71 Aligned_cols=155 Identities=22% Similarity=0.273 Sum_probs=120.7
Q ss_pred chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCcccc
Q psy1096 46 PWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEII 121 (239)
Q Consensus 46 ~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~ 121 (239)
++...+..++.|++.||+| |++|++||||||+||++ +.++.++++|||++........ .....++..|++||.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE--cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence 4566677899999999999 99999999999999999 6778999999999876432211 1122345679999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 122 NYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 122 ~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
.+..++.++|+||+|+++|+|++ |..||.+................... ....+..+.+++..||+.+|++|||+.+
T Consensus 254 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 254 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 88889999999999999999997 99999765443333332222222111 1246788999999999999999999999
Q ss_pred Hhhc
Q psy1096 201 CLSH 204 (239)
Q Consensus 201 ll~h 204 (239)
+++|
T Consensus 332 il~~ 335 (343)
T cd05103 332 LVEH 335 (343)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=201.72 Aligned_cols=181 Identities=15% Similarity=0.258 Sum_probs=145.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcC------CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAG------TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
..|++|||+++++|.+++.....+ ..+++..+..++.|++.||+| |+.+++|+||||+||++ +..+.++++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili--~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV--SSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE--eCCCcEEEc
Confidence 457899999999999998643322 168899999999999999999 99999999999999999 667789999
Q ss_pred ecccceecCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCc
Q psy1096 93 DFGLAQKINPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFD 169 (239)
Q Consensus 93 dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 169 (239)
|||++....... ......++..|++||.+.+...+.++|+||+|++++++++ |..||...........+......++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 999876433211 1222345667999999988888999999999999999998 8899977666666666554443332
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
. ...++..+.+++.+||..+|++|||+.++++.
T Consensus 240 ~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 V--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 2 13578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=199.45 Aligned_cols=181 Identities=15% Similarity=0.206 Sum_probs=137.4
Q ss_pred EEEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++..... ........+..++.|++.||.| |+.+++|+||||+||++ +.++.++|+|||++
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~--~~~~~~~l~Dfg~~ 146 (268)
T cd05086 69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL--TSDLTVKVGDYGIG 146 (268)
T ss_pred ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE--cCCccEEecccccc
Confidence 35789999999999998865332 2445666778999999999999 99999999999999999 77788999999987
Q ss_pred eecCCCC---CCccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccC
Q psy1096 98 QKINPDH---PPRVLFGTPEFIPPEIINY-------EPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEF 166 (239)
Q Consensus 98 ~~~~~~~---~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~ 166 (239)
....... ......++..|+|||.+.. ..++.++|+||+|+++|+|++ |..||...+..+....+.+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence 5432111 1123457788999999853 234678999999999999987 6788877666666555443322
Q ss_pred -CC-chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 167 -DF-DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 167 -~~-~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.. .+.....+++.+.+++..|| .+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 11 11112346788999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=202.82 Aligned_cols=179 Identities=17% Similarity=0.180 Sum_probs=136.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++.. ....+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~--~~~~~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE--cCCCCEEECCCcccc
Confidence 36789999999999998753 23467888899999999999999 99999999999999999 667789999999987
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------chHHHHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN--------------DSETFAN 160 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~--------------~~~~~~~ 160 (239)
....... .....++..|+|||.+.+..++.++|+||+|+++|+++++..|+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 6543221 123446667999999988888999999999999999999776542211 0011111
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
........+ ....++..+.+|+.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111111111 123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=202.93 Aligned_cols=182 Identities=13% Similarity=0.111 Sum_probs=139.2
Q ss_pred EEEeeCccCCCCccchhhhhhh---------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK---------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~v 89 (239)
..|++|||+.+++|.+++.... ....+.+..+..++.|++.||+| |+.|++|+||||+||++ +.++.+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill--~~~~~~ 168 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV--GNHYTI 168 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE--cCCCcE
Confidence 3578999999999999885421 11246777888999999999999 99999999999999999 667789
Q ss_pred EEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchHHHHHHHhc
Q psy1096 90 KIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS--GLSPFMGENDSETFANITRA 164 (239)
Q Consensus 90 kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~--g~~p~~~~~~~~~~~~i~~~ 164 (239)
+|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++++|++ +..||...+.......+...
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 248 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHh
Confidence 9999999865433221 122335668999999988889999999999999999987 67788776655544433221
Q ss_pred ----cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 165 ----EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 165 ----~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
............+..+.+++.+||..+|++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000001111246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=182.96 Aligned_cols=186 Identities=21% Similarity=0.284 Sum_probs=155.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+.+|.|||....-. +.. .-+|.+..++++.++.|+++||.+ |++++.|||+||.|++| ..+|.+|++|||+++
T Consensus 75 kltlvfe~cdqdlkk-yfd--slng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli--n~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFCDQDLKK-YFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI--NRNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHhhHHHHH-HHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe--ccCCcEEecccchhh
Confidence 445778899866544 332 558999999999999999999999 99999999999999999 888999999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH--
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF-- 173 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~-- 173 (239)
.++-.. +....+-|.+|.+|..+.+.+ |+...|+||-||++.++.. |.+.|+|.+..+.+++|......+....|
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 887543 455567889999999998766 6999999999999999997 89999999988888888665443332222
Q ss_pred -----------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 174 -----------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 174 -----------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+.+...-++++++.|.-+|.+|.+++++++||||...
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 2345567899999999999999999999999999763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=231.35 Aligned_cols=181 Identities=13% Similarity=0.113 Sum_probs=133.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec----------------
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS---------------- 83 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~---------------- 83 (239)
.+.++||+ +++|.+++. .....+++..+..++.||+.||.| |++||+||||||+|||+..
T Consensus 55 ~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 55 IVRALECE-DVSLRQWLD--NPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred hhhhhccC-CccHHHHHh--cccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 44556766 558888875 335668999999999999999999 9999999999999999943
Q ss_pred -CCCCcEEEEecccceecCCCC-----------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q psy1096 84 -RTSHHIKIIDFGLAQKINPDH-----------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG 145 (239)
Q Consensus 84 -~~~~~vkl~dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g 145 (239)
+..+.++++|||++....... ......||+.|+|||.+.+..++.++||||+||++|+|++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 233456777777765321100 01113578889999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 146 LSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 146 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+|+.... .....+..... ++... .......+++.+||..+|.+||++.++++||||.+
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 212 VSSREEKS--RTMSSLRHRVL--PPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred CCchhhHH--HHHHHHHHhhc--Chhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 88875322 12222222111 11111 12455678999999999999999999999999976
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=190.38 Aligned_cols=189 Identities=17% Similarity=0.228 Sum_probs=150.9
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
-...|+|+.+|+..... ++. ...-.++...+.+++.+++.||.| |...|+|||+|++|++| +..|.++|+|||+
T Consensus 96 r~t~ylVf~~cehDLaG-lLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI--t~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAG-LLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI--TKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhhhHHH-Hhc--CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE--cCCceEEeecccc
Confidence 34588999999875443 443 334678888999999999999999 99999999999999999 7778999999999
Q ss_pred ceecCCC-----CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 97 AQKINPD-----HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 97 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
++.+... +..+..+-|.+|.+||.+.+. .|+.+.|+|+-||++.+|++|.+.+.+++....+..|..-.....+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 8665422 223445678999999999775 5799999999999999999999999999888777766443322222
Q ss_pred HHHhh-------------------------------cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 171 EAFEA-------------------------------LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~-------------------------------~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+.|++ -++...+|+.++|..||.+|++++++++|.||....
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 22211 134678999999999999999999999999997633
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=213.97 Aligned_cols=177 Identities=20% Similarity=0.265 Sum_probs=156.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+|+|||+++.|.|..|+. .+...++......++.||+.||+| |+.+.|||||-..||+| .+..+|||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV--sSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV--SSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee--cCcceeeecccchhh
Confidence 4799999999999999997 456688888899999999999999 99999999999999999 667799999999999
Q ss_pred ecCCCCCCccccCC--CCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGT--PEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~--~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
............|. ..|||||.+..+.++.++|+|.|||++|+++. |.-||.+-...+..-.+.++...+.+ +.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~n 616 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PN 616 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CC
Confidence 88877655544444 36999999999999999999999999999987 99999998888887788777765544 47
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+++.+..|+.+||+++|.+||++.+|..
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 8999999999999999999999998764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=198.72 Aligned_cols=180 Identities=19% Similarity=0.269 Sum_probs=135.6
Q ss_pred EEeeCccCCCCccchhhhhhhc--CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA--GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.|++|||+++++|.+++..... ........+..++.|++.|++| |+.+++|+||||+||++ +.++.++|+|||.+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~--~~~~~~kL~dfg~~ 147 (269)
T cd05087 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL--TADLTVKIGDYGLS 147 (269)
T ss_pred cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE--cCCCcEEECCcccc
Confidence 5789999999999998864332 2345566778899999999999 99999999999999999 66788999999988
Q ss_pred eecCCCCC---CccccCCCCccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc-c
Q psy1096 98 QKINPDHP---PRVLFGTPEFIPPEIINYE-------PIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRA-E 165 (239)
Q Consensus 98 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~-~ 165 (239)
........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||......+........ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 65432221 1223467789999998542 34789999999999999996 99999776655544333222 2
Q ss_pred CCCch-HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 166 FDFDD-EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...+. ......+..+.+++++|+ .+|++|||+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 22221 111245778999999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=213.65 Aligned_cols=177 Identities=20% Similarity=0.272 Sum_probs=149.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+|++||+|.||+|.++|. ...+.++..+...++.+++.||+| |+.+++||||-..|+|+ ..++.+|++|||++..
T Consensus 236 l~ivmEl~~gGsL~~~L~--k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~--~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLK--KNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY--SKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee--cCCCeEEeCccccccC
Confidence 456899999999999996 334468889999999999999999 99999999999999999 6667899999999866
Q ss_pred cCCCCCCccc-cCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 100 INPDHPPRVL-FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 100 ~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...-...... .-...|+|||.+....++.++||||+||++||+.+ |..||.+....+...++....++.+.+. ..+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCH
Confidence 5421111111 23457999999999999999999999999999998 8999999999999999977666555432 567
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+..++.+|+..+|+.|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 88999999999999999999998764
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=207.64 Aligned_cols=155 Identities=20% Similarity=0.259 Sum_probs=123.3
Q ss_pred chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCC---CCccccCCCCccCcccc
Q psy1096 46 PWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEII 121 (239)
Q Consensus 46 ~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~ 121 (239)
++...+..++.|++.||.| |+.+++|+||||+||++ +..+.++|+|||++....... ......++..|++||.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE--eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 4555677899999999999 99999999999999999 667789999999987653221 12233467789999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 122 NYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 122 ~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
.+..++.++|+||+|+++++|++ |..||......+...........+.. ....+..+.+++++||..+|.+||++++
T Consensus 314 ~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 88888999999999999999998 89999776655544443333222211 1246889999999999999999999999
Q ss_pred Hhhc
Q psy1096 201 CLSH 204 (239)
Q Consensus 201 ll~h 204 (239)
|++.
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=197.90 Aligned_cols=181 Identities=15% Similarity=0.209 Sum_probs=143.4
Q ss_pred eEEEeeCccCCCCccchhhhhhh---cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMK---AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
...+++++|+.+++|.+++.... ....++...+..++.|++.||+| |+.|++|+||||+||++ +.++.++++||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili--~~~~~~kl~df 157 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML--NENMTVCVADF 157 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE--cCCCCEEECcc
Confidence 34567789999999987764321 12357788899999999999999 99999999999999999 66778999999
Q ss_pred ccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|.+........ .....+++.|++||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+.........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 98876543221 112334567999999988888999999999999999998 89999877766666655544322111
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...+..+.+++.+||..+|++|||+.++++.
T Consensus 238 ---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 ---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=198.95 Aligned_cols=179 Identities=15% Similarity=0.123 Sum_probs=136.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+++++|.+++.. ..+.+++..+..++.|++.||+| |++|++|+||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili--~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV--ESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE--CCCCeEEECCCcccc
Confidence 36789999999999998853 34568888999999999999999 99999999999999999 677789999999987
Q ss_pred ecCCCCCC----ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------------HHH
Q psy1096 99 KINPDHPP----RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE---------------TFA 159 (239)
Q Consensus 99 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~---------------~~~ 159 (239)
........ ....++..|++||.+.+..++.++|+||+|+++++|++|..++....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 11123345899999988889999999999999999999877654322110 001
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+.......+ ....++..+.+++.+||..+|++|||++++++.
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111111111 113567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=185.69 Aligned_cols=163 Identities=19% Similarity=0.208 Sum_probs=127.2
Q ss_pred CccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccc
Q psy1096 31 CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVL 109 (239)
Q Consensus 31 ~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~ 109 (239)
|+|.+++. ..+..+++..+..++.|++.||.| |+++ ||+||++ +.++.+++ ||.+....... .
T Consensus 1 GsL~~~l~--~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~--~~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILE--VRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL--TWDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE--cCccceee--ccceEeecccc----C
Confidence 56777775 235679999999999999999999 9998 9999999 77778888 99887654322 2
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCCch---HHHhhcCH--HHHHH
Q psy1096 110 FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDD---EAFEALSE--DAKDF 183 (239)
Q Consensus 110 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~---~~~~~~~~--~~~~l 183 (239)
.|++.|+|||.+.+..++.++||||+||++|+|++|..||...... .....+......... .....++. .+.++
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 5889999999999999999999999999999999999999765432 233333322221100 11122333 69999
Q ss_pred HHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 184 ISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 184 l~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+.+||..+|.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=220.41 Aligned_cols=103 Identities=30% Similarity=0.541 Sum_probs=87.9
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhh
Q psy1096 110 FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189 (239)
Q Consensus 110 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 189 (239)
+||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.........+......++... ..++..+.+++..||.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~-~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGE-EKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCccc-ccCCHHHHHHHHHHcc
Confidence 358889999999999999999999999999999999999998888777777766555444322 3578889999999999
Q ss_pred hCcccCCCHHHHhhccccccCCCC
Q psy1096 190 KRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 190 ~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.||.+||+++++++|+||...++.
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~~~~~ 643 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHGVDWE 643 (669)
T ss_pred cChhHCcCHHHHHhCHhhcCCCHH
Confidence 999999999999999999875543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=197.26 Aligned_cols=188 Identities=18% Similarity=0.229 Sum_probs=148.2
Q ss_pred EEEeeCccCCCCc--cchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCM--ITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
.-|+.||+++-.. |+-++.+ ..+..+++++..+|...+..||.| .+.+||||||||+|||+ +..|.|||||||
T Consensus 137 dcWiCMELMd~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl--dr~G~vKLCDFG 213 (361)
T KOG1006|consen 137 DCWICMELMDISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL--DRHGDVKLCDFG 213 (361)
T ss_pred ceeeeHHHHhhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE--ecCCCEeeeccc
Confidence 4578899887543 2222222 346788889999999999999999 67799999999999999 888999999999
Q ss_pred cceecCCCCCCccccCCCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhccCCCchHH
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIIN--YEPIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAEFDFDDEA 172 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~ 172 (239)
.+-.....--.+.-.|..+|||||.+. +..|+.++|+||||+.+++++||..|+.+.+. .+.+..+..+..+.....
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 986665444344456889999999994 44689999999999999999999999987653 445555555544332211
Q ss_pred --HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 173 --FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 173 --~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.-.++..+..|+..||.+|-..||...++++++|++..
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 12368889999999999999999999999999999763
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=221.26 Aligned_cols=180 Identities=18% Similarity=0.235 Sum_probs=150.5
Q ss_pred EEEeeCccCCCCccchhhhhhhc----CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA----GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
..++++||++||+|..+|++..+ ...+.-.....++.+|+.|+.| ++.++|||||...|+|+ +....||++||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL--~~~r~VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL--DERRVVKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee--cccCcEEEccc
Confidence 34677899999999999987533 3456666778999999999999 99999999999999999 66689999999
Q ss_pred ccceecCCCCCCcc---ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDHPPRV---LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|+++.+........ ..-...|||||.+....++.++|||||||++||+++ |..||.+.+..+.+..+..+....++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 99985543332222 123357999999999999999999999999999999 99999999998888866666533332
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..+|++||++..|++.
T Consensus 927 ---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 927 ---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred ---CCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 4789999999999999999999999999864
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=207.57 Aligned_cols=191 Identities=18% Similarity=0.302 Sum_probs=154.3
Q ss_pred cCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 13 NNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 13 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl 91 (239)
.++.++|++|. .-..+|.++|..+..+-.+.-..++.+..|+..||.. -..|++|.||||+||||+.. ...+||
T Consensus 504 ~hknHLClVFE----~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~-k~iLKL 578 (752)
T KOG0670|consen 504 KHKNHLCLVFE----PLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES-KNILKL 578 (752)
T ss_pred hhcceeEEEeh----hhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC-cceeee
Confidence 45667888876 3456788888888888888889999999999999999 99999999999999998543 357899
Q ss_pred EecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 92 IDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 92 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
||||.+.....+. .+.+.-+..|.|||++.|.+|+...|+||+||+||++.||+..|+|.+...++.........+|.-
T Consensus 579 CDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 579 CDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 9999987766443 333456678999999999999999999999999999999999999998887766553333333321
Q ss_pred HHh--------------------------------------------------------hcCHHHHHHHHHhhhhCcccC
Q psy1096 172 AFE--------------------------------------------------------ALSEDAKDFISSLLVKRKEKR 195 (239)
Q Consensus 172 ~~~--------------------------------------------------------~~~~~~~~ll~~~l~~~p~~R 195 (239)
... ..-..+++|+.+||.+||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 110 012247799999999999999
Q ss_pred CCHHHHhhcccccc
Q psy1096 196 LTAKQCLSHLWIAQ 209 (239)
Q Consensus 196 pt~~~ll~h~~~~~ 209 (239)
.|+.++|+||||..
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=206.64 Aligned_cols=186 Identities=20% Similarity=0.280 Sum_probs=135.2
Q ss_pred EEEeeCccCCCCccchhhhhhh---------------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK---------------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPE 77 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~---------------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~ 77 (239)
..|+|+||+++++|.+++.... ....+....+..++.|++.+|.| |+.+++||||||+
T Consensus 259 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~ 338 (507)
T PLN03224 259 SQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPE 338 (507)
T ss_pred ceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchH
Confidence 3689999999999998875321 01123445678899999999999 9999999999999
Q ss_pred CeEEecCCCCcEEEEecccceecCCCCCCcc--ccCCCCccCccccccCC--------------------C--CchhhHH
Q psy1096 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEP--------------------I--GIESDMW 133 (239)
Q Consensus 78 nili~~~~~~~vkl~dfg~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~--------------------~--~~~~Diw 133 (239)
||++ +.++.++|+|||++........... ..+++.|++||.+.... + ..+.|+|
T Consensus 339 NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dvw 416 (507)
T PLN03224 339 NLLV--TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSY 416 (507)
T ss_pred hEEE--CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchh
Confidence 9999 6667899999999865443222221 23478999999985332 1 2346999
Q ss_pred HHHHHHHHHHhCCC-CCCCCCc-----------hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCc---ccCCCH
Q psy1096 134 SIGVITYVLLSGLS-PFMGEND-----------SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK---EKRLTA 198 (239)
Q Consensus 134 slG~~l~~~~~g~~-p~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p---~~Rpt~ 198 (239)
|+||++++|++|.. |+.+... ...+..+......+ ..++..+....+|+.+||..+| .+|+|+
T Consensus 417 SlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa 494 (507)
T PLN03224 417 TAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSV 494 (507)
T ss_pred hHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence 99999999999875 6643211 11111222222222 2345678999999999999866 689999
Q ss_pred HHHhhcccccc
Q psy1096 199 KQCLSHLWIAQ 209 (239)
Q Consensus 199 ~~ll~h~~~~~ 209 (239)
+++|+||||..
T Consensus 495 ~eaL~Hp~f~~ 505 (507)
T PLN03224 495 GQALSHRFFLP 505 (507)
T ss_pred HHHhCCCCcCC
Confidence 99999999964
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=208.80 Aligned_cols=191 Identities=16% Similarity=0.185 Sum_probs=164.0
Q ss_pred cCCCceeEEE---------eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEe
Q psy1096 13 NNRTSVVITW---------SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCV 82 (239)
Q Consensus 13 ~~~~~~~~~~---------~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~ 82 (239)
..|++++.+| +|+|++..|+|.+.|.. +..+.+.......++.||+.||.| .++++|||||-..|+++
T Consensus 168 L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll- 245 (1039)
T KOG0199|consen 168 LQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL- 245 (1039)
T ss_pred ccCcceeEEeeeeccchhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee-
Confidence 4578888777 56899999999999986 677888888889999999999999 99999999999999999
Q ss_pred cCCCCcEEEEecccceecCCCCCCccc----cCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHH
Q psy1096 83 SRTSHHIKIIDFGLAQKINPDHPPRVL----FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSET 157 (239)
Q Consensus 83 ~~~~~~vkl~dfg~~~~~~~~~~~~~~----~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~ 157 (239)
-....|||+|||+.+..+.+...... .-...|+|||.++...++.++|+|++||.+|||++ |..||-|.....+
T Consensus 246 -asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 246 -ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred -cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 55668999999999887655433222 12347999999999999999999999999999998 9999999999999
Q ss_pred HHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 158 FANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+++|.++.....+ ..++.++.++++.||..+|++|||+..|.+..++.+
T Consensus 325 L~~iD~~erLpRP---k~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 325 LKNIDAGERLPRP---KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHhccccccCCCC---CCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999876554433 467899999999999999999999999987766654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=196.19 Aligned_cols=178 Identities=16% Similarity=0.164 Sum_probs=137.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ....++...+..++.|++.||++ |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV--ESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE--cCCCCEEEccccccc
Confidence 46789999999999998853 23368888899999999999999 99999999999999999 667899999999987
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------------HHHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE--------------TFAN 160 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~--------------~~~~ 160 (239)
....... .....++..|++||.+.+..++.++|+||+|+++++|++|..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653211 111234456999999988888999999999999999999999986432211 1111
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
........+. ....+..+.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112111111 1345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=203.73 Aligned_cols=184 Identities=15% Similarity=0.230 Sum_probs=153.6
Q ss_pred ccccCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCc
Q psy1096 10 GVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHH 88 (239)
Q Consensus 10 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~ 88 (239)
|+|...+. .|+++||+.+|+|.+||++ ++...++......++.||.+|+.| ..+++|||||-..|+|| ..+..
T Consensus 330 GVCT~EpP---FYIiTEfM~yGNLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV--gEnhi 403 (1157)
T KOG4278|consen 330 GVCTHEPP---FYIITEFMCYGNLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHI 403 (1157)
T ss_pred hhhccCCC---eEEEEecccCccHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc--cccce
Confidence 45544443 4778899999999999998 666777777788999999999999 99999999999999999 88889
Q ss_pred EEEEecccceecCCCCCCcc--ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcc
Q psy1096 89 IKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 89 vkl~dfg~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~ 165 (239)
||++|||+++.+........ ..-.+.|.|||.+....++.++|+|+|||+||++.| |..||+|.+..+.+..+.++-
T Consensus 404 VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 404 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred EEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 99999999988764432221 223457999999999999999999999999999998 999999998887777766653
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
....+ ..+++.+.+|++.||++.|.+||+++++-
T Consensus 484 RM~~P---eGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 484 RMDGP---EGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred cccCC---CCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 32222 47899999999999999999999998874
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=213.65 Aligned_cols=194 Identities=24% Similarity=0.313 Sum_probs=143.8
Q ss_pred cccCCCcee----------EEEeeCccCCCCccchhhhhhhcCCCch-HHHHHHHHHHHHHHHHH-hhhcccCCCCCCCC
Q psy1096 11 VSNNRTSVV----------ITWSSPPYDGGCMITGYVVEMKAGTQPW-VELSERLFESTERGLGH-HSLVTVDPKILPEN 78 (239)
Q Consensus 11 ~~~~~~~~~----------~~~~~~e~~~~~~l~~~l~~~~~~~~~~-~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~n 78 (239)
.|..|++++ ..|++.|.|. .+|.+++......-... ......++.|+++||++ |+.+||||||||.|
T Consensus 558 eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQN 636 (903)
T KOG1027|consen 558 ESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQN 636 (903)
T ss_pred hccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCce
Confidence 345666666 4567788887 56777764320111111 12346889999999999 99999999999999
Q ss_pred eEEec---CCCCcEEEEecccceecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy1096 79 IMCVS---RTSHHIKIIDFGLAQKINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFM 150 (239)
Q Consensus 79 ili~~---~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~ 150 (239)
|||.. ++...++|+|||+++....+.. .....||-+|.|||++....-+.+.||+|+||++|++++ |..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99976 4557899999999998765432 233569999999999998888889999999999999998 699995
Q ss_pred CCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 151 GENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
... +...+|..+......-.. .....+.+||.+|++++|..||++.++|.||+|=
T Consensus 717 d~~--~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 717 DSL--ERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred chH--HhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 332 233355555443322110 1112789999999999999999999999999993
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=210.24 Aligned_cols=183 Identities=18% Similarity=0.252 Sum_probs=157.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+.+++||+++|.|..+|++ +.|.++.-+...+++-|++|+.| -+.|+|||||-..|||| +.+-.+|++|||+++
T Consensus 704 PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV--NsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV--NSNLVCKVSDFGLSR 779 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee--ccceEEEecccccee
Confidence 35678999999999999984 45778888999999999999999 99999999999999999 778899999999999
Q ss_pred ecCCCC--CCccccCCC--CccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDH--PPRVLFGTP--EFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~--~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
..++.. ...+..|.+ .|.|||.+..++++.++|+||+|+++||+++ |.-||..++..+.++.|..+-..+++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---
Confidence 886543 233344543 6999999999999999999999999999887 99999999999999888776544443
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc--ccccc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH--LWIAQ 209 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h--~~~~~ 209 (239)
-.++..+.+|+..||++|-.+||++++|+.+ ..+++
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3689999999999999999999999999864 35543
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=187.78 Aligned_cols=185 Identities=23% Similarity=0.352 Sum_probs=155.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|.|.||+.||.|.=.+ .....++++-++-+-..|+.||.| |++||++||+|.+|+++ +..|++||.|||..+
T Consensus 325 rlffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll--daeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL--DAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE--ccCCceeecccchhh
Confidence 577888999999998333 567899999999999999999999 99999999999999999 888899999999876
Q ss_pred e-cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCch-HHHHHHHhccCCCc
Q psy1096 99 K-INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-------ENDS-ETFANITRAEFDFD 169 (239)
Q Consensus 99 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-------~~~~-~~~~~i~~~~~~~~ 169 (239)
. ..+.....++.|||.|.|||.+++..|+...|-|++||++++|+.|+.||.- .+.. -..+-|.....++|
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 5 3455667788999999999999999999999999999999999999999941 1111 22333444445554
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCC------HHHHhhccccccCCCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLT------AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt------~~~ll~h~~~~~~~~~ 213 (239)
.+++.....+++..|++||.+|.. ..++..|+||+..+|.
T Consensus 480 ----rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 480 ----RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ----ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 467888999999999999999974 5789999999987765
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=198.29 Aligned_cols=176 Identities=20% Similarity=0.247 Sum_probs=139.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC--cEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH--HIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~--~vkl~dfg~~ 97 (239)
..++||||.||+|..++....+...+++.+...++.++..||.| |++||+||||||.||++.....| .-||+|||.+
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 34789999999999999988888999999999999999999999 99999999999999998554433 3599999999
Q ss_pred eecCCCCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----ch-HHHHHHHhcc------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLSPFMGEN----DS-ETFANITRAE------ 165 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~----~~-~~~~~i~~~~------ 165 (239)
+..+.+....+.+||+-|++||... ...|+.-.|.||+||++|+++||..||..-. .. -++.-+.+..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 9999888888999999999999998 5788999999999999999999999994221 11 2222222110
Q ss_pred --------------CCCchHHHhhcCHHHHHHHHHhhhhCcccCC
Q psy1096 166 --------------FDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196 (239)
Q Consensus 166 --------------~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp 196 (239)
++++......+...+-.++..+|+.+|.+|-
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111122233455678889999999998
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=191.86 Aligned_cols=181 Identities=18% Similarity=0.210 Sum_probs=133.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc---ccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV---TVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~---ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..+|.||+.+|+|.+.+...... .+++..+.+|+.+++.||+| |+.. |||||||++|||+ |.+...||+|||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~aKlsDFGL 223 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFNAKLSDFGL 223 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCCEEccCccC
Confidence 34555699999999998753222 88999999999999999999 9864 9999999999999 7888999999999
Q ss_pred ceecCC-CCCCccc-cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHH----HHHhccC-
Q psy1096 97 AQKINP-DHPPRVL-FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---DSETFA----NITRAEF- 166 (239)
Q Consensus 97 ~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~---~~~~~~----~i~~~~~- 166 (239)
+..... .....+. .||.+|++||+......+.++||||+||++.++++|+.+..... ...... .+.....
T Consensus 224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence 955543 2222222 79999999999998889999999999999999999998775321 111111 1111100
Q ss_pred C-CchHHH-hhcC-----HHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 167 D-FDDEAF-EALS-----EDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 167 ~-~~~~~~-~~~~-----~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
. ..+... ...+ ..+..+...|++.+|.+||+..++++.
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 0 000000 1122 225567779999999999999997543
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=201.41 Aligned_cols=179 Identities=19% Similarity=0.272 Sum_probs=145.4
Q ss_pred EEEeeCccCCCCccchhhhhhh-----------cC--CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-----------AG--TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-----------~~--~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
.+++++|||..|.|.+++.+.. .+ ..+.......+..||+.|++| ++..+||||+-..||++ ..
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi--~~ 453 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI--TK 453 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--cC
Confidence 4678899999999999998755 01 137777788999999999999 99999999999999999 66
Q ss_pred CCcEEEEecccceecCCCCCCccc--cC--CCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-chHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDHPPRVL--FG--TPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGEN-DSETFA 159 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~~~~--~~--~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~-~~~~~~ 159 (239)
+..+|++|||+++...+....... .+ ...|||||.+....|+.++|+||+|+++|+|.+ |..||.+.. ..+..+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 678999999999866554433321 12 235999999999999999999999999999998 999999865 445555
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+..+.....+ ...+.++.++++.||+.+|++||++.++.+
T Consensus 534 ~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55555443332 356999999999999999999999998763
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=167.36 Aligned_cols=180 Identities=22% Similarity=0.339 Sum_probs=140.6
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
++.||+.+.....+. ..++.-.++.++.+++.||.| |+.||.|||+||.|++|+... -.++|+|+|++..+.
T Consensus 112 LiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcC
Confidence 345666666665443 355566778899999999999 999999999999999995433 368999999999999
Q ss_pred CCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhc-------------cC
Q psy1096 102 PDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFM-GENDSETFANITRA-------------EF 166 (239)
Q Consensus 102 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~-~~~~~~~~~~i~~~-------------~~ 166 (239)
+.......+.+..|-.||.+..-+ |+.+-|+||+||++..|+..+.||. |.+.-+.+-+|.+. ..
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 888888888999999999997654 6999999999999999999888874 55555544444222 11
Q ss_pred CCchHHH--------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 167 DFDDEAF--------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 167 ~~~~~~~--------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..++... .-.++++.+|+.+.|.+|-++|+|+.|++.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111110 013688999999999999999999999999999965
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=165.36 Aligned_cols=146 Identities=18% Similarity=0.285 Sum_probs=118.5
Q ss_pred eEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..+|+.||.+.-. |.-+..+. ..++.+++...-+|+..+..||.| |++ .++|||+||+|||+ +..|+||+||||
T Consensus 118 gdvwIcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI--n~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI--NYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE--ccCCcEEEcccc
Confidence 3578888888743 44344333 668899999999999999999999 876 79999999999999 788899999999
Q ss_pred cceecCCCCCCccccCCCCccCccccc----cCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhccCC
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIIN----YEPIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFD 167 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~i~~~~~~ 167 (239)
.+-...+..-.+...|...|+|||.+. ...|+.++||||||+.+.+|.+++.||.. .+..+.++++.....+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 998877655444456888999999984 34689999999999999999999999964 4566777777665443
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=181.44 Aligned_cols=181 Identities=27% Similarity=0.400 Sum_probs=143.4
Q ss_pred eCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEe-cCCCCcEEEEeccccee
Q psy1096 24 SPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCV-SRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 24 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~-~~~~~~vkl~dfg~~~~ 99 (239)
|.|||+|..|.=|| +.+..+++.+++.|+-||+.||.| .+.. |||-||||.|||+. ....|.+|+.|||+++.
T Consensus 546 VLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 57899999999777 567899999999999999999999 7654 99999999999874 35568999999999988
Q ss_pred cCCCCC--------CccccCCCCccCccccccC--C--CCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHH--HH-h
Q psy1096 100 INPDHP--------PRVLFGTPEFIPPEIINYE--P--IGIESDMWSIGVITYVLLSGLSPFMGEND-SETFAN--IT-R 163 (239)
Q Consensus 100 ~~~~~~--------~~~~~~~~~~~aPE~~~~~--~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~--i~-~ 163 (239)
+..... .....||.+|++||.+.-. + .+.+.||||+||++|+++.|+-||..+.. ..++.. |. .
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 764432 1224689999999999543 2 47899999999999999999999954432 222221 21 1
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....+|+- +-.+.+.++||++||++.-+.|..+.++..||+|.-
T Consensus 703 tEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 22233321 246899999999999999999999999999999964
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=197.18 Aligned_cols=187 Identities=21% Similarity=0.298 Sum_probs=152.2
Q ss_pred eCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCC
Q psy1096 24 SPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINP 102 (239)
Q Consensus 24 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~ 102 (239)
.||||++ +|..+++ .++.+....+..++.|++.|+.| |+.|+.|||+|++|+++ ..+|.+|++|||.+..+.-
T Consensus 399 ~mE~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~--~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV--TENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhhcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE--ecCCceEEeecCcceeecc
Confidence 4999999 9998885 35788999999999999999999 99999999999999999 7777999999999876643
Q ss_pred CC-----CCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHHHhccCCCchH
Q psy1096 103 DH-----PPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETF-----ANITRAEFDFDDE 171 (239)
Q Consensus 103 ~~-----~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~-----~~i~~~~~~~~~~ 171 (239)
.. ......|+-+|+|||.+.+..| ....||||.|+++..|.+|+.||......+.. ..........+..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 22 2233568899999999999998 56789999999999999999999644333221 1112222233445
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCcc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGV 216 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~ 216 (239)
.+..++.+.+.++..||+++|.+|.|+++|++++||++.+++...
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD 597 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence 556789999999999999999999999999999999998776543
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=184.23 Aligned_cols=188 Identities=16% Similarity=0.173 Sum_probs=148.6
Q ss_pred cCCCceeEEEe----------eCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEE
Q psy1096 13 NNRTSVVITWS----------SPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMC 81 (239)
Q Consensus 13 ~~~~~~~~~~~----------~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili 81 (239)
..||+++-++- ++||++.|.|.++++++.... ...+....++.||++||+| .+.++||||+.+.|+|+
T Consensus 592 LkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv 670 (807)
T KOG1094|consen 592 LKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV 670 (807)
T ss_pred cCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceee
Confidence 45666665553 489999999999998653322 3444556799999999999 99999999999999999
Q ss_pred ecCCCCcEEEEecccceecCCCCCCc---cccCCCCccCccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCchH
Q psy1096 82 VSRTSHHIKIIDFGLAQKINPDHPPR---VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL--SGLSPFMGENDSE 156 (239)
Q Consensus 82 ~~~~~~~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~--~g~~p~~~~~~~~ 156 (239)
++++++|++|||.++..-....+. ..+-...|||+|.+.-.+++.++|+|++|+.+|+++ +..-||...++.+
T Consensus 671 --~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 671 --DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred --cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 889999999999988665444333 234557899999999999999999999999999986 4899998888877
Q ss_pred HHHHHHhccCCCch----HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 157 TFANITRAEFDFDD----EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 157 ~~~~i~~~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..++.......... ....-++..+.+++..||..+.++||+++++-.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 77665443222111 111246788999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=204.83 Aligned_cols=172 Identities=17% Similarity=0.175 Sum_probs=124.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h---hhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H---SLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h---~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
.|+||||+++++|.+++. .+.+..+..++.+++.||+| | +.+++||||||+||++ +..+..++. ++.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-ecc
Confidence 468999999999999884 26778889999999999999 9 6699999999999999 555555554 444
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHh--cc-------
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND--SETFANITR--AE------- 165 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~--~~~~~~i~~--~~------- 165 (239)
...... .....+++.|+|||.+.+..++.++||||+||++|+|++|+.||..... ......... ..
T Consensus 829 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 829 PGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred cccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence 322211 1223578899999999988999999999999999999999999853211 111111100 00
Q ss_pred ---CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 166 ---FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 166 ---~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.............++.+++.+||+.||++|||++++++.
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000001123457789999999999999999999876
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=189.60 Aligned_cols=186 Identities=22% Similarity=0.319 Sum_probs=160.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||+||+|.+.. ---|.+++.++....+..+.||+| |+.|-+|||||-.||++ ...|.+|++|||.+-
T Consensus 86 klwicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill--td~gDvklaDfgvsa 160 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL--TDEGDVKLADFGVSA 160 (829)
T ss_pred CcEEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee--cccCceeecccCchh
Confidence 678999999999999987 457889999999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCC-CCCccccCCCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-H
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA-F 173 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-~ 173 (239)
.+... .....+.||+.|||||.- +...|...+|+|++|+...++..-++|.+..-....+....+..+.++... -
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 76643 456678899999999998 456688999999999999999998999877777777777777777655322 1
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...+..+.+|++.+|..+|.+|||++.+|+|||+.+.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2467889999999999999999999999999999874
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=169.93 Aligned_cols=176 Identities=14% Similarity=0.135 Sum_probs=144.3
Q ss_pred eeCccCCCCccchhhh-----hhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 23 SSPPYDGGCMITGYVV-----EMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
+...+.+-|+|..++. +......+...+...++.|+..|+++ |++|+||.||-..|.+| ++.-+|||+|-.+
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI--dd~LqVkltDsaL 442 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI--DDQLQVKLTDSAL 442 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee--hhheeEEeccchh
Confidence 3445788899999887 43444556666677899999999999 99999999999999999 7778999999988
Q ss_pred ceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 97 AQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 97 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
++..-+... ....-....||+||.+....|+.++|+|||||++|++++ |+.|+...++.+....+..+-....+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP-- 520 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP-- 520 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC--
Confidence 866533321 112224568999999999999999999999999999998 99999988888888777766543332
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++++++..++.-||+.+|++||+++|+..
T Consensus 521 -~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 -FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 478999999999999999999999999864
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=164.52 Aligned_cols=163 Identities=23% Similarity=0.291 Sum_probs=127.5
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCC--ccccCCCCccCcccc
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPP--RVLFGTPEFIPPEII 121 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~aPE~~ 121 (239)
.++.+-++-++.||++||.| |+.+|.||||||-|+++ +++-.+|+||||+++..+..... +..+-|..|.|||.+
T Consensus 152 ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV--NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 152 ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV--NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELL 229 (449)
T ss_pred CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe--ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHh
Confidence 44445567789999999999 99999999999999999 66778999999999876644322 224567889999999
Q ss_pred ccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH---------------------------
Q psy1096 122 NYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF--------------------------- 173 (239)
Q Consensus 122 ~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~--------------------------- 173 (239)
.+.. |+.+.||||+||++.+++.++..|...+..+.++.|..-...+..+.-
T Consensus 230 MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtl 309 (449)
T KOG0664|consen 230 MGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKI 309 (449)
T ss_pred hcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeee
Confidence 7754 799999999999999999999999888777776666443222211110
Q ss_pred ---hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 174 ---EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 174 ---~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..-......++.++|..||++|.+.++.+.|+++.+
T Consensus 310 sS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 310 ASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred cCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 011234567888999999999999999999999865
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=182.68 Aligned_cols=176 Identities=19% Similarity=0.204 Sum_probs=150.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+.+|++|+++|.|.+++++. ...+-.+....|..||+.||.| |++.+|||||-..|||| ..-..+|+.|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV--ksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV--KSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee--cCCCeEEEEecchhhc
Confidence 45678999999999999874 3455567788999999999999 99999999999999999 6677999999999988
Q ss_pred cCCCCCCcc-cc--CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHPPRV-LF--GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~~~~-~~--~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
......... .. -.+.|+|-|.+....|+.++||||+||.+||++| |.-|+.+....++.+.+.++.....+ +.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP---pi 924 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP---PI 924 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---CC
Confidence 765543222 22 3357999999999999999999999999999999 99999999999998888887663333 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+-++..++.+||..|+..||+++++..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 7888999999999999999999998753
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=168.45 Aligned_cols=191 Identities=18% Similarity=0.285 Sum_probs=142.3
Q ss_pred CCcccc-cCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh--------cccCCCCCC
Q psy1096 7 GAIGVS-NNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL--------VTVDPKILP 76 (239)
Q Consensus 7 ~~~~~~-~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~--------~ivH~dikp 76 (239)
|.|+++ ....+...+|+|++|-+.|+|+|||. ...++-+...+++..+++||++ |.. .|.|||||.
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 556666 45578999999999999999999985 3577888899999999999999 953 599999999
Q ss_pred CCeEEecCCCCcEEEEecccceecCCCC-----CCccccCCCCccCccccccCC----C--CchhhHHHHHHHHHHHHhC
Q psy1096 77 ENIMCVSRTSHHIKIIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINYEP----I--GIESDMWSIGVITYVLLSG 145 (239)
Q Consensus 77 ~nili~~~~~~~vkl~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~----~--~~~~DiwslG~~l~~~~~g 145 (239)
.||+| ..+|.+-++|+|++....... .....+||-.|||||.+...- + -..+||||+|.++||++.+
T Consensus 345 KNILV--Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 345 KNILV--KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccEEE--ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999 788899999999997765432 233468999999999995432 2 2469999999999998653
Q ss_pred ----------CCCCCCC----CchHHHHHHHh-ccCCCch-HHHhhcC--HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 146 ----------LSPFMGE----NDSETFANITR-AEFDFDD-EAFEALS--EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 146 ----------~~p~~~~----~~~~~~~~i~~-~~~~~~~-~~~~~~~--~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
++||.+. ...+.+.++.. ...++.. ..|.+.+ ..+..+++.||..+|.-|.|+-.+-+
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 6788543 23334444333 2222222 1121111 23567899999999999999877653
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=169.38 Aligned_cols=102 Identities=26% Similarity=0.413 Sum_probs=73.8
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHhccCCCchHH-----------
Q psy1096 110 FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN------DSETFANITRAEFDFDDEA----------- 172 (239)
Q Consensus 110 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~------~~~~~~~i~~~~~~~~~~~----------- 172 (239)
+.|..|.|||++.+.+|+..+||||++|++++++||...|...+ +.+.+..|..-...+|...
T Consensus 412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF 491 (590)
T KOG1290|consen 412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF 491 (590)
T ss_pred hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence 35678999999999999999999999999999999999985321 1222222221111111100
Q ss_pred ---------------------H------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 ---------------------F------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ---------------------~------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
. ..-...+.+|+.-||+.+|++||||.++|+|||+....
T Consensus 492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 0 01134578999999999999999999999999998543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-24 Score=160.27 Aligned_cols=180 Identities=21% Similarity=0.290 Sum_probs=134.9
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
.++||++.|+|..-+. + ..+-+...+.++.|+++|+.| |+.++||||||.+||||...+-..|||||||.+...+
T Consensus 99 F~qE~aP~gdL~snv~---~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE---A-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EeeccCccchhhhhcC---c-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 4689999999987653 2 345677789999999999999 9999999999999999987666799999999986654
Q ss_pred CCCCCccccCCCCccCccccccC---C--CCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHhccCCCchHH
Q psy1096 102 PDHPPRVLFGTPEFIPPEIINYE---P--IGIESDMWSIGVITYVLLSGLSPFMGENDSE----TFANITRAEFDFDDEA 172 (239)
Q Consensus 102 ~~~~~~~~~~~~~~~aPE~~~~~---~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~----~~~~i~~~~~~~~~~~ 172 (239)
..... .-.+..|.+||.+... . ..+..|+|.+|++++.+++|.+||....... .+.+.........+..
T Consensus 175 ~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 32221 2244568888887422 2 3678999999999999999999997433221 1222222322333444
Q ss_pred HhhcCHHHHHHHHHhhhhCcccC---CCHHHHhhccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKR---LTAKQCLSHLWIA 208 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~R---pt~~~ll~h~~~~ 208 (239)
...+++.+..+.++-|..++++| .++.......|..
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 56789999999999999999999 5666677777763
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=168.78 Aligned_cols=183 Identities=25% Similarity=0.341 Sum_probs=133.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+-+|+||.+.....+++.+ ++...++.+++.++.||++ |+.|||||||||.|++.+.. .+.-.|+|||++.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~-t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR-TQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc-cCCceEEechhHH
Confidence 44567889999999988763 3467889999999999999 99999999999999997443 3577899999976
Q ss_pred ecC-----------------C-----------------CC-----------CCccccCCCCccCccccccCC-CCchhhH
Q psy1096 99 KIN-----------------P-----------------DH-----------PPRVLFGTPEFIPPEIINYEP-IGIESDM 132 (239)
Q Consensus 99 ~~~-----------------~-----------------~~-----------~~~~~~~~~~~~aPE~~~~~~-~~~~~Di 132 (239)
..+ + .. ......||++|.|||.+...+ .+.+.|+
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 110 0 00 000245999999999996554 5899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCch-HHHHHH--------------Hhcc--------C-----------C-----------
Q psy1096 133 WSIGVITYVLLSGLSPFMGENDS-ETFANI--------------TRAE--------F-----------D----------- 167 (239)
Q Consensus 133 wslG~~l~~~~~g~~p~~~~~~~-~~~~~i--------------~~~~--------~-----------~----------- 167 (239)
||.||++..++++..||....+. ..+..+ ..+. . .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999998643211 111111 0000 0 0
Q ss_pred ---CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 168 ---FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 168 ---~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......+.++..+.+|+.+||+.||.+|.|++++|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000001123557889999999999999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=153.42 Aligned_cols=148 Identities=30% Similarity=0.466 Sum_probs=126.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
...++++||++|++|.+++... ...++.+.+..++.+++.++.+ |+.|++|+||+|.||++ +. .+.++++||+.
T Consensus 64 ~~~~~~~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~--~~~~~~~~l~d~~~ 139 (215)
T cd00180 64 NHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL--DSDNGKVKLADFGL 139 (215)
T ss_pred CeEEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE--eCCCCcEEEecCCc
Confidence 3677899999999999887532 2467888999999999999999 99999999999999999 55 67899999999
Q ss_pred ceecCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 97 AQKINPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 97 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
+....... ......+...|++||.+... ..+.+.|+|++|++++++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 140 SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred eEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 87665432 12234577889999999877 778999999999999999
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
..+.+++.+|+..+|++||+++++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6688999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=161.24 Aligned_cols=177 Identities=21% Similarity=0.297 Sum_probs=131.3
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh---------cccCCCCCCCCeEEecCCCC
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL---------VTVDPKILPENIMCVSRTSH 87 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~---------~ivH~dikp~nili~~~~~~ 87 (239)
..-.|+|++|-+.|+|.++|. ...+++....+++..+++||+| |+- .|+|||||..|||| +.++
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~Dl 353 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDL 353 (534)
T ss_pred ccceeEEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCC
Confidence 346789999999999999974 5678888999999999999999 963 59999999999999 6777
Q ss_pred cEEEEecccceecCCCCCCc---cccCCCCccCccccccCC-CC-----chhhHHHHHHHHHHHHhCC------------
Q psy1096 88 HIKIIDFGLAQKINPDHPPR---VLFGTPEFIPPEIINYEP-IG-----IESDMWSIGVITYVLLSGL------------ 146 (239)
Q Consensus 88 ~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~-~~-----~~~DiwslG~~l~~~~~g~------------ 146 (239)
.+-|+|||++..+.+..... ..+||..|||||.+.+.- +. ...||||+|.++|+|+++-
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 89999999998887554332 367999999999996542 22 3689999999999998752
Q ss_pred CCCC-----CCCchHHHHHHHhccCCCc-hHHHhhc--CHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 147 SPFM-----GENDSETFANITRAEFDFD-DEAFEAL--SEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 147 ~p~~-----~~~~~~~~~~i~~~~~~~~-~~~~~~~--~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
+||. ..+..++...+...+.++. +..|... -.-+++.+..||+.|++-|.|+.=
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 2332 1122233333333333222 2222222 245778899999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=145.18 Aligned_cols=141 Identities=28% Similarity=0.367 Sum_probs=115.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCC-chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQ-PWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~-~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+++||+++++|.+++.. ... +.+..+..++.+++.++.+ |+.+++|+||+|+||++ +.++.++++|||.+
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v--~~~~~~~l~d~g~~ 145 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRK---KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL--GMDGLVKLADFGLA 145 (225)
T ss_pred ceEEEEeccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeeCcee
Confidence 46788999999999988753 223 7888899999999999999 99999999999999999 66689999999998
Q ss_pred eecCCCC--CCccccCCCCccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCch-HHHHHHHhcc
Q psy1096 98 QKINPDH--PPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLSGLSPFMG-ENDS-ETFANITRAE 165 (239)
Q Consensus 98 ~~~~~~~--~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~-~~~~~i~~~~ 165 (239)
....... ......++..|++||.+ ....++.++|+|++|+++++|++|..||.. .+.. ...+.+..+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 146 RFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred eEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 7765442 22344577889999999 666778899999999999999999999977 4443 5555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=160.45 Aligned_cols=126 Identities=22% Similarity=0.443 Sum_probs=108.6
Q ss_pred EEEeeCccC-CCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYD-GGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~-~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++||-- +|-.|.+++ .-...+.+-+++.||.|+..|+++ |+.||||||||-+|+.+ +++|.+||+|||.+
T Consensus 643 ~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv--d~~g~~klidfgsa 717 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV--DSNGFVKLIDFGSA 717 (772)
T ss_pred eeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccCceecccccccEEE--ecCCeEEEeeccch
Confidence 345666544 344566666 557899999999999999999999 99999999999999999 99999999999987
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMG 151 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~ 151 (239)
.... +.+...+.||..|.|||.+.+.+| +...|||++|+++|.++....||.+
T Consensus 718 a~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 5554 455677889999999999999998 7889999999999999999999864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=154.76 Aligned_cols=180 Identities=19% Similarity=0.266 Sum_probs=141.0
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHHhhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-+..|+.|++|.-.+|.+.+.........+......++.|+..|+.| +|.+|+|+||.||+. ..+..+++.|||+.
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y--k~~ihrdlkp~nif~--~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY--KGLIHRDLKPSNIFF--SDDDQLKIGDFGLV 403 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh--ccchhhhcccccccc--ccchhhhhhhhhhe
Confidence 45689999999999999999877778888888999999999999999 999999999999998 55568999999998
Q ss_pred eecCCCC-------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCc
Q psy1096 98 QKINPDH-------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFD 169 (239)
Q Consensus 98 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 169 (239)
....... ......||..||+||.+.+..|+.++|||+||+++++++. =...+. .......+..+ .+|
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g--~ip 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDG--IIP 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcC--CCC
Confidence 7665433 3445689999999999999999999999999999999986 222221 11122222222 233
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
+..+... +.-..|+.+++...|.+||++.+.--|.|+
T Consensus 479 ~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3333333 344689999999999999987777777665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-18 Score=138.95 Aligned_cols=187 Identities=28% Similarity=0.403 Sum_probs=145.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~~ 98 (239)
.|++++++.++.+.+++........+.......++.|++.++.+ |+.+++|||+||+||++ +..+ .++++|||.+.
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~--~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAK 150 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee--cCCCCeEEEeccCcce
Confidence 68899999999999665321111378889999999999999999 99999999999999999 6666 69999999987
Q ss_pred ecCCCC-------CCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhc
Q psy1096 99 KINPDH-------PPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGEND----SETFANITRA 164 (239)
Q Consensus 99 ~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~----~~~~~~i~~~ 164 (239)
...... ......++..|++||.+.+ ...+...|+|++|++++++++|..||..... ......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 554332 2355679999999999987 5679999999999999999999999876653 3444444444
Q ss_pred cCC-CchHHHhhc----CHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 165 EFD-FDDEAFEAL----SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 165 ~~~-~~~~~~~~~----~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
... ......... ...+.+++..++..+|..|.+..+...+++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 432 111111111 257889999999999999999999888876654
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=136.23 Aligned_cols=184 Identities=17% Similarity=0.180 Sum_probs=145.8
Q ss_pred CCcccccCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEec
Q psy1096 7 GAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVS 83 (239)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~ 83 (239)
+++++|+..++.+++-- |++.|+|++++.+ ..+-.....++.+++.++++|++| |+-. |.---+....++|+.
T Consensus 251 pvlgacnsppnlv~isq---~mp~gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide 326 (448)
T KOG0195|consen 251 PVLGACNSPPNLVIISQ---YMPFGSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE 326 (448)
T ss_pred hhhhhccCCCCceEeee---eccchHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc
Confidence 46788888888887765 9999999999987 566667777899999999999999 9864 444467888999966
Q ss_pred CCCCcEEEEecccceecCCCCCCccccCCCCccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy1096 84 RTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI---GIESDMWSIGVITYVLLSGLSPFMGENDSETFAN 160 (239)
Q Consensus 84 ~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~ 160 (239)
+-...+..+|-.++... ......|.|++||.+...+- -.++|+|||++++|++.|+..||...+..+.-.+
T Consensus 327 dltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk 400 (448)
T KOG0195|consen 327 DLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK 400 (448)
T ss_pred hhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence 66666666776654332 12336788999999976654 3689999999999999999999999988888877
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
+.-+..+... .+.++.....|++-|++.||.+||.++.++
T Consensus 401 ialeglrv~i--ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 401 IALEGLRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhccccccC--CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 7655443221 137899999999999999999999988765
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-18 Score=140.42 Aligned_cols=196 Identities=14% Similarity=0.103 Sum_probs=140.5
Q ss_pred CCcccccCC-CceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC
Q psy1096 7 GAIGVSNNR-TSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 7 ~~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~ 84 (239)
++..+.... .....-|+||+.++ .+|.++... .+.+.++..++..++.|++.+|.+ |+.|++||||||+|+++...
T Consensus 81 ~~~~~~~~G~~~~~~~~iVM~l~G-~sL~dl~~~-~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 81 HFPKLLDHGRSTEDFNFIVMSLLG-PSLEDLRKR-NPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS 158 (322)
T ss_pred CCCEEEEeccCCCceeEEEEeccC-ccHHHHHHh-CCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence 444444333 34455677787776 455555433 447899999999999999999999 99999999999999999433
Q ss_pred C-C--CcEEEEecccce--ecC-CCC-----C---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy1096 85 T-S--HHIKIIDFGLAQ--KIN-PDH-----P---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM 150 (239)
Q Consensus 85 ~-~--~~vkl~dfg~~~--~~~-~~~-----~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~ 150 (239)
. . ..+.+.|||+++ .+. ... . .....||..|+++....+...+.+.|+||++.++.++..|.+||.
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 2 1 469999999998 321 111 1 112449999999999999999999999999999999999999998
Q ss_pred CCCchHHHHHHHhccCCCchH-HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 151 GENDSETFANITRAEFDFDDE-AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+.........+.......... .....+..+.++...+-..+...+|..+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 239 ALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 766543333332222111111 112345677788887777899999998887654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-19 Score=150.71 Aligned_cols=176 Identities=26% Similarity=0.352 Sum_probs=147.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+++++..|+.+..-+ .......+...+.+...++.++.. |+.+++|+|+|++||++ +..|++++.|||.++
T Consensus 71 kl~l~ld~~rgg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill--d~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 71 KLYLILDFLRGGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL--LLEGHIKLTDFGLSK 145 (612)
T ss_pred chhHhhhhcccchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee--cccCccccCCchhhh
Confidence 445677888887777554 455666777788899999999999 99999999999999999 888999999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..-..... .||.-|||||.+. .....+|-||+|++.++|++|..||.+ +....|.+.....+. .++.
T Consensus 146 e~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~ 212 (612)
T KOG0603|consen 146 EAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSA 212 (612)
T ss_pred HhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhH
Confidence 76543322 6899999999998 677899999999999999999999987 677777776666664 5688
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~~ 213 (239)
.+++++.+++..+|..|.- +.++.+|+||...++.
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 8999999999999999985 4789999999875554
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.3e-19 Score=154.47 Aligned_cols=158 Identities=18% Similarity=0.204 Sum_probs=113.8
Q ss_pred hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC---CCCCCcc-----ccC
Q psy1096 41 KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN---PDHPPRV-----LFG 111 (239)
Q Consensus 41 ~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~---~~~~~~~-----~~~ 111 (239)
...+.+...+.+=|+.|++.||.- |+.||+|||||.+|||| .+-+.+.|+||...+..- +++-... ...
T Consensus 112 STRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi--TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrR 189 (1431)
T KOG1240|consen 112 STRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI--TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRR 189 (1431)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE--eeechhhhhcccccCCccCCCCCcccceEEEecCCc
Confidence 334455555667789999999999 99999999999999999 667789999998654431 1111111 123
Q ss_pred CCCccCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh-cCH
Q psy1096 112 TPEFIPPEIINYE----------P-IGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA-LSE 178 (239)
Q Consensus 112 ~~~~~aPE~~~~~----------~-~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~ 178 (239)
...|+|||.+... + .+++-||||+||++.|+++ |+++|. ...+-....+....+....+. -+.
T Consensus 190 RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~Le~Ied~ 265 (1431)
T KOG1240|consen 190 RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQLLEKIEDV 265 (1431)
T ss_pred eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHHHHhCcCc
Confidence 3479999998542 1 4678899999999999988 899985 222223333322222222222 256
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+++++..|++.||++|.++++.|+.
T Consensus 266 ~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 266 SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cHHHHHHHHHccCchhccCHHHHHHh
Confidence 79999999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-19 Score=138.87 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=91.2
Q ss_pred HHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccccCCCCccCccccccC------
Q psy1096 52 ERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE------ 124 (239)
Q Consensus 52 ~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------ 124 (239)
..+..|++..+++ |+.|++|+||+|+|+++ +.+|.+.|+||+.....+..... ...+..|.+||.....
T Consensus 148 l~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll--~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~ 223 (288)
T PF14531_consen 148 LSLTVQMIRLVANLHSYGLVHGDIKPENFLL--DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQN 223 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHS
T ss_pred HHHHHHHHHHHHHHhhcceEecccceeeEEE--cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcc
Confidence 5677999999999 99999999999999999 77889999999876555432221 3345678999987442
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccC
Q psy1096 125 --PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195 (239)
Q Consensus 125 --~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 195 (239)
.++.+.|.|++|+++|.|+++..||........... .+. ....++..++.||..+|+.+|.+|
T Consensus 224 ~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~----~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 224 NAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFS----RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp EEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGT----TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cch----hcCCcCHHHHHHHHHHccCCcccC
Confidence 468899999999999999999999976543322221 111 112568899999999999999988
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-17 Score=130.89 Aligned_cols=172 Identities=15% Similarity=0.190 Sum_probs=123.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC--CcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS--HHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~--~~vkl~dfg~ 96 (239)
.+|+||.-+. .+| +++..-...+.+...-++.|+++|+.+ |++|+.|||+|.+||++--+.+ -.+.++|||.
T Consensus 317 tlylvMkrY~-~tL----r~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 317 TLYLVMKRYR-QTL----REYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred eEEEehhcch-hhH----HHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 5667775544 233 344456677788889999999999999 9999999999999999854443 4578899997
Q ss_pred ceecCCCCC-------CccccCCCCccCccccccCCC------CchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHH
Q psy1096 97 AQKINPDHP-------PRVLFGTPEFIPPEIINYEPI------GIESDMWSIGVITYVLLSGLSPFMGENDSETF-ANIT 162 (239)
Q Consensus 97 ~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~------~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~-~~i~ 162 (239)
+-....... .-...|.-..||||.....+- -.++|.|+.|.+.||++....||.+....... ....
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 644433211 122457788999999966542 36899999999999999999999874322111 1111
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK 199 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~ 199 (239)
..+.+ ......++.+++++...|+.||++|++..
T Consensus 472 e~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 472 ESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhCC---CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 11221 12246789999999999999999999854
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.3e-17 Score=126.30 Aligned_cols=175 Identities=15% Similarity=0.170 Sum_probs=138.0
Q ss_pred eCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec---CCCCcEEEEeccccee
Q psy1096 24 SPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS---RTSHHIKIIDFGLAQK 99 (239)
Q Consensus 24 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~---~~~~~vkl~dfg~~~~ 99 (239)
|+|+. |-+|+++.. --+..++..++..++.|++.-+++ |++++|+|||||+|+||.. .....|.++|||+++.
T Consensus 102 VidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 44444 345555543 347788889999999999999999 9999999999999999942 2235689999999988
Q ss_pred cCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CchHHHHHHHhccC-C
Q psy1096 100 INPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE---NDSETFANITRAEF-D 167 (239)
Q Consensus 100 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~---~~~~~~~~i~~~~~-~ 167 (239)
+.+..+ .....||..||+-....++..+.+.|+-|+|-++.+.+.|.+||.|. +..+.+++|-.... .
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 754322 33467999999999999999999999999999999999999999875 45566666644433 3
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHH
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQC 201 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~l 201 (239)
........++.++...+.-.-..+.++-|..+-+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 3345567789999999998888899999987643
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.6e-18 Score=147.73 Aligned_cols=152 Identities=32% Similarity=0.524 Sum_probs=132.9
Q ss_pred HHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCC----------------CCccccCCCCccCcccc
Q psy1096 59 ERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH----------------PPRVLFGTPEFIPPEII 121 (239)
Q Consensus 59 ~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~----------------~~~~~~~~~~~~aPE~~ 121 (239)
+.+++| |+.||+|+|+||+|.+| ..-|++|+.|||+++...... ......||+-|.|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllI--T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCccee--eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 778999 99999999999999999 777899999999987542111 01224699999999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCC---CH
Q psy1096 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL---TA 198 (239)
Q Consensus 122 ~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---t~ 198 (239)
....|+-..|=|++|+++|+.+-|..||.+++..+.+..+......++.. ...+++++++++.++|+.+|..|. .+
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 99999999999999999999999999999999999999998888888876 456899999999999999999997 36
Q ss_pred HHHhhccccccCCCC
Q psy1096 199 KQCLSHLWIAQKDSS 213 (239)
Q Consensus 199 ~~ll~h~~~~~~~~~ 213 (239)
-++.+|.||+.-++.
T Consensus 310 ~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 310 LEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhccceeecccc
Confidence 678899999988887
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=135.70 Aligned_cols=191 Identities=18% Similarity=0.265 Sum_probs=140.7
Q ss_pred CCcccccCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcc-cCCCCCCCCeEEecC
Q psy1096 7 GAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVT-VDPKILPENIMCVSR 84 (239)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~i-vH~dikp~nili~~~ 84 (239)
..+|++...+..+.+|- ||..|+|.+.+. ...-.+.+--...++++++.||+| |..-| .||.++..|.++ +
T Consensus 11 ~f~g~~~~~~~~~~i~~---~c~rGsl~D~i~--~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--d 83 (484)
T KOG1023|consen 11 KFIGASVDGPEMIVIWE---YCSRGSLLDILS--NEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--D 83 (484)
T ss_pred hheeeEecCCceEEEEe---eecCccHHhHHh--ccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee--e
Confidence 34667766666666666 999999999985 335556666677899999999999 87754 999999999999 8
Q ss_pred CCCcEEEEecccceecCCC---CCCccccCCCCccCccccccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy1096 85 TSHHIKIIDFGLAQKINPD---HPPRVLFGTPEFIPPEIINYEP-------IGIESDMWSIGVITYVLLSGLSPFMGEND 154 (239)
Q Consensus 85 ~~~~vkl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~~l~~~~~g~~p~~~~~~ 154 (239)
....+|+.|||+....... ..........-|.|||.+.+.. .+.++|+||+|++++++++...||.....
T Consensus 84 ~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 84 SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccc
Confidence 8889999999997665421 1111122445799999997642 36679999999999999999999975322
Q ss_pred ----hHHHHHHHh-ccCCCch--HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 155 ----SETFANITR-AEFDFDD--EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 155 ----~~~~~~i~~-~~~~~~~--~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+....+.+ +...+.+ .......+.+..+++.||..+|++||+++++-..
T Consensus 164 ~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 164 VEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred cCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 244555555 2211222 1122455678999999999999999999987643
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-16 Score=117.58 Aligned_cols=175 Identities=15% Similarity=0.145 Sum_probs=136.0
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEe-cCCCCcEEEEecccceec
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCV-SRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~-~~~~~~vkl~dfg~~~~~ 100 (239)
+||++. |.+|++++. .-...++-.++.-++.|++.-++| |.++++||||||+|++.- ......+.++|||+++.+
T Consensus 88 lVMdLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 445555 456666653 345677778899999999999999 999999999999999973 233457899999999887
Q ss_pred CCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccCCCc
Q psy1096 101 NPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANITRAEFDFD 169 (239)
Q Consensus 101 ~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~~~~~~~~ 169 (239)
-+... .....||..|.+-....+...+.+.|+-|+|.++.+.-.|.+||.+.... +.+++|.......+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54322 23457999999988888888899999999999999999999999986554 44555555444444
Q ss_pred -hHHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 170 -DEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 170 -~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
......+|.++.-.+.-|-....++-|...-
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 4556778999999999999999999898543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-16 Score=137.85 Aligned_cols=187 Identities=21% Similarity=0.341 Sum_probs=147.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h-hhcccCCCCCCCCeEEecCCCC-cEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H-SLVTVDPKILPENIMCVSRTSH-HIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h-~~~ivH~dikp~nili~~~~~~-~vkl~dfg~ 96 (239)
.-|++.+|..|+.+.+.+.+ ......+...+..++.|+..++.| | ..+++|+||||+|.++ +.++ ..++.|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l--~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL--DESGSALKIADFGL 171 (601)
T ss_pred ccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh--ccCCCcccCCCchh
Confidence 45677899999999987741 222256667788999999999999 9 9999999999999999 6666 899999999
Q ss_pred ceecCC-CC---CCccccC-CCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhccCCCc
Q psy1096 97 AQKINP-DH---PPRVLFG-TPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETF-ANITRAEFDFD 169 (239)
Q Consensus 97 ~~~~~~-~~---~~~~~~~-~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~-~~i~~~~~~~~ 169 (239)
+..+.. .. ......| ++.|.+||...+..+ ....|+||+|+++..+.+|..||......... ...........
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 987765 22 2223467 999999999988654 78899999999999999999999755443322 11122222223
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...+..++....+++.+++..+|+.|.+.+++..++|+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 4455678999999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=109.00 Aligned_cols=121 Identities=17% Similarity=0.144 Sum_probs=88.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCC-CCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKI-LPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~di-kp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.|++|+|+.|.+|..... .+ ...++.|++.+|.+ |++||+|||| ||+||++ +.++.++|+|||++.
T Consensus 73 ~~lvmeyI~G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv--~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPP----RG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV--QEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhhhh----hh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE--cCCCCEEEEECCCce
Confidence 389999999999864431 11 13578899999999 9999999999 7999999 566789999999998
Q ss_pred ecCCCCCC----c----------cccCCCCccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy1096 99 KINPDHPP----R----------VLFGTPEFIPPEIINYE-PIG-IESDMWSIGVITYVLLSGLSPFMGEN 153 (239)
Q Consensus 99 ~~~~~~~~----~----------~~~~~~~~~aPE~~~~~-~~~-~~~DiwslG~~l~~~~~g~~p~~~~~ 153 (239)
........ . -...++.++.|+...-. ..+ ...+-++.|.-+|.++|+..+..+++
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 65543321 0 01256667777665433 233 45666778999999999998876554
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.6e-14 Score=127.74 Aligned_cols=123 Identities=17% Similarity=0.163 Sum_probs=105.1
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-----CCCCcEEEEecc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-----RTSHHIKIIDFG 95 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-----~~~~~vkl~dfg 95 (239)
+++++|.+.|+|.+++ ..+..+.+.++..+..|++..+.. |..+||||||||+|+++.. ..+..++|+|||
T Consensus 770 ~lv~ey~~~Gtlld~~---N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLI---NTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeeccccccHHHhh---ccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 4678999999999998 578899999999999999999999 9999999999999999832 223568999999
Q ss_pred cceecC---CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy1096 96 LAQKIN---PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147 (239)
Q Consensus 96 ~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~ 147 (239)
-+.-+. +........+|-.|-++|...++++++.+|.|.++.+++-|+.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 886543 2323444567888999999999999999999999999999998843
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.5e-14 Score=117.30 Aligned_cols=92 Identities=17% Similarity=0.213 Sum_probs=71.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCC-CCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKI-LPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~di-kp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.|++|||++|++|... ...+ ...++.+++.+|.+ |++||+|||| ||+||++ +.++.++|+|||++.
T Consensus 93 ~~LVmE~~~G~~L~~~----~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv--~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA----RPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM--GPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHHHh----Cccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE--cCCCCEEEEECccce
Confidence 6899999999998622 1111 14688999999999 9999999999 9999999 666789999999998
Q ss_pred ecCCCCCC---------ccccCCCCccCccccccC
Q psy1096 99 KINPDHPP---------RVLFGTPEFIPPEIINYE 124 (239)
Q Consensus 99 ~~~~~~~~---------~~~~~~~~~~aPE~~~~~ 124 (239)
........ ....+++.|++||.+.-.
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 76543211 234577789999999543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-14 Score=107.54 Aligned_cols=74 Identities=9% Similarity=-0.011 Sum_probs=62.2
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h-hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H-SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h-~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
|++|||++|+.+..... ..+.++.+.+..++.|++.+|.+ | +.|++||||||+||+++ ++.++|+|||++..
T Consensus 93 ~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---~~~v~LiDFG~a~~ 166 (190)
T cd05147 93 VLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---DGKLYIIDVSQSVE 166 (190)
T ss_pred EEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE---CCcEEEEEcccccc
Confidence 79999999987765432 34578888999999999999998 5 88999999999999994 36799999999865
Q ss_pred cC
Q psy1096 100 IN 101 (239)
Q Consensus 100 ~~ 101 (239)
..
T Consensus 167 ~~ 168 (190)
T cd05147 167 HD 168 (190)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.4e-15 Score=112.81 Aligned_cols=99 Identities=13% Similarity=0.095 Sum_probs=72.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|.+|.++.. ++ .....+++.++.. |+.|++|||++|+||++ +.+| ++++|||...
T Consensus 117 ~~~lvmEyi~G~tL~~~~~-------~~----~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili--~~~g-i~liDfg~~~ 182 (232)
T PRK10359 117 TYIMLIEYIEGVELNDMPE-------IS----EDVKAKIKASIESLHQHGMVSGDPHKGNFIV--SKNG-LRIIDLSGKR 182 (232)
T ss_pred CeEEEEEEECCccHHHhhh-------cc----HHHHHHHHHHHHHHHHcCCccCCCChHHEEE--eCCC-EEEEECCCcc
Confidence 4788999999999987631 12 2356689999999 99999999999999999 5555 9999999765
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL 143 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~ 143 (239)
......... .......+..++|+||+|+.+....
T Consensus 183 ~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 183 CTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 442111100 0223344667899999998887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=5e-14 Score=106.29 Aligned_cols=74 Identities=16% Similarity=0.057 Sum_probs=62.1
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
|++|||++|+++..... ..+.++.+....++.|++.++.+ |+ .|++||||||+||+++ ++.++|+|||++..
T Consensus 93 ~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---~~~~~liDFG~a~~ 166 (190)
T cd05145 93 VLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---DGKPYIIDVSQAVE 166 (190)
T ss_pred EEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---CCCEEEEEccccee
Confidence 78999999986543322 24567788889999999999999 99 9999999999999994 57899999999876
Q ss_pred cC
Q psy1096 100 IN 101 (239)
Q Consensus 100 ~~ 101 (239)
..
T Consensus 167 ~~ 168 (190)
T cd05145 167 LD 168 (190)
T ss_pred cC
Confidence 54
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.1e-13 Score=107.06 Aligned_cols=191 Identities=15% Similarity=0.092 Sum_probs=132.4
Q ss_pred cccccCCCceeEEEeeCccCCCCccchhhhhhhcCC-CchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecC
Q psy1096 9 IGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGT-QPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSR 84 (239)
Q Consensus 9 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~ 84 (239)
++.+........+-.+.||+.-|++..+|.+.+.++ .++...-++|+.||+.||.| |+.. ++|+++..+.|++ +
T Consensus 135 yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi--q 212 (458)
T KOG1266|consen 135 YWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI--Q 212 (458)
T ss_pred hhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee--c
Confidence 344433333334445678999999999998876554 55566668999999999999 9886 9999999999999 7
Q ss_pred CCCcEEEEecccceecCCC------CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHH
Q psy1096 85 TSHHIKIIDFGLAQKINPD------HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM-GENDSET 157 (239)
Q Consensus 85 ~~~~vkl~dfg~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~-~~~~~~~ 157 (239)
.+|.+|+.--... ..... .......+.++|.+||.-.......++|||++|++..+|.-+..--. +.+....
T Consensus 213 ~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ 291 (458)
T KOG1266|consen 213 HNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEV 291 (458)
T ss_pred CCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeeh
Confidence 8888887533221 11111 01111236678999999888888899999999999999987765532 2222222
Q ss_pred HHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 158 FANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...+...-+.. -...-+.++.+|++-.|..||++..++.||.+-+
T Consensus 292 ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 292 EENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred hhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 22222221111 1233457889999999999999999999998744
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.1e-13 Score=117.56 Aligned_cols=192 Identities=23% Similarity=0.347 Sum_probs=157.3
Q ss_pred ceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 17 SVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 17 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..--.+++|+|.+|+.|...++ +-+....+.++..+..+..++.+ |...+.|+|++|.|+++ ...|..++.+|+
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~--~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI--AYDGHRPLTDFG 949 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhccccchhhcccccccchhh--cccCCcccCccc
Confidence 3345678899999999888774 34567777888889999999999 99999999999999999 777889999987
Q ss_pred cceecCC------C--------------------------CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHH
Q psy1096 96 LAQKINP------D--------------------------HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL 143 (239)
Q Consensus 96 ~~~~~~~------~--------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~ 143 (239)
.....+. . .......+|+.|.+||...+......+|.|+.|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 3221100 0 0012346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHH---HHhhccccccCCCCC
Q psy1096 144 SGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK---QCLSHLWIAQKDSSP 214 (239)
Q Consensus 144 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~---~ll~h~~~~~~~~~~ 214 (239)
+|.+||..........++......++... ...+...++++...+..++.+|..+. +.-.|+||+..++..
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 99999999999999988888877776533 34688999999999999999999877 888999998866653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.3e-12 Score=100.36 Aligned_cols=75 Identities=15% Similarity=0.113 Sum_probs=62.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc-ccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV-TVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~-ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.|+||||++|+++.... ..+..+....+..++.|++.++.+ |+.| ++|+||||+||+++ .+.++++|||.+.
T Consensus 123 ~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~---~~~i~LiDFg~a~ 196 (237)
T smart00090 123 NVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH---DGKVVIIDVSQSV 196 (237)
T ss_pred ceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE---CCCEEEEEChhhh
Confidence 47999999999887654 234455666778999999999999 9999 99999999999994 6789999999876
Q ss_pred ecC
Q psy1096 99 KIN 101 (239)
Q Consensus 99 ~~~ 101 (239)
..+
T Consensus 197 ~~~ 199 (237)
T smart00090 197 ELD 199 (237)
T ss_pred ccC
Confidence 543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=9e-12 Score=104.84 Aligned_cols=180 Identities=21% Similarity=0.154 Sum_probs=137.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHH----HHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTER----GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~----~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
..|+-+|+|+ ..+..+.. .....+++..+...+.+..+ ||.. |..+++|-|++|+||+...+. ..+++.||
T Consensus 192 ~lfiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDF 267 (524)
T ss_pred cceeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCc
Confidence 5677888998 44444544 44556778888889999999 9999 999999999999999984432 67899999
Q ss_pred ccceecCCCCCCc------cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHhccC
Q psy1096 95 GLAQKINPDHPPR------VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE--NDSETFANITRAEF 166 (239)
Q Consensus 95 g~~~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~--~~~~~~~~i~~~~~ 166 (239)
++...+....... ...+...|++||... ..++..+|++++|.++.+...+....... +....... .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-----~ 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-----G 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-----c
Confidence 9988876554222 224777899999987 44688999999999999988877666433 22222211 1
Q ss_pred CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 167 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++.+.....+..+...+.+|++.++-.|++.+.++++.++.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2455555566777888999999999999999999999999975
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-12 Score=109.68 Aligned_cols=153 Identities=20% Similarity=0.270 Sum_probs=110.0
Q ss_pred HHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCc----------cccCCCCccCccccc
Q psy1096 55 FESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR----------VLFGTPEFIPPEIIN 122 (239)
Q Consensus 55 ~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~----------~~~~~~~~~aPE~~~ 122 (239)
+.++..|+.+ |. .++||++|.|++|.+ ..+|..|++.|+++.......... ......-|.+||.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~--na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV--NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheee--ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455588899 75 489999999999999 778889999998765544321110 112445799999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch-HHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 123 YEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD-EAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 123 ~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
..-.+.++|++|+|+++|.+.. |+..+...+.... ............ -....++.++++-+++++..++.-||++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 8778999999999999999995 5555544332222 222222111111 011367899999999999999999999999
Q ss_pred HhhccccccC
Q psy1096 201 CLSHLWIAQK 210 (239)
Q Consensus 201 ll~h~~~~~~ 210 (239)
++..+||.+.
T Consensus 262 l~~~~ff~D~ 271 (700)
T KOG2137|consen 262 LLSIPFFSDP 271 (700)
T ss_pred hhcccccCCc
Confidence 9999999763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.9e-11 Score=90.59 Aligned_cols=70 Identities=16% Similarity=0.126 Sum_probs=58.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||++|+++..+.. ......++.+++.++.+ |+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 106 ~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill--~~~~~~~liDfg~~~~ 174 (198)
T cd05144 106 HAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV--DDDEKIYIIDWPQMVS 174 (198)
T ss_pred ceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE--cCCCcEEEEECCcccc
Confidence 478999999999876532 03456788899999999 99999999999999999 6677999999998855
Q ss_pred cC
Q psy1096 100 IN 101 (239)
Q Consensus 100 ~~ 101 (239)
..
T Consensus 175 ~~ 176 (198)
T cd05144 175 TD 176 (198)
T ss_pred CC
Confidence 44
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=91.04 Aligned_cols=70 Identities=11% Similarity=0.050 Sum_probs=55.4
Q ss_pred EEEeeCccCCC-CccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGG-CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++||+++| .+|.+++. .+.++++ .+.+++.++.+ |+.||+|+||||+||++ +.++.++|+|||.+
T Consensus 120 ~~~lV~e~l~G~~~L~~~l~----~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv--~~~~~v~LIDfg~~ 189 (239)
T PRK01723 120 RADILIERIEGARDLVALLQ----EAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL--DPDGKFWLIDFDRG 189 (239)
T ss_pred eeeEEEEecCCCCCHHHHHh----cCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE--cCCCCEEEEECCCc
Confidence 34588999997 67777653 2344443 36788999999 99999999999999999 55668999999987
Q ss_pred ee
Q psy1096 98 QK 99 (239)
Q Consensus 98 ~~ 99 (239)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 55
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-10 Score=88.41 Aligned_cols=68 Identities=12% Similarity=0.058 Sum_probs=52.3
Q ss_pred eeCcc--CCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHH-HH-hhhcccCCCCCCCCeEEecC--CCCcEEEEeccc
Q psy1096 23 SSPPY--DGGCMITGYVVEMKAGTQPWVELSERLFESTERGL-GH-HSLVTVDPKILPENIMCVSR--TSHHIKIIDFGL 96 (239)
Q Consensus 23 ~~~e~--~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l-~~-h~~~ivH~dikp~nili~~~--~~~~vkl~dfg~ 96 (239)
+++|| +.+++|.+++.+ +.+.+. ..++.+++.++ .| |+++|+||||||+||++... +++.++|+|++.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 68999 448999999843 234444 35678888777 89 99999999999999999642 345799999543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.2e-10 Score=89.17 Aligned_cols=69 Identities=22% Similarity=0.228 Sum_probs=58.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||++|++|.+++.. ... ....++.+++.+|.+ |+.+++|+|++|.||++. .+.++++|||.+..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~---~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINS---NGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHh---ccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCcccC
Confidence 4578999999999988742 111 778899999999999 999999999999999994 57899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-10 Score=88.05 Aligned_cols=65 Identities=23% Similarity=0.309 Sum_probs=55.3
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+++|||++|++|.+++... .. .++.+++.+|.+ |+.|++|+|++|.||++. .+.++++|||.+..
T Consensus 73 ~lv~e~~~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCCcC
Confidence 6889999999998876421 10 789999999999 999999999999999994 67899999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-10 Score=99.19 Aligned_cols=66 Identities=20% Similarity=0.254 Sum_probs=56.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||++|++|.+++. ....++.+++.+|.+ |+.|++||||||+||++ + ++.++++|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl--~-~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV--R-DDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE--E-CCcEEEEeCccccc
Confidence 468899999999998763 356789999999999 99999999999999999 3 45799999998855
Q ss_pred c
Q psy1096 100 I 100 (239)
Q Consensus 100 ~ 100 (239)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-10 Score=84.41 Aligned_cols=74 Identities=19% Similarity=0.124 Sum_probs=56.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+++|||++++.+........ .. ...+..++.+++.++.+ |. .+++|+||+|+||+++ ++.++++|||.+.
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---~~~~~liDfg~a~ 162 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---DGKVYIIDVPQAV 162 (187)
T ss_pred CEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---CCcEEEEECcccc
Confidence 478999999965442211101 01 15678899999999999 99 9999999999999994 6789999999886
Q ss_pred ecC
Q psy1096 99 KIN 101 (239)
Q Consensus 99 ~~~ 101 (239)
...
T Consensus 163 ~~~ 165 (187)
T cd05119 163 EID 165 (187)
T ss_pred ccc
Confidence 544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.6e-09 Score=84.30 Aligned_cols=154 Identities=17% Similarity=0.214 Sum_probs=113.1
Q ss_pred CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccccCCCCccCccccc-
Q psy1096 45 QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN- 122 (239)
Q Consensus 45 ~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~- 122 (239)
...+.-.....+.++++.+- |.+|.+-||++++|+|| .+.+.|.|.|-.......++......+|...|.+||...
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV--sd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~ 190 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV--SDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTL 190 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee--ecCceEEEEcccceeeccCCceEecccCccccCCHHHhcc
Confidence 44455677889999999999 99999999999999999 677789999877655555566667788999999999975
Q ss_pred ----cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch----HHHH-HHHhccC----------CCc--hHHHhhcCHHH
Q psy1096 123 ----YEPIGIESDMWSIGVITYVLLS-GLSPFMGENDS----ETFA-NITRAEF----------DFD--DEAFEALSEDA 180 (239)
Q Consensus 123 ----~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~----~~~~-~i~~~~~----------~~~--~~~~~~~~~~~ 180 (239)
+-..+...|.|.||+++++++. |..||.|.... ..++ .|..+.+ .++ ...+.-+++.+
T Consensus 191 ~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~v 270 (637)
T COG4248 191 PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDV 270 (637)
T ss_pred ccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHH
Confidence 2334678999999999999987 59999764211 1111 2322221 111 12234578999
Q ss_pred HHHHHHhhhhC--cccCCCHHH
Q psy1096 181 KDFISSLLVKR--KEKRLTAKQ 200 (239)
Q Consensus 181 ~~ll~~~l~~~--p~~Rpt~~~ 200 (239)
+.+..+|+..- +.-|||++.
T Consensus 271 qAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 271 QALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHhcccCCCCCCCCHHH
Confidence 99999999853 458999865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.9e-09 Score=81.73 Aligned_cols=80 Identities=11% Similarity=0.075 Sum_probs=63.7
Q ss_pred eeEEEeeCccCCCC-ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-----CCCCcEE
Q psy1096 18 VVITWSSPPYDGGC-MITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-----RTSHHIK 90 (239)
Q Consensus 18 ~~~~~~~~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-----~~~~~vk 90 (239)
.-.-|+|||++++. +|.+++.+.. ...........++.++...++- |+.|++|+|+++.||++.. ++.+.+.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 34567899999987 7888875432 3445566778999999999999 9999999999999999954 2356899
Q ss_pred EEecccce
Q psy1096 91 IIDFGLAQ 98 (239)
Q Consensus 91 l~dfg~~~ 98 (239)
++||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.8e-09 Score=79.37 Aligned_cols=75 Identities=8% Similarity=-0.020 Sum_probs=55.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-+++|||++++.+..-. .....+..+....++.+++.+|.. |+.|+||||+++.||++. .+.+.++|||.+.
T Consensus 99 ~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~---~~~v~iIDF~qav 172 (197)
T cd05146 99 HVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH---DGKVWFIDVSQSV 172 (197)
T ss_pred CEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE---CCcEEEEECCCce
Confidence 35788899886543221 112334455667888999999975 899999999999999993 3579999999876
Q ss_pred ecC
Q psy1096 99 KIN 101 (239)
Q Consensus 99 ~~~ 101 (239)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-08 Score=72.38 Aligned_cols=68 Identities=22% Similarity=0.237 Sum_probs=55.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh---cccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL---VTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~---~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..|++|||++|..+..+ .......++.+++.+++. |.. +++|+|++|+||++ +..+.+++.||+
T Consensus 67 ~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~ 134 (155)
T cd05120 67 WSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWE 134 (155)
T ss_pred ccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEecc
Confidence 46788899998877754 345667788999999999 884 79999999999999 446789999999
Q ss_pred ccee
Q psy1096 96 LAQK 99 (239)
Q Consensus 96 ~~~~ 99 (239)
.+..
T Consensus 135 ~~~~ 138 (155)
T cd05120 135 YAGY 138 (155)
T ss_pred cccC
Confidence 7643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.2e-08 Score=73.38 Aligned_cols=64 Identities=25% Similarity=0.324 Sum_probs=49.2
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
++|||++|..|.+++.+. ...++..+=.-+.- |..||+|||++++||.+ .+ +.+.++|||++..
T Consensus 76 I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl--~~-~~i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL--SG-GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEE--eC-CcEEEEECCcccc
Confidence 678999999999988642 13344444444555 99999999999999999 33 3499999999754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.9e-08 Score=74.11 Aligned_cols=78 Identities=13% Similarity=0.084 Sum_probs=62.5
Q ss_pred eEEEeeCccCCCC-ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecc
Q psy1096 19 VITWSSPPYDGGC-MITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFG 95 (239)
Q Consensus 19 ~~~~~~~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg 95 (239)
...|+++|++++. +|.+++.. ...........++.++...++- |+.|++|+|+++.|||+..+. ...+.++||+
T Consensus 90 ~~s~lite~l~~~~~L~~~~~~---~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld 166 (206)
T PF06293_consen 90 YRSYLITEALPGAQDLRDLLQQ---WEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLD 166 (206)
T ss_pred eeEEEEEEeCCCcccHHHHHHh---hcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcch
Confidence 5668899999985 68877743 2236667788999999999999 999999999999999995443 3378999998
Q ss_pred ccee
Q psy1096 96 LAQK 99 (239)
Q Consensus 96 ~~~~ 99 (239)
.+..
T Consensus 167 ~~~~ 170 (206)
T PF06293_consen 167 RMRF 170 (206)
T ss_pred hcee
Confidence 7654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.6e-08 Score=82.94 Aligned_cols=74 Identities=16% Similarity=0.162 Sum_probs=55.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHH-HHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTER-GLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~-~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+++|||++|..+.++..... .+. ....+...++. .+.. |..|++|+|++|.||++ +.++.++++|||.+.
T Consensus 233 ~vLvmE~i~G~~L~~~~~~~~-~~~----~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv--~~~g~i~liDfG~~~ 305 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAALDE-AGL----DRKALAENLARSFLNQVLRDGFFHADLHPGNIFV--LKDGKIIALDFGIVG 305 (437)
T ss_pred ceEEEEeECCcccccHHHHHh-cCC----CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEE--CCCCcEEEEeCCCee
Confidence 368999999999998764321 221 12334444444 3456 99999999999999999 667789999999987
Q ss_pred ecC
Q psy1096 99 KIN 101 (239)
Q Consensus 99 ~~~ 101 (239)
...
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 665
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-08 Score=86.57 Aligned_cols=174 Identities=14% Similarity=0.106 Sum_probs=119.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+-.|||.+++...-. ..-..+.+.....+..|++.++.+ |+..++|+|++|+||++..++ +..++.||+....
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc
Confidence 34567899888877333 334455566778899999999999 999999999999999995443 7788999988764
Q ss_pred cCCCCCCccccCCCCcc--CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 100 INPDHPPRVLFGTPEFI--PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..-. .......-.+. ++.......+..++|++++|.-+.+..++...-...+. ...+..+.....+ ...
T Consensus 417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~----~~~ 487 (524)
T KOG0601|consen 417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLP----GLK 487 (524)
T ss_pred ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCC----chH
Confidence 2211 11111222233 45555566678899999999999988887655432222 2223333222221 233
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..++.+.+.++..++..|+.+.++..|.=+
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 677888999999999999999998887644
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.2e-08 Score=70.32 Aligned_cols=77 Identities=17% Similarity=0.200 Sum_probs=58.3
Q ss_pred eeCccCCC-CccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEeccccee
Q psy1096 23 SSPPYDGG-CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLAQK 99 (239)
Q Consensus 23 ~~~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~~~ 99 (239)
+.|||.+| .++.+++.+..... ..++....++..+=+.+.- |..+++||||+.+||++.++++. .+.++|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 56788888 67788887654433 3333446788888888888 99999999999999999765543 358999999865
Q ss_pred c
Q psy1096 100 I 100 (239)
Q Consensus 100 ~ 100 (239)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-07 Score=69.60 Aligned_cols=63 Identities=17% Similarity=0.139 Sum_probs=49.0
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcc-----cCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVT-----VDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~i-----vH~dikp~nili~~~~~~~vkl~dfg 95 (239)
+++|||++|..+.+.. .....++.+++.+|+. |+.++ +|||++|.||+++ ++.++++||+
T Consensus 67 ~lv~e~i~G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~---~~~~~liDf~ 132 (170)
T cd05151 67 VLITEFIEGSELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD---DGRLWLIDWE 132 (170)
T ss_pred eEEEEecCCCcccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE---CCeEEEEecc
Confidence 5788999998876430 1123466788899999 99885 9999999999994 4579999999
Q ss_pred cce
Q psy1096 96 LAQ 98 (239)
Q Consensus 96 ~~~ 98 (239)
.+.
T Consensus 133 ~a~ 135 (170)
T cd05151 133 YAG 135 (170)
T ss_pred ccc
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.3e-08 Score=71.83 Aligned_cols=72 Identities=22% Similarity=0.183 Sum_probs=46.1
Q ss_pred EeeCccCC--CCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 22 WSSPPYDG--GCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 22 ~~~~e~~~--~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.++|||++ |..+..+... .+..+....++.+++..+.. |+.|++|||+.+.||++. .+ .+.++|||.+
T Consensus 82 ~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--~~-~~~iIDf~qa 153 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--DG-KVYIIDFGQA 153 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE--TT-CEEE--GTTE
T ss_pred EEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee--cc-eEEEEecCcc
Confidence 37889999 7666654321 11134556677777774443 899999999999999994 33 7999999987
Q ss_pred eecC
Q psy1096 98 QKIN 101 (239)
Q Consensus 98 ~~~~ 101 (239)
....
T Consensus 154 v~~~ 157 (188)
T PF01163_consen 154 VDSS 157 (188)
T ss_dssp EETT
T ss_pred eecC
Confidence 5544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=75.00 Aligned_cols=73 Identities=15% Similarity=0.076 Sum_probs=51.4
Q ss_pred EeeCccCCCCccchhhhhhhcCC----CchHHHHHHHHHHHHHHHHHhhhcccCCCCCCCCeEEecCC--CCcEEEEecc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGT----QPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRT--SHHIKIIDFG 95 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l~~h~~~ivH~dikp~nili~~~~--~~~vkl~dfg 95 (239)
+++|||+.|+.+.++..- ...+ .+.+..+..++.|++ ..|++|+|++|.||+++.++ .+.++++|||
T Consensus 237 VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qif------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFG 309 (537)
T PRK04750 237 VMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQVF------RDGFFHADMHPGNIFVSYDPPENPRYIALDFG 309 (537)
T ss_pred eEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHHH------hCCeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence 489999999999875321 2233 244444555555554 48999999999999994322 2389999999
Q ss_pred cceecC
Q psy1096 96 LAQKIN 101 (239)
Q Consensus 96 ~~~~~~ 101 (239)
......
T Consensus 310 ivg~l~ 315 (537)
T PRK04750 310 IVGSLN 315 (537)
T ss_pred eEEECC
Confidence 876654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.2e-06 Score=62.46 Aligned_cols=95 Identities=9% Similarity=0.038 Sum_probs=67.7
Q ss_pred CCCCCcccccCCCceeEEEeeCccCC-CCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEE
Q psy1096 4 PPSGAIGVSNNRTSVVITWSSPPYDG-GCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMC 81 (239)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~e~~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili 81 (239)
+|-.+.+-....+.....++|+|-.+ -.+|.+++.+ ..-...+......++.++...++- |+.|+.|+|+-+.||++
T Consensus 83 VP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll 161 (216)
T PRK09902 83 VPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV 161 (216)
T ss_pred CCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee
Confidence 55555443344555667788888444 4567666643 223355677778999999999999 99999999999999999
Q ss_pred ecCCCCcEEEEeccccee
Q psy1096 82 VSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 82 ~~~~~~~vkl~dfg~~~~ 99 (239)
..++...+.++||..+..
T Consensus 162 ~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 162 KTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cCCCCeeEEEEEhhccch
Confidence 443333499999986543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.9e-06 Score=65.55 Aligned_cols=64 Identities=17% Similarity=0.036 Sum_probs=47.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++|||++|..+.++.. +.+ .+...+..++.- |+.|+.|||.+|.|+++. . +.++++|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~--~-~~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS--N-NGIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE--C-CcEEEEECccc
Confidence 3447999999999987631 122 244555666777 999999999999999983 3 34999999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.9e-06 Score=70.68 Aligned_cols=115 Identities=16% Similarity=0.126 Sum_probs=78.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h-hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H-SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h-~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+|+|+|-+..-. .++.+. .+..+.--+.||+.||.| | +.+++|+||.-+.|+| +..|.-+|++|...
T Consensus 83 ~~ylvTErV~Pl~--~~lk~l------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV--n~~GeWkLggle~v 152 (690)
T KOG1243|consen 83 TLYLVTERVRPLE--TVLKEL------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV--NESGEWKLGGLELV 152 (690)
T ss_pred ceEEEeeccccHH--HHHHHh------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE--cCCCcEEEeeeEEE
Confidence 5667777665433 234321 155667789999999999 5 7789999999999999 77889999999876
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~ 146 (239)
........ .....--..|..|+.+.... -..|.|.||+++++++.|.
T Consensus 153 ~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 153 SKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred eccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 55443221 11111122355555543221 3569999999999999983
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.7e-05 Score=70.61 Aligned_cols=170 Identities=15% Similarity=0.118 Sum_probs=114.7
Q ss_pred eCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCC---CeEEecCCCCcEEEE--ecccc
Q psy1096 24 SPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPE---NIMCVSRTSHHIKII--DFGLA 97 (239)
Q Consensus 24 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~---nili~~~~~~~vkl~--dfg~~ 97 (239)
..++|....+...+ ..-+..+.++++.+..+++.||++ |+....|.-+..+ +--+ ++.+.+... ||+.+
T Consensus 264 ~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~--~~e~~~~~sl~~~~ss 338 (1351)
T KOG1035|consen 264 LQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTV--DGEGVVAISLSDFDSS 338 (1351)
T ss_pred HHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccccccc--Cccceeecchhhhccc
Confidence 35677777777666 345778888999999999999999 9986555444433 2222 333445555 88877
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI--GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..............+..+.++|....... +...|+|.+|.....+..|..+-.... ....+. . ..
T Consensus 339 ~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~~~~~l-------~---~~ 405 (1351)
T KOG1035|consen 339 KPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---VPVSLL-------D---VL 405 (1351)
T ss_pred ccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc---chhhhh-------c---cc
Confidence 77665554444455667788888766655 445799999999999988755432110 000000 0 01
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
......+...+|+.-++++|+++.+++.|+|++...
T Consensus 406 ~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 406 STSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred cchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 112567888899999999999999999999997543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.9e-05 Score=61.63 Aligned_cols=68 Identities=16% Similarity=0.088 Sum_probs=51.4
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
-++|||++|-.|..+= +..+....++..|+.-+.. -..|+||||+.+-||++ +.+|.+.++||--+..
T Consensus 183 aVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 183 AVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--TEDGDIVVIDWPQAVP 251 (304)
T ss_pred eeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE--ecCCCEEEEeCccccc
Confidence 4678899997777542 1344556667777776666 78999999999999999 6677899999975543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00013 Score=55.91 Aligned_cols=32 Identities=16% Similarity=0.191 Sum_probs=25.2
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++|+|+.+.||+++.+.++.+.++||+.+.
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 46899999999999944325678999998653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00015 Score=56.12 Aligned_cols=74 Identities=18% Similarity=0.097 Sum_probs=53.3
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
-++|||++....-. -..+.-.+..+.+..+..+++..+.- +..++||+||..-|||+ . .+.+.++|++-+..
T Consensus 142 VLvMEfIg~~g~pA---P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~--~-~~~p~iID~~QaV~ 215 (268)
T COG1718 142 VLVMEFIGDDGLPA---PRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV--H-DGEPYIIDVSQAVT 215 (268)
T ss_pred eEEEEeccCCCCCC---CCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE--E-CCeEEEEECccccc
Confidence 36788888773211 01122233344788899999998887 66999999999999999 4 56899999997755
Q ss_pred cC
Q psy1096 100 IN 101 (239)
Q Consensus 100 ~~ 101 (239)
..
T Consensus 216 ~~ 217 (268)
T COG1718 216 ID 217 (268)
T ss_pred cC
Confidence 44
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0048 Score=52.69 Aligned_cols=131 Identities=15% Similarity=0.163 Sum_probs=93.6
Q ss_pred CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccccCCCCccCccccc
Q psy1096 44 TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN 122 (239)
Q Consensus 44 ~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~ 122 (239)
...+|+..=.++-|+..||.+ |+.|+.-+-+.+.+|++ .+...++++..|.......... +.+.
T Consensus 388 ~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv--~G~~RIriS~C~i~Dvl~~d~~-------------~~le 452 (655)
T KOG3741|consen 388 LKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV--TGKMRIRISGCGIMDVLQEDPT-------------EPLE 452 (655)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe--eCcceEEEecccceeeecCCCC-------------cchh
Confidence 455667778999999999999 99999999999999999 5555789988887766554331 0111
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHH-HHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 123 YEPIGIESDMWSIGVITYVLLSGLSPF-MGENDSET-FANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 123 ~~~~~~~~DiwslG~~l~~~~~g~~p~-~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
...+.|.-.||.+++.+.+|..-- ......+. ...| ...++.++++++.-....++.+ -++++
T Consensus 453 ---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 453 ---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred ---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 123568999999999999985542 21211111 1111 1346888899999888888877 78888
Q ss_pred Hhhc
Q psy1096 201 CLSH 204 (239)
Q Consensus 201 ll~h 204 (239)
++.+
T Consensus 518 llp~ 521 (655)
T KOG3741|consen 518 LLPM 521 (655)
T ss_pred HHHH
Confidence 8865
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.28 E-value=4.9e-05 Score=65.84 Aligned_cols=181 Identities=18% Similarity=0.121 Sum_probs=115.6
Q ss_pred eEEEeeCccCCCC-ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGC-MITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
-..|+.|++|.++ +... .+ ......+..-+...+.+.-..++++ |+.--+|+| ||+. .++..+..+|+.
T Consensus 307 ~~~~i~~~i~s~~rs~~~-~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~---s~~~~~~~~~~v 377 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSAL-EM-TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG---SEEEVKLLDFAV 377 (829)
T ss_pred cccchhhhhhcCCccccc-cC-ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc---cccccccccccC
Confidence 3556677777777 2110 10 0111122222345677778888999 887778888 8874 446789999998
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...+.......+..+++.+++||......+....|.|++|+--.++.-|.+|-...... ...+-.+.-.+....-...
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhc
Confidence 87777666667788999999999999999999999999998777777777775431110 0000000000000000001
Q ss_pred CHHHH-HHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 177 SEDAK-DFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 177 ~~~~~-~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+.... ++...|+...|..|++...++.|.+|.+.
T Consensus 456 ~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 456 SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 11112 46778899999999999999999888763
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0093 Score=44.82 Aligned_cols=75 Identities=15% Similarity=0.053 Sum_probs=54.1
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh---hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS---LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~---~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
++++||.+.+.+.+...........++..+.+|+.+++..+.. +. ..+.-.|++++|+-+ ..+|.++++|....
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv--~~~~~lk~iDld~v 109 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV--NDDGRLKLIDLDDV 109 (188)
T ss_pred EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE--eCCCcEEEEechhc
Confidence 4667788876554321111122355678888999999999988 44 348889999999999 56678999999765
Q ss_pred e
Q psy1096 98 Q 98 (239)
Q Consensus 98 ~ 98 (239)
.
T Consensus 110 ~ 110 (188)
T PF12260_consen 110 F 110 (188)
T ss_pred c
Confidence 3
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0022 Score=55.46 Aligned_cols=74 Identities=22% Similarity=0.264 Sum_probs=50.2
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHHhhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
++|||++|-.+.+...-.. .|.-...++..++...+.-+ -..|+.|.|..|-||++ +..|.+.+.|||......
T Consensus 243 LtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~--~~dgffHaDpHpGNi~v--~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 243 LTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL--LRDGFFHADPHPGNILV--RSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred EEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH--HhcCccccCCCccceEE--ecCCcEEEEcCcceecCC
Confidence 6789999999998854323 33333333333222222211 23789999999999999 666899999999876654
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0042 Score=53.84 Aligned_cols=75 Identities=15% Similarity=0.091 Sum_probs=51.3
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecC--CCCcEEEEecccc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSR--TSHHIKIIDFGLA 97 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~--~~~~vkl~dfg~~ 97 (239)
-++||||+|.-+.++..- ...+.-..+++ ..+.++... -..|++|+|=.|-||++.++ .++.+.+.|||+.
T Consensus 278 VLtME~~~G~~i~Dl~~i-~~~gi~~~~i~----~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~ 352 (538)
T KOG1235|consen 278 VLTMEYVDGIKINDLDAI-DKRGISPHDIL----NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY 352 (538)
T ss_pred EEEEEecCCccCCCHHHH-HHcCCCHHHHH----HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence 368999999999987543 33343333333 223332222 34679999999999999643 5778999999987
Q ss_pred eecC
Q psy1096 98 QKIN 101 (239)
Q Consensus 98 ~~~~ 101 (239)
....
T Consensus 353 ~~is 356 (538)
T KOG1235|consen 353 AVIS 356 (538)
T ss_pred cccc
Confidence 6654
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.00048 Score=65.62 Aligned_cols=127 Identities=14% Similarity=0.008 Sum_probs=87.6
Q ss_pred EEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhh-----cccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSL-----VTVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~-----~ivH~dikp~nili~~~~~~~vkl~d 93 (239)
.|..++||.+|.+.+.+..-.. ...+...-+.....+......- |+. --+|.++|+-|.+| ..+..+++.+
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI--Vtny~v~~gk 1383 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI--VTNYNVKLGK 1383 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce--ecCCcccccc
Confidence 4567889999999888753211 1222233333344443444333 433 27899999999999 6677899999
Q ss_pred cccceecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy1096 94 FGLAQKIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPF 149 (239)
Q Consensus 94 fg~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~ 149 (239)
+|+.+... .....+...+++.|+.++....-.++.++|+|+.|+.+|....|..+|
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99987332 223344556777788888887777888899999999999888887776
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.068 Score=44.32 Aligned_cols=75 Identities=11% Similarity=0.030 Sum_probs=56.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...+||+|+++..--. -......++...+..+..+++.-+.. +.+++||.||.--|+|+ ..|.+.++|.+-+
T Consensus 238 ~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---hdG~lyiIDVSQS 311 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---HDGKLYIIDVSQS 311 (520)
T ss_pred cceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE---ECCEEEEEEcccc
Confidence 3457888998655332 22445667777788888888888776 89999999999999998 4578999998765
Q ss_pred eec
Q psy1096 98 QKI 100 (239)
Q Consensus 98 ~~~ 100 (239)
...
T Consensus 312 VE~ 314 (520)
T KOG2270|consen 312 VEH 314 (520)
T ss_pred ccC
Confidence 443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.042 Score=42.17 Aligned_cols=31 Identities=32% Similarity=0.400 Sum_probs=20.2
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++|+|+.+.||+++ +.++.+.++||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~-~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVD-PSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEE-SSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceee-eccceeEEEecccce
Confidence 4699999999999995 244566899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.033 Score=48.02 Aligned_cols=84 Identities=18% Similarity=0.129 Sum_probs=60.0
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch--------HHHhhcCHHHHHHHHHhhhhCcccCCCH
Q psy1096 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--------EAFEALSEDAKDFISSLLVKRKEKRLTA 198 (239)
Q Consensus 127 ~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~ 198 (239)
++++||||+|.++.++.-|...+......+....+.+-...... ......+..+..+.++|+-..|..||..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 36999999999999998887776544444444444332222111 1112357778899999999999999999
Q ss_pred HHHhhccccccC
Q psy1096 199 KQCLSHLWIAQK 210 (239)
Q Consensus 199 ~~ll~h~~~~~~ 210 (239)
.++.+++-|.+.
T Consensus 189 ~~~~k~~i~~ev 200 (725)
T KOG1093|consen 189 MELSKRCSFTEV 200 (725)
T ss_pred hHHhcCccHHHH
Confidence 999999988765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.053 Score=42.15 Aligned_cols=30 Identities=23% Similarity=0.405 Sum_probs=24.1
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++|||+.+.||++ +.++.+-++||+.+
T Consensus 163 ~~~l~HGD~~~~Nvlv--~~~~i~giIDw~~a 192 (235)
T cd05155 163 PPVWFHGDLAPGNLLV--QDGRLSAVIDFGCL 192 (235)
T ss_pred CceEEeCCCCCCcEEE--ECCCEEEEEeCccc
Confidence 3459999999999999 55555679999865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.2 Score=41.55 Aligned_cols=49 Identities=20% Similarity=0.214 Sum_probs=40.9
Q ss_pred HHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 48 VELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 48 ~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++..++.+.++.+.. -.-..-|||+.-.||+| + .|.|.|+||.+++.
T Consensus 320 ~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--d-~GnvtLIDfklsRl 370 (488)
T COG5072 320 SEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--D-EGNVTLIDFKLSRL 370 (488)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--e-cCceEEEEeeeeec
Confidence 45677899999888877 33358999999999999 6 78999999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.39 Score=36.41 Aligned_cols=60 Identities=15% Similarity=0.045 Sum_probs=37.1
Q ss_pred CCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCc--EEEEe
Q psy1096 30 GCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHH--IKIID 93 (239)
Q Consensus 30 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~--vkl~d 93 (239)
.|.+..-+.++...+.+.. ...+.+.+. ..+ -+.+|+.+|++|.||++....++. +.++|
T Consensus 103 dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 103 DGNISPTLEDYLKEGGLTE-ELRQALDEF---KRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCCcCccHHHHHHcCCccH-HHHHHHHHH---HHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 3444444555555555555 333333333 345 778899999999999997666555 55565
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.11 Score=42.21 Aligned_cols=30 Identities=20% Similarity=0.402 Sum_probs=24.8
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++|+|+.+.|+++ +.++.+.++||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~--~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLF--DGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEE--ECCceEEEeecccc
Confidence 3689999999999999 44556689999865
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.11 Score=40.23 Aligned_cols=30 Identities=27% Similarity=0.472 Sum_probs=24.4
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+++|+|+.+.||+++.. ++.+.++||..+
T Consensus 170 ~~l~H~Dl~~~Nil~~~~-~~~~~lIDwe~a 199 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEE-KNSVKFIDYEYA 199 (235)
T ss_pred EEEEcCCCCcCcEEEeCC-CCCEEEEEcccC
Confidence 469999999999999431 357999999865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.057 Score=44.03 Aligned_cols=29 Identities=17% Similarity=0.312 Sum_probs=23.9
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+++|+|+.+.||++ +++..+-++||+.+
T Consensus 187 ~~liHgD~~~~Nil~--~~~~~~~iIDf~~~ 215 (319)
T PRK05231 187 RGVIHADLFRDNVLF--EGDRLSGFIDFYFA 215 (319)
T ss_pred cccCCCCCCCCcEEE--ECCceEEEEecccc
Confidence 479999999999999 44445589999865
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.081 Score=43.34 Aligned_cols=36 Identities=14% Similarity=0.121 Sum_probs=26.3
Q ss_pred HHHHHHHHHHHHHH----HH-hhhcccCCCCCCCCeEEecC
Q psy1096 49 ELSERLFESTERGL----GH-HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 49 ~~~~~~~~~i~~~l----~~-h~~~ivH~dikp~nili~~~ 84 (239)
+-++.++.|++... +. .-.+.+|-||||+|||+...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 315 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS 315 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence 34567888887765 22 34579999999999998544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.089 Score=42.95 Aligned_cols=66 Identities=14% Similarity=0.073 Sum_probs=43.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHH-HhhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLG-HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~-~h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|||++.|-.+..+-. .. -+..+...+...+- ...+|+||||..--||++ +..+.++++||--.
T Consensus 183 H~Vvmelv~g~Pl~~v~~-v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv--~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 183 HCVVMELVDGYPLRQVRH-VE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV--KDDDKIVVIDFPQM 249 (465)
T ss_pred eeeHHHhhcccceeeeee-cC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEE--ecCCCEEEeechHh
Confidence 456788888888775421 11 11222222222222 277899999999999999 55668999999643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.64 E-value=0.11 Score=39.28 Aligned_cols=32 Identities=25% Similarity=0.299 Sum_probs=25.4
Q ss_pred hhcccCCCCCCCCeEEecCCCC---cEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSH---HIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~---~vkl~dfg~~ 97 (239)
...++|||+.+.|+++..+..| .+.++||..+
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 3469999999999999654444 5899999865
|
subfamily of choline kinases |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.64 E-value=0.28 Score=39.73 Aligned_cols=28 Identities=18% Similarity=0.266 Sum_probs=23.2
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+++|||+.+.||++ +. +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~--~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILL--KD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEE--eC-CcEEEEECccc
Confidence 478999999999999 43 46889999854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.59 E-value=0.1 Score=42.04 Aligned_cols=29 Identities=17% Similarity=0.326 Sum_probs=24.4
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+++|+|+.|.|+++ +.++.+.++||+.+
T Consensus 175 ~~l~HgD~~~~Nil~--~~~~~~~iIDfe~a 203 (296)
T cd05153 175 RGVIHADLFRDNVLF--DGDELSGVIDFYFA 203 (296)
T ss_pred CcCCccCcCcccEEE--eCCceEEEeehhhh
Confidence 479999999999999 55556789999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=92.47 E-value=0.17 Score=39.49 Aligned_cols=29 Identities=24% Similarity=0.284 Sum_probs=24.3
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..++|+|+.|.||++ +.++.+.|+||+.+
T Consensus 163 ~~l~HgD~~~~Nil~--~~~~~~~iIDwe~a 191 (244)
T cd05150 163 LVVTHGDACLPNIIV--DPGKFSGFIDLGRL 191 (244)
T ss_pred eEEECCCCCCccEEE--eCCcEEEEEEcccc
Confidence 459999999999999 55556789999865
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.15 Score=38.22 Aligned_cols=28 Identities=18% Similarity=0.364 Sum_probs=23.1
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
-.+|+|+.|.|+++ .++| ++++|++.+.
T Consensus 78 ~p~H~D~~~~N~~~--~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVH--SASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEE--ECCC-EEEEeCCccc
Confidence 47999999999998 4444 8899998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.13 Score=41.58 Aligned_cols=31 Identities=23% Similarity=0.405 Sum_probs=24.3
Q ss_pred hcccCCCCCCCCeEEecC--CCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSR--TSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~--~~~~vkl~dfg~~ 97 (239)
..++|+|+.+.||+++.+ ..+.+.++||..+
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 368999999999999432 0257999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.85 E-value=0.21 Score=40.85 Aligned_cols=36 Identities=14% Similarity=0.083 Sum_probs=26.6
Q ss_pred HHHHHHHHHHHHHH-HH----hhhcccCCCCCCCCeEEecC
Q psy1096 49 ELSERLFESTERGL-GH----HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 49 ~~~~~~~~~i~~~l-~~----h~~~ivH~dikp~nili~~~ 84 (239)
+-++.++.|++... .+ .-.+.+|-||||+|||+...
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 34567888887765 33 24579999999999998554
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.36 Score=45.87 Aligned_cols=33 Identities=24% Similarity=0.290 Sum_probs=25.0
Q ss_pred hcccCCCCCCCCeEEecCCCCcE-EEEeccccee
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHI-KIIDFGLAQK 99 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~v-kl~dfg~~~~ 99 (239)
.++||+|+.++||+++.+..+.+ -++|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 57999999999999954433345 4999997643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=91.34 E-value=0.16 Score=39.30 Aligned_cols=27 Identities=15% Similarity=0.115 Sum_probs=23.0
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.++|||+.|.||++ +.++ +.++||+.+
T Consensus 154 ~~~HgD~~~~Nii~--~~~~-~~iIDwe~a 180 (226)
T TIGR02172 154 TCLHGDFQIGNLIT--SGKG-TYWIDLGDF 180 (226)
T ss_pred ceEecCCCCCcEEE--cCCC-cEEEechhc
Confidence 57899999999999 5555 899999865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.58 Score=37.33 Aligned_cols=43 Identities=19% Similarity=0.298 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHH-hhh--cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 53 RLFESTERGLGH-HSL--VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 53 ~~~~~i~~~l~~-h~~--~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+..+-.++.- +.. -.+|+|+.|+|++. +..+.++|+||.-+
T Consensus 136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~--t~~~~l~LIDWEyA 181 (269)
T COG0510 136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLL--TDKGGLFLIDWEYA 181 (269)
T ss_pred HHHHHHHHHhhhcCCCceeeecCCCCccceEE--cCCCcEEEEecccC
Confidence 345555555555 333 59999999999998 55578999999765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.42 E-value=0.23 Score=39.11 Aligned_cols=27 Identities=19% Similarity=0.360 Sum_probs=22.5
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.++|+|+.|.||+++ .++ +.++||..+
T Consensus 147 ~l~H~Dl~~~Nil~~--~~~-~~lIDwE~a 173 (256)
T TIGR02721 147 APLHMDVHAYNLVVT--PQG-LKLIDWEYA 173 (256)
T ss_pred eeecCCCCcCcEEEe--CCC-CEEEecccc
Confidence 589999999999994 443 789999865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.25 E-value=0.38 Score=37.24 Aligned_cols=41 Identities=24% Similarity=0.329 Sum_probs=30.7
Q ss_pred HHHHHHHHHHH-hh--hcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 54 LFESTERGLGH-HS--LVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 54 ~~~~i~~~l~~-h~--~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
++..-+.+|.- |+ .+.+|||..|+||+. +..|.+||.|-+.
T Consensus 146 ~i~agi~~L~~fH~~~~~~lHGD~np~NiM~--D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSENQHCLHGDCNPDNIMC--DKFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhccCCCeecCCCChhheee--cCCCCEEecChhh
Confidence 33333444555 73 469999999999999 8888999999763
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.18 E-value=0.38 Score=38.53 Aligned_cols=33 Identities=21% Similarity=0.267 Sum_probs=24.6
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
...++|||+++.||+++.+ +..+-++||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 3469999999999999432 33457999987633
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.86 E-value=0.58 Score=38.48 Aligned_cols=27 Identities=22% Similarity=0.397 Sum_probs=22.6
Q ss_pred ccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 69 TVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 69 ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
+||+|+.|.||++ +... .+.++||+-+
T Consensus 199 iIH~D~~~~NVl~--d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLF--DDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeE--cCCCCeeeEEEcccc
Confidence 8999999999999 4444 4889999865
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.79 E-value=0.55 Score=38.34 Aligned_cols=35 Identities=20% Similarity=0.257 Sum_probs=28.8
Q ss_pred hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 65 h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
+...++|||..+.|+++ +..+.+-+.||+.+..-+
T Consensus 196 ~~~~lvHGD~~~gNlii--~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 196 GPPVLVHGDYRPGNLII--DPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCceeeeCCcccCCEEE--eCCCeeEEEeccccccCC
Confidence 56679999999999999 555569999999875543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=89.64 E-value=0.59 Score=38.70 Aligned_cols=31 Identities=26% Similarity=0.306 Sum_probs=24.9
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...++|+|+++.||+++.+ ++.+.++||..+
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~-~~~~~lID~Eya 229 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEE-TRAITIIDYEYA 229 (344)
T ss_pred CceEEeCCCCcCcEEEeCC-CCcEEEEeehhc
Confidence 3479999999999999432 357999999865
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.34 E-value=0.61 Score=44.23 Aligned_cols=33 Identities=24% Similarity=0.298 Sum_probs=25.1
Q ss_pred hhcccCCCCCCCCeEEecCCCCc---EEEEecccce
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHH---IKIIDFGLAQ 98 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~---vkl~dfg~~~ 98 (239)
..++||+|+.++||++..+..+. .-++|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 36799999999999995543233 4789999753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.24 E-value=0.26 Score=40.06 Aligned_cols=28 Identities=21% Similarity=0.216 Sum_probs=24.6
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
+++|+|+.+.|+++ ++++.+.++||..+
T Consensus 197 ~lcHgD~~~~Nvl~--~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLY--DETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEE--cCCCCEEEEEhhhc
Confidence 79999999999999 66667899999865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=88.63 E-value=0.6 Score=37.53 Aligned_cols=31 Identities=26% Similarity=0.328 Sum_probs=25.5
Q ss_pred hcccCCCCCCCCeEEecCCCC---cEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSH---HIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~---~vkl~dfg~~ 97 (239)
.-++|||+...||++..+..| .+.+.||..+
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~ 248 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA 248 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccc
Confidence 359999999999999766655 6889999765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=87.69 E-value=1.3 Score=33.72 Aligned_cols=32 Identities=31% Similarity=0.500 Sum_probs=19.9
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
...++|+|+.+.||++ ...++.++++||..+.
T Consensus 142 ~~v~cHnDl~~~Nil~-~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILI-NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp GEEEE-S--SGGGEEE-TSSSSCEEE--GTT-E
T ss_pred CceEeeccCccccEEe-ccCCCeEEEecHHHHh
Confidence 4579999999999998 2234579999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=86.90 E-value=6.2 Score=32.81 Aligned_cols=106 Identities=16% Similarity=0.176 Sum_probs=66.2
Q ss_pred cCCCceeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHHhhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 13 NNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 13 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
....++++.|-+.+... .+ ..-..+.+....+++.+.+..|.-|.+.-.|--+.|+||++ +.++.+.+.
T Consensus 58 ~~~Ds~vIsy~i~~~~~-----~F----~~~k~~~k~~Klr~a~~~I~~l~e~~~tr~~~~laPeNilf--~~~l~p~~v 126 (434)
T COG4499 58 EDNDSFVISYPIPEAAK-----SF----ASAKRKEKTRKLRLALQNIATLSELNNTRYTFFLAPENILF--DGGLTPFFV 126 (434)
T ss_pred ccCceeEEEecCccccc-----hH----HHHHHHHHHHHHHHHHHHHHHHHHhhccceeEEecchheEE--cCCCceEEE
Confidence 45556667655433222 12 11223334445566788888887777777888899999999 888889999
Q ss_pred ecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy1096 93 DFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM 150 (239)
Q Consensus 93 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~ 150 (239)
.+|+.....+-. +.||.+ .-++-+++..++.|..+|.
T Consensus 127 H~Glk~~lpPye-----------~tee~f----------~~~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 127 HRGLKNSLPPYE-----------MTEERF----------LKEYKALAIYAFNGKFSFE 163 (434)
T ss_pred ecchhccCCCCC-----------CCHHHH----------HHHHHHHHHHHHcCCccHH
Confidence 999865544322 223222 1235566677777877773
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.60 E-value=1 Score=36.97 Aligned_cols=28 Identities=25% Similarity=0.364 Sum_probs=22.6
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+++|+|+.+.||++ ++ .+.++||+-+
T Consensus 195 ~~~liHgD~h~~NvL~--~d--~~~iIDFDd~ 222 (325)
T PRK11768 195 RLLRLHGDCHPGNILW--RD--GPHFVDLDDA 222 (325)
T ss_pred CccceecCCCchhccc--cC--CcEEEeCCCC
Confidence 3478999999999999 33 3678999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=85.29 E-value=1.3 Score=33.74 Aligned_cols=38 Identities=29% Similarity=0.357 Sum_probs=30.4
Q ss_pred HHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 53 ~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
+-+.++++-+.. |+.||+-+|+++.|.. ++ +|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 456667777777 9999999999999987 33 79999854
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.28 E-value=1.4 Score=37.15 Aligned_cols=31 Identities=13% Similarity=0.195 Sum_probs=25.2
Q ss_pred hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 65 h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
+...++|||+.|-||+++.+ .++++|..++.
T Consensus 225 ~~~aLlHGDlHtGSI~v~~~---~~kvIDpEFAf 255 (409)
T PRK12396 225 NAQALIHGDLHTGSVFVKND---STKVIDPEFAF 255 (409)
T ss_pred cchhhccCcCCCCCEEecCC---ceEEEcccccc
Confidence 56679999999999999443 48999987763
|
|
| >KOG2269|consensus | Back alignment and domain information |
|---|
Probab=84.20 E-value=2.2 Score=35.15 Aligned_cols=70 Identities=7% Similarity=0.058 Sum_probs=52.8
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+||.|++...+-.= ..++-.++.++.+....|+..++.- |+.-+||-|+.--|+|... |.|-++|..-+
T Consensus 359 vLVMsFiGd~~~aAP---kLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~---gKvw~IDVsQs 430 (531)
T KOG2269|consen 359 VLVMSFIGDQGLAAP---KLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTP---GKVWVIDVSQS 430 (531)
T ss_pred eEEEEeecCCCCCCc---cccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecC---CceEEEechhc
Confidence 356667776655421 1345678889999999999999876 9999999999999999833 46888887543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=81.75 E-value=3.6 Score=30.78 Aligned_cols=65 Identities=20% Similarity=0.212 Sum_probs=38.6
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHHhhhcccCCCCC-CCCeEEecCCCCcEEEEecccce
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKIL-PENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~h~~~ivH~dik-p~nili~~~~~~~vkl~dfg~~~ 98 (239)
+.|||..|-.|.+.-. ++ ....+..-+-.+...-..||-|+.|+ |...++. ..+.+.++||..++
T Consensus 89 i~me~i~G~~L~~~~~----~~-----~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv--~~~~~~iIDFd~At 154 (201)
T COG2112 89 IRMEYIDGRPLGKLEI----GG-----DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV--NDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcCcchhhhhh----cc-----cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEe--cCCcEEEEEccchh
Confidence 4588888877775431 11 22333333333333367789999997 5444442 22369999999775
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=81.49 E-value=2.6 Score=35.71 Aligned_cols=29 Identities=17% Similarity=0.233 Sum_probs=23.8
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...++|||+.+.||++..+ .++++|+.++
T Consensus 222 ~~~l~HgDl~~gni~~~~~---~~~viD~E~a 250 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE---ETKVIDPEFA 250 (401)
T ss_pred CCceeeccCCcccEEeeCC---CcEEEecccc
Confidence 4569999999999999433 4899999865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 239 | ||||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-39 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-38 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-38 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-38 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-37 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-37 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-36 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-36 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-36 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-36 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-36 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-36 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-36 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-36 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-36 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-35 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-35 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-34 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-34 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-34 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-31 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-31 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-30 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-23 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-23 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-22 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 2nzi_A | 305 | Crystal Structure Of Domains A168-A170 From Titin L | 6e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-04 | ||
| 3lpw_A | 197 | Crystal Structure Of The Fniii-Tandem A77-A78 From | 4e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-04 |
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NZI|A Chain A, Crystal Structure Of Domains A168-A170 From Titin Length = 305 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LPW|A Chain A, Crystal Structure Of The Fniii-Tandem A77-A78 From The A-Band Of Titin Length = 197 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 239 | |||
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-82 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-82 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-82 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-81 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-81 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-79 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-79 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-12 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-79 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-76 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-56 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-56 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-56 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-55 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-55 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-54 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-53 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-53 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-52 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-52 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-52 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-52 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-51 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-50 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-49 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-47 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-46 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-46 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-46 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-46 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-45 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-44 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-40 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-39 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-36 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-35 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-34 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-31 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-31 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-29 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-28 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-27 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-27 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-26 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-26 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-26 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-26 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-26 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-26 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-26 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-26 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-26 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-26 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-26 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-26 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-26 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-25 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-25 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-25 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-25 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-25 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-25 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-25 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-24 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-24 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-24 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-24 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-24 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-23 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-23 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-23 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-22 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-21 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-20 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-20 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-19 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-18 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 9e-17 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-14 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-14 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-14 | |
| 1bpv_A | 112 | Titin, A71, connectin; fibronectin type III; NMR { | 2e-12 | |
| 2yuw_A | 110 | Myosin binding protein C, SLOW type; fibronectin I | 2e-12 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-12 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-12 | |
| 2yux_A | 120 | Myosin-binding protein C, SLOW-type; fibronectin I | 4e-12 | |
| 1x5y_A | 111 | Myosin binding protein C, fast-type; fast MYBP-C, | 6e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-12 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-11 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-11 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-11 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-11 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-10 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-10 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-10 | |
| 2crz_A | 110 | Fibronectin type-III domain containing protein 3A; | 1e-10 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-10 | |
| 2crm_A | 120 | Fibronectin type-III domain containing protein 3A; | 2e-10 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-10 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-10 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-10 | |
| 1uem_A | 117 | KIAA1568 protein; immunoglobulin-like beta-sandwic | 3e-10 | |
| 2haz_A | 105 | N-CAM 1, neural cell adhesion molecule 1; fibronec | 3e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-10 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-10 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-10 | |
| 1x4z_A | 121 | Biregional cell adhesion molecule-related/DOWN- re | 7e-10 | |
| 1x3d_A | 118 | Fibronectin type-III domain containing protein 3A; | 7e-10 | |
| 3lpw_A | 197 | A77-A78 domain from titin; intracellular FNIII-tan | 8e-10 | |
| 3lpw_A | 197 | A77-A78 domain from titin; intracellular FNIII-tan | 1e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-10 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 9e-10 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-09 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-09 | |
| 1x5x_A | 109 | Fibronectin type-III domain containing protein 3A; | 2e-09 | |
| 2nzi_A | 305 | Titin; IG-domain, FNIII-domain, transferase; 2.90A | 2e-09 | |
| 2vkw_A | 209 | Neural cell adhesion molecule 1,140 kDa isoform; a | 2e-09 | |
| 2vkw_A | 209 | Neural cell adhesion molecule 1,140 kDa isoform; a | 3e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-09 | |
| 1uey_A | 127 | KIAA0343 protein; immunoglobulin-like beta-sandwic | 3e-09 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-09 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-09 | |
| 1wf5_A | 121 | Sidekick 2 protein; FNIII domain, structural genom | 4e-09 | |
| 1wis_A | 124 | KIAA1514 protein; FNIII domain, sidekick-2, struct | 4e-09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-09 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-09 | |
| 1x5f_A | 120 | Neogenin; RGM binding, fibronectin type III domain | 7e-09 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-09 | |
| 2e3v_A | 122 | Neural cell adhesion molecule 1, 140 kDa isoform; | 9e-09 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-08 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-08 | |
| 3mtr_A | 215 | N-CAM-1, NCAM-1, neural cell adhesion molecule 1; | 2e-08 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-08 | |
| 1v5j_A | 108 | KIAA1355 protein, RSGI RUH-008; FN3 domain, human | 2e-08 | |
| 1x4x_A | 106 | Fibronectin type-III domain containing protein 3A; | 2e-08 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-08 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-08 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-08 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-08 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-08 | |
| 2jll_A | 389 | NCAM2, neural cell adhesion molecule 2; immunoglob | 4e-08 | |
| 2jll_A | 389 | NCAM2, neural cell adhesion molecule 2; immunoglob | 1e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-08 | |
| 2ic2_A | 115 | CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin t | 5e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-07 | |
| 2yrz_A | 118 | Integrin beta-4; GP150, CD104 antigen, structural | 4e-07 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-07 | |
| 2ibg_A | 214 | CG9211-PA, GH03927P; IHOG, fibronectin type III, p | 6e-07 | |
| 2ibg_A | 214 | CG9211-PA, GH03927P; IHOG, fibronectin type III, p | 9e-06 | |
| 1cfb_A | 205 | Drosophila neuroglian; neural adhesion molecule; H | 1e-06 | |
| 1cfb_A | 205 | Drosophila neuroglian; neural adhesion molecule; H | 1e-05 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-06 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-06 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-06 | |
| 2db8_A | 110 | Tripartite motif protein 9, isoform 2; ring finger | 3e-06 | |
| 2ed7_A | 119 | Netrin receptor DCC; tumor suppressor protein DCC, | 3e-06 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-06 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-06 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-06 | |
| 1x5g_A | 116 | Neogenin; RGM binding, fibronectin type III domain | 5e-06 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-06 | |
| 2dn7_A | 107 | Receptor-type tyrosine-protein phosphatase F; LAR | 6e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-06 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-06 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-05 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-05 | |
| 2kbg_A | 114 | N-CAM 2, neural cell adhesion molecule 2; fibronec | 1e-05 | |
| 2dmk_A | 127 | Midline 2 isoform 2; midline defect 2, tripartite | 1e-05 | |
| 2edb_A | 116 | Netrin receptor DCC; tumor suppressor protein DCC, | 2e-05 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-05 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-05 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-05 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 2dju_A | 106 | Receptor-type tyrosine-protein phosphatase F; LAR | 4e-05 | |
| 2dm4_A | 108 | Sortilin-related receptor; beta-sandwich, sorting | 4e-05 | |
| 2ed8_A | 106 | Netrin receptor DCC; tumor suppressor protein DCC, | 5e-05 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-05 | |
| 1wfo_A | 130 | Sidekick 2; FN3, cell adhesion, structural genomic | 6e-05 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-05 | |
| 3l5h_A | 589 | Interleukin-6 receptor subunit beta; IG-like, FNII | 8e-05 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-04 | |
| 3fl7_A | 536 | Ephrin receptor; ATP-binding, kinase, nucleotide-b | 1e-04 | |
| 3fl7_A | 536 | Ephrin receptor; ATP-binding, kinase, nucleotide-b | 2e-04 | |
| 2v5y_A | 731 | Receptor-type tyrosine-protein phosphatase MU; mem | 1e-04 | |
| 2v5y_A | 731 | Receptor-type tyrosine-protein phosphatase MU; mem | 2e-04 | |
| 2v5y_A | 731 | Receptor-type tyrosine-protein phosphatase MU; mem | 5e-04 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-04 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-04 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-04 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-04 | |
| 2dtg_E | 897 | Insulin receptor; IR ectodomain, X-RAY crystallogr | 2e-04 | |
| 2dtg_E | 897 | Insulin receptor; IR ectodomain, X-RAY crystallogr | 4e-04 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-04 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-04 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-04 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-04 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-04 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-04 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-04 | |
| 3p4l_A | 211 | Neogenin; iron homeostasis, hemojuvelin receptor, | 4e-04 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-04 | |
| 3f7q_A | 234 | Integrin beta-4, GP150; hemidesmosome, cell adhesi | 5e-04 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-04 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-04 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-04 | |
| 1x5i_A | 126 | Neogenin; RGM binding, fibronectin type III domain | 5e-04 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-04 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 6e-04 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-04 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-04 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-04 | |
| 2ede_A | 114 | Netrin receptor DCC; tumor suppressor protein DCC, | 8e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-04 |
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-82
Identities = 65/160 (40%), Positives = 101/160 (63%), Gaps = 1/160 (0%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+ +R S IKII+FG A+++ P R+LF PE+ PE+ ++ + +DMWS+
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G + YVLLSG++PF+ E + + NI AE+ FD+EAF+ +S +A DF+ LLVK ++ R
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
+TA + L H W+ QK K+I T K ++Y + +
Sbjct: 250 MTASEALQHPWLKQKIERVS-TKVIRTLKHRRYYHTLIKK 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-82
Identities = 82/165 (49%), Positives = 112/165 (67%), Gaps = 5/165 (3%)
Query: 76 PENIMCVSRT--SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
PENIM + R IKIIDFGLA KI+ + + +FGTPEF+ PEI+NYEP+G+E+DMW
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
SIGVITY+LLSG SPF+G+ ET AN++ ++F+DE F S AKDFI LLVK +
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKI---ISTDKLKKYIYRRKWQ 235
KR+T + L H WI KD+ +++ ++ +K KK+ R+K
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSN 306
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 6e-82
Identities = 83/165 (50%), Positives = 111/165 (67%), Gaps = 5/165 (3%)
Query: 76 PENIMCVSRTSH--HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
PENIM + + HIK+IDFGLA +I + +FGTPEF+ PEI+NYEP+G+E+DMW
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
SIGVITY+LLSG SPF+G+ ET ANIT +DFD+E F SE AKDFI LLVK
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNK---IISTDKLKKYIYRRKWQ 235
KRLT ++ L H WI D+ + + +++ + +K RR+W+
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWK 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 4e-81
Identities = 84/165 (50%), Positives = 111/165 (67%), Gaps = 5/165 (3%)
Query: 76 PENIMCVSRTSH--HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
PENIM + + HIK+IDFGLA +I + +FGTPEF+ PEI+NYEP+G+E+DMW
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
SIGVITY+LLSG SPF+G+ ET ANIT +DFD+E F SE AKDFI LLVK
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR 262
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNK---IISTDKLKKYIYRRKWQ 235
KRLT ++ L H WI D+ + + +++ + KK RR+W+
Sbjct: 263 KRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 8e-81
Identities = 69/163 (42%), Positives = 103/163 (63%), Gaps = 3/163 (1%)
Query: 76 PENIMCVSRTS-HHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
P+NI+ S IKI+DFG+++KI R + GTPE++ PEI+NY+PI +DMW+
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
IG+I Y+LL+ SPF+GE++ ET+ NI++ D+ +E F ++S+ A DFI SLLVK EK
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKI--ISTDKLKKYIYRRKWQ 235
R TA+ CLSH W+ Q D + S+ + + + R
Sbjct: 279 RPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSED 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-79
Identities = 75/164 (45%), Positives = 106/164 (64%), Gaps = 2/164 (1%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENIMC ++ + +KIIDFGLA K+NPD +V T EF PEI++ EP+G +DMW+I
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ YVLLSGLSPF GE+D ET N+ R +++FD++AF ++S +AKDFI +LL K KR
Sbjct: 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSRH 239
LT L H W+ S+ I + + K + K +++
Sbjct: 297 LTVHDALEHPWLKGDHSNL--TSRIPSSRYNKIRQKIKEKYADW 338
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-79
Identities = 68/163 (41%), Positives = 99/163 (60%), Gaps = 1/163 (0%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENIM ++ S+ +K+IDFGL ++P +V GT EF PE+ +P+G +DMWS+
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV++Y+LLSGLSPF GEND ET N+ +++ DD AF +SED KDFI LL+ R
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 402
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSR 238
+T Q L H W+ ++PG + I + + K K ++
Sbjct: 403 MTIHQALEHPWL-TPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 15/57 (26%), Positives = 28/57 (49%), Gaps = 1/57 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFES 57
P+PP I + +V+++W P DGG ++T Y +E + A W ++ +
Sbjct: 10 PEPPRFPIIENILDEAVILSWKPPALDGGSLVTNYTIEKREAMGGSWSPCAKSRYTY 66
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 8e-79
Identities = 74/158 (46%), Positives = 107/158 (67%), Gaps = 4/158 (2%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+CV+R + IKIIDFGLA++ P +V FGTPEF+ PE++NY+ + +DMWS+
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GVI Y+LLSGLSPF+G+ND+ET NI +D +DE F+ +SE+AK+FIS LL+K K R
Sbjct: 275 GVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
++A + L H W++ ++ +S K K +
Sbjct: 335 ISASEALKHPWLSDHK----LHSRLSAQKKKNRGSDAQ 368
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 8e-76
Identities = 75/141 (53%), Positives = 96/141 (68%), Gaps = 2/141 (1%)
Query: 76 PENIMCVSRT--SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
PENIM + + + IK+IDFG+A KI + + +FGTPEF+ PEI+NYEP+G+E+DMW
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
SIGVITY+LLSG SPF+GE ET NI+ +DFD+E F SE AKDFI LLVK +
Sbjct: 196 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPK 255
Query: 194 KRLTAKQCLSHLWIAQKDSSP 214
+R+T Q L H WI
Sbjct: 256 RRMTIAQSLEHSWIKAIRRRN 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-56
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPP-----RVLFGTPEFIPPEIINY--EPIGI 128
PEN + + S IK++DFGL+++ + GTP F+ PE++N E G
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
+ D WS GV+ ++LL G PF G ND++T + + + F++ + LS A+D +S+LL
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315
Query: 189 VKRKEKRLTAKQCLSHLWIAQKDSSP 214
+ ++R A + L H WI+Q
Sbjct: 316 NRNVDERFDAMRALQHPWISQFSDKI 341
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-56
Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 2/162 (1%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S+ +K+ DFGLA ++N GTP ++ PE++ +P D+W+
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LL G PF E+ +A I +D+ ++ ++ +AK I S+L +K
Sbjct: 216 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 275
Query: 195 RLTAKQCLSHLWIAQKDSSP-GVNKIISTDKLKKYIYRRKWQ 235
R+TA Q L WI ++ +++ + D LKK+ RRK +
Sbjct: 276 RITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLK 317
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-55
Identities = 56/162 (34%), Positives = 87/162 (53%), Gaps = 3/162 (1%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ + +KI DFGL++ + + + GTP + PEI+ G E DMWS
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 135 IGVITYVLLSGLSPFMGE-NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
+G+ITY+LL G PF E D F I E+ F ++ +S +AKD + L+V +
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
KRLT Q L H W+ ++ V+ + KL+++ RRK +
Sbjct: 296 KRLTTFQALQHPWV-TGKAANFVHMDTAQKKLQEFNARRKLK 336
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-55
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 4/163 (2%)
Query: 76 PENIMCVSRTSHH-IKIIDFGLAQKINPDHPP-RVLFGTPEFIPPEIINYEPIGIESDMW 133
P ++ S+ + +K+ FG+A ++ GTP F+ PE++ EP G D+W
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVW 217
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
GVI ++LLSG PF G + F I + ++ + + +SE AKD + +L+
Sbjct: 218 GCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPA 276
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIIST-DKLKKYIYRRKWQ 235
+R+T + L+H W+ ++D + T ++L+K+ RRK +
Sbjct: 277 ERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-54
Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 2/152 (1%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S+ +K+ DFGLA ++N GTP ++ PE++ +P D+W+
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LL G PF E+ +A I +D+ ++ ++ +AK I S+L +K
Sbjct: 193 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 252
Query: 195 RLTAKQCLSHLWIAQKD-SSPGVNKIISTDKL 225
R+TA Q L WI ++ + +++ + D L
Sbjct: 253 RITADQALKVPWICNRERVASAIHRQDTVDCL 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-53
Identities = 48/135 (35%), Positives = 68/135 (50%), Gaps = 3/135 (2%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PENI+ + H IKIIDFGLA+ D GT ++ PE+ + + + D+WS
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWS 210
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GV+ Y LL+G PF G + E T E ++ E L+ A D + +L K E+
Sbjct: 211 AGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPER 269
Query: 195 RLTAKQCLSHLWIAQ 209
R +A Q L H W Q
Sbjct: 270 RPSAAQVLHHEWFKQ 284
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-53
Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 3/163 (1%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPP-RVLFGTPEFIPPEIINYEPIGIESDMW 133
PEN++ S+ +K+ DFGLA ++ + GTP ++ PE++ +P G D+W
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
+ GVI Y+LL G PF E+ + I +DF ++ ++ +AKD I+ +L
Sbjct: 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIIST-DKLKKYIYRRKWQ 235
KR+TA + L H WI+ + + T D LKK+ RRK +
Sbjct: 258 KRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 7/166 (4%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S+ IKI+DFGL+ + GT +I PE++ + + D+WS
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWS 222
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
IGVI ++LL+G PF G+ D E + + ++ FD ++ +SE AKD I +L ++
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQR 282
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKIISTD-----KLKKYIYRRKWQ 235
R++A+Q L H WI + S + + ++K+ +K
Sbjct: 283 RISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-52
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 7/166 (4%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PENI+ S+ IKIIDFGL+ + + GT +I PE++ + D+WS
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LLSG PF G+N+ + + ++ FD + +S+DAKD I +L
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKIISTD-----KLKKYIYRRKWQ 235
R+TA QCL H WI + S + + ++++ +K
Sbjct: 268 RITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLA 313
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-52
Identities = 50/165 (30%), Positives = 90/165 (54%), Gaps = 6/165 (3%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PENI+ ++ S +IKI+DFGL+ + D+ R GT +I PE++ + + D+WS
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWS 232
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LL G PF G+ND + + + ++ FD ++ +S++AK+ I +L K
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNK 292
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKIIST----DKLKKYIYRRKWQ 235
R TA++ L+ WI + ++ + + ++K+ +K
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLA 337
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-52
Identities = 52/145 (35%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII--NYEPIGIESDM 132
PEN + ++ + +K+IDFGLA + P R GTP ++ P+++ Y G E D
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY---GPECDE 190
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
WS GV+ YVLL G PF DSE I F F ++ + +S A+ I LL K
Sbjct: 191 WSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSP 250
Query: 193 EKRLTAKQCLSHLWIAQKDSSPGVN 217
++R+T+ Q L H W ++ SS N
Sbjct: 251 KQRITSLQALEHEWFEKQLSSSPRN 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-51
Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 6/165 (3%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S++ +I+IIDFGL+ + GT +I PE+++ + D+WS
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWS 212
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LLSG PF G N+ + + + ++ F+ ++ +SE AKD I +L
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKIISTD----KLKKYIYRRKWQ 235
R++A+ L H WI + S D ++++ +K
Sbjct: 273 RISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLA 317
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-50
Identities = 52/138 (37%), Positives = 75/138 (54%), Gaps = 2/138 (1%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PENI+ S+ IKIIDFGL+ + + GT +I PE++ + D+WS
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y+LLSG PF G+N+ + + ++ FD + +S+DAKD I +L
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 195 RLTAKQCLSHLWIAQKDS 212
R+TA QCL H WI + S
Sbjct: 268 RITATQCLEHPWIQKYSS 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-49
Identities = 49/145 (33%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII------NYEPIGIE 129
PENI+ + IK+ DFG + +++P R + GTP ++ PEII N+ G E
Sbjct: 152 PENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 130 SDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
DMWS GVI Y LL+G PF I + F ++ S+ KD +S LV
Sbjct: 210 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 269
Query: 190 KRKEKRLTAKQCLSHLWIAQKDSSP 214
+ +KR TA++ L+H + Q
Sbjct: 270 VQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-47
Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 76 PENIMCVSRTSHH--IKIIDFGLAQKINPDHPP-RVLFGTPEFIPPEIINYEPIGIESDM 132
P NI+ V + + I+I DFG A+++ ++ T F+ PE++ + D+
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDI 203
Query: 133 WSIGVITYVLLSGLSPFMG---ENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
WS+GV+ Y +L+G +PF + E A I +F + ++S+ AKD +S +L
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLH 263
Query: 190 KRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
+RLTA L H WI D P +L + +
Sbjct: 264 VDPHQRLTAALVLRHPWIVHWDQLP-------QYQLNRQDAPHLVK 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 46/140 (32%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII------NYEPIGIE 129
PENI+ I++ DFG + + P R L GTP ++ PEI+ + G E
Sbjct: 228 PENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 130 SDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
D+W+ GVI + LL+G PF I ++ F ++ S KD IS LL
Sbjct: 286 VDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQ 345
Query: 190 KRKEKRLTAKQCLSHLWIAQ 209
E RLTA+Q L H + +
Sbjct: 346 VDPEARLTAEQALQHPFFER 365
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 5/156 (3%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESD 131
PEN++ S+ IKI DFG ++ + R L GTP ++ PE++ D
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201
Query: 132 MWSIGVITYVLLSGLSPFMGENDSET-FANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
WS+GVI ++ LSG PF + IT +++F E + +SE A D + LLV
Sbjct: 202 CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
Query: 191 RKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLK 226
+ R T ++ L H W+ +D ++S +
Sbjct: 262 DPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S+ + +K+ DFG A++ + TP ++ PE++ E DMWS
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 135 IGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
+GVI Y+LL G PF + I +++F + + +SE+ K I +LL
Sbjct: 249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT 308
Query: 191 RKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
+R+T + ++H WI Q P + ++ LK+ R +
Sbjct: 309 EPTQRMTITEFMNHPWIMQSTKVPQTP-LHTSRVLKEDKERWE 350
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-46
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPP-RVLFGTPEFIPPEIINYEPIGIESDMW 133
PEN++ + IKIIDFG A+ PD+ P + T + PE++N D+W
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193
Query: 134 SIGVITYVLLSGLSPFMGENDS-------ETFANITRAEFDFDDEAFEALSEDAKDFISS 186
S+GVI Y +LSG PF + S E I + +F F+ EA++ +S++AKD I
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 187 LLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
LL KRL + W+
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-45
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIINYEPIGIESD 131
PEN++ S+ +K+ DFG A++ + L TP ++ PE++ E D
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 132 MWSIGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDDEAFEALSEDAKDFISSL 187
MWS+GVI Y+LL G PF I ++ F + + +SEDAK I L
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 271
Query: 188 LVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLK--KYIYRRKWQF 236
L +RLT Q ++H WI Q P + + L+ K + +
Sbjct: 272 LKTDPTERLTITQFMNHPWINQSMVVPQTP-LHTARVLQEDKDHWDEVKEE 321
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 5/151 (3%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII---NYEPIGIESD 131
PEN++ S+ IKI DFG ++ + R L GTP ++ PE++ D
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 132 MWSIGVITYVLLSGLSPFMGENDSET-FANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
WS+GVI ++ LSG PF + IT +++F E + +SE A D + LLV
Sbjct: 327 CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 386
Query: 191 RKEKRLTAKQCLSHLWIAQKDSSPGVNKIIS 221
+ R T ++ L H W+ +D ++S
Sbjct: 387 DPKARFTTEEALRHPWLQDEDMKRKFQDLLS 417
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-40
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 76 PENIMCVSRTSHH-IKIIDFGLAQKINPDHPPRVLF--------GTPEFIPPEIINYEPI 126
PENI+C +KI DF L I + + G+ E++ PE++
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 127 GIES-----DMWSIGVITYVLLSGLSPFMGENDSET---------------FANITRAEF 166
D+WS+GVI Y+LLSG PF+G S+ F +I ++
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213
+F D+ + +S AKD IS LLV+ ++RL+A Q L H W+
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PEN++ S+ + +K+ DFG A E E DMWS
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFA--------------------KETTG-EKYDKSCDMWS 183
Query: 135 IGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
+GVI Y+LL G PF + I +++F + + +SE+ K I +LL
Sbjct: 184 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT 243
Query: 191 RKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
+R+T + ++H WI Q P + ++ LK+ R +
Sbjct: 244 EPTQRMTITEFMNHPWIMQSTKVPQTP-LHTSRVLKEDKERWE 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-36
Identities = 50/142 (35%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PEN++ S +KI DFG + P L GT +++PPE+I + D+WS+
Sbjct: 137 PENLLLGSA--GELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ Y L G PF ET+ I+R EF F D ++E A+D IS LL +R
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISRLLKHNPSQR 249
Query: 196 LTAKQCLSHLWIAQKDSSPGVN 217
++ L H WI +SS N
Sbjct: 250 PMLREVLEHPWI-TANSSKPSN 270
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-35
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 8/139 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PEN++ + +KI DFG + P R + GT +++PPE+I + + D+W
Sbjct: 142 PENLLMGYK--GELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ Y L G+ PF + +ET I + F LS+ +KD IS LL +R
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF----LSDGSKDLISKLLRYHPPQR 254
Query: 196 LTAKQCLSHLWIAQKDSSP 214
L K + H W+ + +S
Sbjct: 255 LPLKGVMEHPWV-KANSRR 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 20/161 (12%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---------------GTPEFIPPEI 120
P NI S ++KI DFGLA+ ++ L GT ++ E+
Sbjct: 144 PMNIFIDE--SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 121 INYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
++ + DM+S+G+I + ++ G + +F + + +
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKV 259
Query: 180 AKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKII 220
K I L+ KR A+ L+ W+ K + + +
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEAL 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 54/227 (23%), Positives = 84/227 (37%), Gaps = 39/227 (17%)
Query: 36 YVVEMKAGTQPWVELSE----RLFESTERGLGH-HSLVTV--DPKILPENIMCVSRTSHH 88
V + E L G+ H HSL + D K P+NI+ + +
Sbjct: 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK--PQNILVSTSSRFT 155
Query: 89 -----------IKIIDFGLAQKINPDHPPRVLF-----GTPEFIPPEIIN-------YEP 125
I I DFGL +K++ GT + PE++
Sbjct: 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRR 215
Query: 126 IGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF---EALSEDAK 181
+ D++S+G + Y +LS G PF + E +NI R F D+ +L +A
Sbjct: 216 LTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEAT 273
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKY 228
D IS ++ KR TA + L H K +S D+L+
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS-DRLEIE 319
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 8/140 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWS 134
N++ +IKI DFGLA ++ H GTP +I PEI G+ESD+WS
Sbjct: 140 LSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWS 197
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
+G + Y LL G PF + T + A+++ LS +AKD I LL +
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF----LSIEAKDLIHQLLRRNPAD 253
Query: 195 RLTAKQCLSHLWIAQKDSSP 214
RL+ L H ++ ++SS
Sbjct: 254 RLSLSSVLDHPFM-SRNSST 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHH---IKIIDFGLAQKINPDHPPRVLF---- 110
GL H HSL V D K P NI+ +H I DFGL +K+
Sbjct: 130 GLAHLHSLNIVHRDLK--PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 111 GTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEF 166
GT +I PE+++ E D++S G + Y ++S G PF + +
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLK 226
D + A++ I ++ +KR +AK L H + + + +S D+++
Sbjct: 248 DC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVS-DRIE 305
Query: 227 K 227
K
Sbjct: 306 K 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 21/148 (14%), Positives = 44/148 (29%), Gaps = 24/148 (16%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE----------- 124
P +I+ + + + + F + + F PPE+
Sbjct: 234 PVDIV-LDQRGG-VFLTGFEHLVRDGARVVSS---VSRGFEPPELEARRATISYHRDRRT 288
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
+ D W++G++ Y + P + I R+ + + + +
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNI--------PQPVRALL 340
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDS 212
L KE RL Q + Q +
Sbjct: 341 EGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 41/140 (29%), Positives = 60/140 (42%), Gaps = 8/140 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKI-NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
N+ +KI DFGLA K+ +VL GTP +I PE+++ + E D+WS
Sbjct: 143 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
IG I Y LL G PF ET+ I + E+ ++ A I +L
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDPTA 256
Query: 195 RLTAKQCLSHLWIAQKDSSP 214
R T + L+ + P
Sbjct: 257 RPTINELLNDEFF-TSGYIP 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 21/157 (13%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI--GIESDMW 133
P NI+ +K+ DFG + + D + GT EF+PPE + E G + D+W
Sbjct: 180 PSNILMDKN--GRVKLSDFGES-EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 134 SIGVITYVLLSGLSPFMGE-NDSETFANITRAEFDF---------------DDEAFEALS 177
S+G+ YV+ + PF + + E F NI ++ + LS
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
+ DF+ L K +R+T++ L H W+A +
Sbjct: 297 NEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 35/167 (20%)
Query: 76 PENIMCVSRTSHH--IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI------- 126
P NIM V K+ DFG A+++ D L+GT E++ P++ +
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 127 -GIESDMWSIGVITYVLLSGLSPF----MGENDSETFANITRA----------------- 164
G D+WSIGV Y +G PF + E I
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 165 EFDFDDEAFEALSEDAKD----FISSLLVKRKEKRLTAKQCLSHLWI 207
++ D +LS + ++++L +EK Q +
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-31
Identities = 41/140 (29%), Positives = 60/140 (42%), Gaps = 8/140 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKI-NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
N+ +KI DFGLA K+ +VL GTP +I PE+++ + E D+WS
Sbjct: 169 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
IG I Y LL G PF ET+ I + E+ ++ A I +L
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDPTA 282
Query: 195 RLTAKQCLSHLWIAQKDSSP 214
R T + L+ + P
Sbjct: 283 RPTINELLNDEFF-TSGYIP 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEII----------- 121
P N + V +K+IDFG+A ++ PD V GT ++PPE I
Sbjct: 136 PANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFEALSEDA 180
+ I +SD+WS+G I Y + G +PF + I + + +D
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDL 250
Query: 181 KDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYI 229
+D + L + ++R++ + L+H ++ + +T+++K +
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 21/154 (13%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIINYEP------- 125
P N + V +K+IDFG+A ++ PD V GT ++PPE I
Sbjct: 155 PANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 126 ----IGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFEALSEDA 180
I +SD+WS+G I Y + G +PF + I + + +D
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDL 269
Query: 181 KDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
+D + L + ++R++ + L+H ++ Q + P
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYV-QIQTHP 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 37/169 (21%), Positives = 71/169 (42%), Gaps = 20/169 (11%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIINYEP------- 125
P N + V +K+IDFG+A ++ PD V G ++PPE I
Sbjct: 183 PANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 126 ----IGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFEALSEDA 180
I +SD+WS+G I Y + G +PF + I + + +D
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDL 297
Query: 181 KDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYI 229
+D + L + ++R++ + L+H ++ + +T+++K +
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 346
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 22/141 (15%), Positives = 44/141 (31%), Gaps = 11/141 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII--NYEPIGIESDMW 133
P+N+ + + + D K+ P + P E + + + W
Sbjct: 222 PDNLF-IMPDGR-LMLGDVSALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAW 277
Query: 134 SIGVITYVLLSGLSPFMGENDS--ETFANITRAEFDFDDEAFEA---LSEDAKDFISSLL 188
+G+ Y + PF ++ + D AF + L + K I L
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337
Query: 189 VKRKEKRLTAKQCLSHLWIAQ 209
+ +RL + + Q
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQ 358
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 7/140 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
EN++ + +IKI DFG + + G P + PE+ + G E D+WS
Sbjct: 142 AENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
+GVI Y L+SG PF G+N E + R ++ +S D ++ + LV K
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY----MSTDCENLLKRFLVLNPIK 255
Query: 195 RLTAKQCLSHLWIAQKDSSP 214
R T +Q + WI
Sbjct: 256 RGTLEQIMKDRWINAGHEED 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 61 GLGH-HSLVTVDPKIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHP-PRVLFGTP 113
L H +L P N+ ++K+ DFGLA+ +N D + GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 114 EFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173
++ PE +N +SD+WS+G + Y L + + PF + E I +F +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
S++ + I+ +L + R + ++ L + I +
Sbjct: 241 ---SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 13/130 (10%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRV----LFGTPEFIPPEIINYEPIGIES 130
PENI+ HI+I DFG A K+ + GT +++ PE++ + S
Sbjct: 158 PENILL---NEDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 131 DMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
D+W++G I Y L++GL PF N+ F I + E+DF ++ A+D + LLV
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLVEKLLVL 269
Query: 191 RKEKRLTAKQ 200
KRL ++
Sbjct: 270 DATKRLGCEE 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 34/166 (20%), Positives = 55/166 (33%), Gaps = 35/166 (21%)
Query: 76 PENIMCVSRTSHH--IKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI------- 126
P NIM V K+ DFG A+++ D L+GT E++ P++ +
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 127 -GIESDMWSIGVITYVLLSGLSPF----MGENDSETFANITRAEFDFDDEAFE------- 174
G D+WSIGV Y +G PF + E I + +
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 175 --------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
L ++++L +EK Q +
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
LGH H + D K PENIM + H+K+ DFGL + I+ GT E++
Sbjct: 133 ALGHLHQKGIIYRDLK--PENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PEI+ D WS+G + Y +L+G PF GEN +T I + + + L
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----L 244
Query: 177 SEDAKDFISSLLVKRKEKRL 196
+++A+D + LL + RL
Sbjct: 245 TQEARDLLKKLLKRNAASRL 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 14/139 (10%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF----GTPEFIPPEIINYEP---IGI 128
P N++ HIKI DFG++ + L GTP F+ PE ++ G
Sbjct: 165 PSNLLVGE--DGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGK 219
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
D+W++GV Y + G PFM E + I +F D ++ED KD I+ +L
Sbjct: 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRML 277
Query: 189 VKRKEKRLTAKQCLSHLWI 207
K E R+ + H W+
Sbjct: 278 DKNPESRIVVPEIKLHPWV 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 49/144 (34%), Positives = 70/144 (48%), Gaps = 12/144 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
GL HS V D K +NI+ HIKI DFG+ + + D GTP++I
Sbjct: 130 GLQFLHSKGIVYRDLK--LDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYI 185
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PEI+ + D WS GV+ Y +L G SPF G+++ E F +I + L
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----L 241
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQ 200
++AKD + L V+ EKRL +
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRG 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-26
Identities = 20/141 (14%), Positives = 44/141 (31%), Gaps = 17/141 (12%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV--LFGTPEFIPPEIINYEP-----IGI 128
P +I+ + + + + F + + F PE ++ + +
Sbjct: 239 PVDIV-LDQ-RGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
D W++G+ Y + P + I R+ + + + + + L
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFL 348
Query: 189 VKRKEKRLTAKQCLSHLWIAQ 209
KE RL Q + Q
Sbjct: 349 RYPKEDRLLPLQAMETPEYEQ 369
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIINYEPI----GIE 129
P+N++ S H+K+ DFG K+N + R GTP++I PE++ + G E
Sbjct: 196 PDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 130 SDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
D WS+GV Y +L G +PF ++ T++ I + +S++AK+ I + L
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT 313
Query: 190 KRKEKRL 196
R E RL
Sbjct: 314 DR-EVRL 319
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
L H HSL + D K PENI+ HIK+ DFGL+ + I+ + GT E++
Sbjct: 138 ALDHLHSLGIIYRDLK--PENILLDE--EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE++N +D WS GV+ + +L+G PF G++ ET I +A+ L
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----L 249
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S +A+ + L + RL
Sbjct: 250 SPEAQSLLRMLFKRNPANRL 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 42/140 (30%), Positives = 61/140 (43%), Gaps = 9/140 (6%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
GL H V D K PENI+ H HI+I D GLA + + GT ++
Sbjct: 298 GLEDLHRERIVYRDLK--PENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYM 352
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE++ E D W++G + Y +++G SPF + R + +E E
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S A+ S LL K +RL
Sbjct: 413 SPQARSLCSQLLCKDPAERL 432
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 11/139 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDM 132
EN + + +KI DFG ++ P+ GTP +I PE++ Y+ G +D+
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD--GKIADV 201
Query: 133 WSIGVITYVLLSGLSPFMGENDSETF----ANITRAEFDFDDEAFEALSEDAKDFISSLL 188
WS GV YV+L G PF + + I ++ D+ +S + IS +
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIF 259
Query: 189 VKRKEKRLTAKQCLSHLWI 207
V R++ + +H W
Sbjct: 260 VADPATRISIPEIKTHSWF 278
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 46/140 (32%), Positives = 66/140 (47%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
L + HS V D K EN+M HIKI DFGL + I+ + GTPE++
Sbjct: 117 ALEYLHSRDVVYRDIK--LENLMLDK--DGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE++ G D W +GV+ Y ++ G PF ++ F I E F L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----L 228
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S +AK ++ LL K ++RL
Sbjct: 229 SPEAKSLLAGLLKKDPKQRL 248
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
L H + D K +N++ H K+ DFG+ + I GTP++I
Sbjct: 136 ALMFLHDKGIIYRDLK--LDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYI 191
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PEI+ G D W++GV+ Y +L G +PF EN+ + F I E + L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----L 247
Query: 177 SEDAKDFISSLLVKRKEKRL 196
EDA + S + K RL
Sbjct: 248 HEDATGILKSFMTKNPTMRL 267
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-26
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 13/131 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEII-------NYEPI 126
P+NI+ HI++ DFG K+ D R V GTP+++ PEI+
Sbjct: 190 PDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE-ALSEDAKDFIS 185
G E D W++GV Y + G +PF ++ +ET+ I + + + E+A+DFI
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQ 307
Query: 186 SLLVKRKEKRL 196
LL E RL
Sbjct: 308 RLLCPP-ETRL 317
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 15/139 (10%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIIN----YEPIGI 128
P N++ + +KI G+A+ ++P G+P F PPEI N + G
Sbjct: 137 PGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS--GF 192
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
+ D+WS GV Y + +GL PF G+N + F NI + + + D + +L
Sbjct: 193 KVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD----CGPPLSDLLKGML 248
Query: 189 VKRKEKRLTAKQCLSHLWI 207
KR + +Q H W
Sbjct: 249 EYEPAKRFSIRQIRQHSWF 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 15/154 (9%)
Query: 60 RGLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
L H HS V D K P NI + K+ DFGL ++ V G P ++
Sbjct: 168 LALAHLHSQGLVHLDVK--PANIF-LGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLS-PFMGENDSETFANITRAEFDFDDEAFEA 175
PE++ G +D++S+G+ + + P GE + EF
Sbjct: 224 APELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAG 276
Query: 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
LS + + + +L + R TA+ L+ + Q
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 48/140 (34%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
GL S + D K +N+M S HIKI DFG+ + I + GTP++I
Sbjct: 133 GLFFLQSKGIIYRDLK--LDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYI 188
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PEII Y+P G D W+ GV+ Y +L+G +PF GE++ E F +I + +
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----M 244
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S++A L+ K KRL
Sbjct: 245 SKEAVAICKGLMTKHPGKRL 264
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 29/165 (17%), Positives = 62/165 (37%), Gaps = 21/165 (12%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
PENI+ KIID G A++++ GT +++ PE++ + + D WS
Sbjct: 149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE-------------------- 174
G + + ++G PF+ + R + + ++
Sbjct: 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSG 268
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI 219
L+ + ++ +L+ + +R T Q + DS + +
Sbjct: 269 ILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLL 313
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 45/129 (34%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIINYEPI-----GI 128
P+NI+ + HI++ DFG K+ D + V GTP++I PEI+ G
Sbjct: 203 PDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-DEAFEALSEDAKDFISSL 187
E D WS+GV Y +L G +PF E+ ET+ I + F +SE+AKD I L
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320
Query: 188 LVKRKEKRL 196
+ +E RL
Sbjct: 321 I-CSREHRL 328
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 49/144 (34%), Positives = 70/144 (48%), Gaps = 14/144 (9%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSH-HIKIIDFGLA-QKINPDHPPRVLFGTPEF 115
LG+ HSL V D K PENI+ S HI + DFGL + I + GTPE+
Sbjct: 151 ALGYLHSLNIVYRDLK--PENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175
+ PE+++ +P D W +G + Y +L GL PF N +E + NI
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN---- 261
Query: 176 LSEDAKDFISSLLVKRKEKRLTAK 199
++ A+ + LL K + KRL AK
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAK 285
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 7/133 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
PEN++ + ++KI DFGL+ + + + G+P + PE+IN + G E D+WS
Sbjct: 136 PENLLLDD--NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
G++ YV+L G PF E F + + D LS A+ I ++V +
Sbjct: 194 CGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF----LSPGAQSLIRRMIVADPMQ 249
Query: 195 RLTAKQCLSHLWI 207
R+T ++ W
Sbjct: 250 RITIQEIRRDPWF 262
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-25
Identities = 41/133 (30%), Positives = 58/133 (43%), Gaps = 7/133 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
PEN++ + + KI DFGL+ ++ R G+P + PE+I+ G E D+WS
Sbjct: 139 PENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
GVI Y LL G PF E+ F I F + L+ + +L K
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY----LNRSVATLLMHMLQVDPLK 252
Query: 195 RLTAKQCLSHLWI 207
R T K H W
Sbjct: 253 RATIKDIREHEWF 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 48/140 (34%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
GL S + D K +N+M S HIKI DFG+ + I + GTP++I
Sbjct: 454 GLFFLQSKGIIYRDLK--LDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYI 509
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PEII Y+P G D W+ GV+ Y +L+G +PF GE++ E F +I + +
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----M 565
Query: 177 SEDAKDFISSLLVKRKEKRL 196
S++A L+ K KRL
Sbjct: 566 SKEAVAICKGLMTKHPGKRL 585
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-25
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 10/135 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
P NI V + +KI DFGL + D GT ++ PE I+ + G E D++++
Sbjct: 150 PSNIFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G+I LL S+ F ++ + + K + LL K+ E R
Sbjct: 208 GLILAELLHVCDTAF--ETSKFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDR 259
Query: 196 LTAKQCLSHLWIAQK 210
+ L L + +K
Sbjct: 260 PNTSEILRTLTVWKK 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 46/141 (32%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 61 GLGH-HSLVTV---DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEF 115
L + HS V D K EN+M HIKI DFGL + I + GTPE+
Sbjct: 260 ALDYLHSEKNVVYRDLK--LENLMLDK--DGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175
+ PE++ G D W +GV+ Y ++ G PF ++ + F I E F
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RT 371
Query: 176 LSEDAKDFISSLLVKRKEKRL 196
L +AK +S LL K ++RL
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRL 392
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 18/149 (12%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSH-HIKIIDFGLA-QKINPDHPPRVLFGTPEF 115
GL H H + D K PEN++ +++I D GLA + + GTP F
Sbjct: 301 GLEHLHQRNIIYRDLK--PENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS----ETFANITRAEFDFDDE 171
+ PE++ E D +++GV Y +++ PF + E + + D+
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQ 200
S +KDF +LL K EKRL +
Sbjct: 416 ----FSPASKDFCEALLQKDPEKRLGFRD 440
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
ENI+ + +K+IDFG + D GT + PPE I Y G + +WS
Sbjct: 177 DENIL-IDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
+G++ Y ++ G PF + + I R + F +S + + I L R
Sbjct: 235 LGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSECQHLIRWCLALRPSD 284
Query: 195 RLTAKQCLSHLWIAQKDSSP 214
R T ++ +H W+ Q P
Sbjct: 285 RPTFEEIQNHPWM-QDVLLP 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-24
Identities = 33/206 (16%), Positives = 62/206 (30%), Gaps = 33/206 (16%)
Query: 39 EMKAGTQPWVELSE----RLFESTERGLGH-HSLVTVDPKIL-----PENIMCVSRTSHH 88
E++ L+E L RGL H+ P NI+
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-----KGYAHRDLKPTNILLGD--EGQ 172
Query: 89 IKIIDFGLAQKINPDHPPRV----------LFGTPEFIPPEIIN---YEPIGIESDMWSI 135
++D G + T + PE+ + + I +D+WS+
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 136 GVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
G + Y ++ G P+ ++ A + + S ++S++ +
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQ 290
Query: 195 RLTAKQCLSHLWIAQKDSSPGVNKII 220
R LS L Q + I
Sbjct: 291 RPHIPLLLSQLEALQPPAPGQHTTQI 316
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-24
Identities = 42/142 (29%), Positives = 61/142 (42%), Gaps = 12/142 (8%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDM 132
PEN++ + + KI DFGL+ ++ R G+P + PE+I+ Y G E D+
Sbjct: 144 PENVLLDA--HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA--GPEVDI 199
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
WS GVI Y LL G PF ++ F I F L+ + +L
Sbjct: 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY----LNPSVISLLKHMLQVDP 255
Query: 193 EKRLTAKQCLSHLWIAQKDSSP 214
KR T K H W ++D
Sbjct: 256 MKRATIKDIREHEWF-KQDLPK 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-24
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 13/143 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
ENI+ IK+IDFG A + GT E+ PE++ P G E +MWS
Sbjct: 158 DENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWS 215
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
+GV Y L+ +PF A +S++ +S LL E+
Sbjct: 216 LGVTLYTLVFEENPF------CELEETVEAAIHPPYL----VSKELMSLVSGLLQPVPER 265
Query: 195 RLTAKQCLSHLWIAQKDSSPGVN 217
R T ++ ++ W+ Q +
Sbjct: 266 RTTLEKLVTDPWVTQPVNLADYT 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-23
Identities = 46/121 (38%), Positives = 65/121 (53%), Gaps = 8/121 (6%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENI+ HIKI DFG A K PD L GTP++I PE+++ +P D WS
Sbjct: 134 PENILLDKNG--HIKITDFGFA-KYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
G++ Y +L+G +PF N +T+ I AE F +ED KD +S L+ + +R
Sbjct: 190 GILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDLLSRLITRDLSQR 245
Query: 196 L 196
L
Sbjct: 246 L 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 18/144 (12%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
GL H H+ V D K P NI+ H H++I D GLA P GT ++
Sbjct: 304 GLEHMHNRFVVYRDLK--PANILL---DEHGHVRISDLGLA-CDFSKKKPHASVGTHGYM 357
Query: 117 PPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGEND---SETFANITRAEFDFDDEA 172
PE++ +D +S+G + + LL G SPF E + D
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS- 416
Query: 173 FEALSEDAKDFISSLLVKRKEKRL 196
S + + + LL + +RL
Sbjct: 417 ---FSPELRSLLEGLLQRDVNRRL 437
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-23
Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 13/133 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWS 134
ENI+ + K+IDFG + D P GT + PPE I+ + + +WS
Sbjct: 167 DENIL-IDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWS 224
Query: 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
+G++ Y ++ G PF + + I AE F +S D I L +
Sbjct: 225 LGILLYDMVCGDIPFERDQE------ILEAELHFPAH----VSPDCCALIRRCLAPKPSS 274
Query: 195 RLTAKQCLSHLWI 207
R + ++ L W+
Sbjct: 275 RPSLEEILLDPWM 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-23
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
L + H + D K +N++ S HIK+ D+G+ + + P GTP +I
Sbjct: 122 ALNYLHERGIIYRDLK--LDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 177
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM---------GENDSETFANITRAEFD 167
PEI+ E G D W++GV+ + +++G SPF + F I +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRL 196
LS A + S L K ++RL
Sbjct: 238 IPRS----LSVKAASVLKSFLNKDPKERL 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PEN++ + +I++ DFG A+++ L GTPE + PEII + D W++
Sbjct: 169 PENLLIDQQG--YIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ Y + +G PF + + + I + F S D KD + +LL KR
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVDLTKR 280
Query: 196 L 196
Sbjct: 281 F 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-23
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 6/161 (3%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDM 132
I +NI +++ DFG+A+ +N GTP ++ PEI +P +SD+
Sbjct: 151 IKSQNIFLTK--DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
W++G + Y L + F + I F + S D + +S L +
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY---SYDLRSLVSQLFKRNP 265
Query: 193 EKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
R + L +IA++ ++I+ + K +
Sbjct: 266 RDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-22
Identities = 29/139 (20%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIIN---YEPIGIE 129
PEN++ R ++KI DFGLA ++ R+L GT ++ PE++ +
Sbjct: 133 PENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEP 188
Query: 130 SDMWSIGVITYVLLSGLSPF-MGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
D+WS G++ +L+G P+ + + +++ + + ++ + + +L
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKIL 246
Query: 189 VKRKEKRLTAKQCLSHLWI 207
V+ R+T W
Sbjct: 247 VENPSARITIPDIKKDRWY 265
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLA-QKINPDHPPRVLFGTPEFI 116
L + H + D K +N++ S HIK+ D+G+ + + P GTP +I
Sbjct: 165 ALNYLHERGIIYRDLK--LDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 220
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFM---------GENDSETFANITRAEFD 167
PEI+ E G D W++GV+ + +++G SPF + F I +
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRL 196
LS A + S L K ++RL
Sbjct: 281 IPRS----LSVKAASVLKSFLNKDPKERL 305
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 29/139 (20%), Positives = 51/139 (36%), Gaps = 15/139 (10%)
Query: 76 PENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPI---GIESD 131
P+NI+ H H+ I DF +A + + + GT ++ PE+ + D
Sbjct: 143 PDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 132 MWSIGVITYVLLSGLSPFMG---ENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
WS+GV Y LL G P+ + E + A S++ + LL
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLL 255
Query: 189 VKRKEKRL-TAKQCLSHLW 206
++R + +
Sbjct: 256 EPNPDQRFSQLSDVQNFPY 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-22
Identities = 29/139 (20%), Positives = 61/139 (43%), Gaps = 13/139 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIIN---YEPIGIE 129
PEN++ R ++KI DFGLA ++ R+L GT ++ PE++ +
Sbjct: 133 PENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEP 188
Query: 130 SDMWSIGVITYVLLSGLSPF-MGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLL 188
D+WS G++ +L+G P+ + + +++ + + ++ + + +L
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKIL 246
Query: 189 VKRKEKRLTAKQCLSHLWI 207
V+ R+T W
Sbjct: 247 VENPSARITIPDIKKDRWY 265
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 21/148 (14%)
Query: 61 GLGH-HSLVTV--DPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRV--LFGTPE 114
L H H L + D K ENI+ S+ H+ + DFGL+++ D R GT E
Sbjct: 171 ALEHLHKLGIIYRDIK--LENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 115 FIPPEIINYEPIGIES--DMWSIGVITYVLLSGLSPFMGEND----SETFANITRAEFDF 168
++ P+I+ G + D WS+GV+ Y LL+G SPF + + +E I ++E +
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 169 DDEAFEALSEDAKDFISSLLVKRKEKRL 196
E +S AKD I LL+K +KRL
Sbjct: 286 PQE----MSALAKDLIQRLLMKDPKKRL 309
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 25/156 (16%), Positives = 47/156 (30%), Gaps = 24/156 (15%)
Query: 65 HSLVTVDPKILPENIMCVSR---------TSHHIKIIDFGLAQKINPDHPPRVLF----G 111
H + I P+N + + S + +ID G + + P +F
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK-LFPKGTIFTAKCE 247
Query: 112 TPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFDFDD 170
T F E+++ +P + D + + Y +L G + E + R D
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLD- 306
Query: 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
+F +L L + L
Sbjct: 307 --------MWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-20
Identities = 43/198 (21%), Positives = 70/198 (35%), Gaps = 37/198 (18%)
Query: 50 LSE----RLFESTERGLGH-HSLVTVDPKIL-----PENIMCVSRTSHHIKIIDFGLAQK 99
LS ++F T R + H H P I+ EN++ + IK+ DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSN--QGTIKLCDFGSATT 187
Query: 100 INPDHPPRVL-------------FGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLL 143
I+ TP + PEII+ PIG + D+W++G I Y+L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 144 SGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203
PF I ++ + I ++L E+RL+ + +
Sbjct: 248 FRQHPFEDGA----KLRIVNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301
Query: 204 HLWIAQKDSSPGVNKIIS 221
L + I+
Sbjct: 302 QLQEIAAARNVNPKSPIT 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-19
Identities = 29/150 (19%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-------------GTPEFIPPEIIN 122
P NI +K+ DFGL ++ D + + GT ++ PE I+
Sbjct: 146 PSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203
Query: 123 YEPIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAEFDFDDEAFEALSEDAK 181
+ D++S+G+I + L L PF + + T ++ +F F
Sbjct: 204 GNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLTDVRNLKF---PPLFTQKYPCEY 257
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211
+ +L +R A + + D
Sbjct: 258 VMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-18
Identities = 27/145 (18%), Positives = 50/145 (34%), Gaps = 20/145 (13%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-------------GTPEFIPPEIIN 122
P NI +K+ DFGL ++ D + + GT ++ PE I+
Sbjct: 192 PSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 123 YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKD 182
+ D++S+G+I + LL S M ++ +F F
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLL---FTQKYPQEHM 304
Query: 183 FISSLLVKRKEKRLTAKQCLSHLWI 207
+ +L +R A + +
Sbjct: 305 MVQDMLSPSPTERPEATDIIENAIF 329
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 31/144 (21%), Positives = 60/144 (41%), Gaps = 7/144 (4%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDM 132
I P N+ ++ + +K+ D GL + + L GTP ++ PE I+ +SD+
Sbjct: 162 IKPANVF-ITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 133 WSIGVITYVLLSGLSPFMGENDS--ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
WS+G + Y + + SPF G+ + I + D+ + SE+ + ++ +
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINP 277
Query: 191 RKEKRLTAKQCLSHLWIAQKDSSP 214
EKR ++
Sbjct: 278 DPEKRPDVTYVYDVAKRMHACTAS 301
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-17
Identities = 29/134 (21%), Positives = 61/134 (45%), Gaps = 6/134 (4%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGV 137
NI ++ + +KI D GLA V+ GTPEF+ PE+ E D+++ G+
Sbjct: 161 NIF-ITGPTGSVKIGDLGLATLKRASFAKAVI-GTPEFMAPEMYE-EKYDESVDVYAFGM 217
Query: 138 ITYVLLSGLSPFMG-ENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRL 196
+ + P+ +N ++ + +T + + + K+ I + + K++R
Sbjct: 218 CMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY 275
Query: 197 TAKQCLSHLWIAQK 210
+ K L+H + ++
Sbjct: 276 SIKDLLNHAFFQEE 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 18/121 (14%), Positives = 46/121 (38%), Gaps = 10/121 (8%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSP 148
KI D G +I+ P+V G F+ E++ ++D++++ +
Sbjct: 174 KIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 149 FMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208
+ + + I + + LS++ + + ++ E+R +A + H +
Sbjct: 231 P---RNGDQWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
Query: 209 Q 209
Sbjct: 285 S 285
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 40/211 (18%), Positives = 63/211 (29%), Gaps = 71/211 (33%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPP-------RVLFGTPEFIPPEIINYEPIGI 128
PENI+ + IK+IDFG + + R PE+I G+
Sbjct: 228 PENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR---------APEVILGARYGM 278
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANI---------------TRAEFDFDDEAF 173
DMWS+G I LL+G GE++ + A + RA+ + +
Sbjct: 279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGY 338
Query: 174 EALSEDAK----------------------------------------DFISSLLVKRKE 193
DF+ L
Sbjct: 339 PRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIISTDK 224
R+T Q L H W+ ++ P + S +
Sbjct: 399 VRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 33/96 (34%), Positives = 45/96 (46%), Gaps = 12/96 (12%)
Query: 60 RGLGH-HS--LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
L + HS LV D K PENIM T +K+ID G +IN L+GTP F
Sbjct: 193 PALSYLHSIGLVYNDLK--PENIM---LTEEQLKLIDLGAVSRINSFGY---LYGTPGFQ 244
Query: 117 PPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE 152
PEI+ P + +D++++G L L G
Sbjct: 245 APEIVRTGPT-VATDIYTVGRTLAALTLDLPTRNGR 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 27/148 (18%), Positives = 53/148 (35%), Gaps = 10/148 (6%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF------GTPEFIPPEIINYEPIG 127
+ +N++ +S + DFG A + PD + L GT + PE++ +P
Sbjct: 176 VKADNVL-LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 128 IESDMWSIGVITYV-LLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISS 186
+ D+WS + +L+G P+ I + + + I
Sbjct: 235 AKVDIWSSC-CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQAIQE 292
Query: 187 LLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
L K R +A + + A ++
Sbjct: 293 GLRKEPVHRASAMELRRKVGKALQEVGG 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-14
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 17/149 (11%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIG--IES 130
I +N++ ++ S +KI DFG ++++ +P F GT +++ PEII+ P G +
Sbjct: 148 IKGDNVL-INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 131 DMWSIGVITYV-LLSGLSPFMGENDSETFANITRAEF-----DFDDEAFEALSEDAKDFI 184
D+WS+G T + + +G PF E A F E E++S +AK FI
Sbjct: 207 DIWSLG-CTIIEMATGKPPF-----YE-LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213
+KR A L ++
Sbjct: 260 LKCFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >1bpv_A Titin, A71, connectin; fibronectin type III; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 112 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-12
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 1/59 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
DPP + ++ R +V + W+ P Y GG IT Y+VE + W++ + E
Sbjct: 11 IDPPGKPVPLNITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKANFSNILENE 69
|
| >2yuw_A Myosin binding protein C, SLOW type; fibronectin III domain, SLOW- type protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 110 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-12
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
PP+ S T+V + W P + G + GYV+E GT+ W+ ++ L + T+
Sbjct: 8 TSPPTLLTVDSVTDTTVTMRWRPPDHIGAAGLDGYVLEYCFEGTEDWIVANKDLIDKTK 66
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 32/124 (25%), Positives = 64/124 (51%), Gaps = 4/124 (3%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+K+ DFG +I+ D P R GTP ++ PE+I+ E D+WS+G++ ++ G
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 147 SPFMGENDSETFANITRAEF-DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
P+ ++ + + + + +S +DF+ +LV+ ++R TA++ L H
Sbjct: 239 PPYFSDSPVQAMKRLRDSPPPKLKNS--HKVSPVLRDFLERMLVRDPQERATAQELLDHP 296
Query: 206 WIAQ 209
++ Q
Sbjct: 297 FLLQ 300
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 20/161 (12%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
H K+ DFG+A ++ R GTP ++ PE+I +D+WS+G+ + G
Sbjct: 163 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 147 SPFMGENDSETFANITRAEF--------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTA 198
P+ + RA F F E S++ DF+ LVK E+R TA
Sbjct: 223 PPYADIH-------PMRAIFMIPTNPPPTFRKP--ELWSDNFTDFVKQCLVKSPEQRATA 273
Query: 199 KQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSRH 239
Q L H ++ + +I ++ +R+ R
Sbjct: 274 TQLLQHPFVRSAKGVSILRDLI--NEAMDVKLKRQESQQRE 312
|
| >2yux_A Myosin-binding protein C, SLOW-type; fibronectin III domain, structural genomics., NPPSFA; NMR {Homo sapiens} Length = 120 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-12
Identities = 15/59 (25%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFEST 58
P PP +V +TW+ P DG ITGY ++ + W + E ++
Sbjct: 17 RPGPPQIVKIEDVWGENVALTWTPPKDDGNAAITGYTIQKADKKSMEWFTVIEHYHRTS 75
|
| >1x5y_A Myosin binding protein C, fast-type; fast MYBP-C, fibronectin type III domain containing protein, cytoskeleton, muscle contraction; NMR {Mus musculus} SCOP: b.1.2.1 Length = 111 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-12
Identities = 14/59 (23%), Positives = 21/59 (35%), Gaps = 1/59 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
P T+ + W P G I GY+VE G++ WV ++ E
Sbjct: 9 TSAPQHLTVEDVTDTTTTLKWRPPDRIGAGGIDGYLVEYCLEGSEEWVPANKEPVERCG 67
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 34/183 (18%), Positives = 60/183 (32%), Gaps = 50/183 (27%)
Query: 76 PENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESD 131
PEN++ IKI D G A + + + T E+ PE++ P G +D
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREYRSPEVLLGAPWGCGAD 217
Query: 132 MWSIGVITYVLLSGLSPFMGENDSETFANI---------------------TRAEFDFDD 170
+WS + + L++G F + + F+
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 171 --------------------EAFEALSEDAK---DFISSLLVKRKEKRLTAKQCLSHLWI 207
E ++ ++AK DF+S +L KR A ++H W+
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 208 AQK 210
Sbjct: 338 KDT 340
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 4/124 (3%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+K+ DFG +I P+ R GTP ++ PE++ + G + D+WS+G++ ++ G
Sbjct: 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 147 SPFMGENDSETFANITRAEF-DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
P++ EN I + + E LS +DF++ L EKR +AK+ L H
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 206 WIAQ 209
++
Sbjct: 272 FLKI 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-11
Identities = 38/165 (23%), Positives = 59/165 (35%), Gaps = 45/165 (27%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPI 126
PENI+ + IK+ DFG A+ + P E PE++ Y P
Sbjct: 130 PENILITKHS--VIKLCDFGFARLLTG--PSDYY--DDEVATRWYRSPELLVGDTQYGP- 182
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA-------------------EFD 167
+ D+W+IG + LLSG+ + G++D + I +
Sbjct: 183 PV--DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 168 FDD--------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
D F +S A + L +RLT +Q L H
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-11
Identities = 25/95 (26%), Positives = 39/95 (41%), Gaps = 16/95 (16%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPP-------RVLFGTPEFIPPEIINYEPIGI 128
PENI+ + IKI+DFG + ++ R PE++ P +
Sbjct: 187 PENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR---------SPEVLLGMPYDL 237
Query: 129 ESDMWSIGVITYVLLSGLSPFMGENDSETFANITR 163
DMWS+G I + +G F G N+ + I
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-11
Identities = 34/153 (22%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIES-----DMWSIGVITYV 141
+K++DFG++ +++ R F GTP ++ PE+I + + D+WS+G+
Sbjct: 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 142 LLSGLSPFMGENDSETFANITRAEF-DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200
+ G P + I R + + S+ + FI S LVK +R +Q
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQ 283
Query: 201 CLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
+ H +I + + V + D + + +R
Sbjct: 284 LMKHPFIRDQPNERQVRIQL-KDHIDRTKKKRG 315
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-11
Identities = 33/127 (25%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGL 146
+K+ DFG+A ++ R F GTP ++ PE+I ++D+WS+G+ L G
Sbjct: 157 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
Query: 147 SPFMGENDSETFANITRAE---FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203
P + + I + + S+ K+F+ + L K R TAK+ L
Sbjct: 217 PPHSELHPMKVLFLIPKNNPPTLE------GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270
Query: 204 HLWIAQK 210
H +I +
Sbjct: 271 HKFILRN 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 23/154 (14%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPI-----GIESDMWSIGVITYV 141
I++ DFG++ K R F GTP ++ PE++ E + ++D+WS+G+
Sbjct: 155 DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
Query: 142 LLSGLSPFMGENDSETFANITRAEF--------DFDDEAFEALSEDAKDFISSLLVKRKE 193
+ P N R S + +DF+ L K E
Sbjct: 215 MAQIEPPHHELN-------PMRVLLKIAKSDPPTLLTP--SKWSVEFRDFLKIALDKNPE 265
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKK 227
R +A Q L H +++ S+ + ++++ K +
Sbjct: 266 TRPSAAQLLEHPFVSSITSNKALRELVAEAKAEV 299
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 36/164 (21%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWS 134
P N+M + +++ID+GLA+ +P V + F PE++ +Y+ DMWS
Sbjct: 158 PHNVM-IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216
Query: 135 IGVITYVLLSGLSPF----------------MGENDSETFANITRAEFD----------- 167
+G + ++ PF +G D + + E D
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276
Query: 168 -------FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
E +S +A DF+ LL + RLTA++ + H
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 42/154 (27%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+K+ DFGLA+ P R T E + P+++ Y + D+WSIG I
Sbjct: 157 ALKLADFGLARAFGI--PVRSY--THEVVTLWYRAPDVLMGSKKYST-SV--DIWSIGCI 209
Query: 139 TYVLLSGLSPFMGENDSETFANITRA-------------------EFDFDD-------EA 172
+++G F G D + I + F
Sbjct: 210 FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI 269
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
++ D +S++L KR++A+ ++H +
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >2crz_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 110 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-10
Identities = 13/53 (24%), Positives = 19/53 (35%), Gaps = 2/53 (3%)
Query: 2 PDPPSGAIGVSNNR-TSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSE 52
P P + + + W P DGG I+ Y VEM E+ +
Sbjct: 9 PGPCLPPRLQGRPKAKEIQLRWGPPLVDGGSPISCYSVEMSPIEKDEPREVYQ 61
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 33/165 (20%), Positives = 53/165 (32%), Gaps = 45/165 (27%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPI 126
PENI+ +K+ DFG A+ + P V E PE++ Y
Sbjct: 152 PENILVSQSG--VVKLCDFGFARTLAA--PGEVY--DDEVATRWYRAPELLVGDVKYGK- 204
Query: 127 GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA-------------------EFD 167
+ D+W+IG + + G F G++D + +I
Sbjct: 205 AV--DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 168 FDD--------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ + LSE D L +KR + L H
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307
|
| >2crm_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 120 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-10
Identities = 17/54 (31%), Positives = 21/54 (38%), Gaps = 3/54 (5%)
Query: 2 PDPPSGAIGVSN-NRTSVVITWSSPPYDGGCMITGYVVEMKAGTQ--PWVELSE 52
P P + S ITW P +GG I YVVEM G+ W +
Sbjct: 18 PGIPVKPSVKGKIHSHSFKITWDPPKDNGGATINKYVVEMAEGSNGNKWEMIYS 71
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-10
Identities = 34/203 (16%), Positives = 58/203 (28%), Gaps = 73/203 (35%)
Query: 76 PENIMCVSRTSHH-----------------IKIIDFGLAQKINPDHPP-------RVLFG 111
PENI+ V+ I++ DFG A + H R
Sbjct: 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR---- 206
Query: 112 TPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI---------- 161
PPE+I D+WSIG I + G + F + E +
Sbjct: 207 -----PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSH 261
Query: 162 -----TRAEFDFDDEA-FEALSEDAK------------------------DFISSLLVKR 191
+ ++ + ++ S D + D + +L
Sbjct: 262 MIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321
Query: 192 KEKRLTAKQCLSHLWIAQKDSSP 214
+R+T + L H + A
Sbjct: 322 PAQRITLAEALLHPFFAGLTPEE 344
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 42/162 (25%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+KI DFGLA+ P R T E I PPEI+ +Y D+WSI I
Sbjct: 175 VLKIGDFGLARAFGI--PIRQF--THEIITLWYRPPEILLGSRHY---STSVDIWSIACI 227
Query: 139 TYVLLSGLSPFMGENDSETFANITR--------------------AEF------DFDDEA 172
+L F G+++ + I F
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
L ++ D ++++L KR++AK L H + + D P
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-10
Identities = 29/158 (18%), Positives = 55/158 (34%), Gaps = 39/158 (24%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII---NYEPIGIESDMWSIGVIT 139
+K+ DFGLA+ + + TP + PE++ Y + DMWS+G I
Sbjct: 158 TVKLADFGLARIY--SYQMAL---TPVVVTLWYRAPEVLLQSTYAT-PV--DMWSVGCIF 209
Query: 140 YVLLSGLSPFMGENDSETFANITRA----------------EFDFDD-------EAFEAL 176
+ F G ++++ I F +
Sbjct: 210 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM 269
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
E + +L KR++A + L H ++ + + +P
Sbjct: 270 EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-10
Identities = 39/193 (20%), Positives = 64/193 (33%), Gaps = 48/193 (24%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+K+ DFGLA+ + P + E + PP+I+ +Y I DMW +G I
Sbjct: 138 ELKLADFGLARAKSI--PTKTY--DNEVVTLWYRPPDILLGSTDYST-QI--DMWGVGCI 190
Query: 139 TYVLLSGLSPFMGENDSETFANITRA-------------------EFDFDD-------EA 172
Y + +G F G E I R +++
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS----PGVNKIISTD--KLK 226
L D D ++ LL R++A+ + H + P I + +L+
Sbjct: 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQ 310
Query: 227 KYIYRRKWQFSRH 239
K R H
Sbjct: 311 KEASLRSAHHHHH 323
|
| >1uem_A KIAA1568 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 117 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-10
Identities = 12/60 (20%), Positives = 26/60 (43%), Gaps = 3/60 (5%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEM--KAGTQPWVELSERLFEST 58
+P PPS + SV ++W P G + Y++E ++ + W ++ + +
Sbjct: 15 LPGPPSKPQVTDVTKNSVTLSWQ-PGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTL 73
|
| >2haz_A N-CAM 1, neural cell adhesion molecule 1; fibronectin type III repeat, FN1, beta sandwich; 1.70A {Homo sapiens} SCOP: b.1.2.1 Length = 105 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-10
Identities = 12/59 (20%), Positives = 20/59 (33%), Gaps = 2/59 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFEST 58
P P V ++ + + P GG I Y E + G + W E++
Sbjct: 6 TPSSP-SIDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEAS 63
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-10
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDH--PPRVLFGTPEFIPPEIINYEPIGIESD 131
I P+NI+ + +KI DFG+A+ ++ + GT ++ PE E +D
Sbjct: 137 IKPQNIL-IDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 132 MWSIGVITYVLLSGLSPFMGEN 153
++SIG++ Y +L G PF GE
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGET 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 37/158 (23%), Positives = 53/158 (33%), Gaps = 46/158 (29%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+K+ DFGLA+ P + E + P+++ Y I D+WS G I
Sbjct: 146 QLKLGDFGLARAFGI--PVNTF--SSEVVTLWYRAPDVLMGSRTYST-SI--DIWSCGCI 198
Query: 139 TYVLLSGLSPFMGENDSETFANITR--------------------AEF----------DF 168
+++G F G ND E I
Sbjct: 199 LAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258
Query: 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
E L + DF+ LL + RL+AKQ L H W
Sbjct: 259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-10
Identities = 26/82 (31%), Positives = 47/82 (57%), Gaps = 6/82 (7%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPP----RVLFGTPEFIPPEIINYEPIGIESD 131
P NIM +S T + +K++DFG+A+ I + GT +++ PE + + SD
Sbjct: 144 PANIM-ISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 132 MWSIGVITYVLLSGLSPFMGEN 153
++S+G + Y +L+G PF G++
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDS 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-10
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 41/153 (26%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+KI DFGLA+ P R T E + P+++ Y I D+WS+G I
Sbjct: 138 ELKIADFGLARAFGI--PVRKY--THEIVTLWYRAPDVLMGSKKYST-TI--DIWSVGCI 190
Query: 139 TYVLLSGLSPFMGENDSETFANITRA------------------EFDFD-------DEAF 173
+++G F G ++++ I R + +F +
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
+ L E D +S +L +R+TAKQ L H +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >1x4z_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1 Length = 121 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-10
Identities = 15/55 (27%), Positives = 24/55 (43%), Gaps = 3/55 (5%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERL 54
P+ P + + TSV +TW P +GG I + VE K W+ + +
Sbjct: 18 PEAPDRPTISTASETSVYVTWI-PRGNGGFPIQSFRVEYKKLKKVGDWILATSAI 71
|
| >1x3d_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 118 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-10
Identities = 12/58 (20%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTE 59
PD P+ + + S+ + W P D G I +V+E G + +
Sbjct: 18 PDIPNPPRIANRTKNSLTLQWK-APSDNGSKIQNFVLEWDEGKGNGEFCQCYMGSQKQ 74
|
| >3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} Length = 197 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-10
Identities = 19/52 (36%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSE 52
P PP + R SV ++W P +DGG I GY+VEM+ G+ W +
Sbjct: 103 PLPPGKITLMDVTRNSVSLSWEKPEHDGGSRILGYIVEMQTKGSDKWATCAT 154
|
| >3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-09
Identities = 16/52 (30%), Positives = 25/52 (48%), Gaps = 1/52 (1%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELS 51
P PP +TSV +TW P DGG I Y+VE + + + + ++
Sbjct: 5 TPGPPQDLKVKEVTKTSVTLTWDPPLLDGGSKIKNYIVEKRESTRKAYSTVA 56
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 53/200 (26%)
Query: 76 PENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIES 130
P N+ C +KI+DFGLA++ + + V T + PE+I N+
Sbjct: 156 PGNLAVNEDC------ELKILDFGLARQADSEMTGYV--VTRWYRAPEVILNWMRYTQTV 207
Query: 131 DMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT------------- 162
D+WS+G I +++G + F G + +E +
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSSPGVNKI 219
+ DF S A + + +LV E+R+TA + L+H + + P V K
Sbjct: 268 LEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY 326
Query: 220 --------ISTDKLKKYIYR 231
+ D+ K+ Y+
Sbjct: 327 DDSFDDVDRTLDEWKRVTYK 346
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 9e-10
Identities = 32/154 (20%), Positives = 55/154 (35%), Gaps = 42/154 (27%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+K+ +FGLA+ P R + E + PP+++ Y DMWS G I
Sbjct: 139 ELKLANFGLARAFGI--PVRCY--SAEVVTLWYRPPDVLFGAKLY---STSIDMWSAGCI 191
Query: 139 TYVLLSGLSP-FMGENDSETFANITRA----------EF----DFDD-----------EA 172
L + P F G + + I R D+
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
L+ +D + +LL +R++A++ L H +
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 45/188 (23%), Positives = 65/188 (34%), Gaps = 60/188 (31%)
Query: 60 RGLGH-HSLVTVDPKIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHP-------- 105
R L + HS+ I P+N+ + S +K+IDFG A+ + P
Sbjct: 152 RSLAYIHSI-----GICHRDIKPQNL-LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 106 ----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI 161
P ++FG + I D+WS G + L+ G F GE+ + I
Sbjct: 206 YYRAPELIFGATNYTTN-I----------DIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254
Query: 162 TR-----------------AEFDFD-------DEAFEA-LSEDAKDFISSLLVKRKEKRL 196
+ E F + F DA D IS LL RL
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314
Query: 197 TAKQCLSH 204
TA + L H
Sbjct: 315 TAIEALCH 322
|
| >1x5x_A Fibronectin type-III domain containing protein 3A; structural genomics, KIAA0970, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 109 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-09
Identities = 9/53 (16%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSER 53
P P+ + T + + WS P Y++EM+ + +
Sbjct: 8 PSMPASPVLTKAGITWLSLQWSKPSGTPSDEGISYILEMEEETSGYGFKPKYD 60
|
| >2nzi_A Titin; IG-domain, FNIII-domain, transferase; 2.90A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 20/52 (38%), Positives = 28/52 (53%), Gaps = 1/52 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSE 52
PDPP G +R SV +TW+ P DGG IT Y+VE + W+ + +
Sbjct: 199 PDPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQ 250
|
| >2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A Length = 209 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 12/58 (20%), Positives = 19/58 (32%), Gaps = 1/58 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTE 59
P P + + S+ + DGG I Y+V +A + W S
Sbjct: 110 PSAPKLEGQMGEDGNSIKVNLI-KQDDGGSPIRHYLVRYRALSSEWKPEIRLPSGSDH 166
|
| >2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A Length = 209 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFEST 58
P PS V ++ + + P GG I Y E + G + W E++
Sbjct: 9 PSSPSIDQ-VEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEAS 65
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 50/168 (29%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI------PPEII----NY-E 124
P N+ V+ +K+ DFG A+K++P P +I PE+I +Y
Sbjct: 159 PHNV-LVNEADGTLKLCDFGSAKKLSPSEP------NVAYICSRYYRAPELIFGNQHYTT 211
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT--RAEFD 167
+ D+WS+G I ++ G F G+N E + + D
Sbjct: 212 AV----DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD 267
Query: 168 FDD-----------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204
+ + +++A D +S+LL E+R+ + L H
Sbjct: 268 LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-09
Identities = 31/150 (20%), Positives = 50/150 (33%), Gaps = 39/150 (26%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII---NYEPIGIESDMWSIGVIT 139
IK+ DFGLA+ + T + PE++ +Y + D+WS+G I
Sbjct: 158 QIKLADFGLARIY--SFQMAL---TSVVVTLWYRAPEVLLQSSYAT-PV--DLWSVGCIF 209
Query: 140 YVLLSGLSPFMGENDSETFANITRA----------------EFDFDD-------EAFEAL 176
+ F G +D + I F + +
Sbjct: 210 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
E KD + L KR++A LSH +
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 44/185 (23%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLSGL 146
+KI+DFGLA+ + + V T + PE+I ++ D+WS+G I +L+G
Sbjct: 164 ELKILDFGLARHADAEMTGYV--VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 147 SPFMGEN---------------DSETFANIT-------------RAEFDFDDEAFEALSE 178
+ F G++ +E + DF + F S
Sbjct: 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASP 280
Query: 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSSPGVNKII---------STDKLK 226
A D + +L +KRLTA Q L+H + + + + D+ K
Sbjct: 281 QAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK 340
Query: 227 KYIYR 231
++IY+
Sbjct: 341 QHIYK 345
|
| >1uey_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, NG-CAM related cell adhesion molecule, fibronectin type III domain, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 127 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-09
Identities = 13/49 (26%), Positives = 24/49 (48%), Gaps = 2/49 (4%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWV 48
+P+PP SV ++W+ P D IT +++E + A +P +
Sbjct: 16 VPNPPFDLELTDQLDKSVQLSWT-PGDDNNSPITKFIIEYEDAMHKPGL 63
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 42/184 (22%), Positives = 64/184 (34%), Gaps = 52/184 (28%)
Query: 60 RGLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
R L + HS D K P+N+ + + +K+ DFG A+++ P +I
Sbjct: 167 RSLAYIHSFGICHRDIK--PQNL-LLDPDTAVLKLCDFGSAKQLVRGEPNV------SYI 217
Query: 117 ------PPEII----NY-EPIGIESDMWSIGVITYVLLSGLSPFMGEN------------ 153
PE+I +Y I D+WS G + LL G F G++
Sbjct: 218 CSRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 154 ---DSETFANIT--RAEFDFD-------DEAFEA-LSEDAKDFISSLLVKRKEKRLTAKQ 200
E + EF F + F +A S LL RLT +
Sbjct: 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333
Query: 201 CLSH 204
+H
Sbjct: 334 ACAH 337
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-09
Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 6/133 (4%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIG----IESDMWSIGVITYVLL 143
+IK+ DFG++ ++ G ++ PE I+ + SD+WS+G+ Y L
Sbjct: 164 NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 144 SGLSPFMG-ENDSETFANITRAE-FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQC 201
+G P+ + + + + + + S +F++ L K + KR K+
Sbjct: 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
Query: 202 LSHLWIAQKDSSP 214
L H +I +
Sbjct: 284 LKHPFILMYEERA 296
|
| >1wf5_A Sidekick 2 protein; FNIII domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 121 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-09
Identities = 13/55 (23%), Positives = 24/55 (43%), Gaps = 3/55 (5%)
Query: 1 IPDPPSGAIGVSNNRT--SVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSER 53
+P P + + ++ +TW+ P+DG + Y++EM PW L
Sbjct: 17 LPHAPEHPVATLSTVERRAINLTWT-KPFDGNSPLIRYILEMSENNAPWTVLLAS 70
|
| >1wis_A KIAA1514 protein; FNIII domain, sidekick-2, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 124 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-09
Identities = 15/68 (22%), Positives = 26/68 (38%), Gaps = 1/68 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERG 61
P PP+ + SV + + P YDG I+ ++VE + G E + + +
Sbjct: 18 PGPPTNLGISNIGPRSVTLQFR-PGYDGKTSISRWLVEAQVGVVGEGEEWLLIHQLSNEP 76
Query: 62 LGHHSLVT 69
V
Sbjct: 77 DARSMEVP 84
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 31/135 (22%), Positives = 56/135 (41%), Gaps = 13/135 (9%)
Query: 88 HIKIIDFGLAQKIN-----PDHPPRVLF-GTPEFIPPEII-NYEPIGIESDMWSIGVITY 140
++I DFG++ + + R F GTP ++ PE++ ++D+WS G+
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 141 VLLSGLSPFMGENDSETFANITR------AEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
L +G +P+ + + D E + + + IS L K EK
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278
Query: 195 RLTAKQCLSHLWIAQ 209
R TA + L H + +
Sbjct: 279 RPTAAELLRHKFFQK 293
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-09
Identities = 35/165 (21%), Positives = 53/165 (32%), Gaps = 48/165 (29%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLS 147
+KI D G A T ++ E++ +D+WS + + L +G
Sbjct: 234 KVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 148 PFMGEN------DSETFANI----------------TRAEFDFDD--------------- 170
F + D + A I EF F
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF-FTKKGDLKHITKLKPWGL 350
Query: 171 -----EAFEALSEDAK---DFISSLLVKRKEKRLTAKQCLSHLWI 207
E +E E+A DF+ +L EKR TA +CL H W+
Sbjct: 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 48/200 (24%), Positives = 75/200 (37%), Gaps = 53/200 (26%)
Query: 76 PENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NYEPIGIES 130
P N+ C +KI+DFGLA+ + V T + PEI+ N+
Sbjct: 160 PSNLAVNEDC------ELKILDFGLARHTADEMTGYV--ATRWYRAPEIMLNWMHYNQTV 211
Query: 131 DMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT------------- 162
D+WS+G I LL+G + F G + +E I+
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSSPGVNKI 219
+ +F F + A D + +LV +KR+TA Q L+H + AQ D P +
Sbjct: 272 MPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 330
Query: 220 --------ISTDKLKKYIYR 231
+ D+ K Y
Sbjct: 331 DQSLESRDLLIDEWKSLTYD 350
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-09
Identities = 35/152 (23%), Positives = 53/152 (34%), Gaps = 40/152 (26%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVI 138
+K+ DFGLA+ P R T + + PE++ Y G+ DMW++G I
Sbjct: 150 VLKLADFGLAKSFGS--PNRAY--THQVVTRWYRAPELLFGARMYGV-GV--DMWAVGCI 202
Query: 139 TYVLLSGLSPFMGENDSETFANITRA----------------------EFDFDD--EAFE 174
LL + G++D + I F F
Sbjct: 203 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 262
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
A +D D I L + R+TA Q L +
Sbjct: 263 AAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-09
Identities = 43/183 (23%), Positives = 68/183 (37%), Gaps = 50/183 (27%)
Query: 60 RGLGH-HSLVTV--DPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI 116
R +G HSL D K P+N+ V+ + +K+ DFG A+K+ P P + +I
Sbjct: 152 RAVGFIHSLGICHRDIK--PQNL-LVNSKDNTLKLCDFGSAKKLIPSEP------SVAYI 202
Query: 117 ------PPEII----NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN------------- 153
PE++ Y P I D+WSIG + L+ G F GE
Sbjct: 203 CSRFYRAPELMLGATEYTP-SI--DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 154 --DSETFANIT--RAEFDFD-------DEAF-EALSEDAKDFISSLLVKRKEKRLTAKQC 201
E + E F + E A D + +L + R+ +
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319
Query: 202 LSH 204
++H
Sbjct: 320 MAH 322
|
| >1x5f_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 120 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-09
Identities = 9/59 (15%), Positives = 16/59 (27%), Gaps = 1/59 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
P P + + + +TW +P D Y V G + +
Sbjct: 18 PSAPRDVVASLVSTRFIKLTWRTPASDPHGDNLTYSVFYTKEGIARERVENTSHPGEMQ 76
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-09
Identities = 36/204 (17%), Positives = 54/204 (26%), Gaps = 81/204 (39%)
Query: 76 PENIMCVS-----------------------RTSHHIKIIDFGLAQKINPDHPP------ 106
PENI+ S IK+IDFG A + H
Sbjct: 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ 224
Query: 107 -RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI---- 161
R PE+I + SDMWS G + L +G F E A +
Sbjct: 225 YR---------APEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESII 275
Query: 162 -------------TRAEFDFDDEAFEALSEDAK-------------------------DF 183
T + + + + DF
Sbjct: 276 QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335
Query: 184 ISSLLVKRKEKRLTAKQCLSHLWI 207
+ S+L R + + L H ++
Sbjct: 336 LYSILQIDPTLRPSPAELLKHKFL 359
|
| >2e3v_A Neural cell adhesion molecule 1, 140 kDa isoform; NCAM, N-CAM 1, NCAM-120, CD56 antigen, membra protein, glycoprotein, structural genomics, NPPSFA; HET: PGE BTB; 1.95A {Homo sapiens} Length = 122 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-09
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFEST 58
P PS V ++ + + P GG I Y E + G + W E++
Sbjct: 8 PSSPS-IDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEAS 64
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 20/80 (25%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMW 133
PENI+ VS ++DFG+A + + GT ++ PE + +D++
Sbjct: 162 PENIL-VSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 134 SIGVITYVLLSGLSPFMGEN 153
++ + Y L+G P+ G+
Sbjct: 220 ALTCVLYECLTGSPPYQGDQ 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 34/166 (20%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII-NYEPIGIE 129
P N+ ++ +KI DFGLA+ ++P + + + + P ++ +
Sbjct: 148 PANLF-INTEDLVLKIGDFGLARIMDPHYSHKG-HLSEGLVTKWYRSPRLLLSPNNYTKA 205
Query: 130 SDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
DMW+ G I +L+G + F G ++ E I + +E + L +I + +
Sbjct: 206 IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT 265
Query: 190 KRK--------------------------EKRLTAKQCLSHLWIAQ 209
+ RLTA++ LSH +++
Sbjct: 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 18/76 (23%), Positives = 34/76 (44%), Gaps = 3/76 (3%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
P N++ + +KI DFG A I G+ ++ PE+ + D++S
Sbjct: 133 PPNLL-LVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYSEKCDVFSW 189
Query: 136 GVITYVLLSGLSPFMG 151
G+I + +++ PF
Sbjct: 190 GIILWEVITRRKPFDE 205
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-08
Identities = 36/196 (18%), Positives = 56/196 (28%), Gaps = 73/196 (37%)
Query: 76 PENIMCVSRT-----------------SHHIKIIDFGLAQKINPDHPP-------RVLFG 111
PENI+ V + IK++DFG A + H R
Sbjct: 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR---- 201
Query: 112 TPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI---------- 161
PE+I D+WSIG I G + F + E A +
Sbjct: 202 -----APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKH 256
Query: 162 -----TRAEFDFDDE-------------------------AFEALSEDAKDFISSLLVKR 191
+ ++ D + + E D I +L
Sbjct: 257 MIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316
Query: 192 KEKRLTAKQCLSHLWI 207
KR+T ++ L H +
Sbjct: 317 PAKRITLREALKHPFF 332
|
| >3mtr_A N-CAM-1, NCAM-1, neural cell adhesion molecule 1; immunoglobulin domain, fibronectin type III repeat, CE adhesion; 1.80A {Homo sapiens} Length = 215 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFEST 58
P PS V ++ + + P GG I Y E + G + W E++
Sbjct: 114 PSSPSIDQ-VEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEAS 170
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 31/134 (23%), Positives = 55/134 (41%), Gaps = 11/134 (8%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIG----IESDMWSIGVITYV-L 142
+K+ DFG++ + D + G ++ PE IN E ++SD+WS+G IT + L
Sbjct: 148 QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG-ITMIEL 206
Query: 143 LSGLSPFMG-ENDSETFANITRAE-FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200
P+ + + + F S + DF S L K ++R T +
Sbjct: 207 AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPE 263
Query: 201 CLSHLWIAQKDSSP 214
+ H + +S
Sbjct: 264 LMQHPFFTLHESKG 277
|
| >1v5j_A KIAA1355 protein, RSGI RUH-008; FN3 domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, cell adhesion; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 108 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-08
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 2/52 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSER 53
PP G + V++ W PP + GYV+E + G+Q W L
Sbjct: 8 LSPPRGLV-AVRTPRGVLLHWD-PPELVPKRLDGYVLEGRQGSQGWEVLDPA 57
|
| >1x4x_A Fibronectin type-III domain containing protein 3A; FN3, immunoglobulin-like beta- sandwich fold, KIAA0970, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 106 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-08
Identities = 9/49 (18%), Positives = 13/49 (26%), Gaps = 1/49 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVEL 50
PD + T + W P G +T Y +E
Sbjct: 8 PDQCKPPQVTCRSATCAQVNWE-VPLSNGTDVTEYRLEWGGVEGSMQIC 55
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 37/174 (21%), Positives = 62/174 (35%), Gaps = 43/174 (24%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
+ P NI+ SR IK+ DFG++ ++ D GT ++ PE + ++SD+W
Sbjct: 158 VKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA--------------------- 172
S+G+ + G P + E E
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 173 ---FEAL----------------SEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
FE L S + +DF++ L+K +R KQ + H +I
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 1/75 (1%)
Query: 77 ENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIG 136
+ + ++ +KI DFGLA++ + G ++ PE+I SD+WS G
Sbjct: 143 QKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 137 VITYVLLSGLSPFMG 151
V+ + LL+G PF G
Sbjct: 202 VLLWELLTGEVPFRG 216
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 15/150 (10%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIG-----I 128
+ P NI+ R IK+ DFG++ ++ D G ++ PE I+ I
Sbjct: 151 VKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 129 ESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAE---FDFDDEAFEALSEDAKDFI 184
+D+WS+G+ L +G P+ + D E + + E F S D + F+
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHMGF---SGDFQSFV 264
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
L K KR + L H +I + ++
Sbjct: 265 KDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 28/158 (17%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYE---PIGIESDMWSIGVITYVLL 143
+K+ DFG A + P F GTP ++ PE+I + D+WS+G+ L
Sbjct: 192 LVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 144 SGLSPFMGENDSETFANITRAEF--------DFDDEAFEALSEDAKDFISSLLVKRKEKR 195
P N A + + SE ++F+ S L K + R
Sbjct: 248 ERKPPLFNMN-------AMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDR 297
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRK 233
T++ L H ++ ++ + +I + K +
Sbjct: 298 PTSEVLLKHRFVLRERPPTVIMDLI--QRTKDAVRELD 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 28/191 (14%), Positives = 54/191 (28%), Gaps = 54/191 (28%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFI------PPEII-NYEPIGIESDMWSIGVITY 140
I I DF LA++ D ++ PE++ ++ DMWS G +
Sbjct: 172 DITICDFNLAREDTADAN------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 141 VLLSGLSPFMGEN---------------DSETFANIT--------------RAEFDFDDE 171
+ + + F G E + +
Sbjct: 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-A 284
Query: 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ----KDSSPGV-------NKII 220
A D I+ +L ++R++ +Q L H + D + G+ +
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVT 344
Query: 221 STDKLKKYIYR 231
+ K
Sbjct: 345 DVYDMHKIFTA 355
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 32/186 (17%), Positives = 56/186 (30%), Gaps = 60/186 (32%)
Query: 76 PENIMCVSRTSHH--IKIIDFGLAQKINPDHPPRVLF-GTPEFI-----PPEII----NY 123
P NI+ + +KI D G A+ N P + L P + PE++ +Y
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNS--PLKPLADLDPVVVTFWYRAPELLLGARHY 213
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE------------------ 165
I D+W+IG I LL+ F + +N +
Sbjct: 214 TK-AI--DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 270
Query: 166 -------------------------FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200
+ ++ A + LL KR+T++Q
Sbjct: 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330
Query: 201 CLSHLW 206
+ +
Sbjct: 331 AMQDPY 336
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 82/238 (34%)
Query: 60 RGLGH-HS--LVTVDPKILPENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGT 112
G+ H HS ++ D K P NI+ C +KI+DFGLA+ T
Sbjct: 138 CGIKHLHSAGIIHRDLK--PSNIVVKSDC------TLKILDFGLARTAGTSF-----MMT 184
Query: 113 PE-----FIPPEII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN----------- 153
P + PE+I Y+ D+WS+G I ++ G F G +
Sbjct: 185 PYVVTRYYRAPEVILGMGYKE---NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241
Query: 154 ----DSETFANI-----------------------TRAEFDFDDEAFEALSEDAKDFISS 186
E + F D E + + A+D +S
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 301
Query: 187 LLVKRKEKRLTAKQCLSHLWIAQ-------KDSSPGV------NKIISTDKLKKYIYR 231
+LV KR++ + L H +I + P + + + ++ K+ IY+
Sbjct: 302 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYK 359
|
| >2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A Length = 389 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 12/52 (23%), Positives = 25/52 (48%), Gaps = 1/52 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSE 52
P P G + ++T+ ++++ P GG I Y V++K ++ W +
Sbjct: 196 PSSPYGVKIIELSQTTAKVSFNKPDSHGGVPIHHYQVDVKEVASEIWKIVRS 247
|
| >2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A Length = 389 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 12/49 (24%), Positives = 21/49 (42%), Gaps = 3/49 (6%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVE 49
P PPS G ++ S ++ + DGG I Y+V+ + +
Sbjct: 294 PSPPS-IHGQPSSGKSFKLSIT-KQDDGGAPILEYIVKYRSKDKEDQWL 340
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 46/207 (22%), Positives = 74/207 (35%), Gaps = 60/207 (28%)
Query: 76 PENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI------PPEII-NYE 124
P N++ C +KI DFGLA+ +PDH F T E++ PEI+ N +
Sbjct: 156 PSNLLLNTTC------DLKICDFGLARVADPDHDHTG-FLT-EYVATRWYRAPEIMLNSK 207
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT------- 162
D+WS+G I +LS F G++ E I
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 163 ------RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ---KDSS 213
+ + + + F A D + +L KR+ +Q L+H ++ Q
Sbjct: 268 LLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 214 PGVNKII---------STDKLKKYIYR 231
P +KLK+ I+
Sbjct: 327 PIAEAPFKFDMELDDLPKEKLKELIFE 353
|
| >2ic2_A CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin type III, protein binding; HET: MSE; 1.30A {Drosophila melanogaster} SCOP: b.1.2.1 Length = 115 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-08
Identities = 10/62 (16%), Positives = 23/62 (37%), Gaps = 3/62 (4%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERLFEST 58
PP+ + SV++ W P + G I + V+ + + W ++ +
Sbjct: 2 STYPPTPPNVTRLSDESVMLRW-MVPRNDGLPIVIFKVQYRMVGKRKNWQTTNDNIPYGK 60
Query: 59 ER 60
+
Sbjct: 61 PK 62
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-08
Identities = 39/217 (17%), Positives = 64/217 (29%), Gaps = 68/217 (31%)
Query: 76 PENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-----------PPEI 120
P N++ C +K+ DFGLA+ I+ + PE+
Sbjct: 140 PSNLLINSNC------DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 121 I-NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN----------------DSETFANIT- 162
+ D+WS G I L F G + I
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIES 253
Query: 163 ------------RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ- 209
++ F ++ D + +LV KR+TAK+ L H ++
Sbjct: 254 PRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312
Query: 210 --KDSSPGVNKI-------------ISTDKLKKYIYR 231
+ P I ++T LKK I+
Sbjct: 313 HDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWN 349
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 40/155 (25%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFI-----PPEII----NYEPIGIESDMWSIGVIT 139
+K+ DFGLA+ + + T + PPE++ +Y P I D+W G I
Sbjct: 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP-PI--DLWGAGCIM 219
Query: 140 YVLLSGLSPFMGENDSETFANITRA-------------------EFDFD-------DEAF 173
+ + G + A I++ + + +
Sbjct: 220 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 279
Query: 174 EAL--SEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
+A A D I LLV +R+ + L+H +
Sbjct: 280 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 47/238 (19%), Positives = 78/238 (32%), Gaps = 82/238 (34%)
Query: 60 RGLGH-HSLVTV--DPKILPENIM----CVSRTSHHIKIIDFGLAQKINPDHPPRVLFGT 112
G+ H HS + D K P NI+ C +KI+DFGLA+ T
Sbjct: 175 CGIKHLHSAGIIHRDLK--PSNIVVKSDC------TLKILDFGLARTAGTSF-----MMT 221
Query: 113 PEFI-----PPEII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN----------- 153
P + PE+I Y+ D+WS+G I ++ F G +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKE---NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
Query: 154 ----DSETFANIT-----------------------RAEFDFDDEAFEALSEDAKDFISS 186
E + + F D E + + A+D +S
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 187 LLVKRKEKRLTAKQCLSHLWIAQ----KDSSPGV---------NKIISTDKLKKYIYR 231
+LV KR++ L H +I + + + ++ K+ IY+
Sbjct: 339 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYK 396
|
| >2yrz_A Integrin beta-4; GP150, CD104 antigen, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-07
Identities = 13/60 (21%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTE 59
+PD P+ + + TS+ ++W P + + GY VE + L+ T
Sbjct: 17 VPDTPTRLVFSALGPTSLRVSWQEPRCERP--LQGYSVEYQLLNGGELHRLNIPNPAQTS 74
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 23/77 (29%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQ-KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWS 134
N++ + + +K+ DFGL++ K + + GTPE++ PE++ EP +SD++S
Sbjct: 167 SPNLLVDKK--YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 135 IGVITYVLLSGLSPFMG 151
GVI + L + P+
Sbjct: 225 FGVILWELATLQQPWGN 241
|
| >2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A Length = 214 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-07
Identities = 10/60 (16%), Positives = 19/60 (31%), Gaps = 2/60 (3%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKA--GTQPWVELSERLFESTE 59
P + T+VV+ WS +ITGY + + + + +
Sbjct: 116 MPVPELLEIEEYSETAVVLHWSLASDADEHLITGYYAYYRPSSSAGEYFKATIEGAHARS 175
|
| >2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A Length = 214 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 9e-06
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 3/70 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERLFESTE 59
PP+ + SV++ W P + G I + V+ + + W ++ +
Sbjct: 2 TYPPTPPNVTRLSDESVMLRW-MVPRNDGLPIVIFKVQYRMVGKRKNWQTTNDNIPYGKP 60
Query: 60 RGLGHHSLVT 69
+
Sbjct: 61 KWNSELGKSF 70
|
| >1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 Length = 205 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-06
Identities = 11/59 (18%), Positives = 19/59 (32%), Gaps = 4/59 (6%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQP--WVELSERLFEST 58
P+ P G++ I W D I Y ++ P W E++ +
Sbjct: 6 PNAPKL-TGITCQADKAEIHWE-QQGDNRSPILHYTIQFNTSFTPASWDAAYEKVPNTD 62
|
| >1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 Length = 205 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-05
Identities = 10/61 (16%), Positives = 18/61 (29%), Gaps = 3/61 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPP-YDGGCMITGYVVEMK--AGTQPWVELSERLFEST 58
P +G ++VI+W+ P + Y V K W + +
Sbjct: 105 FKNPDNVVGQGTEPNNLVISWTPMPEIEHNAPNFHYYVSWKRDIPAAAWENNNIFDWRQN 164
Query: 59 E 59
Sbjct: 165 N 165
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 6/71 (8%)
Query: 87 HHIKIIDFGLAQKINPDHPPRVL---FGTPEFIPPEIINYE---PIGIESDMWSIGVITY 140
+ +KI DFGLA + + G+ ++ PE+I + P +SD+++ G++ Y
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 141 VLLSGLSPFMG 151
L++G P+
Sbjct: 217 ELMTGQLPYSN 227
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 21/78 (26%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 89 IKIIDFGLAQKINPD-HPPRVLFGTP-EFIPPEIINYEPIGIESDMWSIGVITYVLLS-G 145
+K+ DFGL++ + D + P ++ PE + Y I+SD+W+ GV+ + + + G
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416
Query: 146 LSPFMGENDSETFANITR 163
+SP+ G + S+ + + +
Sbjct: 417 MSPYPGIDLSQVYELLEK 434
|
| >2db8_A Tripartite motif protein 9, isoform 2; ring finger protein 91, TRIM9, KIAA0282, RNF91, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 110 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-06
Identities = 10/51 (19%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 1 IPDPPSGAIGVSN-NRTSVVITWSSPPYDGGCMITGYVVEMKAGTQ-PWVE 49
+P P + + S ++W P GY++E+ G + E
Sbjct: 9 VPATPILQLEECCTHNNSATLSWK-QPPLSTVPADGYILELDDGNGGQFRE 58
|
| >2ed7_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 119 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-06
Identities = 12/60 (20%), Positives = 22/60 (36%), Gaps = 2/60 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVE-MKAGTQPWVELSERLFESTE 59
+P P + V + V ++W PP + I + V + G L+ S +
Sbjct: 17 LPSAPRDVVPVLVSSRFVRLSW-RPPAEAKGNIQTFTVFFSREGDNRERALNTTQPGSLQ 75
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-06
Identities = 24/198 (12%), Positives = 49/198 (24%), Gaps = 59/198 (29%)
Query: 88 HIKIIDFGLA-------QKINPDHPPRVLF-GTPEFIPPEIINYEPIG--IESDMWSIGV 137
+ + Q+ H ++ PE++ G +SD++S+G+
Sbjct: 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
Query: 138 ITYVLLSGLSPF------------------------------------------MGENDS 155
L +G PF +
Sbjct: 226 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285
Query: 156 ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215
T S F+ L + + R +A L+H + Q
Sbjct: 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI----- 340
Query: 216 VNKIISTDKLKKYIYRRK 233
K +++ L + +
Sbjct: 341 --KRRASEALPELLRPVT 356
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 20/106 (18%), Positives = 36/106 (33%), Gaps = 28/106 (26%)
Query: 60 RGLGH-HSLVTVDPKIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF--- 110
RG+ H+L +P I ++M +I +
Sbjct: 122 RGMAFLHTL---EPLIPRHALNSRSVMIDED--MTARISMADVK---------FSFQSPG 167
Query: 111 --GTPEFIPPEIINYEPIGIE---SDMWSIGVITYVLLSGLSPFMG 151
P ++ PE + +P +DMWS V+ + L++ PF
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 37/240 (15%), Positives = 63/240 (26%), Gaps = 100/240 (41%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----------------------PEII--- 121
+K+ DFGLA+ IN + ++ E PE+I
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 122 -NY-EPIGIESDMWSIGVITYVLLSGLSP-----------FMGENDSETFANITRAEFDF 168
NY + I D+WS G I LL+ L F G + + +
Sbjct: 227 ENYTKSI----DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHE 282
Query: 169 DD-----------------EAFEAL-SEDAKDFISSLLVKRK------------------ 192
+ + + + +I ++
Sbjct: 283 KSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342
Query: 193 --------EKRLTAKQCLSHLWIAQ---KDSSPGVNKII----------STDKLKKYIYR 231
KR+T Q L H ++ K K I S +L+ +
Sbjct: 343 ESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLK 402
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 23/80 (28%), Positives = 34/80 (42%), Gaps = 9/80 (11%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
K+ DFGLA+ I + P PE Y I+SD+WS G++ L +
Sbjct: 320 KVADFGLARLIEDNEYTAR---QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ G + E + R
Sbjct: 377 KGRVPYPGMVNREVLDQVER 396
|
| >1x5g_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 116 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-06
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVE-MKAGTQPWVELSERLFESTE 59
+P P + + TS+ +TW +P G I Y + M+ GT ++ T
Sbjct: 17 LPGPAPNLRAYAASPTSITVTWETPVSGNG-EIQNYKLYYMEKGTDKEQDVDVSSHSYTI 75
Query: 60 RGL 62
GL
Sbjct: 76 NGL 78
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 15/79 (18%)
Query: 86 SHHIKIIDFGLA---------------QKINPDHPPRVLFGTPEFIPPEIINYEPIGIES 130
+ ++ + DFGLA K + G P ++ PE+IN +
Sbjct: 144 NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203
Query: 131 DMWSIGVITYVLLSGLSPF 149
D++S G++ ++ ++
Sbjct: 204 DVFSFGIVLCEIIGRVNAD 222
|
| >2dn7_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 107 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-06
Identities = 9/51 (17%), Positives = 18/51 (35%), Gaps = 3/51 (5%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELS 51
P P+ I + + ++ W P G + GY ++ A +
Sbjct: 8 PGRPTMMI-STTAMNTALLQWHPPKELPG-ELLGYRLQYCRADEARPNTID 56
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-06
Identities = 23/80 (28%), Positives = 34/80 (42%), Gaps = 9/80 (11%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
K+ DFGLA+ I + P PE Y I+SD+WS G++ L +
Sbjct: 403 KVADFGLARLIEDNEYTAR---QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ G + E + R
Sbjct: 460 KGRVPYPGMVNREVLDQVER 479
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 16/103 (15%)
Query: 60 RGLGH-HSLVTVDPKIL-----PENIMCVSRTSH---HIKIIDFGLAQKINPDHPPRVLF 110
G+ + + +P I+ NI S + K+ DFGL+Q+ +
Sbjct: 133 LGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL-- 187
Query: 111 GTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMG 151
G +++ PE I E ++D +S +I Y +L+G PF
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 21/82 (25%), Positives = 32/82 (39%), Gaps = 15/82 (18%)
Query: 87 HHIKIIDFGLA------QKINPDHPPRVLFGTPEFIPPEII---------NYEPIGIESD 131
+ I DFGL Q + R+ G + PEII + P SD
Sbjct: 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225
Query: 132 MWSIGVITYVLLSGLSPFMGEN 153
++++G I Y L + PF +
Sbjct: 226 VFALGTIWYELHAREWPFKTQP 247
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ V T H+KI DFGLA+ + + G +P E I + +SD+
Sbjct: 147 NVL-VK-TPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIKWMALESILHRIYTHQSDV 202
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165
WS GV + L++ G P+ G SE + + + E
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 42/226 (18%), Positives = 65/226 (28%), Gaps = 85/226 (37%)
Query: 88 HIKIIDFGLAQKINPDHPPRVLFGTPEFIP----------------------PEII---- 121
H+K+ DFGL++ PEI+
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---------------DSETFANIT---- 162
Y GI DMWS+G I +L G F G + +E +I
Sbjct: 207 KYTK-GI--DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
Query: 163 ------------------RAEFDFDDEAFEAL------SEDAKDFISSLLVKRKEKRLTA 198
R F + +E+A D + LL KR++A
Sbjct: 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323
Query: 199 KQCLSHLWIAQ---KDSSPGVNKII----------STDKLKKYIYR 231
L H +++ + P + II S D + +Y
Sbjct: 324 NDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYS 369
|
| >2kbg_A N-CAM 2, neural cell adhesion molecule 2; fibronectin type III module, beta-sheet sandwich, cell membrane, glycoprotein, immunoglobulin domain; NMR {Homo sapiens} Length = 114 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-05
Identities = 12/46 (26%), Positives = 22/46 (47%), Gaps = 2/46 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P PPS G ++ S ++ + DGG I Y+V+ ++ +
Sbjct: 9 PSPPS-IHGQPSSGKSFKLSIT-KQDDGGAPILEYIVKYRSKDKED 52
|
| >2dmk_A Midline 2 isoform 2; midline defect 2, tripartite motif protein 1, midin-2, ring finger protein 60, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 127 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-05
Identities = 10/53 (18%), Positives = 20/53 (37%), Gaps = 4/53 (7%)
Query: 1 IPDPPSGAIGVSN-NRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSE 52
P+PPS + + ++ + W S I+ Y ++ T +S
Sbjct: 15 APNPPSIREELCTASHDTITVHWISD---DEFSISSYELQYTIFTGQANFISL 64
|
| >2edb_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 116 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-05
Identities = 11/51 (21%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELS 51
+PD PS + V ++++W+ PP + ++ GY++ G+ +
Sbjct: 17 VPDQPSS-LHVRPQTNCIIMSWT-PPLNPNIVVRGYIIGYGVGSPYAETVR 65
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 35/155 (22%)
Query: 31 CMITGYVVEMKAG---------TQPWVELSERLFESTERGLGH-HSLVTVD---PKIL-- 75
+IT Y + G T V R+ S GL H H + P I
Sbjct: 82 WLITHY---HEMGSLYDYLQLTTLDTVSCL-RIVLSIASGLAHLHIEIFGTQGKPAIAHR 137
Query: 76 ---PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-----GTPEFIPPEIINYEPIG 127
+NI+ V + + I D GLA + + GT ++ PE+++
Sbjct: 138 DLKSKNIL-VKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 128 IE------SDMWSIGVITYVLLSGLSPFMGENDSE 156
D+W+ G++ + + + D +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 7/91 (7%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEF----IPPEIINYEPIGIESDMW 133
N++ V+R H+ KI DFGL++ + D ++ PE IN+ SD+W
Sbjct: 466 NVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523
Query: 134 SIGVITYVLLS-GLSPFMGENDSETFANITR 163
S GV + LS G P+ E A I +
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ V T H+KI DFGLA+ + + G +P E I + +SD+
Sbjct: 147 NVL-VK-TPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIKWMALESILHRIYTHQSDV 202
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165
WS GV + L++ G P+ G SE + + + E
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 18/73 (24%), Positives = 29/73 (39%), Gaps = 8/73 (10%)
Query: 90 KIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIE-----SDMWSIGVITYV 141
I DFGLA K GT ++ PE++ DM+++G++ +
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 142 LLSGLSPFMGEND 154
L S + G D
Sbjct: 231 LASRCTAADGPVD 243
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-05
Identities = 32/202 (15%), Positives = 54/202 (26%), Gaps = 64/202 (31%)
Query: 47 WVELSERLFESTERGLGHHSLVTVDPK---------ILPENIMCVSRTSHHIKIID-FGL 96
W ++ + L +SLV PK L + + + H I+D + +
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI 455
Query: 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE 156
+ + D IPP + Y IG + L E
Sbjct: 456 PKTFDSDD----------LIPPYLDQYF-------YSHIG---HHL-------KNIEHPE 488
Query: 157 TFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGV 216
DF F+ ++K + H A S +
Sbjct: 489 RMTLFRMVFLDFR-------------FL-----EQK---------IRHDSTAWNASGSIL 521
Query: 217 NKIISTDKLKKYIYRRKWQFSR 238
N + K YI ++ R
Sbjct: 522 NTLQQLKFYKPYICDNDPKYER 543
|
| >2dju_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 106 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-05
Identities = 14/53 (26%), Positives = 23/53 (43%), Gaps = 4/53 (7%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSER 53
P PP + TSV +TW S +T Y ++ + AGT+ + +
Sbjct: 8 PKPPIDLVVTETTATSVTLTWDSG---NSEPVTYYGIQYRAAGTEGPFQEVDG 57
|
| >2dm4_A Sortilin-related receptor; beta-sandwich, sorting protein-related receptor containing LDLR class A repeats, sorla; NMR {Homo sapiens} Length = 108 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-05
Identities = 13/53 (24%), Positives = 21/53 (39%), Gaps = 4/53 (7%)
Query: 2 PDPPSG--AIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK-AGTQPWVELS 51
PD P +V W+ P + G +I Y+VE +G++ W
Sbjct: 8 PDAPRNLQLSLPREAEGVIVGHWAPPIHTHG-LIREYIVEYSRSGSKMWASQR 59
|
| >2ed8_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 106 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-05
Identities = 15/49 (30%), Positives = 21/49 (42%), Gaps = 2/49 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVE-MKAGTQPWVE 49
P P VS + TS++ITW P Y G + GY + + T
Sbjct: 8 PGPVENLQAVSTSPTSILITWEPPAYANG-PVQGYRLFCTEVSTGKEQN 55
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-05
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEF----IPPEIINYEPIGIESDMW 133
N++ V++ H+ KI DFGL++ + D ++ PE INY +SD+W
Sbjct: 147 NVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 204
Query: 134 SIGVITYVLLS-GLSPFMGENDSETFANITR 163
S GV+ + S G P+ G SE A + +
Sbjct: 205 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >1wfo_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 130 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-05
Identities = 14/60 (23%), Positives = 23/60 (38%), Gaps = 1/60 (1%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTER 60
+P PP G + TSV + W P G +I Y + + T + + + R
Sbjct: 27 VPGPPMGILFPEVRTTSVRLIWQPPAAPNG-IILAYQITHRLNTTTANTATVEVLAPSAR 85
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-05
Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 10/92 (10%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ + + +++ DFG+A + PD + P E I++ +SD+
Sbjct: 145 NVL-LK-SPSQVQVADFGVADLLPPDDKQLLYSEAK--TPIKWMALESIHFGKYTHQSDV 200
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV + L++ G P+ G +E + +
Sbjct: 201 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens} Length = 589 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 12/63 (19%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 1 IPDPPSG--AIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFES 57
P+PP I + + +TW+ P +I Y ++ + W ++ S
Sbjct: 198 KPNPPHNLSVINSEELSSILKLTWT-NPSIKSVIILKYNIQYRTKDASTWSQIPPEDTAS 256
Query: 58 TER 60
T
Sbjct: 257 TRS 259
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 29/93 (31%), Positives = 41/93 (44%), Gaps = 11/93 (11%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPP-RVLFGTPEFIP-----PEIINYEPIGIESD 131
N++ V+R H+ KI DFGL++ + D P PE IN+ SD
Sbjct: 140 NVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGK--WPLKWYAPECINFRKFSSRSD 195
Query: 132 MWSIGVITYVLLS-GLSPFMGENDSETFANITR 163
+WS GV + LS G P+ E A I +
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* Length = 536 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 1e-04
Identities = 8/40 (20%), Positives = 12/40 (30%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK 41
P + V + W+ P GG Y V +
Sbjct: 333 PPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCE 372
|
| >3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* Length = 536 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 2e-04
Identities = 9/40 (22%), Positives = 15/40 (37%), Gaps = 1/40 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMK 41
P + TS+ ++WS PP + Y V +
Sbjct: 441 QTEPPKVRLEGRSTTSLSVSWSIPPPQQS-RVWKYEVTYR 479
|
| >2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens} Length = 731 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 1e-04
Identities = 12/72 (16%), Positives = 20/72 (27%), Gaps = 1/72 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGG-CMITGYVVEMKAGTQPWVELSERLFESTER 60
P V + I W Y+ C V ++ E + TE
Sbjct: 360 MRGPRKLEVVEVKSRQITIRWEPFGYNVTRCHSYNLTVHYCYQVGGQEQVREEVSWDTEN 419
Query: 61 GLGHHSLVTVDP 72
H++ + P
Sbjct: 420 SHPQHTITNLSP 431
|
| >2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens} Length = 731 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 2e-04
Identities = 10/50 (20%), Positives = 17/50 (34%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELS 51
P P + S T + I ++ +G I VE + W +
Sbjct: 262 PVPIAPPQLASVGATYLWIQLNANSINGDGPIVAREVEYCTASGSWNDRQ 311
|
| >2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens} Length = 731 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 5e-04
Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 1/70 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERG 61
P+ +I S + + W P G +IT Y + KA + E+
Sbjct: 463 GAVPTESIQGSTFEEKIFLQWREPTQTYG-VITLYEITYKAVSSFDPEIDLSNQSGRVSK 521
Query: 62 LGHHSLVTVD 71
LG+ +
Sbjct: 522 LGNETHFLFF 531
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
NI+ ++ ++ K+ DFGL + + D P IP PE I Y SD+
Sbjct: 177 NIL-IN-SNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS G++ + ++S G P+ ++ + +
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 8/92 (8%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N M + +K+ DFGLA+ + V T +P E + + +SD+
Sbjct: 222 NCM-LD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 279
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV+ + L++ G P+ N + + +
Sbjct: 280 WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N M + S +K+ DFGLA+ I V +P E + +SD+
Sbjct: 154 NCM-LD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDV 211
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV+ + LL+ G P+ + + + +
Sbjct: 212 WSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 17/82 (20%), Positives = 27/82 (32%), Gaps = 19/82 (23%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDH--------PPRVLFGTPEFIPPEIINYEP 125
+ ENI + + +G A + P G EFI ++
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS---MDLH- 240
Query: 126 IGIE----SDMWSIGVITYVLL 143
G SD+ S+G Y +L
Sbjct: 241 KGCGPSRRSDLQSLG---YCML 259
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 9/80 (11%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
KI DFGLA+ I + P PE IN+ I+SD+WS G++ +++
Sbjct: 324 KIADFGLARVIEDNEYTAREGAK---FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ G ++ E + R
Sbjct: 381 YGRIPYPGMSNPEVIRALER 400
|
| >2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E Length = 897 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 2e-04
Identities = 9/60 (15%), Positives = 14/60 (23%), Gaps = 1/60 (1%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERG 61
D V + W P G +I Y V + + L +
Sbjct: 793 DDIVGPVTHEIFENNVVHLMWQEPKEPNG-LIVLYEVSYRRYGDEELHLCDTRKHFALER 851
|
| >2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E Length = 897 | Back alignment and structure |
|---|
Score = 40.3 bits (93), Expect = 4e-04
Identities = 25/174 (14%), Positives = 45/174 (25%), Gaps = 35/174 (20%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQ--------------- 45
P P I VSN+ + +++ W P G IT Y+V + +
Sbjct: 594 NPSVPLDPISVSNSSSQIILKWKPPSDPNG-NITHYLVFWERQAEDSELFELDYCLKGLK 652
Query: 46 -PWVELSERLFESTERGLGHHSLVTVD------PKILPENIMCVSRTSHHIKIIDFGLAQ 98
P S + PK + + + +S
Sbjct: 653 LPSRTWSPPFESEDSQKHNQSEYEDSAGECCSCPKTDSQILKELEESSFRK--------- 703
Query: 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVI---TYVLLSGLSPF 149
V P + + G + + +++SGL F
Sbjct: 704 TFEDYLHNVVFVPRPSRKRRSLGDVGNAGNNEEHRPFEKVVNKESLVISGLRHF 757
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 8/92 (8%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N M + +K+ DFGLA+ + V T +P E + + +SD+
Sbjct: 158 NCM-LD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 215
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV+ + L++ G P+ N + + +
Sbjct: 216 WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 21/81 (25%), Positives = 38/81 (46%), Gaps = 9/81 (11%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLL 143
IK+ DFG+ + + D P PE+ ++ +SD+WS GV+ + +
Sbjct: 143 IKVSDFGMTRFVLDDQYTSSTGTK---FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 144 S-GLSPFMGENDSETFANITR 163
S G P+ ++SE +I+
Sbjct: 200 SEGKIPYENRSNSEVVEDIST 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 11/92 (11%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ VS ++ +K+ DFGL++ + + +P PE IN+ SD+
Sbjct: 521 NVL-VS-SNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
W GV + +L G+ PF G +++ I
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ +R +KI DFGL + + + + +P PE + SD
Sbjct: 151 NLLLATR--DLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
W GV + + + G P++G N S+ I +
Sbjct: 208 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N++ V ++ K+ DFGL++ + D P T IP PE I + SD+
Sbjct: 181 NVL-VD-SNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237
Query: 133 WSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV+ + +L+ G P+ + + +++
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 17/82 (20%), Positives = 33/82 (40%), Gaps = 19/82 (23%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDH--------PPRVLFGTPEFIPPEIINYEP 125
I N++ + + + D+GL+ + P+ P + GT EF ++
Sbjct: 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDAH- 232
Query: 126 IGIE----SDMWSIGVITYVLL 143
G+ SD+ +G Y +L
Sbjct: 233 KGVALSRRSDVEILG---YCML 251
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 4e-04
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDM 132
N + V + +KI DFG+++ + RV G +P PE I Y ESD+
Sbjct: 163 NCL-VGA-NLLVKIGDFGMSRDVYSTDYYRV--GGHTMLPIRWMPPESIMYRKFTTESDV 218
Query: 133 WSIGV-----ITYVLLSGLSPFMGENDSETFANITR 163
WS GV TY G P+ +++E IT+
Sbjct: 219 WSFGVILWEIFTY----GKQPWFQLSNTEVIECITQ 250
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 35/140 (25%)
Query: 31 CMITGY------VVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVD----PKIL---- 75
++ Y + T WV RL S RGL + H+ + P I
Sbjct: 88 LLVMEYYPNGSLXKYLSLHTSDWVSSC-RLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 76 -PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---------GTPEFIPPEII---- 121
N++ + I DFGL+ ++ + R GT ++ PE++
Sbjct: 147 NSRNVL--VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204
Query: 122 ---NYEPIGIESDMWSIGVI 138
+ E + DM+++G+I
Sbjct: 205 NLRDXESALKQVDMYALGLI 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 4e-04
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 9/80 (11%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
K+ DFGL++ + D + P PE++ Y +SD+W+ GV+ + + S
Sbjct: 160 KVSDFGLSRYVLDDEYTSSVGSK---FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ +SET +I +
Sbjct: 217 LGKMPYERFTNSETAEHIAQ 236
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 28/132 (21%), Positives = 54/132 (40%), Gaps = 23/132 (17%)
Query: 60 RGLGH-HSLVTVD---PKIL-----PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF 110
GL H H+ + P I +NI+ + + I D GLA K D +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNIL--VKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 111 -----GTPEFIPPEII------NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET-F 158
GT ++PPE++ N+ I +DM+S G+I + + + + +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 159 ANITRAEFDFDD 170
++ ++ ++D
Sbjct: 263 HDLVPSDPSYED 274
|
| >3p4l_A Neogenin; iron homeostasis, hemojuvelin receptor, FNIII domain, fibron type III, cell adhesion; 1.80A {Homo sapiens} PDB: 1x5k_A Length = 211 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 4e-04
Identities = 9/49 (18%), Positives = 14/49 (28%), Gaps = 3/49 (6%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPP---YDGGCMITGYVVEMKAGTQPW 47
PP G + ++ ITW+ + Y V K
Sbjct: 5 MMPPVGVQASILSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPAN 53
|
| >3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A Length = 234 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 5e-04
Identities = 11/69 (15%), Positives = 19/69 (27%), Gaps = 1/69 (1%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTER 60
+P P + T ++W+ P G IT Y V + +
Sbjct: 98 VPSEPGRLAFNVVSSTVTQLSWAEPAETNG-EITAYEVCYGLVNDDNRPIGPMKKVLVDN 156
Query: 61 GLGHHSLVT 69
L+
Sbjct: 157 PKNRMLLIE 165
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 5e-04
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 23/98 (23%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEF------IP-----PEIINYEPI 126
NI+ V+ + +K+ DFGL+ R + + +P PE IN+
Sbjct: 143 NIL-VA-SPECVKLGDFGLS---------RYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 127 GIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITR 163
SD+W V + +LS G PF + + + +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 87 HHIKIIDFGLAQKINPDHPP-RVLFGT--PEF-IPPEIINYEPIGIESDMWSIGVITYVL 142
+ +KI DFGL + + D +V P F PE + + SD+WS GV+ Y L
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
Query: 143 LS 144
+
Sbjct: 242 FT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 87 HHIKIIDFGLAQKINPDHPP-RVLFGT--PEF-IPPEIINYEPIGIESDMWSIGVITYVL 142
+ +KI DFGL + + D +V P F PE + + SD+WS GV+ Y L
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 143 LS 144
+
Sbjct: 211 FT 212
|
| >1x5i_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 126 | Back alignment and structure |
|---|
Score = 37.8 bits (88), Expect = 5e-04
Identities = 13/48 (27%), Positives = 24/48 (50%), Gaps = 2/48 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVE 49
P+ PS + V TS+V++W+ PP + ++ GY + G+
Sbjct: 28 PEVPSS-LHVRPLVTSIVVSWT-PPENQNIVVRGYAIGYGIGSPHAQT 73
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 16/80 (20%), Positives = 34/80 (42%), Gaps = 13/80 (16%)
Query: 90 KIIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
K+ DFGL ++ + P + + PE + + +SD+WS G++ + + S
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ + + +
Sbjct: 382 FGRVPYPRIPLKDVVPRVEK 401
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 6e-04
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 25/100 (25%)
Query: 78 NIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFI-------------PPEIINYE 124
NI+ V+ ++ K+ DFGL+ RVL PE PE I+Y
Sbjct: 177 NIL-VN-SNLVCKVSDFGLS---------RVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 125 PIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITR 163
SD+WS G++ + +++ G P+ ++ E I
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 6e-04
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 78 NIMCVSRTSHHI-KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESD 131
N + + KI DFG+A+ I R G +P PE ++D
Sbjct: 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 132 MWSIGVITYVLLS-GLSPFMGENDSETFANITR 163
WS GV+ + + S G P+ +++ E +T
Sbjct: 228 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 6e-04
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 7/85 (8%)
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVIT 139
+ H+KI DFGLA+ + D V+ P P PE ++ +SD+WS GV+
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 140 YVLLS-GLSPFMGENDSETFANITR 163
Y L + + R
Sbjct: 221 YELFTYCDKSCSPSAEFLRMMGCER 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 18/81 (22%), Positives = 38/81 (46%), Gaps = 9/81 (11%)
Query: 89 IKIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLL 143
+K+ DFG+ + + D + P PE+ +Y +SD+W+ G++ + +
Sbjct: 143 VKVSDFGMTRYVLDDQYVSSVGTK---FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 144 S-GLSPFMGENDSETFANITR 163
S G P+ +SE +++
Sbjct: 200 SLGKMPYDLYTNSEVVLKVSQ 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 26/80 (32%), Positives = 38/80 (47%), Gaps = 9/80 (11%)
Query: 90 KIIDFGLAQKINPDHPPRVLFGTPEFIP-----PEIINYEPIGIESDMWSIGVITYVLLS 144
KI DFGLA+ I + P PE INY I+SD+WS G++ +++
Sbjct: 149 KIADFGLARLIEDNEYTAREGAK---FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
Query: 145 -GLSPFMGENDSETFANITR 163
G P+ G + E N+ R
Sbjct: 206 HGRIPYPGMTNPEVIQNLER 225
|
| >2ede_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 114 | Back alignment and structure |
|---|
Score = 37.0 bits (86), Expect = 8e-04
Identities = 9/40 (22%), Positives = 15/40 (37%), Gaps = 3/40 (7%)
Query: 2 PDPPSG--AIGVSNNRTSVVITWSSPPYDGGCMITGYVVE 39
P I +V+++W P G IT Y++
Sbjct: 9 TSAPKDLTVITREGKPRAVIVSWQPPLEANG-KITAYILF 47
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 8e-04
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 19/82 (23%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPD----HPP----RVLFGTPEFIPPEIINYEP 125
I N++ + + ++D+GLA + P+ R GT EF I+
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAH- 233
Query: 126 IGIE----SDMWSIGVITYVLL 143
G+ D+ +G Y ++
Sbjct: 234 NGVAPSRRGDLEILG---YCMI 252
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.74 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.54 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.32 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.97 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 92.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 89.1 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 86.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.09 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=318.86 Aligned_cols=186 Identities=25% Similarity=0.435 Sum_probs=168.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||.| |++||+||||||+|||+ +.+|.+||+|||+++
T Consensus 106 ~~yivmEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl--~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE--cCCCCEEEEEcCCce
Confidence 5678999999999999985 45789999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... ...+.+||+.|+|||.+.+..|+.++|+||+||++|+|++|..||.+.+..+...++.+....++. .
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~ 256 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----K 256 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----T
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----c
Confidence 875332 334568999999999999999999999999999999999999999999999999999988877763 6
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHH------HhhccccccCCCCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQ------CLSHLWIAQKDSSP 214 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~------ll~h~~~~~~~~~~ 214 (239)
+++++++|+++||+.||++|+|++| +++||||++.++..
T Consensus 257 ~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp CCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred cCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 8999999999999999999999987 68999999877764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=315.98 Aligned_cols=184 Identities=25% Similarity=0.390 Sum_probs=164.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+|||+ +.+|.+||+|||+++
T Consensus 100 ~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE--cCCCCEEecccccce
Confidence 4678999999999999985 45689999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... .....+..||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.+....++. .++
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s 250 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLS 250 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCC
Confidence 6543 33445678999999999999999999999999999999999999999999999999999888776653 689
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
+++++|+++||+.||++||| ++|+++||||+..++
T Consensus 251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 99999999999999999998 589999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=318.71 Aligned_cols=186 Identities=24% Similarity=0.409 Sum_probs=163.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ++.++++.+..++.||+.||.| |++||+||||||+|||+ +.+|.+||+|||++.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--CCCCCEEEecCcCce
Confidence 4689999999999999874 2468999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... ....+.+||+.|+|||.+.+..|+.++||||+||++|+|++|.+||.+.+..+.+..+...... ....+..++
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s 297 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVS 297 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSC
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCC
Confidence 87543 3445678999999999999999999999999999999999999999999888888877665322 222335789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
+.+++|+.+||+.||++|||++|+|+||||++...
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999999999999987443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=308.26 Aligned_cols=180 Identities=26% Similarity=0.429 Sum_probs=151.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||| +|+|.+++. ..+.+++..+..++.|++.||+| |++||+||||||+||++ +.++.+||+|||+++
T Consensus 87 ~~~ivmEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl--~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL--DEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--CTTCCEEECCSSCC-
T ss_pred EEEEEEeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE--CCCCCEEEeecCCCe
Confidence 467899999 567777774 46789999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.........+..||+.|+|||.+.+..+ +.++||||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s 236 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLS 236 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Confidence 7766655666789999999999998887 6899999999999999999999999888888888888877665 3689
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+.+++|+++||+.||++|||++|+++||||+.
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=320.73 Aligned_cols=184 Identities=22% Similarity=0.311 Sum_probs=163.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++.. ..+..+++..+..++.||+.||.| |++|||||||||+|||+ +.+|.+||+|||+++
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--TKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE--CTTCCEEECSTTEES
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE--CCCCCEEEcccccce
Confidence 46889999999999999864 345678899999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ...+.+||+.|+|||.+.+..|+.++||||+||++|+|++|..||.+.+..+...++..+...... ..++
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~---~~~s 250 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS---LHYS 250 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---TTSC
T ss_pred eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC---ccCC
Confidence 765322 223457999999999999999999999999999999999999999999998998888887764332 4689
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++++|+.+||+.||++|||++++|+||||++
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=304.58 Aligned_cols=180 Identities=17% Similarity=0.253 Sum_probs=151.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
+|+|||||+||+|.+++. .++.+++..+..++.||+.||+| |++| |+||||||+|||+ ++ +|.+||+|||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcC
Confidence 578999999999999985 35678999999999999999999 9999 9999999999999 53 57899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhccCCCchHHHhh
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF-ANITRAEFDFDDEAFEA 175 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~ 175 (239)
++... .....+..||+.|+|||.+.+ +|+.++||||+||++|+|++|..||.+.+..... ..+..... +......
T Consensus 179 a~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~ 254 (290)
T 3fpq_A 179 ATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKV 254 (290)
T ss_dssp GGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGC
T ss_pred CEeCC-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCcc
Confidence 97543 333456789999999999875 6999999999999999999999999876654444 44443322 2223345
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++.+++|+.+||+.||++|||++++|+||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 7889999999999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=320.01 Aligned_cols=185 Identities=24% Similarity=0.411 Sum_probs=162.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. .+.+++..+..++.||+.||.| |++|||||||||+|||+ +.+|.+||+|||++.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl--~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEEECCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--cCCCCEEEecCccce
Confidence 4689999999999999874 3468999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... ....+.+||+.|||||.+.+..|+.++||||+||++|+|++|.+||.+.+..+.+..+...... ....+..++
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s 374 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVS 374 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSC
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCC
Confidence 77543 3445678999999999999999999999999999999999999999999888888887665322 222234689
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+++|+.+||+.||++|||++|+|+||||++..
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999999999998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=308.05 Aligned_cols=185 Identities=17% Similarity=0.174 Sum_probs=157.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||.| |++|||||||||+|||+ +.+| .+||+|||++
T Consensus 124 ~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL--SSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE--CTTSCCEEECCCTTC
T ss_pred EEEEEEeccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE--eCCCCEEEEeeCCCC
Confidence 4678999999999999985 35679999999999999999999 99999999999999999 5555 6999999999
Q ss_pred eecCCCCC------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDHP------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
+....... .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+......++........ .
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~ 277 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-E 277 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-G
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-h
Confidence 87654321 2234699999999999999999999999999999999999999998888777778777654322 2
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHH-------------hhccccccC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQC-------------LSHLWIAQK 210 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~l-------------l~h~~~~~~ 210 (239)
....+++.+.+|+.+||+.||++|||++|+ ++|||+.+.
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 234789999999999999999999999998 578999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=318.44 Aligned_cols=207 Identities=35% Similarity=0.603 Sum_probs=181.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++||||+||+|.+++. ...+.+++..+..++.||+.||.| |++||+||||||+||+++.+..+.+||+|||++.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~--~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEEEECCCCCBHHHHHT--CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEEEEeecCCCcHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 5688999999999998885 345789999999999999999999 9999999999999999976666899999999999
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
...........+||+.|+|||.+.+..|+.++||||+||++|+|++|..||.+.+..+.+..+......++...+..++.
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred EccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 88766656667899999999999999999999999999999999999999999999999999999888877777778999
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHH
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYI 229 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~ 229 (239)
.+++|+++||+.||.+|||++|+|+||||+...... ....+......+..
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~-~~~~~p~~~~~~~~ 435 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG-RDSQIPSSRYTKIR 435 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT-TTCEECGGGGHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC-chhhCCCcccccch
Confidence 999999999999999999999999999998755433 23333444444433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=298.50 Aligned_cols=185 Identities=18% Similarity=0.226 Sum_probs=156.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+ |+|.+++ ..++.+++..+..++.||+.||.| |++|||||||||+|||+ +.+|.+|++|||+++
T Consensus 133 ~~~ivmE~~~-g~L~~~i---~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~--~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV--NENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHH---TSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc--CCCCCEEEeecceee
Confidence 4689999997 4577777 457789999999999999999999 99999999999999999 778899999999997
Q ss_pred ecCCC-----CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-
Q psy1096 99 KINPD-----HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE- 171 (239)
Q Consensus 99 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~- 171 (239)
..... ....+.+||+.|+|||.+.+.. ++.++||||+||++|+|++|.+||.+.+..+.+..|......++..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 65422 2344578999999999988765 5999999999999999999999999999888888876654433321
Q ss_pred --------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 --------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 --------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....++..+.+|+++||..||++|+|++++|+||||++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 122468899999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=287.47 Aligned_cols=184 Identities=17% Similarity=0.239 Sum_probs=140.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+|++||||.||+|.+++.............+..++.||+.||.| |++||+||||||+|||+ +.+|.+||+|||+++.
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl--~~~~~vKl~DFGla~~ 167 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTA 167 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCCCCC--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE--CCCCcEEEccCcccee
Confidence 68999999999999998643333344556788999999999999 99999999999999999 7778999999999987
Q ss_pred cCCCCC-------------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhcc
Q psy1096 100 INPDHP-------------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAE 165 (239)
Q Consensus 100 ~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~ 165 (239)
...... ....+||+.|+|||.+.+..|+.++||||+||++|+|++ ||.+... ......+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~- 243 (299)
T 4g31_A 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL- 243 (299)
T ss_dssp ------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT-
T ss_pred cCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC-
Confidence 653321 223469999999999999999999999999999999996 7754321 1222333322
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..++ .....++.+.+|+++||+.||++|||++++++||||++.++
T Consensus 244 -~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 244 -KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp -CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred -CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2232 33456778899999999999999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=292.16 Aligned_cols=183 Identities=26% Similarity=0.354 Sum_probs=144.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+|++|.+++. .+++..++.++.|++.||+| |++||+||||||+|||++.+ .+.+||+|||+++
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~-~~~~kl~DFGla~ 166 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR-LKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT-TTEEEECCCTTCE
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC-CCeEEECcCCCCc
Confidence 5689999999999998872 48889999999999999999 99999999999999999432 2689999999997
Q ss_pred ecCCCC-----------------------------CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCC
Q psy1096 99 KINPDH-----------------------------PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSP 148 (239)
Q Consensus 99 ~~~~~~-----------------------------~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p 148 (239)
...... ...+.+||+.|+|||.+.+.. ++.++||||+||++|+|++|..|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 654321 122357999999999998764 79999999999999999999999
Q ss_pred CCCCC-chHHHHHHHhccC--------------------------------------C------------CchHHHhhcC
Q psy1096 149 FMGEN-DSETFANITRAEF--------------------------------------D------------FDDEAFEALS 177 (239)
Q Consensus 149 ~~~~~-~~~~~~~i~~~~~--------------------------------------~------------~~~~~~~~~~ 177 (239)
|.+.+ ..+.+..+..... . .....+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 96544 3333333322100 0 0011123578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+++.+|+++||+.||++|+|++|+|+||||++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 89999999999999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=284.89 Aligned_cols=181 Identities=20% Similarity=0.278 Sum_probs=147.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||+||+|.+++. ...+.+++..+..++.||+.||+| |+++||||||||+|||+ +.++.+||+|||+++.
T Consensus 106 ~~iVmEy~~gGsL~~~l~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL--HEGLTVKIGDFGLATV 181 (307)
T ss_dssp CEEEEECCSSCBHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE--ETTEEEEECCCSSCBC
T ss_pred EEEEEEcCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE--CCCCcEEEeeccCcee
Confidence 468999999999999986 445779999999999999999999 99999999999999999 6778999999999976
Q ss_pred cCCC---CCCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--hH
Q psy1096 100 INPD---HPPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD--DE 171 (239)
Q Consensus 100 ~~~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~ 171 (239)
.... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+.......+ ..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 5432 22344679999999999964 3589999999999999999999999998777666555554433222 22
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
....++..+.+|+.+||+.||++|||+++++++.
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2346789999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=304.50 Aligned_cols=183 Identities=20% Similarity=0.265 Sum_probs=158.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||.||+|.+++. ..+.+++..++.++.||+.||.| |++|||||||||+|||+ +.+|.+||+|||+++
T Consensus 266 ~lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl--d~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE--eCCCCEEecccceee
Confidence 4678999999999999985 45789999999999999999999 99999999999999999 788899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLSPFMGEND---SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ..+.+||+.|+|||.+. +..|+.++|+||+||++|+|++|.+||.+.+. ......+......++ .
T Consensus 341 ~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~ 415 (689)
T 3v5w_A 341 DFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----D 415 (689)
T ss_dssp ECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----c
Confidence 776443 34568999999999996 45789999999999999999999999976433 234455555555555 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
.+++++++|+++||+.||.+|++ ++++++||||+..+|
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 68999999999999999999998 799999999987554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=285.31 Aligned_cols=215 Identities=41% Similarity=0.704 Sum_probs=179.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC--CcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS--HHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~--~~vkl~dfg~ 96 (239)
..|+||||+.|++|.+++ ...+.+++..+..++.|++.||.| |++||+||||||+||+++.++. ..++|+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHH---TTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 467899999999999988 446789999999999999999999 9999999999999999943321 2799999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+.............||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++...+..+
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 98877655556677999999999999989999999999999999999999999999999999999988888888878889
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCcc---ccccchhHHHHHHHHhhhccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGV---NKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~~ 237 (239)
+..+++|+++||..||.+|||++++++||||+..++.... ........++++..+++|+.+
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLS 309 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHHHHTCBCCHHHHHHHTC-------
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhhcccchhhHHHHHHHHHHhHHHHH
Confidence 9999999999999999999999999999999865432211 122344667777777777764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=281.25 Aligned_cols=181 Identities=17% Similarity=0.223 Sum_probs=155.6
Q ss_pred EEeeCccCCCCccchhhhhhh----------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK----------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~v 89 (239)
.|+|||||++|+|.+++.... ....+++..+..++.||+.||+| |+++||||||||+|||+ +.++.+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl--~~~~~~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--GENLLV 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE--CCCCcE
Confidence 568999999999999996532 24578999999999999999999 99999999999999999 777899
Q ss_pred EEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcc
Q psy1096 90 KIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 90 kl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~ 165 (239)
||+|||+++....... .....||+.|+|||.+.+..++.++||||+||++|+|+| |+.||.+.+..+....+..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976543322 223458999999999999999999999999999999998 999999999888888888766
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
....+ ..++..+.+|+.+||+.||++|||++++. +|+.
T Consensus 248 ~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 248 VLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 43322 46899999999999999999999999994 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=281.11 Aligned_cols=179 Identities=18% Similarity=0.229 Sum_probs=147.8
Q ss_pred EEeeCccCCCCccchhhhhhh------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH 87 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~ 87 (239)
.|+|||||++|+|.+++.... ..+.+++..+..++.|++.||+| |+++||||||||+|||+ +.++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl--~~~~ 195 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGL 195 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE--CCCC
Confidence 578999999999999986532 23568899999999999999999 99999999999999999 6778
Q ss_pred cEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHh
Q psy1096 88 HIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITR 163 (239)
Q Consensus 88 ~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~ 163 (239)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|+|+| |+.||.+.+..+....+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997654332 2233568999999999999999999999999999999998 9999999988888888877
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+.....+ ..+++.+.+|+.+||+.||++|||+++++++
T Consensus 276 g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6432222 4689999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=278.53 Aligned_cols=179 Identities=18% Similarity=0.212 Sum_probs=154.4
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|+|||||++|+|.+++....+ .+.+++..+..++.||+.||+| |+++||||||||+|||+ +.+
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--~~~ 181 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDK 181 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--CCC
Confidence 4688999999999999965322 3468888999999999999999 99999999999999999 777
Q ss_pred CcEEEEecccceecCCC---CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPD---HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.+||+|||+++..... .......||+.|+|||.+.+..++.++||||+||++|||+| |..||.+.+..+....+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 89999999998765432 22334578999999999999999999999999999999998 899999999888888887
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+.....+ ..++..+.+|+.+||+.||++|||+++|+++
T Consensus 262 ~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 76543332 4689999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=284.53 Aligned_cols=179 Identities=20% Similarity=0.226 Sum_probs=149.9
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
+|+|||||++|+|.+++..... ...++++.+..++.||+.||.| |+++||||||||+|||+ +.+
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--~~~ 221 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEK 221 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--CCC
Confidence 5789999999999999975332 3568889999999999999999 99999999999999999 677
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHH-HH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFA-NI 161 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~-~i 161 (239)
+.+||+|||+++....... .....||+.|+|||.+.+..++.++||||+||++|+|+| |..||.+.+..+... .+
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7999999999987654332 223568899999999999999999999999999999998 999999876554444 44
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+.....+ ..+++++.+++.+||+.||++|||++++++|
T Consensus 302 ~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 443322111 3678999999999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=287.50 Aligned_cols=215 Identities=27% Similarity=0.481 Sum_probs=183.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg~~ 97 (239)
..|++||||.|++|.+.+. ..+.+++..+..++.|++.||.| |++||+||||||+||+++.+ .++.++|+|||++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEEEEECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 4578999999999998885 35679999999999999999999 99999999999999999543 4578999999999
Q ss_pred eecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+..+...++...+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 7765432 234467999999999999989999999999999999999999999999999999999988888777666788
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC-CccccccchhHHHHHHHHhhhccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS-PGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
++.+.+|+.+||..||++|||++++|+||||+..... ...........++++.++++++.+
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~ 302 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999753211 112222344688889999988865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=275.96 Aligned_cols=213 Identities=41% Similarity=0.663 Sum_probs=179.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC----cEEEEec
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH----HIKIIDF 94 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~----~vkl~df 94 (239)
..|++|||+.+++|.+++. ..+.+++..+..++.|++.||.| |+.|++||||||+||++ +..+ .++|+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll--~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE--ecCCCCCCCEEEEEC
Confidence 4678999999999999884 46789999999999999999999 99999999999999999 4444 7999999
Q ss_pred ccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
|++.............||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+.......+...+.
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 99988765555556679999999999998899999999999999999999999999988888888888887777777777
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc---cccccchhHHHHHHHHhhhccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG---VNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
.++..+.+|+++||..||++|||++++++||||+..+.... .......++++++..++++++.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNG 308 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHHHHHHHHCBCCHHHHHHHTTC------
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchhhhhhhcccccHHHHHHHHHHHHhhcc
Confidence 88999999999999999999999999999999987553321 1223455677777777776654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=279.56 Aligned_cols=214 Identities=27% Similarity=0.468 Sum_probs=181.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
..|++||||.|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||+++.+. ++.++|+|||++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEEEEECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 4578999999999998874 45678999999999999999999 999999999999999995443 357999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+..+...++...+..++
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 87765555555679999999999999899999999999999999999999999988888888888888877776677889
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC-CccccccchhHHHHHHHHhhhcc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS-PGVNKIISTDKLKKYIYRRKWQF 236 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~ 236 (239)
..+.+|+.+||..||++|||++++++||||...... ...........++++..+++++.
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 318 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKG 318 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999753211 12222233466777777777765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.40 Aligned_cols=189 Identities=35% Similarity=0.572 Sum_probs=170.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||+|++|.+++. .....+++..+..++.|++.||.| |++|++||||||+||+++.+.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 4678999999999998885 334578999999999999999999 9999999999999999965447899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++...+..++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 87665555556799999999999988889999999999999999999999999998889999998888888877788999
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.+.+|+.+||..||.+|||++++++||||++.
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=274.72 Aligned_cols=214 Identities=28% Similarity=0.416 Sum_probs=169.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++. ..+.+++..+..++.|++.||.| |+.|++||||||+||+++. +.++.++|+|||++
T Consensus 122 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEEEEECCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred eEEEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 4678999999999998884 45678999999999999999999 9999999999999999954 33788999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE-TFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 176 (239)
.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+..... ....+...........+..+
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 87665444455679999999999999899999999999999999999999998766554 55666666655555445678
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHHHHhhhccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
+..+.+|+++||..||++|||++++++||||.+...+.. .......+++++.++++++.+
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 338 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV-HMDTAQKKLQEFNARRKLKAA 338 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS-CCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh-hhcchHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987665443 233345678889999988864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=271.95 Aligned_cols=183 Identities=26% Similarity=0.417 Sum_probs=164.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++.. ++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIADFGFSN 162 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSTTCCG
T ss_pred EEEEEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE--cCCCCEEEeeccCce
Confidence 46789999999999998853 4678999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............||+.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+..+....+. .++
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s 238 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMS 238 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCC
Confidence 7765555556779999999999988887 48999999999999999999999999988888888888776663 578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+|+++||..||.+|||++++++||||+...
T Consensus 239 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999999998644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=273.37 Aligned_cols=217 Identities=24% Similarity=0.449 Sum_probs=175.8
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
..|+|||||+|++|.+++.... .+..+++..+..++.|++.||.| |++||+||||||+||+++.+. .+.++|+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 4688999999999988776543 34568899999999999999999 999999999999999995433 34599999999
Q ss_pred ceecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 97 AQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 97 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
+........ .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+. .......+...........+..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 987764432 33457999999999999888999999999999999999999999875 3456667777777777777778
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC-CccccccchhHHHHHHHHhhhccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS-PGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
++..+.+|+++||..||++|||++++++||||++.+.. .........++++++..+++++.+
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 321 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999864321 122222334678888888887754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=273.47 Aligned_cols=192 Identities=41% Similarity=0.685 Sum_probs=169.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++. ..+..+++..+..++.|++.||.| |++||+||||||+||+++.+..+.++|+|||++.
T Consensus 122 ~~~lv~E~~~gg~L~~~l~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEEEEECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence 4678999999999998875 334578999999999999999999 9999999999999999965566789999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+.......+...+..++.
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 87655544556799999999999988899999999999999999999999999888888888887776666555567899
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.+.+|+++||..||.+|||++++++||||+.....
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 99999999999999999999999999999875544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=266.87 Aligned_cols=213 Identities=41% Similarity=0.698 Sum_probs=180.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC----cEEEEec
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH----HIKIIDF 94 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~----~vkl~df 94 (239)
..|++|||+++++|.+++. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++ .++|+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~--~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE--ecCCCCcCCEEEccC
Confidence 4678999999999999884 46789999999999999999999 99999999999999999 5444 7999999
Q ss_pred ccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
|++.............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+....+.......+.....
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 99988766555556679999999999998899999999999999999999999999988888888888887777777777
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc---cccccchhHHHHHHHHhhhccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG---VNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
.++..+.+|+.+||..||++|||++++++||||+..+.... .......+.+++...+++|+.+
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLS 309 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHHHHHHHCEECHHHHHHHHHHCC----
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccccccccchhhHHHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999987554321 2233445667777777777654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=273.32 Aligned_cols=183 Identities=23% Similarity=0.347 Sum_probs=159.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||.|++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--DHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE--CCCCCEEEcccccee
Confidence 46899999999999988853 4678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++. .++
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 248 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLH 248 (353)
T ss_dssp CSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred ecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCC
Confidence 5432 23344567999999999999888999999999999999999999999999999999999888777663 579
Q ss_pred HHHHHHHHHhhhhCcccCCCH------HHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA------KQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~------~~ll~h~~~~~~~ 211 (239)
..+.+|+++||..||.+||++ +++++||||++.+
T Consensus 249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 999999999999999999998 9999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=267.40 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=161.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 79 ~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE--CCCCCEEEeeccchh
Confidence 4688999999999998874 35678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++
T Consensus 154 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 229 (337)
T 1o6l_A 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLS 229 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred hcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCC
Confidence 6432 23344567999999999999999999999999999999999999999998888888888877766653 679
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+|+++||..||++|| +++++++||||+..+
T Consensus 230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999999999 999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=274.52 Aligned_cols=191 Identities=24% Similarity=0.433 Sum_probs=154.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
.+|+|||||.|++|.+++.. .....+++..+..++.|++.||.| |++||+||||||+||+++.+. ++.+||+|||++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHC-C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 46899999999999999864 223568999999999999999999 999999999999999994422 688999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHhccCCCchHHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS----ETFANITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~ 173 (239)
.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.... .....+..+...++...+
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp EECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 8776555455667999999999999899999999999999999999999999765433 245566666666665555
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..++..+.+|+++||..||++|||++++++||||.+..
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 67899999999999999999999999999999997644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=272.19 Aligned_cols=188 Identities=40% Similarity=0.746 Sum_probs=168.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|.+++.. ....+++..+..++.|++.||.| |+.||+||||||+||++..+..+.++|+|||++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 45789999999999988863 34568888999999999999999 9999999999999999977777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++...+..++.
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 87765555566799999999999988899999999999999999999999999988888888888777766666667899
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+.+|+.+||..||.+|||++++++||||++
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=264.77 Aligned_cols=195 Identities=38% Similarity=0.613 Sum_probs=164.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg~~ 97 (239)
..|++|||+.+++|.+++.. ...+.+++..+..++.|++.||+| |++|++||||||+||+++.. ..+.++|+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred eEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 46789999999999998754 334678999999999999999999 99999999999999999431 1678999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+.......+......++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 88765555555679999999999999999999999999999999999999999988888888887777766666566789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
..+.+|+.+||+.||++|||++++++||||++.+++..
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 99999999999999999999999999999998766543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.24 Aligned_cols=190 Identities=30% Similarity=0.509 Sum_probs=166.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg~~ 97 (239)
..|++||||.|++|.+.+.. .+.+++..+..++.|++.||.| |++||+||||||+||+++.. ..+.++|+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 45789999999999988854 4578999999999999999999 99999999999999999542 3467999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............||+.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+..+....+..+...+....+..++
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 87765555556679999999999975 58999999999999999999999999999989999998888777766777899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
..+.+|+++||..||.+|||++++|+||||++....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 999999999999999999999999999999875544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=268.44 Aligned_cols=183 Identities=26% Similarity=0.418 Sum_probs=162.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE--cCCCcEEEEeCCccc
Confidence 56899999999999998853 4578999999999999999999 99999999999999999 778899999999987
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++. .++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 245 (353)
T 2i0e_A 170 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMS 245 (353)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred ccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCC
Confidence 6432 23344567999999999999999999999999999999999999999999888888888887776663 689
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+|+++||..||.+|| +++++++||||+..+
T Consensus 246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 9999999999999999999 479999999998644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=267.70 Aligned_cols=184 Identities=27% Similarity=0.376 Sum_probs=162.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.||+|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--DKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE--CCCCCEEEeEChhhh
Confidence 46789999999999998853 4678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++ ..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 242 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLE 242 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSC
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccC
Confidence 6432 2233456799999999999999999999999999999999999999999988888888887766655 3679
Q ss_pred HHHHHHHHHhhhhCcccCCCHH-HHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAK-QCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~-~ll~h~~~~~~~~ 212 (239)
..+.+|+++||..||++||+++ ++++||||+..++
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 9999999999999999999998 9999999987553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=260.44 Aligned_cols=191 Identities=19% Similarity=0.259 Sum_probs=157.3
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
....|++|||+++ +|.+++.. .....+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||+
T Consensus 91 ~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 91 EIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEEEEECCCC-BHHHHHHT-CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE--CTTSCEEECSCSC
T ss_pred ceeEEEEehhhhc-CHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--cCCCCEEEeeCcc
Confidence 3457899999985 88877754 333458999999999999999999 99999999999999999 7778999999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
+.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+.......+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9877655555667899999999999989999999999999999999999999998888777777654322111
Q ss_pred ----------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 170 ----------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 170 ----------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
......++..+.+|+.+||+.||++|||++++|+||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 1122357889999999999999999999999999999987443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.00 Aligned_cols=181 Identities=28% Similarity=0.467 Sum_probs=162.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 80 ~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITDFGFAK 154 (318)
T ss_dssp EEEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTSCEEECCCSSCE
T ss_pred EEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE--cCCCCEEEeecCcce
Confidence 4688999999999999884 45678999999999999999999 99999999999999999 778899999999997
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++.
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 228 (318)
T 1fot_A 155 YVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNE 228 (318)
T ss_dssp ECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred ecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 76532 23457999999999999999999999999999999999999999998888888888887766653 6789
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
.+.+++++||..||++|+ +++++++||||++.+
T Consensus 229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 999999999999999999 999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.15 Aligned_cols=189 Identities=26% Similarity=0.468 Sum_probs=168.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++||||.|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||+++. +..+.++|+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEEEEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 4678999999999998884 46779999999999999999999 9999999999999999954 34578999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............||+.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+..+....+..+...++...+..++
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred EEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 87766555555679999999999976 68999999999999999999999999999999999999888877766677899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+|+++||..||.+|||++++|+||||+....
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999999986443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=268.38 Aligned_cols=183 Identities=22% Similarity=0.348 Sum_probs=156.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||+.|++|..++. ..+.+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++|+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE--CCCCCEEEeecceee
Confidence 4678999999999998885 35679999999999999999999 99999999999999999 778899999999987
Q ss_pred ec-CCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------chHHHHHHHhccCCC
Q psy1096 99 KI-NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---------DSETFANITRAEFDF 168 (239)
Q Consensus 99 ~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~---------~~~~~~~i~~~~~~~ 168 (239)
.. ..........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.. .......+......+
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence 63 23334455679999999999999999999999999999999999999996432 223455566666555
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCH------HHHhhccccccCC
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTA------KQCLSHLWIAQKD 211 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~------~~ll~h~~~~~~~ 211 (239)
+. .++..+.+|+++||+.||.+|+++ +++++||||+..+
T Consensus 282 p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 282 PR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp CT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred CC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 53 689999999999999999999984 8999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=257.34 Aligned_cols=184 Identities=26% Similarity=0.401 Sum_probs=156.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++.. ..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--CCCCCEEEeeCCCce
Confidence 35789999999999998753 358889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+........ .....++
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 243 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLS 243 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSC
T ss_pred ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccC
Confidence 765433 23345799999999999999999999999999999999999999988877666665544332211 1124689
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
..+.+|+.+||+.||++|||++++++||||+..
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=265.65 Aligned_cols=189 Identities=24% Similarity=0.440 Sum_probs=161.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC--CcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS--HHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~--~~vkl~dfg~ 96 (239)
.+|+|||||.|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++..+.+ +.++|+|||+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEEEEECCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 4689999999999998884 46679999999999999999999 9999999999999999854322 4699999999
Q ss_pred ceecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCchHHHHHHHhccCCCchHH
Q psy1096 97 AQKINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG---ENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 97 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~---~~~~~~~~~i~~~~~~~~~~~ 172 (239)
+...... .......||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+ .+..+....+..+....+...
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 9876543 233456789999999999888889999999999999999999999975 345566777777777766555
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..++..+.+|+++||..||++|||++++++||||...+
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 567899999999999999999999999999999997643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=264.86 Aligned_cols=183 Identities=26% Similarity=0.444 Sum_probs=161.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.|++|.+++.. .+.+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCBCG
T ss_pred EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--CCCCCEEEeeCcccc
Confidence 45789999999999988853 5678889999999999999999 99999999999999999 778899999999987
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
... .........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++. .++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~ 263 (373)
T 2r5t_A 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NIT 263 (373)
T ss_dssp GGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSC
T ss_pred ccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCC
Confidence 643 333445567999999999999999999999999999999999999999999888888888877666553 679
Q ss_pred HHHHHHHHHhhhhCcccCCCH----HHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA----KQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~----~~ll~h~~~~~~~ 211 (239)
..+.+|+++||+.||.+|+++ +++++|+||+..+
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 999999999999999999986 7999999998644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=264.30 Aligned_cols=182 Identities=24% Similarity=0.386 Sum_probs=163.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE--CCCCCEEEcccccce
Confidence 46899999999999998853 4578999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .++.
T Consensus 190 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 263 (350)
T 1rdq_E 190 RVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSS 263 (350)
T ss_dssp ECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCH
T ss_pred eccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCH
Confidence 76543 23456999999999999999999999999999999999999999999888888888888766653 6799
Q ss_pred HHHHHHHHhhhhCcccCCC-----HHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~~ 212 (239)
.+.+++++||+.||.+||+ ++++++||||+..++
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 9999999999999999998 999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=264.33 Aligned_cols=185 Identities=28% Similarity=0.463 Sum_probs=164.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++.. +..+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~--~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL--DDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEEEecCccc
Confidence 46789999999999998853 4678899999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYE------PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
............||+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+.......+......+....
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 87665555567799999999998633 478899999999999999999999998888888888888877777766
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+...+..+.+++++||..||++|||++++++||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 7788999999999999999999999999999999963
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=254.57 Aligned_cols=189 Identities=29% Similarity=0.487 Sum_probs=167.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.| |++|++|+||||+||++.. +.++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 35789999999999988853 5668899999999999999999 9999999999999999844 34568999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............+++.|+|||.+.+. ++.++|+||+|+++++|++|..||.+.+..+....+.......+...+..++
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred eeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 887765555566799999999998754 8999999999999999999999999998888888888888888877777899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++.+||+.||++|||+.++++||||++...
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 99999999999999999999999999999976433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=269.80 Aligned_cols=188 Identities=23% Similarity=0.401 Sum_probs=159.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++.. ..+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE--CCCCCEEEeccceeE
Confidence 46789999999999988742 468899999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCC--CCccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEP----IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ...+..||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.+.......+...........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 765433 233567999999999997665 78999999999999999999999999988888888876432211111
Q ss_pred HhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCCCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~~~ 213 (239)
...++..+++|+++||..+|.+ |++++++++||||+..++.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 2368999999999999999988 9999999999999986654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=255.01 Aligned_cols=191 Identities=26% Similarity=0.477 Sum_probs=167.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
..|++|||+.+++|.+.+.. .+.+++..+..++.|++.||.| |+.|++||||||+||+++.+. .+.++|+|||.+
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 34789999999999888753 4678899999999999999999 999999999999999995433 245999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............|++.|+|||.+.+..++.++|+||+|+++++|++|..||.+.+.......+.......+...+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 87766555555679999999999999889999999999999999999999999998888888888887777766556789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
+.+.+|+.+||..||++|||++++++||||+..+..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 999999999999999999999999999999875433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=260.87 Aligned_cols=190 Identities=27% Similarity=0.460 Sum_probs=145.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
..|++|||++|++|.+++. .++.+++..+..++.|++.||.| |++||+||||||+||+++.++ ...++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp EEEEEECCCCSCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEEEEEEccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 4678999999999999884 46789999999999999999999 999999999999999995432 237999999999
Q ss_pred eecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHhccCCCc
Q psy1096 98 QKINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND-------SETFANITRAEFDFD 169 (239)
Q Consensus 98 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-------~~~~~~i~~~~~~~~ 169 (239)
...... .......+|+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+. .+....+..+...++
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 766543 233445689999999999999999999999999999999999999976433 456777777777777
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
...+..++..+.+|+.+||..||.+|||++++++||||++...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 7777789999999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=261.66 Aligned_cols=183 Identities=22% Similarity=0.345 Sum_probs=155.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.|++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK 158 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCGGGCB
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--CCCCCEEEEeccccc
Confidence 46889999999999988853 4678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CchHHHHHHHhccCCC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE---------NDSETFANITRAEFDF 168 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~---------~~~~~~~~i~~~~~~~ 168 (239)
... .........||+.|+|||.+.+..++.++|+||+||++|+|++|..||... ........+......+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 238 (345)
T 3a8x_A 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238 (345)
T ss_dssp CSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC
T ss_pred cccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC
Confidence 643 223344567999999999999999999999999999999999999999652 2233445555555555
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCH------HHHhhccccccCC
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTA------KQCLSHLWIAQKD 211 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~------~~ll~h~~~~~~~ 211 (239)
+ ..++..+.+|+++||..||.+||++ +++++||||+..+
T Consensus 239 p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 239 P----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp C----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred C----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 4 3679999999999999999999995 8999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=265.07 Aligned_cols=181 Identities=25% Similarity=0.435 Sum_probs=154.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+ +|+|.+++.. .+.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL--DDNLNVKIADFGLSN 156 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE--CTTCCEEECCSSCTB
T ss_pred EEEEEEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE--cCCCCEEEEEeccce
Confidence 457899999 5777777743 4678999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............||+.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.........+.......+ ..++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 232 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLS 232 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSC
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCC
Confidence 7766555566779999999999988876 7899999999999999999999987665554444444444433 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+.+.+|+++||..||.+|||++++++||||+..
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.81 Aligned_cols=182 Identities=28% Similarity=0.429 Sum_probs=163.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++ ..++.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 90 ~~~lv~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll--~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL--DAHMNAKIADFGLSN 164 (476)
T ss_dssp EEEEEEECCSSEEHHHHT---TSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE--CTTCCEEECCCSSCE
T ss_pred EEEEEEeCCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE--ecCCCeEEEeccchh
Confidence 467899999999999988 456789999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............||+.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence 8766555556779999999999988776 7899999999999999999999999888888888887766554 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+.+.+|+++||..||.+|||++++++||||++.
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=258.22 Aligned_cols=183 Identities=26% Similarity=0.423 Sum_probs=156.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--CTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE--CCCCcEEEEeCCccc
Confidence 3578999999999998884 34578889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+.......+. .++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCC
Confidence 54322 2334457999999999999888999999999999999999999999998888888888877666553 678
Q ss_pred HHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..+.+|+++||..||++|| +++++++||||+..+
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999999999 899999999998644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=270.85 Aligned_cols=183 Identities=27% Similarity=0.378 Sum_probs=160.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+||||++|++|.+++. .++.+++..+..++.|++.||.| |+ +||+||||||+||++ +.++.++|+|||++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll--~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLC 296 (446)
T ss_dssp EEEEEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE--CSSSCEEECCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE--CCCCCEEEccCCCc
Confidence 3578999999999998884 35678999999999999999999 98 899999999999999 77789999999998
Q ss_pred eecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+......++. .+
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 372 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TL 372 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TS
T ss_pred eeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cC
Confidence 75432 23344567999999999999999999999999999999999999999998888888888877776653 67
Q ss_pred CHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
++.+.+|+.+||..||.+|| |++++++||||+..+
T Consensus 373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 99999999999999999999 999999999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=282.35 Aligned_cols=184 Identities=26% Similarity=0.419 Sum_probs=165.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.| |++||+||||||+|||+ +.+|.++|+|||++.
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl--~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE--CSSSCEEECCCTTCE
T ss_pred EEEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE--cCCCcEEEeecceee
Confidence 46899999999999988853 4678999999999999999999 99999999999999999 777899999999998
Q ss_pred ecC-CCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KIN-PDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
... .........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+......++. .++
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 566 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMS 566 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSC
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 643 233344567999999999999999999999999999999999999999999999999999888777764 689
Q ss_pred HHHHHHHHHhhhhCcccCCCH-----HHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTA-----KQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~-----~~ll~h~~~~~~~~ 212 (239)
..+.+|+++||+.||++|+++ ++|++||||+..++
T Consensus 567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 999999999999999999997 99999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=263.52 Aligned_cols=194 Identities=24% Similarity=0.248 Sum_probs=159.5
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
....|++|||++++.+..+.........+++..+..++.|++.||.| |++||+||||||+||+++. .++.++|+|||+
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcEEEeeCCC
Confidence 34478999999987666544433457789999999999999999999 9999999999999999931 567999999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH---
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA--- 172 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~--- 172 (239)
+.............+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+.+....+....
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9887666556667799999999999765 489999999999999999999999999887777766655322222111
Q ss_pred ----------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 173 ----------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 173 ----------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
....++.+.+|+.+||+.||.+|||++++++||||++.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 1236789999999999999999999999999999986443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=269.17 Aligned_cols=186 Identities=26% Similarity=0.413 Sum_probs=152.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~~ 98 (239)
.|++|||+.+++|.+++ ..++.+++..+..++.|++.||.| |++||+||||||+||+++.++ .+.++|+|||++.
T Consensus 214 ~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 57899999999999887 456789999999999999999999 999999999999999995432 3469999999998
Q ss_pred ecCCCCCCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~ 174 (239)
............||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+... ......+........+..+.
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 7765555556779999999999854 5678899999999999999999999976543 34556666777777777777
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++..+.+|+++||..||++|||++++++||||++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 89999999999999999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=271.19 Aligned_cols=190 Identities=28% Similarity=0.484 Sum_probs=169.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~~ 97 (239)
..|+|||||.|++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||+++.++. ..++|+|||++
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence 45789999999999988853 4678999999999999999999 9999999999999999944332 36999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............||+.|+|||.+. ..++.++||||+||++|+|++|..||.+.+..+....+..+...++...+..++
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (504)
T 3q5i_A 197 SFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275 (504)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred EEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCC
Confidence 8877655555677999999999987 468999999999999999999999999999999999999998888888888899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
..+.+|+++||..||.+|||++++|+||||++....
T Consensus 276 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 999999999999999999999999999999875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=255.35 Aligned_cols=188 Identities=18% Similarity=0.264 Sum_probs=151.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ ++.+++. .....+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 93 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI--NSDGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSE-EHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEcCCCC-CHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE--CCCCCEEEccCcCce
Confidence 35789999996 5655654 345568999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCC-CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
..... .......+|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+........+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 76533 23334568999999999976 45799999999999999999999999988777766665442221111
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++.++.+|+++||+.||++|||++++++||||++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 112346788999999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.14 Aligned_cols=183 Identities=21% Similarity=0.258 Sum_probs=147.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|+||||++++.+. .+ ...+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|||++
T Consensus 140 ~~~~lv~E~~~~~l~~-~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll--~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCCC
T ss_pred CeEEEEEeCCCCCHHH-HH-----hhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE--eCCCCEEEEEEEee
Confidence 3568999999987444 33 2348888999999999999999 99999999999999999 77789999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh---
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE--- 174 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~--- 174 (239)
.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+....+..+......+.+....
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 87766555566789999999999999999999999999999999999999999988877777766543333222111
Q ss_pred -----------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 -----------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 -----------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+..+.+|+++||..||++|||++++|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 11467899999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=270.15 Aligned_cols=189 Identities=28% Similarity=0.445 Sum_probs=160.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||.||+|.+++.. .++.+++..+..++.|++.||.| |+.||+||||||+||++ +.+|.+||+|||++.
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE--cCCCCEEEcchhhhh
Confidence 36899999999999999853 35789999999999999999999 99999999999999999 778899999999997
Q ss_pred ecCCCCC--CccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--CCCc
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FDFD 169 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~--~~~~ 169 (239)
....... .....||+.|+|||.+. ...++.++|+||+||++|+|++|..||.+.+..+....+.... ..++
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 7654332 23357999999999996 4567999999999999999999999999998888888876532 2222
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCccc--CCCHHHHhhccccccCCCC
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEK--RLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~--Rpt~~~ll~h~~~~~~~~~ 213 (239)
. ....++..+++|+++||+.+|++ |++++++++||||+..++.
T Consensus 304 ~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 304 T-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp S-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred c-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 2 11357999999999999998888 9999999999999876654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=260.25 Aligned_cols=183 Identities=17% Similarity=0.275 Sum_probs=156.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.|++|.+++. .++.+++..+..++.|++.||.| |++||+||||||+||++ +..|.++|+|||++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--CCCCCEEEeccceee
Confidence 4678999999999998884 46789999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGEND---SETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~ 172 (239)
............||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+... ......+.......+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p--- 240 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--- 240 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC---
T ss_pred eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC---
Confidence 8766655666789999999999964 4578999999999999999999999975433 334444555554444
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCC-HHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLT-AKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt-~~~ll~h~~~~~~~ 211 (239)
..++..+.+|+++||..||.+||+ ++++++||||+..+
T Consensus 241 -~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 241 -SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 367899999999999999999998 99999999998644
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=257.69 Aligned_cols=185 Identities=21% Similarity=0.199 Sum_probs=153.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec---------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--------------- 83 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--------------- 83 (239)
..|++|||+ +++|.+++.. .....+++..+..++.|++.||.| |++||+||||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITR-NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred eeEEEEcCC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 467899999 8899988864 334468889999999999999999 9999999999999999943
Q ss_pred --------CCCCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy1096 84 --------RTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS 155 (239)
Q Consensus 84 --------~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~ 155 (239)
...+.++|+|||++..... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 1367899999999976543 234457899999999999999999999999999999999999999988877
Q ss_pred HHHHHHHhccCCCchHHH------------------------------------------hhcCHHHHHHHHHhhhhCcc
Q psy1096 156 ETFANITRAEFDFDDEAF------------------------------------------EALSEDAKDFISSLLVKRKE 193 (239)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~------------------------------------------~~~~~~~~~ll~~~l~~~p~ 193 (239)
+....+.......+.... ...+..+.+|+++||+.||+
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 777666554444332211 11236788999999999999
Q ss_pred cCCCHHHHhhccccc
Q psy1096 194 KRLTAKQCLSHLWIA 208 (239)
Q Consensus 194 ~Rpt~~~ll~h~~~~ 208 (239)
+|||++++|+||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.84 Aligned_cols=186 Identities=27% Similarity=0.497 Sum_probs=166.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
..|+|||||.|++|.+.+.. .+.+++..+..++.|++.||.| |++||+||||||+||+++... .+.++|+|||++
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 46789999999999988853 4678899999999999999999 999999999999999995432 456999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............||+.|+|||.+. ..++.++||||+||++|+|++|..||.+.+..+....+......++...+..++
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred eECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 8877655555677999999999986 468999999999999999999999999999999999999888887777777899
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+.+|+++||..||.+|||++++|+||||++
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=262.16 Aligned_cols=184 Identities=21% Similarity=0.217 Sum_probs=150.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||+++ +|.+++. .+.+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 85 ~~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL--NAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCSE-EHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEecccCc-CHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE--cCCCCEEecCCcccc
Confidence 46889999995 6776664 2478888999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCC----------------------CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q psy1096 99 KINPD----------------------HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDS 155 (239)
Q Consensus 99 ~~~~~----------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~ 155 (239)
..... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 11233579999999999976 56899999999999999999999999998887
Q ss_pred HHHHHHHhccCCCchHHH-------------------------------------------hhcCHHHHHHHHHhhhhCc
Q psy1096 156 ETFANITRAEFDFDDEAF-------------------------------------------EALSEDAKDFISSLLVKRK 192 (239)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~-------------------------------------------~~~~~~~~~ll~~~l~~~p 192 (239)
.....+......+..... ...+..+.+|+++||..||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 777776543322221111 1457889999999999999
Q ss_pred ccCCCHHHHhhccccccC
Q psy1096 193 EKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 193 ~~Rpt~~~ll~h~~~~~~ 210 (239)
++|||++++|+||||+..
T Consensus 318 ~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGSCCHHHHTTSTTTTTT
T ss_pred ccCCCHHHHhCCHHHHHh
Confidence 999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=256.56 Aligned_cols=191 Identities=28% Similarity=0.461 Sum_probs=151.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.. .+.+++..+..++.|++.||+| |++|++||||||+||+++.++. +.++|+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 46789999999999999854 4578899999999999999999 9999999999999999943322 34999999998
Q ss_pred eecCCCC--------CCccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------
Q psy1096 98 QKINPDH--------PPRVLFGTPEFIPPEIINY-----EPIGIESDMWSIGVITYVLLSGLSPFMGEND---------- 154 (239)
Q Consensus 98 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---------- 154 (239)
....... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 6653211 1223458999999999975 4578999999999999999999999977543
Q ss_pred -----hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 155 -----SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 155 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
......+......++...+..++..+.+|+++||..||++|||++++++||||++....
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 33556667777777766667789999999999999999999999999999999875443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=261.22 Aligned_cols=186 Identities=22% Similarity=0.388 Sum_probs=142.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||+++.+..+.++|+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 3678999999999998884 35578999999999999999999 9999999999999999965555569999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIE-SDMWSIGVITYVLLSGLSPFMGEND----SETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~ 173 (239)
............||+.|+|||.+.+..++.+ +||||+||++|+|++|..||.+... ......+.......+..
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD-- 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--
Confidence 5544444455679999999999988887655 8999999999999999999986543 23334444444443321
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
..++..+.+|+++||..||++|||++++++||||.+.
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 2578999999999999999999999999999999653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=256.58 Aligned_cols=179 Identities=18% Similarity=0.204 Sum_probs=135.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh--------cccCCCCCCCCeEEecCCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL--------VTVDPKILPENIMCVSRTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~--------~ivH~dikp~nili~~~~~~~vk 90 (239)
.+|+|||||++|+|.+++.. ..++++.+..++.|++.||+| |++ +|+||||||+|||+ +.++.+|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~K 148 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCC 148 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEE
T ss_pred EEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEE
Confidence 46899999999999999853 357888899999999999999 987 89999999999999 7788999
Q ss_pred EEecccceecCCCCC-----CccccCCCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCC-------
Q psy1096 91 IIDFGLAQKINPDHP-----PRVLFGTPEFIPPEIINYE------PIGIESDMWSIGVITYVLLSGLSPFMGE------- 152 (239)
Q Consensus 91 l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~~g~~p~~~~------- 152 (239)
|+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|+|++|.+||...
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 999999987654321 2235799999999999754 3577999999999999999997765321
Q ss_pred ---C----c-hHHHHHHHhccCCCch-HHH--hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 153 ---N----D-SETFANITRAEFDFDD-EAF--EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 153 ---~----~-~~~~~~i~~~~~~~~~-~~~--~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
. . ......+......+.. ... ...+..+.+|+.+||+.||++|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 1 1222233333332211 111 1123568899999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=259.50 Aligned_cols=187 Identities=18% Similarity=0.212 Sum_probs=153.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h--hhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H--SLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h--~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|+||||+++ +|.+++.. ...+.+++..+..++.|++.||.| | +.||+||||||+||+++.+..+.++|+|||+
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRN-TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCCC-CHHHHHhh-cCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 46789999976 88888764 333568899999999999999999 9 5799999999999999666678899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh-
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA- 175 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~- 175 (239)
+...... .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++......
T Consensus 208 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 208 SCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp CEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 9876532 3346789999999999999999999999999999999999999998888777777665433222211100
Q ss_pred -----------------------------------------------------------cCHHHHHHHHHhhhhCcccCC
Q psy1096 176 -----------------------------------------------------------LSEDAKDFISSLLVKRKEKRL 196 (239)
Q Consensus 176 -----------------------------------------------------------~~~~~~~ll~~~l~~~p~~Rp 196 (239)
.+..+.+|+.+||+.||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 013689999999999999999
Q ss_pred CHHHHhhccccccC
Q psy1096 197 TAKQCLSHLWIAQK 210 (239)
Q Consensus 197 t~~~ll~h~~~~~~ 210 (239)
|++++|+||||++.
T Consensus 366 ta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHTTSGGGCC-
T ss_pred CHHHHhcCcccccC
Confidence 99999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=264.61 Aligned_cols=188 Identities=27% Similarity=0.449 Sum_probs=158.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.|++|.+++.. .+..+++..+..++.|++.||.| |++||+||||||+||++ +..|.+||+|||++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--d~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee--cCCCCEEEeechhhe
Confidence 46899999999999999863 34578999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCC--CccccCCCCccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--CC
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIIN-------YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE--FD 167 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~--~~ 167 (239)
....... .....||+.|+|||.+. ...++.++|+||+||++|+|++|..||.+.+..+....+.... ..
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7654332 23357999999999997 3567999999999999999999999999988888887776532 22
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccC---CCHHHHhhccccccCCCC
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKR---LTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R---pt~~~ll~h~~~~~~~~~ 213 (239)
++. ....++..+++|+++||+ +|.+| ++++++++||||+..++.
T Consensus 291 ~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 291 LPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp CC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred CCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 221 124689999999999999 99998 599999999999886665
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=262.93 Aligned_cols=191 Identities=21% Similarity=0.242 Sum_probs=150.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++.. .....+++..+..++.|++.||+| |++||+||||||+||+++.++...++|+|||++.
T Consensus 173 ~~~lv~e~~~~-~L~~~l~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLSM-NLYELIKK-NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCCC-BHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEEeccCC-CHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 45788999975 77777754 333458889999999999999999 9999999999999999944333349999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH-----
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF----- 173 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~----- 173 (239)
..... .....||+.|+|||.+.+..++.++||||+||++|+|++|.+||.+.+..+....+......++....
T Consensus 251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 251 YEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred ecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 65432 33457899999999999999999999999999999999999999988877776665543222221111
Q ss_pred --------------------------------------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 174 --------------------------------------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 174 --------------------------------------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
...++.+.+|+++||+.||++|||++++|+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 123678999999999999999999999999
Q ss_pred ccccccCCCCC
Q psy1096 204 HLWIAQKDSSP 214 (239)
Q Consensus 204 h~~~~~~~~~~ 214 (239)
||||++....+
T Consensus 409 Hpw~~~~~~~~ 419 (429)
T 3kvw_A 409 HPWLRRRLPKP 419 (429)
T ss_dssp STTTC------
T ss_pred ChhhccCCCCC
Confidence 99998754443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=251.62 Aligned_cols=182 Identities=24% Similarity=0.398 Sum_probs=154.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++ ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 112 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~~~ 185 (298)
T 2zv2_A 112 HLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV--GEDGHIKIADFGVSN 185 (298)
T ss_dssp EEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--CCCCCEEEecCCCcc
Confidence 468899999999999764 35678999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ......||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.........+.......+. ..
T Consensus 186 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 263 (298)
T 2zv2_A 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--QP 263 (298)
T ss_dssp ECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--SS
T ss_pred ccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--cc
Confidence 765432 223456999999999998765 378899999999999999999999888777766666665544432 13
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++..+.+++.+||+.||++|||++++++||||++
T Consensus 264 ~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 57899999999999999999999999999999963
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=249.33 Aligned_cols=188 Identities=29% Similarity=0.444 Sum_probs=152.9
Q ss_pred EEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~ 96 (239)
..|++|||+++++|.+++... ..+..+++..+..++.|++.||.| |++|++||||||+||+++. +..+.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 457899999999999988654 345789999999999999999999 9999999999999999954 3347899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+.............+++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.+.......+.......... ...+
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL 251 (285)
T ss_dssp CCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred ceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence 97766554455567999999999986 467899999999999999999999999888777766665554443322 1347
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
++.+.+|+++||..||++|||++++++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=251.04 Aligned_cols=186 Identities=20% Similarity=0.270 Sum_probs=148.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++.+..+. ..++.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~--~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 75 KLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--NRNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeecccce
Confidence 457899999986555433 446789999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCC-CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHhccCCCchH----
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSP-FMGENDSETFANITRAEFDFDDE---- 171 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p-~~~~~~~~~~~~i~~~~~~~~~~---- 171 (239)
..... .......+|+.|+|||.+.+.. ++.++|+||+||++|+|++|..| |.+.+.......+......+...
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 76533 2334457899999999998766 79999999999999999987777 45555555555554322211110
Q ss_pred ---------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ---------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ---------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....++..+++|+++||+.||++|||++++++||||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 112468899999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.69 Aligned_cols=185 Identities=22% Similarity=0.399 Sum_probs=157.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++. ...+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 116 ~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL--TLDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCcEEEeeeeeee
Confidence 4578999999999998864 4568899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+........ .....++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 268 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVS 268 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSC
T ss_pred ecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCC
Confidence 765432 23445799999999999988899999999999999999999999998887777766655433221 1224678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||+.||++|||++++++||||.+..
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 9999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=250.37 Aligned_cols=188 Identities=43% Similarity=0.708 Sum_probs=161.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC--CCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT--SHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~--~~~vkl~dfg~ 96 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.+ |++|++|+||||+||+++.++ .+.++|+|||.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 46789999999999998853 4678899999999999999999 999999999999999994332 23799999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+.............+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+.+.......+.......+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 98776554445567899999999999888999999999999999999999999998888888888877777777666788
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
+..+.+++++||..||++|||++++++||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=254.24 Aligned_cols=185 Identities=19% Similarity=0.346 Sum_probs=152.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||+|++|.+++ ..++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLAT 153 (323)
T ss_dssp EEEEEEECCTTEEGGGGS---BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEEcCCCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE--eCCCCEEEEEeeccc
Confidence 457899999999999988 446678999999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCC---CCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhccCCCchHHH
Q psy1096 99 KINPD---HPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSE-TFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~ 173 (239)
..... .......||+.|+|||.+.+..+ +.++||||+||++|+|++|..||.+..... ............. .+
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 231 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PW 231 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST--TG
T ss_pred eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC--cc
Confidence 65322 12234579999999999987775 789999999999999999999998765542 2223222222222 23
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..++..+.+|+.+||..||++|||++++++||||++..
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 56899999999999999999999999999999998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=250.19 Aligned_cols=187 Identities=28% Similarity=0.474 Sum_probs=164.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. +..+++..+..++.|++.||.| |++|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--cCCCcEEEecccchh
Confidence 46789999999999999853 4678899999999999999999 99999999999999999 777889999999998
Q ss_pred ecCCCCCCccccCCCCccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN------YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
............+++.|+|||.+. ...++.++|+||+|+++++|++|..||.+.+.......+.......+...
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 876555555567899999999985 34578899999999999999999999998888888888877776666555
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..++..+.+++.+||..||++|||++++++||||++..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 567899999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=256.64 Aligned_cols=191 Identities=18% Similarity=0.226 Sum_probs=154.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++ ++.+.+. .....+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--TRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEeccCC-CHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE--cCCCCEEEccchhcc
Confidence 46899999997 4444553 344678999999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCC-----CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-----HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+......++...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 76422 223345689999999999764 579999999999999999999999999887777776655433333221
Q ss_pred Hhh----------------------------cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCc
Q psy1096 173 FEA----------------------------LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPG 215 (239)
Q Consensus 173 ~~~----------------------------~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~ 215 (239)
+.. .++.+.+|+.+||+.||++|||++++++||||.+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 111 2677999999999999999999999999999987554443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=257.30 Aligned_cols=192 Identities=28% Similarity=0.436 Sum_probs=159.2
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------------------------------------CCCchHHHHHHHHHHHHHHH
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------------------------------------GTQPWVELSERLFESTERGL 62 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------------------------------------~~~~~~~~~~~~~~~i~~~l 62 (239)
..|+|||||+|++|.+++..... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 46789999999999988742111 22346677889999999999
Q ss_pred HH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCC-----CCccccCCCCccCcccccc--CCCCchhhHHH
Q psy1096 63 GH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINY--EPIGIESDMWS 134 (239)
Q Consensus 63 ~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Diws 134 (239)
.| |+.|++||||||+||+++.+..+.++|+|||++....... ......||+.|+|||.+.+ ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99 9999999999999999955555589999999998654321 1234568999999999975 56789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 135 IGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 135 lG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+|+++|+|++|..||.+.+..+....+.......+......++..+.+|+.+||+.||.+|||++++++||||++..
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999988888888888777666665567899999999999999999999999999999998744
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=255.56 Aligned_cols=191 Identities=21% Similarity=0.270 Sum_probs=149.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC---CCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR---TSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~---~~~~vkl~dfg 95 (239)
..|++|||+++ +|.+++. .++.+++..+..++.|++.||.| |++||+||||||+||+++.+ ..+.++|+|||
T Consensus 107 ~~~lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 45789999996 7777773 45678999999999999999999 99999999999999999542 33569999999
Q ss_pred cceecCCC-CCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch---
Q psy1096 96 LAQKINPD-HPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--- 170 (239)
Q Consensus 96 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 170 (239)
++...... .......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..||.+.+.......+......+..
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 98766532 2233456899999999998754 799999999999999999999999988877776666543221111
Q ss_pred -----------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 171 -----------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 171 -----------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.....++..+.+|+++||+.||++|||++++++||||++.++.|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 11122678999999999999999999999999999999876654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=250.95 Aligned_cols=191 Identities=22% Similarity=0.276 Sum_probs=154.3
Q ss_pred EEEeeCccCCCCccchhhhhhhc---CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA---GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..|++|||+++ +|.+++..... ...+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||
T Consensus 77 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg 153 (317)
T 2pmi_A 77 KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI--NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCS
T ss_pred eEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE--cCCCCEEECcCc
Confidence 46789999995 78777765432 2458889999999999999999 99999999999999999 777899999999
Q ss_pred cceecCCC-CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch---
Q psy1096 96 LAQKINPD-HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--- 170 (239)
Q Consensus 96 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 170 (239)
++...... .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+....+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876533 233445789999999999764 5799999999999999999999999988877776666442111110
Q ss_pred ---------------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 171 ---------------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 171 ---------------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.....++..+.+|+.+||+.||++|||++++++||||++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0011467899999999999999999999999999999875443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=249.84 Aligned_cols=185 Identities=28% Similarity=0.458 Sum_probs=158.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. .+.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili--~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIADFGWSV 157 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE--CTTSCEEECSCCEES
T ss_pred EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE--cCCCCEEEEeccccc
Confidence 46789999999999998854 4568899999999999999999 99999999999999999 777899999999875
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+.......+. .++.
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 232 (279)
T 3fdn_A 158 HAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTE 232 (279)
T ss_dssp CC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred cCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCH
Confidence 54432 233456899999999999888999999999999999999999999988888888888777666553 5789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
.+.+|+.+||..||.+|||++++++||||+....++
T Consensus 233 ~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 233 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 999999999999999999999999999998755444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=253.08 Aligned_cols=179 Identities=21% Similarity=0.257 Sum_probs=145.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+ +++|.+++.. .+..+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++.
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL--GPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CGGGCEEECCCTTCE
T ss_pred EEEEEEecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--CCCCCEEEccceeee
Confidence 357899999 5577766653 35679999999999999999999 99999999999999999 667789999999988
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............||+.|+|||.+.+ .++.++||||+||++|+|++|..|+.+. .....+.... .+......++.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~ 279 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGY--LPPEFTAGLSS 279 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTC--CCHHHHTTSCH
T ss_pred ecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccC--CCcccccCCCH
Confidence 7765555555679999999999876 6899999999999999999997766543 2333333322 34445567899
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+.+++.+||+.||++|||++++++||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.13 Aligned_cols=191 Identities=22% Similarity=0.302 Sum_probs=156.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h--hhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H--SLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h--~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|++|||++++.+..+.........+++..+..++.|++.||.| | ++||+||||||+||+++. .++.++|+|||+
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEEECCCTT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEEEeeCCC
Confidence 478999999986555444333567788999999999999999999 9 999999999999999932 257999999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh-
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE- 174 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~- 174 (239)
+.............||+.|+|||.+.+.. ++.++||||+||++|+|++|..||.+.+.......+......++...+.
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98776655555667899999999997655 7999999999999999999999999988877777765543332222111
Q ss_pred ---------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 175 ---------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ---------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+..+.+|+.+||+.||.+|||++++++||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 1356899999999999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.59 Aligned_cols=185 Identities=22% Similarity=0.313 Sum_probs=158.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.||+|.+++.. .....+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++|+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~-~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl--d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHS-SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE--eCCCCeEEEecccce
Confidence 46899999999999988854 223458999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND----SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~ 174 (239)
............||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+... ......+......++ .
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~ 410 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E 410 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c
Confidence 87655544556799999999999988899999999999999999999999987543 334444544444443 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
.++..+.+|+++||+.||.+|| +++++++||||+..+
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 6899999999999999999999 899999999998744
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=249.83 Aligned_cols=185 Identities=19% Similarity=0.246 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++. ...+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--NREGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCSE-EHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCTTHHH
T ss_pred eEEEEEEecCC-CHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEEeECcccc
Confidence 45788999997 7776664 335678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
..... .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+.......+........
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence 66532 223345689999999999764 479999999999999999999999998877766666543211110
Q ss_pred ------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 ------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 ------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......++..+.+|+++||..||++|||++++++||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0111246889999999999999999999999999999976
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=259.47 Aligned_cols=190 Identities=21% Similarity=0.211 Sum_probs=153.9
Q ss_pred eEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..++++|||++++ +.+++... ..+..+++..+..++.||+.||.| |++||+||||||+||+++. .++.+||+|||+
T Consensus 126 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~DFG~ 203 (420)
T 1j1b_A 126 VYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEECCCTT
T ss_pred eeEEeehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEeccchh
Confidence 3467899999974 44444433 456789999999999999999999 9999999999999999943 235789999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH----
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE---- 171 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---- 171 (239)
+.............+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.+....+...
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9887655555567799999999999765 68999999999999999999999999888776666655432111111
Q ss_pred ---------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ---------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ---------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....+..+.+|+++||..||.+|||++++++||||.+.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 012457899999999999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=258.04 Aligned_cols=190 Identities=13% Similarity=0.197 Sum_probs=149.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+|||||++++|.+++.. .....+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll--~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHH-TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEcccccce
Confidence 35789999999999999865 334668999999999999999999 99999999999999999 777899999999876
Q ss_pred ecCCC--------CCCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCC
Q psy1096 99 KINPD--------HPPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 99 ~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
..... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 54211 12223468899999999987 568999999999999999999999998876655554433221110
Q ss_pred ------------------------------------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 169 ------------------------------------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 169 ------------------------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.......++..+.+|+++||+.||++|||++++|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00122356888999999999999999999999999999
Q ss_pred cccCCC
Q psy1096 207 IAQKDS 212 (239)
Q Consensus 207 ~~~~~~ 212 (239)
|++...
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=250.61 Aligned_cols=188 Identities=21% Similarity=0.246 Sum_probs=149.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++ ...+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||.+.
T Consensus 76 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI--TKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE--cCCCCEEEeeCCCch
Confidence 457899999999999876 446678999999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCC-CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
..... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+........+
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 76532 23344568999999999976 56799999999999999999999999988777666555432221111
Q ss_pred ---------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 ---------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 ---------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++..+.+|+++||..||++|||++++++||||++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 112357888999999999999999999999999999987443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.99 Aligned_cols=187 Identities=21% Similarity=0.277 Sum_probs=148.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++ +|.+++. ..+..+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++..
T Consensus 75 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 75 LTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI--NERGELKLADFGLARA 149 (324)
T ss_dssp EEEEEECCSE-EHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE--CTTCCEEECSSSEEEC
T ss_pred EEEEeccccc-CHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE--CCCCCEEEccCccccc
Confidence 5789999985 6776665 335578899999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCC-CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 100 INPD-HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 100 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
.... .......+|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+......+..
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 150 KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp C------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 5432 22334568999999999976 56799999999999999999999999998877777666553222211
Q ss_pred -------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 -------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 -------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.....++..+.+|+++||+.||++|||++++++||||.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 111246888999999999999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=256.22 Aligned_cols=190 Identities=21% Similarity=0.288 Sum_probs=158.1
Q ss_pred eeEEEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
....|+||||+++ +|.+++... ..++.+++..+..++.|++.||.| |++||+||||||+||+++. .++.++|+|||
T Consensus 110 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~-~~~~~kl~Dfg 187 (383)
T 3eb0_A 110 NKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS-KDNTLKLCDFG 187 (383)
T ss_dssp CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEET-TTTEEEECCCT
T ss_pred ceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcC-CCCcEEEEECC
Confidence 3458899999995 666666543 456789999999999999999999 9999999999999999942 35689999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH---
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE--- 171 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--- 171 (239)
++.............+++.|+|||.+.+.. ++.++||||+||++|+|++|..||.+.+..+....+......+...
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 267 (383)
T 3eb0_A 188 SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI 267 (383)
T ss_dssp TCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 998876666666677899999999987754 8999999999999999999999999988877777765532222211
Q ss_pred ----------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 172 ----------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 172 ----------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.....+..+.+|+.+||..||++|||++++++||||++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 268 RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 11236788999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=245.29 Aligned_cols=182 Identities=28% Similarity=0.427 Sum_probs=150.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL--DAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE--CTTSCEEECCCCGGG
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE--CCCCCEEEeeccccc
Confidence 46789999999999999853 4568899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
............+++.|+|||.+.+..+ +.++|+||+|+++++|++|..||.+.........+.......+ ..++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 235 (276)
T 2h6d_A 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLN 235 (276)
T ss_dssp CCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSC
T ss_pred ccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcC
Confidence 7665544445678999999999988766 6899999999999999999999988877777777776655544 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
..+.+++.+||..||++|||++++++||||++.
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999999763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=246.86 Aligned_cols=184 Identities=26% Similarity=0.423 Sum_probs=132.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .....+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL--TRNMNIKIADFGLAT 160 (278)
T ss_dssp EEEEEEECCTTEEHHHHHH--TCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEEEeeccee
Confidence 4678999999999999885 334678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.......+ ..++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 236 (278)
T 3cok_A 161 QLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLS 236 (278)
T ss_dssp ECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSC
T ss_pred eccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccC
Confidence 76532 223345689999999999988889999999999999999999999987776666555544444333 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||..||++|||++++++||||.+..
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999999999998644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=251.10 Aligned_cols=183 Identities=16% Similarity=0.232 Sum_probs=147.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||++++|.+++..........+..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE--eCCCCEEEeecCccc
Confidence 589999999999999999765544555666789999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCC-------------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Q psy1096 99 KINPDH-------------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 99 ~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~ 165 (239)
...... ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..|+.. .......+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~- 289 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL- 289 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT-
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc-
Confidence 765432 22335699999999999999999999999999999999998776521 11222222222
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.. +......++.+.+|+.+||..||++|||++++++||||++
T Consensus 290 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 290 -KF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -CC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -CC-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 22 2233456888999999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=249.84 Aligned_cols=188 Identities=21% Similarity=0.263 Sum_probs=152.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT------------- 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~------------- 85 (239)
..|++|||+ +++|.+++.. .....+++..+..++.|++.||+| |++|++||||||+||+++.+.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKE-NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred cEEEEEcCC-CCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 567899999 7888888764 233468889999999999999999 999999999999999994433
Q ss_pred ----CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy1096 86 ----SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ----~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i 161 (239)
++.++|+|||.+...... .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 568999999998765432 33456899999999999989999999999999999999999999988776665555
Q ss_pred HhccCCCchHHHh----------------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHH
Q psy1096 162 TRAEFDFDDEAFE----------------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQC 201 (239)
Q Consensus 162 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~l 201 (239)
.......+..... ..+..+.+|+.+||+.||.+|||++++
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 4433333322111 124678899999999999999999999
Q ss_pred hhccccccCC
Q psy1096 202 LSHLWIAQKD 211 (239)
Q Consensus 202 l~h~~~~~~~ 211 (239)
++||||+..+
T Consensus 327 l~hp~f~~~~ 336 (339)
T 1z57_A 327 LKHPFFDLLK 336 (339)
T ss_dssp TTSGGGGGGG
T ss_pred hcCHHHHHHh
Confidence 9999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=264.54 Aligned_cols=186 Identities=22% Similarity=0.310 Sum_probs=158.4
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|+||||+.|++|.+++.... .+..+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++|+|||++
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl--~~~g~vkL~DFGla 336 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE--eCCCCEEEeeccee
Confidence 4689999999999998886432 24578999999999999999999 99999999999999999 77889999999999
Q ss_pred eecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN----DSETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~ 172 (239)
........ .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+ .......+......++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87764433 233579999999999999999999999999999999999999998753 3455556665555554
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~ 211 (239)
..++..+.+|+++||..||++||+ ++++++||||+..+
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 368999999999999999999996 58999999998743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=253.44 Aligned_cols=183 Identities=21% Similarity=0.308 Sum_probs=154.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+ +++|.+++.. +.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE--cCCCCEEEEeeeccc
Confidence 358999999 7888888742 568889999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-----
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA----- 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----- 172 (239)
..... .....+|+.|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+......++...
T Consensus 177 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 76532 334578999999999977 6789999999999999999999999999888777777655443333221
Q ss_pred ----------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 ----------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ----------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
....++.+.+|+.+||..||++|||++++++||||++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 124578899999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=248.00 Aligned_cols=188 Identities=30% Similarity=0.509 Sum_probs=162.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~ 97 (239)
..|++|||+.+++|.+++.. ...+++..+..++.|++.||.+ |++|++|+||||+||+++.++ .+.++|+|||.+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred eEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 46789999999999988753 4568899999999999999999 999999999999999995433 357999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............+++.|+|||.+.+. ++.++|+||+|+++++|++|..||.+.+.......+.......+...+..++
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred eeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 776655444455688899999998754 8999999999999999999999999988888888888777666555556789
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++++||..||++|||++++++||||++..
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=245.77 Aligned_cols=182 Identities=25% Similarity=0.419 Sum_probs=159.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKIADFGWSV 162 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--cCCCCEEEecccccc
Confidence 46789999999999998854 4568899999999999999999 99999999999999999 777899999999986
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
...... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.......+ ..++.
T Consensus 163 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 237 (284)
T 2vgo_A 163 HAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSD 237 (284)
T ss_dssp ECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCH
T ss_pred cCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCH
Confidence 654322 2345689999999999988899999999999999999999999998887777777776665554 35789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.+.+++.+||..||.+|||++++++||||+...
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999999999998644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=256.19 Aligned_cols=182 Identities=21% Similarity=0.282 Sum_probs=140.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++ +|.+++. ..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--cCCCCEEEEEeeccc
Confidence 57899999986 4555552 357888999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH-----
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF----- 173 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~----- 173 (239)
............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+....+..+......+.+...
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 766544445567999999999999989999999999999999999999999988877777666554332221111
Q ss_pred ---------------------------------hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 174 ---------------------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 174 ---------------------------------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...+..+.+|+++||..||++|||++++++||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 112567899999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.36 Aligned_cols=189 Identities=21% Similarity=0.251 Sum_probs=143.6
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|+||||+++ +|.+++ ..+..+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++
T Consensus 103 ~~~~lv~e~~~~-~L~~~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl--~~~~~~kL~DFGla 176 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL--NQDCSVKVCDFGLA 176 (432)
T ss_dssp CCEEEEEECCSE-EHHHHH---HSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred CeEEEEEecCCc-CHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE--CCCCCEEEccCCCc
Confidence 357899999985 777777 456779999999999999999999 99999999999999999 77789999999999
Q ss_pred eecCCCC-----------------------CCccccCCCCccCcccc-ccCCCCchhhHHHHHHHHHHHHh---------
Q psy1096 98 QKINPDH-----------------------PPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLS--------- 144 (239)
Q Consensus 98 ~~~~~~~-----------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~~--------- 144 (239)
....... ......||+.|+|||.+ .+..++.++||||+||++|+|++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 8764322 12456799999999986 55668999999999999999997
Q ss_pred --CCCCCCCCCc-----------------hHHHHHHHhccCCCc---------------------------hHHHhhcCH
Q psy1096 145 --GLSPFMGEND-----------------SETFANITRAEFDFD---------------------------DEAFEALSE 178 (239)
Q Consensus 145 --g~~p~~~~~~-----------------~~~~~~i~~~~~~~~---------------------------~~~~~~~~~ 178 (239)
|.++|.+.+. ...+..+......++ ......+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 4444544331 112222211111111 111235789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.+.+|+++||..||++|||++++|+||||++....
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999999999999999999999999999875443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=251.92 Aligned_cols=184 Identities=21% Similarity=0.334 Sum_probs=153.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||++|++|.+++.. ++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--ETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE--cCCCCEEEeeccCccc
Confidence 3899999999999999853 4578899999999999999999 99999999999999999 6667899999999876
Q ss_pred cCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ......|++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.+...............+......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 54322 22234689999999999998999999999999999999999999998887777777766666555555556
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
++..+.+++.+||+.||++||+..+++.|+|++.
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8999999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=249.67 Aligned_cols=186 Identities=26% Similarity=0.415 Sum_probs=156.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~~~ 98 (239)
.|++|||+++++|.+++ ..++.+++..+..++.|++.||.| |++|++||||||+||+++.++ .+.++|+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHH---STTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 57899999999999887 446788999999999999999999 999999999999999994432 3459999999998
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~ 174 (239)
............|++.|+|||.+. ...++.++|+||+|+++|+|++|..||...... .....+........+..+.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 765443333456899999999974 456789999999999999999999999765433 4455566666666666667
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++..+.+|+++||..||++|||++++++||||+.
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 78999999999999999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=255.10 Aligned_cols=191 Identities=26% Similarity=0.427 Sum_probs=132.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
-..|++|||++|++|.+++.. ..+..+++..+..++.|++.||.| |++|++||||||+||+++.++ .+.++|+|||+
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHT-C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred ceEEEEEeccCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 347899999999999999864 334578999999999999999999 999999999999999995432 46799999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHHhccCCCchHH
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDDEA 172 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~----~~~i~~~~~~~~~~~ 172 (239)
+....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+...... ...+.......+...
T Consensus 178 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 178 AKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp CEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred ceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 87665332 3345689999999999888889999999999999999999999976654433 222333333334333
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..++..+.+|+.+||..||++|||++++++||||++..
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 456899999999999999999999999999999998743
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=250.30 Aligned_cols=184 Identities=23% Similarity=0.334 Sum_probs=160.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLAT 189 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE--cCCCCEEEeeccCce
Confidence 46789999999999988743 4678899999999999999999 99999999999999999 777889999999998
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+....+.......+. .++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~ 265 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HIN 265 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCC
Confidence 76533 2233456899999999999888999999999999999999999999988877777777776665553 678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+|+++||+.||++|||++++++|+||++...
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 99999999999999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=247.37 Aligned_cols=191 Identities=22% Similarity=0.250 Sum_probs=157.4
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++.. .....+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||.+
T Consensus 92 ~~~~lv~e~~~~-~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili--~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVDQ-DLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCSC-BHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECSCCSC
T ss_pred ceEEEEEecCCC-CHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE--cCCCCEEEecCccc
Confidence 356789999995 88877754 334558899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-------- 169 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 169 (239)
.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+........
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 766543333445689999999999988899999999999999999999999998887777666654211110
Q ss_pred ---------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 170 ---------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 ---------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
......++..+.+|+.+||..||++|||++++++||||++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 11123578899999999999999999999999999999876544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=244.83 Aligned_cols=184 Identities=23% Similarity=0.334 Sum_probs=160.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||.+.
T Consensus 89 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLAT 163 (294)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE--cCCCCEEEEeccCce
Confidence 4678999999999998874 34678899999999999999999 99999999999999999 777899999999988
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+....+.......+ ..++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN 239 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSC
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccC
Confidence 76533 223345689999999999988899999999999999999999999998887777777777665554 3678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++++||..||++|||++++++|+||++...
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 99999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.57 Aligned_cols=188 Identities=22% Similarity=0.242 Sum_probs=141.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..+|+||||++ ++|.+++ ...+.+++..+..++.||+.||.| |+.||+||||||+|||+ +.++.+||+|||++
T Consensus 130 ~~~~lv~e~~~-~~L~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl--~~~~~~kl~DFGla 203 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLF---RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV--NQDCSVKVCDFGLA 203 (458)
T ss_dssp CCEEEEECCCS-EEHHHHH---HSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred ceEEEEEeccc-cchhhhc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE--CCCCCEeecccccc
Confidence 35789999986 5666666 456789999999999999999999 99999999999999999 77789999999999
Q ss_pred eecCCCC----------------------------CCccccCCCCccCcccc-ccCCCCchhhHHHHHHHHHHHHh----
Q psy1096 98 QKINPDH----------------------------PPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGVITYVLLS---- 144 (239)
Q Consensus 98 ~~~~~~~----------------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~~---- 144 (239)
....... .....+||+.|+|||.+ .+..++.++||||+||++|+|++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 7654221 12335689999999986 55668999999999999999998
Q ss_pred -------CCCCCCCCCc--------------------hHHHHHHHhccCCCch---------------------------
Q psy1096 145 -------GLSPFMGEND--------------------SETFANITRAEFDFDD--------------------------- 170 (239)
Q Consensus 145 -------g~~p~~~~~~--------------------~~~~~~i~~~~~~~~~--------------------------- 170 (239)
|.++|.+.+. ...+..+......+..
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 7777766442 1222222211111111
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+...+..+.+|+++||..||++|||++++|+||||++...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 112345889999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=241.30 Aligned_cols=182 Identities=16% Similarity=0.259 Sum_probs=149.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecC-CCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSR-TSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~-~~~~vkl~dfg 95 (239)
..|++|||+++++|.+++.. .+.+++..+..++.|++.||.| |+.| ++|+||||+||++ + .++.++|+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTT
T ss_pred eEEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeCC
Confidence 36889999999999999853 4678889999999999999999 9999 9999999999999 5 56789999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
++...... ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||.+................ +......
T Consensus 178 ~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (290)
T 1t4h_A 178 LATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 254 (290)
T ss_dssp GGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred Cccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCC
Confidence 98654332 233456899999999887 45899999999999999999999999876554444433333222 2223345
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++.+.+++.+||..||.+|||++++++||||++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 6789999999999999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=247.90 Aligned_cols=207 Identities=23% Similarity=0.367 Sum_probs=158.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+..+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE--cCCCCEEEeeCcCce
Confidence 56899999999999999865 234678889999999999999999 99999999999999999 777889999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......|++.|+|||.+. ...++.++|+||+|+++|+|++|..||.+.........+........ .
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 255 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--K 255 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--S
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC--C
Confidence 65432 2233456899999999997 45678999999999999999999999988776666655554432211 1
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHHHHhhhcc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQF 236 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 236 (239)
...++..+.+|+.+||..||.+|||++++++||||++...... ....++..+.+.+.+.
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 314 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQ-----VRIQLKDHIDRTKKKR 314 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHH-----HHHHHHHHHHHHHHCC
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccc-----eeehhhhhhhhhcccc
Confidence 1357899999999999999999999999999999986433221 2234566666655544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=247.00 Aligned_cols=195 Identities=23% Similarity=0.347 Sum_probs=160.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. ..+..+++..+..++.|++.||.| |+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 98 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL--NTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEEEECCTTEEHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEeecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE--CCCCCEEEeecccch
Confidence 4578999999999999885 346788999999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+....... ......++
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 252 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELWS 252 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSC
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccCC
Confidence 765432 2334568999999999998889999999999999999999999998777665555444432211 11123578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI 219 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~ 219 (239)
..+.+++.+||..||.+|||++++++||||+........+..
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~ 294 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHH
Confidence 999999999999999999999999999999886655444443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=249.12 Aligned_cols=185 Identities=20% Similarity=0.266 Sum_probs=148.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++++.++. ...+.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE--cCCCcEEEEeCCCce
Confidence 357899999999999876 345678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------ 170 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 170 (239)
..... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+........+
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 65432 223345689999999999875 6799999999999999999999999988776666555432221111
Q ss_pred ---------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 171 ---------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 171 ---------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.....++..+.+|+.+||..||++|||++++++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 112256889999999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=248.93 Aligned_cols=175 Identities=24% Similarity=0.351 Sum_probs=149.0
Q ss_pred EEEeeCccCCCC-ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGC-MITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+.+| +|.+++ ..++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHH---HTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE--cCCCcEEEeecccc
Confidence 456889999777 888877 456679999999999999999999 99999999999999999 67789999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
.............||+.|+|||.+.+..+ +.++||||+|+++|+|++|..||..... ........+ ..+
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~----~~~ 247 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP----YLV 247 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS----SCC
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC----ccc
Confidence 88776655566779999999999988876 8899999999999999999999975321 111222222 247
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+..+.+|+++||..||++|||++++++||||++
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 899999999999999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=250.09 Aligned_cols=190 Identities=21% Similarity=0.285 Sum_probs=155.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+.| ++.+++. .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 128 ~~~lv~e~~~g-~l~~~l~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 128 TAWLVMEYCLG-SASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEEECCSE-EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--ETTTEEEECCCTTCB
T ss_pred eEEEEEecCCC-CHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEeeccCce
Confidence 46789999985 5666654 335678899999999999999999 99999999999999999 667799999999987
Q ss_pred ecCCCCCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ....||+.|+|||.+. ...++.++||||+||++|+|++|..||.+.+.......+......... ...
T Consensus 203 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 277 (348)
T 1u5q_A 203 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGH 277 (348)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTT
T ss_pred ecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCC
Confidence 65432 3356999999999984 456789999999999999999999999888877766666555432221 135
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI 219 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~ 219 (239)
++..+.+|+.+||+.||++|||++++++|+|+..........+.
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~ 321 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHH
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhhHH
Confidence 78999999999999999999999999999999876555444333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=259.57 Aligned_cols=180 Identities=16% Similarity=0.152 Sum_probs=143.0
Q ss_pred CceeEEEeeCccCCCCccchhhhhhhcC----CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEE
Q psy1096 16 TSVVITWSSPPYDGGCMITGYVVEMKAG----TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIK 90 (239)
Q Consensus 16 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vk 90 (239)
..++..|++|||+ +|+|.+++.....- ..+++..+..++.|++.||+| |++||+||||||+||++ +.++.+|
T Consensus 170 ~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll--~~~~~~k 246 (377)
T 3byv_A 170 MWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--DQRGGVF 246 (377)
T ss_dssp CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEE
T ss_pred eEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEE
Confidence 3445689999999 57999988654221 223457778899999999999 99999999999999999 6778999
Q ss_pred EEecccceecCCCCCCccccCCCCccCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy1096 91 IIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE-----------PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFA 159 (239)
Q Consensus 91 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~ 159 (239)
|+|||++..... ......| +.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+......
T Consensus 247 L~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~ 323 (377)
T 3byv_A 247 LTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323 (377)
T ss_dssp ECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG
T ss_pred EEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh
Confidence 999999876443 2233457 999999999887 78999999999999999999999997665433332
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+... ...++..+.+|+.+||+.||++|||++++++||||++
T Consensus 324 ~~~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 324 WIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp GGGSS--------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred hhhhh--------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 22221 1357899999999999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=248.31 Aligned_cols=188 Identities=19% Similarity=0.227 Sum_probs=150.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec---------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--------------- 83 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--------------- 83 (239)
..|++|||++++.+ +++.. .....+++..+..++.|++.||.| |++||+||||||+||++..
T Consensus 96 ~~~lv~e~~~~~l~-~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 96 HMCIAFELLGKNTF-EFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEEECCCCBHH-HHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred eEEEEEeccCCChH-HHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 46789999955544 45543 334578899999999999999999 9999999999999999943
Q ss_pred --CCCCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q psy1096 84 --RTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI 161 (239)
Q Consensus 84 --~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i 161 (239)
+..+.++|+|||++...... .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 24578999999998765432 33456999999999999989999999999999999999999999988776666555
Q ss_pred HhccCCCchHHHh----------------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHH
Q psy1096 162 TRAEFDFDDEAFE----------------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQC 201 (239)
Q Consensus 162 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~l 201 (239)
.......+..... ..+..+.+|+++||+.||++|||++++
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 5443333322110 113578899999999999999999999
Q ss_pred hhccccccCC
Q psy1096 202 LSHLWIAQKD 211 (239)
Q Consensus 202 l~h~~~~~~~ 211 (239)
++||||++.+
T Consensus 332 l~hp~f~~~~ 341 (355)
T 2eu9_A 332 LLHPFFAGLT 341 (355)
T ss_dssp TTSGGGGGCC
T ss_pred hcChhhcCCC
Confidence 9999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=248.22 Aligned_cols=185 Identities=23% Similarity=0.289 Sum_probs=152.4
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++. .+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTCDLKICDFGLA 175 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred ceEEEEEcccCc-CHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE--CCCCCEEEEeCcce
Confidence 457899999996 6776663 3468899999999999999999 99999999999999999 77788999999999
Q ss_pred eecCCCC----CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-
Q psy1096 98 QKINPDH----PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE- 171 (239)
Q Consensus 98 ~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~- 171 (239)
....... ......||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+......+...
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 7765322 1234579999999998754 457999999999999999999999999888777777665432222211
Q ss_pred --------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 --------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 --------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....++..+.+|+.+||+.||++|||++++++||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 113468899999999999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=248.68 Aligned_cols=188 Identities=17% Similarity=0.185 Sum_probs=146.0
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
....|++|||++| ++.+++. ..+..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||+
T Consensus 106 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 106 MHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNL 180 (362)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCTTC
T ss_pred cceEEEEEccCCC-CHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE--cCCCCEEEEecCc
Confidence 3457899999995 5665654 345678999999999999999999 99999999999999999 7778899999999
Q ss_pred ceecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-----
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD----- 170 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 170 (239)
+.............+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+......+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 976655544555678999999999977 66899999999999999999999999988877766666543222221
Q ss_pred -----------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 171 -----------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 171 -----------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
......++.+.+|+.+||..||++|||++++++||||++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 1112457889999999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=249.17 Aligned_cols=186 Identities=20% Similarity=0.243 Sum_probs=152.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++ +|.+++. .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHH--hcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE--cCCCCEEEEeccccee
Confidence 4678999997 6666664 344578888999999999999999 99999999999999999 7778999999999877
Q ss_pred cCCC-CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 100 INPD-HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 100 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
.... .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+.......+......+..
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 6432 233446789999999999764 4799999999999999999999999988877777766543221111
Q ss_pred -----------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 171 -----------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 -----------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.....++..+.+|+++||..||++|||++++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 11235678999999999999999999999999999998644
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.30 Aligned_cols=192 Identities=19% Similarity=0.216 Sum_probs=139.1
Q ss_pred EEEeeCccCCCCccchhhhhhh------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec--CCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--RTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--~~~~~vk 90 (239)
.+|++|||+++ +|.+++.... ....+++..+..++.||+.||.| |++||+||||||+||++.. +..+.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 46889999986 5555554322 12358899999999999999999 9999999999999999954 3457899
Q ss_pred EEecccceecCCC----CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------H
Q psy1096 91 IIDFGLAQKINPD----HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDS---------E 156 (239)
Q Consensus 91 l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---------~ 156 (239)
|+|||++...... .......||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999776532 223345789999999999874 4899999999999999999999999765432 3
Q ss_pred HHHHHHhccCCCchHHHh----------------------------------hcCHHHHHHHHHhhhhCcccCCCHHHHh
Q psy1096 157 TFANITRAEFDFDDEAFE----------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCL 202 (239)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~----------------------------------~~~~~~~~ll~~~l~~~p~~Rpt~~~ll 202 (239)
.+..+......+....+. ..+..+.+|+++||..||.+|||++++|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 333333221111111000 1167789999999999999999999999
Q ss_pred hccccccCCC
Q psy1096 203 SHLWIAQKDS 212 (239)
Q Consensus 203 ~h~~~~~~~~ 212 (239)
+||||++...
T Consensus 333 ~hp~f~~~~~ 342 (405)
T 3rgf_A 333 QDPYFLEDPL 342 (405)
T ss_dssp TSGGGTSSSC
T ss_pred cChhhccCCC
Confidence 9999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=253.90 Aligned_cols=183 Identities=27% Similarity=0.390 Sum_probs=149.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||+++++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCcEEEeeCCCCe
Confidence 46789999999999998853 4578899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhccCCCch
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYE--PIGIESDMWSIGVITYVLLSGLSPFMGEND----SETFANITRAEFDFDD 170 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~ 170 (239)
...... ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||..... ......+.......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 286 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 286 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC-
Confidence 654322 22235699999999999863 468999999999999999999999975432 233333433333333
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
..++..+.+|+.+||..||.+|| |++++++|+||....
T Consensus 287 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 287 ---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 36789999999999999999999 999999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=243.91 Aligned_cols=184 Identities=21% Similarity=0.295 Sum_probs=147.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC-cEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~-~vkl~dfg~~ 97 (239)
..+++|||+.+++|.+++. .+++..+..++.|++.||.| |++|++||||||+||++ +..+ .++|+|||++
T Consensus 107 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLA 178 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred ceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--cCCCCEEEEEeCCCc
Confidence 4578899999999998763 37788899999999999999 99999999999999999 4344 8999999999
Q ss_pred eecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHH-------------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANIT------------- 162 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~------------- 162 (239)
.............+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.... .......+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 88776655566779999999999977 568999999999999999999999995433 222222221
Q ss_pred hccCCCch--------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 163 RAEFDFDD--------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 163 ~~~~~~~~--------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.......+ .....++..+.+|+++||+.||++|||++++|+||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11111111 01123689999999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=252.66 Aligned_cols=187 Identities=19% Similarity=0.234 Sum_probs=143.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCC-----------
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRT----------- 85 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~----------- 85 (239)
...|++|||++++.+..+.. ...+.+++..+..++.|++.||.| |++ ||+||||||+||+++.++
T Consensus 118 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 118 THICMVFEVLGHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp EEEEEEECCCCCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred ceEEEEEeccCccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 35789999996665554432 334678999999999999999999 998 999999999999994321
Q ss_pred ------------------------------------CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCch
Q psy1096 86 ------------------------------------SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIE 129 (239)
Q Consensus 86 ------------------------------------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 129 (239)
...++|+|||.+...... .....||+.|+|||.+.+..++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcH
Confidence 127999999999776533 334568999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHHhccCCCchHH-------------------------------
Q psy1096 130 SDMWSIGVITYVLLSGLSPFMGENDS------ETFANITRAEFDFDDEA------------------------------- 172 (239)
Q Consensus 130 ~DiwslG~~l~~~~~g~~p~~~~~~~------~~~~~i~~~~~~~~~~~------------------------------- 172 (239)
+||||+||++|+|++|..||.+.+.. .....+.......+...
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 99999999999999999999765432 22222222111111110
Q ss_pred -------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 -------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 -------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....+..+.+|+.+||+.||++|||++++|+||||++
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0123567889999999999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=239.13 Aligned_cols=185 Identities=19% Similarity=0.354 Sum_probs=151.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++ ..+..+++..+..++.|++.||.+ |++|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 79 ~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEEECCTTEEGGGGS---BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE--ccCCCEEEeeCCCcc
Confidence 457899999999999887 345678899999999999999999 99999999999999999 677889999999987
Q ss_pred ecCCC---CCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccCCCchHHH
Q psy1096 99 KINPD---HPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~ 173 (239)
..... .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.... .....+........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 231 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PW 231 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST--TG
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC--ch
Confidence 65322 12234568999999999987765 78999999999999999999999876543 23333333222221 23
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..++..+.+++.+||..||++|||++++++|+||++..
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 46899999999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=249.59 Aligned_cols=182 Identities=26% Similarity=0.333 Sum_probs=139.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+++||+ +++|.+++. .+.+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE--CCCCCEEEeeccccc
Confidence 457888998 678887764 3578999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------ 171 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------ 171 (239)
..... .....+|+.|+|||.+.+ ..++.++||||+||++++|++|..||.+.+.......+......+...
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 65432 334578999999999977 668999999999999999999999999888777766665432222211
Q ss_pred ---------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ---------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ---------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....++.+.+|+++||..||++|||++++|+||||++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 112457889999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=260.93 Aligned_cols=184 Identities=13% Similarity=0.088 Sum_probs=143.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHH------HHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELS------ERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~------~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl 91 (239)
...|+||||++ ++|.+++..... .+..... ..++.|++.||+| |++||+||||||+||++ +.++.+||
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll--~~~~~~kL 235 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI--MPDGRLML 235 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE--CTTSCEEE
T ss_pred eeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE--CCCCCEEE
Confidence 44799999999 899999875422 2233333 5677999999999 99999999999999999 77789999
Q ss_pred EecccceecCCCCCCccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHH---HHhc
Q psy1096 92 IDFGLAQKINPDHPPRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPFMGENDSET--FAN---ITRA 164 (239)
Q Consensus 92 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~--~~~---i~~~ 164 (239)
+|||++....... ....+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+...... ... ....
T Consensus 236 ~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 313 (371)
T 3q60_A 236 GDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313 (371)
T ss_dssp CCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCC
T ss_pred EecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcc
Confidence 9999998765322 13457799999999987 6789999999999999999999999976643211 000 0011
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...........++..+.+|+.+||+.||++|||++++++||||++
T Consensus 314 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 111111222467899999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=242.85 Aligned_cols=184 Identities=19% Similarity=0.303 Sum_probs=138.8
Q ss_pred EEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.|++|||+++ +|.+++... ..+..+++..+..++.|++.||.| |++ |++||||||+||++ +..+.++|+|||.+
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI--NALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE--CTTCCEEBCCC---
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE--CCCCCEEEeecCCc
Confidence 5789999986 666666543 456789999999999999999999 998 99999999999999 77789999999999
Q ss_pred eecCCCCCCccccCCCCccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhccCCCchHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEII----NYEPIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANITRAEFDFDDEA 172 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~ 172 (239)
.............|++.|+|||.+ .+..++.++|+||+|+++|+|++|..||.... .................
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 235 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-- 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC--
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc--
Confidence 877655545555799999999996 45567899999999999999999999997633 33333333333222111
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...++..+.+++.+||+.||++|||++++++||||+.
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1367899999999999999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=240.87 Aligned_cols=184 Identities=22% Similarity=0.327 Sum_probs=156.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .+.+++..+..++.|++.||.+ |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 94 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEEEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE--CCCCCEEEeecccce
Confidence 4678999999999998863 4678899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+........ ...++
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 244 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYS 244 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCC
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccC
Confidence 765432 23345689999999999988899999999999999999999999988777666666554433221 13678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+.+++.+||..||++|||++++++|+||.....
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999999999999976443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=244.52 Aligned_cols=186 Identities=23% Similarity=0.388 Sum_probs=156.0
Q ss_pred EEEeeCccCCCCccchh------hhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCCcEEE
Q psy1096 20 ITWSSPPYDGGCMITGY------VVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSHHIKI 91 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~------l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~~vkl 91 (239)
..|++|||+++++|.++ +.. ...+.+++..+..++.|++.||.| |+ +|++||||+|+||++ +.++.++|
T Consensus 117 ~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~--~~~~~~kl 193 (348)
T 2pml_X 117 EVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM--DKNGRVKL 193 (348)
T ss_dssp EEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE--CTTSCEEE
T ss_pred eEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE--cCCCcEEE
Confidence 56889999999999998 432 236789999999999999999999 99 999999999999999 77789999
Q ss_pred EecccceecCCCCCCccccCCCCccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhccCCC
Q psy1096 92 IDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGI-ESDMWSIGVITYVLLSGLSPFMGEND-SETFANITRAEFDF 168 (239)
Q Consensus 92 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i~~~~~~~ 168 (239)
+|||.+...... ......+++.|+|||.+.+. .++. ++|+||+|+++|+|++|..||.+... .+....+.......
T Consensus 194 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~ 272 (348)
T 2pml_X 194 SDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272 (348)
T ss_dssp CCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCC
T ss_pred eccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCC
Confidence 999998776543 23345689999999999877 5555 99999999999999999999988776 66666766655444
Q ss_pred chH---------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 169 DDE---------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 169 ~~~---------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+.. ....++..+.+|+.+||+.||.+|||++++++||||++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 311 11357899999999999999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=241.39 Aligned_cols=187 Identities=27% Similarity=0.399 Sum_probs=157.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++++ +.+++.. .....+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~--~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE--cCCCcEEeecccccc
Confidence 468899999988 5555543 446778999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC---CCccccCCCCccCccccccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEPI--GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~--~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
...... ......|++.|+|||.+.+... +.++|+||+|+++|+|++|..||.+.+.......+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP---- 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence 765322 2223468999999999986544 7899999999999999999999998888888888777766554
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
..++..+.+++++||..||.+|||++++++|+||++.....
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 35789999999999999999999999999999998755543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=244.50 Aligned_cols=189 Identities=20% Similarity=0.288 Sum_probs=153.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ....+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM--TLEGDIRLADFGVSA 165 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTSCEEECCCHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE--CCCCCEEEEECCCCc
Confidence 45789999999999988763 35678899999999999999999 99999999999999999 777789999999864
Q ss_pred ecCC-CCCCccccCCCCccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEII-----NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
.... ........|++.|+|||.+ .+..++.++|+||+|+++|+|++|..||...+.......+........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence 3221 1122334689999999998 456688999999999999999999999988877766666655543221 11
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
...++..+.+++.+||..||++|||++++++||||++....
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 24678999999999999999999999999999999875543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=247.22 Aligned_cols=191 Identities=20% Similarity=0.227 Sum_probs=147.5
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecC----CCCcEEE
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSR----TSHHIKI 91 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~----~~~~vkl 91 (239)
....+++|||+ +++|.+++.. ..++.+++..+..++.|++.||.| |++ ||+||||||+||+++.+ ..+.++|
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl 179 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred CceEEEEEecC-CCCHHHHHHH-hhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEE
Confidence 34678999999 8888888865 335568889999999999999999 998 99999999999999542 3347999
Q ss_pred EecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHhcc
Q psy1096 92 IDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND------SETFANITRAE 165 (239)
Q Consensus 92 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~------~~~~~~i~~~~ 165 (239)
+|||++...... .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+. ......+....
T Consensus 180 ~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (373)
T 1q8y_A 180 ADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257 (373)
T ss_dssp CCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred cccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence 999999776532 2345689999999999999999999999999999999999999976542 22222222211
Q ss_pred CCCchHH--------------------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 166 FDFDDEA--------------------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 166 ~~~~~~~--------------------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
...+... ....+..+.+|+++||+.||++|||++++++||||
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337 (373)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhh
Confidence 1111100 02345778899999999999999999999999999
Q ss_pred ccCCC
Q psy1096 208 AQKDS 212 (239)
Q Consensus 208 ~~~~~ 212 (239)
++...
T Consensus 338 ~~~~~ 342 (373)
T 1q8y_A 338 KDTLG 342 (373)
T ss_dssp TTCTT
T ss_pred hcccC
Confidence 87543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=240.85 Aligned_cols=190 Identities=18% Similarity=0.297 Sum_probs=148.1
Q ss_pred EEeeCccCCCCccchhhhhhh-----cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-----AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~df 94 (239)
.|++|||+++++|.+++.... ..+.+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL--GEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE--cCCCCEEEEec
Confidence 568999999999999986532 35668899999999999999999 99999999999999999 77789999999
Q ss_pred ccceecCCCC------CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCC
Q psy1096 95 GLAQKINPDH------PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 95 g~~~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
|.+....... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9886554221 1233568999999999975 56799999999999999999999999887766555444433221
Q ss_pred Cch------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 168 FDD------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 168 ~~~------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
... .....++..+.+++.+||+.||.+|||++++++||||++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 111 111346789999999999999999999999999999986443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=242.07 Aligned_cols=189 Identities=16% Similarity=0.251 Sum_probs=145.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCC---CchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGT---QPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..|++|||+.+++|.+++.....+. .+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli--~~~~~~kl~Dfg 182 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML--AEDMTVCVADFG 182 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEECCCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE--cCCCCEEEeecc
Confidence 3489999999999999987544322 58899999999999999999 99999999999999999 777899999999
Q ss_pred cceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 96 LAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 96 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
++........ .....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+.......+........+
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 261 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP- 261 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC-
Confidence 9876644322 122346778999999999999999999999999999999 99999998888888777665433222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCC-------HHHHhhccccccCCCC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLT-------AKQCLSHLWIAQKDSS 213 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt-------~~~ll~h~~~~~~~~~ 213 (239)
..++..+.+++.+||..||++||| .+++++|+|+......
T Consensus 262 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 262 --PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred --CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 367899999999999999999999 7788899999874443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=237.14 Aligned_cols=181 Identities=17% Similarity=0.200 Sum_probs=145.7
Q ss_pred EEEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR------------- 84 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~------------- 84 (239)
..|++|||+++++|.+++..... .+.+++..+..++.|++.||.| |++|++||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 45789999999999999875432 3678999999999999999999 99999999999999999432
Q ss_pred ----CCCcEEEEecccceecCCCCCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q psy1096 85 ----TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFA 159 (239)
Q Consensus 85 ----~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~ 159 (239)
....++|+|||.+....... ...|++.|+|||.+.+. .++.++||||+|+++++|++|.+++... ....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~ 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred cccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence 34479999999988765432 23589999999999866 4578999999999999999998877543 2333
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+........+ ..++..+.+++.+||..||++|||++++++||||++
T Consensus 239 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 239 EIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 44444332221 367899999999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.22 Aligned_cols=180 Identities=26% Similarity=0.339 Sum_probs=145.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++ +|.+++ +..+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++..
T Consensus 122 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQT-DLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--NEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCE-EHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECSTTCC--
T ss_pred EEEEEccccc-cHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE--CCCCCEEEEecCcccc
Confidence 4889999995 555444 3458899999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH-------
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------- 171 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------- 171 (239)
.... .....+|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+......++..
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 5432 234568999999999987 678999999999999999999999999888777666665432222111
Q ss_pred --------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 --------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 --------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....++..+.+|+++||+.||++|||++++++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 113468899999999999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=249.43 Aligned_cols=182 Identities=20% Similarity=0.361 Sum_probs=143.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++|| +.+++|.+++. ..+.+++..+..++.||+.||.| |+.||+||||||+||++ + ++.+||+|||++.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--V-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE--S-SSCEEECCCSSSC
T ss_pred EEEEEEe-cCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--E-CCeEEEEecCccc
Confidence 3678999 67889998885 35578888899999999999999 99999999999999999 3 3689999999997
Q ss_pred ecCCCC---CCccccCCCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHh
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINY-----------EPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITR 163 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~ 163 (239)
...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.... .....+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 765332 2234579999999999865 35789999999999999999999999875433 34444443
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....... ....+..+.+|+.+||..||.+|||++++++||||+..
T Consensus 283 ~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 3322211 12357889999999999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=248.95 Aligned_cols=184 Identities=18% Similarity=0.266 Sum_probs=147.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.. .+.+++..+..++.|++.||.| |+. |++||||||+||++ +.++.++|+|||++
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE--CTTCCEEECCCCCC
T ss_pred EEEEEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE--CCCCCEEEEECCCC
Confidence 35789999999999999853 4568899999999999999999 996 99999999999999 67778999999988
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH----------------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANI---------------- 161 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i---------------- 161 (239)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 654322 223456899999999999999999999999999999999999999876544332221
Q ss_pred --------------------------HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 162 --------------------------TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 162 --------------------------~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
...... ......++..+.+|+++||..||++|||++++++||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 111110 001124688999999999999999999999999999998633
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=244.77 Aligned_cols=182 Identities=21% Similarity=0.382 Sum_probs=141.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|| +.+++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||+++ ++.++|+|||++.
T Consensus 83 ~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCCSSSC
T ss_pred EEEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeeccccc
Confidence 5678899 67788988884 36678899999999999999999 999999999999999993 4689999999997
Q ss_pred ecCCCCC---CccccCCCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHh
Q psy1096 99 KINPDHP---PRVLFGTPEFIPPEIINY-----------EPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITR 163 (239)
Q Consensus 99 ~~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~ 163 (239)
....... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.... .....+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7653322 234569999999999864 56789999999999999999999999765443 23333332
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...... .....+..+.+|+.+||..||.+|||++++++||||+..
T Consensus 236 ~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 PNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 222111 112457889999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=242.25 Aligned_cols=186 Identities=19% Similarity=0.222 Sum_probs=145.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.|++|||+++++|.+++........+++..+..++.|++.||+| |++| ++||||||+||++ +.++.++|+|||++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLS 186 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC--
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCC
Confidence 46899999999999998643333348889999999999999999 9999 9999999999999 77789999999998
Q ss_pred eecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+......... ...+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 264 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PRNL 264 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CTTS
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CccC
Confidence 7554332 233456899999999999999999999999999999999999999988877776666433322221 1367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh--ccccccC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS--HLWIAQK 210 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~--h~~~~~~ 210 (239)
+..+.+++++||..||++|||++++++ ..++++.
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 899999999999999999999999987 4666553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=238.91 Aligned_cols=184 Identities=21% Similarity=0.332 Sum_probs=145.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||++|++|.+++.. .+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAK 159 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCSSST
T ss_pred eEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEEeCCCcc
Confidence 46789999999999999853 4578999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-hHHHhh
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-DEAFEA 175 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~ 175 (239)
...... ......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+................ ......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence 654332 22335689999999999998899999999999999999999999998877666555544433222 222345
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
++..+.+++.+||+.||++||+..+.+.+.|..
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 789999999999999999999555555555543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=237.52 Aligned_cols=186 Identities=22% Similarity=0.349 Sum_probs=155.9
Q ss_pred EEEeeCccCCCCccchhhhhhhc-CCCchHHHHHHHHHHHHHHHHH-hhhc-----ccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-GTQPWVELSERLFESTERGLGH-HSLV-----TVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~-h~~~-----ivH~dikp~nili~~~~~~~vkl~ 92 (239)
..|++|||+++++|.+++..... +..+++..+..++.|++.||.| |+.| ++|+||||+||++ +.++.++|+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~ 158 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLG 158 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEEC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEe
Confidence 46889999999999999876433 4558899999999999999999 9999 9999999999999 777899999
Q ss_pred ecccceecCCCCC-CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 93 DFGLAQKINPDHP-PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 93 dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
|||.+........ .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+..+.....+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~- 237 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP- 237 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC-
T ss_pred cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC-
Confidence 9999876543221 12346899999999999888999999999999999999999999988877777777666543222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
..++..+.+++.+||..||++|||++++++|+|+.+.
T Consensus 238 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 --YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 3678999999999999999999999999999999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=246.19 Aligned_cols=182 Identities=13% Similarity=0.114 Sum_probs=145.6
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+ |++|.+++.. .++.+++..+..++.|++.||.| |++||+||||||+||+++.+..+.++|+|||++
T Consensus 125 ~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a 201 (364)
T 3op5_A 125 SYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201 (364)
T ss_dssp EEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTC
T ss_pred ceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcc
Confidence 3478999999 9999998863 45789999999999999999999 999999999999999996547789999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD 169 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 169 (239)
........ .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+..................
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 281 (364)
T 3op5_A 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN 281 (364)
T ss_dssp EESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC
T ss_pred eecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh
Confidence 77643221 1234599999999999999999999999999999999999999986443333222222111111
Q ss_pred -hHHH------hhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 170 -DEAF------EALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 170 -~~~~------~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.... ..++..+.+++..||..||++||+++++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 282 IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111 346899999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.60 Aligned_cols=184 Identities=20% Similarity=0.308 Sum_probs=144.1
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|++|||+++++|.+++.. .+..+++..+..++.|++.||+| |++|++|+||||+||++ +.++.++|+|||.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI--DESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCCCCC
T ss_pred CceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE--cCCCCEEEeeCcch
Confidence 457899999999999999863 34567778889999999999999 99999999999999999 77789999999998
Q ss_pred eecCCC---------------CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHH
Q psy1096 98 QKINPD---------------HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFAN 160 (239)
Q Consensus 98 ~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~ 160 (239)
...... .......|++.|+|||.+.+. .++.++|+||+|+++|+|++ ||.. .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 765421 122335688999999999865 57999999999999999998 5542 233344445
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+.......+.......+..+.+++++||..||.+|||++++++||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 5544444444333456788999999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=241.43 Aligned_cols=186 Identities=19% Similarity=0.226 Sum_probs=148.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+++ +|.+++. .+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI--NSNCDLKVCDFGLA 159 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred ceEEEEEeccCc-cHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--cCCCcEEEEecccc
Confidence 456889999985 6776664 2578899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCCC-----------CccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Q psy1096 98 QKINPDHP-----------PRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 98 ~~~~~~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~ 165 (239)
........ .....||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 77643211 122468999999998754 668999999999999999999999998877655544433211
Q ss_pred CCC----------------------------chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 166 FDF----------------------------DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 166 ~~~----------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+ .......++..+.+|+++||..||++|||++++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 100 0112236789999999999999999999999999999998744
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=242.53 Aligned_cols=179 Identities=19% Similarity=0.213 Sum_probs=151.1
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|+||||+++++|.+++..... ...++...+..++.|++.||.| |++||+||||||+||++ +.+
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~ 239 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TEN 239 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--CCC
Confidence 5689999999999999875332 2457888999999999999999 99999999999999999 777
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.+||+|||++........ .....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+....+.
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 8999999999987654322 223446788999999999999999999999999999999 999999888877777766
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.......+ ..++..+.+++.+||..||++|||+++++++
T Consensus 320 ~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 EGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55432222 3678999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=241.51 Aligned_cols=187 Identities=21% Similarity=0.222 Sum_probs=150.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec--CCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--RTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--~~~~~vkl~dfg~ 96 (239)
..|++|||+++++|.+++........+++..+..++.|++.||.| |++||+||||||+||++.. +..+.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 457899999999999999876566669999999999999999999 9999999999999998743 3445799999999
Q ss_pred ceecCCCCCCccccCCCCccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIIN--------YEPIGIESDMWSIGVITYVLLSGLSPFMGEND----SETFANITRA 164 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~----~~~~~~i~~~ 164 (239)
+.............||+.|+|||.+. +..++.++||||+||++|+|++|..||..... ......+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 98877665555667999999999986 46678999999999999999999999964332 3344444332
Q ss_pred cC---------------------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 165 EF---------------------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 165 ~~---------------------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.. .........++..+.+++++||+.||++|||++++++||-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21 1111112345678899999999999999999999999973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=238.35 Aligned_cols=189 Identities=22% Similarity=0.287 Sum_probs=150.3
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||++ ++|.+++. .+.+++..+..++.|++.||+| |++|++||||||+||+++. .++.++|+|||.+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVLKIGDFGLA 168 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTTEEEECCCTTC
T ss_pred CceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCeEEEccCccc
Confidence 35678999998 47777763 4678899999999999999999 9999999999999999942 3468999999998
Q ss_pred eecCCC----CCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc---
Q psy1096 98 QKINPD----HPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD--- 169 (239)
Q Consensus 98 ~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 169 (239)
...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 765422 22234567889999998865 6689999999999999999999999998877666665544322111
Q ss_pred -----------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 170 -----------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 170 -----------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
......++..+.+|+++||+.||++|||++++++||||+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 11123578999999999999999999999999999999875543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=237.19 Aligned_cols=189 Identities=21% Similarity=0.270 Sum_probs=147.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++........+++..+..++.|++.||.| |++|++|+||||+||+++.. ++.++|+|||.+.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSK 171 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeeccccc
Confidence 457899999999999998754444566788889999999999999 99999999999999999431 5789999999987
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhccCCCchHHHh
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP--IGIESDMWSIGVITYVLLSGLSPFMGENDSETF-ANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~ 174 (239)
...... ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||......... ......... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 249 (295)
T 2clq_A 172 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--PEIPE 249 (295)
T ss_dssp ESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--CCCCT
T ss_pred ccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--ccccc
Confidence 765432 233456899999999997654 789999999999999999999999765433221 111111111 11123
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
.++..+.+++.+||..||++|||++++++|+||+...
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 6789999999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=239.51 Aligned_cols=181 Identities=25% Similarity=0.325 Sum_probs=145.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++ +|.+++ +..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--NEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCSE-EGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CTTCCEEECSTTCTT
T ss_pred eEEEEeccccC-CHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE--CCCCcEEEeeccccc
Confidence 34889999984 666665 2358899999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch-------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD------- 170 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 170 (239)
..... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+.+....++.
T Consensus 175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 65432 234568999999999977 56799999999999999999999999988776666555442211111
Q ss_pred --------------------HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 171 --------------------EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 171 --------------------~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....++..+.+|+.+||+.||++|||++++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1112468899999999999999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=233.04 Aligned_cols=182 Identities=13% Similarity=0.113 Sum_probs=146.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC---CCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT---SHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~---~~~vkl~dfg 95 (239)
..|++|||+ +++|.+++.. .+..+++..+..++.|++.||.| |++|++||||||+||+++.++ .+.++|+|||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred eeEEEEEec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 457899999 9999999863 34568999999999999999999 999999999999999994322 2349999999
Q ss_pred cceecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhc
Q psy1096 96 LAQKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND---SETFANITRA 164 (239)
Q Consensus 96 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~---~~~~~~i~~~ 164 (239)
++........ .....||+.|+|||.+.+..++.++||||+|+++|+|++|..||.+... ......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987654322 2345699999999999998999999999999999999999999987543 3333333333
Q ss_pred cCCCc-hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 165 EFDFD-DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 165 ~~~~~-~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....+ ......++..+.+++.+||+.||++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22222 23334679999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=242.51 Aligned_cols=186 Identities=15% Similarity=0.172 Sum_probs=155.1
Q ss_pred EEeeCccCCCCccchhhhhhhc----CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA----GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~df 94 (239)
.|+|||||.|++|.+++..... ...++...+..++.|++.||.| |++||+||||||+||+++.+ .+..++|+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 3688999999999999976432 2468888999999999999999 99999999999999999432 2346999999
Q ss_pred ccceecCC---CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINP---DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|++..... ........+|+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+........+
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~ 308 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99875422 223344568899999999998899999999999999999998 99999998888887777766543332
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..++..+.+|+.+||+.||++|||+++++++.+...
T Consensus 309 ---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 309 ---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 367899999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=238.92 Aligned_cols=177 Identities=17% Similarity=0.181 Sum_probs=149.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE--SSSSCEEECSCSGGGG
T ss_pred cEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE--CCCCeEEECCCCcccc
Confidence 4688999999999998863 34578888999999999999999 99999999999999999 7778999999999987
Q ss_pred cCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.........+........+ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65432 2233457789999999998899999999999999999999 99999988877777777665433222 34
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||..||.+|||+++++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68889999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.06 Aligned_cols=179 Identities=14% Similarity=0.092 Sum_probs=144.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCc-----EEEEe
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHH-----IKIID 93 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~-----vkl~d 93 (239)
..|++|||+ +++|.+++.. .++.+++..+..++.|++.||.| |+.||+||||||+||++ +.++. ++|+|
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill--~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI--GRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CCGGGTCTTSEEECC
T ss_pred ccEEEEEeC-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee--ccCCCCCCceEEEEE
Confidence 457899999 9999998864 25689999999999999999999 99999999999999999 55555 99999
Q ss_pred cccceecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHH
Q psy1096 94 FGLAQKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANIT 162 (239)
Q Consensus 94 fg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~ 162 (239)
||++........ .....||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.. +....+.
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 999987644322 23467999999999999999999999999999999999999999875443 3344443
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
......+........+.+.+++..||..||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 DTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 33333333222222349999999999999999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=240.78 Aligned_cols=180 Identities=19% Similarity=0.218 Sum_probs=152.5
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|+||||+++++|.+++..... ...+++..+..++.|++.||.| |+.||+||||||+||++ +.+
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~ 227 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TED 227 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--cCC
Confidence 4688999999999999875432 2468999999999999999999 99999999999999999 777
Q ss_pred CcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++....... ......+++.|+|||.+.+..++.++||||+||++++|++ |..||.+.+..+....+.
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999987665432 2223456788999999999999999999999999999999 999999888777777766
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
.......+ ..++..+.+++.+||..||++|||+++++++.
T Consensus 308 ~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 308 EGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp TTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 65432222 36789999999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=237.51 Aligned_cols=184 Identities=20% Similarity=0.292 Sum_probs=137.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+ ++.+..+.. ...+.+++..+..++.|++.||.| |+. |++|+||||+||++ +.++.++|+|||++
T Consensus 98 ~~~lv~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--DERGQIKLCDFGIS 172 (318)
T ss_dssp EEEEEECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred cEEEEEecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE--CCCCCEEEEECCCc
Confidence 467899999 444444433 336778999999999999999999 995 99999999999999 77789999999998
Q ss_pred eecCCCCCCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhccCCCchH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGE-NDSETFANITRAEFDFDDE 171 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~ 171 (239)
.............+++.|+|||.+. ...++.++|+||+|+++|+|++|..||... ........+........+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 251 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP- 251 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-
Confidence 7765544444567999999999995 456789999999999999999999999864 344444555444322211
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....++..+.+++.+||..||.+|||++++++||||++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 11247899999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=237.33 Aligned_cols=177 Identities=16% Similarity=0.225 Sum_probs=148.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+++++|.+++. ...+.+++..+..++.|++.||.| |+.||+||||||+||++ +.++.++|+|||++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CEEEEECCTTCBHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCSSCEE
T ss_pred cEEEeeCCCCCcHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--CCCCCEEECCCCcccc
Confidence 468999999999999985 345678999999999999999999 99999999999999999 7778999999999987
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.........+........+ .
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP---M 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---T
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC---C
Confidence 654321 112235678999999998889999999999999999999 99999988888887777665332222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.++..+.+++.+||..||++|||++++++.
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=231.18 Aligned_cols=177 Identities=16% Similarity=0.244 Sum_probs=150.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++. ...+.++++.+..++.|++.||.+ |++|++||||||+||++ +.++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEEEECCTTCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CGGGCEEECCTTGGGG
T ss_pred eEEEEEeCCCCcHHHHHH--hcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE--cCCCCEEecccccccc
Confidence 578999999999999885 345678899999999999999999 99999999999999999 6667899999999876
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+.......+........+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLA 232 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTS
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcC
Confidence 54321 1222346778999999998899999999999999999999 99999988888877777665433322 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||++|||+++++++
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 8999999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=232.99 Aligned_cols=177 Identities=16% Similarity=0.188 Sum_probs=140.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRY 165 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECC------
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE--CCCCCEEECccccccc
Confidence 4688999999999998863 35578899999999999999999 99999999999999999 5567899999999877
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+........+ ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~ 242 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---PNC 242 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC---CCC
Confidence 654322 122346678999999998889999999999999999996 99999988887777777665432222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||++|||+++++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=240.18 Aligned_cols=182 Identities=13% Similarity=0.062 Sum_probs=144.5
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++|||+ +++|.+++.. .+.+++..+..++.|++.||.| |++||+||||||+||+++.+..+.++|+|||++
T Consensus 125 ~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a 200 (345)
T 2v62_A 125 SYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200 (345)
T ss_dssp EEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTC
T ss_pred cEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCc
Confidence 4578999999 9999998853 4488999999999999999999 999999999999999996655559999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHH-HhccCC
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND-SETFANI-TRAEFD 167 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-~~~~~~i-~~~~~~ 167 (239)
........ .....|++.|+|||.+.+..++.++||||+||++|+|++|..||.+... ....... ......
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 280 (345)
T 2v62_A 201 YRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE 280 (345)
T ss_dssp EESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT
T ss_pred eecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc
Confidence 77643211 1334689999999999988899999999999999999999999965322 2222221 111122
Q ss_pred CchHHHh-----hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 168 FDDEAFE-----ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 168 ~~~~~~~-----~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..... .++..+.+++.+||..||++|||++++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 281 LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2222111 578899999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=231.58 Aligned_cols=182 Identities=14% Similarity=0.133 Sum_probs=147.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++|||+ +++|.+++. .....+++..+..++.|++.||.| |++|++||||||+||+++. +.++.++|+|||.+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ceEEEEEec-CCCHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 457899999 899998885 345678999999999999999999 9999999999999999941 25578999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhccC
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN---DSETFANITRAEF 166 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~---~~~~~~~i~~~~~ 166 (239)
........ .....|++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.. .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654322 234569999999999999999999999999999999999999997643 2334444443333
Q ss_pred CCc-hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 167 DFD-DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 167 ~~~-~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+ ......++..+.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 333 22234678999999999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=245.70 Aligned_cols=186 Identities=23% Similarity=0.315 Sum_probs=136.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec---CCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS---RTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~---~~~~~vkl~dfg 95 (239)
..|++||||+| +|.+++.. ......+..+..++.|++.||.| |++||+||||||+||+++. ++...++|+|||
T Consensus 92 ~~~lv~E~~~g-~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 92 FQYIAIELCAA-TLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEEEEECCSE-EHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEEEEECCCC-CHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 35789999985 78877753 33344455667899999999999 9999999999999999943 233468899999
Q ss_pred cceecCCCC----CCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCC
Q psy1096 96 LAQKINPDH----PPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFD 167 (239)
Q Consensus 96 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~ 167 (239)
++....... ......||+.|+|||.+. ...++.++||||+||++|+|++ |..||...........+......
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 248 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc
Confidence 987765331 223456999999999997 3556889999999999999999 99999655444333222221111
Q ss_pred CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 168 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
... .....+..+.+|+.+||+.||.+|||++++++||||..
T Consensus 249 ~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 CLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TSC-TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccC-ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 111 11234566889999999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=236.82 Aligned_cols=181 Identities=17% Similarity=0.224 Sum_probs=149.9
Q ss_pred EEEeeCccCCCCccchhhhhhh-------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|++|||+++++|.+++.... ....+++..+..++.|++.||.| |++|++||||||+||++ +.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~~ 177 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GE 177 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE--cC
Confidence 4678999999999999986432 23578899999999999999999 99999999999999999 66
Q ss_pred CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc
Q psy1096 86 SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRA 164 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~ 164 (239)
++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+...
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 77899999999875443333334457788999999988888999999999999999998 99999988877777766554
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
.....+ ..++..+.+++.+||..||.+|||+++++++.
T Consensus 258 ~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 258 YRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp CCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 322111 36789999999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=230.76 Aligned_cols=181 Identities=14% Similarity=0.131 Sum_probs=146.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEe-cCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCV-SRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~-~~~~~~vkl~dfg~~ 97 (239)
..|++|||+ +++|.+++. .....+++..+..++.|++.||.| |++|++||||||+||++. .+.++.++|+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred ceEEEEEcc-CCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 457899999 999998885 335678999999999999999999 999999999999999993 234568999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccC
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANITRAEF 166 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~~~~~ 166 (239)
........ .....|++.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.. .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654322 22456899999999999999999999999999999999999999764432 33333333333
Q ss_pred CCch-HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 167 DFDD-EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 167 ~~~~-~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+. .....++..+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2222 222467899999999999999999999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=230.09 Aligned_cols=178 Identities=18% Similarity=0.251 Sum_probs=150.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. .+..+++..+..++.|++.||.| |+.|++||||||+||++ +.++.++|+|||.+..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRY 153 (268)
T ss_dssp EEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE--CTTCCEEECCTTCEEE
T ss_pred eEEEEEccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE--CCCCCEEEccCcccee
Confidence 5789999999999999864 34468889999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+.......+........+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 654321 122335667999999998889999999999999999999 99999988877777777665543333 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
+..+.+++.+||+.||++|||+++++++.
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 88999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=230.80 Aligned_cols=178 Identities=20% Similarity=0.275 Sum_probs=151.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||.+..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--CTTSCEEECSTTGGGG
T ss_pred eEEEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE--cCCCCEEEcccccccc
Confidence 5789999999999999864 24568899999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+........+ ...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 54321 1222346778999999998899999999999999999998 99999988888777777665443332 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
+..+.+++.+||+.||++|||++++++|.
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 89999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=235.75 Aligned_cols=177 Identities=18% Similarity=0.191 Sum_probs=149.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++++|+.+++|.+++.. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCTTHHHH
T ss_pred eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE--CCCCCEEEccCcceeE
Confidence 4578899999999998863 45678899999999999999999 99999999999999999 6667899999999977
Q ss_pred cCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
....... ....+|+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+.......+........+ ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC---cc
Confidence 6543322 22346778999999999999999999999999999999 99999988877777766655433222 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=236.39 Aligned_cols=177 Identities=23% Similarity=0.342 Sum_probs=146.3
Q ss_pred EEEeeCccCCC-CccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGG-CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++||++.+ ++|.+++.. .+.+++..+..++.|++.||.| |+.|++||||||+||+++. ..+.++|+|||++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCTTC
T ss_pred cEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-CCCCEEEeeCccc
Confidence 45778899986 889988853 5678899999999999999999 9999999999999999932 4578999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .+.......+ ..+
T Consensus 198 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~~~ 266 (320)
T 3a99_A 198 ALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRV 266 (320)
T ss_dssp EECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCC
T ss_pred ccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----ccC
Confidence 7765432 334568999999999987765 788999999999999999999996432 2222332222 357
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
+..+.+|+.+||..||++|||++++++||||++..
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 89999999999999999999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=239.79 Aligned_cols=155 Identities=22% Similarity=0.276 Sum_probs=128.0
Q ss_pred chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCcccc
Q psy1096 46 PWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEII 121 (239)
Q Consensus 46 ~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~ 121 (239)
+++..+..++.|++.||+| |++||+||||||+||++ +.++.++|+|||++........ .....+|+.|+|||.+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhh
Confidence 8888999999999999999 99999999999999999 6677899999999976543321 2234578889999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHH
Q psy1096 122 NYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ 200 (239)
Q Consensus 122 ~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ 200 (239)
.+..++.++||||+|+++|+|++ |..||.+................... ...+++.+.+++.+||..||++|||+++
T Consensus 268 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 98899999999999999999998 99999887755544443333222211 1357899999999999999999999999
Q ss_pred Hhhc
Q psy1096 201 CLSH 204 (239)
Q Consensus 201 ll~h 204 (239)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=232.57 Aligned_cols=179 Identities=16% Similarity=0.194 Sum_probs=150.1
Q ss_pred EEeeCccCCCCccchhhhhhhc---------------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA---------------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPEN 78 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~n 78 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 4688999999999999975432 2347888999999999999999 99999999999999
Q ss_pred eEEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy1096 79 IMCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGEND 154 (239)
Q Consensus 79 ili~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~ 154 (239)
|++ +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+...
T Consensus 181 Ili--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 181 ILV--AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp EEE--ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEE--cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999 6677899999999877653321 223346778999999998889999999999999999999 9999998888
Q ss_pred hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 155 SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
......+........+ ..++..+.+++.+||..||++|||+++++++
T Consensus 259 ~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcCCcCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777766655432222 3678999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=230.96 Aligned_cols=179 Identities=20% Similarity=0.245 Sum_probs=152.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++. .....+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHH--hCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE--cCCCCEEECcccceee
Confidence 578999999999999885 345678999999999999999999 99999999999999999 5667899999999987
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+........+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~---~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---P 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC---T
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC---C
Confidence 653321 222346788999999988889999999999999999998 99999988887777777665432221 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.++..+.+++.+||..||++|||+++++++.+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 67899999999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=239.75 Aligned_cols=187 Identities=21% Similarity=0.323 Sum_probs=127.3
Q ss_pred EEEeeCccCCCCccchhhhhhh--cCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..|++|||+++ +|.+++.... ....+++..+..++.|++.||.| |+. |++||||||+||++ +.++.++|+|||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg 171 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL--DRSGNIKLCDFG 171 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE--ETTTEEEECCCS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE--cCCCCEEEccCC
Confidence 45789999997 6666654322 36788899999999999999999 999 99999999999999 667799999999
Q ss_pred cceecCCCCCCccccCCCCccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHhccC-CCc
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEII----NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITRAEF-DFD 169 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~~~~-~~~ 169 (239)
++.............|++.|+|||.+ .+..++.++|+||+|+++|+|++|..||.+.... .....+..... ..+
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 98776554444445699999999999 4566899999999999999999999999764422 22212211111 111
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......++..+.+|+.+||..||++|||++++++||||..
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1112357899999999999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=237.11 Aligned_cols=179 Identities=18% Similarity=0.208 Sum_probs=150.2
Q ss_pred EEeeCccCCCCccchhhhhhhc---------------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA---------------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPEN 78 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~n 78 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 4788999999999999875322 2678889999999999999999 99999999999999
Q ss_pred eEEecCCCCcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy1096 79 IMCVSRTSHHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGEND 154 (239)
Q Consensus 79 ili~~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~ 154 (239)
|++ +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.
T Consensus 205 Il~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 205 CLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp EEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EEE--CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999 667789999999987654321 2233457889999999998889999999999999999999 9999998888
Q ss_pred hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 155 SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+....+........+ ..++..+.+++++||..||++|||+++++++
T Consensus 283 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 7777777665543222 3678999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=229.55 Aligned_cols=176 Identities=16% Similarity=0.197 Sum_probs=146.6
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||.+...
T Consensus 88 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--EETTEEEECCCCGGGCC
T ss_pred EEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE--CCCCcEEeCccCCCccc
Confidence 689999999999999863 35568889999999999999999 99999999999999999 55678999999998765
Q ss_pred CCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 101 NPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 101 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+........+ ..++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 240 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP---DLCP 240 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---TTCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---CCCC
Confidence 53321 223346778999999998889999999999999999998 99999887777777666655433222 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+.+++.+||..||++|||+++++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=229.80 Aligned_cols=180 Identities=22% Similarity=0.352 Sum_probs=150.8
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|++|||+++++|.+++.. ..+..+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 169 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLV 169 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHH-GGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE--cCCCCEEECcchhh
Confidence 347899999999999999865 345678899999999999999999 99999999999999999 56678999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+... ......+..... + ..++
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~~--~----~~~~ 241 (284)
T 2a19_B 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGII--S----DIFD 241 (284)
T ss_dssp EESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTCC--C----TTSC
T ss_pred eeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcccc--c----ccCC
Confidence 8876655555567999999999999888999999999999999999998887422 122223322221 1 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+.+++.+||..||++|||+.+++++.+.-.
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 89999999999999999999999999987754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=241.74 Aligned_cols=176 Identities=13% Similarity=0.147 Sum_probs=147.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++... ....+++..+..++.|++.||+| |++|++||||||+||++ +.++.+||+|||++.
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--CCCCCEEEeeCCCcc
Confidence 367899999999999998752 33347888999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+..+.....+ ..++
T Consensus 338 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p---~~~~ 412 (450)
T 1k9a_A 338 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DGCP 412 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC---TTCC
T ss_pred cccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CcCC
Confidence 654322 22357788999999999999999999999999999998 99999988877777777655322221 4678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.+++.+||..||++|||++++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.88 Aligned_cols=177 Identities=17% Similarity=0.222 Sum_probs=141.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++. .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARD 241 (373)
T ss_dssp CEEEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----
T ss_pred eEEEEECCCCCCHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE--CCCCCEEEeecccccc
Confidence 468899999999999985 345668888999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCC-----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 100 INPDHP-----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 100 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |.+||.+.+..+....+..+.....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p--- 318 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 318 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 543221 122346778999999999999999999999999999999 78888887777766666655443332
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||++|||+++++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.86 Aligned_cols=182 Identities=20% Similarity=0.225 Sum_probs=148.5
Q ss_pred EEeeCccCCCCccchhhhhhhc--------------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCe
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA--------------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENI 79 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~ni 79 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 5688999999999999865322 1347888899999999999999 999999999999999
Q ss_pred EEecCCCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy1096 80 MCVSRTSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDS 155 (239)
Q Consensus 80 li~~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~ 155 (239)
++ +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....
T Consensus 204 ll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 204 LV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EE--cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99 6677999999999876643322 123446778999999998889999999999999999998 99999887766
Q ss_pred HHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 156 ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.....+......... ....+..+.+++.+||..||.+|||+++++++..
T Consensus 282 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 555555444333221 1357899999999999999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=239.44 Aligned_cols=176 Identities=16% Similarity=0.223 Sum_probs=147.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+++++|.+++.. .+..++...+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~--~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV--TEKNVLKISDFGMSRE 262 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCGGGCEE
T ss_pred cEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE--cCCCcEEECcCCCcee
Confidence 4788999999999999863 34568888999999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... .....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+....+..+.....+ ..
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 339 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP---EL 339 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC---TT
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CC
Confidence 543211 111234667999999998889999999999999999998 99999988877776666655432222 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
++..+.+++.+||+.||++|||++++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=242.80 Aligned_cols=187 Identities=25% Similarity=0.370 Sum_probs=136.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCC----chHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC----------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQ----PWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR---------- 84 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~----~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~---------- 84 (239)
..|++||||+ ++|.+++........ ..+..+..++.|++.||.| |++||+||||||+||+++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 4678999997 589988854221111 1222356799999999999 99999999999999999643
Q ss_pred -CCCcEEEEecccceecCCCCC-----CccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy1096 85 -TSHHIKIIDFGLAQKINPDHP-----PRVLFGTPEFIPPEIINY-------EPIGIESDMWSIGVITYVLLS-GLSPFM 150 (239)
Q Consensus 85 -~~~~vkl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~~-g~~p~~ 150 (239)
..+.++|+|||++........ .....||+.|+|||.+.+ ..++.++||||+||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 345899999999987654321 223569999999999976 567999999999999999998 999997
Q ss_pred CCCchHHHHHHHhccCCCchH---HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 151 GENDSETFANITRAEFDFDDE---AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
+..... ..+.......+.. ....++..+.+++.+||+.||.+|||++++++||||..
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 655433 2333333222210 01235678999999999999999999999999999964
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=229.64 Aligned_cols=180 Identities=16% Similarity=0.196 Sum_probs=146.9
Q ss_pred EEEeeCccCCCCccchhhhhh---hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM---KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
..|++|||+.+++|.+++... .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli--~~~~~~kl~Dfg 192 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML--RDDMTVCVADFG 192 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE--CTTSCEEECSCS
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCcEEEeecC
Confidence 458899999999999988543 234678999999999999999999 99999999999999999 777899999999
Q ss_pred cceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchH
Q psy1096 96 LAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDE 171 (239)
Q Consensus 96 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 171 (239)
++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.........+........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 271 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP- 271 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCB-
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCC-
Confidence 987654332 1223456778999999998899999999999999999999 99999988887777777665432222
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||++|||+++++++
T Consensus 272 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 272 --EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3678999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=231.64 Aligned_cols=182 Identities=20% Similarity=0.367 Sum_probs=140.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|| +.+++|.+++. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +. +.++|+|||++.
T Consensus 102 ~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--ET-TEEEECCCSSSC
T ss_pred EEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--EC-CeEEEeeccccc
Confidence 4678899 67888988885 35678889999999999999999 99999999999999999 33 789999999987
Q ss_pred ecCCCCC---CccccCCCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHh
Q psy1096 99 KINPDHP---PRVLFGTPEFIPPEIINY-----------EPIGIESDMWSIGVITYVLLSGLSPFMGENDS-ETFANITR 163 (239)
Q Consensus 99 ~~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~-~~~~~i~~ 163 (239)
....... .....|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... .....+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 6643321 223468999999999975 46788999999999999999999999765443 23333332
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
....... ....+..+.+++.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 2221111 12457889999999999999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=226.88 Aligned_cols=177 Identities=19% Similarity=0.284 Sum_probs=143.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc---ccCCCCCCCCeEEecC------CCCcEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV---TVDPKILPENIMCVSR------TSHHIK 90 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~---ivH~dikp~nili~~~------~~~~vk 90 (239)
.|++|||+++++|.+++. +..+++..+..++.|++.||.| |++| ++||||||+||+++.+ ..+.++
T Consensus 81 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred eEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 578999999999998863 5678899999999999999999 9999 8999999999999432 267899
Q ss_pred EEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 91 IIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 91 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|+|||.+........ ....|++.|+|||.+.+..++.++|+||+|+++++|++|..||.+.+.......+.......+.
T Consensus 157 l~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp ECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred EccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 999999876554332 2456899999999999888999999999999999999999999988877766666555443322
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...++..+.+++.+||..||++|||+++++++
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 --PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 13678999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=227.11 Aligned_cols=175 Identities=18% Similarity=0.193 Sum_probs=141.1
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCc-----EEEEe
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHH-----IKIID 93 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~-----vkl~d 93 (239)
+++|||+.+++|.+++. .....+++..+..++.|++.||.| |++| ++|+||||+||++ +..+. ++|+|
T Consensus 97 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHh--cccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCC
Confidence 57899999999988876 345678999999999999999999 9999 9999999999999 44444 99999
Q ss_pred cccceecCCCCCCccccCCCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHhccCCCc
Q psy1096 94 FGLAQKINPDHPPRVLFGTPEFIPPEIIN--YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET--FANITRAEFDFD 169 (239)
Q Consensus 94 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~--~~~i~~~~~~~~ 169 (239)
||++..... ......|++.|+|||.+. ...++.++|+||+|+++|+|++|..||...+.... ...+........
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999875433 233456899999999994 34468899999999999999999999987655443 333333322221
Q ss_pred hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 170 DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 170 ~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....+++.+.+++.+||+.||++|||++++++.
T Consensus 251 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 251 --IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 124678999999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=231.74 Aligned_cols=177 Identities=18% Similarity=0.194 Sum_probs=144.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++++|+.+++|.+++.. ..+.+++..+..++.|++.||.| |++|++||||||+||++ +..+.++|+|||++..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCTTC---
T ss_pred ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE--cCCCCEEEccCcceeE
Confidence 5678999999999998863 35678899999999999999999 99999999999999999 5667899999999977
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.........+........+ ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---cc
Confidence 643322 122346778999999999999999999999999999999 99999988887777777665433322 35
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
++..+.+++++||..||.+|||++++++.
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78999999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=229.60 Aligned_cols=173 Identities=24% Similarity=0.423 Sum_probs=138.1
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC-CCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT-SHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~-~~~vkl~dfg~ 96 (239)
...|++|||+++++|.+++.. ..+..+++..+..++.|++.||.| |++|++||||||+||+++.+. ++.++|+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred ceEEEEEeecCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 357899999999999999875 334578999999999999999999 999999999999999994422 67899999998
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----HHHhccCCCchHH
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFA----NITRAEFDFDDEA 172 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~----~i~~~~~~~~~~~ 172 (239)
+.... +..++.++|+||+||++|+|++|..||.+........ .+.......+...
T Consensus 167 a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 167 AKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp CEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 86533 2346789999999999999999999997665433221 2222334445555
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
+..++..+.+|+.+||..||.+|||++++++||||++....
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 56789999999999999999999999999999999875443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=232.84 Aligned_cols=179 Identities=14% Similarity=0.185 Sum_probs=150.1
Q ss_pred EEeeCccCCCCccchhhhhhhc-------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--~~~~~~kl~ 180 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIG 180 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--CTTCCEEEC
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE--cCCCeEEEC
Confidence 4688999999999999875432 1566888999999999999999 99999999999999999 777899999
Q ss_pred ecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence 9999875543221 122346788999999998889999999999999999999 899998888777777766654432
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+ ..++..+.+++.+||..||++|||+++++++
T Consensus 261 ~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 261 KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22 3678999999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=227.89 Aligned_cols=178 Identities=17% Similarity=0.219 Sum_probs=148.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++. .....++...+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLAR 176 (298)
T ss_dssp CCEEEEECCTTCBHHHHHH--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECSCGGGC
T ss_pred ceEEEEeCCCCCCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE--CCCCCEEECcccccc
Confidence 3468899999999999985 345678888999999999999999 99999999999999999 778899999999987
Q ss_pred ecCCCC-----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDH-----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
...... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |.+||.+.+.......+........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-- 254 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC--
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC--
Confidence 654322 1223456778999999998899999999999999999999 77788777777776666665544332
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||++|||++++++.
T Consensus 255 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 255 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=228.87 Aligned_cols=180 Identities=21% Similarity=0.332 Sum_probs=136.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||+.+++|.+++. .....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVKIGDFGLATE 169 (289)
T ss_dssp CEEEEECCCEEEHHHHHT--TC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTTEEEECCCC----
T ss_pred cEEEEEecCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--CCCCCEEEccceeccc
Confidence 468899999999998885 345678889999999999999999 99999999999999999 6677999999999875
Q ss_pred cCCC---CCCccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH-hccCCCch-H
Q psy1096 100 INPD---HPPRVLFGTPEFIPPEIIN---YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT-RAEFDFDD-E 171 (239)
Q Consensus 100 ~~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~-~ 171 (239)
.... .......|++.|+|||.+. +..++.++||||+|+++|+|++|..||.+........... ........ .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 5431 2223356899999999996 5667889999999999999999999998866655444433 33322221 1
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....++..+.+++.+||..||.+|||++++++.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 123578999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=230.09 Aligned_cols=180 Identities=22% Similarity=0.245 Sum_probs=147.7
Q ss_pred EEeeCccCCCCccchhhhhhhc---------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA---------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~ 84 (239)
.|++|||+++++|.+++..... +..+++..+..++.|++.||.| |++|++||||||+||++ +
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~ 179 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--T 179 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--E
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--c
Confidence 4688999999999999875322 2258899999999999999999 99999999999999999 6
Q ss_pred CCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q psy1096 85 TSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFAN 160 (239)
Q Consensus 85 ~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~ 160 (239)
.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 677999999999877654332 223346778999999998889999999999999999998 9999988776555555
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.......... ...++..+.+++.+||..||.+|||+++++++
T Consensus 260 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4443332221 13578999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=235.73 Aligned_cols=177 Identities=18% Similarity=0.229 Sum_probs=138.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+++++|.+++. ..+..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp CEEEEECCTTCBHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----
T ss_pred eEEEEeCCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--cCCCCEEECcCccccc
Confidence 468899999999999986 335578899999999999999999 99999999999999999 7778999999999877
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++||||+|+++|++++ |..||.+.+.......+........+ .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---M 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---T
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---c
Confidence 653321 111235678999999998999999999999999999998 99999988877777666554332222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.++..+.+++.+||+.||++|||++++++.
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 578899999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=242.87 Aligned_cols=178 Identities=20% Similarity=0.273 Sum_probs=148.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+|+|.+++... .+..++...+..++.|++.||.| |++|++||||||+||++ +.++.+||+|||++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--CTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE--CCCCcEEEeeCCCceE
Confidence 47899999999999998642 23356778889999999999999 99999999999999999 7778999999999876
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+....++.++||||+||++|+|++ |..||.+.+..+....+..+.....+ ..+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~ 410 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP---ENC 410 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC---TTS
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence 54321 1122335678999999998899999999999999999999 99999998888877777665332222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||++|||++++++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=224.54 Aligned_cols=177 Identities=16% Similarity=0.251 Sum_probs=149.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+.+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||.+..
T Consensus 78 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRF 153 (267)
T ss_dssp CEEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CGGGCEEECCTTGGGG
T ss_pred eEEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--CCCCCEEEcccccccc
Confidence 5688999999999998863 34678899999999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+........+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~ 230 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLA 230 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccC
Confidence 54321 1222346778999999998889999999999999999999 99999988877777777665333222 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||++|||+++++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=233.65 Aligned_cols=174 Identities=15% Similarity=0.164 Sum_probs=140.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++.. ..+.+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--CTTSCEEECCCTTCE
T ss_pred eeEEEEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE--CCCCCEEEeecccce
Confidence 35789999999999999863 36678899999999999999999 99999999999999999 777889999999997
Q ss_pred ecCCCCCC---------------ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----H
Q psy1096 99 KINPDHPP---------------RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET-----F 158 (239)
Q Consensus 99 ~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~-----~ 158 (239)
........ ....||+.|+|||.+.+..++.++||||+|+++|+|++|..||........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 76433211 145689999999999999999999999999999999999999865332111 1
Q ss_pred HHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 159 ANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
....... . ...++..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~--~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 237 RGFLDRY--C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHT--C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccccc--C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111111 0 1356888999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=228.30 Aligned_cols=175 Identities=21% Similarity=0.210 Sum_probs=147.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 92 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHH---hCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE--eCCCcEEEccCCccee
Confidence 568999999999999985 35678899999999999999999 99999999999999999 5567899999999877
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+........+ .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---A 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 654322 112335678999999988888999999999999999999 99999988877777766655432221 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+++.+||..||++|||++++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999885
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=231.23 Aligned_cols=179 Identities=19% Similarity=0.213 Sum_probs=149.6
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+||++ +.+
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~ 193 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TEN 193 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--cCC
Confidence 4689999999999999875332 2347888999999999999999 99999999999999999 777
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~ 162 (239)
+.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+.
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 8999999999987654321 222346778999999988889999999999999999999 999999888777776666
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.......+ ..++..+.+++.+||..||.+|||+++++++
T Consensus 274 ~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55432222 3678999999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=230.83 Aligned_cols=178 Identities=16% Similarity=0.212 Sum_probs=144.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. .++.+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC--
T ss_pred CcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE--CCCCcEEECCCCcch
Confidence 35789999999999999863 45678999999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+........+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP--- 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc---
Confidence 7653321 112235678999999998889999999999999999998 99999888877777776655322221
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||+.||++||++++++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=226.81 Aligned_cols=178 Identities=15% Similarity=0.217 Sum_probs=149.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||++|++|.+++.. .....+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||.+..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE--CGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE--cCCCCEEEccCcccee
Confidence 5789999999999999865 345668899999999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+........+ ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 237 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGC 237 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---TTC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC---CCC
Confidence 553321 122346778999999998899999999999999999999 99999988877777666655332222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||.+|||++++++.
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=240.26 Aligned_cols=183 Identities=19% Similarity=0.243 Sum_probs=148.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++.. ..+..++...+..++.|++.||+| |++|++||||||+||++ +.++.+||+|||++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--CCCCCEEECCCcccee
Confidence 4789999999999999864 234568888999999999999999 99999999999999999 6677899999999976
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.+..+....+..+.....+ ..+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~ 406 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---PEC 406 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence 643221 122346678999999998899999999999999999999 99999998888877777655332222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc--ccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH--LWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h--~~~~~ 209 (239)
+..+.+++.+||..||++|||++++++. .++..
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 8999999999999999999999999864 46554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=229.59 Aligned_cols=176 Identities=23% Similarity=0.325 Sum_probs=145.0
Q ss_pred EEeeCcc-CCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPY-DGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~-~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.|++||| +.+++|.+++.. ++.+++..+..++.|++.||.| |++|++||||||+||+++. .++.++|+|||++.
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGA 188 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TTTEEEECCCSSCE
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CCCeEEEEEcchhh
Confidence 4577888 899999999854 4568899999999999999999 9999999999999999931 56789999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.. .+.......+ ..++
T Consensus 189 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~----~~~~ 257 (312)
T 2iwi_A 189 LLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP----AHVS 257 (312)
T ss_dssp ECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC----TTSC
T ss_pred hcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc----ccCC
Confidence 765432 334568999999999977666 458999999999999999999996432 2223333333 3578
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
..+.+++.+||..||++|||++++++|+||+...
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 9999999999999999999999999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=244.77 Aligned_cols=177 Identities=16% Similarity=0.162 Sum_probs=141.3
Q ss_pred eEEEeeCccCCCCccchhhhhh----hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 19 VITWSSPPYDGGCMITGYVVEM----KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~d 93 (239)
...+++|+++ +++|.+++... ..++.+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl--~~~~~~kL~D 254 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--DQRGGVFLTG 254 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECC
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE--ecCCeEEEEe
Confidence 3445556554 57787777432 225567788889999999999999 99999999999999999 7777899999
Q ss_pred cccceecCCCCCCccccCCCCccCcccc----------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Q psy1096 94 FGLAQKINPDHPPRVLFGTPEFIPPEII----------NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR 163 (239)
Q Consensus 94 fg~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~ 163 (239)
||++...... .....| +.|+|||.+ ....++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 255 FG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 331 (413)
T 3dzo_A 255 FEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331 (413)
T ss_dssp GGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS
T ss_pred ccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh
Confidence 9998765533 233457 999999999 555578899999999999999999999987655443332222
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.. ..++..+.+|+.+||+.||++|||+.++++||||++
T Consensus 332 ~~--------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 332 SC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SC--------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 11 256889999999999999999999999999999965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=230.60 Aligned_cols=186 Identities=15% Similarity=0.176 Sum_probs=153.0
Q ss_pred EEeeCccCCCCccchhhhhhhcC----CCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEec
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAG----TQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDF 94 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~df 94 (239)
.|++|||+++++|.+++...... ..+++..+..++.|++.||.| |++|++||||||+||+++.+ ....++|+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 37889999999999998754321 458888999999999999999 99999999999999999432 3456999999
Q ss_pred ccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCch
Q psy1096 95 GLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDD 170 (239)
Q Consensus 95 g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 170 (239)
|++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.........+.........
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 267 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC
Confidence 9986543221 2234567889999999988889999999999999999998 99999888777777776665433222
Q ss_pred HHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 171 EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 171 ~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..++..+.+++.+||..||.+|||+++++++.|...
T Consensus 268 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 268 ---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 367899999999999999999999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=223.14 Aligned_cols=177 Identities=18% Similarity=0.188 Sum_probs=146.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++. ..+..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 98 ~~~v~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML--DESFTVKVADFGLARD 173 (298)
T ss_dssp CEEEECCCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECCTTSSCT
T ss_pred cEEEEecccCCCHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCcEEeCcCCCccc
Confidence 368899999999999886 346778889999999999999999 99999999999999999 7778999999999875
Q ss_pred cCCC-----CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 100 INPD-----HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 100 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
.... .......+++.|+|||.+.+..++.++|+||+|+++|+|++ +.+||...+.......+........+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP--- 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC---
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC---
Confidence 4322 12233457889999999999999999999999999999999 55666666666666666555433222
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||.+|||++++++.
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=233.00 Aligned_cols=180 Identities=18% Similarity=0.241 Sum_probs=147.6
Q ss_pred EEeeCccCCCCccchhhhhhhc-----------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-----------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHH 88 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~ 88 (239)
.|++|||+++++|.+++..... +..+++..+..++.|++.||.| |++|++||||||+||++ +.++.
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--~~~~~ 202 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHV 202 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE--EGGGE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE--CCCCe
Confidence 5688999999999999875432 4567889999999999999999 99999999999999999 56678
Q ss_pred EEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc
Q psy1096 89 IKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRA 164 (239)
Q Consensus 89 vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~ 164 (239)
++|+|||++........ .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.........+...
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 99999999876543322 223446778999999998889999999999999999998 99999887766655555444
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
...... ....+..+.+++.+||..||.+|||+++++++
T Consensus 283 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 GYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 333221 13568899999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=228.07 Aligned_cols=177 Identities=13% Similarity=0.118 Sum_probs=136.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--ENENRVKIGDFGLTKV 163 (295)
T ss_dssp CEEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCCSCC-
T ss_pred eEEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE--cCCCeEEEccCccccc
Confidence 4689999999999999864 23458888999999999999999 99999999999999999 5567899999999877
Q ss_pred cCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------------HHHH
Q psy1096 100 INPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS----------------ETFA 159 (239)
Q Consensus 100 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~----------------~~~~ 159 (239)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 64332 122234667799999999999999999999999999999999998543211 1111
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+........ ...++..+.+++.+||..||++|||++++++.
T Consensus 244 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 244 LLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1222211111 13678999999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=229.77 Aligned_cols=180 Identities=20% Similarity=0.232 Sum_probs=146.0
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
.|++|||+++++|.+++..... ...+++..+..++.|++.||.| |++|++||||||+||++ +..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--~~~ 184 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEK 184 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--CCC
Confidence 5788999999999999864322 1238889999999999999999 99999999999999999 667
Q ss_pred CcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHH-HH
Q psy1096 87 HHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFA-NI 161 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~-~i 161 (239)
+.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+........ .+
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 7899999999876643322 123457788999999998899999999999999999998 999998776544433 33
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
........+ ...+..+.+++.+||..||.+|||++++++|.
T Consensus 265 ~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 265 KEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 333221111 35789999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=234.61 Aligned_cols=184 Identities=15% Similarity=0.114 Sum_probs=143.6
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|++|||+ +++|.+++.. ..++.+++..+..++.|++.||.| |++|++||||||+||+++.++...++|+|||++
T Consensus 131 ~~~~lv~e~~-~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a 208 (352)
T 2jii_A 131 KYRFLVLPSL-GRSLQSALDV-SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208 (352)
T ss_dssp TEEEEEEECC-CEEHHHHHHH-SGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGC
T ss_pred cEEEEEecCC-CcCHHHHHHh-CCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcce
Confidence 3568899999 9999999864 234789999999999999999999 999999999999999994433238999999998
Q ss_pred eecCCCC--------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHh----c
Q psy1096 98 QKINPDH--------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEN-DSETFANITR----A 164 (239)
Q Consensus 98 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~-~~~~~~~i~~----~ 164 (239)
....... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.. .......... .
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (352)
T 2jii_A 209 FRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDK 288 (352)
T ss_dssp BCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHS
T ss_pred eeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCC
Confidence 7654321 1123469999999999999899999999999999999999999997654 2222222211 1
Q ss_pred cCCCc--hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 165 EFDFD--DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 165 ~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..... ...+..++..+.+++.+||..||++|||++++++.
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 289 PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 11111 00112468999999999999999999999999854
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.45 Aligned_cols=177 Identities=20% Similarity=0.300 Sum_probs=148.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.+++|.+++... .+..+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||.+..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE--cCCCCEEECCCccccc
Confidence 46899999999999988542 23368888999999999999999 99999999999999999 7778999999999987
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+....+........+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 235 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNC 235 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc---ccc
Confidence 65432 1223346778999999988888999999999999999999 99999988877777766554322221 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+..+.+++.+||..||++|||++++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 899999999999999999999999886
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=227.61 Aligned_cols=180 Identities=17% Similarity=0.252 Sum_probs=140.4
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h--------hhcccCCCCCCCCeEEecCCCCcE
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H--------SLVTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h--------~~~ivH~dikp~nili~~~~~~~v 89 (239)
...|++|||+++++|.+++. ...+++..+..++.|++.||.| | ++|++||||||+||++ +.++.+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--~~~~~~ 152 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--KKNGQC 152 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE--CTTSCE
T ss_pred ceeEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE--cCCCCE
Confidence 34679999999999999873 4578899999999999999999 9 9999999999999999 777899
Q ss_pred EEEecccceecCCCCC-----CccccCCCCccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCC
Q psy1096 90 KIIDFGLAQKINPDHP-----PRVLFGTPEFIPPEIINYE------PIGIESDMWSIGVITYVLLSG----------LSP 148 (239)
Q Consensus 90 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~~g----------~~p 148 (239)
+|+|||++........ .....||+.|+|||.+.+. .++.++||||+|+++|+|++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 9999999876543322 2234699999999999876 345799999999999999999 888
Q ss_pred CCCCC----chHHHHHHHhccC---CCchH-HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 149 FMGEN----DSETFANITRAEF---DFDDE-AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 149 ~~~~~----~~~~~~~i~~~~~---~~~~~-~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
|.... ............. ..+.. .....+..+.+++.+||+.||++|||++++++.
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 86532 2223333222211 11110 112345789999999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=246.69 Aligned_cols=176 Identities=20% Similarity=0.247 Sum_probs=146.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||.+++|.+++. .....+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 410 ~~lv~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl--~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEEECCTTCBHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCSTTTT
T ss_pred eEEEEEeCCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE--cCCCcEEEeeccCccc
Confidence 578999999999999885 345678999999999999999999 99999999999999999 5667999999999876
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+..+.....+ .
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---P 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC---T
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 543221 112235678999999998999999999999999999998 99999999888888887766432222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+++.+||..||++|||++++++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67899999999999999999999999853
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.16 Aligned_cols=178 Identities=15% Similarity=0.224 Sum_probs=149.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+.+++|.+++.. .....+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV--GENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE--CCCCcEEEeeccccee
Confidence 4688999999999999864 334568889999999999999999 99999999999999999 6677999999999877
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+........+ ..+
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 444 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGC 444 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---TTC
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence 64322 1122345678999999998889999999999999999999 99999988877777766554322211 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+|+.+||..||++|||++++++.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8999999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=221.23 Aligned_cols=176 Identities=13% Similarity=0.133 Sum_probs=145.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|++|||+++++|.+++.. ..+..+++..+..++.|++.||.| |++| ++|+||||+||++ +.++.+++.||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADV 159 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGS
T ss_pred CeEeeecccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccc
Confidence 34688999999999999864 233368999999999999999999 9999 9999999999999 7777899998887
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGI---ESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
...... ....+|+.|+|||.+.+..++. ++|+||+|+++|+|++|..||.+.+.......+......... .
T Consensus 160 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 233 (271)
T 3kmu_A 160 KFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--P 233 (271)
T ss_dssp CCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--C
T ss_pred eeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--C
Confidence 654332 2345889999999998765543 899999999999999999999988877776666655433222 2
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||++|||++++++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4679999999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=236.87 Aligned_cols=181 Identities=15% Similarity=0.159 Sum_probs=146.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++|||+ +++|.+++. .....+++..+..++.||+.||.| |++||+||||||+|||+.. +..+.++|+|||++
T Consensus 77 ~~~lvme~~-g~sL~~ll~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFN--FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEEEECC-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 447899999 899998885 335678999999999999999999 9999999999999999942 35678999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccC
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---ETFANITRAEF 166 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---~~~~~i~~~~~ 166 (239)
........ .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.... ..+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 87654332 12457999999999999999999999999999999999999999875543 33333333222
Q ss_pred -CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 167 -DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 167 -~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.........++..+.+|+..||..||++||++++|++
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2222333578999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=226.10 Aligned_cols=177 Identities=15% Similarity=0.199 Sum_probs=136.4
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh---hcccCCCCCCCCeEEecCCCCc-EEEEecc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS---LVTVDPKILPENIMCVSRTSHH-IKIIDFG 95 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~---~~ivH~dikp~nili~~~~~~~-vkl~dfg 95 (239)
.|++|||+++++|.+++........++...+..++.|++.||.| |+ +|++||||||+||++ +.++. ++|+|||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~~~~kl~Dfg 151 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFG 151 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE--ETTTTEEEECCCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE--eCCCCEEEEcccc
Confidence 36899999999999998654333457788899999999999999 99 899999999999999 44454 7999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhccCCCchHHH
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE--TFANITRAEFDFDDEAF 173 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~--~~~~i~~~~~~~~~~~~ 173 (239)
++...... .....|++.|+|||.+.+..++.++||||+|+++|+|++|..||....... ....+....... ..
T Consensus 152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 226 (307)
T 2eva_A 152 TACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LI 226 (307)
T ss_dssp C--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC---CB
T ss_pred cccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC---cc
Confidence 98665432 223458999999999999899999999999999999999999997644322 222222222211 12
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+++.+||..||++|||+++++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4678999999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=224.61 Aligned_cols=176 Identities=12% Similarity=0.130 Sum_probs=142.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++... ....+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE--eCCCcEEEeeccccc
Confidence 457899999999999998642 22336788899999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+........ ...++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---cccCC
Confidence 65432 223357888999999998889999999999999999998 9999988877777766655432211 13678
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+.+.+++++||..||++|||++++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=226.60 Aligned_cols=178 Identities=17% Similarity=0.209 Sum_probs=148.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.+++|||+.+++|.+++... .+.+++..+..++.|++.||.+ |++|++|+||||+||++ +.++.++|+|||++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--cCCCCEEEcccccccc
Confidence 46889999999999988642 4568889999999999999999 99999999999999999 5567899999999877
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.......+.......+. ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--Cc
Confidence 654322 223456778999999988888999999999999999999 99999988888777777665443332 13
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.++..+.+++.+||..||++|||+++++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 678999999999999999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=227.65 Aligned_cols=179 Identities=16% Similarity=0.221 Sum_probs=137.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ++.+++..+..++.|++.||.| |++|++|+||||+||++ +.++.++|+|||++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV--SADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSCCC--
T ss_pred eEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE--cCCCCEEEecCccCc
Confidence 45789999999999998853 4578899999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 99 KINPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 99 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+ ......+......+
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGI 261 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTC
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCC
Confidence 654332 223456899999999999888999999999999999999999999876655333333 33333333333568
Q ss_pred CHHHHHHHHHhhhhCcccCC-CHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRL-TAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rp-t~~~ll~h 204 (239)
+..+.+++.+||..||++|| |++++++.
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHHH
Confidence 89999999999999999999 88888764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=229.97 Aligned_cols=179 Identities=18% Similarity=0.207 Sum_probs=138.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh----------cccCCCCCCCCeEEecCCCCc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL----------VTVDPKILPENIMCVSRTSHH 88 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~----------~ivH~dikp~nili~~~~~~~ 88 (239)
..|++||||++++|.+++.. ..+++..+..++.|++.||+| |+. |++||||||+||++ +..+.
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill--~~~~~ 169 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLT 169 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE--CTTCC
T ss_pred eEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE--CCCCe
Confidence 35899999999999999853 358899999999999999999 999 99999999999999 77789
Q ss_pred EEEEecccceecCCCCC---CccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----
Q psy1096 89 IKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYE-----PIGIESDMWSIGVITYVLLSGLSPFMGENDS----- 155 (239)
Q Consensus 89 vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~----- 155 (239)
+||+|||++........ .....||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+....
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999977654322 2235689999999999863 4467889999999999999999999754321
Q ss_pred -----------HHHHHHHhccCCCch-HHH--hhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 156 -----------ETFANITRAEFDFDD-EAF--EALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 156 -----------~~~~~i~~~~~~~~~-~~~--~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.....+......+.. ..+ ...+..+.+|+.+||+.||++|||++++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111122222111111 000 1124559999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=226.00 Aligned_cols=181 Identities=20% Similarity=0.283 Sum_probs=137.5
Q ss_pred EEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+++++|.+++.... .+..+++..+..++.|++.||.| |+.|++|+||||+||++ +.++.++|+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~--~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE--cCCCCEEEEeccce
Confidence 4678999999999999987543 35678899999999999999999 99999999999999999 77789999999998
Q ss_pred eecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHhccCCCchHHHh
Q psy1096 98 QKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND--SETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 98 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~ 174 (239)
....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+... ......+........ ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 261 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSD 261 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTT
T ss_pred eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--ccc
Confidence 7654332 22334689999999999988899999999999999999999999976543 233334443333221 124
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.++..+.+++.+||..||++|||+++++++
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 678999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=227.80 Aligned_cols=175 Identities=14% Similarity=0.223 Sum_probs=137.4
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC------CcEEEEec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS------HHIKIIDF 94 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~------~~vkl~df 94 (239)
|++|||+++++|.+++.. ....+++..+..++.|++.||.| |++|++||||||+||+++.+.. +.++|+||
T Consensus 88 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 688999999999999864 23448888999999999999999 9999999999999999955432 12999999
Q ss_pred ccceecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHH
Q psy1096 95 GLAQKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF 173 (239)
Q Consensus 95 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 173 (239)
|.+..... .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|..|+...................+.
T Consensus 166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (289)
T 4fvq_A 166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA--- 239 (289)
T ss_dssp CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---
T ss_pred cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC---
Confidence 98755432 223457889999999987 66899999999999999999955444444333333333333333332
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
..+..+.+++.+||+.||++|||+++++++-
T Consensus 240 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 240 -PKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp -CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 4577899999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=229.87 Aligned_cols=183 Identities=19% Similarity=0.178 Sum_probs=142.0
Q ss_pred EEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.|++|||+++++|.+++.... ....+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE--CCCCCEEEeeccccc
Confidence 468899999999999885432 22368889999999999999999 99999999999999999 777899999999987
Q ss_pred ecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HH----HHhccC--
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF---AN----ITRAEF-- 166 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~---~~----i~~~~~-- 166 (239)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....... .. ......
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 654322 122345889999999998888999999999999999999999999765432211 10 001100
Q ss_pred ----CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 167 ----DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 167 ----~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
..........+..+.+++.+||+.||++|||+++++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000111123467789999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=229.73 Aligned_cols=179 Identities=21% Similarity=0.300 Sum_probs=128.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
..|++|||++ |+|.+++......+.+++..+..++.|++.||.| |+.| ++||||||+||++ +.++.++|+|||+
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTSCEEBCCCTT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCCCEEEecCcc
Confidence 4688999997 6788888766677889999999999999999999 9999 9999999999999 7777999999999
Q ss_pred ceecCCCCCC-------------ccccCCCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q psy1096 97 AQKINPDHPP-------------RVLFGTPEFIPPEII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFAN 160 (239)
Q Consensus 97 ~~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~ 160 (239)
+......... ....+++.|+|||.+ .+..++.++||||+|+++|+|++|..||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 8776543211 134588999999998 556678999999999999999999999976554333222
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
....+. ....+..+.+|+++||+.||++|||+++++++.+-
T Consensus 265 ----~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 265 ----KYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp -----CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ----cccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 222111 13456789999999999999999999999988643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=248.02 Aligned_cols=175 Identities=21% Similarity=0.210 Sum_probs=147.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+.+++|.+++. .++.+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 444 ~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl--~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKA 518 (635)
T ss_dssp EEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCTTHHHH
T ss_pred EEEEEEccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE--eCCCCEEEEEcCCccc
Confidence 468999999999999984 46778999999999999999999 99999999999999999 5667899999999876
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....+++.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+..+.....+ .
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~ 595 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---A 595 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 643321 122346678999999999899999999999999999998 99999999888887777766533222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+++.+||..||++|||++++++
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 67899999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.84 Aligned_cols=178 Identities=15% Similarity=0.157 Sum_probs=142.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++... .+.+++..+..++.|++.||+| |++|++|+||||+||++ +.++.++|+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV--ESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE--CCCCCEEEcccccce
Confidence 467899999999999998643 3468899999999999999999 99999999999999999 566789999999998
Q ss_pred ecCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHH
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---------------ETFA 159 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---------------~~~~ 159 (239)
...... ......+++.|+|||.+.+..++.++||||+|+++|+|++|..||...... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 765432 122345778899999999888899999999999999999999998643221 1111
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..... .+. ...++..+.+++.+||+.||++|||+++++++
T Consensus 256 ~~~~~~~-~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQR-LPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccC-CCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222211 111 13678999999999999999999999999655
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=236.41 Aligned_cols=185 Identities=21% Similarity=0.237 Sum_probs=146.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec--CCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS--RTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~--~~~~~vkl~dfg~ 96 (239)
..|++||||.+++|.+++........+++..+..++.|++.||.| |++||+||||||+||++.. +..+.++|+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 457899999999999999765555669999999999999999999 9999999999999999743 3445799999999
Q ss_pred ceecCCCCCCccccCCCCccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC----CchHHHHHHHhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINY--------EPIGIESDMWSIGVITYVLLSGLSPFMGE----NDSETFANITRA 164 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~~~~g~~p~~~~----~~~~~~~~i~~~ 164 (239)
+.............||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||... ...+....+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 988765555555679999999999865 45678999999999999999999999642 334444444443
Q ss_pred cCC---------------------CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 165 EFD---------------------FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 165 ~~~---------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
... ........++..+.+++.+||+.||++|||+++++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 211 0011113456778899999999999999999998654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=249.21 Aligned_cols=189 Identities=17% Similarity=0.281 Sum_probs=148.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEecccce
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGLAQ 98 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~~~ 98 (239)
.|++||||+|++|.+++........+++..+..++.|++.||.| |+.|++||||||+||+++.++. ..++|+|||.+.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 47889999999999998765555578889999999999999999 9999999999999999954432 348999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---------HHH-----Hhc
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF---------ANI-----TRA 164 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~---------~~i-----~~~ 164 (239)
............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+......+ ..+ ..+
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 877665556678999999999999999999999999999999999999999754321111 000 000
Q ss_pred cC------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 165 EF------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 165 ~~------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.. ..+......++..+.+|+.+||..||++|||++++++|+||+.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00 1111112346788999999999999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=241.68 Aligned_cols=183 Identities=19% Similarity=0.243 Sum_probs=151.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+.+++|.+++... .+..+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--cCCCcEEEccccccee
Confidence 47899999999999998642 34568888999999999999999 99999999999999999 6677899999999876
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..+.....+ ..+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---PEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence 54221 1122346678999999998899999999999999999999 99999998887877777655332211 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc--ccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH--LWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h--~~~~~ 209 (239)
+..+.+|+.+||..||++|||+++|++. .++..
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 8999999999999999999999999864 45554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=224.21 Aligned_cols=181 Identities=19% Similarity=0.258 Sum_probs=142.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++........+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||++..
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLARA 182 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE--cCCCcEEEeecccccc
Confidence 46889999999999998766667789999999999999999999 99999999999999999 7778999999999877
Q ss_pred cCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----HHHHhccCCCc---
Q psy1096 100 INPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF----ANITRAEFDFD--- 169 (239)
Q Consensus 100 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~----~~i~~~~~~~~--- 169 (239)
...... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+....... ..+........
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI 261 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS
T ss_pred cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc
Confidence 653321 223468999999999875 4789999999999999999999999765433221 12111111000
Q ss_pred ----hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 170 ----DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 170 ----~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.......+..+.+++.+||..||.+|||+++++++
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00012345678999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=225.18 Aligned_cols=176 Identities=15% Similarity=0.164 Sum_probs=140.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+++++|.+++.. ..+.+++..+..++.|++.||+| |++|++||||||+||++ +.++.++|+|||.+..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE--cCCCCEEECccccccc
Confidence 5789999999999999863 35668899999999999999999 99999999999999999 5567899999999987
Q ss_pred cCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------Cch-HHHHH
Q psy1096 100 INPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGE--------------NDS-ETFAN 160 (239)
Q Consensus 100 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~--------------~~~-~~~~~ 160 (239)
..... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|+... ... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 65433 223345778899999999888999999999999999999998876321 111 11112
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+.... ..+ ....++..+.+++.+||+.||.+|||++++++
T Consensus 256 ~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LKEGK-RLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHTTC-CCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhccC-CCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22221 111 11357899999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=223.60 Aligned_cols=178 Identities=18% Similarity=0.181 Sum_probs=143.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. .+..+++..+..++.|++.||.| |++|++||||||+||++ + ++.++|+|||++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~--~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY--D-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE--C---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE--e-CCCEEEeecCCcc
Confidence 36789999999999998853 34578889999999999999999 99999999999999999 4 4689999999876
Q ss_pred ecCCC------CCCccccCCCCccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Q psy1096 99 KINPD------HPPRVLFGTPEFIPPEIINY---------EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITR 163 (239)
Q Consensus 99 ~~~~~------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~ 163 (239)
..... .......|++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.+.........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 54311 12223458899999999974 3468899999999999999999999988887777666655
Q ss_pred ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 164 AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
....... ...++..+.+++.+||..||++|||++++++.
T Consensus 258 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 258 GMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp TCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 5432221 12568899999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=224.55 Aligned_cols=181 Identities=21% Similarity=0.305 Sum_probs=138.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh--------cccCCCCCCCCeEEecCCCCcE
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL--------VTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~--------~ivH~dikp~nili~~~~~~~v 89 (239)
...|++|||+++++|.+++.. ..+++..+..++.|++.||.| |++ |++||||||+||++ +.++.+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--~~~~~~ 181 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTC 181 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE--CTTSCE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE--CCCCCE
Confidence 456899999999999999842 368889999999999999999 998 99999999999999 777899
Q ss_pred EEEecccceecCCCCC-----CccccCCCCccCccccccCCCCch------hhHHHHHHHHHHHHhC----------CCC
Q psy1096 90 KIIDFGLAQKINPDHP-----PRVLFGTPEFIPPEIINYEPIGIE------SDMWSIGVITYVLLSG----------LSP 148 (239)
Q Consensus 90 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~------~DiwslG~~l~~~~~g----------~~p 148 (239)
+|+|||++........ .....||+.|+|||.+.+...+.. +||||+||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999999976643322 124569999999999987766544 9999999999999999 777
Q ss_pred CCCCC----chHHHHHHH-hccCC--CchH-HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 149 FMGEN----DSETFANIT-RAEFD--FDDE-AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 149 ~~~~~----~~~~~~~i~-~~~~~--~~~~-~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
|.... ......... ..... .+.. ....++..+.+++.+||+.||++|||+++++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 75432 122222222 12111 1111 1124567799999999999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=231.08 Aligned_cols=189 Identities=21% Similarity=0.269 Sum_probs=135.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh---------cccCCCCCCCCeEEecCCCCcE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL---------VTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~---------~ivH~dikp~nili~~~~~~~v 89 (239)
..|++||||++++|.+++.. ...++..+..++.|++.||.| |+. ||+||||||+||++ +..+.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill--~~~~~~ 159 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KNDGTC 159 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE--CTTSCE
T ss_pred eEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE--cCCCcE
Confidence 35799999999999998843 234777888999999999999 999 99999999999999 777899
Q ss_pred EEEecccceecCCCC---------CCccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy1096 90 KIIDFGLAQKINPDH---------PPRVLFGTPEFIPPEIINY-------EPIGIESDMWSIGVITYVLLSGLSPFMGEN 153 (239)
Q Consensus 90 kl~dfg~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~ 153 (239)
+|+|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997764321 1223469999999999976 345678999999999999999976663321
Q ss_pred c-----------------hHHHHHHHhccC---CCchH--HHhhcCHHHHHHHHHhhhhCcccCCCHHHHh------hcc
Q psy1096 154 D-----------------SETFANITRAEF---DFDDE--AFEALSEDAKDFISSLLVKRKEKRLTAKQCL------SHL 205 (239)
Q Consensus 154 ~-----------------~~~~~~i~~~~~---~~~~~--~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll------~h~ 205 (239)
. ............ ..+.. .....+..+.+|+.+||..||++|||+++++ .++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 111111111111 11100 0011345799999999999999999999994 467
Q ss_pred ccccCCCCC
Q psy1096 206 WIAQKDSSP 214 (239)
Q Consensus 206 ~~~~~~~~~ 214 (239)
|-++....+
T Consensus 320 ~~~~~~~~~ 328 (336)
T 3g2f_A 320 WERNKSVSP 328 (336)
T ss_dssp CCC------
T ss_pred HHhcccCCC
Confidence 776644443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=224.64 Aligned_cols=185 Identities=17% Similarity=0.171 Sum_probs=142.8
Q ss_pred EEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhh---cccCCCCCCCCeEEecCCCCcEEEEecc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSL---VTVDPKILPENIMCVSRTSHHIKIIDFG 95 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~---~ivH~dikp~nili~~~~~~~vkl~dfg 95 (239)
.|++|||+.+++|.+++.... ....+++..+..++.|++.||.| |++ |++||||||+||++ +.++.++|+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE--CTTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE--CCCCCEEeccCc
Confidence 368899999999999987543 23458899999999999999999 999 99999999999999 777899999999
Q ss_pred cceecCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCchHHHHHHHhccC--
Q psy1096 96 LAQKINPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-----ENDSETFANITRAEF-- 166 (239)
Q Consensus 96 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-----~~~~~~~~~i~~~~~-- 166 (239)
++........ .....||+.|+|||.+.+..++.++||||+|+++|+|++|..||.. .........+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9987653322 2234589999999999888899999999999999999999999951 111111111111000
Q ss_pred --------CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 167 --------DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 167 --------~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..........+..+.+++.+||+.||.+|||+++++++..-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000112335678999999999999999999999988643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.60 Aligned_cols=177 Identities=16% Similarity=0.181 Sum_probs=147.5
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+++++|.+++.. .+..+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl--~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE--eCCCCEEEEecCCCee
Confidence 4789999999999998863 34568889999999999999999 99999999999999999 5567999999999877
Q ss_pred cCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+........+ ..+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---PNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC---TTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC---ccc
Confidence 6543221 22346678999999998899999999999999999997 99999988888877777665433222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+++.+||..||++|||++++++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999999999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=223.29 Aligned_cols=175 Identities=16% Similarity=0.136 Sum_probs=140.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ..+++..+..++.|++.||.+ |+.|++|+||||+||++ +.++.++|+|||.+.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL--DNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCGGGCE
T ss_pred eEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE--cCCCCEEECCccccc
Confidence 46789999999999998742 348889999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDS---------------ETFA 159 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~---------------~~~~ 159 (239)
....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 7654321 22345778899999999888999999999999999999999998643211 1111
Q ss_pred HHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 160 NITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 160 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+........ ...++..+.+|+++||+.||++|||++++++
T Consensus 263 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPR---PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCC---CccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1122211111 1357899999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=232.56 Aligned_cols=181 Identities=13% Similarity=0.068 Sum_probs=139.0
Q ss_pred EEeeCccCCCCccchhhhhhh--cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec---------CCCCc
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK--AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS---------RTSHH 88 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~---------~~~~~ 88 (239)
.|+|||||++|+|.+++.... .+..+++..+..++.|++.||+| |++||+||||||+||+++. +..+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 478999999999999997543 45779999999999999999999 9999999999999999943 11689
Q ss_pred EEEEecccceecCC---CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Q psy1096 89 IKIIDFGLAQKINP---DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAE 165 (239)
Q Consensus 89 vkl~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~ 165 (239)
++|+|||++..... ........||+.|+|||.+.+..++.++||||+||++|+|++|..||......... ....
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~ 298 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEGL 298 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECSC
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---echh
Confidence 99999999976542 22233456999999999999999999999999999999999999999543221100 0011
Q ss_pred CCCchHHHhhcCHHHHHHHHHhhhhCcccCCC-HHHHhh--cccccc
Q psy1096 166 FDFDDEAFEALSEDAKDFISSLLVKRKEKRLT-AKQCLS--HLWIAQ 209 (239)
Q Consensus 166 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt-~~~ll~--h~~~~~ 209 (239)
.... ..+..+.+++..||+.+|.+|++ ++++.+ ..|+.+
T Consensus 299 ~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 299 FRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp CTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 1100 23567889999999999999975 444433 245543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=221.45 Aligned_cols=183 Identities=17% Similarity=0.227 Sum_probs=142.9
Q ss_pred eEEEeeCccCCCCccchhhhhhh-cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMK-AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
...|++|||+.+++|.+++.... .+..+++..+..++.|++.||.| |++|++||||||+||++ +.++.++|+|||.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--cCCCCEEEEecCc
Confidence 36689999999999999887543 35778999999999999999999 99999999999999999 7778899999998
Q ss_pred ceecCCCCCC----------ccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCC--CchHHHHHH
Q psy1096 97 AQKINPDHPP----------RVLFGTPEFIPPEIINYEP---IGIESDMWSIGVITYVLLSGLSPFMGE--NDSETFANI 161 (239)
Q Consensus 97 ~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~~--~~~~~~~~i 161 (239)
+......... ....|++.|+|||.+.+.. ++.++||||+|+++|+|++|..||... ........+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 7654321110 1234789999999997654 588999999999999999999999531 111111222
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccc
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~ 206 (239)
.. ....+. ...++..+.+++.+||+.||.+|||+++++++..
T Consensus 261 ~~-~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 261 QN-QLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HC-C--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hc-cCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 22 222221 1357899999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=223.66 Aligned_cols=179 Identities=18% Similarity=0.242 Sum_probs=140.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h--------hhcccCCCCCCCCeEEecCCCCcEE
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H--------SLVTVDPKILPENIMCVSRTSHHIK 90 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h--------~~~ivH~dikp~nili~~~~~~~vk 90 (239)
..|++|||+++++|.+++.. ..+++..+..++.|++.||.| | +.|++||||||+||++ +.++.++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE--CTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE--CCCCCEE
Confidence 57899999999999999853 368889999999999999999 9 8999999999999999 7778999
Q ss_pred EEecccceecCCCC-----CCccccCCCCccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCC
Q psy1096 91 IIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINYEP------IGIESDMWSIGVITYVLLSG----------LSPF 149 (239)
Q Consensus 91 l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~~g----------~~p~ 149 (239)
|+|||++....... ......|++.|+|||.+.+.. ++.++||||+|+++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997765433 223456999999999997653 23789999999999999999 7888
Q ss_pred CCCCc-----hHHHHHHHhccCCCc--hH-HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 150 MGEND-----SETFANITRAEFDFD--DE-AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 150 ~~~~~-----~~~~~~i~~~~~~~~--~~-~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..... ......+........ .. .....+..+.+++.+||..||++|||+++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 65432 222333322222211 11 011334678999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=220.76 Aligned_cols=177 Identities=13% Similarity=0.136 Sum_probs=140.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+++++|.+++.. ....+++..+..++.|++.||.+ |+.|++||||||+||++ +.++.++|+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli--~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--ENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE--cCCCcEEEecCcchh
Confidence 35789999999999999863 34568889999999999999999 99999999999999999 556789999999998
Q ss_pred ecCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------------h----HHH
Q psy1096 99 KINPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGEND------------S----ETF 158 (239)
Q Consensus 99 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~------------~----~~~ 158 (239)
....... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||..... . ...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 7654322 2223466789999999888889999999999999999999998853210 0 011
Q ss_pred HHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 159 ANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.... ..+. ...++..+.+++++||..||++|||++++++
T Consensus 274 ~~~~~~~-~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNG-RLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTC-CCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCC-CCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122111 1111 1357899999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=224.09 Aligned_cols=176 Identities=10% Similarity=0.093 Sum_probs=136.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h-hhcccCCCCCCCCeEEecCC-----------
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-H-SLVTVDPKILPENIMCVSRT----------- 85 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h-~~~ivH~dikp~nili~~~~----------- 85 (239)
-..|+|||||.+|++.+.+. .+.+++..+..++.||+.||.| | ++||+||||||+||+++.++
T Consensus 135 ~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 135 DQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred CeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 35789999999997766653 2568899999999999999999 9 99999999999999995543
Q ss_pred -------CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCc-hH
Q psy1096 86 -------SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVI-TYVLLSGLSPFMGEND-SE 156 (239)
Q Consensus 86 -------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~-l~~~~~g~~p~~~~~~-~~ 156 (239)
...+||+|||++...... ...||+.|+|||.+.+.. +.++||||++++ .+++++|..||.+... ..
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~ 285 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH
T ss_pred cccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH
Confidence 128999999999876532 347999999999998776 899999998766 6778889999853211 11
Q ss_pred HHHHHHh---ccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHh-hccccc
Q psy1096 157 TFANITR---AEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL-SHLWIA 208 (239)
Q Consensus 157 ~~~~i~~---~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll-~h~~~~ 208 (239)
....+.. ............+++.+.+|+++||+.| |++++| +||||+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 2222221 1222233445578899999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=229.30 Aligned_cols=166 Identities=22% Similarity=0.285 Sum_probs=134.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||++|++|.+++. ..+++..+..++.||+.||.| |++||+||||||+||++ +. +.++|+|||++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll--~~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML--TE-EQLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CS-SCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE--eC-CcEEEEecccchh
Confidence 689999999999998763 278899999999999999999 99999999999999999 43 3799999999987
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 179 (239)
.... ....||+.|+|||.+.+. ++.++||||+||++++|++|..||.+..... .. ........+..
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~-~~~~~~~~~~~ 296 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP-EDDPVLKTYDS 296 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC-TTCHHHHHCHH
T ss_pred cccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------cc-ccccccccCHH
Confidence 6543 445699999999999765 4889999999999999999999986532110 00 11112245788
Q ss_pred HHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 180 AKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 180 ~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
+.+++.+||+.||++||+..+.+.|+|..
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999988888887763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-29 Score=198.15 Aligned_cols=151 Identities=12% Similarity=0.015 Sum_probs=118.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+||||++|++|.+++. .+. ....+..++.|++.||.| |++||+||||||+||++ +.+|.++|++++
T Consensus 105 ~~~lv~e~~~g~~L~~~l~----~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll--~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVAD----TSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV--SIDGDVVLAYPA--- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHT----TCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--ETTSCEEECSCC---
T ss_pred cEEEEEEecCCCCHHHHHh----cCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE--cCCCCEEEEecc---
Confidence 4678999999999999873 233 444678899999999999 99999999999999999 666788887433
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFA---NITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~ 175 (239)
|++ .++.++||||+||++|+|++|..||.+.+...... .........+......
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 222 36889999999999999999999998766533221 1112222222333456
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
++..+.+++.+||+.||++| |++++++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 89999999999999999999 99999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-26 Score=197.18 Aligned_cols=118 Identities=19% Similarity=0.178 Sum_probs=84.2
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
-..|+|||||+|++|.+++. .++.++++ +|+.||+.||+| |++|||||||||+|||+ +.+|.+||+|||++
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL--~~dg~vKL~DFGlA 386 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV--DARQHARLIDFGSI 386 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE--CTTSCEEECCCTTE
T ss_pred CEEEEEEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE--CCCCCEEEeecccC
Confidence 36899999999999999994 45666653 589999999999 99999999999999999 77789999999999
Q ss_pred eecCCC-CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q psy1096 98 QKINPD-HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG 145 (239)
Q Consensus 98 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g 145 (239)
+..... ....+.+||+.|++||.+.+. +..++|+||+|++.+.+.++
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred eeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 776543 334456799999999999754 56789999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=9.9e-20 Score=156.83 Aligned_cols=113 Identities=18% Similarity=0.186 Sum_probs=94.9
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
|++|||++|++|.+++.. +..++.|++.||.| |++||+||||||+||++ +. .++|+|||+++..
T Consensus 415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl--~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF--DK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE--SS--SEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE--CC--eEEEEECccCEEC
Confidence 789999999999998753 56899999999999 99999999999999999 44 8999999999887
Q ss_pred CCCCC--------CccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q psy1096 101 NPDHP--------PRVLFGTPEFIPPEIINY--EPIGIESDMWSIGVITYVLLSGLSPF 149 (239)
Q Consensus 101 ~~~~~--------~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~ 149 (239)
..... .....||+.|+|||.+.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 54321 124579999999999976 56778889999888777777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=9e-16 Score=121.76 Aligned_cols=77 Identities=16% Similarity=0.060 Sum_probs=63.1
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||++|++|.+ +. . .....++.|++.||.+ |++||+||||||+||++ + ++.++|+|||++..
T Consensus 175 ~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl--~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 175 NAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV--S-EEGIWIIDFPQSVE 241 (282)
T ss_dssp TEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--E-TTEEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE--E-CCcEEEEECCCCeE
Confidence 378999999999997 31 1 2345799999999999 99999999999999999 4 78999999999864
Q ss_pred cCCCCCCccccCCCCccCccccc
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIIN 122 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~ 122 (239)
. ..+.|||.+.
T Consensus 242 ~------------~~~~a~e~l~ 252 (282)
T 1zar_A 242 V------------GEEGWREILE 252 (282)
T ss_dssp T------------TSTTHHHHHH
T ss_pred C------------CCCCHHHHHH
Confidence 3 2356777763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1e-12 Score=102.83 Aligned_cols=70 Identities=17% Similarity=0.096 Sum_probs=55.3
Q ss_pred EEeeCccCCC-C----ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-h-hhcccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 21 TWSSPPYDGG-C----MITGYVVEMKAGTQPWVELSERLFESTERGLGH-H-SLVTVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 21 ~~~~~e~~~~-~----~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h-~~~ivH~dikp~nili~~~~~~~vkl~d 93 (239)
.++||||+++ | .|.++... .++..+..++.|++.||.+ | +.|++||||||+||++ +. .++|+|
T Consensus 143 ~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl--~~--~~~liD 212 (258)
T 1zth_A 143 NVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY--ID--KVYFID 212 (258)
T ss_dssp TEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE--SS--SEEECC
T ss_pred CEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE--cC--cEEEEE
Confidence 3689999953 4 44433221 2345678999999999999 9 9999999999999999 44 799999
Q ss_pred cccceec
Q psy1096 94 FGLAQKI 100 (239)
Q Consensus 94 fg~~~~~ 100 (239)
||++...
T Consensus 213 FG~a~~~ 219 (258)
T 1zth_A 213 MGQAVTL 219 (258)
T ss_dssp CTTCEET
T ss_pred CcccccC
Confidence 9998664
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-10 Score=95.81 Aligned_cols=70 Identities=9% Similarity=-0.085 Sum_probs=55.6
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCC--------cEEEE
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSH--------HIKII 92 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~--------~vkl~ 92 (239)
++||||++|..+..+... .....++.|++.+|.+ |++|+|||||||.|||+..++.+ .+.++
T Consensus 187 ~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iI 257 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIII 257 (397)
T ss_dssp EEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEEC
T ss_pred eEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEE
Confidence 589999999998765421 2346789999999999 99999999999999999655432 37899
Q ss_pred ecccceec
Q psy1096 93 DFGLAQKI 100 (239)
Q Consensus 93 dfg~~~~~ 100 (239)
||+-+...
T Consensus 258 D~~Q~V~~ 265 (397)
T 4gyi_A 258 XFPQMVSM 265 (397)
T ss_dssp CCTTCEET
T ss_pred EeCCcccC
Confidence 99866543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.19 E-value=8.9e-07 Score=70.50 Aligned_cols=79 Identities=20% Similarity=0.286 Sum_probs=48.4
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccccCCCCc---cCcccccc-----C---------CCCchh
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEF---IPPEIINY-----E---------PIGIES 130 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~---~aPE~~~~-----~---------~~~~~~ 130 (239)
.++|||+++.||+++.+.++.+.++||+.+....+.. ........ ..++.... . ......
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~ 268 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKE 268 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHH
Confidence 5799999999999954335568899999876543210 00000011 12222110 0 012236
Q ss_pred hHHHHHHHHHHHHhCCCCC
Q psy1096 131 DMWSIGVITYVLLSGLSPF 149 (239)
Q Consensus 131 DiwslG~~l~~~~~g~~p~ 149 (239)
+.|+++.++|.+.+|..+|
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 8899999999999997776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.16 E-value=3.2e-06 Score=68.84 Aligned_cols=75 Identities=11% Similarity=0.134 Sum_probs=57.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh--------------------------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-------------------------------- 66 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-------------------------------- 66 (239)
..|++|||++|..+.+.. ...++.+....++.++..+|+. |+
T Consensus 115 ~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp SCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 467899999999886422 2235667777888888888888 86
Q ss_pred --------------------------hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 67 --------------------------LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 67 --------------------------~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
..++|||+++.||+++.++...+.++||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 469999999999999544333468999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2.2e-06 Score=66.55 Aligned_cols=69 Identities=17% Similarity=0.124 Sum_probs=50.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh--------------------------------
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-------------------------------- 66 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-------------------------------- 66 (239)
..|++|||++|.++.+... .......++.++..+|+. |+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred ceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 4689999999999876521 112234667777777777 87
Q ss_pred ---------------------------hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 ---------------------------LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ---------------------------~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++|||+++.||++ +.++.+.++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhcc
Confidence 568999999999999 444456799998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=9.8e-06 Score=62.56 Aligned_cols=30 Identities=23% Similarity=0.202 Sum_probs=24.2
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.++|||++|.||++ +.++.+.++||+.+..
T Consensus 185 ~l~HgDl~~~Nil~--~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 185 VVTHGDACLPNIMV--ENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EEECSSCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred EEECCCCCCCcEEE--ECCcEEEEEcchhccc
Confidence 49999999999999 4445567999997643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0009 Score=50.08 Aligned_cols=121 Identities=11% Similarity=-0.029 Sum_probs=75.2
Q ss_pred ccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH--hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecCCCCCCccc
Q psy1096 32 MITGYVVEMKAGTQPWVELSERLFESTERGLGH--HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVL 109 (239)
Q Consensus 32 ~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~--h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~~~~~~~~~ 109 (239)
+|.++|. ..+..++++++=.++.|.+.+|.- +.+.-...=+.|..|++ ..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l--~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV--WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE--ETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE--ecCCceeccc-cccc-----------
Confidence 4667776 668899999999999999998766 22222223334678888 5566666553 1110
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhh
Q psy1096 110 FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189 (239)
Q Consensus 110 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 189 (239)
.....+.+||... ...+.+.-|||||+++|..+.-..|-. ....+++.+.+||..|..
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~---------------------eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN---------------------EERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT---------------------EEECCCHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc---------------------cchhhCHHHHHHHHHHHh
Confidence 1223456777663 345678899999999999886433311 113578888999988875
Q ss_pred h
Q psy1096 190 K 190 (239)
Q Consensus 190 ~ 190 (239)
.
T Consensus 156 ~ 156 (229)
T 2yle_A 156 T 156 (229)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.002 Score=51.11 Aligned_cols=32 Identities=22% Similarity=0.312 Sum_probs=24.1
Q ss_pred cccCCCCCCCCeEEecC--CCCcEEEEeccccee
Q psy1096 68 VTVDPKILPENIMCVSR--TSHHIKIIDFGLAQK 99 (239)
Q Consensus 68 ~ivH~dikp~nili~~~--~~~~vkl~dfg~~~~ 99 (239)
.++|+|+++.||++..+ .+..+.++||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 57999999999999431 133458999987654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0086 Score=48.31 Aligned_cols=32 Identities=9% Similarity=0.118 Sum_probs=25.4
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
...++|+|+.+.||+++ .++.+.++||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~--~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYR--DFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEE--TTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEe--CCcEEEEEccccccc
Confidence 35799999999999994 444578999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.04 Score=43.83 Aligned_cols=29 Identities=14% Similarity=0.097 Sum_probs=24.8
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..++|||+++.||++ +.++.+.++||+.+
T Consensus 222 ~~l~HgD~~~~Nil~--~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL--GENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEE--CGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEE--eCCCcEEEEehhhc
Confidence 469999999999999 54567999999865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.54 E-value=0.04 Score=45.59 Aligned_cols=33 Identities=9% Similarity=0.122 Sum_probs=26.8
Q ss_pred hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 65 h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+...++|||+++.||++ +.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~--~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMV--TQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEE--CSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEE--eCCC-CEEEeCcccccC
Confidence 46689999999999999 4444 999999877543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.97 E-value=0.095 Score=41.69 Aligned_cols=36 Identities=19% Similarity=0.272 Sum_probs=27.3
Q ss_pred hhhcccCCCCCCCCeEEecCC--CCcEEEEecccceec
Q psy1096 65 HSLVTVDPKILPENIMCVSRT--SHHIKIIDFGLAQKI 100 (239)
Q Consensus 65 h~~~ivH~dikp~nili~~~~--~~~vkl~dfg~~~~~ 100 (239)
+...++|||+.+.||++..+. .+.+.++||+.+...
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 345799999999999994321 257899999977543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=92.41 E-value=0.049 Score=41.88 Aligned_cols=31 Identities=19% Similarity=0.205 Sum_probs=24.8
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
..++|||+.+.||++ +.++.+-|+||+.+..
T Consensus 193 ~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 193 SVVTHGDFSLDNLIF--DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEE--ECCeEEEEEECccccc
Confidence 358999999999999 5555677999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.66 E-value=0.062 Score=42.46 Aligned_cols=30 Identities=17% Similarity=0.269 Sum_probs=24.1
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+++|+|+.+.||++ +.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFF--LGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEE--eCCceEEEecchhcc
Confidence 579999999999999 444455799998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.20 E-value=0.19 Score=39.69 Aligned_cols=29 Identities=17% Similarity=0.249 Sum_probs=23.8
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
..++|||+++.||++ ++ .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~--~~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILW--RD--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEE--SS--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeE--cC--CCEEEECCCCCc
Confidence 468999999999999 42 789999986533
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=89.10 E-value=0.52 Score=38.38 Aligned_cols=32 Identities=16% Similarity=0.167 Sum_probs=25.2
Q ss_pred hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 65 h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+...++|||+.+.||++ +.+ .+.++||..+..
T Consensus 225 ~~~~L~HGDl~~~Nil~--~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 225 SAETLIHGDLHTGSIFA--SEH-ETKVIDPEFAFY 256 (397)
T ss_dssp BCCEEECSCCSGGGEEE--CSS-CEEECCCTTCEE
T ss_pred CCCceeeCCCCcCcEEE--eCC-CeEEEeCccccc
Confidence 45689999999999999 333 488999976643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.92 E-value=0.27 Score=39.30 Aligned_cols=31 Identities=23% Similarity=0.295 Sum_probs=25.6
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
..++|+|+.+.||++ +.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~--~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLV--GNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEE--CGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEE--eCCCeEEEEECCCCee
Confidence 469999999999999 5455789999986644
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.61 E-value=0.56 Score=37.80 Aligned_cols=29 Identities=21% Similarity=0.421 Sum_probs=23.2
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++|+|+.+.||++ +.+ .+.++||..+.
T Consensus 212 ~~l~HgDl~~~Nil~--~~~-~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIIN--TNK-CLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEE--CC--CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEe--cCC-cEEEEEecCCC
Confidence 469999999999998 443 48999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.16 E-value=0.58 Score=39.18 Aligned_cols=16 Identities=25% Similarity=0.389 Sum_probs=14.4
Q ss_pred hcccCCCCCCCCeEEe
Q psy1096 67 LVTVDPKILPENIMCV 82 (239)
Q Consensus 67 ~~ivH~dikp~nili~ 82 (239)
..++|+|+.+.||++.
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 4699999999999995
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.89 E-value=0.46 Score=39.40 Aligned_cols=18 Identities=11% Similarity=0.119 Sum_probs=15.0
Q ss_pred hcccCCCCCCCCeEEecC
Q psy1096 67 LVTVDPKILPENIMCVSR 84 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~ 84 (239)
..++|+|+.+.||++..+
T Consensus 249 ~v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEEECSCCCGGGEEEEC-
T ss_pred eEEEeCCCCCCeEEeeCC
Confidence 469999999999999553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=86.55 E-value=0.68 Score=36.09 Aligned_cols=31 Identities=19% Similarity=0.246 Sum_probs=24.1
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
...++|+|+.+.||+. + ++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil~--~-~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFLD--T-GERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEEE--C-SSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEEE--C-CCCEEEEecccccC
Confidence 3469999999999994 3 34679999987644
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.24 E-value=0.65 Score=37.86 Aligned_cols=34 Identities=21% Similarity=0.366 Sum_probs=26.0
Q ss_pred hhcccCCCCCCCCeEEecC--CCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSR--TSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~--~~~~vkl~dfg~~~~ 99 (239)
...++|+|+.+.||++..+ ..+.+.++||..+..
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3479999999999999554 236789999987643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 239 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-24 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-21 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-21 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-20 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-20 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-20 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-19 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-19 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-19 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-19 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-19 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-18 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-18 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-17 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-15 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-14 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-11 | |
| d1x5ga1 | 103 | b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [ | 1e-05 | |
| d2crza1 | 97 | b.1.2.1 (A:8-104) Fibronectin type-III domain cont | 2e-05 | |
| d2dtge2 | 196 | b.1.2.1 (E:593-807) Insulin receptor {Human (Homo | 4e-05 | |
| d1x5fa1 | 107 | b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [ | 5e-05 | |
| d1x5ya1 | 98 | b.1.2.1 (A:8-105) Myosin binding protein C, fast-t | 5e-05 | |
| d2dtge3 | 125 | b.1.2.1 (E:468-592) Insulin receptor {Human (Homo | 6e-05 | |
| d1x4za1 | 108 | b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) { | 6e-05 | |
| d1wf5a1 | 108 | b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens) | 9e-05 | |
| d1uema_ | 117 | b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens | 1e-04 | |
| d1f6fb2 | 103 | b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattu | 3e-04 | |
| d1x5la1 | 98 | b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human | 4e-04 | |
| d1x3da1 | 105 | b.1.2.1 (A:8-112) Fibronectin type-III domain cont | 5e-04 | |
| d1cd9b1 | 107 | b.1.2.1 (B:1-107) Granulocyte colony-stimulating f | 0.001 | |
| d2dn7a1 | 94 | b.1.2.1 (A:8-101) Receptor-type tyrosine-protein p | 0.001 | |
| d1wfna1 | 106 | b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens) | 0.001 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.001 | |
| d1va9a1 | 109 | b.1.2.1 (A:8-116) Down syndrome cell adhesion mole | 0.003 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (358), Expect = 2e-41
Identities = 68/165 (41%), Positives = 100/165 (60%), Gaps = 1/165 (0%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
+ PENIM ++ S+ +K+IDFGL ++P +V GT EF PE+ +P+G +DMW
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
S+GV++Y+LLSGLSPF GEND ET N+ +++ DD AF +SED KDFI LL+
Sbjct: 210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269
Query: 194 KRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFSR 238
R+T Q L H W+ ++PG + I + + K K ++
Sbjct: 270 TRMTIHQALEHPWL-TPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-40
Identities = 81/165 (49%), Positives = 108/165 (65%), Gaps = 2/165 (1%)
Query: 64 HHSLVTVDPKILPENIMCVSR--TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII 121
HSL + PENIM + R IKIIDFGLA KI+ + + +FGTPEF+ PEI+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 122 NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
NYEP+G+E+DMWSIGVITY+LLSG SPF+G+ ET AN++ ++F+DE F S AK
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 182 DFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLK 226
DFI LLVK +KR+T + L H WI KD+ ++ S + +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-40
Identities = 66/164 (40%), Positives = 102/164 (62%), Gaps = 1/164 (0%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYE 124
HS I PENI+ +R S IKII+FG A+++ P R+LF PE+ PE+ ++
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFI 184
+ +DMWS+G + YVLLSG++PF+ E + + NI AE+ FD+EAF+ +S +A DF+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 185 SSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKY 228
LLVK ++ R+TA + L H W+ ++ K+I T K ++Y
Sbjct: 239 DRLLVKERKSRMTASEALQHPWL-KQKIERVSTKVIRTLKHRRY 281
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 1e-39
Identities = 61/164 (37%), Positives = 91/164 (55%), Gaps = 1/164 (0%)
Query: 73 KILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESD 131
+ PEN++ S I I DFGL++ +P GTP ++ PE++ +P D
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191
Query: 132 MWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKR 191
WSIGVI Y+LL G PF END++ F I +AE++FD ++ +S+ AKDFI L+ K
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 192 KEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQ 235
EKR T +Q L H WIA + ++++KK + KW+
Sbjct: 252 PEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWK 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (336), Expect = 4e-38
Identities = 75/147 (51%), Positives = 103/147 (70%), Gaps = 1/147 (0%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PENIMC ++ + +KIIDFGLA K+NPD +V T EF PEI++ EP+G +DMW+I
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ YVLLSGLSPF GE+D ET N+ R +++FD++AF ++S +AKDFI +LL K KR
Sbjct: 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 274
Query: 196 LTAKQCLSHLWIAQKDSSPGVNKIIST 222
LT L H W+ + D S ++I S+
Sbjct: 275 LTVHDALEHPWL-KGDHSNLTSRIPSS 300
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-35
Identities = 53/155 (34%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
L + HS + I PEN++ S + +KI DFG + P L GT +++PP
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 173
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178
E+I + D+WS+GV+ Y L G PF ET+ I+R EF F D ++E
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTE 229
Query: 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213
A+D IS LL +R ++ L H WI +SS
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWI-TANSS 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (311), Expect = 5e-35
Identities = 49/142 (34%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII------NYEPIG 127
+ PENI+ +IK+ DFG + +++P R + GTP ++ PEII N+ G
Sbjct: 136 LKPENILLDD--DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 193
Query: 128 IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSL 187
E DMWS GVI Y LL+G PF I + F ++ S+ KD +S
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 188 LVKRKEKRLTAKQCLSHLWIAQ 209
LV + +KR TA++ L+H + Q
Sbjct: 254 LVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 8e-32
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 40 MKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99
K G+ E H + + PENI+ HI+I DFG A+
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKV 157
Query: 100 INPDHPPRV---LFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE 156
++P+ GT +++ PE++ + SD+W++G I Y L++GL PF N+
Sbjct: 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
Query: 157 TFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
F I + E+DF ++ A+D + LLV KRL ++ + +
Sbjct: 218 IFQKIIKLEYDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-31
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 59 ERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPD-HPPRVLFGTPEFIP 117
R G H+++ D + P N+ ++K+ DFGLA+ +N D + GTP ++
Sbjct: 127 RRSDGGHTVLHRD--LKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 118 PEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
PE +N +SD+WS+G + Y L + + PF + E I +F + S
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY---S 239
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
++ + I+ +L + R + ++ L + I
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-30
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYE-----PIG 127
+ NI+ IK+ DFG++ K R F GTP ++ PE++ E P
Sbjct: 136 LKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 128 IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSL 187
++D+WS+G+ + P N I ++E + S + KDF+
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRWSSNFKDFLKKC 252
Query: 188 LVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDK 224
L K + R T Q L H ++ DS+ + ++I+ K
Sbjct: 253 LEKNVDARWTTSQLLQHPFV-TVDSNKPIRELIAEAK 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 4e-30
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 16/182 (8%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
+GL + HS + + NI+ +K+ DFG A + P + GTP ++ P
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPAN---SFVGTPYWMAP 180
Query: 119 EII---NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175
E+I + + D+WS+G+ L P N +I + E
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-- 238
Query: 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDK-----LKKYIY 230
SE ++F+ S L K + R T++ L H ++ ++ + +I K L Y
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
Query: 231 RR 232
R+
Sbjct: 299 RK 300
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-30
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 5/167 (2%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR-VLFGTPEFIP 117
+ L HS + I +NI+ +K+ DFG +I P+ R + GTP ++
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 118 PEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
PE++ + G + D+WS+G++ ++ G P++ EN I + + E LS
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS 243
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDK 224
+DF++ L EKR +AK+ L H ++ + +I+ K
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-29
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 6/161 (3%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSH-HIKIIDFGLAQKINPDHPPRVLFGTPEFIP 117
+ + HS+ + PEN++ S+ + +K+ DFG A++ + TP ++
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
Query: 118 PEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSET----FANITRAEFDFDDEAF 173
PE++ E DMWS+GVI Y+LL G PF + I +++F + +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
+SE+ K I +LL +R+T + ++H WI Q P
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-28
Identities = 28/133 (21%), Positives = 60/133 (45%), Gaps = 6/133 (4%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
+NI ++ + +KI D GLA + + + GTPEF+ PE+ E D+++
Sbjct: 142 CDNIF-ITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAF 198
Query: 136 GVITYVLLSGLSPFMGE-NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEK 194
G+ + + P+ N ++ + +T + + + K+ I + + K++
Sbjct: 199 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDE 256
Query: 195 RLTAKQCLSHLWI 207
R + K L+H +
Sbjct: 257 RYSIKDLLNHAFF 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-28
Identities = 36/162 (22%), Positives = 70/162 (43%), Gaps = 8/162 (4%)
Query: 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF- 110
R F G+ + H + I PEN++ R ++KI DFGLA ++ R+L
Sbjct: 107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNK 164
Query: 111 --GTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167
GT ++ PE++ D+WS G++ +L+G P+ +DS + + +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
+ + ++ + + +LV+ R+T W +
Sbjct: 225 YLNP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-27
Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 20/162 (12%)
Query: 49 ELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV 108
++ E + G+ H + ENI+ + +K+IDFG + D
Sbjct: 118 QVLEAVRHCHNCGVLHRDIK-------DENIL-IDLNRGELKLIDFGSG-ALLKDTVYTD 168
Query: 109 LFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFD 167
GT + PPE I Y G + +WS+G++ Y ++ G PF + I R +
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF 222
Query: 168 FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
F +S + + I L R R T ++ +H W+
Sbjct: 223 FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-26
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEI 120
L +V D K +NI+ HIKI DFG+ ++ F GTP++I PEI
Sbjct: 119 LHSKGIVYRDLK--LDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 121 INYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDA 180
+ + D WS GV+ Y +L G SPF G+++ E F +I + L ++A
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEA 230
Query: 181 KDFISSLLVKRKEKRLTAK-QCLSHLWIAQKD 211
KD + L V+ EKRL + H + +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-25
Identities = 35/191 (18%), Positives = 63/191 (32%), Gaps = 43/191 (22%)
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINY 123
+ + P NI+ SR IK+ DFG++ ++ D GT ++ PE +
Sbjct: 121 REKHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQG 177
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE--------- 174
++SD+WS+G+ + G P + E E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 175 -------------------------------ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203
S + +DF++ L+K +R KQ +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 204 HLWIAQKDSSP 214
H +I + D+
Sbjct: 298 HAFIKRSDAEE 308
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.8 bits (248), Expect = 1e-25
Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
+ PENI+ HIKI DFG A+ + L GTP++I PE+++ +P D W
Sbjct: 130 LKPENILLDKNG--HIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 134 SIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKE 193
S G++ Y +L+G +PF N +T+ I AE F +ED KD +S L+ +
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDLLSRLITRDLS 241
Query: 194 KRL-----TAKQCLSHLWIAQKD 211
+RL + +H W +
Sbjct: 242 QRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 4e-25
Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 26/172 (15%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
RGL HS V + P+NI+ S S IK+ DFGLA+ + + T + P
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAF----- 173
E++ D+WS+G I + F G +D + I +E +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 174 ------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ E KD + L KR++A LSH +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 7e-25
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 12/144 (8%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF-GTPEFIPPEIINYEPIGIESDM 132
I EN+M HIKI DFGL ++ D F GTPE++ PE++ G D
Sbjct: 131 IKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 133 WSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
W +GV+ Y ++ G PF ++ F I E F LS +AK ++ LL K
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 193 EKRL-----TAKQCLSHLWIAQKD 211
++RL AK+ + H + +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-24
Identities = 40/207 (19%), Positives = 70/207 (33%), Gaps = 29/207 (14%)
Query: 31 CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHI 89
V+ + T +GL + H + + P N++ + +
Sbjct: 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVL 139
Query: 90 KIIDFGLAQKIN-PDHPPRVLFGTPEFIPPEIIN-YEPIGIESDMWSIGVITYVLLSGLS 147
K+ DFGLA+ P+ T + PE++ G+ DMW++G I LL +
Sbjct: 140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 148 PFMGENDSETFANITRAEFDFDDE------------------------AFEALSEDAKDF 183
G++D + I +E F A +D D
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 184 ISSLLVKRKEKRLTAKQCLSHLWIAQK 210
I L + R+TA Q L + + +
Sbjct: 260 IQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 2e-24
Identities = 31/145 (21%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLA---QKINPDHPPRVLFGTPEFIPPEIINYE---PIG 127
+ NI +KI DFGLA + + H L G+ ++ PE+I + P
Sbjct: 130 LKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 128 IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--EAFEALSEDAKDFIS 185
+SD+++ G++ Y L++G P+ N+ + + + D + + K ++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247
Query: 186 SLLVKRKEKRLTAKQCLSHLWIAQK 210
L K++++R Q L+ + + +
Sbjct: 248 ECLKKKRDERPLFPQILASIELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 94.8 bits (235), Expect = 6e-24
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 2/136 (1%)
Query: 74 ILPENIMCVSRTSHHIK--IIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESD 131
+ P NIM + + + I +A N + GT +++ PE + + SD
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 196
Query: 132 MWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKR 191
++S+G + Y +L+G PF G++ R + E LS D + L K
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 192 KEKRLTAKQCLSHLWI 207
E R + +
Sbjct: 257 PENRYQTAAEMRADLV 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 3e-22
Identities = 32/175 (18%), Positives = 55/175 (31%), Gaps = 37/175 (21%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPD-----HPPRVLFGTPEFIPPEIINYE-PIG 127
+ N++ +K+ DFGLA+ + + T + PPE++ E G
Sbjct: 143 MKAANVLITR--DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200
Query: 128 IESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE------------- 174
D+W G I + + G + A I++ E +
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 260
Query: 175 ---------------ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214
A D I LLV +R+ + L+H + D P
Sbjct: 261 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF-WSDPMP 314
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 89.9 bits (222), Expect = 4e-22
Identities = 32/157 (20%), Positives = 58/157 (36%), Gaps = 27/157 (17%)
Query: 80 MCVSRTSHHIKIIDFGLAQKI-NPDHPPRVLFGTPEFIPPEII-NYEPIGIESDMWSIGV 137
+ +KI DFGLA+ P T + P+++ + D+WS+G
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 138 ITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA------------------------- 172
I +++G F G ++++ I R + +
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
+ L E D +S +L +R+TAKQ L H + +
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 4e-22
Identities = 33/158 (20%), Positives = 65/158 (41%), Gaps = 10/158 (6%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMW 133
+ NI+ + KI DFGL++ + ++ E +NY SD+W
Sbjct: 153 LAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 210
Query: 134 SIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRK 192
S GV+ + ++S G +P+ G +E + + + + E ++ D + ++
Sbjct: 211 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKP 267
Query: 193 EKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIY 230
+R + Q L L ++ VN T +K+ Y
Sbjct: 268 YERPSFAQILVSLNRMLEERKTYVN----TTLYEKFTY 301
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 6e-22
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINP--DHPPRVLFGTPEFIPPEII 121
H L + I ENI+ ++ H+ + DFGL+++ GT E++ P+I+
Sbjct: 145 LHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 122 --NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSED 179
D WS+GV+ Y LL+G SPF + + + A I+R + + +S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 180 AKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211
AKD I LL+K +KRL A + HL+ + +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.6 bits (224), Expect = 6e-22
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
GL H H+ V + P NI+ H++I D GLA + P GT ++ P
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHAS-VGTHGYMAP 174
Query: 119 EII-NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
E++ +D +S+G + + LL G SPF + I R E ++ S
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS 233
Query: 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211
+ + + LL + +RL A++ + D
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 9e-22
Identities = 44/216 (20%), Positives = 76/216 (35%), Gaps = 46/216 (21%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGT----PEFIPPEI 120
HS + + P N++ + + +KI DFGLA+ +PDH + PEI
Sbjct: 126 HSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 121 INYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE-------- 171
+ D+WS+G I +LS F G++ + +I E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 172 -------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ--- 209
F A D + +L KR+ +Q L+H ++ Q
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 210 ---KDSSPGVNKI------ISTDKLKKYIYRRKWQF 236
+ + K + +KLK+ I+ +F
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARF 339
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 2e-21
Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 8/169 (4%)
Query: 40 MKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99
+L E + E S + + N + +K+ DFGL++
Sbjct: 92 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRY 149
Query: 100 INPD--HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSE 156
+ D + PPE++ Y +SD+W+ GV+ + + S G P+ +SE
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 157 TFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
T +I + + SE + S ++ ++R T K LS++
Sbjct: 210 TAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-21
Identities = 33/177 (18%), Positives = 57/177 (32%), Gaps = 28/177 (15%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
R L + HS I P+N+ + + +K+ DFG A+++ P + + P
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL-LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 119 -EIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA------------- 164
I D+WS G + LL G F G++ + I +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 165 ------------EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
+ +A S LL RLT + +H + +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 3e-21
Identities = 32/159 (20%), Positives = 57/159 (35%), Gaps = 10/159 (6%)
Query: 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF- 110
R G+G+ S + + N++ +R +KI DFGL + + + V+
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 111 ---GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEF 166
+ PE + SD W GV + + + G P++G N S+ I +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
E +D + + + E R T L
Sbjct: 233 RLPRP--EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.6 bits (216), Expect = 6e-21
Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 13/141 (9%)
Query: 76 PENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSI 135
PEN++ +I++ DFG A+++ L GTPE + PEII + D W++
Sbjct: 169 PENLLI--DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 136 GVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKR 195
GV+ Y + +G PF + + + I + F S D KD + +LL KR
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVDLTKR 280
Query: 196 L-----TAKQCLSHLWIAQKD 211
+H W A D
Sbjct: 281 FGNLKNGVNDIKNHKWFATTD 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (212), Expect = 8e-21
Identities = 21/148 (14%), Positives = 52/148 (35%), Gaps = 9/148 (6%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPP 118
+ + V + N++ + K+ DFGL ++ + ++ P
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAP 169
Query: 119 EIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
E + + +SD+WS G++ + + S G P+ + + + + +A +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCP 226
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + + R + Q L
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 2e-20
Identities = 48/211 (22%), Positives = 74/211 (35%), Gaps = 43/211 (20%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEII-NY 123
HS + + P N+ +KI+DFGLA+ D T + PEI+ N+
Sbjct: 138 HSADIIHRDLKPSNLAV--NEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNW 193
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------------ 171
D+WS+G I LL+G + F G + + I R E
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 172 ---------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ------- 209
F + A D + +LV +KR+TA Q L+H + AQ
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 210 ----KDSSPGVNKIISTDKLKKYIYRRKWQF 236
++ + D+ K Y F
Sbjct: 314 PVADPYDQSFESRDLLIDEWKSLTYDEVISF 344
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 4e-20
Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 29/163 (17%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKIN-PDHPPRVLFGTPEFIPPEII-NYEPIGIESD 131
+ P+N++ T IK+ DFGLA+ P T + PEI+ + D
Sbjct: 128 LKPQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 132 MWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDD--------------------- 170
+WS+G I +++ + F G+++ + I R D+
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245
Query: 171 ----EAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
+ L ED + +S +L KR++AK L+H +
Sbjct: 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 4e-20
Identities = 34/151 (22%), Positives = 60/151 (39%), Gaps = 9/151 (5%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV---LFGTPEF 115
+G+ V + N++ +KI DFGLA+ I D V ++
Sbjct: 175 KGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174
+ PE + I+SD+WS G++ + + S G++P+ G F + + F D
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--F 290
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+E+ + S KR + S L
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 6e-20
Identities = 27/142 (19%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF---GTPEFIPPEIINYEPIGIES 130
+ N++ + H+KI DFGLA+ + + +++ E I + +S
Sbjct: 137 LAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
Query: 131 DMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLV 189
D+WS GV + L++ G P+ G SE + + + E + D + +
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPICTIDVYMIMVKCWM 251
Query: 190 KRKEKRLTAKQCLSHLWIAQKD 211
+ R ++ + +D
Sbjct: 252 IDADSRPKFRELIIEFSKMARD 273
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (209), Expect = 6e-20
Identities = 44/258 (17%), Positives = 83/258 (32%), Gaps = 53/258 (20%)
Query: 25 PPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSR 84
Y ++ + ++ +S L++ HS + + P NI+ S
Sbjct: 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 85 TSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
+KI+DFGLA+ T + PE+I D+WS+G I ++
Sbjct: 156 --CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 145 GLSPFMGENDSETFANITR--------------------------------------AEF 166
F G + + + + + F
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI-------------AQKDSS 213
D E + + A+D +S +LV KR++ L H +I Q
Sbjct: 274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDK 333
Query: 214 PGVNKIISTDKLKKYIYR 231
+ + ++ K+ IY+
Sbjct: 334 QLDEREHTIEEWKELIYK 351
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 1e-19
Identities = 27/135 (20%), Positives = 54/135 (40%), Gaps = 8/135 (5%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKINPD--HPPRVLFGTPEFIPPEIINYEPIGIESD 131
+ N + + IK+ DFG+ + + D ++ PE+ ++ +SD
Sbjct: 127 LAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 132 MWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVK 190
+WS GV+ + + S G P+ ++SE +I+ + S ++ +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWKE 241
Query: 191 RKEKRLTAKQCLSHL 205
R E R + L L
Sbjct: 242 RPEDRPAFSRLLRQL 256
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 83.7 bits (206), Expect = 1e-19
Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 36/177 (20%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEI-INY 123
HS+ + + P N+M + +++ID+GLA+ +P V + F PE+ ++Y
Sbjct: 146 HSMGIMHRDVKPHNVM-IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 124 EPIGIESDMWSIGVITYVLLSGLSPFM-GENDSETFANITRA------------------ 164
+ DMWS+G + ++ PF G ++ + I +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 165 ---------------EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLW 206
E E +S +A DF+ LL + RLTA++ + H +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 2e-19
Identities = 36/149 (24%), Positives = 57/149 (38%), Gaps = 12/149 (8%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR----VLFGTPEFIP 117
L + V D N++ V++ H+ KI DFGL++ + D ++
Sbjct: 123 LEESNFVHRDLA--ARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 118 PEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176
PE INY +SD+WS GV+ + S G P+ G SE A + + E
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGC 235
Query: 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ D ++ E R L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 2e-19
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 8/144 (5%)
Query: 65 HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPD--HPPRVLFGTPEFIPPEIIN 122
+ V + NI+ K+ DFGLA+ I + + ++ PE
Sbjct: 130 ERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 123 YEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAK 181
Y I+SD+WS G++ L + G P+ G + E + R + E
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLH 244
Query: 182 DFISSLLVKRKEKRLTAKQCLSHL 205
D + K E+R T + + L
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.6 bits (203), Expect = 3e-19
Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 10/151 (6%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVL---FGTPEF 115
G+ + V + N + +KI DFGL++ I + +
Sbjct: 151 AGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRW 208
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174
+PPE I Y ESD+W+ GV+ + + S GL P+ G E + E
Sbjct: 209 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI---LACPE 265
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + + K R + L
Sbjct: 266 NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 3e-19
Identities = 37/172 (21%), Positives = 62/172 (36%), Gaps = 14/172 (8%)
Query: 53 RLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF- 110
L G+ + V + N++ V+R H+ KI DFGL++ + D
Sbjct: 113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARS 170
Query: 111 ---GTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEF 166
++ PE IN+ SD+WS GV + LS G P+ E A I + +
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 230
Query: 167 DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAK---QCLSHLWIAQKDSSPG 215
E + +S + + E R Q + + + G
Sbjct: 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 6e-19
Identities = 27/145 (18%), Positives = 54/145 (37%), Gaps = 8/145 (5%)
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRVLF--GTPEFIPPEII 121
S V I N++ ++ +K+ DFGL++ + + +++ PE I
Sbjct: 124 LESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 122 NYEPIGIESDMWSIGVITY-VLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSEDA 180
N+ SD+W GV + +L+ G+ PF G +++ I E
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTL 238
Query: 181 KDFISSLLVKRKEKRLTAKQCLSHL 205
++ +R + + L
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 9e-19
Identities = 32/164 (19%), Positives = 63/164 (38%), Gaps = 30/164 (18%)
Query: 74 ILPENIMCVSRTSHHIKIIDFGLAQKIN-PDHPPRVLFGTPEFIPPEIINYEPI-GIESD 131
+ P+N++ + +K+ +FGLA+ P T + PP+++ + D
Sbjct: 127 LKPQNLLI--NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 132 MWSIGVITYVLLSGLSP-FMGENDSETFANITRAEFDFDDEAFEA--------------- 175
MWS G I L + P F G + + I R +E + +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 176 ----------LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209
L+ +D + +LL +R++A++ L H + +
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.5 bits (198), Expect = 1e-18
Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 10/183 (5%)
Query: 27 YDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85
Y + ++ +L + G+ + + NI+
Sbjct: 88 YMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERNYIHRDLRAANILVSDT- 145
Query: 86 SHHIKIIDFGLAQKINPDHPPR--VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLL 143
KI DFGLA+ I + ++ PE INY I+SD+WS G++ ++
Sbjct: 146 -LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 144 S-GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCL 202
+ G P+ G + E N+ R + E+ + +R E R T
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLR 261
Query: 203 SHL 205
S L
Sbjct: 262 SVL 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 2e-18
Identities = 46/236 (19%), Positives = 84/236 (35%), Gaps = 43/236 (18%)
Query: 40 MKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98
MK + L +GL + H+ + + P N+ +KI+DFGLA+
Sbjct: 113 MKHEKLGEDRIQ-FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLAR 169
Query: 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF 158
+ + + V+ P I+N+ D+WS+G I +++G + F G + +
Sbjct: 170 QADSEMTGYVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 159 ANITRAEFDFDDE---------------------------AFEALSEDAKDFISSLLVKR 191
I + E S A + + +LV
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288
Query: 192 KEKRLTAKQCLSHLWIAQKDSS---PGVNKIIST--------DKLKKYIYRRKWQF 236
E+R+TA + L+H + + P V K + D+ K+ Y+ F
Sbjct: 289 AEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSF 344
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.8 bits (196), Expect = 3e-18
Identities = 31/173 (17%), Positives = 56/173 (32%), Gaps = 12/173 (6%)
Query: 40 MKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99
G ++L L + V + NI+ S K+ DFGL++
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRF 177
Query: 100 INPDHPPRVL------FGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGE 152
+ D + PE I Y SD+WS G++ + ++S G P+
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 153 NDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + I + D+ + K + R Q ++ L
Sbjct: 238 TNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.7 bits (193), Expect = 6e-18
Identities = 24/153 (15%), Positives = 48/153 (31%), Gaps = 16/153 (10%)
Query: 74 ILPENIMCVSR-TSHHIKIIDFGLAQKINPD--------HPPRVLFGTPEFIPPEIINYE 124
+ P+N + + + IIDFGLA+K + L GT +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 125 PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDF----DDEAFEALSEDA 180
D+ S+G + G P+ G + R + + +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 181 KDFISSLLVKRKEKRLTA---KQCLSHLWIAQK 210
+++ R + + +Q +L+ Q
Sbjct: 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 2e-17
Identities = 26/148 (17%), Positives = 55/148 (37%), Gaps = 11/148 (7%)
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPD-----HPPRVLFGTPEFIPP 118
S V + N M + +K+ DFGLA+ + H +++
Sbjct: 146 LASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 119 EIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALS 177
E + + +SD+WS GV+ + L++ G P+ N + + + E
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCP 260
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + + + E R + + +S +
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.3 bits (187), Expect = 4e-17
Identities = 33/190 (17%), Positives = 72/190 (37%), Gaps = 8/190 (4%)
Query: 27 YDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTS 86
+ + Y+ E V L + + + + N + +
Sbjct: 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GEN 151
Query: 87 HHIKIIDFGLAQKINPD--HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS 144
H +K+ DFGL++ + D ++ PE + Y I+SD+W+ GV+ + + +
Sbjct: 152 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 145 -GLSPFMGENDSETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203
G+SP+ G + S+ + + + D+ E E E + + + R + +
Sbjct: 212 YGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
Query: 204 HLWIAQKDSS 213
++SS
Sbjct: 269 AFETMFQESS 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 5e-17
Identities = 34/151 (22%), Positives = 60/151 (39%), Gaps = 9/151 (5%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV---LFGTPEF 115
+G+ S + + NI+ + + +KI DFGLA+ I D ++
Sbjct: 145 KGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLSGL-SPFMGENDSETFANITRAEFDFDDEAFE 174
+ PE I I+SD+WS GV+ + + S SP+ G E F + A +
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPD 260
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + + +R T + + HL
Sbjct: 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 75.6 bits (185), Expect = 8e-17
Identities = 23/191 (12%), Positives = 51/191 (26%), Gaps = 16/191 (8%)
Query: 31 CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS---RTS 86
+ + G + V+ + + H V I P+N + + +
Sbjct: 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 142
Query: 87 HHIKIIDFGLAQKINPD--------HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVI 138
+ I ++DFG+ + + L GT ++ D+ ++G +
Sbjct: 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
Query: 139 TYVLLSGLSPFMGENDSETFANITRAEFDFD----DEAFEALSEDAKDFISSLLVKRKEK 194
L G P+ G + R E E+ ++ +
Sbjct: 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDA 262
Query: 195 RLTAKQCLSHL 205
Sbjct: 263 TPDYDYLQGLF 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (181), Expect = 2e-16
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 8/169 (4%)
Query: 41 KAGTQPWVELSERLFESTERGLGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100
K G ++L L ++ V + NI+ S K+ DFGL++ +
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVL 160
Query: 101 NPD----HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE 156
D + + PE I+Y SD+WS G++ + +++ E +
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 157 TFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
F + + + +R +S L
Sbjct: 221 EVMKAINDGFRLPTP--MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 3e-15
Identities = 31/151 (20%), Positives = 60/151 (39%), Gaps = 10/151 (6%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPR---VLFGTPEF 115
RG+ + S + + N++ + +KI DFGLA+ I+ + ++
Sbjct: 146 RGMEYLASKKCIHRDLAARNVLVTED--NVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174
+ PE + +SD+WS GV+ + + + G SP+ G E F + +
Sbjct: 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR---MDKPS 260
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ + + +R T KQ + L
Sbjct: 261 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (171), Expect = 6e-15
Identities = 36/151 (23%), Positives = 56/151 (37%), Gaps = 9/151 (5%)
Query: 60 RGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPDHPPRV---LFGTPEF 115
+G+ S + + NI+ KI DFGLA+ I D V ++
Sbjct: 156 KGMAFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 116 IPPEIINYEPIGIESDMWSIGVITYVLLSGLSP-FMGENDSETFANITRAEFDFDDEAFE 174
+ PE I ESD+WS G+ + L S S + G F + + F E
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--E 271
Query: 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
+ D + + KR T KQ + +
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 1e-14
Identities = 35/180 (19%), Positives = 59/180 (32%), Gaps = 46/180 (25%)
Query: 74 ILPENIMC--VSRTSHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESD 131
I PEN++ V + I+I L D T E+ PE++ P G +D
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 211
Query: 132 MWSIGVITYVLLSGLSPF---------------------MGENDSETFANITRAEFDFDD 170
+WS + + L++G F +GE S N F+
Sbjct: 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 271
Query: 171 EAF-----------------------EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207
+ +++ DF+S +L KR A ++H W+
Sbjct: 272 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-14
Identities = 25/162 (15%), Positives = 57/162 (35%), Gaps = 14/162 (8%)
Query: 62 LGHHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINPD---HPPRVLFGTPEFIPP 118
L + V D N M +KI DFG+ + I ++ P
Sbjct: 149 LNANKFVHRDLA--ARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 119 EIINYEPIGIESDMWSIGVITYVLLSGL-SPFMGENDSETFANITRAEFDFDDEAFEALS 177
E + SD+WS GV+ + + + P+ G ++ + + + +
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCP 261
Query: 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKI 219
+ + + + R + + +S + +++ PG ++
Sbjct: 262 DMLFELMRMCWQYNPKMRPSFLEIISSI---KEEMEPGFREV 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 3e-11
Identities = 26/172 (15%), Positives = 50/172 (29%), Gaps = 33/172 (19%)
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKINP-----DHPPRVLFGTPEFIPP 118
+ +NI+ I D GLA + + D P GT ++ P
Sbjct: 124 QGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 119 EII------NYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETF-------------- 158
E++ + +D++++G++ + + S D +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 159 -----ANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205
R ++ EAL + RLTA + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1x5ga1 b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-05
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 2/63 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVE-MKAGTQPWVELSERLFESTE 59
+P P + + TS+ +TW P G I Y + M+ GT ++ T
Sbjct: 10 LPGPAPNLRAYAASPTSITVTW-ETPVSGNGEIQNYKLYYMEKGTDKEQDVDVSSHSYTI 68
Query: 60 RGL 62
GL
Sbjct: 69 NGL 71
|
| >d2crza1 b.1.2.1 (A:8-104) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 97 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-05
Identities = 12/47 (25%), Positives = 17/47 (36%), Gaps = 1/47 (2%)
Query: 2 PDPPSGAIGVSNNR-TSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P P + + + W P DGG I+ Y VEM +
Sbjct: 2 PGPCLPPRLQGRPKAKEIQLRWGPPLVDGGSPISCYSVEMSPIEKDE 48
|
| >d2dtge2 b.1.2.1 (E:593-807) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 196 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Insulin receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-05
Identities = 13/48 (27%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWV 48
P P I VSN+ + +++ W P G IT Y+V + +
Sbjct: 2 NPSVPLDPISVSNSSSQIILKWKPPSDPNG-NITHYLVFWERQAEDSE 48
|
| >d1x5fa1 b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 107 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 5e-05
Identities = 8/47 (17%), Positives = 14/47 (29%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
+P P + + + +TW +P D Y V
Sbjct: 10 LPSAPRDVVASLVSTRFIKLTWRTPASDPHGDNLTYSVFYTKEGIAR 56
|
| >d1x5ya1 b.1.2.1 (A:8-105) Myosin binding protein C, fast-type {Mouse (Mus musculus) [TaxId: 10090]} Length = 98 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Myosin binding protein C, fast-type species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.1 bits (90), Expect = 5e-05
Identities = 10/46 (21%), Positives = 13/46 (28%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P T+ + W P G I GY+VE
Sbjct: 2 TSAPQHLTVEDVTDTTTTLKWRPPDRIGAGGIDGYLVEYCLEGSEE 47
|
| >d2dtge3 b.1.2.1 (E:468-592) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Insulin receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 6e-05
Identities = 8/87 (9%), Positives = 26/87 (29%), Gaps = 3/87 (3%)
Query: 4 PPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLG 63
+ + +++ W + G+++ K V + G
Sbjct: 4 ELLKFSYIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDG---QDACGSN 60
Query: 64 HHSLVTVDPKILPENIMCVSRTSHHIK 90
++V +DP + + + ++
Sbjct: 61 SWTVVDIDPPLRSNDPKSQNHPGWLMR 87
|
| >d1x4za1 b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Brother of CDO precursor (BOC) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.0 bits (90), Expect = 6e-05
Identities = 14/46 (30%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P+ P + + TSV +TW P +GG I + VE K +
Sbjct: 11 PEAPDRPTISTASETSVYVTW-IPRGNGGFPIQSFRVEYKKLKKVG 55
|
| >d1wf5a1 b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (89), Expect = 9e-05
Identities = 13/49 (26%), Positives = 24/49 (48%), Gaps = 3/49 (6%)
Query: 1 IPDPPSGAIGVSNN--RTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
+P P + + R ++ +TW+ P+DG + Y++EM PW
Sbjct: 10 LPHAPEHPVATLSTVERRAINLTWT-KPFDGNSPLIRYILEMSENNAPW 57
|
| >d1uema_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA1568 protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 1e-04
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 3/88 (3%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVE--MKAGTQPWVELSERLFEST 58
+P PPS + SV ++W P G + Y++E ++ + W ++ + +
Sbjct: 15 LPGPPSKPQVTDVTKNSVTLSW-QPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTL 73
Query: 59 ERGLGHHSLVTVDPKILPENIMCVSRTS 86
G + N +S S
Sbjct: 74 YTVRGLRPNTIYLFMVRAINPQGLSDPS 101
|
| >d1f6fb2 b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Prolactin receptor species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.9 bits (84), Expect = 3e-04
Identities = 10/53 (18%), Positives = 18/53 (33%), Gaps = 7/53 (13%)
Query: 2 PDPPSG----AIGVSNNRTSVVITWSSPPY---DGGCMITGYVVEMKAGTQPW 47
P+PP + + +T + + WS P G Y + +K
Sbjct: 3 PEPPRNLTLEVKQLKDKKTYLWVKWSPPTITDVKTGWFTMEYEIRLKPEEAEE 55
|
| >d1x5la1 b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Ephrin type-A receptor 8 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (83), Expect = 4e-04
Identities = 9/46 (19%), Positives = 15/46 (32%), Gaps = 1/46 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P +TSV + W P G +I Y ++ +
Sbjct: 4 PSQVVVIRQERAGQTSVSLLWQEPEQPNG-IILEYEIKYYEKDKEM 48
|
| >d1x3da1 b.1.2.1 (A:8-112) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 105 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (83), Expect = 5e-04
Identities = 12/46 (26%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
PD P+ + + S+ + W P D G I +V+E G
Sbjct: 11 PDIPNPPRIANRTKNSLTLQW-KAPSDNGSKIQNFVLEWDEGKGNG 55
|
| >d1cd9b1 b.1.2.1 (B:1-107) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]} Length = 107 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Granulocyte colony-stimulating factor (GC-SF) receptor species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.3 bits (80), Expect = 0.001
Identities = 7/82 (8%), Positives = 25/82 (30%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERG 61
P PS + + T+ ++ P + + + ++ + ++
Sbjct: 5 PASPSNLSCLMHLTTNSLVCQWEPGPETHLPTSFILKSFRSRADCQYQGDTIPDCVAKKR 64
Query: 62 LGHHSLVTVDPKILPENIMCVS 83
+ S+ + + + V
Sbjct: 65 QNNCSIPRKNLLLYQYMAIWVQ 86
|
| >d2dn7a1 b.1.2.1 (A:8-101) Receptor-type tyrosine-protein phosphatase F, PTPRF {Human (Homo sapiens) [TaxId: 9606]} Length = 94 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Receptor-type tyrosine-protein phosphatase F, PTPRF species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.2 bits (80), Expect = 0.001
Identities = 8/46 (17%), Positives = 17/46 (36%), Gaps = 2/46 (4%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
P P+ I + + ++ W P G + GY ++ +
Sbjct: 1 PGRPTMMI-STTAMNTALLQWHPPKELPGE-LLGYRLQYCRADEAR 44
|
| >d1wfna1 b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 106 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.2 bits (80), Expect = 0.001
Identities = 10/47 (21%), Positives = 19/47 (40%), Gaps = 1/47 (2%)
Query: 1 IPDPPSGAIGVSNNRTSVVITWSSPPYDGGCMITGYVVEMKAGTQPW 47
+P P TS+ ++W P G ++TGY + + +
Sbjct: 10 VPGPVGHLSFSEILDTSLKVSWQEPGEKNG-ILTGYRISWEEYNRTN 55
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.3 bits (83), Expect = 0.001
Identities = 17/116 (14%), Positives = 39/116 (33%), Gaps = 17/116 (14%)
Query: 27 YDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85
++G ++ + + K + VE + + + + + V + N++ +
Sbjct: 82 WEGNAVLMELI-DAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S 137
Query: 86 SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIG 136
I IIDF + + G E + ++ N E D+ S
Sbjct: 138 EEGIWIIDFPQS--VEVGEE-----GWREILERDVRNIITYFSRTYRTEKDINSAI 186
|
| >d1va9a1 b.1.2.1 (A:8-116) Down syndrome cell adhesion molecule-like protein 1, DSCAML1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Down syndrome cell adhesion molecule-like protein 1, DSCAML1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.1 bits (77), Expect = 0.003
Identities = 9/41 (21%), Positives = 16/41 (39%), Gaps = 1/41 (2%)
Query: 2 PDPPSGAIGVSNNRTSVVITWSSPPYD-GGCMITGYVVEMK 41
PP S+ +TW +P + +I GY + +
Sbjct: 9 DGPPMDVTLQPVTSQSIQVTWKAPKKELQNGVIRGYQIGYR 49
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.99 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 91.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 86.24 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-49 Score=316.52 Aligned_cols=215 Identities=32% Similarity=0.516 Sum_probs=169.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++.. +.++.+||+|||++
T Consensus 81 ~~~lvmE~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEEEECCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEEEeccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 4678999999999999984 46789999999999999999999 9999999999999999964 34678999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
..........+..||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++......++
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 87766655566789999999999999999999999999999999999999999998888888998888777666666889
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCCccccccchhHHHHHHHHhhhccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSPGVNKIISTDKLKKYIYRRKWQFS 237 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 237 (239)
+.+.+|+++||+.||++|||++|+++||||++.............+++++...+++++.+
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCCTTTSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHhhhhhh
Confidence 999999999999999999999999999999864433332222233566666666666653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-47 Score=308.33 Aligned_cols=191 Identities=37% Similarity=0.642 Sum_probs=174.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ...+.+++..+..++.||+.||.| |++||+||||||+||+++.+.++.+||+|||++.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEEEECCCCSCBHHHHHT--CTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 5678999999999998885 345679999999999999999999 9999999999999999976667899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++......++.
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 88766666667899999999999999999999999999999999999999999998899999988888777766678999
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
.+++|+++||+.||++|||++++|+||||++...
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999999999999999999987544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=300.68 Aligned_cols=180 Identities=28% Similarity=0.452 Sum_probs=162.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||+| |++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~ivmEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill--~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIADFGWSV 154 (263)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCSCS
T ss_pred EEEEEEeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee--cCCCCEeecccceee
Confidence 4678999999999999885 35678999999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++. .+++
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 229 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTE 229 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCH
T ss_pred ecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCH
Confidence 65533 344567999999999999999999999999999999999999999999988888888888776653 6799
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.+++|+.+||+.||++|||++|+|+||||++
T Consensus 230 ~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 230 GARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.2e-47 Score=306.95 Aligned_cols=192 Identities=41% Similarity=0.685 Sum_probs=173.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ..+..+++..+..++.||+.||.| |++||+||||||+|||++....+.+||+|||++.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEEEECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEEcCCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccce
Confidence 4678999999999988764 345679999999999999999999 9999999999999999965577899999999999
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+......++...+..+++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 88776666667899999999999999999999999999999999999999999999999999988887777666668899
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhccccccCCCC
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSS 213 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~ 213 (239)
.+.+|+++||+.||.+|||++++|+||||+.....
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 99999999999999999999999999999875433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=297.40 Aligned_cols=183 Identities=25% Similarity=0.394 Sum_probs=158.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. .+.+++..+..++.||+.||.| |++||+||||||+||++ +.+|.+||+|||++.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE--CCCCcEeeccchhhe
Confidence 4678999999999998764 2468999999999999999999 99999999999999999 667899999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+........ .....++
T Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s 243 (293)
T d1yhwa1 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLS 243 (293)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSC
T ss_pred eeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCC
Confidence 775433 34456799999999999999999999999999999999999999998887777666655433211 2234689
Q ss_pred HHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
..+++|+.+||+.||++|||++++|+||||+.
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=294.43 Aligned_cols=184 Identities=20% Similarity=0.325 Sum_probs=153.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++ ..++.+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|||++.
T Consensus 77 ~~~ivmEy~~gg~L~~~l---~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl--~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEEECCTTEEGGGGS---BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eeEEEEeccCCCcHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE--CCCCCEEEccchhhe
Confidence 467899999999999988 456789999999999999999999 99999999999999999 677789999999998
Q ss_pred ecCCC---CCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPD---HPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
..... .......||+.|+|||.+.+..+ +.++||||+||++|+|++|..||.+.+................ ..+.
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 230 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWK 230 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-TTGG
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-Cccc
Confidence 76432 22344679999999999988876 6789999999999999999999977654433333222222211 2235
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
.++..+.+|+++||+.||++|||++++++||||++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 78999999999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=296.37 Aligned_cols=192 Identities=44% Similarity=0.713 Sum_probs=169.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC--CcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS--HHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~--~~vkl~dfg~ 96 (239)
..|+|||||+||+|.+++.+ ++.+++..+..++.|++.||+| |++||+||||||+||+++.++. ..+|++|||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 46789999999999999854 4579999999999999999999 9999999999999999954332 3599999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
+.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++......+
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 98887666666678999999999999989999999999999999999999999999999999999988888887777789
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
+..+++|+++||+.||++|||++++++||||+..++..
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 99999999999999999999999999999998755443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=292.77 Aligned_cols=182 Identities=23% Similarity=0.355 Sum_probs=151.6
Q ss_pred EEeeCccCCCCccchhhhhh-hcCCCchHHHHHHHHHHHHHHHHH-hhhc-----ccCCCCCCCCeEEecCCCCcEEEEe
Q psy1096 21 TWSSPPYDGGCMITGYVVEM-KAGTQPWVELSERLFESTERGLGH-HSLV-----TVDPKILPENIMCVSRTSHHIKIID 93 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~-h~~~-----ivH~dikp~nili~~~~~~~vkl~d 93 (239)
+|++||||+||+|.+++... ..++.+++..+..++.|++.||.| |++| |+||||||+||++ +.++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEee
Confidence 57899999999999998654 346789999999999999999999 9987 9999999999999 7778999999
Q ss_pred cccceecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 94 FGLAQKINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 94 fg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
||++....... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+..+.....+
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 235 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-- 235 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC--
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 99998765432 334567999999999999999999999999999999999999999998888888888777654332
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWI 207 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~ 207 (239)
..+++.+.+|+++||+.||.+|||++|+++|||+
T Consensus 236 -~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 3689999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=295.78 Aligned_cols=186 Identities=25% Similarity=0.426 Sum_probs=162.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++|+|||+++
T Consensus 82 ~~~ivmEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll--~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc--CCCceEEecccccce
Confidence 4689999999999998874 45789999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
...... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+......++.+....++. .
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~ 232 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----K 232 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----T
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----c
Confidence 765332 233457999999999999999999999999999999999999999999988888898888776653 6
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHH------HhhccccccCCCCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQ------CLSHLWIAQKDSSP 214 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~------ll~h~~~~~~~~~~ 214 (239)
+++.+++|+++||+.||++|||++| +++||||++.++..
T Consensus 233 ~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 8999999999999999999999987 68899998876653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-45 Score=290.57 Aligned_cols=185 Identities=29% Similarity=0.491 Sum_probs=166.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++.+ ++.++++.++.++.||+.||+| |++||+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred ceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE--cCCCCeEEccchhee
Confidence 46799999999999999853 5679999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY------EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
............||+.|++||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+..+...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8776655566789999999999953 3458899999999999999999999999998888888888877766666
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...+++++++|+++||+.||.+|||++++++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 6689999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=296.31 Aligned_cols=188 Identities=35% Similarity=0.569 Sum_probs=172.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+|++|.+++. ..+..++++.+..++.||+.||.| |++||+||||||+||+++.+..+.++++|||++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~--~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhh
Confidence 5689999999999999885 334579999999999999999999 9999999999999999966667789999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
............+++.|++||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++...+..++.
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 87766555667899999999999999999999999999999999999999999999999999999988888888788999
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
++++|+++||..||++|||++++++||||++
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 9999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=286.54 Aligned_cols=181 Identities=17% Similarity=0.257 Sum_probs=150.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhc--ccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLV--TVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~--ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
.+|++||||+||+|.+++. .++.+++..+..++.||+.||+| |+++ |+||||||+||+++. .++.+||+|||+
T Consensus 86 ~~~ivmE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGL 161 (270)
T ss_dssp EEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTG
T ss_pred EEEEEEeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CCCCEEEeecCc
Confidence 3578999999999999985 35678999999999999999999 9999 999999999999932 356899999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhccCCCchHHHhh
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE-TFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 175 (239)
+..... .......||+.|+|||.+.+ +++.++||||+||++|+|++|..||.+..... ....+..+.. +......
T Consensus 162 a~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~ 237 (270)
T d1t4ha_ 162 ATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKV 237 (270)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGC
T ss_pred ceeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCcc
Confidence 975433 23345679999999999875 59999999999999999999999998765544 4444443322 2233346
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIA 208 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~ 208 (239)
.++.+.+|+.+||+.||++|||++|+|+||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 789999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=294.41 Aligned_cols=185 Identities=21% Similarity=0.308 Sum_probs=158.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++.+ .++.+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll--~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF--TLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE--CCCCCEEEEechhhh
Confidence 46789999999999988763 35679999999999999999999 99999999999999999 677899999999987
Q ss_pred ecCCC-CCCccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIIN-----YEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......||+.|+|||.+. ...++.++||||+||++|+|++|..||.+.+..+...++......... .
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~ 237 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-Q 237 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-S
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-c
Confidence 65322 1223456999999999984 455789999999999999999999999999888888888776543221 1
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
...+++++.+|+++||+.||++|||++|+++||||+.
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 2468999999999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=299.14 Aligned_cols=192 Identities=23% Similarity=0.433 Sum_probs=163.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC-CCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR-TSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~-~~~~vkl~dfg~~ 97 (239)
.+|+|||||+||+|.+++.. ..+..+++..+..++.|++.||+| |++||+||||||+||+++.. ..+.+||+|||++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 46899999999999999864 234579999999999999999999 99999999999999999543 3568999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----HHHhccCCCchHHH
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFA----NITRAEFDFDDEAF 173 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~----~i~~~~~~~~~~~~ 173 (239)
+............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+...... .+......++...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 88776666667789999999999999999999999999999999999999998776554433 33444555555556
Q ss_pred hhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 174 EALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 174 ~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
..+++++.+|+++||+.||++|||++++++||||.+...
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 678999999999999999999999999999999976443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=295.54 Aligned_cols=182 Identities=27% Similarity=0.383 Sum_probs=164.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. .++.++++.++.++.|++.||.| |++||+||||||+||++ +.+|.+||+|||+++
T Consensus 79 ~~~iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl--~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred ccccceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe--cCCCCEEEeeccccc
Confidence 4678999999999998874 46788999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCC-CCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINP-DHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|.+||.+.+..+....+......++. .++
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s 229 (337)
T d1o6la_ 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLS 229 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred ccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCC
Confidence 7643 33445567999999999999999999999999999999999999999999998888888888877663 689
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQK 210 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~ 210 (239)
+++++|+++||+.||.+|++ ++++++||||++.
T Consensus 230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999999999994 9999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-44 Score=289.16 Aligned_cols=182 Identities=27% Similarity=0.467 Sum_probs=163.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||.||++..++ ..+..+.+..+..++.||+.||.| |++||+||||||+||++ +.+|.+||+|||++.
T Consensus 78 ~~~ivmE~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl--~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITDFGFAK 152 (316)
T ss_dssp EEEEEECCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTSCEEECCCSSCE
T ss_pred eeeeEeeecCCccccccc---cccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE--cCCCCEEEecCccce
Confidence 568899999999999877 456778888999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... ..+..||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++. .+++
T Consensus 153 ~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 226 (316)
T d1fota_ 153 YVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNE 226 (316)
T ss_dssp ECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred Eeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCH
Confidence 76543 33467999999999999999999999999999999999999999999998999998888776653 6899
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~ 212 (239)
++.+++++||+.||.+|+ |++++++||||++.++
T Consensus 227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 999999999999999996 9999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-45 Score=290.16 Aligned_cols=183 Identities=22% Similarity=0.280 Sum_probs=156.9
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++||||.+|++..++ ..++.+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++.
T Consensus 89 ~~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--ETTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE--CCCCCEEEeeccccc
Confidence 467899999999997555 346789999999999999999999 99999999999999999 667899999999997
Q ss_pred ecCCCCCCccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY---EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
..... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+....+......... ...
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 238 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGH 238 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTT
T ss_pred ccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCC
Confidence 65532 34569999999999864 35789999999999999999999999988888877777766543322 135
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
+++.+.+|+.+||+.||++|||++++|+||||.+...
T Consensus 239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 7899999999999999999999999999999986443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=288.65 Aligned_cols=183 Identities=27% Similarity=0.378 Sum_probs=163.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. .++.+++..+..++.||+.||.| |++|++||||||+|||+ +..+.+||+|||+++
T Consensus 77 ~~yivmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~--~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--DKDGHIKIADFGMCK 151 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred ceeEEEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee--cCCCceeccccchhh
Confidence 4789999999999999884 45678899999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+...++......++. .++
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s 227 (320)
T d1xjda_ 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLE 227 (320)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred hcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCC
Confidence 665433 334467999999999999999999999999999999999999999999998888888887766653 679
Q ss_pred HHHHHHHHHhhhhCcccCCCHH-HHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLTAK-QCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt~~-~ll~h~~~~~~~ 211 (239)
+.+.+|+++||+.||++|||++ ++++||||++.+
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 9999999999999999999995 899999998743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=291.89 Aligned_cols=185 Identities=18% Similarity=0.244 Sum_probs=148.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhh-cccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSL-VTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~-~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
.+|+|||||.||+|.+++.. ++.+++..+..++.|++.||.| |++ ||+||||||+|||+ +.+|.+||+|||++
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl--~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE--CTTCCEEECCCCCC
T ss_pred EEEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE--CCCCCEEEeeCCCc
Confidence 46789999999999999853 5678999999999999999999 975 89999999999999 77789999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-------------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRA------------- 164 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~------------- 164 (239)
...... ...+..||+.|+|||.+.+..++.++||||+||++|+|++|+.||.+.+...........
T Consensus 153 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 153 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred cccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 765432 234568999999999999999999999999999999999999999876543221110000
Q ss_pred ---------------------------cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 165 ---------------------------EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 165 ---------------------------~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...++......++.++.+|+.+||+.||.+|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000000012357899999999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-44 Score=290.24 Aligned_cols=182 Identities=24% Similarity=0.386 Sum_probs=163.1
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.||+|..++.. .+.+++..+..++.||+.||.| |++|||||||||+|||+ +.+|.+||+|||+++
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl--~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred ccccccccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc--CCCCCEEeeeceeee
Confidence 35789999999999988853 4678999999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
..... .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+.......+.......+. .+++
T Consensus 190 ~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 263 (350)
T d1rdqe_ 190 RVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSS 263 (350)
T ss_dssp ECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCH
T ss_pred ecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCH
Confidence 87543 33467999999999999999999999999999999999999999999988888888888776653 6899
Q ss_pred HHHHHHHHhhhhCcccCC-----CHHHHhhccccccCCC
Q psy1096 179 DAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKDS 212 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~~ 212 (239)
++.+|+++||+.||.+|+ |++++++||||+..++
T Consensus 264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 999999999999999995 9999999999987553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=283.50 Aligned_cols=193 Identities=21% Similarity=0.216 Sum_probs=161.8
Q ss_pred eeEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccc
Q psy1096 18 VVITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGL 96 (239)
Q Consensus 18 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~ 96 (239)
....|++|||++++.+.... ......++++.+..++.|++.||+| |++||+||||||+|||+ +..+.++++|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi--~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE--cCCCCeeecchhh
Confidence 34568899999999877333 3567788999999999999999999 99999999999999999 7778999999999
Q ss_pred ceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
+.............||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......+.
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 8776555555567899999999999999999999999999999999999999999888777776644221111
Q ss_pred ----------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCCCC
Q psy1096 170 ----------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDSSP 214 (239)
Q Consensus 170 ----------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~~~ 214 (239)
......++..+.+|+++||+.||++|||++|+|+||||++-+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k 303 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence 111234688999999999999999999999999999998765543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-44 Score=290.44 Aligned_cols=185 Identities=20% Similarity=0.265 Sum_probs=153.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+|||||+||+|.+++. .++.+++..+..++.||+.||.| |++||+||||||+|||+ +..|.+||+|||++.
T Consensus 81 ~~~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl--~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CSSSCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE--cCCCcEEEeeeceee
Confidence 4678999999999999884 35678899999999999999999 99999999999999999 777899999999998
Q ss_pred ecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhcC
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEALS 177 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 177 (239)
...... .....||+.|+|||.+.. ..++.++||||+||++|+|++|..||.+.+.......... ....+......++
T Consensus 156 ~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s 233 (364)
T d1omwa3 156 DFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFS 233 (364)
T ss_dssp ECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSC
T ss_pred ecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCCCCCCCCC
Confidence 776543 344579999999999964 5689999999999999999999999987655433322222 1111112224689
Q ss_pred HHHHHHHHHhhhhCcccCCC-----HHHHhhccccccCC
Q psy1096 178 EDAKDFISSLLVKRKEKRLT-----AKQCLSHLWIAQKD 211 (239)
Q Consensus 178 ~~~~~ll~~~l~~~p~~Rpt-----~~~ll~h~~~~~~~ 211 (239)
+.+++|+.+||+.||++||| ++++++||||++.+
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 99999999999999999999 79999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=279.01 Aligned_cols=186 Identities=20% Similarity=0.228 Sum_probs=155.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
+|+|||||.++.+..+. ..++.+++..+..++.||+.||.| |++||+||||||+||++ +..+.+||+|||++..
T Consensus 75 ~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli--~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKS 149 (299)
T ss_dssp CEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCCGGGST
T ss_pred eeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe--cCCCccccccCccccc
Confidence 47899999999887554 457789999999999999999999 99999999999999999 7778999999999977
Q ss_pred cCCCC-CCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--------
Q psy1096 100 INPDH-PPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-------- 169 (239)
Q Consensus 100 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 169 (239)
..... ......||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+.+....+.
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 65432 33456799999999998654 579999999999999999999999999888887777654322111
Q ss_pred ----------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 170 ----------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 170 ----------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
......++..+.+|+++||+.||++|||++|+|+||||++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 111235688999999999999999999999999999998744
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=272.10 Aligned_cols=181 Identities=19% Similarity=0.270 Sum_probs=146.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++||||+||+|.+++. ..++.+++..+..++.||+.||+| |+++||||||||+||++ +.++.+||+|||++..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl--~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL--HEDLTVKIGDFGLATV 153 (276)
T ss_dssp CEEEEECCCEEEHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTSSEEECCCCCSCC
T ss_pred EEEEEecCCCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE--cCCCCEEEccccceee
Confidence 468999999999999886 345679999999999999999999 99999999999999999 6678999999999876
Q ss_pred cCCCC---CCccccCCCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--hH
Q psy1096 100 INPDH---PPRVLFGTPEFIPPEIINYE---PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD--DE 171 (239)
Q Consensus 100 ~~~~~---~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~ 171 (239)
..... ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+.......+ ..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 64322 23345799999999999643 478999999999999999999999998776655554444333222 22
Q ss_pred HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 172 AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 172 ~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
....+++.+.+|+.+||..||++|||+++++++.
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2346789999999999999999999999999873
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=275.96 Aligned_cols=190 Identities=21% Similarity=0.195 Sum_probs=157.6
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC-CcEEEEeccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS-HHIKIIDFGL 96 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~-~~vkl~dfg~ 96 (239)
..+|+|||||+++.+..+......+..+++..++.++.||+.||.| |++||+||||||+|||+ +.+ ..+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl--~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE--ecCCCceeEecccc
Confidence 3468899999988666554444567789999999999999999999 99999999999999999 544 3799999999
Q ss_pred ceecCCCCCCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH----
Q psy1096 97 AQKINPDHPPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE---- 171 (239)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---- 171 (239)
+..........+..|++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+.+........
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 988876666667789999999999875 468999999999999999999999999888777766664422211111
Q ss_pred ---------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 ---------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 ---------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....++.+.+|+++||..||++|||++|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 112468899999999999999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=270.30 Aligned_cols=181 Identities=20% Similarity=0.253 Sum_probs=155.2
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||++|+|.+++. ...+.+++..+..++.|++.||+| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 83 ~~lvmE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee--ccCCceeeccchhhhc
Confidence 578999999999998874 445689999999999999999999 99999999999999999 5677999999999987
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....||+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+..+.....+ .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~ 235 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---P 235 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC---T
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 654322 223458889999999998899999999999999999998 99999998888888888776543222 4
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHH---hhccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQC---LSHLWIA 208 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~l---l~h~~~~ 208 (239)
.+++.+.+|+.+||..||++|||+.++ |+|.|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 689999999999999999999999888 5677764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=269.18 Aligned_cols=175 Identities=23% Similarity=0.349 Sum_probs=146.3
Q ss_pred EEEeeCccCCC-CccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGG-CMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
..|++|||+.+ +++.+++ ..++.++++.+..++.|++.||.| |++||+||||||+||+++. +.+.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~---~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHH---HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeEEECccccc
Confidence 45788999986 4566666 345689999999999999999999 9999999999999999943 3368999999999
Q ss_pred eecCCCCCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... ...+..||+.|+|||.+.+..+ +.++||||+||++|+|++|..||.+. ..+......++ ..+
T Consensus 159 ~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~ 227 (273)
T d1xwsa_ 159 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRV 227 (273)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCC
T ss_pred eecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCC
Confidence 765533 3345679999999999987775 67799999999999999999999753 23444544444 368
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
++++++|+++||..||++|||++|+++||||++
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=275.37 Aligned_cols=180 Identities=19% Similarity=0.223 Sum_probs=150.8
Q ss_pred EEeeCccCCCCccchhhhhhh--------------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCe
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK--------------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENI 79 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~ni 79 (239)
+|+|||||++|+|.+++.... ..+.+++..+..++.|++.||+| |++||+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 468899999999999986532 12457888999999999999999 999999999999999
Q ss_pred EEecCCCCcEEEEecccceecCCCCCC---ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy1096 80 MCVSRTSHHIKIIDFGLAQKINPDHPP---RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDS 155 (239)
Q Consensus 80 li~~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~ 155 (239)
++ +.++.+||+|||+++........ ....||+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..
T Consensus 196 ll--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 196 LV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cc--ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99 67789999999999776543322 23457899999999999999999999999999999997 89999988777
Q ss_pred HHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 156 ETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.....+......++. ...+++.+.+|+.+||+.||++|||+++|++|
T Consensus 274 ~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666666665544332 13678999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=270.16 Aligned_cols=179 Identities=20% Similarity=0.217 Sum_probs=151.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||++|+|.+++. .+..+++..+..++.||+.||+| |++||+||||||+||++ +.++.++++|||+++.
T Consensus 82 ~~lvmE~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill--~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKA 156 (277)
T ss_dssp EEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc--cccCcccccchhhhhh
Confidence 468999999999999884 46779999999999999999999 99999999999999999 6677999999999987
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....||+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+.++.....+ .
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~ 233 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---A 233 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---c
Confidence 654322 223468899999999999999999999999999999997 89999998888887777765433222 4
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHh---hcccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCL---SHLWI 207 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll---~h~~~ 207 (239)
.++..+.+|+.+||+.||++|||+++++ +|+|+
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 6899999999999999999999999984 55554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=269.42 Aligned_cols=187 Identities=22% Similarity=0.263 Sum_probs=153.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++||||.++.+..+.. ..+..++++.+..++.|++.||.| |++|||||||||+||++ +.++.+|++|||.+.
T Consensus 75 ~~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~--~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 75 KLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--NTEGAIKLADFGLAR 150 (298)
T ss_dssp EEEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSTTHHH
T ss_pred ceeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee--cccCcceeccCCcce
Confidence 4678999999876663322 456779999999999999999999 99999999999999999 777799999999997
Q ss_pred ecCCC-CCCccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 99 KINPD-HPPRVLFGTPEFIPPEIINYEPI-GIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 99 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
..... .......||+.|+|||.+....+ +.++|+||+||++|+|++|..||.+.+.......+.+....+.
T Consensus 151 ~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 151 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp HHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred eccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 76533 34445679999999999877665 8899999999999999999999998887776666543211111
Q ss_pred ------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 170 ------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 170 ------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
......++..+.+|+++||..||++|||++|+++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 11123567889999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-42 Score=269.44 Aligned_cols=183 Identities=22% Similarity=0.355 Sum_probs=150.6
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+|||||+|++|.+++. ..+.+++..+..++.|++.||.| |++||+||||||+||++ +..+.++++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll--~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTSCEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc--Cccccceeehhhhhh
Confidence 4789999999999998874 45678999999999999999999 99999999999999999 667789999999886
Q ss_pred ecCCCC----CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPDH----PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+......++.....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 654322 2334579999999999999999999999999999999999999999988888887777776666555556
Q ss_pred hcCHHHHHHHHHhhhhCcccCC-CHHHHhhccccc
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRL-TAKQCLSHLWIA 208 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rp-t~~~ll~h~~~~ 208 (239)
.+++.+.+|+.+||+.||++|| |++++ .|+|.+
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 7899999999999999999999 55655 466654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=267.34 Aligned_cols=183 Identities=20% Similarity=0.296 Sum_probs=153.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||++|+|.+++.. ..+..+++..+..++.||+.||.| |+++|+||||||+||++ +.++.+||+|||+++.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll--~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee--ecccceeeccccceEE
Confidence 3689999999999987754 334468889999999999999999 99999999999999999 7788999999999987
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......|++.|+|||.+.+..++.++||||+||++|+|++ |.+|+...+..+....+..+.....+ ..+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---ccC
Confidence 75432 2233568899999999998889999999999999999999 56666677777777777665433222 468
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh--cccccc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS--HLWIAQ 209 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~--h~~~~~ 209 (239)
+..+.+|+.+||+.||++|||++++++ ++||+.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 899999999999999999999999998 788864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-41 Score=268.47 Aligned_cols=177 Identities=16% Similarity=0.216 Sum_probs=143.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++||||++|+|.+++. ...+.+++..+..++.||+.||.| |+++++||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~iv~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl--~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKVSDFGLSRF 177 (299)
T ss_dssp CEEEEECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----
T ss_pred EEEEEEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE--CCCCcEEECCcccceE
Confidence 468899999999998875 446678999999999999999999 99999999999999999 7788999999999987
Q ss_pred cCCCCCCc------cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 100 INPDHPPR------VLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 100 ~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
........ ...||+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+..+.....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 255 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP-- 255 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC--
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 65432211 1347889999999999999999999999999999998 89999998888888877765433322
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..++..+.+|+.+||+.||++|||+++++++
T Consensus 256 -~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 -MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3678999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-41 Score=261.84 Aligned_cols=177 Identities=16% Similarity=0.238 Sum_probs=141.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||++|+|.+++. .....++++.+..++.|++.||.| |+++|+||||||+||++ +.++.+||+|||+++.
T Consensus 75 ~~lv~E~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRF 150 (263)
T ss_dssp CEEEEECCTTCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE--CGGGCEEECSCC----
T ss_pred eEEEEEecCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee--cCCCCeEecccchhee
Confidence 467899999999999875 345678889999999999999999 99999999999999999 7777999999999977
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....||+.|+|||.+.+..++.++||||+||++|+|++ |.+||.+.+..+....+..+.....+ ...
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~ 227 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLA 227 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTS
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---ccc
Confidence 654322 223568899999999999999999999999999999998 67777777777777777665443322 356
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
++.+.+|+.+||+.||++|||+++++++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 8999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-41 Score=266.37 Aligned_cols=180 Identities=19% Similarity=0.203 Sum_probs=142.4
Q ss_pred EEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTS 86 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~ 86 (239)
+|++||||++|+|.+++..... ...+++..+..++.||+.||.| |++||+||||||+||++ +.+
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--~~~ 170 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEK 170 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CGG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--CCC
Confidence 5788999999999999875432 3458889999999999999999 99999999999999999 677
Q ss_pred CcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHH
Q psy1096 87 HHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGENDSETFANIT 162 (239)
Q Consensus 87 ~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~i~ 162 (239)
+.+||+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|+|++| .+||.+.........+.
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999997654332 23345699999999999999999999999999999999985 67887766555544443
Q ss_pred hccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 163 RAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.....+.. ...+++.+.+++.+||+.||++|||++++++|
T Consensus 251 ~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33322221 14678999999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-40 Score=263.04 Aligned_cols=184 Identities=19% Similarity=0.234 Sum_probs=149.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++|||+.++.+..+. ...+.+++..+..++.||+.||+| |+.||+||||||+||++ +.++.+|++|||.+..
T Consensus 75 ~~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll--~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--NREGELKIADFGLARA 149 (286)
T ss_dssp EEEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCTTHHHH
T ss_pred eeEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE--cCCCCEEeccccccee
Confidence 45789999988887665 557889999999999999999999 99999999999999999 7778999999999887
Q ss_pred cCCCC-CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc--------
Q psy1096 100 INPDH-PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD-------- 169 (239)
Q Consensus 100 ~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 169 (239)
..... ......+++.|++||.+.+.. ++.++|+||+||++|+|++|..||.+.+..+...++......+.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 65433 233456899999999997654 58999999999999999999999998877777666543221111
Q ss_pred -----------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 -----------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 -----------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......++..+.+|+++||..||++|||++|+++||||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1112346889999999999999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=256.45 Aligned_cols=178 Identities=19% Similarity=0.254 Sum_probs=153.8
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|+||||+++|++.+++. .....+++..+..++.|++.||+| |+.||+||||||+||++ +.++.+||+|||++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill--~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSR 148 (258)
T ss_dssp SEEEEEECCTTEEHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE--CTTCCEEECCCSSCC
T ss_pred ceEEEEEccCCCcHHHhhh--ccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE--cCCCcEEECcchhhe
Confidence 3678899999999998875 445678888999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhh
Q psy1096 99 KINPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEA 175 (239)
Q Consensus 99 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 175 (239)
....... .....+|+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+..+.....+ ..
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~ 225 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HL 225 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TT
T ss_pred eccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---cc
Confidence 6554322 223568889999999999999999999999999999998 89999999988888888775443332 46
Q ss_pred cCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 176 LSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 176 ~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+..+.+|+++||+.||++|||++++++|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 78999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-40 Score=262.51 Aligned_cols=177 Identities=14% Similarity=0.187 Sum_probs=144.8
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++||||++|+|.+++.. .....+++..+..++.|++.||.| |++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl--~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE--CCCCcEEEccccceee
Confidence 4678999999999998865 456788999999999999999999 99999999999999999 6778999999999976
Q ss_pred cCCCCCC--ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHPP--RVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPF-MGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
....... ....|++.|+|||.+.+..++.++||||+||++|+|++|..|| .+.+.......+..+ ..++. ...+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~~--~~~~ 241 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER--PEGC 241 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCC--CTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCCC--Cccc
Confidence 6543221 2234788999999999999999999999999999999966655 444544444444443 22221 2468
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
++.+.+|+.+||+.||++|||++++++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=260.26 Aligned_cols=177 Identities=16% Similarity=0.188 Sum_probs=143.7
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||.+|++.+++. ...+.+++..+..++.|++.||.| |+++++||||||+||++ +..+.+||+|||++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll--~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRY 157 (273)
T ss_dssp CEEEEECCTTEEHHHHHH--HTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECC------
T ss_pred EEEEEEeccCCcHHhhhh--ccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee--cCCCcEEEccchhhee
Confidence 578999999999998765 456788999999999999999999 99999999999999999 6667899999999977
Q ss_pred cCCCCC--CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDHP--PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
...... .....||+.|+|||.+.+..++.++||||+||++|+|++ |.+||.+.+..+....+..+.....+ ..+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~ 234 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---PNC 234 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TTC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence 653322 233457889999999999999999999999999999997 89999999888888888776543222 468
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
+..+.+|+.+||+.||++|||+++++++
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=263.51 Aligned_cols=185 Identities=18% Similarity=0.193 Sum_probs=151.3
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++||||+++.+.... .....+++..++.++.|++.||.| |++||+||||||+||++ +.++.++++|||++.
T Consensus 91 ~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl--~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--TRDGVLKLADFGLAR 165 (318)
T ss_dssp CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred eEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee--cCCCcEEeeecceee
Confidence 368899999988877443 456788889999999999999999 99999999999999999 777899999999997
Q ss_pred ecCCC-----CCCccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPD-----HPPRVLFGTPEFIPPEIINYE-PIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 172 (239)
..... .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 65432 223335699999999999765 579999999999999999999999998887776666544332222111
Q ss_pred ----------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 173 ----------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 173 ----------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
....++.+.+|+++||+.||++|||++|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 0123677889999999999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=268.32 Aligned_cols=187 Identities=27% Similarity=0.370 Sum_probs=152.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|++|||+.+++|.+++. .++.+.+..+..++.|++.||.| |+.|++||||||+||++ +.+|.++|+|||++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill--~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee--cCCCCEEEeeccchh
Confidence 5678899999999999884 45567788899999999999999 99999999999999999 777899999999987
Q ss_pred ecCCC--CCCccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 99 KINPD--HPPRVLFGTPEFIPPEIINYEP--IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 99 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
..... .......|++.|++||.+.+.. ++.++||||+||++|+|++|..||.+.+.......+.............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 76432 2234467999999999997654 5789999999999999999999998776655555444432222222223
Q ss_pred hcCHHHHHHHHHhhhhCcccCC-----CHHHHhhccccccCC
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRL-----TAKQCLSHLWIAQKD 211 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rp-----t~~~ll~h~~~~~~~ 211 (239)
.+++.+.+|+++||++||++|| |++|+++||||++..
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 6899999999999999999999 589999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-40 Score=258.24 Aligned_cols=185 Identities=18% Similarity=0.233 Sum_probs=149.0
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+|||||.+|++..++.. ..++.+++..+..++.||+.||+| |+.|++||||||+||++ +.++.+||+|||++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll--~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE--CCCCcEEEcccchhhh
Confidence 3689999999999988765 334568999999999999999999 99999999999999999 6678999999999976
Q ss_pred cCCCC--CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 100 INPDH--PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 100 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... ......||+.|+|||.+....++.++||||+||++|+|++| .+|+.+....+....+........ ...+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~---~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---Cccc
Confidence 64332 22235688999999999999999999999999999999994 555666666667776665533222 2468
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhh--ccccccCC
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLS--HLWIAQKD 211 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~--h~~~~~~~ 211 (239)
+..+.+|+.+||+.||++|||++++++ ++||+...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999999987 88997644
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-39 Score=260.17 Aligned_cols=186 Identities=20% Similarity=0.272 Sum_probs=149.0
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++||||.+++|..+. ..+++..++.++.||+.||.| |++||+||||||+|||++.+ ++.++++|||++.
T Consensus 106 ~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~-~~~vkl~DFG~a~ 178 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE-HRKLRLIDWGLAE 178 (328)
T ss_dssp SEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TTEEEECCGGGCE
T ss_pred ceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCC-CCeeeecccccce
Confidence 367789999999998653 468899999999999999999 99999999999999999433 3469999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhc------------
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSE-TFANITRA------------ 164 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~-~~~~i~~~------------ 164 (239)
............+|+.|+|||.+.+.. ++.++|+||+||++++|++|..||....... ....+...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 877666666778999999999987654 6999999999999999999999997654322 22221110
Q ss_pred -cCC--------------------CchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCCC
Q psy1096 165 -EFD--------------------FDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKDS 212 (239)
Q Consensus 165 -~~~--------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~~ 212 (239)
... ........+++++.+|+++||..||++|||++|+|+||||+...+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 011112346889999999999999999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=261.84 Aligned_cols=182 Identities=21% Similarity=0.301 Sum_probs=150.7
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.+|++|||| +.++..+. .++.+++..+..++.|++.||.| |++||+||||||+||++ +.++.++++|||.+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc--cccccccccccccee
Confidence 458999999 45555554 34579999999999999999999 99999999999999999 778899999999998
Q ss_pred ecCCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-----
Q psy1096 99 KINPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA----- 172 (239)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----- 172 (239)
..... .....||+.|+|||.+.+.. ++.++||||+||++|+|++|..||.+.+....+..+......++...
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 76543 34567999999999997654 58999999999999999999999998887776666554333322211
Q ss_pred ----------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 173 ----------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 173 ----------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...+++.+.+|+++||..||++|||++++|+||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 12457889999999999999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=261.13 Aligned_cols=182 Identities=24% Similarity=0.293 Sum_probs=146.2
Q ss_pred eeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceecC
Q psy1096 23 SSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKIN 101 (239)
Q Consensus 23 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~~ 101 (239)
++|+|+.|++|.+++. .+.+++..++.++.|++.||.| |++||+||||||+||++ +..+.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE--CCCCCEEEcccCceeecc
Confidence 3345677889998874 2368999999999999999999 99999999999999999 777899999999987654
Q ss_pred CCC----CCccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCc-------
Q psy1096 102 PDH----PPRVLFGTPEFIPPEIINY-EPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFD------- 169 (239)
Q Consensus 102 ~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 169 (239)
... ......||+.|+|||.+.. ..++.++||||+||++++|++|..||.+.+..............+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 322 2344569999999999854 4568999999999999999999999988776555444322211111
Q ss_pred --------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 170 --------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 170 --------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
......+++.+.+|+.+||+.||++|||++++|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 12223567889999999999999999999999999999853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=261.14 Aligned_cols=184 Identities=21% Similarity=0.234 Sum_probs=143.1
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccc
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLA 97 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~ 97 (239)
...|++||||.++.+..+ ...+++..++.++.|++.||.| |+.||+||||||+||++ +.++.++++|||++
T Consensus 95 ~~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~--~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLA 166 (355)
T ss_dssp CEEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC-
T ss_pred ceeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc--ccccceeeechhhh
Confidence 467899999988776633 4568899999999999999999 99999999999999999 66778999999998
Q ss_pred eecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchH------
Q psy1096 98 QKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDE------ 171 (239)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------ 171 (239)
.............+|+.|+|||.+.+..++.++||||+||++++|++|.+||.+.+.......+..........
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 87766655666779999999999999999999999999999999999999999887766665554322221111
Q ss_pred --------------------------------HHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 172 --------------------------------AFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 172 --------------------------------~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
.....++.+.+|+++||..||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 112346678999999999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-39 Score=255.21 Aligned_cols=179 Identities=18% Similarity=0.206 Sum_probs=152.5
Q ss_pred EEEeeCccCCCCccchhhhhhhc-------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKA-------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
.+|+|||||.+|+|.+++..... ...+++..+..++.|++.||+| |+++||||||||+||++ +.
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--~~ 170 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TE 170 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CT
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--cC
Confidence 35678999999999999975432 3568999999999999999999 99999999999999999 77
Q ss_pred CCcEEEEecccceecCCCC---CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q psy1096 86 SHHIKIIDFGLAQKINPDH---PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANI 161 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i 161 (239)
++.+||+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.......+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 7899999999988765432 2333568889999999999999999999999999999998 79999888887777776
Q ss_pred HhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 162 TRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
..+.....+ ..+++.+.+|+.+||+.||++|||++++++
T Consensus 251 ~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 251 KEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 655332222 467899999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=252.43 Aligned_cols=176 Identities=15% Similarity=0.198 Sum_probs=140.6
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++||||.++++.+++. ...+.+++..+..++.|++.||.| |+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl--~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEEECCTTEEHHHHHH--HTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC---
T ss_pred eEEEEEecccCcchhhhh--cccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE--CCCCeEEEcccchhhc
Confidence 467899999999998775 445678899999999999999999 99999999999999999 7788999999999977
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....||+.|+|||.+.+..++.++||||+||++|+|++| .+|+.+.+..+....+..+.....+ .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~---~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---M 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc---h
Confidence 643321 1224578899999999999999999999999999999995 5555666666666666554332222 3
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+|+.+||..||++|||+.++++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 57899999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=256.87 Aligned_cols=177 Identities=18% Similarity=0.192 Sum_probs=149.7
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+++++|+.+++|.+++. .....+++..+..++.||+.||.| |++||+||||||+||++ +.++.+||+|||++...
T Consensus 86 ~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll--~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHH--HTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCccccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee--CCCCCeEeeccccceec
Confidence 46788999999988776 456788999999999999999999 99999999999999999 66779999999999876
Q ss_pred CCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhc
Q psy1096 101 NPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEAL 176 (239)
Q Consensus 101 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (239)
..... .....||+.|+|||.+.+..++.++||||+||++|+|+| |.+||.+.+..+....+..+.....+ ..+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p---~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC---TTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---ccc
Confidence 54332 223458999999999999999999999999999999998 89999988888877777665533222 367
Q ss_pred CHHHHHHHHHhhhhCcccCCCHHHHhhcc
Q psy1096 177 SEDAKDFISSLLVKRKEKRLTAKQCLSHL 205 (239)
Q Consensus 177 ~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~ 205 (239)
+..+.+|+.+||..||.+|||+.++++|.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 89999999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-39 Score=256.79 Aligned_cols=180 Identities=16% Similarity=0.193 Sum_probs=152.1
Q ss_pred EEEeeCccCCCCccchhhhhh-------------hcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCC
Q psy1096 20 ITWSSPPYDGGCMITGYVVEM-------------KAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRT 85 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~ 85 (239)
..|+|||||++|+|.+++... .....+++..+..++.||+.||.| |+++++||||||+|||+ +.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~--~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE--cC
Confidence 457899999999999998643 235788999999999999999999 99999999999999999 66
Q ss_pred CCcEEEEecccceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHhc
Q psy1096 86 SHHIKIIDFGLAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGENDSETFANITRA 164 (239)
Q Consensus 86 ~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~i~~~ 164 (239)
.+.+||+|||++.............||..|+|||.+.+..++.++|||||||++|+|++| .+||.+.+..+....+..+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 778999999998766544444455689999999999999999999999999999999995 5678888888888877665
Q ss_pred cCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 165 EFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.....+ ..+++.+.+|+.+||+.||++|||+++++++
T Consensus 243 ~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332221 4689999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=252.64 Aligned_cols=177 Identities=18% Similarity=0.215 Sum_probs=150.3
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|++||||+++++.+++. ...+.+++..+..++.|++.||.| |++||+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll--~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRA 160 (273)
T ss_dssp CEEEEECCTTCBHHHHHH--HHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCEE
T ss_pred hheeeeeecCcchhhhhh--cccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc--ccccceeeccchhhhh
Confidence 367899999999998776 345678999999999999999999 99999999999999999 5567899999999988
Q ss_pred cCCCCC----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHh
Q psy1096 100 INPDHP----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFE 174 (239)
Q Consensus 100 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 174 (239)
...... .....++..|+|||.+.+..++.++||||+||++|+|++ |..||.+.+..+....+.+....++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~ 238 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 238 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cc
Confidence 754432 223457788999999999999999999999999999998 89999999999988888777654432 24
Q ss_pred hcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 175 ALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 175 ~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.++..+.+|+.+||..||++|||++++++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67899999999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=256.37 Aligned_cols=181 Identities=27% Similarity=0.304 Sum_probs=147.8
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+++|+|+.|++|.+++. .+.+++..+..++.||+.||.| |++||+||||||+||++ +.+|.++++|||.+...
T Consensus 98 ~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi--~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARHT 171 (348)
T ss_dssp CEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCC----CC
T ss_pred EEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc--cccccccccccchhccc
Confidence 45567888999998873 4569999999999999999999 99999999999999999 77789999999998655
Q ss_pred CCCCCCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccCCCchHH-------
Q psy1096 101 NPDHPPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMGENDSETFANITRAEFDFDDEA------- 172 (239)
Q Consensus 101 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------- 172 (239)
.. ......|++.|+|||.+.+.. ++.++||||+||++|+|++|..||.+.+.......+...........
T Consensus 172 ~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp TG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred Cc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 42 233456889999999987665 58999999999999999999999998887777776655443332211
Q ss_pred --------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccC
Q psy1096 173 --------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQK 210 (239)
Q Consensus 173 --------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~ 210 (239)
...+++.+.+|+++||+.||.+|||++|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 13468899999999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=247.24 Aligned_cols=176 Identities=12% Similarity=0.146 Sum_probs=144.9
Q ss_pred EEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.|+||||+++|+|.+++... ....+++..+..++.||+.||.| |+.+++||||||+||++ +.++.++++|||++..
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~--~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKE 152 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEECCCCC---
T ss_pred EEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee--cCCCCEeeccccccee
Confidence 48899999999999998642 23357888999999999999999 99999999999999999 7788999999999876
Q ss_pred cCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhccCCCchHHHhhcCH
Q psy1096 100 INPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFANITRAEFDFDDEAFEALSE 178 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 178 (239)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+..+.....+ ..+++
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~ 227 (262)
T d1byga_ 153 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DGCPP 227 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC---TTCCH
T ss_pred cCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCH
Confidence 5432 233457889999999998899999999999999999998 89999988888888887665332222 36789
Q ss_pred HHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 179 DAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 179 ~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
.+.+|+++||..||.+|||+.+++++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-38 Score=251.41 Aligned_cols=178 Identities=17% Similarity=0.194 Sum_probs=148.6
Q ss_pred EEeeCccCCCCccchhhhhhhc---------------------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA---------------------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPEN 78 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~n 78 (239)
.+++|||+++|+|.+++..... ...++...+..++.|++.||+| |++++|||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 4578999999999999864321 2347788899999999999999 99999999999999
Q ss_pred eEEecCCCCcEEEEecccceecCCC---CCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCc
Q psy1096 79 IMCVSRTSHHIKIIDFGLAQKINPD---HPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGEND 154 (239)
Q Consensus 79 ili~~~~~~~vkl~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~ 154 (239)
|++ +.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||+||++|+|++| .+||.+.+.
T Consensus 171 ILl--d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 171 CLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEE--CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999 67789999999998765432 223345688899999999999999999999999999999997 578888888
Q ss_pred hHHHHHHHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 155 SETFANITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+....+..+.....+ ..+++++.+|+.+||+.||++|||+.++++
T Consensus 249 ~e~~~~v~~~~~~~~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888888776643322 468899999999999999999999999965
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=247.43 Aligned_cols=185 Identities=18% Similarity=0.242 Sum_probs=148.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..+++++++.++.+..++ ..++.+++..+..++.|++.||+| |++||+||||||+||++ +..+.++++|||.+.
T Consensus 75 ~~~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli--~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--NRNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred ceeEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc--ccCCceeeeecchhh
Confidence 446789999999998776 456788899999999999999999 99999999999999999 667789999999998
Q ss_pred ecCCCC-CCccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhccCCCc------
Q psy1096 99 KINPDH-PPRVLFGTPEFIPPEIINYEP-IGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFDFD------ 169 (239)
Q Consensus 99 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~i~~~~~~~~------ 169 (239)
...... ......+++.|+|||.+.... ++.++||||+||++|+|++|..||.. .+..+....+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 876443 333445777899999987665 58999999999999999999988654 444444444433211111
Q ss_pred -------------------hHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhhcccccc
Q psy1096 170 -------------------DEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQ 209 (239)
Q Consensus 170 -------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~ 209 (239)
......++..+.+|+++||+.||.+|||++|+|+||||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1112346788999999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=247.63 Aligned_cols=179 Identities=22% Similarity=0.256 Sum_probs=149.3
Q ss_pred EEeeCccCCCCccchhhhhhh---------------cCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC
Q psy1096 21 TWSSPPYDGGCMITGYVVEMK---------------AGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR 84 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~ 84 (239)
.|++||||++|+|.+++.... ....+++..+..++.||+.||+| |+++++||||||+||++ +
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--~ 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--T 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--E
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--c
Confidence 467999999999999987543 23467888999999999999999 99999999999999999 6
Q ss_pred CCCcEEEEecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q psy1096 85 TSHHIKIIDFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLS-GLSPFMGENDSETFAN 160 (239)
Q Consensus 85 ~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~ 160 (239)
..+.++++|||.++....... .....||+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 677999999999987654332 223468899999999999999999999999999999998 7777877777666666
Q ss_pred HHhccCCCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 161 ITRAEFDFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 161 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
+......+... ...+..+.+|+.+||+.||.+|||++++++
T Consensus 260 ~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 260 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 65554433321 357899999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-37 Score=246.28 Aligned_cols=187 Identities=14% Similarity=0.119 Sum_probs=144.2
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEec-CCCCcEEEEecccc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVS-RTSHHIKIIDFGLA 97 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~-~~~~~vkl~dfg~~ 97 (239)
..|++|||++++.+. .+. ..++.+++..+..++.|++.||+| |++||+||||||+||+++. +.+..++++|||++
T Consensus 77 ~~~ivme~~~~~l~~-~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 77 YNVMVMELLGPSLED-LFN--FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEEEECCCCBHHH-HHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEEEcCCchhh-hhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 456789999766554 333 456789999999999999999999 9999999999999999843 34567999999999
Q ss_pred eecCCCCC--------CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hccC
Q psy1096 98 QKINPDHP--------PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSETFANIT---RAEF 166 (239)
Q Consensus 98 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~i~---~~~~ 166 (239)
........ .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.........+. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 87654321 234579999999999999999999999999999999999999998765544333322 1111
Q ss_pred -CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHH---Hhhcccccc
Q psy1096 167 -DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQ---CLSHLWIAQ 209 (239)
Q Consensus 167 -~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~---ll~h~~~~~ 209 (239)
.........+++.+.+|+..||..+|++||++++ +|+|+|.++
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 2223334568999999999999999999999874 577777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-37 Score=244.86 Aligned_cols=178 Identities=16% Similarity=0.183 Sum_probs=144.5
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..|+|||||++++|.+++. .....+....+..++.|++.||.| |+.+|+||||||+|||+ +.++.+||+|||++.
T Consensus 103 ~~~lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl--~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLAR 178 (311)
T ss_dssp EEEEEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECSSGGGC
T ss_pred ceEEEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE--CCCCCEEEecccchh
Confidence 4678999999999999875 455677778888999999999999 99999999999999999 778899999999997
Q ss_pred ecCCCCC-----CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhccCCCchHH
Q psy1096 99 KINPDHP-----PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMG-ENDSETFANITRAEFDFDDEA 172 (239)
Q Consensus 99 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~ 172 (239)
....... .....||+.|+|||.+....++.++||||||+++|+|++|..||.. .+..+....+..+.....+
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p-- 256 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-- 256 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC--
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence 7643321 1224588899999999999999999999999999999996666644 4444455555554433222
Q ss_pred HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 173 FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 173 ~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
..+++.+.+|+.+||..||++|||+++++++
T Consensus 257 -~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 257 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3678999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=243.52 Aligned_cols=178 Identities=14% Similarity=0.177 Sum_probs=150.5
Q ss_pred EEeeCccCCCCccchhhhhhhc-------CCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEE
Q psy1096 21 TWSSPPYDGGCMITGYVVEMKA-------GTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKII 92 (239)
Q Consensus 21 ~~~~~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~ 92 (239)
.|+|||||.+|+|.+++..... ...++...+..++.|++.||.| |+++|+||||||+|||+ +.++.+||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl--d~~~~~Kl~ 175 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIG 175 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--CTTCCEEEC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee--cCCceEEEe
Confidence 4678999999999998864321 1346778889999999999999 99999999999999999 778899999
Q ss_pred ecccceecCCCCC---CccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHhccCCC
Q psy1096 93 DFGLAQKINPDHP---PRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSG-LSPFMGENDSETFANITRAEFDF 168 (239)
Q Consensus 93 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~i~~~~~~~ 168 (239)
|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++| .+||.+.+..+....+.++....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999876543222 2234588999999999999999999999999999999997 68898888888888887765433
Q ss_pred chHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 169 DDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 169 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.+ ..++..+.+++.+||+.||++|||++++++
T Consensus 256 ~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc---ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 32 367899999999999999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-35 Score=233.14 Aligned_cols=181 Identities=13% Similarity=0.105 Sum_probs=143.4
Q ss_pred EEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecC---CCCcEEEEecc
Q psy1096 20 ITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSR---TSHHIKIIDFG 95 (239)
Q Consensus 20 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~---~~~~vkl~dfg 95 (239)
..|+||||+ +++|.+++. ..+..++...+..++.|++.||.| |++||+||||||+||+++.. ..+.++|+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~--~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHH--hhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence 457889999 567777765 445678999999999999999999 99999999999999999542 35689999999
Q ss_pred cceecCCCC--------CCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHhc
Q psy1096 96 LAQKINPDH--------PPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE---TFANITRA 164 (239)
Q Consensus 96 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~---~~~~i~~~ 164 (239)
+++...... ......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+..... ....+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 998764321 2234579999999999999999999999999999999999999998654432 23333322
Q ss_pred cC-CCchHHHhhcCHHHHHHHHHhhhhCcccCCCHHHHhh
Q psy1096 165 EF-DFDDEAFEALSEDAKDFISSLLVKRKEKRLTAKQCLS 203 (239)
Q Consensus 165 ~~-~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~ 203 (239)
.. .........+++.+.+++..|+..+|++||+.+.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22 2223333568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=234.43 Aligned_cols=180 Identities=18% Similarity=0.201 Sum_probs=135.9
Q ss_pred eEEEeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh--------hcccCCCCCCCCeEEecCCCCcE
Q psy1096 19 VITWSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS--------LVTVDPKILPENIMCVSRTSHHI 89 (239)
Q Consensus 19 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~--------~~ivH~dikp~nili~~~~~~~v 89 (239)
...|+|||||.+|+|.+++.. ..+++.....++.|++.||+| |+ .||+||||||+||++ +.++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCE
T ss_pred eEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCe
Confidence 357899999999999999853 257788888999999999999 96 599999999999999 777899
Q ss_pred EEEecccceecCCCC-----CCccccCCCCccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q psy1096 90 KIIDFGLAQKINPDH-----PPRVLFGTPEFIPPEIINYEP------IGIESDMWSIGVITYVLLSGLSPFMGEN----- 153 (239)
Q Consensus 90 kl~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~~g~~p~~~~~----- 153 (239)
||+|||++....... ......||+.|+|||.+.+.. ++.++||||+||++|+|++|..||....
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998765432 223457999999999987543 4678999999999999999988763211
Q ss_pred ---------c-hHHHHHHHhccCCCc--hHH-HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhc
Q psy1096 154 ---------D-SETFANITRAEFDFD--DEA-FEALSEDAKDFISSLLVKRKEKRLTAKQCLSH 204 (239)
Q Consensus 154 ---------~-~~~~~~i~~~~~~~~--~~~-~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h 204 (239)
. ......+......+. ... .......+.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 122222222222211 111 11223558899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-34 Score=234.42 Aligned_cols=188 Identities=20% Similarity=0.221 Sum_probs=138.7
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hh-hcccCCCCCCCCeEEecCCCC----cEEEEecc
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HS-LVTVDPKILPENIMCVSRTSH----HIKIIDFG 95 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~-~~ivH~dikp~nili~~~~~~----~vkl~dfg 95 (239)
+.+++++..+..............+.+..+..++.|++.||.| |+ .||+||||||+||+++.++.+ .++++|||
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg 177 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 177 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecc
Confidence 3445555555555445555777888999999999999999999 97 899999999999999654432 48999999
Q ss_pred cceecCCCCCCccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhccCCCc
Q psy1096 96 LAQKINPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIGVITYVLLSGLSPFMGENDSE------TFANITRAEFDFD 169 (239)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~------~~~~i~~~~~~~~ 169 (239)
.+..... ......||+.|+|||.+.+..++.++|+||+||++++|++|+.||....... ............+
T Consensus 178 ~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~ 255 (362)
T d1q8ya_ 178 NACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255 (362)
T ss_dssp TCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC
T ss_pred ccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCC
Confidence 9876543 2344679999999999999999999999999999999999999997543221 1111111000000
Q ss_pred hHH--------------------------------------HhhcCHHHHHHHHHhhhhCcccCCCHHHHhhccccccCC
Q psy1096 170 DEA--------------------------------------FEALSEDAKDFISSLLVKRKEKRLTAKQCLSHLWIAQKD 211 (239)
Q Consensus 170 ~~~--------------------------------------~~~~~~~~~~ll~~~l~~~p~~Rpt~~~ll~h~~~~~~~ 211 (239)
... ....++.+.+|+.+||..||.+|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 000 113467789999999999999999999999999998643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.48 E-value=6.8e-16 Score=113.75 Aligned_cols=100 Identities=13% Similarity=-0.009 Sum_probs=67.6
Q ss_pred EeeCccCCCCccchhhhhhhcCCCchHHHHHHHHHHHHHHHHH-hhhcccCCCCCCCCeEEecCCCCcEEEEecccceec
Q psy1096 22 WSSPPYDGGCMITGYVVEMKAGTQPWVELSERLFESTERGLGH-HSLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQKI 100 (239)
Q Consensus 22 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-h~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~~ 100 (239)
+++|||+++..+.++ ....+..++.|++.++++ |++||+||||||+||+++ . +.++++|||.+...
T Consensus 86 ~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--~-~~~~liDFG~a~~~ 152 (191)
T d1zara2 86 AVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--E-EGIWIIDFPQSVEV 152 (191)
T ss_dssp EEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--T-TEEEECCCTTCEET
T ss_pred EEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee--C-CCEEEEECCCcccC
Confidence 478899998776543 224456899999999999 999999999999999994 3 34899999998766
Q ss_pred CCCCCCccccCCCCccCccccccCCCCchhhHHHHH
Q psy1096 101 NPDHPPRVLFGTPEFIPPEIINYEPIGIESDMWSIG 136 (239)
Q Consensus 101 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 136 (239)
...........+... -.+ +..+.|+.++|+||+.
T Consensus 153 ~~~~~~~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 153 GEEGWREILERDVRN-IIT-YFSRTYRTEKDINSAI 186 (191)
T ss_dssp TSTTHHHHHHHHHHH-HHH-HHHHHHCCCCCHHHHH
T ss_pred CCCCcHHHHHHHHHH-HHH-HHcCCCCCcccHHHHH
Confidence 433211000000000 001 1235678889999965
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.79 E-value=0.0065 Score=46.25 Aligned_cols=32 Identities=16% Similarity=0.265 Sum_probs=26.0
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
..|+||+|+.++||++ +++...-+.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFF--LGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhc--ccccceeEeccccccc
Confidence 4689999999999999 5555668999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.99 E-value=0.025 Score=41.24 Aligned_cols=30 Identities=27% Similarity=0.265 Sum_probs=23.9
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
..++|+|+.|.||++ +.++.+.++||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~--~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMV--ENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred ceEEeCCCCCcceEE--eCCceEEEEEchhcc
Confidence 358999999999999 444456799998653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=91.59 E-value=0.042 Score=40.16 Aligned_cols=29 Identities=21% Similarity=0.252 Sum_probs=23.4
Q ss_pred cccCCCCCCCCeEEecCCCCcEEEEecccce
Q psy1096 68 VTVDPKILPENIMCVSRTSHHIKIIDFGLAQ 98 (239)
Q Consensus 68 ~ivH~dikp~nili~~~~~~~vkl~dfg~~~ 98 (239)
.++|+|+.|.||++ +.++.+.++||+.+.
T Consensus 184 ~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceee--cCCceEEEeechhcc
Confidence 48999999999999 555556799998653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.47 E-value=0.12 Score=39.30 Aligned_cols=29 Identities=17% Similarity=0.269 Sum_probs=22.7
Q ss_pred hcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 67 LVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 67 ~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
.++||+|+.+.||++ +++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~--~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILW--RDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEE--SSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEE--eCC--ceEEechhccc
Confidence 479999999999998 432 45889987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=86.24 E-value=0.47 Score=36.80 Aligned_cols=31 Identities=16% Similarity=0.174 Sum_probs=24.6
Q ss_pred hhcccCCCCCCCCeEEecCCCCcEEEEeccccee
Q psy1096 66 SLVTVDPKILPENIMCVSRTSHHIKIIDFGLAQK 99 (239)
Q Consensus 66 ~~~ivH~dikp~nili~~~~~~~vkl~dfg~~~~ 99 (239)
...++|||+.+.||++ +.+ .++++||..+..
T Consensus 222 ~~~LiHGDl~~gNIlv--~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFA--SEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEE--CSS-CEEECCCTTCEE
T ss_pred CcceeccCCcCCceeE--cCC-ceEEechhhccc
Confidence 3469999999999999 433 489999987644
|